Citrus Sinensis ID: 037623
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 749 | 2.2.26 [Sep-21-2011] | |||||||
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.950 | 0.808 | 0.486 | 0.0 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.943 | 0.806 | 0.479 | 0.0 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.955 | 0.840 | 0.475 | 0.0 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.958 | 0.823 | 0.455 | 0.0 | |
| O64483 | 876 | Senescence-induced recept | no | no | 0.947 | 0.810 | 0.462 | 0.0 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.959 | 0.807 | 0.446 | 0.0 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.961 | 0.800 | 0.442 | 1e-180 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.961 | 0.821 | 0.447 | 1e-179 | |
| C0LGG3 | 885 | Probable LRR receptor-lik | no | no | 0.955 | 0.809 | 0.435 | 1e-178 | |
| Q9FN93 | 887 | Probable LRR receptor-lik | no | no | 0.961 | 0.811 | 0.442 | 1e-175 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/777 (48%), Positives = 501/777 (64%), Gaps = 65/777 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
F+SIDCGIPE+++Y D T I YVSDA+ +++G H I EF E+QF N+RSFPEG
Sbjct: 31 FVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQFQNVRSFPEG 90
Query: 61 IRNCYTLKPDSDHE-KFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
RNCY +KP K+LIR RFMYGNY+ K P F+L L ++WDSV ++ +IV+K
Sbjct: 91 NRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTIDNATTIVTK 150
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EIIH + +++HVCLV+ + GTPF+SALE+R L + TY T SL + RWD+G
Sbjct: 151 EIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDSLILFKRWDLGGLGALP 210
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN--FQPPSTVMQSAVIPANGGSSLMLS 237
RY DDV+DRIW P F + + S + S N FQP VM +A P + ++ S
Sbjct: 211 VRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFS 270
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGK-LWYGPLSPSYLDTDTVFSTTP 296
W+P + K +VY +F+E E N+TR+ + +N K + SP YL TDT+F P
Sbjct: 271 WEPKDPTWKYFVYMHFAEV-VELPSNETREFKVLLNEKEINMSSFSPRYLYTDTLFVQNP 329
Query: 297 TMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISV 356
++ + + + T S LPPI+NA+E Y+V EFLQ T+QQDV
Sbjct: 330 -VSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDV---------------- 372
Query: 357 DAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPH 416
DAIM IKSKY + + W GDPCAP Y W+ +NCSY N++PRI S+NLSSSG+ GEI
Sbjct: 373 DAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAA 432
Query: 417 IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-------------------------- 450
+LT + LDLSNNSLTG +P+FL L L L
Sbjct: 433 FSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILL 492
Query: 451 -VDGNPNLCLSASC-----KGKKNKFIVPLLASVVSFSVLLAALAILRSLRRRKQELCPV 504
+DGNP+LC+SASC K KKN +I+PL+ASVV L+ A+A+ ++R +
Sbjct: 493 RIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYKKRHRRGGSG 552
Query: 505 G-KKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG 563
G + G L+ R Y+ V+K+TNNFERVLG+GGFG VYHG L+D QVAVK+LS SS QG
Sbjct: 553 GVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLNDDQVAVKILSESSAQG 612
Query: 564 YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAE 623
YK+F+AEVELL+R HHKNLT L+GYC E KM L+YEFMANG L +L +
Sbjct: 613 YKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYL----------SG 662
Query: 624 DKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
+K+ +LSW+ RLQI+ ++AQGLEYLH+GCKPPIV RDVK ANIL+NEK QAK+ADFGLSR
Sbjct: 663 EKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSR 722
Query: 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740
++G + +T V GT GYLDPEY+++ +L+EKSD+YSFGVVLLE+++GQPVI ++
Sbjct: 723 SVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARS 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/776 (47%), Positives = 500/776 (64%), Gaps = 69/776 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
F+SIDCGIPE+++Y D T I Y+SDA+ +++G H I S+F K+ E+QF +RSFPEG
Sbjct: 30 FVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTIHSIDSKFQKKNLEKQFQKVRSFPEG 89
Query: 61 IRNCYTLKPDSDHE-KFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
+NCY ++P K+LIR RFMYGNY+ K P F+L L ++WDSV +S +IV+K
Sbjct: 90 KKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGVNLWDSVTLENSTTIVTK 149
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EII+ + + +HVCLV+ + GTPF+S LELR L N Y T S SL Y RWD+G+T +
Sbjct: 150 EIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLKNNIYETASDSLMLYRRWDLGATGDLP 209
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMK--STGNFQPPSTVMQSAVIPANGG-SSLML 236
RY DD++DR W P F ++ ++TS + S+ F PPS VM +AV P N +M+
Sbjct: 210 ARYKDDIFDRFWMPLMFPNFLILNTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMV 269
Query: 237 SWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKL--WYGPLSPSYLDTDTVFST 294
W+P + K Y+Y +F+E E + N+TR+ ++++N + PSYL TDT++
Sbjct: 270 YWEPRDPNWKFYIYIHFAEVE-KLPSNETREFSVFLNKEQIDTTSVFRPSYLYTDTLYVQ 328
Query: 295 TPTMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKI 354
P ++ + ++ S PPI+NA+E Y+ EFL L T+Q DV
Sbjct: 329 NP-VSGPFLEFVLRQGVKSTRPPIMNAIETYRTNEFLDLPTDQNDV-------------- 373
Query: 355 SVDAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEIL 414
DAIM IK+KY++ ++W GDPCAP Y WQG+NCSY AN PRI S+NLS SG+ G+I
Sbjct: 374 --DAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRIISVNLSFSGLTGQID 431
Query: 415 PHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL------------------------ 450
P +LT ++ LDLSNN LTG+VP+FLA L L L
Sbjct: 432 PVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSL 491
Query: 451 ---VDGNPNLCLSASCKGKKNK---FIVPLLASVVSFSVLLAALAILRSLRRRKQELCPV 504
V GNP+LC+S SC+ KK + +I+P +ASV LL AL ++R+Q +
Sbjct: 492 SLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQQSV--- 548
Query: 505 GKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGY 564
K G L+ K R Y+ +++ITNNFERVLG+GGFG VY+G L +QVA+KMLS SS QGY
Sbjct: 549 -KTGPLDTK-RYYKYSEIVEITNNFERVLGQGGFGKVYYGVLRGEQVAIKMLSKSSAQGY 606
Query: 565 KQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAED 624
K+F+AEVELL+R HHKNL L+GYC E +M L+YE++ NG L +L +
Sbjct: 607 KEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGK---------- 656
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
+ ILSW+ RLQI+ ++AQGLEYLH+GCKPPIVHRDVK NIL+NEK QAK+ADFGLSR
Sbjct: 657 NSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRS 716
Query: 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740
F +EG S VST V GT GYLDPE+Y + +EKSDVYSFGVVLLE+ITGQPVI ++
Sbjct: 717 FTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/786 (47%), Positives = 493/786 (62%), Gaps = 70/786 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCGIP ++Y D TGINYVSD+S ++TGVS I +RQ NLRSFPEG
Sbjct: 31 FISIDCGIPSGSSYKDDTTGINYVSDSSFVETGVSKSIPF-----TAQRQLQNLRSFPEG 85
Query: 61 IRNCYTLKP-DSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
RNCYTL P +K+LIRA FMYGNY+G++ P F+L L ++WD+V + SIVSK
Sbjct: 86 SRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSPEFDLFLGGNIWDTVLLSNGSSIVSK 145
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPL--PNLTYMTQSGSLSRYGRWDVGSTTN 177
E++++ + E I VCL N GTPFIS LELR L N TY + +G+L RWD+ S
Sbjct: 146 EVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGNDNTTYDSPNGALFFSRRWDLRSLMG 205
Query: 178 KTFRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN-FQPPSTVMQSAVIPANGGSSLML 236
RY DDVYDRIW P NF +I+TS + S N + S VM +A+ P N + +
Sbjct: 206 SPVRYDDDVYDRIWIPRNFGYCREINTSLPVTSDNNSYSLSSLVMSTAMTPINTTRPITM 265
Query: 237 SWKPANRMIKNYVYFYFSEFESERAK-NQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTT 295
+ + ++ ++ +VY +F+E E K NQTR+ +I ING SP YL T+T F
Sbjct: 266 TLENSDPNVRYFVYMHFAEVEDLSLKPNQTREFDISINGVTVAAGFSPKYLQTNTFFLNP 325
Query: 296 PTMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKIS 355
+ ++ ++ T S LPPI+NALEIY F Q LTNQ+D
Sbjct: 326 ESQSKIAFSLV--RTPKSTLPPIVNALEIYVANSFSQSLTNQEDG--------------- 368
Query: 356 VDAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILP 415
DA+ ++K+ Y++ ++W GDPC PNDY+W+GLNCSYD+ PRI SLNLSSSG+ G I
Sbjct: 369 -DAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRITSLNLSSSGLTGHISS 427
Query: 416 HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL------------------------- 450
+LT I+ LDLSNN LTG +PEFL++L+FLRVL
Sbjct: 428 SFSNLTMIQELDLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTGSVPSELLERSNTGSFS 487
Query: 451 --VDGNPNLCLSASC-KGKKNKFIVPLLASVVSFSVLLAALAILRSLRRRKQELCPVGKK 507
+ NP LC SC K K ++PL+AS + +LL + +R R+ + +
Sbjct: 488 LRLGENPGLCTEISCRKSNSKKLVIPLVASFAALFILLLLSGVFWRIRNRRNKSVNSAPQ 547
Query: 508 GSLELKNRK---LSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGY 564
S K+ ++A+V+K+TNNF +VLGKGGFGTVYHG+ D+ QVAVK+LS +S QG+
Sbjct: 548 TSPMAKSENKLLFTFADVIKMTNNFGQVLGKGGFGTVYHGFYDNLQVAVKLLSETSAQGF 607
Query: 565 KQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAED 624
K+F++EVE+L+R HH NLT L+GY E +MGL+YEFMANGN+ HL +
Sbjct: 608 KEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLAGKYQ-------- 659
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
LSW+ RLQIA ++AQGLEYLH GCKPPIVHRDVK++NILLNEK +AKLADFGLSR
Sbjct: 660 --HTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSRS 717
Query: 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT-PER 743
F E SHVST V GTPGYLDP + +N L EKSD+YSFGVVLLE+ITG+ VI+++ +R
Sbjct: 718 FHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIKESQTKR 777
Query: 744 TLIGQW 749
+ W
Sbjct: 778 VHVSDW 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/782 (45%), Positives = 490/782 (62%), Gaps = 64/782 (8%)
Query: 1 FISIDCG-IPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG +P+NA YT+ T I Y SDA+ ID+G+ +IS+E+ ++ ++ ++ +RSFPE
Sbjct: 29 FISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEYKAQLQQQTWT-VRSFPE 87
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G RNCY + ++LIRA F YGNY+G + P F++ + W SV+ G+
Sbjct: 88 GERNCYNFNLTA-KSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTSVKLDGVGNGAVL 146
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
E+IH+ ++ + +CLV T G PFIS+LELRPL N TY+TQSGSL + R S T
Sbjct: 147 EMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQSGSLIGFARV-FFSATPTF 205
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWK 239
RY +D++DR+W IST + ++ + P V ++A +P+N L+ W
Sbjct: 206 IRYDEDIHDRVWVRQFGNGLKSISTDLLVDTSNPYDVPQAVAKTACVPSNASQPLIFDWT 265
Query: 240 PANRMIKNYVYFYFSEFESERAKNQTRDLNI-YINGKLWYGPLSPSYLDTDTVFSTTPTM 298
N ++YVY +F+E ++ + N R+ NI Y G+ Y L P + T+F + P
Sbjct: 266 LDNITSQSYVYMHFAEIQTLK-DNDIREFNITYNGGQNVYSYLRPEKFEISTLFDSKPLS 324
Query: 299 NRD-RHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
+ D + T NS LPP++N LEIY+V + L+L T+Q +V
Sbjct: 325 SPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLELETDQDEV----------------S 368
Query: 358 AIMNIKSKYELLR--DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILP 415
A++NIK+ Y+L + WQGDPCAP Y W+GLNCSY + PRI SLNL+ + + G I P
Sbjct: 369 AMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAENKLTGTITP 428
Query: 416 HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSASC------------ 463
I LT + LDLS N L+G +PEF A+++ L+ L++ + NL L+++
Sbjct: 429 EISKLTQLIELDLSKNDLSGEIPEFFADMKLLK-LINLSGNLGLNSTIPDSIQQRLDSKS 487
Query: 464 ---------------KGKKNKF-IVPLLASVVSFSVLLAALAILRSLRRRKQELCPVGKK 507
KGK K ++P++ASV LL LAI +RR+ E G
Sbjct: 488 LILILSKTVTKTVTLKGKSKKVPMIPIVASVAGVFALLVILAIFFVVRRKNGE-SNKGTN 546
Query: 508 GSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQF 567
S+ K R+++Y VLK+TNNFERVLGKGGFGTVYHG L+D QVAVKMLS SS QGYK+F
Sbjct: 547 PSIITKERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLEDTQVAVKMLSHSSAQGYKEF 606
Query: 568 QAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG 627
+AEVELL+R HH+NL LVGYCD+ + L+YE+MANG+L+ ++ +
Sbjct: 607 KAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENM---------SGKRGGN 657
Query: 628 ILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687
+L+W+ R+QIA E+AQGLEYLH+GC PP+VHRDVK+ NILLNE++ AKLADFGLSR FPV
Sbjct: 658 VLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPV 717
Query: 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIG 747
+G SHVST V GTPGYLDPEYY +N L+EKSDVYSFGVVLLE++T QPV KT ERT I
Sbjct: 718 DGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRERTHIN 777
Query: 748 QW 749
+W
Sbjct: 778 EW 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/772 (46%), Positives = 475/772 (61%), Gaps = 62/772 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCGIP++++Y D TGI YVSD++ +D+G + +I+++F +R N+RSFP+
Sbjct: 30 FISIDCGIPDDSSYNDETTGIKYVSDSAFVDSGTTKRIAAQFQSSGFDRHLLNVRSFPQS 89
Query: 61 IRNCYTL-KPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
R+CY + P K+LIR RFMYGNY+ + P F+L L + WDSV+ D+ +I++K
Sbjct: 90 KRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDLYLGVNFWDSVKLDDATTILNK 149
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EII IP + + VC+V+ ++GTPF+S LE+R L N TY T +L+ R D T
Sbjct: 150 EIITIPLLDNVQVCVVDKNAGTPFLSVLEIRLLLNTTYETPYDALTLLRRLDYSKTGKLP 209
Query: 180 FRYPDDVYDRIWFPHNFYSWAQI---STSSNMKSTGNFQPPSTVMQSAVIPANGGSSLML 236
RY DD+YDRIW P S +I S + + +QP STVM +A N L L
Sbjct: 210 SRYKDDIYDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQPASTVMSTAETARNESLYLTL 269
Query: 237 SWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTP 296
S++P + K YVY +F+E E ++ NQTR+ +I++N + YL TDT + P
Sbjct: 270 SFRPPDPNAKFYVYMHFAEIEVLKS-NQTREFSIWLNEDVISPSFKLRYLLTDTFVTPDP 328
Query: 297 TMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISV 356
+ ++ LPPI+NALE+YQV EFLQ+ T+ QDV
Sbjct: 329 VSGITINFSLLQPPGEFVLPPIINALEVYQVNEFLQIPTHPQDV---------------- 372
Query: 357 DAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNC-SYDANQAPRIKSLNLSSSGIAGEILP 415
DA+ IK+ Y + ++WQGDPC P DY W+G++C D PR+ SLN+S S + G+I P
Sbjct: 373 DAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLNISFSELRGQIDP 432
Query: 416 HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGN-------------------- 454
+LTSI LDLS N+LTG +P FLA L L L V+GN
Sbjct: 433 AFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQRLHERSKNGSLS 492
Query: 455 ------PNLCLSASCKG--KKNK-FIVPLLASVVSFSVLLAALAILRSLRRRKQELCPVG 505
P+LCLS SC KKNK + L V VLL ALA+ R ++++Q
Sbjct: 493 LRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLTALALFRRFKKKQQRGTLGE 552
Query: 506 KKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYK 565
+ G L+ R Y+ V+ ITNNFERV+GKGGFG VYHG ++ +QVAVK+LS S QGYK
Sbjct: 553 RNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHGVINGEQVAVKVLSEESAQGYK 612
Query: 566 QFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDK 625
+F+AEV+LLMR HH NLT LVGYC+E M L+YE+MAN NL +L A +
Sbjct: 613 EFRAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYL----------AGKR 662
Query: 626 TGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685
+ ILSW+ RL+I+ ++AQGLEYLH+GCKPPIVHRDVK NILLNEK QAK+ADFGLSR F
Sbjct: 663 SFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSF 722
Query: 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 737
VEG +ST V G+ GYLDPEYY + ++ EKSDVYS GVVLLE+ITGQP I
Sbjct: 723 SVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAI 774
|
Involved in innate immune response of plants. Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 639 bits (1649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/799 (44%), Positives = 489/799 (61%), Gaps = 80/799 (10%)
Query: 1 FISIDCG-IPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG +P+ YT+ T I Y SD ID+G+ KI+ + + ++Q +RSFP
Sbjct: 29 FISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQF-QQQVWAVRSFPV 87
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G RNCY + +++ K+LIR F+YGNY+G ++ PSF+L + + W SV+ +
Sbjct: 88 GQRNCYNVNLTANN-KYLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNTSMH 146
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EIIH+ ++ + VCLV T TPFIS+LE+RPL N +Y+TQSGSL + R S+++
Sbjct: 147 EIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLTQSGSLMLFARVYFPSSSSSF 206
Query: 180 FRYPDDVYDRIW--FPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLS 237
RY +D++DR+W F + W IST + ++ ++ P +VM++A +P N +L
Sbjct: 207 IRYDEDIHDRVWNSFTDDETVW--ISTDLPIDTSNSYDMPQSVMKTAAVPKNASEPWLLW 264
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKL-WYGPLSPSYLDTDTVFSTTP 296
W ++YVY +F+E ++ A N+TR+ NI NG L W+ L P L T+F+
Sbjct: 265 WTLDENTAQSYVYMHFAEVQNLTA-NETREFNITYNGGLRWFSYLRPPNLSISTIFNPRA 323
Query: 297 TMNRDR-HDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKIS 355
+ + + T NS LPP+LNALEIY V + LQL TN+ +V
Sbjct: 324 VSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKDEV--------------- 368
Query: 356 VDAIMNIKSKYELLR--DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEI 413
A+MNIK Y L + WQGDPCAP Y W+GLNCSY ++ RI SLNL+ S + G I
Sbjct: 369 -SAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGSI 427
Query: 414 LPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNLCLSA----------- 461
I LT + LDLSNN L+G +P F AE++ L+++ + GNPNL L+A
Sbjct: 428 TSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNS 487
Query: 462 -----------SCKGKKNKFIVPLLA---SVVSFSVLLAALAILRSLRRRKQELC----- 502
+ KK VP++A SV LL LAI ++R+ +
Sbjct: 488 KSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRKNVKAHKSPGP 547
Query: 503 -PVGKKG-----------SLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQ 550
P+ G S+ + RK++Y VLK+TNNFERVLGKGGFGTVYHG LD +
Sbjct: 548 PPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNLDGAE 607
Query: 551 VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAH 610
VAVKMLS SS QGYK+F+AEVELL+R HH++L LVGYCD+ + L+YE+MANG+L+ +
Sbjct: 608 VAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLREN 667
Query: 611 LLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670
+ + +L+W+ R+QIA E+AQGLEYLH+GC+PP+VHRDVK+ NILLNE
Sbjct: 668 M---------SGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNE 718
Query: 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
+ AKLADFGLSR FP++G HVST V GTPGYLDPEYY +N L+EKSDVYSFGVVLLE+
Sbjct: 719 RCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEI 778
Query: 731 ITGQPVIQKTPERTLIGQW 749
+T QPVI KT ER I W
Sbjct: 779 VTNQPVIDKTRERPHINDW 797
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1634), Expect = e-180, Method: Compositional matrix adjust.
Identities = 355/803 (44%), Positives = 489/803 (60%), Gaps = 83/803 (10%)
Query: 1 FISIDCG-IPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG +P Y D TG+ Y +D + +G + +I F + I + LR FP+
Sbjct: 33 FISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQKAF-ESIFSKPSLKLRYFPD 91
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G RNCYTL D +LI+A F+YGNY+G + PPSF+L L ++W +V + +
Sbjct: 92 GFRNCYTLNVTQD-TNYLIKAVFVYGNYDGLNNPPSFDLYLGPNLWVTVDMNGRTNGTIQ 150
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EIIH + + VCLV T + +P I+ LELRPL N TY TQSGSL + R+ S + +
Sbjct: 151 EIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQSGSLKYFFRYYF-SGSGQN 209
Query: 180 FRYPDDVYDRIWFPH-NFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSW 238
RYPDDV DR W+P + W +++T+ N+ S+ + PP VM SA P + + SW
Sbjct: 210 IRYPDDVNDRKWYPFFDAKEWTELTTNLNINSSNGYAPPEVVMASASTPISTFGTWNFSW 269
Query: 239 KPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTM 298
+ + YVY +F+E ++ R+ + TR+ + +NGKL Y SP L T+T+F +TP
Sbjct: 270 LLPSSTTQFYVYMHFAEIQTLRSLD-TREFKVTLNGKLAYERYSPKTLATETIFYSTPQQ 328
Query: 299 NRDRHDII-INTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
D ++ + T S LPP++NALE++ V +F Q+ TN DV
Sbjct: 329 CEDGTCLLELTKTPKSTLPPLMNALEVFTVIDFPQMETNPDDVA---------------- 372
Query: 358 AIMNIKSKYELLR-DWQGDPCAPNDYLWQGLNCS-YDANQAPRIKSLNLSSSGIAGEILP 415
AI +I+S Y L + WQGDPC P +LW+GLNC+ D + P + SLNLSSS + G I
Sbjct: 373 AIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDNSTPPIVTSLNLSSSHLTGIIAQ 432
Query: 416 HIFSLTSIESLDLSNNSLTGSVPEFLAELQFL------------------------RVLV 451
I +LT ++ LDLSNN+LTG +PEFLA+++ L ++++
Sbjct: 433 GIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNNFNGSIPQILLQKKGLKLIL 492
Query: 452 DGNPNL------CLSASCKG--KKNKFIVPLLASVVSFSVLLAALAILRSLR----RRKQ 499
+GN NL C++ + G KK ++P++ASV VL +ALA + Q
Sbjct: 493 EGNANLICPDGLCVNKAGNGGAKKMNVVIPIVASVAFVVVLGSALAFFFIFKKKKTSNSQ 552
Query: 500 ELCPVG------------KKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLD 547
+L P + ++ KNR+ +Y+ V+ +TNNFERVLGKGGFG VYHG ++
Sbjct: 553 DLGPSSYTQVSEVRTIRSSESAIMTKNRRFTYSEVVTMTNNFERVLGKGGFGMVYHGTVN 612
Query: 548 D-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606
+ +QVAVKMLS SS QGYK+F+AEVELL+R HHKNL LVGYCDE + L+YE+MANG+
Sbjct: 613 NTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLALIYEYMANGD 672
Query: 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666
L+ H+ + IL+W+ RL+I ESAQGLEYLH+GCKPP+VHRDVK+ NI
Sbjct: 673 LREHM---------SGKRGGSILNWETRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNI 723
Query: 667 LLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVV 726
LLNE AKLADFGLSR FP+EG +HVST V GTPGYLDPEYY +N L EKSDVYSFG+V
Sbjct: 724 LLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIV 783
Query: 727 LLELITGQPVIQKTPERTLIGQW 749
LLE+IT Q VI ++ E+ I +W
Sbjct: 784 LLEIITNQLVINQSREKPHIAEW 806
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 630 bits (1624), Expect = e-179, Method: Compositional matrix adjust.
Identities = 353/788 (44%), Positives = 476/788 (60%), Gaps = 68/788 (8%)
Query: 1 FISIDCG-IPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG +P Y + T I Y SDA+ ID+GV KI+ + + ++Q LRSFPE
Sbjct: 25 FISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPGKINEVYRTQF-QQQIWALRSFPE 83
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G RNCY + K+LIR F+YGNY+G ++ PSF+L + + W SV P +
Sbjct: 84 GQRNCYNFSLTA-KRKYLIRGTFIYGNYDGLNQLPSFDLYIGPNKWTSVSIPGVRNGSVS 142
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
E+IH+ +++++ +CLV T TPFIS+LELRPL N TY+T+SGSL R S T
Sbjct: 143 EMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYVTKSGSLIVVARLYF-SPTPPF 201
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWK 239
RY +DV+DRIW P + +ST ++ ++ + P TV ++A +P N L ++W
Sbjct: 202 LRYDEDVHDRIWIPFLDNKNSLLSTELSVDTSNFYNVPQTVAKTAAVPLNATQPLKINWS 261
Query: 240 PANRMIKNYVYFYFSEFESERAKNQTRDLNI-YINGKLWYGPLSPSYLDTDTVFSTTPTM 298
+ ++Y+Y +F+E E+ A N+TR+ NI Y G+ W+ P TV++
Sbjct: 262 LDDITSQSYIYMHFAEIENLEA-NETREFNITYNGGENWFSYFRPPKFRITTVYNPAAVS 320
Query: 299 NRDRH-DIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
+ D + + + T NS PP++N LEIYQV E QL T Q +V
Sbjct: 321 SLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQLDTYQDEV----------------S 364
Query: 358 AIMNIKSKYELLR--DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILP 415
A+MNIK+ Y L + WQGDPCAP Y W+GLNCSY P+I SLNLS S ++G I
Sbjct: 365 AMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLSGSNLSGTITS 424
Query: 416 HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNL----------------- 457
I LT + LDLSNN L+G +P ++++ L ++ + GN NL
Sbjct: 425 DISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPETLQKRIDNKSL 484
Query: 458 CLSASCKGKKNKFIVPLLASVVSFSVLLAALAILRSLRRRKQELCPVGKKGSL------- 510
L GK + +V + ASV S +L LAI+ + R+KQ S
Sbjct: 485 TLIRDETGKNSTNVVAIAASVASVFAVLVILAIVFVVIRKKQRTNEASGPRSFTTGTVKS 544
Query: 511 ---------ELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSV 561
K RK +Y+ VLK+T NFERVLGKGGFGTVYHG LDD QVAVKMLS SS
Sbjct: 545 DARSSSSSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNLDDTQVAVKMLSHSSA 604
Query: 562 QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTD 621
QGYK+F+AEVELL+R HH++L LVGYCD+ + L+YE+M G+L+ ++ + ++
Sbjct: 605 QGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSGKHSV---- 660
Query: 622 AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681
+LSW+ R+QIA E+AQGLEYLH+GC+PP+VHRDVK NILLNE+ QAKLADFGL
Sbjct: 661 -----NVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGL 715
Query: 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741
SR FPV+G SHV T V GTPGYLDPEYY +N L+EKSDVYSFGVVLLE++T QPV+ K
Sbjct: 716 SRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNR 775
Query: 742 ERTLIGQW 749
ER I +W
Sbjct: 776 ERPHINEW 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1610), Expect = e-178, Method: Compositional matrix adjust.
Identities = 348/800 (43%), Positives = 489/800 (61%), Gaps = 84/800 (10%)
Query: 1 FISIDCGIPE-NANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG+ + Y TG+ Y SDA + +G + +++ EF + + ++ LR FPE
Sbjct: 26 FISVDCGLSLLESPYDAPQTGLTYTSDADLVASGKTGRLAKEF-EPLVDKPTLTLRYFPE 84
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G+RNCY L SD +LI+A F+YGNY+G + P+FNL L ++W +V D+ +
Sbjct: 85 GVRNCYNLNVTSD-TNYLIKATFVYGNYDGLNVGPNFNLYLGPNLWTTVSSNDT----IE 139
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EII + + + VCLV T PFI+ LELRP+ Y+TQSGSL R + +++ +
Sbjct: 140 EIILVTRSNSLQVCLVKTGISIPFINMLELRPMKKNMYVTQSGSLKYLFRGYISNSSTR- 198
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWK 239
R+PDDVYDR W+P SW Q++T+ + ++ ++ P +VM A P +L ++W
Sbjct: 199 IRFPDDVYDRKWYPLFDDSWTQVTTNLKVNTSITYELPQSVMAKAATPIKANDTLNITWT 258
Query: 240 PANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTP-TM 298
+ Y Y + +E ++ RA N+TR+ N+ +NG+ +GP SP L T ++ +P
Sbjct: 259 VEPPTTQFYSYVHIAEIQALRA-NETREFNVTLNGEYTFGPFSPIPLKTASIVDLSPGQC 317
Query: 299 NRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDA 358
+ R + + T S LPP+LNA+E + V +F Q+ TN+ DV
Sbjct: 318 DGGRCILQVVKTLKSTLPPLLNAIEAFTVIDFPQMETNENDVA----------------G 361
Query: 359 IMNIKSKYELLR-DWQGDPCAPNDYLWQGLNC-SYDANQAPRIKSLNLSSSGIAGEILPH 416
I N++ Y L R WQGDPC P LW GLNC + D + P I SL+LSSSG+ G I
Sbjct: 362 IKNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDISTPPIITSLDLSSSGLTGIITQA 421
Query: 417 IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL------------------------VD 452
I +LT ++ LDLS+N+LTG VPEFLA+++ L V+ V+
Sbjct: 422 IKNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGNNLSGSVPPSLLQKKGMKLNVE 481
Query: 453 GNPN-LCLSASC------KGKKNKFIVPLLASVVSFSVLLAALAILRSLRRRKQELC--- 502
GNP+ LC + SC KK IVP++AS+ S +VL+ AL + LR+++
Sbjct: 482 GNPHILCTTGSCVKKKEDGHKKKSVIVPVVASIASIAVLIGALVLFLILRKKRSPKVEGP 541
Query: 503 ------------PVGKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDD-K 549
P + ++ KNR+ SY+ V+ +TNNF+R+LGKGGFG VYHG+++ +
Sbjct: 542 PPSYMQASDGRLPRSSEPAIVTKNRRFSYSQVVIMTNNFQRILGKGGFGMVYHGFVNGTE 601
Query: 550 QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQA 609
QVAVK+LS SS QGYKQF+AEVELL+R HHKNL LVGYCDE + L+YE+MANG+L+
Sbjct: 602 QVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVGYCDEGDNLALIYEYMANGDLKE 661
Query: 610 HLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669
H+ IL+W RL+I ESAQGLEYLH+GCKPP+VHRDVK+ NILLN
Sbjct: 662 HM---------SGTRNRFILNWGTRLKIVIESAQGLEYLHNGCKPPMVHRDVKTTNILLN 712
Query: 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 729
E F+AKLADFGLSR F +EG +HVST V GTPGYLDPEY+ +N LTEKSDVYSFG++LLE
Sbjct: 713 EHFEAKLADFGLSRSFLIEGETHVSTVVAGTPGYLDPEYHRTNWLTEKSDVYSFGILLLE 772
Query: 730 LITGQPVIQKTPERTLIGQW 749
+IT + VI ++ E+ IG+W
Sbjct: 773 IITNRHVIDQSREKPHIGEW 792
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN93|Y5596_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g59680 OS=Arabidopsis thaliana GN=At5g59680 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 352/795 (44%), Positives = 486/795 (61%), Gaps = 75/795 (9%)
Query: 1 FISIDCGIPEN--ANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFP 58
FIS+DCG+P N + YT+ TG+ + SDA+ I +G +I + + + + +R FP
Sbjct: 29 FISLDCGLPANEPSPYTEPRTGLQFSSDAAFIQSGKIGRIQANLEADFL-KPSTTMRYFP 87
Query: 59 EGIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVS 118
+G RNCY L + LIRARF+YGNY+G+D P F+L L + W ++ +
Sbjct: 88 DGKRNCYNLNVEKGR-NHLIRARFVYGNYDGRDTGPKFDLYLGPNPWATIDLAKQVNGTR 146
Query: 119 KEIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNK 178
EI+HIP + VCLV T TP IS LE+RP+ + TY+T+SGSL Y R + S ++
Sbjct: 147 PEIMHIPTSNKLQVCLVKTGETTPLISVLEVRPMGSGTYLTKSGSLKLYYR-EYFSKSDS 205
Query: 179 TFRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSW 238
+ RYPDD+YDR W W QI+T+S++ ++ +++PP + +A IP N + L W
Sbjct: 206 SLRYPDDIYDRQWTSFFDTEWTQINTTSDVGNSNDYKPPKVALTTAAIPTNASAPLTNEW 265
Query: 239 KPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTP-T 297
N + YVY +FSE + +A N+TR+ N+ +NGKL++GP+ P L T+ S +P T
Sbjct: 266 SSVNPDEQYYVYAHFSEIQELQA-NETREFNMLLNGKLFFGPVVPPKLAISTILSVSPNT 324
Query: 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
++ + T S LPP+LNA E+Y+V +F QL TN+ DV
Sbjct: 325 CEGGECNLQLIRTNRSTLPPLLNAYEVYKVIQFPQLETNETDV----------------S 368
Query: 358 AIMNIKSKYELLR-DWQGDPCAPNDYLWQGLNCSY-DANQAPRIKSLNLSSSGIAGEILP 415
A+ NI++ YEL R +WQ DPC P ++W GLNCS D PRI +LNLSSSG+ G I
Sbjct: 369 AVKNIQATYELSRINWQSDPCVPQQFMWDGLNCSITDITTPPRITTLNLSSSGLTGTITA 428
Query: 416 HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRV-----------------------LVD 452
I +LT++E LDLSNN+LTG VPEFL+ ++ L V L
Sbjct: 429 AIQNLTTLEKLDLSNNNLTGEVPEFLSNMKSLLVINLSGNDLNGTIPQSLQRKGLELLYQ 488
Query: 453 GNPNLCLSASCKGKKNK-FIVPLLASVVSFSVLLAALAILRSLRRRKQELCPV------- 504
GNP L S + K K F V ++ASV S ++L+ L ++ LR++K V
Sbjct: 489 GNPRLISPGSTETKSGKSFPVTIVASVGSAAILIVVLVLVLFLRKKKPSAVEVVLPRPSR 548
Query: 505 ---------GKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLD-DKQVAVK 554
+ S+E+K RK +Y+ V K+TNNF RV+G+GGFG V HG ++ +QVAVK
Sbjct: 549 PTMNVPYANSPEPSIEMKKRKFTYSEVTKMTNNFGRVVGEGGFGVVCHGTVNGSEQVAVK 608
Query: 555 MLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQ 614
+LS SS QGYK+F+AEV+LL+R HH NL LVGYCDE + L+YEF+ NG+L+ HL
Sbjct: 609 LLSQSSTQGYKEFKAEVDLLLRVHHTNLVSLVGYCDEGDHLALIYEFVPNGDLRQHL--- 665
Query: 615 LAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674
+ I++W RL+IA E+A GLEYLH GC PP+VHRDVK+ NILL+E ++A
Sbjct: 666 ------SGKGGKPIVNWGTRLRIAAEAALGLEYLHIGCTPPMVHRDVKTTNILLDEHYKA 719
Query: 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
KLADFGLSR FPV G SHVST + GTPGYLDPEYY ++RL+EKSDVYSFG+VLLE+IT Q
Sbjct: 720 KLADFGLSRSFPVGGESHVSTVIAGTPGYLDPEYYHTSRLSEKSDVYSFGIVLLEMITNQ 779
Query: 735 PVIQKTPERTLIGQW 749
VI + ++ I QW
Sbjct: 780 AVIDRNRRKSHITQW 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 749 | ||||||
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.961 | 0.786 | 0.545 | 0.0 | |
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.961 | 0.812 | 0.518 | 0.0 | |
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.961 | 0.807 | 0.53 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.961 | 0.814 | 0.517 | 0.0 | |
| 356522218 | 890 | PREDICTED: putative leucine-rich repeat | 0.955 | 0.804 | 0.495 | 0.0 | |
| 356556632 | 884 | PREDICTED: putative leucine-rich repeat | 0.958 | 0.812 | 0.510 | 0.0 | |
| 255549708 | 883 | Nodulation receptor kinase precursor, pu | 0.959 | 0.814 | 0.503 | 0.0 | |
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.961 | 0.814 | 0.508 | 0.0 | |
| 356547364 | 887 | PREDICTED: putative leucine-rich repeat | 0.961 | 0.811 | 0.486 | 0.0 | |
| 358248460 | 898 | putative leucine-rich repeat receptor-li | 0.950 | 0.792 | 0.486 | 0.0 |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/784 (54%), Positives = 543/784 (69%), Gaps = 64/784 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCGI ENA YTDS T I+YVSDA+ IDTG S I++E+ + +Q N+RSF EG
Sbjct: 58 FISIDCGISENATYTDSTTSIDYVSDAAFIDTGKSKSIAAEYTRYNINQQLQNVRSFAEG 117
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
+RNCY + K+LIRA F+YGNY+GQ+K P F+L L + W++V +S I++KE
Sbjct: 118 VRNCYKIGLKKG-AKYLIRAEFLYGNYDGQNKAPIFDLYLGSSKWETVDTINSTMIITKE 176
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
IIH+ YI VCLVNT SGTPF+S LELRP+ Y T GSL+R+ R DVGSTTN+T
Sbjct: 177 IIHLINTSYIDVCLVNTGSGTPFMSKLELRPIRISAYSTSLGSLARFSRSDVGSTTNRTL 236
Query: 181 RYPDDVYDRIWFPHNFYSWAQISTSSNMKSTG--NFQPPSTVMQSAVIPANGGSSLMLSW 238
RY DDVYDRIW P++F+ WA+ISTS + + +++PPS VM++A IPAN + +S
Sbjct: 237 RYADDVYDRIWTPNHFFKWAEISTSETIDALAQNDYRPPSIVMRTAGIPANDNEPMTVSI 296
Query: 239 KPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTM 298
+ + VY +F+E A N++R NI +NG+ W+GPL P YL T TVFS T +
Sbjct: 297 DFEDTTFRFLVYMHFAEILKLEA-NESRQFNISLNGEHWFGPLRPDYLYTTTVFSPT-VL 354
Query: 299 NRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDA 358
+ +++ I TENS LPP+LNA+EIY + + Q +NQ+DV DA
Sbjct: 355 SGGQYEFSIYKTENSTLPPLLNAIEIYYILDLSQPQSNQEDV----------------DA 398
Query: 359 IMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIF 418
I NIKS Y + R+WQGDPCAP YLW+GLNCSY N PRI SLNLSSSG+ GEI I
Sbjct: 399 ITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRIISLNLSSSGLTGEIPSSIS 458
Query: 419 SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL---------------------------V 451
SLTS+ESLDLSNN LTGSVP+FL++L L VL V
Sbjct: 459 SLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGSVPPSLVEKSEQNLLVLSV 518
Query: 452 DGNPNLCLSASCKG-KKNKFIVPLLASVVSFSVLLAALA-ILRSLRRRKQELCPVGKK-- 507
GN NLCL +SCK KKN +VP++AS+ ++++ALA IL + +RRKQ+
Sbjct: 519 GGNANLCLKSSCKNEKKNNVVVPVVASIAGVLIIISALAAILYTRKRRKQQEEDTKTSNI 578
Query: 508 -GSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQ 566
G LE K R+ +Y+ +L ITNNFERVLGKGGFGTVYHGYLDD QVAVK+LSP S QGYK+
Sbjct: 579 YGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYHGYLDDTQVAVKILSPLSAQGYKE 638
Query: 567 FQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT 626
F AEV+LL+R HH+NLT LVG+C+E TKMGL+YE+MANG+L+ HLL+
Sbjct: 639 FHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMANGDLE-HLLSG---------RNR 688
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
+L W+ RL IA E+A+GLEYLH+GCKPPIVHRD+K+ANILLN++FQA+LADFGLS+ FP
Sbjct: 689 HVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQARLADFGLSKSFP 748
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL- 745
VEGG+HVST V GTPGYLDPEY ++N LTEKSDVYSFGVVLL++ITG+PVI ER++
Sbjct: 749 VEGGTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITGRPVIAVIDERSIH 808
Query: 746 IGQW 749
I W
Sbjct: 809 ISHW 812
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/790 (51%), Positives = 540/790 (68%), Gaps = 70/790 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FIS+DCG+P N +Y+D+ T +N++SDAS I+ G+S ++ EF+ R +RSFP+G
Sbjct: 30 FISLDCGLPGNTSYSDATTTLNFISDASYIEIGISKSLAPEFSTNSIFRPLWYVRSFPQG 89
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY + D E +LIRA FMYGNY+G ++ PSF+L L + W SVQ + V KE
Sbjct: 90 SRNCYNVTLTKDTE-YLIRATFMYGNYDGINQRPSFDLYLGPNKWVSVQILNGSIPVRKE 148
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
IIH PKR+YIHVCLVNT+SGTPFISALELRPL N TY+++SGSL+ + R D+ S TN+T
Sbjct: 149 IIHHPKRKYIHVCLVNTNSGTPFISALELRPLKNGTYVSESGSLALFDRADISSITNQTV 208
Query: 181 RYPDDVYDRIWFPHNFYSWAQISTSS--NMKSTGNFQPPSTVMQSAVIPANGGSSLMLSW 238
RYPDDVYDR W P +F W IST+ ++ + ++Q PSTVM+SA P N S + ++
Sbjct: 209 RYPDDVYDRRWSPFHFVEWTDISTTETIDLGKSNSYQLPSTVMRSAGTPRNSSSPMEVTI 268
Query: 239 KPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTM 298
+ +K Y YF+F+E A NQ+R+ NI +NG +WYGP++ YL + TV S+ +
Sbjct: 269 AAEDPTLKFYAYFHFAEIVKLDA-NQSREFNITLNGDIWYGPITLHYLYSTTV-SSGYAI 326
Query: 299 NRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDA 358
+ +D I S LPP+LNA+E+Y + E LQL T Q+DV A
Sbjct: 327 SGGTYDFQIFKVGGSTLPPLLNAVEVYYIVELLQLETKQEDVY----------------A 370
Query: 359 IMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIF 418
++ IKS Y++ R+WQGDPCAP DY+W+GL C+Y + +P I SL+LSSSG+ G++ P
Sbjct: 371 MIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSASPVIISLDLSSSGLTGDVPPVFA 430
Query: 419 SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL---------------------------V 451
+L S+ESLDLSNNSLTG VP+FL++L+ L+VL
Sbjct: 431 NLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNKLTGIIPDDLFKRSQSGLLLLSF 490
Query: 452 DGNPNLCLSASCKGKKNK------FIVPLLASVVSFSVLLAALAILRSLRRRKQELCPVG 505
GNP LC S SC K F+VP++AS+ + V++AAL I+ RRRKQ++
Sbjct: 491 GGNPELCASVSCSNNNKKKKKNNNFVVPVVASIAALLVIVAALTIICCCRRRKQQVARNE 550
Query: 506 KKGS------LELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPS 559
+ + E++NR+ +Y+ VLK+T NFE VLG+GGFGTVY+GYL D +VAVK+LS S
Sbjct: 551 EADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGGFGTVYYGYLGDIEVAVKVLSTS 610
Query: 560 SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILP 619
SVQGYK+F+AEV+LL+R HHKNLT LVGYCDE M L+YE+MANGNL+ HL
Sbjct: 611 SVQGYKEFEAEVKLLLRVHHKNLTTLVGYCDEGGNMILIYEYMANGNLRQHL-------- 662
Query: 620 TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679
+ + ILSW+GRL+IA E+AQGLEYLH+GCKPPIVHRDVK+ANILL++KFQAKLADF
Sbjct: 663 --SGEHPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLDDKFQAKLADF 720
Query: 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739
GLSR+FP EGG+HVST V GTPGYLDPEYY+ N LTEKSDVYSFGVVLLE+IT + VI +
Sbjct: 721 GLSRMFPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLEIITSRSVISQ 780
Query: 740 TPERTLIGQW 749
T E+T + QW
Sbjct: 781 TSEKTHVSQW 790
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/800 (53%), Positives = 535/800 (66%), Gaps = 80/800 (10%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FIS+DCG+P N YTD T +NY SDAS IDTG+S ++ F + RQ +RSFPEG
Sbjct: 28 FISLDCGLPANTTYTDETTSLNYNSDASFIDTGISKSLAPGFTTDNLRRQLWYIRSFPEG 87
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY L D E +LIRA FMYGNY+G ++ P F+L + + W SV+ ++ + V++E
Sbjct: 88 DRNCYNLTLAKDTE-YLIRATFMYGNYDGLNQLPEFDLHIGPNKWVSVKILNASTSVTEE 146
Query: 121 II-HIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSL--SRYGRWDVGSTTN 177
II PK +YIHVCLV D+GTPFISALE RPL N TY+T+SGSL + + R DVGS N
Sbjct: 147 IIIGSPKSKYIHVCLVTKDTGTPFISALETRPLKNGTYVTESGSLGLALFTREDVGSLNN 206
Query: 178 KTFRYPDDVYDRIWFPHNFYSWAQISTS--SNMKSTGNFQPPSTVMQSAVIPANGGSSLM 235
+ RYP+DVYDR WFP++F IST+ ++ +FQPPS VM+SAVI N S L
Sbjct: 207 RIVRYPNDVYDRRWFPYHFKRGTDISTTLTVDLDDHNDFQPPSIVMRSAVISINTSSPLE 266
Query: 236 LSWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTT 295
+ + K Y Y +F+E A NQ+R NI +NGK+WYGP++P+YL T TV+ST+
Sbjct: 267 F-YINNDTTYKLYAYMHFAEIVKLEA-NQSRQFNISLNGKIWYGPVTPTYLYTTTVYSTS 324
Query: 296 PTMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKIS 355
+ ++ ++ E SALPP+LNA+E+Y V + LQ TNQ+DVI
Sbjct: 325 -AITDGMYEFSLSKVEGSALPPLLNAIELYYVVDLLQPETNQRDVI-------------- 369
Query: 356 VDAIMNIKSKYELLR-DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEIL 414
IMNIKS Y + R +WQGDPCAP D++W+GL+C Y+ +P I SLNLSSSG+ GEI
Sbjct: 370 --GIMNIKSTYRISRTNWQGDPCAPEDFVWEGLSCKYNVTSSPVIISLNLSSSGLHGEIA 427
Query: 415 PHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL------------------------ 450
P I +L S+E LDLSNN+LT VP+FL++LQ L+ L
Sbjct: 428 PDIANLKSLEILDLSNNNLTALVPDFLSQLQSLKFLNLTGNRLNGTIPDDLLKRADSGLT 487
Query: 451 --VDGNPNLCLSASCKGK-----KNKFIVPLLASVVSFSVLLAALAILRSLRRRKQELCP 503
VDGNP LC S SC K FIVP++ASV + V++ L + L+RRKQ+
Sbjct: 488 LSVDGNPELCKSVSCNKKKKKKKNTDFIVPVVASVAALLVIIVVLTTIWYLKRRKQKGTY 547
Query: 504 VGK--------------KGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDK 549
+ K LEL R+ +Y++VLKITNNF VLG+GGFGTVYHGYLDD
Sbjct: 548 LHKYILAGRTEAEAKKTHEPLELNKRQFTYSDVLKITNNFGSVLGRGGFGTVYHGYLDDV 607
Query: 550 QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQA 609
+VAVKMLSPSSVQGYK+F AEV LL+R HHKNLT LVGYCDE MGL+YE+MANGNL+
Sbjct: 608 EVAVKMLSPSSVQGYKEFHAEVRLLLRVHHKNLTTLVGYCDEGNNMGLIYEYMANGNLKH 667
Query: 610 HLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669
HL D ILSW+GRLQIA E+AQGL+YLH+GCKPPIVHRDVK+ NILLN
Sbjct: 668 HL---------SGCDHPSILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVKTTNILLN 718
Query: 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE 729
++FQAKLADFGLSR FPVE GSHVST V GTPGYLDP+YY++N LTEKSDVYS+GVVLLE
Sbjct: 719 DRFQAKLADFGLSRTFPVEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYSYGVVLLE 778
Query: 730 LITGQPVIQKTPERTLIGQW 749
+IT +PVI +T ++T + QW
Sbjct: 779 IITSRPVIARTRDKTHVSQW 798
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/787 (51%), Positives = 529/787 (67%), Gaps = 67/787 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCG+P N++YTD T +NY+SDAS ID G+ I+ + T+RQ ++RSFPEG
Sbjct: 31 FISIDCGLPANSSYTDETTSLNYISDASFIDVGIITTITPKVTTNSTDRQQLSVRSFPEG 90
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNC+ ++ + + K+LIRA F +G+Y+G ++ P F+L L + W +V+ ++ V KE
Sbjct: 91 DRNCFNVEL-AKNTKYLIRAIFAHGDYDGSNELPEFDLHLGPNKWVTVKILNASIPVIKE 149
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
IIH P YIH+CLVNTDSG PFISALELRPL N TY+ QSG+L + R D+GS TNKT
Sbjct: 150 IIHTPTLNYIHICLVNTDSGMPFISALELRPLKNTTYVAQSGALVKSTRLDLGSLTNKTV 209
Query: 181 RYPDDVYDRIWFPHNFYSWAQISTSSNMKSTG--NFQPPSTVMQSAVIPANGGSSLMLSW 238
RYPDDV+DRIW P +F+ W +ST + + +FQPPS VM++A +P N ++
Sbjct: 210 RYPDDVFDRIWTPDHFHKWTDLSTPDTVDAQNHIDFQPPSVVMRTANMPTNASENMEFYI 269
Query: 239 KPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTM 298
+ YVY +F+E E NQ+R NI +NG +WYGP+ P++L + TV+S P +
Sbjct: 270 DIDDTTSLFYVYMHFAEI-VELQANQSRLFNISLNGTIWYGPVIPNHLSSGTVYSQFPII 328
Query: 299 NRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDA 358
+ + E S LPP+LNA+EIY V + Q T+Q DV DA
Sbjct: 329 GGNNMFSLFKI-EGSTLPPLLNAIEIYFVVDLSQSETDQDDV----------------DA 371
Query: 359 IMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIF 418
IM IKS Y + ++WQGDPCAP Y+W GLNCSY + P +KSLNLSSSG+ GEI+ I
Sbjct: 372 IMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSGLRGEIVSEIA 431
Query: 419 SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL---------------------------V 451
+L S+E LDLSNNSL+GS+P+FL+ + L+VL V
Sbjct: 432 NLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFERSQQGSLLLSV 491
Query: 452 DGNPNLCLSASCKGKKNKFIVPLLASVVSFSVLLAALA-ILRSLRRRKQELCPVGK---- 506
GNP LC S SC KK +VP++ASVV+F +L AAL ILR R Q K
Sbjct: 492 SGNPELCPSVSCTKKKKSVVVPVVASVVAFFILAAALVVILRYFFVRSQAKTNEAKISYE 551
Query: 507 ---KGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQ 562
+ +E K R+ SY+ +LKITNNF+++LGKGGFGTVYHG L+D QVAVK+LS SS Q
Sbjct: 552 TNDEPLVESKKRQFSYSEILKITNNFDKILGKGGFGTVYHGTLNDGTQVAVKVLSLSSAQ 611
Query: 563 GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDA 622
GYK+FQAEV+LL+R HH+NLT LVGYC+E T +GL+YE+MANGNL+ +L +
Sbjct: 612 GYKEFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEYMANGNLEDYL----------S 661
Query: 623 EDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682
+ LSW+ RL+IATE+AQGLEYLH+GCKP IVHRDVK+ NILLN+KFQAKLADFGLS
Sbjct: 662 DSCLNTLSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGLS 721
Query: 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
RIFPV+G +H+ST V GTPGYLDPEYY++N LT+KSDV+SFGVVLLE+ITG+P I +T E
Sbjct: 722 RIFPVDGSTHISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQTRE 781
Query: 743 RTLIGQW 749
RT I QW
Sbjct: 782 RTHISQW 788
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522218|ref|XP_003529744.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/801 (49%), Positives = 508/801 (63%), Gaps = 85/801 (10%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
F SIDCG+PE ++Y + TGI Y+SDA ID GVS IS K +Q + +RSFP G
Sbjct: 29 FTSIDCGLPEASSYNEKTTGIFYISDAKFIDAGVSKSISPA-QKSTHLQQLAYVRSFPSG 87
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY + S K+LIRA F YGNY+G ++PP F+L L A++WD+V FP++ E
Sbjct: 88 ERNCYRINVTSG-TKYLIRATFFYGNYDGLNQPPQFDLHLGANIWDTVNFPNASLSEISE 146
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSG-SLSRYGRWDVGSTTNKT 179
IIH P +YI CLVNT GTPFISA+ELR L N Y+T S SL+ Y R+D+GS TN
Sbjct: 147 IIHTPSLDYIQPCLVNTGKGTPFISAIELRTLNNAFYVTASAESLAYYQRYDLGSITNLG 206
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKST--GNFQPPSTVMQSAVIPANGGSSLMLS 237
+RY DVYDRIW PH W Q+S++ ++ +++ P VM +A P N +
Sbjct: 207 YRYNYDVYDRIWVPHGLNQWTQLSSTLHLLDIFQNDYKLPEVVMSTAATPINASAPFQFY 266
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPT 297
W P N K Y+Y +FSE E A+N+TR NI++NGKL+YGPL+P YL T+T+++ +
Sbjct: 267 WGPDNVDDKFYIYMHFSEVEI-LAENETRTFNIFMNGKLFYGPLTPGYLTTNTIYAKSAL 325
Query: 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
R+ + T S LPPI+NA+EIY+V +F Q T Q DV D
Sbjct: 326 TGATRYLFSLAKTGTSTLPPIINAMEIYKVIDFPQSETEQDDV----------------D 369
Query: 358 AIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHI 417
AI NIK+ Y + R+WQGDPC P Y+W+GLNCSYD PRI SLNLSSSG+ G+I I
Sbjct: 370 AITNIKNAYGVDRNWQGDPCGPVAYIWEGLNCSYD--NTPRITSLNLSSSGLTGQISSFI 427
Query: 418 FSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL--------------------------- 450
LT ++ LDLSNNSL+GS+P+FL +LQ L+VL
Sbjct: 428 SELTMLQYLDLSNNSLSGSLPDFLTQLQSLKVLNLVNNNLTGPVPGGLVERSKEGSLSLS 487
Query: 451 VDGNPNLCLSASCKGKKNK--------------FIVPLLASVVSFSVL--LAALAILRSL 494
+ NPNLC S C + N ++P SV VL + AI+ L
Sbjct: 488 LGQNPNLCESDPCIQQSNNKQPDAANQNKNKNNIVIPAATSVAGILVLVIIVVTAIICGL 547
Query: 495 RRRKQELCPVGKK------GSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDD 548
++RK P GK K R+ S+ ++KIT++F R+LG+G FG VYHG +DD
Sbjct: 548 KKRK----PQGKATNTPSGSQFASKQRQYSFNELVKITDDFTRILGRGAFGKVYHGIIDD 603
Query: 549 KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608
QVAVKMLSPS+V+GY+QF AEV+LLMR HH+NLT LVGYC+E MGL+YE+MANGNL
Sbjct: 604 TQVAVKMLSPSAVRGYEQFLAEVKLLMRVHHRNLTSLVGYCNEENNMGLIYEYMANGNLD 663
Query: 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668
L + + L+W+ RLQIA ++AQGLEYLH+GCKPPI+HRDVK ANILL
Sbjct: 664 EIL--------SGKSSRAKFLTWEDRLQIALDAAQGLEYLHNGCKPPIIHRDVKCANILL 715
Query: 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 728
NE FQAKLADFGLS+ FP +GGS++ST V GTPGYLDPEY IS+RLTEKSDVYSFGVVLL
Sbjct: 716 NENFQAKLADFGLSKSFPTDGGSYMSTVVAGTPGYLDPEYSISSRLTEKSDVYSFGVVLL 775
Query: 729 ELITGQPVIQKTPERTLIGQW 749
E++TG+P I KTPE+T I QW
Sbjct: 776 EMVTGKPAIAKTPEKTHISQW 796
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556632|ref|XP_003546627.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/794 (51%), Positives = 517/794 (65%), Gaps = 76/794 (9%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCG P+ NYT+S TGINY SDA+ I+TGVS I+SE K ++Q +RSFPEG
Sbjct: 29 FISIDCGAPD-VNYTESTTGINYTSDANFINTGVSRIIASEL-KNGYQKQAWYVRSFPEG 86
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
+RNCY + + +LIRA F+YGNY+G + P F+L+L A+ W +V ++ E
Sbjct: 87 VRNCYKINI-TRGSTYLIRASFLYGNYDGLNMLPQFDLLLGANRWATVTIYNASLDQFNE 145
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
IIH+P + + +CLVNT GTPFISA+ELR L N TY+T+ GSL Y RWD+GS N+ +
Sbjct: 146 IIHVPSLDSVQLCLVNTGHGTPFISAVELRTLKNDTYVTRFGSLETYNRWDLGS--NQAY 203
Query: 181 RYPDDVYDRIWFPH-NFYSWAQ--ISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLS 237
RY DVYDR WF + N W Q +S S + S +F+PP+ VM +AV P N + L++S
Sbjct: 204 RYNYDVYDRAWFTYGNNNDWTQLNVSISVDSLSQSDFKPPAIVMSTAVTPVNASAPLVIS 263
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPT 297
W+P ++ YVY +F+E E KNQTR+ NI NGK WY LSP Y DT++S T
Sbjct: 264 WEPQDQTELYYVYMHFTEVEV-LEKNQTREFNINQNGKPWYQNLSPRYQKADTIYSGIGT 322
Query: 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
+ ++ + TENS LPPI+NA+EIY++K+F Q T Q DV D
Sbjct: 323 -SGEKIKYSLEMTENSNLPPIINAIEIYRLKDFQQSDTYQGDV----------------D 365
Query: 358 AIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHI 417
I IKS Y++ RDWQGDPC P YLW GLNC+Y ANQ+PRI +LNLSSSG+ G+I P I
Sbjct: 366 VITTIKSVYKVTRDWQGDPCGPVAYLWHGLNCTYAANQSPRITTLNLSSSGLLGKIDPSI 425
Query: 418 FSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL--------------------------- 450
L +E LDLSNNSL G VP+FL++LQ L++L
Sbjct: 426 SKLAMLEKLDLSNNSLNGEVPDFLSQLQHLKILNLEKNNLSGSIPSTLVEKSKEGSLSLS 485
Query: 451 VDGNPNLCLSASCKGKKNK-----FIVPLLASVVSFSVLLAALA-ILRSLRRRKQ----- 499
V N LC S C K+ + + PL+ASV +LL +A IL +L+RRK
Sbjct: 486 VGQNSFLCESDQCNEKQKEKKKNNIVTPLVASVSGVVILLVVMAAILWTLKRRKSKEKDQ 545
Query: 500 -ELCPVGKKGS---LELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKM 555
++ P + L+ K + S+++VLKITNNF LGKGGFGTVY G+++D VAVKM
Sbjct: 546 SQISPQYTEQDDSLLQFKKQIYSFSDVLKITNNFNTTLGKGGFGTVYLGHINDTPVAVKM 605
Query: 556 LSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQL 615
LSPSSV GY+QFQAEV+LLMR HHKNLT LVGYC+E T GL+YE+MANGNL HL
Sbjct: 606 LSPSSVHGYQQFQAEVKLLMRVHHKNLTSLVGYCNEGTSKGLIYEYMANGNLLEHL---- 661
Query: 616 AILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675
+ KT +W+ RL+IA ++A GLEYL +GCKPPI+HRDVKS NILLNE FQAK
Sbjct: 662 ----SGKHGKTKFFTWEERLRIAVDAALGLEYLQNGCKPPIIHRDVKSTNILLNELFQAK 717
Query: 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
L+DFGLS++ P EG +HVST V GTPGYLDPEY+I+NRLTEKSDVYSFGVVLLE+IT QP
Sbjct: 718 LSDFGLSKVIPTEGVTHVSTVVAGTPGYLDPEYFITNRLTEKSDVYSFGVVLLEIITSQP 777
Query: 736 VIQKTPERTLIGQW 749
VI + E I +W
Sbjct: 778 VIARNQENIHISEW 791
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/798 (50%), Positives = 514/798 (64%), Gaps = 79/798 (9%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FIS+DCG+ N++YTD TG+ Y+SDA+ I+TGV+ I+ EF + Q +RSFP+G
Sbjct: 29 FISLDCGLQANSSYTDEKTGLKYISDAAFIETGVTKSIAPEFLGSFNQ-QLRQVRSFPKG 87
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY ++ + ++LIRA F+Y NY+G +K P+F+L + + W +VQ + KE
Sbjct: 88 DRNCYKVEL-VKNTRYLIRATFLYANYDGLNKLPAFDLHIGPNKWVNVQITNPLIYPIKE 146
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
IIH P I+VCLV T TPFISALE+RPL N TY+ QSGSLS + R DVGS TN+T
Sbjct: 147 IIHAPTFNNIYVCLVRTGPWTPFISALEIRPLHNSTYVAQSGSLSLFNRVDVGSLTNQTI 206
Query: 181 RYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN-FQPPSTVMQSAVIPANGGSSLMLSWK 239
RYPDDVYDR+W P +F IST N+ S + FQ PSTVM SA +P N ++L+
Sbjct: 207 RYPDDVYDRMWLPFHFDKGTDISTKENITSGIDYFQLPSTVMNSATVPLNASEQIILNID 266
Query: 240 PANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTMN 299
+ + YVY +F+E NQ+R NI +NGK+ YGP++P +L+ TV+S + +
Sbjct: 267 TQDNTFQAYVYIHFAEI-VRLEPNQSRRFNISLNGKILYGPVTPKHLEATTVYSQS-AIP 324
Query: 300 RDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDAI 359
+ S LPP+LNALE+Y V + L TNQ DV +AI
Sbjct: 325 GGKFLFSFYGVGGSTLPPLLNALELYSVVDLLHSETNQVDV----------------NAI 368
Query: 360 MNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFS 419
IKS Y + R+WQGDPC+P DY W GLNC+Y +P I SL+ SSSG+ GEI P I +
Sbjct: 369 TKIKSTYGITRNWQGDPCSPQDYKWDGLNCTYSNTASPVITSLDFSSSGLTGEIDPDISN 428
Query: 420 LTSIESLDLSNNSLTGSVPEFLAEL--------------------------QFLRVLVDG 453
L +E+LDLSNNSLTG VP+FL++L L + V G
Sbjct: 429 LKWLETLDLSNNSLTGPVPDFLSQLPLKSLNLAGNNLTGTIPADLFNRWQSDLLFLSVSG 488
Query: 454 NPNLCLSASCKGKKNKFI-VPLLASVVSFSVLLAALAI-LRSLRRRKQE----------- 500
NP LC S SC K I VP++ SV + V++A AI L L++RKQ+
Sbjct: 489 NPQLCASVSCNSDNKKNITVPVIISVTALFVIIAGSAIILWRLKKRKQQGTVPNGFCWVM 548
Query: 501 LCPV-------GKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAV 553
+ PV K+ LEL+ R+L Y +++ITNNF+R+LGKGGFGTVYHG+LDD +VAV
Sbjct: 549 IWPVVGKMEAEAKREPLELQKRQLRYFEIVQITNNFQRILGKGGFGTVYHGHLDDMEVAV 608
Query: 554 KMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLA 613
KMLSPSS QGYK+FQ EV+LL+R HH+NLT LVGYCDE KM L+YE+MANGNL+ +L
Sbjct: 609 KMLSPSSAQGYKEFQTEVKLLLRVHHRNLTSLVGYCDEGNKMALIYEYMANGNLRDNL-- 666
Query: 614 QLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673
++ LSW+ RL+IA E+AQGLEYLH+GCKPPI+HRDVK NILLN KFQ
Sbjct: 667 --------SDGNGNFLSWEERLRIALEAAQGLEYLHNGCKPPIIHRDVKPTNILLNNKFQ 718
Query: 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 733
AKLADFGLSRI PVEGGSHVST V GTPGYLDPEYY +N LTEKSDV+SFGVVLLE+IT
Sbjct: 719 AKLADFGLSRICPVEGGSHVSTIVAGTPGYLDPEYYATNWLTEKSDVFSFGVVLLEIITS 778
Query: 734 QPVIQKT--PERTLIGQW 749
PVI KT + T + QW
Sbjct: 779 GPVISKTRDGDTTHLSQW 796
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/788 (50%), Positives = 515/788 (65%), Gaps = 68/788 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCG+P N++YTD+ TG+NYVSDA+ IDTG+ + ++ N +RQ ++RSFPEG
Sbjct: 32 FISIDCGLPANSSYTDATTGLNYVSDAAFIDTGIINNLAPGLNTSSIDRQQLSVRSFPEG 91
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY ++ + K+LIRA F+Y NY+G K P F+L L + W +V+ ++ V E
Sbjct: 92 DRNCYQVEL-TRGTKYLIRAIFLYRNYDGLSKLPHFDLHLGPNKWITVKILNATIPVITE 150
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQS-GSLSRYGRWDVGSTTNKT 179
II+ P YIHVCLVNT GTPFISALELRPL N TY +S G+L+++ R D GS TNKT
Sbjct: 151 IIYTPILNYIHVCLVNTGLGTPFISALELRPLKNTTYEIRSEGALAKFARLDFGSVTNKT 210
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKST--GNFQPPSTVMQSAVIPANGGSSLMLS 237
RYPDDVYDRIW P ++Y W +ST + + +FQPPS VM +A +P N +
Sbjct: 211 VRYPDDVYDRIWTPDHYYKWTDLSTPETIDAQFHNDFQPPSIVMSTANVPTNASEDMQFF 270
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPT 297
+ ++ Y Y +F+E A NQ+R NI +NG +++GP+ P YL T +V++ P
Sbjct: 271 IDNEDTSLQFYFYMHFAEIVKLEA-NQSRQFNISLNGTIFFGPVIPDYLYTSSVYNGLP- 328
Query: 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
+N + + S LPP+LNA+EIY + Q T+Q DV D
Sbjct: 329 INAGSNVFSLFKIGGSTLPPLLNAIEIYFFVDLSQSQTDQDDV----------------D 372
Query: 358 AIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHI 417
AI IKS Y + R+WQGD CAP Y+WQGLNCSY N P+I SLNLSSSG+ GEI+ I
Sbjct: 373 AITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITSLNLSSSGLTGEIVSDI 432
Query: 418 FSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL--------------------------- 450
+L S+E LDLSNNSL+G VP+FL+++ L+VL
Sbjct: 433 ANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRIPVDLFERTQKGSLLLS 492
Query: 451 VDGNPNLCLSASCKGKKNKFIVPLLASVVSFSVLLAALA------ILRSLRRRKQELCPV 504
V GNP LC S SCK K+ VP++ASV S +L AA+A ILRS+ +
Sbjct: 493 VSGNPELCPSVSCKKKEKSIAVPVVASVASVFILAAAVAVILRYRILRSVSETGETKLSH 552
Query: 505 GKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSVQG 563
+ELKN++ +Y+ VLKITNNFE+VLGKGGFGTVY+G L D QVAVK+LS SSVQG
Sbjct: 553 ESNEPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGTLADGTQVAVKILSQSSVQG 612
Query: 564 YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAE 623
YK+F AEV+LLMR HH+NLT LVG C E T MGL+YE+MANGNL+ +L +
Sbjct: 613 YKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMANGNLEDYL----------SG 662
Query: 624 DKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
LSW+ RL+IA E+ QGLEYLH GCK PIVHRDVK+ NILLN+KFQAK++DFGLSR
Sbjct: 663 SNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKISDFGLSR 722
Query: 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI--QKTP 741
IFP +GG+HVST V GTPGYLDPEYY++N LT+KSDVYSFGVVLLE+IT +PVI +
Sbjct: 723 IFPADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVIAQNRNH 782
Query: 742 ERTLIGQW 749
E + I QW
Sbjct: 783 ENSHISQW 790
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547364|ref|XP_003542083.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/791 (48%), Positives = 511/791 (64%), Gaps = 71/791 (8%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCG P + NYT+ TGINY SDA+ ++TGVS + +E +RQ N+RSFPEG
Sbjct: 33 FISIDCGAPADINYTEPKTGINYTSDANFVNTGVSGTVETEIISSGYQRQMMNVRSFPEG 92
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY + + +LIR F+YGNY+G +K P F++ L A+ W +V ++ + + E
Sbjct: 93 KRNCYKINI-TRGSTYLIRTNFLYGNYDGLNKAPQFDIHLGANRWYTVTISNASTPQANE 151
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
II++P +Y+ +CLV+TD GTPFISA+ELR L N TY+TQ GSL Y RWD+GS N ++
Sbjct: 152 IIYVPSLDYLQICLVDTDHGTPFISAIELRTLKNYTYVTQFGSLEYYNRWDLGS--NNSY 209
Query: 181 RYPDDVYDRIWFPH-NFYSWAQISTS--SNMKSTGNFQPPSTVMQSAVIPANGGSSLMLS 237
RY DVYDR W+ + + W Q+S S ++ + +++PP ++ +AV P N + L++S
Sbjct: 210 RYNHDVYDRFWYIYGDNKDWKQLSASIPADSLNQNDYKPPEIILSTAVTPVNASAPLVIS 269
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPT 297
W+P ++ YVY +F+E + AKNQTR+ NI NGK W +SP Y + T++S T
Sbjct: 270 WEPPDQTELYYVYMHFTEIQV-LAKNQTREFNIAQNGKPWCPNMSPPYQNVTTIYSRLGT 328
Query: 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
+ + + + T++S+LPPI+NA+EIY+V F Q T+Q DV D
Sbjct: 329 SGK-KIEYSLEKTKDSSLPPIINAIEIYRVINFQQSDTHQGDV----------------D 371
Query: 358 AIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHI 417
AI IKS Y + RDWQGDPC+P YLW GLNC+Y N+ PRI +LNLSSS ++G I P I
Sbjct: 372 AIATIKSVYGMTRDWQGDPCSPVAYLWNGLNCTYRGNENPRITTLNLSSSELSGMIDPSI 431
Query: 418 FSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL--------------------------- 450
LT +E LDLSNN+L G VP+FL+ LQ L+++
Sbjct: 432 SYLTMLEKLDLSNNNLNGEVPDFLSRLQHLKIINLDNNNLTGSIPSELVKKSKEGFLSLS 491
Query: 451 VDGNPNLCLSASC--KGKKNKFIVPLLASVVSFSVLLAALAILR-SLRRRKQE------- 500
V N LC S C K KK + PLLASV +L+ A+A + +L++RK +
Sbjct: 492 VGQNLYLCESGQCNEKKKKKNIVTPLLASVSGVLILVVAVAAISWTLKKRKPKEKNQSEM 551
Query: 501 --LCPVGKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSP 558
C + K + S+++VL+ITNNF ++GKGGFGTVY GY+D VAVKMLS
Sbjct: 552 SAQCTEQDDSLHQFKKQIYSHSDVLRITNNFNTIVGKGGFGTVYLGYIDGTPVAVKMLST 611
Query: 559 SSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAIL 618
SSV GY+QFQAEV+LLMR HH NLT LVGYC+E GL+YE+MANGNL HL
Sbjct: 612 SSVHGYQQFQAEVKLLMRVHHANLTSLVGYCNEGDNKGLIYEYMANGNLHEHL------- 664
Query: 619 PTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678
+ K+ L+W+ RL+IA ++A GLEYL GCKPPI+HRDVKS NILL+EK QAKL+D
Sbjct: 665 -SGKHIKSKFLTWEDRLRIAVDAALGLEYLQTGCKPPIIHRDVKSTNILLDEKLQAKLSD 723
Query: 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738
FGLS+I P++GG+HVST V GTPGYLDPEYYISNRLT+KSD+Y FGVVLLE+IT QPVI
Sbjct: 724 FGLSKIIPIDGGTHVSTVVAGTPGYLDPEYYISNRLTQKSDIYGFGVVLLEIITCQPVIA 783
Query: 739 KTPERTLIGQW 749
ERT I QW
Sbjct: 784 WNEERTHIIQW 794
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248460|ref|NP_001240141.1| putative leucine-rich repeat receptor-like protein kinase At2g19210-like precursor [Glycine max] gi|223452414|gb|ACM89534.1| stress-induced receptor-like kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 727 bits (1877), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/807 (48%), Positives = 516/807 (63%), Gaps = 95/807 (11%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
F+SI CG P N+T ITG+NY SDA+ I+TGV I SE + +R NLRSFPEG
Sbjct: 29 FLSIACGAPAGVNFTVPITGLNYTSDANFINTGVKSTIVSELRDQF-QRHVWNLRSFPEG 87
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKE 120
RNCY + + K+LIRA F+YGNY+G + P F+L+L A+ W +V ++ E
Sbjct: 88 KRNCYKINI-TRGSKYLIRASFLYGNYDGLNMLPQFDLLLGANRWRTVNIKNASVSRHFE 146
Query: 121 IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTF 180
II++P +Y+H+C+V+T GTPFISA+ELR L N Y T+ GSL +Y R D+GS NK +
Sbjct: 147 IIYVPSLDYVHICMVDTGLGTPFISAIELRSLRNDIYETEFGSLEKYIRRDLGS--NKGY 204
Query: 181 RYPDDVYDRIW-------FPHNFYSWAQISTSSNMKS--TGNFQPPSTVMQSAVIPANGG 231
RY DDVYDR W + N W Q++ + S +QPP+ VM +AV PAN
Sbjct: 205 RYDDDVYDRYWNYDDADTWYDNVDKWKQLNFPIDADSLVQKQYQPPAVVMSTAVTPANVS 264
Query: 232 SSLMLSWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTV 291
+ L++SW+P + YVY +F+E + AKNQTR+ NI +NGKLWY SP Y DT+
Sbjct: 265 APLVISWEPYDPKDSFYVYMHFTEIQV-LAKNQTREFNITLNGKLWYENESPRYHSVDTI 323
Query: 292 FSTTPTMNRDRHDIIIN----TTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLY 347
++ + + +IN TE S LPPI+NA+EIY+VKEF Q T Q DV
Sbjct: 324 YTPSGISGK-----LINFSFVMTETSTLPPIINAIEIYRVKEFPQQDTYQGDV------- 371
Query: 348 LFMHIKISVDAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSS 407
DAI IKS Y + RDWQGDPC+P DYLW+GLNC+Y +PRI +LNLSSS
Sbjct: 372 ---------DAITTIKSVYGVTRDWQGDPCSPKDYLWEGLNCTYPVIDSPRIITLNLSSS 422
Query: 408 GIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL----------------- 450
G++G+I P I +LT +E LDLSNNSL G VP+FL++LQ+L++L
Sbjct: 423 GLSGKIDPSILNLTKLEKLDLSNNSLNGEVPDFLSQLQYLKILNLENNNLSGSIPSTLVE 482
Query: 451 ----------VDGNPNLCLSASC---KGKKNKFIVPLLASVVSFSVLLAALAILRSLRRR 497
V NP LC S C K +KN P++ S+ +L+ A+AIL +L+RR
Sbjct: 483 KSKEGSLSLSVSQNPYLCESGQCNFEKKQKNIVTPPIVPSISGALILIVAVAILWTLKRR 542
Query: 498 KQE-----------------LCPVGKKGSL-ELKNRKLSYANVLKITNNFERVLGKGGFG 539
K + L K SL ++K + SY++VLKITNNF ++GKGGFG
Sbjct: 543 KSKEKSTALMEVNDESEILRLRSTKKDDSLAQVKKQIYSYSDVLKITNNFNTIIGKGGFG 602
Query: 540 TVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599
TVY GY+DD VAVK+LSPS+V G++QFQAEV+LL+R HHKNLT L+GYC+E T L+Y
Sbjct: 603 TVYLGYIDDSPVAVKVLSPSAVHGFQQFQAEVKLLIRVHHKNLTSLIGYCNEGTNKALIY 662
Query: 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHR 659
E+MANGNLQ HL + K+ LSW+ RL+IA ++A GLEYL +GCKPPI+HR
Sbjct: 663 EYMANGNLQEHL--------SGKHSKSTFLSWEDRLRIAVDAALGLEYLQNGCKPPIIHR 714
Query: 660 DVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSD 719
DVKS NILLNE FQAKL+DFGLS+ P++G SHVST V GTPGYLDP Y+ +RLT+KSD
Sbjct: 715 DVKSTNILLNEHFQAKLSDFGLSKAIPIDGESHVSTVVAGTPGYLDPHYHKFSRLTQKSD 774
Query: 720 VYSFGVVLLELITGQPVIQKTPERTLI 746
V+SFGVVLLE+IT QPV+++ E+ I
Sbjct: 775 VFSFGVVLLEIITNQPVMERNQEKGHI 801
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 749 | ||||||
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.598 | 0.501 | 0.429 | 2e-184 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.587 | 0.494 | 0.400 | 3.4e-167 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.967 | 0.827 | 0.463 | 1.8e-165 | |
| TAIR|locus:2059804 | 892 | AT2G04300 [Arabidopsis thalian | 0.456 | 0.383 | 0.484 | 4.1e-162 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.971 | 0.826 | 0.444 | 9.3e-162 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.317 | 0.275 | 0.616 | 1.2e-159 | |
| TAIR|locus:2195855 | 876 | AT1G51910 [Arabidopsis thalian | 0.596 | 0.510 | 0.401 | 1.6e-158 | |
| TAIR|locus:2017647 | 885 | AT1G51820 [Arabidopsis thalian | 0.576 | 0.488 | 0.387 | 4.8e-157 | |
| TAIR|locus:2195830 | 837 | AT1G51870 [Arabidopsis thalian | 0.309 | 0.277 | 0.626 | 4.8e-157 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.576 | 0.489 | 0.414 | 8e-155 |
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 2.0e-184, Sum P(2) = 2.0e-184
Identities = 204/475 (42%), Positives = 292/475 (61%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FIS+DCG P ++ + T I Y+SDA+ I+TGV I + + ++Q NLRSFP+G
Sbjct: 29 FISLDCGSPRETSFREKTTNITYISDANFINTGVGGSIKQGYRTQF-QQQTWNLRSFPQG 87
Query: 61 IRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPS-FNLMLEADVWDSVQFPDSGSIVSK 119
IRNCYTL E +LIRA F++G Y+ DKP + F L L ++W +V +
Sbjct: 88 IRNCYTLNLTIGDE-YLIRANFLHGGYD--DKPSTQFELYLGPNLWSTVTTTNETEASIF 144
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
E+IHI + + +CLV T + TPFISALELR L N TY+T+ GSL + R DVG+T N+
Sbjct: 145 EMIHILTTDRLQICLVKTGNATPFISALELRKLMNTTYLTRQGSLQTFIRADVGATVNQG 204
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWK 239
+RY DV+DR+W P+NF +W+QIST+ ++ ++QPP M +A +P + +++ +S
Sbjct: 205 YRYGIDVFDRVWTPYNFGNWSQISTNQSVNINNDYQPPEIAMVTASVPTDPDAAMNISLV 264
Query: 240 PANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTMN 299
R ++ YV+ +F+E + E N TR+ NI N K YGP P T +VF+ T +
Sbjct: 265 GVERTVQFYVFMHFAEIQ-ELKSNDTREFNIMYNNKHIYGPFRPLNFTTSSVFTPTEVVA 323
Query: 300 RDRHDII--INTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVD 357
I + T NS LPP+LNA+EIY V Q T++++V D
Sbjct: 324 DANGQYIFSLQRTGNSTLPPLLNAMEIYSVNLLPQQETDRKEV----------------D 367
Query: 358 AIMNIKSKYELLR-DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPH 416
A+MNIKS Y + + DW+GDPC P DY W G+NC+Y N+ P+I SL+LS+SG+ GEIL
Sbjct: 368 AMMNIKSAYGVNKIDWEGDPCVPLDYKWSGVNCTYVDNETPKIISLDLSTSGLTGEILEF 427
Query: 417 IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP-NLCLSASCKGKKNK 469
I LTS+E LDLSNNSLTGSVPEFLA ++ L+++ + GN N + A+ K+ +
Sbjct: 428 ISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELNGSIPATLLDKERR 482
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 3.4e-167, Sum P(2) = 3.4e-167
Identities = 188/469 (40%), Positives = 278/469 (59%)
Query: 1 FISIDCG-IPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG +P+ YT+ T I Y SD ID+G+ KI+ + + ++ ++ +RSFP
Sbjct: 29 FISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQFQQQVWA-VRSFPV 87
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G RNCY + +++ K+LIR F+YGNY+G ++ PSF+L + + W SV+ +
Sbjct: 88 GQRNCYNVNLTANN-KYLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNTSMH 146
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EIIH+ ++ + VCLV T TPFIS+LE+RPL N +Y+TQSGSL + R S+++
Sbjct: 147 EIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLTQSGSLMLFARVYFPSSSSSF 206
Query: 180 FRYPDDVYDRIW--FPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLS 237
RY +D++DR+W F + W IST + ++ ++ P +VM++A +P N +L
Sbjct: 207 IRYDEDIHDRVWNSFTDDETVW--ISTDLPIDTSNSYDMPQSVMKTAAVPKNASEPWLLW 264
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKL-WYGPLSPSYLDTDTVFSTTP 296
W ++YVY +F+E ++ A N+TR+ NI NG L W+ L P L T+F+
Sbjct: 265 WTLDENTAQSYVYMHFAEVQNLTA-NETREFNITYNGGLRWFSYLRPPNLSISTIFNPRA 323
Query: 297 TMNRDR-HDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKIS 355
+ + + T NS LPP+LNALEIY V + LQL TN+ +V
Sbjct: 324 VSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKDEV--------------- 368
Query: 356 VDAIMNIKSKYELLR--DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEI 413
A+MNIK Y L + WQGDPCAP Y W+GLNCSY ++ RI SLNL+ S + G I
Sbjct: 369 -SAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGSI 427
Query: 414 LPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNLCLSA 461
I LT + LDLSNN L+G +P F AE++ L+++ + GNPNL L+A
Sbjct: 428 TSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTA 476
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1610 (571.8 bits), Expect = 1.8e-165, P = 1.8e-165
Identities = 352/760 (46%), Positives = 461/760 (60%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
FISIDCGIP++++YTD T + YVSD +++G SH I S+ ERQF N+RSFPEG
Sbjct: 27 FISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSHSIVSDLQTTSLERQFQNVRSFPEG 86
Query: 61 IRNCYTLKPDSDHE-KFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
RNCY ++P K+LIR RFMYGNY+G K P F+L + A++W+SV + +I++K
Sbjct: 87 KRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVLINETAIMTK 146
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EII+ P ++IHVCLV+ + GTPF+S LE+R L N TY T +L RWD G+ TN
Sbjct: 147 EIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLKNDTYDTPYEALMLGRRWDFGTATNLQ 206
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN--FQPPSTVMQSAVIPANGGSSLMLS 237
RY DD YDRIW P+ ++TS + T + F+P S VM+SA+ P N + L +
Sbjct: 207 IRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNHNGFRPASIVMRSAIAPGNESNPLKFN 266
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPT 297
W P + K Y+Y +F+E E +N+TR+ +IYIN + P YL TDT ST
Sbjct: 267 WAPDDPRSKFYIYMHFAEVR-ELQRNETREFDIYINDVILAENFRPFYLFTDTR-STVDP 324
Query: 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISV- 356
+ R ++I++ T S LPPI+NA+EIYQ+ EFLQL T+QQDV + + +K +
Sbjct: 325 VGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIKFKYRVKKNWQ 384
Query: 357 -DAIMNIKSKYELLRDWQGDP-CAPNDYLWQ----GLNCSYDANQA--PRIKSLNLSSSG 408
D + + + +E L D +P GL D A I L+LS++
Sbjct: 385 GDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNS 444
Query: 409 IAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQ---FLRVLVDGNPNLCLSASCKG 465
+ G++ + SL ++ L+L N LTGS+P L E L + GNP+LC S SC+
Sbjct: 445 LTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQT 504
Query: 466 ---KKNKFIVPXXXXXXXXXXXXXXXXXXXXXXXXKQELC----PVG-KKGSLELKNRKL 517
KK +IVP + P+G G L+ R
Sbjct: 505 TTKKKIGYIVPVVASLAGLLIVLTALALIWHFKKRSRRGTISNKPLGVNTGPLDTAKRYF 564
Query: 518 SYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA 577
Y+ V+ ITNNFERVLGKGGFG VYHG+L+ QVAVK+LS S QGYK+F+AEVELLMR
Sbjct: 565 IYSEVVNITNNFERVLGKGGFGKVYHGFLNGDQVAVKILSEESTQGYKEFRAEVELLMRV 624
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNXXXXXXXXXXXXPTDAEDKTGILSWKGRLQI 637
HH NLT L+GYC+E+ M L+YE+MANGN ILSW+ RLQI
Sbjct: 625 HHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGKSSL----------ILSWEERLQI 674
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ ++AQGLEYLH GCKPPIVHRDVK ANILLNE QAK+ADFGLSR FPVEG S VST V
Sbjct: 675 SLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVV 734
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 737
GT GYLDPEYY + ++ EKSDVYSFGVVLLE+ITG+P I
Sbjct: 735 AGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAI 774
|
|
| TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 4.1e-162, Sum P(2) = 4.1e-162
Identities = 177/365 (48%), Positives = 235/365 (64%)
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL- 457
+++L+LS++ + G + + L S+ ++LS N+L+GSVP+ L + + L++ ++GN L
Sbjct: 441 LQNLDLSNNNLTGGVPEFLAGLKSLLVINLSGNNLSGSVPQTLLQKKGLKLNLEGNIYLN 500
Query: 458 CLSASCKGK------KNK----FIVPXXXXXXXXXXXXXXXXXXXXXXXXKQELCPVGKK 507
C SC K K K +V + E+ +
Sbjct: 501 CPDGSCVSKDGNGGAKKKNVVVLVVVSIALVVVLGSALALFLVFRKRKTPRNEVSRTSRS 560
Query: 508 --GSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGY 564
++ KNR+ +Y+ V+K+TNNFE++LGKGGFG VYHG ++D +QVAVKMLSPSS QGY
Sbjct: 561 LDPTITTKNRRFTYSEVVKMTNNFEKILGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGY 620
Query: 565 KQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNXXXXXXXXXXXXPTDAED 624
K+F+AEVELL+R HHKNL LVGYCDE + L+YE+MA G+
Sbjct: 621 KEFKAEVELLLRVHHKNLVGLVGYCDEGENLSLIYEYMAKGDLKEHML---------GNQ 671
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
IL WK RL+I ESAQGLEYLH+GCKPP+VHRDVK+ NILL+E FQAKLADFGLSR
Sbjct: 672 GVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRS 731
Query: 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744
FP+EG + V T V GTPGYLDPEYY +N L EKSDVYSFG+VLLE+IT Q VI ++ E+
Sbjct: 732 FPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQHVINQSREKP 791
Query: 745 LIGQW 749
I +W
Sbjct: 792 HIAEW 796
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1575 (559.5 bits), Expect = 9.3e-162, P = 9.3e-162
Identities = 338/761 (44%), Positives = 468/761 (61%)
Query: 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEG 60
F+SIDCGIPE+++Y D T I YVSDA+ +++G H I EF E+QF N+RSFPEG
Sbjct: 31 FVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQFQNVRSFPEG 90
Query: 61 IRNCYTLKPDSDHE-KFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
RNCY +KP K+LIR RFMYGNY+ K P F+L L ++WDSV ++ +IV+K
Sbjct: 91 NRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTIDNATTIVTK 150
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EIIH + +++HVCLV+ + GTPF+SALE+R L + TY T SL + RWD+G
Sbjct: 151 EIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDSLILFKRWDLGGLGALP 210
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN--FQPPSTVMQSAVIPANGGSSLMLS 237
RY DDV+DRIW P F + + S + S N FQP VM +A P + ++ S
Sbjct: 211 VRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFS 270
Query: 238 WKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGK-LWYGPLSPSYLDTDTVFSTTP 296
W+P + K +VY +F+E E N+TR+ + +N K + SP YL TDT+F P
Sbjct: 271 WEPKDPTWKYFVYMHFAEVV-ELPSNETREFKVLLNEKEINMSSFSPRYLYTDTLFVQNP 329
Query: 297 TMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISV 356
++ + + + T S LPPI+NA+E Y+V EFLQ T+QQDV I+ + +K S
Sbjct: 330 -VSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSW 388
Query: 357 --DAIMNIKSKYELLRDWQGDPCAPN----DYLWQGLNCSYDA--NQAPRIKSLNLSSSG 408
D +K ++ + D +P + GL DA + + L+LS++
Sbjct: 389 LGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNS 448
Query: 409 IAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL---VDGNPNLCLSASC-- 463
+ G+I + +L ++ L+L N L+G++P L E +++ +DGNP+LC+SASC
Sbjct: 449 LTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQI 508
Query: 464 ---KGKKNKFIVPXXXXXXXXXXXXXXXXXXXXXXXXKQELCPVG-KKGSLELKNRKLSY 519
K KKN +I+P + G + G L+ R Y
Sbjct: 509 SDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYKKRHRRGGSGGVRAGPLDTTKRYYKY 568
Query: 520 ANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH 579
+ V+K+TNNFERVLG+GGFG VYHG L+D QVAVK+LS SS QGYK+F+AEVELL+R HH
Sbjct: 569 SEVVKVTNNFERVLGQGGFGKVYHGVLNDDQVAVKILSESSAQGYKEFRAEVELLLRVHH 628
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNXXXXXXXXXXXXPTDAEDKTGILSWKGRLQIAT 639
KNLT L+GYC E KM L+YEFMANG +K+ +LSW+ RLQI+
Sbjct: 629 KNLTALIGYCHEGKKMALIYEFMANGTLGDYLSG----------EKSYVLSWEERLQISL 678
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
++AQGLEYLH+GCKPPIV RDVK ANIL+NEK QAK+ADFGLSR ++G + +T V G
Sbjct: 679 DAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAG 738
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740
T GYLDPEY+++ +L+EKSD+YSFGVVLLE+++GQPVI ++
Sbjct: 739 TIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARS 779
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 783 (280.7 bits), Expect = 1.2e-159, Sum P(3) = 1.2e-159
Identities = 153/248 (61%), Positives = 186/248 (75%)
Query: 503 PVGKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSV 561
P + ++ KNR+ +Y+ V +TNNF+R+LGKGGFG VYHG+++ +QVAVK+LS SS
Sbjct: 534 PRSSEPAIVTKNRRFTYSQVAIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSS 593
Query: 562 QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNXXXXXXXXXXXXPTD 621
QGYK+F+AEVELL+R HHKNL LVGYCDE M L+YE+MANG+
Sbjct: 594 QGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFT-- 651
Query: 622 AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681
L+W RL+I ESAQGLEYLH+GCKPP+VHRDVK+ NILLNE FQAKLADFGL
Sbjct: 652 -------LNWGTRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFQAKLADFGL 704
Query: 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741
SR FP+EG +HVST V GTPGYLDPEYY +N LTEKSDVYSFG+VLLELIT +PVI K+
Sbjct: 705 SRSFPIEGETHVSTVVAGTPGYLDPEYYKTNWLTEKSDVYSFGIVLLELITNRPVIDKSR 764
Query: 742 ERTLIGQW 749
E+ I +W
Sbjct: 765 EKPHIAEW 772
|
|
| TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 1.6e-158, Sum P(2) = 1.6e-158
Identities = 192/478 (40%), Positives = 276/478 (57%)
Query: 1 FISIDCG-IPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG IP++ YT+ IT I Y+SDA ID+G++ +IS + ++ ++ ++ LRSFPE
Sbjct: 29 FISLDCGLIPKDTTYTEQITNITYISDADYIDSGLTERISDSYKSQLQQQTWT-LRSFPE 87
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G RNCY ++ K+LIR F+YGNY+G ++ P F+L + + W SV +
Sbjct: 88 GQRNCYNFNLKANL-KYLIRGTFVYGNYDGLNQMPKFDLHIGPNKWTSVILEGVANATIF 146
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EIIH+ ++ + VCLV T TPFIS+LELRPL N TY+TQ GSL + R T
Sbjct: 147 EIIHVLTQDRLQVCLVKTGQTTPFISSLELRPLNNDTYVTQGGSLMSFARIYFPKTAY-F 205
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN-FQPPSTVMQSAVIPANGGSSLMLSW 238
RY DD+YDR+W P + +ST+ + ++ N + P V SA+IPA L + W
Sbjct: 206 LRYSDDLYDRVWVPFSQNETVSLSTNLPVDTSSNSYNVPQNVANSAIIPAEATHPLNIWW 265
Query: 239 KPANRMIKNYVYFYFSEFESERAKNQTRDLNI-YINGKLWYGPLSPSYLDTDTVFSTTPT 297
N +YVY +F+E ++ +A N R+ NI Y G++W + P L T+ S T
Sbjct: 266 DLQNINAPSYVYMHFAEIQNLKA-NDIREFNITYNGGQVWESSIRPHNLSITTISSPTAL 324
Query: 298 MNRDRH-DIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISV 356
+ D + T S LPP++NALE+Y + E L LL QD V
Sbjct: 325 NSSDGFFNFTFTMTTTSTLPPLINALEVYTLVENL-LLETYQD---------------EV 368
Query: 357 DAIMNIKSKYELLR--DWQGDPCAPNDYLWQGLNCSY-DANQAPRIKSLNLSSSGIAGEI 413
A+MNIK Y L + WQGDPC+P Y W+GLNC Y D++Q P I SLNL +SG+ G I
Sbjct: 369 SAMMNIKKTYGLSKKISWQGDPCSPQIYRWEGLNCLYLDSDQ-PLITSLNLRTSGLTGII 427
Query: 414 LPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP--NLCLSASCKGKKN 468
I +L + LDLS+N L+G +P+FLA+++ L ++ + GNP NL + S K + N
Sbjct: 428 THDISNLIQLRELDLSDNDLSGEIPDFLADMKMLTLVNLKGNPKLNLTVPDSIKHRIN 485
|
|
| TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 4.8e-157, Sum P(2) = 4.8e-157
Identities = 179/462 (38%), Positives = 269/462 (58%)
Query: 1 FISIDCGIPE-NANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPE 59
FIS+DCG+ + Y TG+ Y SDA + +G + +++ EF + + ++ LR FPE
Sbjct: 26 FISVDCGLSLLESPYDAPQTGLTYTSDADLVASGKTGRLAKEF-EPLVDKPTLTLRYFPE 84
Query: 60 GIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDSGSIVSK 119
G+RNCY L SD +LI+A F+YGNY+G + P+FNL L ++W +V D+ +
Sbjct: 85 GVRNCYNLNVTSD-TNYLIKATFVYGNYDGLNVGPNFNLYLGPNLWTTVSSNDT----IE 139
Query: 120 EIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKT 179
EII + + + VCLV T PFI+ LELRP+ Y+TQSGSL R + +++ +
Sbjct: 140 EIILVTRSNSLQVCLVKTGISIPFINMLELRPMKKNMYVTQSGSLKYLFRGYISNSSTR- 198
Query: 180 FRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWK 239
R+PDDVYDR W+P SW Q++T+ + ++ ++ P +VM A P +L ++W
Sbjct: 199 IRFPDDVYDRKWYPLFDDSWTQVTTNLKVNTSITYELPQSVMAKAATPIKANDTLNITWT 258
Query: 240 PANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTM- 298
+ Y Y + +E ++ RA N+TR+ N+ +NG+ +GP SP L T ++ +P
Sbjct: 259 VEPPTTQFYSYVHIAEIQALRA-NETREFNVTLNGEYTFGPFSPIPLKTASIVDLSPGQC 317
Query: 299 NRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDA 358
+ R + + T S LPP+LNA+E + V +F Q+ TN+ DV
Sbjct: 318 DGGRCILQVVKTLKSTLPPLLNAIEAFTVIDFPQMETNENDVA----------------G 361
Query: 359 IMNIKSKYELLR-DWQGDPCAPNDYLWQGLNC-SYDANQAPRIKSLNLSSSGIAGEILPH 416
I N++ Y L R WQGDPC P LW GLNC + D + P I SL+LSSSG+ G I
Sbjct: 362 IKNVQGTYGLSRISWQGDPCVPKQLLWDGLNCKNSDISTPPIITSLDLSSSGLTGIITQA 421
Query: 417 IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNL 457
I +LT ++ LDLS+N+LTG VPEFLA+++ L V+ + GN NL
Sbjct: 422 IKNLTHLQILDLSDNNLTGEVPEFLADIKSLLVINLSGN-NL 462
|
|
| TAIR|locus:2195830 AT1G51870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 788 (282.4 bits), Expect = 4.8e-157, Sum P(2) = 4.8e-157
Identities = 151/241 (62%), Positives = 185/241 (76%)
Query: 509 SLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQ 568
S+ K+RK++Y VLK+TNNFERVLGKGGFGTVYHG ++D QVAVKMLS SS QGYK+F+
Sbjct: 513 SIMRKDRKITYPQVLKMTNNFERVLGKGGFGTVYHGNMEDAQVAVKMLSHSSAQGYKEFK 572
Query: 569 AEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNXXXXXXXXXXXXPTDAEDKTGI 628
AEVELL+R HH++L LVGYCD+ + L+YE+MANG+ +
Sbjct: 573 AEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMLGKRGG---------NV 623
Query: 629 LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
L+W+ R+QIA E+AQGLEYLH+GC PP+VHRDVK+ NILLN + AKLADFGLSR FP++
Sbjct: 624 LTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNAQCGAKLADFGLSRSFPID 683
Query: 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
G HVST V GTPGYLDPEYY +N L+EKSDVYSFGVVLLE++T QPVI +T ER I +
Sbjct: 684 GECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVINQTRERPHINE 743
Query: 749 W 749
W
Sbjct: 744 W 744
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 8.0e-155, Sum P(2) = 8.0e-155
Identities = 193/466 (41%), Positives = 272/466 (58%)
Query: 1 FISIDCGI-P-ENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFP 58
FIS+DCG+ P E + Y + TG+ ++SD+S I +G +I + + Q + LR FP
Sbjct: 28 FISLDCGLSPNEQSPYVELETGLQFLSDSSFIQSGKIGRIDASLESKYPRSQ-TTLRYFP 86
Query: 59 EGIRNCYTLKPDSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPDS-GSIV 117
+GIRNCY + +LIRA YGNY+G + P F+L + + W ++ G
Sbjct: 87 DGIRNCYNVNVYKG-TNYLIRATINYGNYDGLNISPRFDLYIGPNFWVTIDLEKHVGGDT 145
Query: 118 SKEIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTN 177
+EIIHIPK + VCL+ T + TP IS LELR LPN TY+T+SGSL R + S +
Sbjct: 146 WEEIIHIPKSNSLDVCLIKTGTSTPIISVLELRSLPNNTYITESGSLKSILRSYL-SVST 204
Query: 178 KTFRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGN-FQPPSTVMQSAVIPANGGSSLML 236
K RYPDD YDR W P+ W QIST + +T N F P V+ +A +P+N +S+ L
Sbjct: 205 KVIRYPDDFYDRKWVPYFESEWRQISTILKVNNTINGFLAPQEVLMTAAVPSN--ASVPL 262
Query: 237 SWKPANRMIKN--YVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTVFST 294
S+ K+ Y YF+FSE + +A NQ+R+ +I NG++ LSP YL T++S
Sbjct: 263 SFTKDLEFPKDKLYFYFHFSEIQPLQA-NQSREFSILWNGEIIIPTLSPKYLKASTLYSV 321
Query: 295 TPTMNRDRHDII-INTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIK 353
+P + ++ + T+NS LPP+L A+E++ V +F Q TN+ DV
Sbjct: 322 SPFVCEVGKCLLELKRTQNSTLPPLLTAIEVFTVIDFPQSKTNEDDV------------- 368
Query: 354 ISVDAIMNIKSKYELLR-DWQGDPCAPNDYLWQGLNCSYDAN--QAPRIKSLNLSSSGIA 410
AI NIK + L R WQGDPC P +LW+GL+C+ D N +PRI SLNLSSSG+
Sbjct: 369 ---SAIKNIKDTHGLSRVSWQGDPCVPRQFLWEGLSCN-DKNVSASPRITSLNLSSSGLV 424
Query: 411 GEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456
G I I + T +E LDLSNN+LTG VPEFLA+++ L + +D N
Sbjct: 425 GTIPSGIQNFTLLEKLDLSNNNLTGLVPEFLAKMETL-LFIDLRKN 469
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034228001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (853 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 749 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-119 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 362 bits (931), Expect = e-119
Identities = 157/340 (46%), Positives = 204/340 (60%), Gaps = 21/340 (6%)
Query: 4 IDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFPEGIRN 63
IDCG+P N +YTD TGI +VSDA IDTG S IS E + + + LRSFP+G RN
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRN 60
Query: 64 CYTLKPDSDHE-KFLIRARFMYGNYNGQDK---PPSFNLMLEADVWDSVQF-PDSGSIVS 118
CYTL K+LIRA F+YGNY+G + PPSF+L L ++W +V DSG V
Sbjct: 61 CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVV 120
Query: 119 KE-IIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTY--MTQSGSLSRYGRWDVGST 175
KE IIH+ K + + VCLVNT +GTPFISALELRPLP+ Y S +L R + G
Sbjct: 121 KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGSQALKLVARLNFGG- 179
Query: 176 TNKTFRYPDDVYDRIWFP-HNFYSWAQISTSSNMKSTGN---FQPPSTVMQSAVIPANGG 231
+ T RYPDDVYDRIW P + W+QISTS ++ + N + PPS V+Q+AV P N
Sbjct: 180 SEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNAS 239
Query: 232 SSLMLSWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTV 291
+ L +W + + YVY +F+E +S +TR+ +IYINGK YG +SP YL TDT
Sbjct: 240 APLNFTWDLVDPNFEYYVYLHFAEIQS----LETREFDIYINGKTVYGDVSPKYLGTDTG 295
Query: 292 FSTTPT----MNRDRHDIIINTTENSALPPILNALEIYQV 327
+I + T S LPP+LNALEI++V
Sbjct: 296 ALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 6e-48
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-KQFQAEVELLMRAHHKNLTIL 585
LG+G FG VY K VA+K++ ++ ++ E+++L + H N+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
++ K+ LV E+ G+L L K G LS + L
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLL------------KKRGRLSEDEARFYLRQILSAL 110
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
EYLH IVHRD+K NILL+E KLADFGL+R TT VGTP Y+
Sbjct: 111 EYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMA 164
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + + D++S GV+L EL+TG+P
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 4e-45
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SPSSVQGYKQFQAEVELLMRAHHKN 581
+ LG+G FG VY G L K +VAVK L +S Q ++F E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C E + +V E+M G+L ++L LS L A +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-----------RKNRPKLSLSDLLSFALQI 111
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
A+G+EYL +HRD+ + N L+ E K++DFGLSR + G
Sbjct: 112 ARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGK 164
Query: 702 G---YLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
++ PE + T KSDV+SFGV+L E+ T
Sbjct: 165 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 72/203 (35%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTILVGYC 589
LG+GGFGTVY K+VA+K++ + E+E+L + +H N+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
++ + LV E+ G+L+ L ++ G LS L+I + +GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL-----------KENEGKLSEDEILRILLQILEGLEYLH 109
Query: 650 DGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
I+HRD+K NILL+ + KLADFGLS++ + T+VGTP Y+ PE
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEV 164
Query: 709 YISNR-LTEKSDVYSFGVVLLEL 730
+ +EKSD++S GV+L EL
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 71/231 (30%), Positives = 103/231 (44%), Gaps = 33/231 (14%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKN 581
+ LG+G FG VY G L +VAVK L + + ++ F E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C + + +V E+M G+L L L+ K LQ+A +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-----------RKHGEKLTLKDLLQMALQI 111
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
A+G+EYL VHRD+ + N L+ E K++DFGLSR
Sbjct: 112 AKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGG 163
Query: 702 GYLD-----PEYYISNRLTEKSDVYSFGVVLLELITG--QPVIQKTPERTL 745
G L PE + T KSDV+SFGV+L E+ T QP + E L
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 214
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 74/218 (33%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 531 RVLGKGGFGTVYHGYLDDK-----QVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTI 584
+ LG+G FG VY G L K +VAVK L S + K F E ++ + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L+G C E + LV E+M G+L +L P + LS K L A + A+G
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKS---RPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG-- 702
+EYL VHRD+ + N L+ E K++DFGLSR T G
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRD-----VYDDDYYRKKTGGKL 169
Query: 703 ---YLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
++ PE T KSDV+SFGV+L E+ T P
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SPSSVQGYKQFQAEVELLMRAHHKN 581
+ LG+G FG VY G L K +VAVK L +S Q ++F E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C E + +V E+M G+L +L K LS L A +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--------KNRPKE--LSLSDLLSFALQI 112
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
A+G+EYL +HRD+ + N L+ E K++DFGLSR + V G
Sbjct: 113 ARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGK 165
Query: 702 G---YLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
++ PE + T KSDV+SFGV+L E+ T
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 78/213 (36%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 529 FERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTI 584
R LG G FGTVY K VAVK+L S + + + E+ +L R H N+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L+ ++ + LV E+ G+L +L G LS +IA + +G
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRG------------GPLSEDEAKKIALQILRG 110
Query: 645 LEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
LEYLH G I+HRD+K NILL+E K+ADFGL++ S TT VGTP Y
Sbjct: 111 LEYLHSNG----IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWY 164
Query: 704 LDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
+ PE + K DV+S GV+L EL+TG+P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 531 RVLGKGGFGTVYHGYLDD--KQVAVK--MLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+LG+G FG+VY D + +AVK LS S + + + E+ +L H N+ V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI---V 62
Query: 587 GY----CDENTKMGLVY-EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
Y DE ++ E+++ G+L + LL + LP E + QI
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLP---EPVIRKYT----RQIL--- 111
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+GL YLH IVHRD+K ANIL++ KLADFG ++ + +V GTP
Sbjct: 112 -EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736
++ PE +D++S G ++E+ TG+P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 531 RVLGKGGFGTVY---HGYLDDKQVAVK--MLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
+ +GKG FG VY D K +K LS S + + EV++L + +H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI--- 61
Query: 586 VGYCD---ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+ Y + E K+ +V E+ G+L + Q E++ IL W +Q+
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ--ILDW--FVQLCL--- 114
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
L+YLH I+HRD+K NI L KL DFG+S++ ++ TVVGTP
Sbjct: 115 -ALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPY 168
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
YL PE + KSD++S G VL EL T + + L
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+GKGGFG VY K+VA+K++ S + ++ E+++L + H N+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
+ ++ +V EF + G+L+ L + E + + E +GLEYL
Sbjct: 66 YLKKDELWIVMEFCSGGSLKD--LLKSTNQTLT-ESQIAY--------VCKELLKGLEYL 114
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
H I+HRD+K+ANILL + KL DFGLS + T+VGTP ++ PE
Sbjct: 115 H---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEV 168
Query: 709 YISNRLTEKSDVYSFGVVLLELITGQP 735
K+D++S G+ +EL G+P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 35/215 (16%)
Query: 532 VLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVG 587
++G+G FG VY G VA+K +S + + K E++LL H N+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ---IATESAQ- 643
+ + + ++ E+ NG+L+ I+ G +A Q
Sbjct: 67 SIETSDSLYIILEYAENGSLR------------------QIIKKFGPFPESLVAVYVYQV 108
Query: 644 --GLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
GL YLH+ G ++HRD+K+ANIL + KLADFG++ S +VVGT
Sbjct: 109 LQGLAYLHEQG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGT 162
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
P ++ PE + + SD++S G ++EL+TG P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 76/229 (33%), Positives = 110/229 (48%), Gaps = 35/229 (15%)
Query: 529 FERVLGKGGFGTVYHGYL------DDK-QVAVKMLS-PSSVQGYKQFQAEVELLMRAHHK 580
+R LG+G FG V+ G +DK VAVK L +S K F+ E ELL H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLA---QLAILPTDAEDKTGILSWKGRLQI 637
N+ G C E +V+E+M +G+L L + A L + + G L+ LQI
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP-DSPMGELTLSQLLQI 127
Query: 638 ATESAQGLEYL---HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVE 688
A + A G+ YL H VHRD+ + N L+ K+ DFG+SR + V
Sbjct: 128 AVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G + + ++ PE + + T +SDV+SFGVVL E+ T QP
Sbjct: 182 GHTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 530 ERVLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
ER LG G FG V+ G + + +VA+K+L + + FQ EV+ L R HK+L L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
C + ++ E M G+L A L E + L + +A + A+G+ YL
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL--------RSPEGQV--LPVASLIDMACQVAEGMAYL 120
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGSHVSTTVVGTPGYLDP 706
+ +HRD+ + NIL+ E K+ADFGL+R+ V S T P
Sbjct: 121 EE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----P 173
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + KSDV+SFG++L E+ T
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 75/233 (32%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 528 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSP---SSVQGYKQFQAEVELLMR-AHHKNLT 583
R LG+G FG VY D K VA+K+L+ S + ++F E+++L H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L + + + LV E++ G+L+ L + G LS L I +
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLL---------KKIGRKGPLSESEALFILAQILS 112
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGS----HVSTTVV 698
LEYLH I+HRD+K NILL+ KL DFGL+++ P G + + +T V
Sbjct: 113 ALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 699 GTPGYLDPEYYISNRL---TEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
GTPGY+ PE + L + SD++S G+ L EL+TG P + + Q
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ-------VAVKMLSPS-SVQGYKQFQAEVELLMRAHHK 580
F LG+G FG VY G L VA+K L + + ++F+ E EL+ H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG----ILSWKGRLQ 636
N+ L+G C + +++E++A+G+L L+ AE L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 637 IATESAQGLEYL--HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH-- 692
IA + A G+EYL H VHRD+ + N L+ E K++DFGLSR + S
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADY 179
Query: 693 --VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
V + + ++ PE + + T +SD++SFGVVL E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 533 LGKGGFGTVY---HGYLDDKQV-AVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
LGKG FG V D ++ A+K+L + K+ + E +L R +H + L
Sbjct: 1 LGKGSFGKVLLVRK--KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
K+ LV E+ G L +HL + A R A E L
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-----------RFYAA-EIVLAL 106
Query: 646 EYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
EYLH G I++RD+K NILL+ KL DFGL++ EG + T GTP YL
Sbjct: 107 EYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYL 160
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + + D +S GV+L E++TG+P
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKML-SPSSVQGYKQFQAEVELLMRAHHKN 581
++ ERV LG+G G VY K A+K + + KQ E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ G + ++ +V E+M G+L A LL ++ +P +L+ IA +
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEP------VLA-----YIARQI 108
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+GL+YLH I+HRD+K +N+L+N K + K+ADFG+S++ +E T VGT
Sbjct: 109 LKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTV 164
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y+ PE + +D++S G+ LLE G+
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 44/233 (18%)
Query: 517 LSYANVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELL 574
+S + ++ N E+ +G+G G VY K+VA+K + Q + E+ ++
Sbjct: 12 VSEGDPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIM 69
Query: 575 MRAHHKNLTILVGYCDENTKMG---LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSW 631
H N+ V Y D +V E+M G+L T I++
Sbjct: 70 KDCKHPNI---VDYYDSYLVGDELWVVMEYMDGGSL------------------TDIITQ 108
Query: 632 -KGRL---QIAT---ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
R+ QIA E QGLEYLH ++HRD+KS NILL++ KLADFG
Sbjct: 109 NFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFG---- 161
Query: 685 FPVEGGSHVS--TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
F + S +VVGTP ++ PE K D++S G++ +E+ G+P
Sbjct: 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 19/202 (9%)
Query: 533 LGKGGFGTVYHGY-LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE 591
+G G FG V+ GY L+ ++VA+K + ++ + F E +++M+ H L L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG 651
+ + LV+EFM +G L +L AQ G S + L + + +G+ YL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-----------RGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 652 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDPEYYI 710
++HRD+ + N L+ E K++DFG++R V + S+T P + PE +
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 711 SNRLTEKSDVYSFGVVLLELIT 732
++ + KSDV+SFGV++ E+ +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQA---EVELLMR-AHHKNL 582
F +++G+G F TV +K+ A+K+L + K+ + E E+L R H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L + + V E+ NG L ++ K G L K A E
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIR------------KYGSLDEKCTRFYAAEIL 112
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF---------------- 685
LEYLH G I+HRD+K NILL++ K+ DFG +++
Sbjct: 113 LALEYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 686 --PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+E + VGT Y+ PE + SD+++ G ++ +++TG+P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
F + LG G FG V+ G K VA+KM+ ++ F E +++M+ H NL L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C + + +V E+MANG L +L + L T L L + ++ + +EY
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKL------GTEWL-----LDMCSDVCEAMEY 115
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
L +HRD+ + N L+ E K++DFGL+R V + S+ P + P
Sbjct: 116 LESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPP 170
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITG 733
E + +R + KSDV+SFGV++ E+ +
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 530 ERVLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
ER LG G FG V+ G + +VAVK L P ++ + F E +++ + H L L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
C E + +V E+M+ G+L L + L + +A + A+G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFL----------KSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI-------------FPVEGGSHVST 695
+HRD+ + NIL+ E K+ADFGL+R+ FP++
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------- 169
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ PE R T KSDV+SFG++L E++T
Sbjct: 170 -------WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 37/207 (17%)
Query: 533 LGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN 592
+GKG FG V G ++VAVK L S + F AE ++ H NL L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC 652
+ +V E+MA G+L +L ++ +++ +L A + +G+EYL +
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSR----------GRAVITLAQQLGFALDVCEGMEYLEE-- 120
Query: 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRI---------FPVEGGSHVSTTVVGTPGY 703
VHRD+ + N+L++E AK++DFGL++ PV+ +
Sbjct: 121 -KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------------W 165
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLEL 730
PE + + KSDV+SFG++L E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 532 VLGKGGFGTVYHGYLDDKQ-VAVKM--LSPSSV----QGYKQFQAEVELLMRAHHKNLTI 584
VLGKG +GTVY G + Q +AVK L S+V + Y++ Q EV+LL H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+G C ++ + + EF+ G++ + +L + LP + K QI G
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPE-------PVFCKYTKQIL----DG 114
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSH--VSTTVVGT 700
+ YLH+ C +VHRD+K N++L KL DFG +R G G+H + ++ GT
Sbjct: 115 VAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741
P ++ PE + KSD++S G + E+ TG+P +
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 71/222 (31%), Positives = 101/222 (45%), Gaps = 21/222 (9%)
Query: 529 FERVLGKGGFGTVYHG-------YLDDKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
+ R +G+G FG V+ Y VAVKML +S FQ E L+ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHL-------LAQLAILPTDAEDKTG---ILS 630
N+ L+G C M L++E+MA G+L L L+ + A LS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
+L IA + A G+ YL + VHRD+ + N L+ E K+ADFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
S ++ PE NR T +SDV+++GVVL E+ +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
R LG G FG V+ G ++ VAVK L P ++ K F AE +++ + H L L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYA 68
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C + +V E M G+L +L L + +A + A G+ Y
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYL----------QGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP---GYL 704
L +HRD+ + N+L+ E K+ADFGL+R+ + G +
Sbjct: 119 LE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWT 171
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + NR + KSDV+SFG++L E++T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 529 FERVLGKGGFGTVYHGYLD---DKQ---VAVKMLSPSSV-QGYKQFQAEVELLMRAHHKN 581
F + LG+G FG V D D VAVK L+ S Q F+ E+E+L H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 582 LTILVGYCDENTKMG--LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ G C++ L+ E++ +G+L+ +L + I K L ++
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----------QRHRDQINL-KRLLLFSS 116
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+ +G++YL +HRD+ + NIL+ + K++DFGL+++ P + +
Sbjct: 117 QICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 700 TPG-YLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+P + PE +++ + SDV+SFGV L EL T
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
LG G +G VY G VAVK L +++ ++F E ++ H NL L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD 650
++ EFM GNL +L + ++ ++ L +AT+ + +EYL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRE------CNRQEVNAVV----LLYMATQISSAMEYLE- 121
Query: 651 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDPEYY 709
K +HRD+ + N L+ E K+ADFGLSR+ + G ++ + P + PE
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESL 177
Query: 710 ISNRLTEKSDVYSFGVVLLELIT 732
N+ + KSDV++FGV+L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-23
Identities = 118/462 (25%), Positives = 192/462 (41%), Gaps = 86/462 (18%)
Query: 50 QFSNLRSFP--EGIRNCYTLKP-DSDHEKFLIRARFMYGNYNGQDKPPSFNLMLEADVWD 106
LR FP +G NCY + H + +R F D P F++ +E
Sbjct: 68 PLKTLRYFPLSDGPENCYNINRVPKGH--YSVRVFFGLVAEPNFDSEPLFDVSVEGTQIS 125
Query: 107 SVQFPDSGS---IVSKEIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLTY-----M 158
S++ S + ++ ++ + +C +T G P I ++E+ + + Y
Sbjct: 126 SLKSGWSSHDEQVFAEALVFLTDGS-ASICFHSTGHGDPAILSIEILQVDDKAYNFGPSW 184
Query: 159 TQSGSLSRYGRWDVGSTTNK-TFRYPDDVY--DRIWFPHNFYSWAQ---ISTSSNMKSTG 212
Q L R G+ +K Y D + DR W + IST + +K
Sbjct: 185 GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKAS 244
Query: 213 ---NFQPPSTVMQSAVIPANGGSSL--MLSWKPANRMIKNY-VYFYFSEFESERAKNQTR 266
NF P S + QSA++ + L + P NR NY V+ +F+E ++ R
Sbjct: 245 NAPNFYPES-LYQSALVSTDTQPDLSYTMDVDP-NR---NYSVWLHFAEIDNSITAEGKR 299
Query: 267 DLNIYINGKLWYGPLSPSYLD----TDTVFSTTPTMNRDRHDIIINTTENSALPPILNAL 322
++ ING + + + T V + T ++ I++ + + I+NA+
Sbjct: 300 VFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTH--AIINAI 357
Query: 323 EIYQV--KEFLQLLTNQQDVIMILFLYLFMHIKISVDAIMNIKSKYEL-LR-DWQGDPCA 378
E++++ E LL V A+ +KS L LR W GDPC
Sbjct: 358 EVFEIITAESKTLLE-------------------EVSALQTLKSSLGLPLRFGWNGDPCV 398
Query: 379 PNDYLWQGLNCSYDA-------------NQAPR------------IKSLNLSSSGIAGEI 413
P + W G +C +D+ NQ R ++S+NLS + I G I
Sbjct: 399 PQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI 458
Query: 414 LPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGN 454
P + S+TS+E LDLS NS GS+PE L +L LR+L ++GN
Sbjct: 459 PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 533 LGKGGFGTVY----HGYLDDKQ---VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
LG+G FG V+ H L ++ VAVK L +S + FQ E ELL H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQ---LAILPTDAEDKTGILSWKGRLQIATESA 642
G C E + +V+E+M +G+L L + IL + G L+ L IA++ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
G+ YL VHRD+ + N L+ + K+ DFG+SR V +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQ 738
++ PE + + T +SD++SFGVVL E+ T QP Q
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 530 ERVLGKGGFGTVYHGYLDDKQ--VAVKMLS-PSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+GKG FG VY VA+K++ + + Q E++ L + +T
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G + +K+ ++ E+ G+ LL + L E I E GLE
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSC-LDLL-KPGKLD---ETYIAF--------ILREVLLGLE 112
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-----TVVGTP 701
YLH+ K +HRD+K+ANILL+E+ KLADFG+S G ST T VGTP
Sbjct: 113 YLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTP 162
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
++ PE + EK+D++S G+ +EL G+P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 531 RVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTILVGY 588
+GKG FG VY G L +VAVK + K+ F E E+L + H N+ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
C + + +V E + G+L L + L K LQ++ ++A G+EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV-----------KKLLQMSLDAAAGMEYL 109
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH-VSTTVVGTP-GYLDP 706
+HRD+ + N L+ E K++DFG+SR EGG + VS + P + P
Sbjct: 110 ESKN---CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAP 164
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITG 733
E R T +SDV+S+G++L E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 532 VLGKGGFGTVY--HGYLDDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVG 587
+GKG FGTV D K + K + ++ + +Q +EV +L H N+ V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---VR 63
Query: 588 YCD-----ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
Y D N + +V E+ G+L A L+ + E++ W+ Q+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEF---IWRILTQLLL--- 116
Query: 643 QGLEYLHDGCKPP--IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
L H+ P ++HRD+K ANI L+ KL DFGL++I + S + T VGT
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGT 173
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
P Y+ PE EKSD++S G ++ EL P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 72/230 (31%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN 581
+R LG+G FG V+ D VAVK L ++ K FQ E ELL H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQ--LAILPTDAE--DKTGILSWKGRLQI 637
+ G C + + +V+E+M +G+L L A A++ D + G L L I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEG---GSHV 693
A++ A G+ YL VHRD+ + N L+ K+ DFG+SR ++ + G H
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTP 741
+ P PE + + T +SDV+SFGV+L E+ T QP Q +
Sbjct: 186 MLPIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 528 NFERVLGKGGFGTVYHGYLDDKQ--VAVKML----SPSSVQGYKQFQAEVELLMRAHHKN 581
V+G G VY VA+K + +SV + + EV+ + + +H N
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPN 60
Query: 582 LTILVGYCD--ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
++ Y ++ LV +++ G+L ++ P D+ I + +
Sbjct: 61 --VVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKS--SYPRGGLDEAIIAT------VLK 109
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGSHVSTTV 697
E +GLEYLH + +HRD+K+ NILL E K+ADFG+S + V T
Sbjct: 110 EVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 698 VGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 741
VGTP ++ PE K+D++SFG+ +EL TG K P
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 60/226 (26%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 517 LSYANVLKITNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGYKQ-FQ 568
+N+ +IT LG+G FG V+ + V VK L + + + F+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 569 AEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI 628
E+++ + HKN+ L+G C E ++ E+ G+L+ L A D + K
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATK---SKDEKLKPPP 113
Query: 629 LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPV 687
LS K ++ + T+ A G+++L + VHRD+ + N L++ + + K++ LS+ ++
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 688 EGGSHVSTTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
E + + P +L PE + + KSDV+SFGV++ E+ T
Sbjct: 171 EYYKLRNALI---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 76/213 (35%), Positives = 115/213 (53%), Gaps = 27/213 (12%)
Query: 531 RVLGKGGFGTVYHGYLDDK-----QVAVKMLSP-SSVQGYKQFQAEVELLMRA-HHKNLT 583
RV+GKG FG VYHG L D AVK L+ + ++ +QF E ++M+ H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE-GIIMKDFSHPNVL 59
Query: 584 ILVGYC--DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
L+G C E + + +V +M +G+L+ + + PT +D G LQ+A
Sbjct: 60 SLLGICLPSEGSPL-VVLPYMKHGDLR-NFIRSETHNPT-VKDLIGF-----GLQVA--- 108
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVSTTVVGT 700
+G+EYL VHRD+ + N +L+E F K+ADFGL+R I+ E S + T
Sbjct: 109 -KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 701 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P ++ E + + T KSDV+SFGV+L EL+T
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 528 NFE--RVLGKGGFGTVYH-GYLDDKQV-------AVKMLSPSSVQGYKQFQAEVELLMRA 577
+FE RV+GKG FG V D K++ K + SV+ E +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQEL 57
Query: 578 HHKNLTIL-VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+H L L + DE M LV + + G+L+ HL ++ +E++ +
Sbjct: 58 NHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKF----SEEQV-------KFW 105
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
I E LEYLH I+HRD+K NILL+E+ + DF ++ ++T+
Sbjct: 106 IC-EIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTS 158
Query: 697 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 733
GTPGY+ PE + D +S GV E + G
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ------VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL 582
F + LGKG FG+V D Q VAVK L S+ + + F+ E+E+L H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 583 TIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
V Y + LV E++ G+L+ +L L + L A++
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-----------RKLLLYASQ 116
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+G+EYL G K VHRD+ + NIL+ + + K+ DFGL+++ P + + V
Sbjct: 117 ICKGMEYL--GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY----KVRE 169
Query: 701 PG-----YLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PG + PE ++ + SDV+SFGVVL EL T
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 530 ERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLT 583
E+V+G G FG V G L + VA+K L S + F E ++ + H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L G ++ + ++ E+M NG+L L + G + + + A
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL-----------RENDGKFTVGQLVGMLRGIAS 117
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-TP- 701
G++YL + VHRD+ + NIL+N K++DFGLSR +E TT G P
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPI 172
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELI----------TGQPVIQK 739
+ PE + T SDV+SFG+V+ E++ + Q VI+
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 531 RVLGKGGFGTVY--HGYLDDKQVAVKM--LSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+ +G+G FG +Y D + +K L+ V+ + + EV LL + H N+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
EN ++ +V E+ G+L + Q +L + ED+ ILSW +QI+ GL+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQ--ILSW--FVQISL----GLK 115
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
++HD I+HRD+KS NI L++ AKL DFG++R + ++ T VGTP YL
Sbjct: 116 HIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLS 170
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + K+D++S G VL EL T
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 41/218 (18%)
Query: 533 LGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
+G G +G VY + VA+K++ ++ Q E+ +L H N+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT-GILSWKGRLQIA---TESAQGLE 646
K+ +V E+ G+LQ D T G LS LQIA E+ +GL
Sbjct: 71 RRDKLWIVMEYCGGGSLQ------------DIYQVTRGPLS---ELQIAYVCRETLKGLA 115
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV------VGT 700
YLH+ K +HRD+K ANILL E KLADFG+S + ++ T+ +GT
Sbjct: 116 YLHETGK---IHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSFIGT 164
Query: 701 PGYLDPEYYISNRL---TEKSDVYSFGVVLLELITGQP 735
P ++ PE R K D+++ G+ +EL QP
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 533 LGKGGFGTVYHGYL-DDKQV-AVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILVGY 588
+GKG FG V+ DK+V A+K + S + ++ +A E +L + + + Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI---IRY 64
Query: 589 CD---ENTKMGLVYEFMANGNLQAHLLAQLAI-LPTDAEDKTGILSWKGRLQIATESAQG 644
+ + K+ +V E+ NG+L L Q LP D W+ +QI G
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED-------QVWRFFIQILL----G 113
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
L +LH I+HRD+KS N+ L+ K+ D G++++ + ++ + T+VGTP YL
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYL 168
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
PE EKSDV++ GVVL E TG+
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVK-MLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
LG G G V K +AVK + + KQ E+++L + + + G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
N + + E+M G+L L +P IL +IA +GL Y
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPER------ILG-----KIAVAVLKGLTY 115
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH+ K I+HRDVK +NIL+N + Q KL DFG+S + + ++ T VGT Y+ PE
Sbjct: 116 LHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPE 169
Query: 708 YYISNRLTEKSDVYSFGVVLLELITGQ---PVIQKTPE 742
N + KSD++S G+ L+EL TG+ P P+
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 531 RVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT 583
++LG+G FG VY Y D KQV SP + + + E++LL H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
G ++ + + E+M G+++ L A A+ T ++ K QI +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--------TETVTRKYTRQIL----E 115
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-RIFPVEGGSHVSTTVVGTPG 702
G+EYLH IVHRD+K ANIL + KL DFG S R+ + +V GTP
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
++ PE K+DV+S G ++E++T +P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 25/240 (10%)
Query: 529 FERVLGKGGFGTVYHGYL-----DDKQ-VAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
F LG+ FG +Y G+L D Q VA+K L ++ Q + +FQ E L+ HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLA---ILPTDAEDKT--GILSWKGRLQ 636
+ L+G + + +++E++ G+L L+ + + + ED T L L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
IA + A G+EYL VH+D+ + NIL+ E+ K++D GLSR V
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 697 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL----------ITGQPVIQKTPERTLI 746
+ ++ PE + + + SD++SFGVVL E+ + Q VI+ +R L+
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 73/225 (32%), Positives = 105/225 (46%), Gaps = 23/225 (10%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN 581
+R LG+G FG V+ D VAVK L +S K F E ELL H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQ--LAILPTDAEDKTGILSWKGRLQIAT 639
+ G C E + +V+E+M +G+L L A A+L + L+ L IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-LTQSQMLHIAQ 127
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEG---GSHVST 695
+ A G+ YL VHRD+ + N L+ E K+ DFG+SR ++ + G H
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQ 738
+ P PE + + T +SDV+S GVVL E+ T QP Q
Sbjct: 185 PIRWMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 42/221 (19%)
Query: 531 RVLGKGGFGTVYHGY-LDD------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT 583
+LG G FG+VY G LDD K+V++ + + KQ + E+ LL + H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+G E + + E + G+L A LL + P I + Q
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEP--------------VIRLYTRQ 110
Query: 644 ---GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST----- 695
GLEYLHD VHRD+K ANIL++ KLADFG+++ V
Sbjct: 111 ILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAK 159
Query: 696 TVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 735
+ G+P ++ PE +D++S G +LE+ TG+P
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-21
Identities = 92/363 (25%), Positives = 159/363 (43%), Gaps = 59/363 (16%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456
P + L+LS + ++GEI ++ ++ S+ +++S+N L GS+P A L V GN +
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 457 LCLSASCKG-------KKNK----FIVPLLASVVSFSVLLAALAILRSLRRRKQELCPVG 505
LC + G +K +I L + + + L A + R EL V
Sbjct: 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLV--LALVAFGFVFIRGRNNLELKRVE 664
Query: 506 KK-GSLELK--NRKLSYA---NVLKITNNFERVLGKGGFGTVYHG--YLDDKQVAVK--- 554
+ G+ EL+ + K+S + N + + E V+ +G G Y G + Q VK
Sbjct: 665 NEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN 724
Query: 555 ---MLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHL 611
+ S + + Q H N+ L+G C L++E++ NL L
Sbjct: 725 DVNSIPSSEIADMGKLQ----------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 612 LAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK 671
LSW+ R +IA A+ L +LH C P +V ++ I+++ K
Sbjct: 775 RN---------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819
Query: 672 FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 731
+ L L + + +S+ Y+ PE + +TEKSD+Y FG++L+EL+
Sbjct: 820 DEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 732 TGQ 734
TG+
Sbjct: 873 TGK 875
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 26/209 (12%)
Query: 532 VLGKGGFGTVYHG-YLDDKQ-VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
LG+G +G+VY + + Q VA+K++ ++ E+ +L + + G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGLE 646
+NT + +V E+ G++ I+ +KT L+ + +IA ++ +GLE
Sbjct: 68 FKNTDLWIVMEYCGAGSV-------SDIM--KITNKT--LTEE---EIAAILYQTLKGLE 113
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YLH +HRD+K+ NILLNE+ QAKLADFG+S + TV+GTP ++ P
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMAKRNTVIGTPFWMAP 168
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITGQP 735
E K+D++S G+ +E+ G+P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 71/221 (32%), Positives = 113/221 (51%), Gaps = 22/221 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDK----QVAVKMLSP-SSVQGYKQFQAEVELLMR-AHHKNL 582
FE V+G+G FG V + A+KML +S ++ F E+E+L + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDA-----EDKTGILSWKGRLQI 637
L+G C+ + + E+ GNL L + +L TD L+ + LQ
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNL-LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A++ A G++YL + +HRD+ + N+L+ E +K+ADFGLSR V +V T+
Sbjct: 125 ASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEV----YVKKTM 177
Query: 698 VGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
P ++ E + T KSDV+SFGV+L E+++ G P
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 71/221 (32%), Positives = 113/221 (51%), Gaps = 22/221 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDK----QVAVK-MLSPSSVQGYKQFQAEVELLMR-AHHKNL 582
F+ V+G+G FG V + A+K M +S ++ F E+E+L + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTD-----AEDKTGILSWKGRLQI 637
L+G C+ + L E+ +GNL L + +L TD A LS + L
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A + A+G++YL + +HRD+ + NIL+ E + AK+ADFGLSR V +V T+
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTM 182
Query: 698 VGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
P ++ E + T SDV+S+GV+L E+++ G P
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 533 LGKGGFGTVY---HGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTILV 586
+ KG +G V+ D A+K++ + + Q E ++L +A + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDI-YAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKL 58
Query: 587 GYCDENTK-MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
Y + K + LV E++ G+L A LL + L D R+ IA E L
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDV----------ARIYIA-EIVLAL 106
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS------RIFPVEGGSHVSTTVVG 699
EYLH I+HRD+K NIL++ KL DFGLS R + +VG
Sbjct: 107 EYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ-KTPERT 744
TP Y+ PE + ++ D +S G +L E + G P +TPE
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 535 KGGFGTVYHGYLDDKQV-----AVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTILV 586
KG FG+VY L K+ A+K+L S + Q +AE ++M +
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 587 GYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
Y + LV E++ G+ A L+ L LP D W Q E G+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPED---------WA--KQYIAEVVLGV 110
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
E LH I+HRD+K N+L+++ KL DFGLSR + VGTP YL
Sbjct: 111 EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLA 161
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + + SD +S G V+ E + G P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 533 LGKGGFGTVYHGYLDDK-----QVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILV 586
LG G FG+V G K +VAVK L G K+F E ++ + H + L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C M LV E G L +L K + ++A + A G+
Sbjct: 63 GVCKGEPLM-LVMELAPLGPLLKYLK------------KRREIPVSDLKELAHQVAMGMA 109
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLD 705
YL + VHRD+ + N+LL + QAK++DFG+SR + +TT P +
Sbjct: 110 YL-ESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 706 PE--YYISNRLTEKSDVYSFGVVLLELIT-GQP 735
PE Y + + KSDV+S+GV L E + G
Sbjct: 167 PECINY--GKFSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 531 RVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
+ LG G FG V+ GY ++ +VAVK L P ++ + F E L+ H L L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
+ + ++ E+MA G+L L L +D K + + + + A+G+ Y+
Sbjct: 71 TKEEPIYIITEYMAKGSL-------LDFLKSDEGGK---VLLPKLIDFSAQIAEGMAYIE 120
Query: 650 DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDPEY 708
+ +HRD+++AN+L++E K+ADFGL+R+ +E + + P + PE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEA 175
Query: 709 YISNRLTEKSDVYSFGVVLLELIT 732
T KSDV+SFG++L E++T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 531 RVLGKGGFG--TVYHGYLDDKQVAVKM--LSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
RVLGKG FG T+Y DD V K L+ S + + E+ +L H N+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ ++ + + E+ G L ++ Q L + E L QI + +
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYL-----FQIVSAVS---- 115
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
Y+H K I+HRD+K+ NI L + KL DFG+S+I E ++ TVVGTP Y+ P
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPYYMSP 170
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + KSD+++ G VL EL+T
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 531 RVLGKGGFGTVYHGYLDD--------KQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
LG G FG VY G D +VAVK L ++ Q K+F E L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C N ++ E M G+L ++L +L+ K L I +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARV-----ERFGPPLLTLKELLDICLDV 115
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA-----KLADFGLSR------IFPVEGG 690
A+G YL +HRD+ + N L++EK K+ DFGL+R + EG
Sbjct: 116 AKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ ++ PE + + T +SDV+SFGV++ E++T QP
Sbjct: 173 GLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 523 LKITNNFE----RVLGKGGFGTVYHGY-LDDKQ-----VAVKMLSPSSVQGYKQFQAEVE 572
L+I E +VLG G FGTVY G + + + VA+K+L + +A E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-----KANKE 55
Query: 573 LLMRAH------HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT 626
+L A+ H ++ L+G C + L+ + M G L ++ D
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRN-----HKDNIGSQ 109
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
+L+W +QIA +G+ YL + +VHRD+ + N+L+ K+ DFGL+++
Sbjct: 110 YLLNWC--VQIA----KGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 687 VEGGSHVSTTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
V P ++ E + T KSDV+S+GV + EL+T
Sbjct: 161 V-DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 45/241 (18%)
Query: 530 ERVLGKGGFGTVYHGYLD-------DKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
R LG+G FG VY G + +VA+K ++ +S++ +F E ++ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAE-DKTGILSWKGRLQIATE 640
+ L+G +V E MA G+L+++L ++ P G + + +Q+A E
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRR---PEAENNPGLGPPTLQKFIQMAAE 127
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--------------IFP 686
A G+ YL VHRD+ + N ++ E K+ DFG++R + P
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPERT 744
V ++ PE T KSDV+SFGVVL E+ T QP + E
Sbjct: 185 VR--------------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 745 L 745
L
Sbjct: 231 L 231
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ---FQA--EVELLMRAHHKN 581
+ LG+G + VY + VA+K + + K F A E++LL H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+ + + LV+EFM +L+ ++ +I+ T A+ K S+ L
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIK----SYM--LMTL--- 112
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+GLEYLH I+HRD+K N+L+ KLADFGL+R F ++ VV T
Sbjct: 113 -RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TR 166
Query: 702 GYLDPE-YYISNRLTEKSDVYSFGVVLLELITGQP 735
Y PE + + D++S G + EL+ P
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 532 VLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE 591
++G+G FG V G ++VAVK + + F E ++ + HHKNL L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG 651
N + +V E M+ GNL L + L + + LQ + + A+G+EYL
Sbjct: 71 N-GLYIVMELMSKGNLVNFLRTRGRALVSVIQ----------LLQFSLDVAEGMEYLE-- 117
Query: 652 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS 711
+VHRD+ + NIL++E AK++DFGL+R+ + G S V + PE
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--GVDNSKLPV---KWTAPEALKH 171
Query: 712 NRLTEKSDVYSFGVVLLELIT 732
+ + KSDV+S+GV+L E+ +
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 5e-20
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 529 FERV--LGKGGFGTVYHGY--LDDKQVAVKM---------LSPSSVQGYKQFQAEVELLM 575
+E++ LG+G +G VY + VA+K + ++++ E+ LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLK 53
Query: 576 RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
H N+ L+ K+ LV+E+ +L+ +L + + G LS
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-----------DKRPGPLSPNLIK 101
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
I + +GL Y H I+HRD+K NIL+N KLADFGL+R F + ++ T
Sbjct: 102 SIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--T 156
Query: 696 TVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
V T Y PE + ++ + D++S G + E+ITG+P
Sbjct: 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 530 ERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLT 583
++V+G G FG V+ G L + VA+K L P + +Q F +E ++ + H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L G + ++ E+M NG L +L D G S + + A
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYL-----------RDHDGEFSSYQLVGMLRGIAA 118
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-G 702
G++YL D VHRD+ + NIL+N + K++DFGLSR+ + +T+ P
Sbjct: 119 GMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ PE + T SDV+SFG+V+ E+++
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 531 RVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQF--QAEVELLMRAHHKNLTILV 586
RV+G+G FG V+ D K V +K + + ++ Q E ++L H N+ +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 587 GYCD---ENTKMGLVYEFMANGNLQAHLLAQL-AILPTDAEDKTGILSWKGRLQIATESA 642
Y + E+ + +V E+ G L ++ + ++L D IL + ++ +A
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT-----ILHFFVQILLA---- 113
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
L ++H I+HRD+K+ NILL++ K K+ DFG+S+I + TVVGTP
Sbjct: 114 --LHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTP 165
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
Y+ PE +KSD+++ G VL EL +
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 530 ERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+ LG G FG V+ GY + +VA+K L S+ + F AE L+ + H L L
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAV 69
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
+ + ++ E+M NG+L + L T K L+ + +A + A+G+ ++
Sbjct: 70 VTQE-PIYIITEYMENGSL-------VDFLKTPEGIK---LTINKLIDMAAQIAEGMAFI 118
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDPE 707
+ +HRD+++ANIL++E K+ADFGL+R+ +E + + P + PE
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPE 173
Query: 708 YYISNRLTEKSDVYSFGVVLLELIT 732
T KSDV+SFG++L E++T
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 32/226 (14%)
Query: 533 LGKGGFGTVY--HGYLDDKQ-------VAVKMLSPSSV-QGYKQFQAEVELL-MRAHHKN 581
LG+G FG V Y DK VAVKML ++ + +E+EL+ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT----GILSWKGRLQI 637
+ L+G C + + ++ E+ A GNL+ L A+ P D T LS+K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 638 ATESAQGLEYLHDG-CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
A + A+G+EYL C +HRD+ + N+L+ E K+ADFGL+R G +
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYY 190
Query: 697 VVGTPG-----YLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ G ++ PE T +SDV+SFG+++ E+ T G P
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)
Query: 533 LGKGGFGTVYH-GYLDDKQV-AVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILVGY 588
LGKG +G+VY L D Q A+K + S+ ++ A E+ +L +H N+ + Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 589 CD---ENTKMGLVYEFMANGNL---QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+ + K+ +V E+ G+L + + ++P W+ +Q+
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ-------EIWRIFIQLL---- 113
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
+GL+ LH+ I+HRD+KSANILL K+ D G+S++ +++ T +GTP
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPH 166
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE + + KSD++S G +L E+ T P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
F + LG G FG V+ G + +VA+K ++ ++ + F E +++M+ H L L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C + + +V EFM NG L +L + G LS L + + +G+EY
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYL-----------RQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
L + +HRD+ + N L++ K++DFG++R V + S++ P + P
Sbjct: 116 LE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPP 170
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + ++ + KSDV+SFGV++ E+ T
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 22/218 (10%)
Query: 532 VLGKGGFGTVYHGYLDDK----QVAVKMLSP-SSVQGYKQFQAEVELLMR-AHHKNLTIL 585
V+G+G FG V + A+K + +S ++ F E+E+L + HH N+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDA-----EDKTGILSWKGRLQIATE 640
+G C+ + L E+ +GNL L + +L TD LS + L A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A+G++YL +HRD+ + NIL+ E + AK+ADFGLSR V +V T+
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRL 173
Query: 701 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
P ++ E + T SDV+S+GV+L E+++ G P
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILVGY 588
+G+G +G VY L + VA+K + A E++LL +H N+ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
+ LV+EFM + +L + + LP E + Q+ QGL +
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLP---ESLIKSYLY----QLL----QGLAFC 114
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
H I+HRD+K N+L+N + KLADFGL+R F + T V T Y PE
Sbjct: 115 H---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPEL 169
Query: 709 YISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQW 749
+ ++ + D++S G + EL++ +P+ P ++ I Q
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLF---PGKSEIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 72/240 (30%), Positives = 113/240 (47%), Gaps = 49/240 (20%)
Query: 533 LGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTILVGYC 589
+GKG FG V+ G + Q VA+K++ + + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGLE 646
+ TK+ ++ E++ G+ L L P D QIAT E +GL+
Sbjct: 72 LKGTKLWIIMEYLGGGSA----LDLLRAGPFD------------EFQIATMLKEILKGLD 115
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-----TVVGTP 701
YLH K +HRD+K+AN+LL+E+ KLADFG++ G T T VGTP
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA-------GQLTDTQIKRNTFVGTP 165
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP------------VIQKTPERTLIGQW 749
++ PE + K+D++S G+ +EL G+P +I K TL G++
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEF 225
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 526 TNNF--ERVLGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAH 578
NF E+ +GKG F VY LD + VA+K + + K Q E++LL +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
H N+ + EN ++ +V E G+L + ++ ++T WK +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERT---IWKYFVQLC 116
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
+ LE++H I+HRD+K AN+ + KL D GL R F + + + ++V
Sbjct: 117 S----ALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLV 167
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
GTP Y+ PE N KSD++S G +L E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 70/223 (31%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 533 LGKGGFGTVYHGYLDD-------KQVAVKMLSPSSV-QGYKQFQAEVELL-MRAHHKNLT 583
LG+G FG V VAVKML + + +E+E++ M HKN+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQ----LAILPTDAEDKTGILSWKGRLQIAT 639
L+G C + + +V E+ A+GNL+ L A+ P D L+ K + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+ A+G+E+L +HRD+ + N+L+ E K+ADFGL+R H+
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRKT 191
Query: 700 TPGYLD-----PEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
T G L PE T +SDV+SFGV+L E+ T G P
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
E LG+G FG V+ G + +VA+K L P ++ + F E +++ + H+ L L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 68
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
E + +V E+M+ G+L L ++ L + +A + A G+ Y
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY----------LRLPQLVDMAAQIASGMAY 117
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
+ + VHRD+++ANIL+ E K+ADFGL+R+ +E + + P + P
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAP 172
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + R T KSDV+SFG++L EL T
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 27/236 (11%)
Query: 531 RVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNL 582
+ LG+G FG V VAVKML ++ + +E LL + +H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILP------------TDAEDKTGILS 630
L G C ++ + L+ E+ G+L++ L + P L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
+ A + ++G++YL + +VHRD+ + N+L+ E + K++DFGLSR E
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV-YEED 181
Query: 691 SHVSTTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPER 743
S+V + P ++ E + T +SDV+SFGV+L E++T G P PER
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 533 LGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTILVGYC 589
+GKG FG V+ G + Q VA+K++ + + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
++TK+ ++ E++ G + L +L D+T I + I E +GL+YLH
Sbjct: 72 LKDTKLWIIMEYLGGG-------SALDLLEPGPLDETQIAT------ILREILKGLDYLH 118
Query: 650 DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV-----VGTPGYL 704
K +HRD+K+AN+LL+E + KLADFG++ G T + VGTP ++
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPFWM 168
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + K+D++S G+ +EL G+P
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+ LG G FG V+ G + + +VAVK L P ++ + F E +++ + H L L
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYA 68
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
E + +V E+M+ G+L L D E + L + +A + A G+ Y
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFL--------KDGEGRA--LKLPNLVDMAAQVAAGMAY 117
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
+ + +HRD++SANIL+ + K+ADFGL+R+ +E + + P + P
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAP 172
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + R T KSDV+SFG++L EL+T
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 72/227 (31%), Positives = 115/227 (50%), Gaps = 34/227 (14%)
Query: 533 LGKGGFGTVYH----GYLDDK-----QVAVKML-SPSSVQGYKQFQAEVELL-MRAHHKN 581
LG+G FG V G +K +VAVKML S ++ + +E+E++ M HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLA------QLAILPTDAEDKTGILSWKGRL 635
+ L+G C ++ + ++ E+ + GNL+ +L A + PT ++ LS+K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ--LSFKDLV 143
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R H+
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDY 195
Query: 696 TVVGTPG-----YLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
T G ++ PE T +SDV+SFGV+L E+ T G P
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 531 RVLGKGGFGTVYHG---YLDDK----QVAVKMLSPSSVQGYKQFQAEVELLMRA------ 577
R LG G FG VY G D QVAVK L S + Q E + LM A
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-----QDESDFLMEALIMSKF 66
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+H+N+ L+G E ++ E MA G+L++ L P ++ L+ K L
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENR---PR--PERPSSLTMKDLLFC 121
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSR-IFPVE---GG 690
A + A+G +YL + +HRD+ + N LL K AK+ADFG++R I+ G
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
+ P PE ++ T K+DV+SFGV+L E+
Sbjct: 179 GRAMLPIKWMP----PEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 532 VLGKGGFGTVYHGYLDDKQ-VAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLTILVGYC 589
+LGKG FG V+ G L DK VAVK Q K +F +E +L + H N+ L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
+ + +V E + G+ + L K L K ++ A ++A G+ YL
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL-----------RKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 650 -DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDPE 707
C +HRD+ + N L+ E K++DFG+SR + G + S+ + P + PE
Sbjct: 111 SKNC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPE 164
Query: 708 YYISNRLTEKSDVYSFGVVLLE 729
R + +SDV+S+G++L E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 533 LGKGGFGTVYHGY-LDDKQV-AVKM--LSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+G G FG VY LD ++ AVK + + + K+ E+++L H NL G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
K+ + E+ + G L LL IL E + + LQ+ +GL YL
Sbjct: 68 EVHREKVYIFMEYCSGGTL-EELLEHGRILD---EHVIRVYT----LQLL----EGLAYL 115
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF------PVEGGSHVSTTVVGTPG 702
H IVHRD+K ANI L+ KL DFG + E + GTP
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPA 168
Query: 703 YLDPEYYISNRLTEK---SDVYSFGVVLLELITGQP 735
Y+ PE + +D++S G V+LE+ TG+
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 532 VLGKGGFGTVYHGY--LDDKQVAVKML---SPSSVQGYKQFQAEVELL---MRAHHKNLT 583
++G+G +G VY G + VA+K++ +P Q EV LL ++ N+T
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNIT 65
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
G + ++ ++ E+ G+++ + A I AE + I E
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PI----AEKYISV--------IIREVLV 112
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
L+Y+H K ++HRD+K+ANIL+ KL DFG++ + S +T VGTP +
Sbjct: 113 ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYW 167
Query: 704 LDPEYYISNRLTE-KSDVYSFGVVLLELITGQP 735
+ PE + + K+D++S G+ + E+ TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 529 FERV--LGKGGFGTVYHGY--LDDKQVAVKMLSPSS-VQGYKQFQA-EVELLMRAHHKNL 582
+E++ +G+G +G VY + VA+K + + +G+ E++LL + H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 583 TILVGYCDENTKMG--LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
L K +V+E+M + +L LL + T+++ K + Q+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTG-LLDSPEVKFTESQIK-CYMK-----QLL-- 110
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL+YLH I+HRD+K +NIL+N KLADFGL+R + S T V T
Sbjct: 111 --EGLQYLH-SNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVIT 164
Query: 701 PGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 738
Y PE + + R + D++S G +L EL G+P+ Q
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 528 NFERVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNL 582
F + LG G FG V A+K+LS + + KQ + E +L H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L G +++ + LV E++ G L +HL K+G A +
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHL------------RKSGRFPEPVARFYAAQVV 111
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
LEYLH IV+RD+K N+LL+ K+ DFG ++ V+G ++ T+ GTP
Sbjct: 112 LALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY---TLCGTPE 163
Query: 703 YLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
YL PE I ++ K+ D ++ G+++ E++ G P
Sbjct: 164 YLAPE-IILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 528 NFERVLGKGGFGTVY-------HGYLDDK-----------QVAVKMLSPS-SVQGYKQFQ 568
NF LG+G FG V+ + + VAVK+L P S + F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 569 AEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI 628
EV++L R N+ L+G C + + ++ E+M NG+L L +A A +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS- 126
Query: 629 LSWKGRLQIATESAQGLEYL--HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--- 683
LS+ L +AT+ A G+ YL + VHRD+ + N L+ + + K+ADFG+SR
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 684 ---IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ V+G ++ E + + T KSDV++FGV L E++T
Sbjct: 182 SSDYYRVQG------RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 533 LGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE 591
LG+G FG V+ G + +VA+K L P ++ + F E +++ + H L L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG 651
+ +V EFM G+L L E L + +A + A G+ Y+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFL----------KEGDGKYLKLPQLVDMAAQIADGMAYIE-- 119
Query: 652 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDPEYYI 710
+ +HRD+++ANIL+ + K+ADFGL+R+ +E + + P + PE +
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 711 SNRLTEKSDVYSFGVVLLELIT 732
R T KSDV+SFG++L EL+T
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 531 RVLGKGGFGTVYHGYLDD--KQVAVKML--SPSSVQGYKQFQA---EVELLMRAHHKNLT 583
++LG+G FG VY Y D +++AVK + P S + K+ A E++LL H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 584 ILVGYC---DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
G C E K+ + E+M G+++ L A G L+ + +
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAY------------GALTENVTRRYTRQ 114
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-RIFPVEGGSHVSTTVVG 699
QG+ YLH IVHRD+K ANIL + KL DFG S RI + +V G
Sbjct: 115 ILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP ++ PE K+DV+S ++E++T +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 533 LGKGGFGTVYHGYL-DDKQV-AVKMLSPSSVQGY-KQFQAEVELLMRAHHKNLTILVGYC 589
LG+G G+V L + + A+K ++ KQ E+E+ + G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 590 --DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ ++ +G+ E+ G+L + + + + G + K +IA +GL Y
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDS--------IYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH I+HRD+K +NILL K Q KL DFG+S E + ++ T GT Y+ PE
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPE 173
Query: 708 YYISNRLTEKSDVYSFGVVLLEL 730
+ SDV+S G+ LLE+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-18
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 29/202 (14%)
Query: 550 QVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTILV--GYCDENTKMGLVYEFMAN 604
+VA+K+L + + +F+ E L R +H N+ L+ G + V+E++
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPG 63
Query: 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSA 664
L+ L A A+ + GRL + L H+ IVHRD+K
Sbjct: 64 RTLREVLAADGALPAGET----------GRLM--LQVLDALACAHNQ---GIVHRDLKPQ 108
Query: 665 NILLNE---KFQAKLADFGLSRIFPVEGGSHV-----STTVVGTPGYLDPEYYISNRLTE 716
NI++++ + AK+ DFG+ + P + V +T V+GTP Y PE +T
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 717 KSDVYSFGVVLLELITGQPVIQ 738
SD+Y++G++ LE +TGQ V+Q
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 69/246 (28%), Positives = 111/246 (45%), Gaps = 32/246 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ------------------VAVKMLSPSSVQGYKQ-FQA 569
F+ LG+G FG V+ + + Q VAVK+L P + + + F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 570 EVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ----AHLLAQLAILPTDAEDK 625
EV++L R N+ L+G C + + ++ E+M NG+L +H L DA
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 626 TGIL---SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682
L S+ L +A + A G++YL VHRD+ + N L+ E K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT---GQPVIQK 739
R + V ++ E + + T SDV++FGV L E++ QP +
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 740 TPERTL 745
T E+ +
Sbjct: 246 TDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLTILV 586
ER+ G+G FG V+ G L D+ VAVK + K +F E +L + H N+ L+
Sbjct: 1 ERI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C + + +V E + G+ L + L K +Q+ +A G+E
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV-----------KELIQMVENAAAGME 108
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-TVVGTP-GYL 704
YL +HRD+ + N L+ EK K++DFG+SR E G + ST + P +
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWT 163
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLE 729
PE R + +SDV+SFG++L E
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+ +GKG FG V G +VAVK + + + F AE ++ + H NL L+G
Sbjct: 10 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 589 -CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+E + +V E+MA G+L +L ++ +L L+ + + + +EY
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEY 117
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
L VHRD+ + N+L++E AK++DFGL++ E S T + + PE
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-WTAPE 169
Query: 708 YYISNRLTEKSDVYSFGVVLLEL 730
+ + KSDV+SFG++L E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 59/208 (28%), Positives = 80/208 (38%), Gaps = 23/208 (11%)
Query: 533 LGKGGFGTVYHGYLDDK-----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTILV 586
LG G FG V G VAVK L + F E ++ H+NL L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 587 GYCDENTKMGLVYEFMANGNLQAHL-LAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
G + +V E G+L L L L +QIA G+
Sbjct: 63 GVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLI------STL-CDYAVQIAN----GM 110
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYL 704
YL +HRD+ + NILL + K+ DFGL R P +V + P +
Sbjct: 111 RYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + + SDV+ FGV L E+ T
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
F + LG G FG V +G + VA+KM+ S+ +F E +++M+ H+ L L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C + + +V E+M+NG L +L L++ + +G+ Y
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ-----------LLEMCKDVCEGMAY 115
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
L +HRD+ + N L++++ K++DFGLSR V + S+ P + P
Sbjct: 116 LE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPP 170
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + ++ + KSDV++FGV++ E+ +
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTIL 585
++ +LG G GTVY Y L + +AVK++ +V+ KQ +E+E+L + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
G ++ + EFM G+L + +L GR+ +A +GL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVL--------------GRIAVAV--VKGL 108
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
YL K I+HRDVK +N+L+N + Q KL DFG+S + ++ T VGT Y+
Sbjct: 109 TYLW-SLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMA 161
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQ---PVIQK 739
PE + SDV+S G+ +EL G+ P IQK
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQK 198
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 531 RVLGKGGFGT---VYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
RV+G+G FG V H D K ++ P S + + E LL + H N+
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLA-ILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ + + +V E+ G+L + Q + P D IL W + G++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT-----ILQW------FVQMCLGVQ 114
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
++H+ ++HRD+KS NI L + + KL DFG +R+ G + T VGTP Y+ P
Sbjct: 115 HIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPP 169
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
E + + KSD++S G +L EL T + Q + LI
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 24/212 (11%)
Query: 531 RVLGKGGFGTV----YHGYLDD--KQVAVKMLSPSSVQGY-KQFQAEVELLMRAHHKNLT 583
R LG+G FG V Y D+ +QVAVK L P S + + E+E+L +H+N+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 584 ILVGYCDENTKMG--LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
G C E+ G L+ EF+ +G+L+ +L +K I + K +L+ A +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL----------PRNKNKI-NLKQQLKYAVQI 118
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+G++YL G + VHRD+ + N+L+ + Q K+ DFGL++ + + + +P
Sbjct: 119 CKGMDYL--GSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 702 GY-LDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ PE I ++ SDV+SFGV L EL+T
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 31/211 (14%)
Query: 533 LGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTILVGYC 589
+GKG FG VY G + + VA+K++ + + Q E+ +L + +T G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
+ TK+ ++ E++ G + L +L ++T I + I E +GL+YLH
Sbjct: 72 LKGTKLWIIMEYLGGG-------SALDLLKPGPLEETYIAT------ILREILKGLDYLH 118
Query: 650 DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-----TVVGTPGYL 704
K +HRD+K+AN+LL+E+ KLADFG++ G T T VGTP ++
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVA-------GQLTDTQIKRNTFVGTPFWM 168
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + K+D++S G+ +EL G+P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 533 LGKGGFGT--VYHGYLDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILVGY 588
+G+G FG + D KQ +K ++ S + ++ ++ EV +L H N+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
+EN + +V ++ G+L + AQ +L ED+ IL W ++ +A L+++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQ--ILDWFVQICLA------LKHV 117
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
HD I+HRD+KS NI L + KL DFG++R+ + ++ T +GTP YL PE
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEI 172
Query: 709 YISNRLTEKSDVYSFGVVLLELIT 732
+ KSD+++ G VL E+ T
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 533 LGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV-GYC 589
LG G FG VY A K++ S + + F E+++L H N+ L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGLE 646
EN K+ ++ EF G L + +L L QI + + L
Sbjct: 73 YEN-KLWILIEFCDGGALDSIMLELERGLTEP--------------QIRYVCRQMLEALN 117
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
+LH ++HRD+K+ NILL KLADFG+S T +GTP ++ P
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAP 172
Query: 707 EY-----YISNRLTEKSDVYSFGVVLLELITGQP 735
E + N K+D++S G+ L+EL +P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 530 ERVLGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTI 584
E+ +G+G F VY LD K VA+K + + K Q E++LL + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 585 LVGYCDENTKMGLVYEFMANGNLQA---HLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ E+ ++ +V E G+L + Q ++P ++T WK +Q+ +
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP----ERT---VWKYFVQLCS-- 117
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+E++H ++HRD+K AN+ + KL D GL R F + + + ++VGTP
Sbjct: 118 --AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTP 170
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
Y+ PE N KSD++S G +L E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 531 RVLGKGGFGTVYHGY-------LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT 583
++LG+G FG VY Y L KQV SP + + + E++LL H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 584 ILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
G + + + + E+M G+++ L A A+ T ++ K QI
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL--------TESVTRKYTRQIL--- 116
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-TVVGT 700
+G+ YLH IVHRD+K ANIL + KL DFG S+ S +V GT
Sbjct: 117 -EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
P ++ PE K+DV+S G ++E++T +P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 49/223 (21%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
R +G G FG VY ++ VA+K +S S Q +++Q EV L + H N
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 586 VG-YCDENTKMGLVYEFM---ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ----- 636
G Y E+T LV E+ A+ L+ H K LQ
Sbjct: 81 KGCYLREHTAW-LVMEYCLGSASDILEVH---------------------KKPLQEVEIA 118
Query: 637 -IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
I + QGL YLH + +HRD+K+ NILL E KLADFG + + +
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL------VSPAN 169
Query: 696 TVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQP 735
+ VGTP ++ PE ++ + K DV+S G+ +EL +P
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 526 TNNFER-VLGKGGFGTVYHGYLDDKQV--AVKMLSPSSVQGYKQFQAEVELLMRAHHKNL 582
N ER VLGKG +G VY QV A+K + + + E+ L H+N+
Sbjct: 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+G EN + E + G+L A L ++ L +D + + + QI
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPL----KDNEQTIIFYTK-QIL---- 118
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+GL+YLHD IVHRD+K N+L+N K++DFG S+ + G + + T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTL 173
Query: 702 GYLDPEYYISNRLT---EKSDVYSFGVVLLELITGQP 735
Y+ PE I +D++S G ++E+ TG+P
Sbjct: 174 QYMAPE-VIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 21/207 (10%)
Query: 533 LGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVG 587
LGKGGFG V + K A K L + +G + E ++L + + + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ + LV M G+L+ H+ + A + GLE+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHI----------YNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH + IV+RD+K N+LL++ +++D GL+ GTPGY+ PE
Sbjct: 111 LH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPE 164
Query: 708 YYISNRLTEKSDVYSFGVVLLELITGQ 734
D ++ G L E+I G+
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 31/222 (13%)
Query: 528 NFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELL--MRA 577
R LG+G FG VY G D +VAVK ++ S S++ +F E ++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL--SWKGRL 635
HH + L+G + +V E MA+G+L+++L + L +AE+ G + + +
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS----LRPEAENNPGRPPPTLQEMI 122
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVE----GG 690
Q+A E A G+ YL+ VHRD+ + N ++ F K+ DFG++R I+ + GG
Sbjct: 123 QMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ ++ PE T SD++SFGVVL E+ +
Sbjct: 180 KGLLPV-----RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 527 NNFER--VLGKGGFGTVYHGYLDDKQ----VAVKML--SPSSVQGYKQFQAEVELLMRAH 578
N +E V+G+G +G V +K VA+K S K EV++L +
Sbjct: 1 NKYEVLGVVGEGAYGVVLK--CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
H+N+ L ++ LV+E++ L L A LP D W Q+
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLP---PDAVRSYIW----QLL 110
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
Q + Y H I+HRD+K NIL++E KL DFG +R + T V
Sbjct: 111 ----QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYV 162
Query: 699 GTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
T Y PE + + K DV++ G ++ EL+ G+P
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 24/222 (10%)
Query: 533 LGKGGFGTVYH----GYLDDK-----QVAVKMLSPSSVQ-GYKQFQAEVELL-MRAHHKN 581
LG+G FG V G DK VAVKML + + +E+E++ M HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI----LSWKGRLQI 637
+ L+G C ++ + ++ E+ + GNL+ +L A+ + D + +++K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ A+G+EYL +HRD+ + N+L+ E K+ADFGL+R V + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197
Query: 698 VG--TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G ++ PE T +SDV+SFGV++ E+ T G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 40/99 (40%), Positives = 60/99 (60%), Gaps = 6/99 (6%)
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
+IA +GL YL++ I+HRD+K +NIL+N + Q KL DFG+S E + ++
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG----ELINSIAD 160
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
T VGT Y+ PE + T KSDV+S G+ ++EL G+
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 29/232 (12%)
Query: 531 RVLGKGGFGTVYHGYLD-------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNL 582
R LG+G FG VY G + +VA+K ++ + S++ +F E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL--SWKGRLQIATE 640
L+G + ++ E M G+L+++L + L + E+ S K +Q+A E
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRS----LRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVE----GGSHVST 695
A G+ YL+ VHRD+ + N ++ E F K+ DFG++R I+ + GG +
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPERTL 745
++ PE T SDV+SFGVVL E+ T QP + E+ L
Sbjct: 185 V-----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 42/244 (17%)
Query: 530 ERVLGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYK-----QFQAEVELLMRAH---- 578
RVLG G GTV D + AVK++ ++G + QAEV L+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVD---MEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 579 ---HKNLTILVGYCDENTK-----MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630
H++ D + LV ++ G+L+ + ++ T E + G+L
Sbjct: 94 VKCHEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
+Q+ L +H ++HRD+KSANILL KL DFG S+++
Sbjct: 150 ----IQV-------LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS 198
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPV----IQKTPERTL 745
V T GTP Y+ PE + ++K+D++S GV+L EL+T +P +++ +TL
Sbjct: 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258
Query: 746 IGQW 749
G++
Sbjct: 259 AGRY 262
|
Length = 496 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 67/244 (27%), Positives = 102/244 (41%), Gaps = 51/244 (20%)
Query: 527 NNFERV--LGKGGFGTVYHGY-LDDKQV-AVKMLSPSSVQGYKQ---FQAEVELLMRAHH 579
++FE + +G+G FG V+ D QV A+K+L S + Q +AE ++L A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ L + + LV E+M G+L LL + + P E+ R IA
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMN-LLIRKDVFP---EETA-------RFYIA- 108
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLS---------------- 682
E L+ +H G +HRD+K NIL++ KLADFGL
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 683 -----------RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 731
R + + + VGTP Y+ PE + D +S GV+L E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 732 TGQP 735
G P
Sbjct: 225 YGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILV 586
+G+G G V+ + VA+K ++ ++G QA E++ L H + L+
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ LV E+M + L+ + D E K +++ + G+
Sbjct: 66 DVFPHGSGFVLVMEYMPSD---------LSEVLRDEERPLPEAQVKSYMRMLLK---GVA 113
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
Y+H I+HRD+K AN+L++ K+ADFGL+R+F E + + V T Y P
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAP 169
Query: 707 E-YYISNRLTEKSDVYSFGVVLLELITGQP 735
E Y + + D+++ G + EL+ G P
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 531 RVLGKGGFGTVYHGYL--DDK---QVAVKM--LSPSSVQGYKQFQAEVELLMRAHHKNLT 583
++LG+G FG+V G L DD +VAVK L + ++F +E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 584 ILVGYCDENTKMG------LVYEFMANGNLQAHLLA-QLAILPTDAEDKTGILSWKGRLQ 636
L+G C E + + ++ FM +G+L + LL +L LP L + L+
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-------LPLQTLLK 117
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVST 695
+ A G+EYL + +HRD+ + N +L E +ADFGLS+ I+ G +
Sbjct: 118 FMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIY--SGDYYRQG 172
Query: 696 TVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQ 734
+ P ++ E T KSDV++FGV + E+ T GQ
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 531 RVLGKGGFGTVYHGYLDD--KQVAVKML-----SPSSVQGYKQFQAEVELLMRAHHKNLT 583
++LG+G FG VY Y D +++AVK + SP + + + E++LL H+ +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 584 ILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
G + + + + E M G+++ L + G L+ + +
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY------------GALTENVTRKYTRQI 115
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS-TTVVGT 700
+G+ YLH IVHRD+K ANIL + KL DFG S+ S +V GT
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
P ++ PE K+D++S G ++E++T +P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 531 RVLGKGGFGTVYHGYL--DD---KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLT 583
R+LGKG FG+V L +D ++VAVKML S ++F E + H N+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 584 ILVGYCDENTKMG------LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
L+G + G ++ FM +G+L LL + ++ L + ++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM------SRIGEEPFTLPLQTLVRF 118
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVSTT 696
+ A G+EYL +HRD+ + N +LNE +ADFGLS+ I+ G +
Sbjct: 119 MIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQGC 173
Query: 697 VVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQ 734
P +L E N T SDV++FGV + E++T GQ
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 22/217 (10%)
Query: 533 LGKGGFGTVYH----GYLDDK-----QVAVKMLSPSSV-QGYKQFQAEVELL-MRAHHKN 581
LG+G FG V G DK VAVKML + + +E+E++ M HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI----LSWKGRLQI 637
+ L+G C ++ + ++ E+ + GNL+ +L A+ + D + L++K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R V + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKTT 194
Query: 698 VG--TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
G ++ PE T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
E+ LG G FG V+ Y +VAVK + P S+ + F AE ++ H L L
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA 68
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ + ++ EFMA G+L L L +D K + + + + A+G+ +
Sbjct: 69 VVTKE-PIYIITEFMAKGSL-------LDFLKSDEGSKQPLPKL---IDFSAQIAEGMAF 117
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
+ + +HRD+++ANIL++ K+ADFGL+R+ +E + + P + P
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAP 172
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E T KSDV+SFG++L+E++T
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 530 ERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLT 583
E+V+G G FG V G L + VA+K L + ++ F +E ++ + H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLL---AQLAILPTDAEDKTGILSWKGRLQIATE 640
L G ++ + +V E+M NG+L A L Q ++ G+L +G
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGML--RG------- 114
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A G++YL D VHRD+ + NIL+N K++DFGLSR+ + + +T
Sbjct: 115 IASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 701 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P + PE + T SDV+S+G+V+ E+++
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 26/239 (10%)
Query: 529 FERVLGKGGFGTVY-------HGYLDDK-----------QVAVKML-SPSSVQGYKQFQA 569
F+ LG+G FG V+ ++D VAVKML ++ F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 570 EVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL 629
E++++ R N+ L+ C + + ++ E+M NG+L L + D I
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI- 127
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 689
S+ + +AT+ A G++YL VHRD+ + N L+ + + K+ADFG+SR
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 690 GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT---GQPVIQKTPERTL 745
+ V ++ E + + T SDV++FGV L E++T QP Q + E+ +
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 529 FERVLGKGGFGTV--YHGYLDDKQVAVKMLS--PSSVQGYKQFQAEVELLMRAHHKNLTI 584
F RV+GKG +G V D KQ +K L+ +S + K + E +LL + H N+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-- 61
Query: 585 LVGYCD----ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
V Y + E+ + +V F G+L L Q L + + ++ W +QIA
Sbjct: 62 -VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQ----VVEW--FVQIA-- 112
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
L+YLH+ I+HRD+K+ N+ L K+ D G++R+ +E +++T++GT
Sbjct: 113 --MALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGT 165
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P Y+ PE + + KSDV++ G + E+ T
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 530 ERVLGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTI 584
E+ +G+G F VY LD VA+K + + K E++LL + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 585 LVGYCDENTKMGLVYEFMANGNLQ---AHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
E+ ++ +V E G+L H Q ++P +KT WK +Q+ +
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP----EKT---VWKYFVQLCS-- 117
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
LE++H ++HRD+K AN+ + KL D GL R F + + + ++VGTP
Sbjct: 118 --ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTP 170
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y+ PE N KSD++S G +L E+ Q
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 532 VLGKGGFGTVYHGY--LDDKQVAVKM--LSPSSVQGYKQ-------FQAEVELLMRAHHK 580
++G G FG+VY G + +AVK L S + E+ LL H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ +G + + + E++ G++ A LL +T + ++ +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFE-----ETLVRNF------VRQ 114
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL YLH+ I+HRD+K ANIL++ K K++DFG+S+ +E S + T
Sbjct: 115 ILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGAR 169
Query: 701 PG------YLDPEYYISNRLTEKSDVYSFGVVLLELITG 733
P ++ PE T K+D++S G +++E++TG
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 532 VLGKGGFGTVYHGYLDD------KQVAVKML----SPSSVQGYKQFQAEVELLMRAHHKN 581
+L +G FG +++G L D ++V VK + S V E LL H+N
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT---LLLQESCLLYGLSHQN 69
Query: 582 LTILVGYCDENTKMGLV-YEFMANGNLQAHLLAQLAILPTDAEDKTGI-LSWKGRLQIAT 639
+ ++ C E+ + V Y +M GNL+ L E LS + + +A
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQ-----CRLGEANNPQALSTQQLVHMAI 124
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVSTTVV 698
+ A G+ YLH K ++H+D+ + N +++E+ Q K+ D LSR +FP H
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP--MDYHCLGDNE 179
Query: 699 GTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P ++ E ++ + SDV+SFGV+L EL+T
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 38/228 (16%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTIL 585
FE++ G+G GTVY ++VA+K ++ Q K+ L+MR + H N+
Sbjct: 24 FEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNI--- 78
Query: 586 VGYCDE---NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT--- 639
V Y D ++ +V E++A G+L TD +T + QIA
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCM----DEGQIAAVCR 122
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGSHVSTTVV 698
E Q LE+LH ++HRD+KS NILL KL DFG ++I P + +T+V
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMV 176
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERTL 745
GTP ++ PE K D++S G++ +E++ G+ P + + P R L
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 529 FERVLGKGGFGTVY----HGYLD---------DKQ---VAVKMLSPSSVQGYKQ-FQAEV 571
+ LG+G FG V+ G + D Q VAVKML + + F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 572 ELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAE-DKTGILS 630
+++ R + N+ L+G C + + ++ E+M NG+L L+Q I T + +S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN-QFLSQREIESTFTHANNIPSVS 127
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
L +A + A G++YL VHRD+ + N L+ + K+ADFG+SR
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLE-----------LITGQPVIQK 739
+ V ++ E + + T SDV++FGV L E L++ + VI+
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
Query: 740 TPE 742
T E
Sbjct: 245 TGE 247
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 50/236 (21%)
Query: 526 TNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHK 580
T FE V+G+G +G VY + VA+K++ + ++ + E +L + ++H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHP 63
Query: 581 NLT------ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
N+ I + ++ LV E G++ TD R
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV------------TDLVKGL--RKKGKR 109
Query: 635 L---QIA---TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
L IA E+ +GL YLH+ ++HRD+K NILL + + KL DFG+S ++
Sbjct: 110 LKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLD 164
Query: 689 GGSHVSTTVVGTPGYLDPE---------YYISNRLTEKSDVYSFGVVLLELITGQP 735
T +GTP ++ PE R SDV+S G+ +EL G+P
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR----SDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 69/219 (31%), Positives = 104/219 (47%), Gaps = 39/219 (17%)
Query: 530 ERV--LGKGGFGTVY---HGYLDDKQVAVKML---SPSSVQGYKQFQAEVELLMRAHHKN 581
ERV +G G GTVY H + A+K++ +V+ +Q E+E+L +H N
Sbjct: 77 ERVNRIGSGAGGTVYKVIH-RPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPN 133
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ D N ++ ++ EFM G+L+ +A L A+ ILS
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFL---ADVARQILS----------- 179
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
G+ YLH + IVHRD+K +N+L+N K+ADFG+SRI S+ VGT
Sbjct: 180 --GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTI 232
Query: 702 GYLDPEYYISNRLTE------KSDVYSFGVVLLELITGQ 734
Y+ PE I+ L D++S GV +LE G+
Sbjct: 233 AYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 70/226 (30%), Positives = 116/226 (51%), Gaps = 34/226 (15%)
Query: 529 FERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
FE++ G+G GTVY +D ++VA+K ++ Q K+ L+MR +KN I
Sbjct: 24 FEKI-GQGASGTVYTA-IDIATGQEVAIKQMNLQQ-QPKKELIINEILVMR-ENKNPNI- 78
Query: 586 VGYCDE---NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ-IATES 641
V Y D ++ +V E++A G+L TD +T + +G++ + E
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCMD--EGQIAAVCREC 124
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGSHVSTTVVGT 700
Q L++LH ++HRD+KS NILL KL DFG ++I P + +T+VGT
Sbjct: 125 LQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGT 178
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERTL 745
P ++ PE K D++S G++ +E++ G+ P + + P R L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 46/222 (20%)
Query: 531 RVLGKGGFGTV----YHGYLDD--KQVAVKML----SPSSVQGYKQFQAEVELLMRAHHK 580
RVLG+G FG V Y D + VAVK L + G+K+ E+ +L +H+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHE 66
Query: 581 NLTILVGYCDENTKMG--LVYEFMANGNLQAHL------LAQLAILPTDAEDKTGILSWK 632
N+ G C E G L+ E++ G+L+ +L LAQL +
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF-------------- 112
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
A + +G+ YLH +HRD+ + N+LL+ K+ DFGL++ P EG +
Sbjct: 113 -----AQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEY 163
Query: 693 VSTTVVG-TPGY-LDPEYYISNRLTEKSDVYSFGVVLLELIT 732
G +P + E N+ + SDV+SFGV L EL+T
Sbjct: 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 530 ERVLGKGGFGTVYHGYLD-----DKQVAVKML-SPSSVQGYKQFQAEVELLMRAHHKNLT 583
E V+G G FG V G L + VA+K L S + + + F +E ++ + H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L G ++ + ++ EFM NG L + L + + ++ G L+ A
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN--------DGQFTVIQLVGMLR---GIAA 117
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-- 701
G++YL + VHRD+ + NIL+N K++DFGLSR + T+ +G
Sbjct: 118 GMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 702 -GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ PE + T SDV+S+G+V+ E+++
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 61/230 (26%)
Query: 528 NFERVLGKGGFGTV--YHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL--- 582
NF ++ G+G G V +QVAVK + Q + EV ++ H N+
Sbjct: 23 NFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 583 --TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL---QI 637
+ LVG DE + +V EF+ G L T I++ R+ QI
Sbjct: 82 YSSYLVG--DE---LWVVMEFLEGGAL------------------TDIVT-HTRMNEEQI 117
Query: 638 ATESAQ---GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
AT L +LH ++HRD+KS +ILL + KL+DFG + VS
Sbjct: 118 ATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVS 166
Query: 695 TTV------VGTPGYLDPEYYISNRL---TEKSDVYSFGVVLLELITGQP 735
V VGTP ++ PE IS RL TE D++S G++++E++ G+P
Sbjct: 167 KEVPRRKSLVGTPYWMAPE-VIS-RLPYGTE-VDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 49/239 (20%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVK-MLSPSSVQGYK-QFQAEVELLMRAHHKN----LTI 584
LG+G FG VY + VA+K +L + G+ E+++L + H N + +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 585 LVGYCDENTK-MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA- 642
V D++ + G VY + P D +G+L +++ TES
Sbjct: 76 AVERPDKSKRKRGSVY----------------MVTPYMDHDLSGLLE-NPSVKL-TESQI 117
Query: 643 --------QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--------- 685
+G+ YLH+ I+HRD+K+ANIL++ + K+ADFGL+R +
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 686 PVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPER 743
GG+ T +V T Y PE + R T D++ G V E+ T +P++Q +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 528 NFERV--LGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT 583
+FE + +G G +G VY + A+K++ + + Q E+ ++ H N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
G K+ + EF G+LQ D TG LS ++ E+ Q
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQ------------DIYHVTGPLSESQIAYVSRETLQ 117
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV------ 697
GL YLH K +HRD+K ANILL + KLADFG+S + ++ T+
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--------AQITATIAKRKSF 166
Query: 698 VGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQP 735
+GTP ++ PE R + D+++ G+ +EL QP
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 529 FERVLGKGGFGTVY----HGYLDDK---QVAVKMLSPSSVQGYKQFQAEVELLMRAH--- 578
F + LG G FG V +G +VAVKML P++ ++ EL + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-ELKIMSHLGN 97
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
H+N+ L+G C + ++ E+ G+L L + L+ + L +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFL----------RRKRESFLTLEDLLSFS 147
Query: 639 TESAQGLEYL-HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ A+G+ +L C +HRD+ + N+LL K+ DFGL+R + S V
Sbjct: 148 YQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI-----MNDSNYV 198
Query: 698 VGTPGYLD-----PEYYISNRLTEKSDVYSFGVVLLELIT 732
V L PE + T +SDV+S+G++L E+ +
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 528 NFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA-EVELLMRAHHKNL 582
NF+++ LG+G + TVY G + VA+K + + +G E+ L+ H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L K+ LV+E+M + +L+ ++ D G L +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYM---------DTHGVRGALDPNTVKSFTYQLL 110
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGSHVSTTVVGT 700
+G+ + H+ ++HRD+K N+L+N++ + KLADFGL+R F PV + S VV T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-T 163
Query: 701 PGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQPVIQKT 740
Y P+ + +R S D++S G ++ E+ITG+P+ T
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 32/225 (14%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
FE++ G+G GTVY ++VA++ ++ Q K+ L+MR +KN I V
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMR-ENKNPNI-V 80
Query: 587 GYCDE---NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ-IATESA 642
Y D ++ +V E++A G+L TD +T + +G++ + E
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCMD--EGQIAAVCRECL 126
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGSHVSTTVVGTP 701
Q LE+LH ++HRD+KS NILL KL DFG ++I P + +T+VGTP
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTP 180
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERTL 745
++ PE K D++S G++ +E+I G+ P + + P R L
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 70/240 (29%), Positives = 107/240 (44%), Gaps = 47/240 (19%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLS----PSSVQGYKQFQAEV--------EL-LMRA 577
LG+G +G V Y L K VA+K + + V +Q EL +M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 578 -HHKNLTILVG-YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
H+N+ LV Y + + + LV + MA +L+ + + I T+++ K IL L
Sbjct: 77 IKHENIMGLVDVYVEGDF-INLVMDIMA-SDLKKVVDRK--IRLTESQVKC-IL-----L 126
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--IFPVEGGSHV 693
QI GL LH K +HRD+ ANI +N K K+ADFGL+R +P +
Sbjct: 127 QILN----GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 694 S----------TTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
T+ V T Y PE + + + D++S G + EL+TG+P+ E
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 70/219 (31%), Positives = 103/219 (47%), Gaps = 41/219 (18%)
Query: 531 RVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
R +G G FG VY ++ VA+K +S S Q +++Q EV+ L R H N
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 586 VG-YCDENTKMGLVYEFM---ANGNLQAHL--LAQLAILPTDAEDKTGILSWKGRLQIAT 639
G Y E+T LV E+ A+ L+ H L ++ I I
Sbjct: 91 KGCYLREHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIA-----------------AITH 132
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+ QGL YLH ++HRD+K+ NILL E Q KLADFG + I + + + VG
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVG 183
Query: 700 TPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQP 735
TP ++ PE ++ + K DV+S G+ +EL +P
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 41/217 (18%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTILVG 587
+G G FG VY ++ VAVK +S S Q +++Q EV+ L + H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 588 -YCDENTKMGLVYEFM---ANGNLQAHL--LAQLAILPTDAEDKTGILSWKGRLQIATES 641
Y E+T LV E+ A+ L+ H L ++ I I +
Sbjct: 89 CYLKEHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIA-----------------AITHGA 130
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
QGL YLH +HRD+K+ NILL E Q KLADFG + S + + VGTP
Sbjct: 131 LQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTP 181
Query: 702 GYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQP 735
++ PE ++ + K DV+S G+ +EL +P
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 533 LGKGGFGTVYHG--YLDDKQVAVKMLS-PSSVQGYKQFQA-EVELLM---RAHHKN---- 581
+G+G +GTVY + VA+K + P S +G E+ LL H N
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 582 LTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
L + G + K+ LV+E + + +L +L K G+ + + +
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYL---------SKCPKPGLPPETIK-DLMRQ 115
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS-TTVVG 699
+G+++LH IVHRD+K NIL+ Q K+ADFGL+RI+ ++ T+VV
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVV 168
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
T Y PE + + D++S G + EL +P+ + T E
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLT-- 583
+V+GKG FG V D K AVK+L ++ + K AE +L+ KN+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL----KNVKHP 56
Query: 584 ILVG--YCDENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
LVG Y + K+ V +++ G L HL + + A A E
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR------------FYAAE 104
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVV 698
A L YLH I++RD+K NILL+ + L DFGL + EG S ++T
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFC 157
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GTP YL PE D + G VL E++ G P
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 63/227 (27%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 528 NFERVLGKGGFGTV----YHGYLDDKQVAVKMLSPSSVQGYKQF---QAEVELLM----- 575
VLG+G FG V Y + A+K L K + EVE LM
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKK--TGELYAIKALK-------KGDIIARDEVESLMCEKRI 52
Query: 576 -----RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630
H L L + V E+ A G+L H+ T + S
Sbjct: 53 FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-------------HTDVFS 99
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
+ A GL+YLH+ IV+RD+K N+LL+ + K+ADFGL + EG
Sbjct: 100 EPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGM 152
Query: 691 SHVST--TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T GTP +L PE T D + GV++ E++ G+
Sbjct: 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 44/233 (18%)
Query: 528 NFERV--LGKGGFGTVYHG--YLDDKQVAVKM---------LSPSSVQGYKQFQAEVELL 574
FE++ +G+G +G VY + VA+K + SS++ E+ LL
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-------EITLL 60
Query: 575 MRAHHKN----LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630
+ H N ++VG + LV E+ +L A LL + ++++ K
Sbjct: 61 LNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQ-DL-ASLLDNMPTPFSESQVKC---- 112
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
+ + +GL+YLH+ I+HRD+K +N+LL +K K+ADFGL+R + +
Sbjct: 113 ------LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163
Query: 691 SHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
++ VV T Y PE + T D+++ G +L EL+ +P++ E
Sbjct: 164 -PMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 531 RVLGKGGFGTVYHGYLDDKQ---VAVKMLS----PSSVQG--YKQFQAEVELLMRAHHKN 581
+ LG G F + Y D K +AVK ++ SS Q + + E+ L+ R +H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ ++G E++ L E+MA G++ +HLL+ K G + +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSV-SHLLS-----------KYGAFKEAVIINYTEQL 112
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRIFP--VEGGSHVSTTVV 698
+GL YLH+ I+HRDVK AN+L++ Q ++ADFG + G ++
Sbjct: 113 LRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GT ++ PE + DV+S G V++E+ T +P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 533 LGKGGFGTVYHGYLDDKQV--AVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
LG G FG VY + A K++ S + + + E+E+L +H + L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD 650
+ K+ ++ EF G + A +L +L T+ + + I + + L+YLH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQV----------ICRQMLEALQYLH- 127
Query: 651 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-----TVVGTPGYLD 705
I+HRD+K+ N+LL KLADFG+S +V T + +GTP ++
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMA 178
Query: 706 PEYYISNRLTE-----KSDVYSFGVVLLELITGQP 735
PE + + + K+D++S G+ L+E+ +P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 531 RVLGKGGFGTVYHG-YLDDKQ-----VAVKMLSP-SSVQGYKQFQAEVELLMRAHHKNLT 583
+VLG G FGTVY G ++ D + VA+K+L +S + K+ E ++ +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG---ILSWKGRLQIATE 640
L+G C +T + LV + M G L ++ + +D+ G +L+W +
Sbjct: 73 RLLGICLTST-VQLVTQLMPYGCLLDYV--------RENKDRIGSQDLLNW------CVQ 117
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A+G+ YL + +VHRD+ + N+L+ K+ DFGL+R+ ++ + +
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
++ E + R T +SDV+S+GV + EL+T
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 51/224 (22%)
Query: 531 RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQFQAEVE--------LLMRAHHK 580
+VLGKG FG V L K AVK L V +VE L + +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL----IDDDVECTMVEKRVLALAWENP 56
Query: 581 NLTILVGYCDENTKMGL--VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI- 637
LT L YC TK L V EF+ G+L H+ +DK GR +
Sbjct: 57 FLTHL--YCTFQTKEHLFFVMEFLNGGDLMFHI-----------QDK-------GRFDLY 96
Query: 638 -----ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR--IFPVEGG 690
A E GL++LH I++RD+K N++L+ K+ADFG+ + +F G
Sbjct: 97 RATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----G 149
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
+ ++T GTP Y+ PE + T D +SFGV+L E++ GQ
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 533 LGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTILVG 587
LG GGFG V ++ A+K + + Q +E E+L +H + L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA--TESAQGL 645
+ + ++ E+ G L +L + + R IA
Sbjct: 61 TFKDKKYIYMLMEYCLGGELW-TILRDRGLFD----------EYTARFYIACVVL---AF 106
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
EYLH+ I++RD+K N+LL+ KL DFG ++ ++ G + T GTP Y+
Sbjct: 107 EYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKK--LKSGQK-TWTFCGTPEYVA 160
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE ++ D +S G++L EL+TG+P
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 531 RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQFQAE-VE---LLMRAHHKNLTI 584
+VLGKG FG V L A+K L V + VE L + H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 585 LVGYCDENTKMGL--VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L +C TK L V E++ G+L H+ + + R A E
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHI-----------QSSGRFDEARARF-YAAEII 106
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
GL++LH K I++RD+K N+LL++ K+ADFG+ + G ++T GTP
Sbjct: 107 CGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCGTPD 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y+ PE + E D +SFGV+L E++ GQ
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 533 LGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVG 587
LGKGGFG V + K A K L+ + +GY+ E +L + H + + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
T + LV M G+L+ H I D E+ G + A + GLE+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYH------IYNVD-EENPGFPEPRACFYTA-QIISGLEH 112
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH + I++RD+K N+LL+ +++D GL+ ++ G + GTPG++ PE
Sbjct: 113 LH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPE 167
Query: 708 YYISNRLTEKSDVYSFGVVLLELI 731
D ++ GV L E+I
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 533 LGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNL-TILV 586
LG G FG V + A+K L + KQ Q E +LM H + ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ DEN ++ + EF+ G L HL + P D + A E E
Sbjct: 86 SFQDEN-RVYFLLEFVVGGELFTHL-RKAGRFPNDV----------AKFYHA-ELVLAFE 132
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YLH I++RD+K N+LL+ K K+ DFG ++ P + T+ GTP YL P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERT 744
E S + D ++ GV+L E I G P TP R
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223
|
Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 533 LGKGGFGTVYHGYLDDKQV--AVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
LG G FG VY + V A K++ S + + + E+++L H N+ L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD 650
+ ++ EF A G + A +L +L T+ + + + ++ + L YLH+
Sbjct: 73 YENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRV----------VCKQTLEALNYLHE 121
Query: 651 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-----TVVGTPGYLD 705
I+HRD+K+ NIL KLADFG+S + T + +GTP ++
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPYWMA 171
Query: 706 PEYYISNRLTE-----KSDVYSFGVVLLELITGQPVIQK-TPERTLI 746
PE + + K+DV+S G+ L+E+ +P + P R L+
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 526 TNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLS-PSSVQGYKQFQAEVELLMRA 577
T F LG+ FG VY G+L + VA+K L + ++F+ E + R
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLA---ILPTDAEDKT--GILSWK 632
H N+ L+G + + +++ + ++ +L L+ + + TD +DKT L
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD-DDKTVKSTLEPA 124
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFP 686
+ I T+ A G+E+L +VH+D+ + N+L+ +K K++D GL R +
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ G S + ++ PE + + + SD++S+GVVL E+ +
Sbjct: 182 LMGNSLLPIR------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTIL 585
RVLGKGGFG V + K A K L ++ G E ++L + + + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHL--LAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+ + LV M G+L+ H+ + + E+ + A E
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-----EEGRAVF-------YAAEICC 113
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GLE LH + IV+RD+K NILL++ +++D GL+ P EG VGT GY
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EG--QTIKGRVGTVGY 167
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743
+ PE + R T D ++ G +L E+I GQ Q+ ++
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 531 RVLGKGGFGTVYHG-YLDDK----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTI 584
R +G+G FG VY G Y+ + VAVK + ++ F E ++ + H ++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLA-----QLAILPTDAEDKTGILSWKGRLQIAT 639
L+G EN + +V E G L+++L LA L + Q++T
Sbjct: 72 LIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYS------------YQLST 118
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
L YL VHRD+ + N+L++ KL DFGLSR +E S+ +
Sbjct: 119 ----ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGK 169
Query: 700 TP-GYLDPEYYISNRLTEKSDVYSFGVVLLE-LITGQPVIQKTPERTLIGQ 748
P ++ PE R T SDV+ FGV + E L+ G Q +IG+
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 531 RVLGKGGFGTVYHGYLDDK----QVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTI 584
+ LG+G FG+V G L+ +VAVK + + + + F +E + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 585 LVGYCDENTKMG------LVYEFMANGNLQAHLL-AQLAILPTDAEDKTGILSWKGRLQI 637
L+G C + + ++ FM +G+L + LL ++L P L + ++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ-------YLPTQMLVKF 117
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
T+ A G+EYL +HRD+ + N +LNE +ADFGLS+ G + +
Sbjct: 118 MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRI 173
Query: 698 VGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQ 734
P ++ E T KSDV+SFGV + E+ T GQ
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-13
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 41/226 (18%)
Query: 533 LGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQAEV---ELLMRAHHKNLTILVG 587
+G+G GTV+ ++VA+K ++ KQ + E+ E+L+ KN I V
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ-----KQPKKELIINEILVMKELKNPNI-VN 80
Query: 588 YCDE---NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ES 641
+ D ++ +V E++A G+L TD +T + QIA E
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSL------------TDVVTETCM----DEAQIAAVCREC 124
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL-SRIFPVEGGSHVSTTVVGT 700
Q LE+LH ++HRD+KS N+LL KL DFG ++I P + +T+VGT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGT 178
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERTL 745
P ++ PE K D++S G++ +E++ G+ P + + P R L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 41/219 (18%)
Query: 531 RVLGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
R +G G FG VY + + VA+K +S S Q +++Q EV L + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 586 VG-YCDENTKMGLVYEFM---ANGNLQAHL--LAQLAILPTDAEDKTGILSWKGRLQIAT 639
G Y E+T LV E+ A+ L+ H L ++ I +
Sbjct: 81 RGCYLREHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIA-----------------AVTH 122
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+ QGL YLH ++HRDVK+ NILL+E KL DFG + I + VG
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVG 173
Query: 700 TPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQP 735
TP ++ PE ++ + K DV+S G+ +EL +P
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 50/224 (22%)
Query: 531 RVLGKGGFGTVYHG-YLDDKQ-VAVKMLSPSSVQGYKQFQA-----EVELLMR-AHHKNL 582
+ LG G FG+VY + + VA+K + + + ++ EV+ L + H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L EN ++ V+E+M GNL L+ P I+ QI
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLY-QLMKDRKGKPFSESVIRSII-----YQIL---- 109
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS-----TTV 697
QGL ++H K HRD+K N+L++ K+ADFGL+R + T
Sbjct: 110 QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDY 158
Query: 698 VGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
V T Y PE Y S D+++ G ++ EL T +P
Sbjct: 159 VSTRWYRAPEILLRSTSYSS-----PVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 533 LGKGGFGTVYHG--YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
+G G +G VY + AVK++ + Q E+ ++ H N+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA---TESAQGLEY 647
K+ + E+ G+LQ D TG LS LQIA E+ QGL Y
Sbjct: 77 SREKLWICMEYCGGGSLQ------------DIYHVTGPLS---ELQIAYVCRETLQGLAY 121
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH K +HRD+K ANILL + KLADFG++ S +GTP ++ PE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPE 176
Query: 708 YYISNR---LTEKSDVYSFGVVLLELITGQP 735
+ + D+++ G+ +EL QP
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 533 LGKGGFGTVYHGYLDD--KQVAVKMLS-PSSVQGYKQFQA-EVELLMRAH---HKNLTIL 585
+G G +GTVY VA+K + ++ G EV LL R H N+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 586 VGYC-----DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ C D TK+ LV+E + + +L+ +L D G+ + + + +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL---------DKVPPPGLPAETIK-DLMRQ 116
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL++LH C IVHRD+K NIL+ Q KLADFGL+RI+ + T VV T
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVT 170
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
Y PE + + D++S G + E+ +P+ E +G+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH-----KNLT 583
+VLGKG FG V L D+ AVK+L + +VE M
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ----DDDVECTMTEKRVLALAGKHP 56
Query: 584 ILVG-YCDENTKMGL--VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
L + TK L V E++ G+L H+ ++G A E
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ------------RSGRFDEPRARFYAAE 104
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVV 698
GL++LH+ I++RD+K N+LL+ + K+ADFG+ + EG G ++T
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTFC 157
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GTP Y+ PE D ++ GV+L E++ GQ
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 31/232 (13%)
Query: 531 RVLGKGGFGTVY-----HGYLDDKQVAVKMLSPSSV----QGYKQFQAEVELLMRAHHKN 581
+VLGKGG+G V+ G K A+K+L +++ + +AE +L H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+ K+ L+ E+++ G L HL ++ GI +E
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEI 109
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+ LE+LH + I++RD+K NILL+ + KL DFGL + + G+ V+ T GT
Sbjct: 110 SLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGT-VTHTFCGTI 164
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI-----QKTPERTLIGQ 748
Y+ PE + + + D +S G ++ +++TG P +KT ++ L G+
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 531 RVLGKGGFGTVYHGYL----DDKQVAVKMLSPSSVQGYKQFQAEVELLM---RAHHKNLT 583
++LG G FGTV+ G D ++ V + + G + FQ + ++ H +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L+G C + LV + G+L H+ D+ D +L+W + A+
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQH-----RDSLDPQRLLNW------CVQIAK 120
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
G+ YL + +VHR++ + NILL ++ADFG++ + + + + +
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ E + R T +SDV+S+GV + E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 12/103 (11%)
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
G++ IA +GL YL + K I+HRDVK +NIL+N + + KL DFG+S G
Sbjct: 102 GKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLI 151
Query: 693 VS--TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 733
S + VGT Y+ PE T +SD++S G+ L+E+ G
Sbjct: 152 DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 532 VLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILVG-Y 588
++G G +G VY G ++ Q+A + + ++ + E+ +L + +HH+N+ G +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 589 CDEN-----TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+N ++ LV EF G++ L + + T W I E +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTD--------LIKNTKGNTLKEEWIA--YICREILR 122
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL +LH + ++HRD+K N+LL E + KL DFG+S G T +GTP +
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYW 177
Query: 704 LDPEYYISNRLTE-----KSDVYSFGVVLLELITGQP 735
+ PE + + KSD++S G+ +E+ G P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 533 LGKGGFGTVYHGYLDDKQVA---VKMLSPSSVQGYK-----QFQAEVELLMRAHHKNLTI 584
LGKG FGTVY D K VA +K+L V Q E +LL + H +
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
E ++ E+ +L L T +E++ + W +L + G
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLL------G 118
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
+ Y+H + I+HRD+K+ NI L K+ DFG+SR+ + G ++TT GTP Y+
Sbjct: 119 VHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYM 172
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLEL 730
PE KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 532 VLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILVG 587
LG+G + TVY G L + VA+K + +G F A E LL H N+ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ LV+E++ + +L+ ++ +D G LS + +GL Y
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM-----------DDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
H + ++HRD+K N+L++E+ + KLADFGL+R V S + V T Y P+
Sbjct: 119 CH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SKTYSNEVVTLWYRPPD 173
Query: 708 YYI-SNRLTEKSDVYSFGVVLLELITGQPV 736
+ S + D++ G + E+ TG+P+
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 44/101 (43%), Positives = 56/101 (55%), Gaps = 5/101 (4%)
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
+GL Y H K +HRD+K +NILLN K Q KLADFGL+R++ E S T V T
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-ESRPYTNKVITLW 182
Query: 703 YLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
Y PE + R DV+S G +L EL T +P+ Q E
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 531 RVLGKGGFGTVYHG-YLDDKQ-----VAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLT 583
+VLG G FGTVY G ++ + + VA+K+L+ ++ + +F E ++ H +L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG---ILSWKGRLQIATE 640
L+G C T + LV + M +G L ++ + +D G +L+W +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYV--------HEHKDNIGSQLLLNW------CVQ 117
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A+G+ YL + +VHRD+ + N+L+ K+ DFGL+R+ + + +
Sbjct: 118 IAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
++ E + T +SDV+S+GV + EL+T G+P
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 531 RVLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILVGY 588
V+G G +G VY G ++ Q+A + + ++ + E+ +L + +HH+N+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 589 CDENTKMG------LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR--LQIATE 640
+ + G LV EF G++ TD T + K I E
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSV------------TDLVKNTKGNALKEDWIAYICRE 129
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL +LH ++HRD+K N+LL E + KL DFG+S G T +GT
Sbjct: 130 ILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGT 184
Query: 701 PGYLDPEYYISNRLTE-----KSDVYSFGVVLLELITGQP 735
P ++ PE + + +SD++S G+ +E+ G P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-13
Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 56/229 (24%)
Query: 533 LGKGGFGTVYHGYLDDKQ----VAVKMLSPSSVQGYKQFQA------------EVELLMR 576
LGKG +G V+ D++ VA+K K F A E+ L
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62
Query: 577 -AHHKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTD--AEDKTGILSW 631
H N+ L V + + + LV+E+M TD A + IL
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYME----------------TDLHAVIRANILED 106
Query: 632 KGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF---PVE 688
+ I + + L+Y+H G ++HRD+K +NILLN + KLADFGL+R
Sbjct: 107 VHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 689 GGSHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 736
+ V T V T Y PE + S R T+ D++S G +L E++ G+P+
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 531 RVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL----- 582
R LG G G V+ +D DK+VAVK + + Q K E++++ R H N+
Sbjct: 11 RPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+ D +G + E + +Q ++ LA + + G LS + +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL-----EQGPLSEEHARLFMYQLL 124
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFP--VEGGSHVSTTVVG 699
+GL+Y+H ++HRD+K AN+ +N E K+ DFGL+RI ++S +V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180
Query: 700 TPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPV 736
T Y P +S N T+ D+++ G + E++TG+P+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 24/227 (10%)
Query: 533 LGKGGFGTVYHGY----LDDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVG 587
+G G FG V G + +V VK L S+ F EV+ +H N+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C E+ LV EF G+L+ +L + ++ A+ ++A E A GL +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV-------LQRMACEVASGLLW 115
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH + +H D+ N L K+ D+GL+ E +L PE
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 708 YY-------ISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPERTL 745
+ T+KS+++S GV + EL T QP + E+ L
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTIL 585
RVLGKGGFG V + K A K L ++ G E ++L + + + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + LV M G+L+ H+ P E++ L A E GL
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERA--------LFYAAEILCGL 115
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
E LH + V+RD+K NILL++ +++D GL+ P EG S VGT GY+
Sbjct: 116 EDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EGESIRGR--VGTVGYMA 169
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743
PE + R T D + G ++ E+I GQ + E+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 70/247 (28%), Positives = 113/247 (45%), Gaps = 39/247 (15%)
Query: 524 KITNNFERV--LGKGGFGTVY---HGYLDDKQVAVKM-LSPSSVQGYKQFQA--EVELLM 575
+ +E++ +G+G FG V+ H VA+K L + +G+ A E+++L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQI-VALKKVLMENEKEGFP-ITALREIKILQ 66
Query: 576 RAHHKNLTILVGYCDENTKMG--------LVYEFMANGNLQAHLLAQLAILPTDAEDKTG 627
H+N+ L+ C LV+EF + +L A LL+ + T +E K
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DL-AGLLSNKNVKFTLSEIKKV 124
Query: 628 ILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF-- 685
+ + GL Y+H + I+HRD+K+ANIL+ + KLADFGL+R F
Sbjct: 125 MK------MLLN----GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 686 PVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPER- 743
+ T V T Y PE + R D++ G ++ E+ T P++Q E+
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231
Query: 744 --TLIGQ 748
TLI Q
Sbjct: 232 QLTLISQ 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRA-HHKNLTI 584
++LGKG FG V+ L ++ A+K L V + E +L A H LT
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 585 LVGYCDENTKMGL--VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L YC TK L V E++ G+L H+ + D T A E
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF---DLPRATFY---------AAEII 106
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
GL++LH IV+RD+K NILL+ K+ADFG+ + + G + T GTP
Sbjct: 107 CGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCGTPD 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y+ PE + + D +SFGV+L E++ GQ
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 39/106 (36%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
G++ +A A L YL + K ++HRDVK +NILL+ KL DFG+S V+ +
Sbjct: 117 GKMTVAIVKA--LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAK 171
Query: 693 VSTTVVGTPGYLDPEYYISNRLTEK----SDVYSFGVVLLELITGQ 734
T G Y+ PE K +DV+S G+ L+EL TGQ
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCK 653
K+ L+ E+ + G+L + +L E + G+L ++ L L+ +H
Sbjct: 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHSRK- 189
Query: 654 PPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR 713
++HRD+KSANI L KL DFG S+ + V+++ GTP YL PE + R
Sbjct: 190 --MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247
Query: 714 LTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
++K+D++S GV+L EL+T + +R ++ Q
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
|
Length = 478 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 528 NFERV--LGKGGFGTVYHGYLDDKQV-----AVKMLSPSSVQGYKQFQ---AEVELLMRA 577
+ ER+ +G G FG V+ L ++ A+K+++ V KQ Q E +L
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H + L + + ++ E++ G L ++L +G S L
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN------------SGRFSNSTGLFY 106
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A+E LEYLH IV+RD+K NILL+++ KL DFG ++ + T+
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTL 158
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GTP YL PE S + D ++ G+++ E++ G P
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 69/213 (32%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTIL 585
+V+GKG FG V LD K AVK+L V + K AE +L++ +
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 586 VGYCDENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+ Y + T K+ V +F+ G L HL + + + R A E A
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHL-----------QRERSFPEPRARFYAA-EIASA 108
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVVGTPG 702
L YLH IV+RD+K NILL+ + L DFGL + EG S +TT GTP
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPE 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
YL PE D + G VL E++ G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 531 RVLGKGGFGTV--YHGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
++LGKG FG V K A+K+L + + E +L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
++ V E++ G L HL + +ED+T E L
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVF----SEDRTRFY--------GAEIVSAL 108
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST--TVVGTPGY 703
+YLH G IV+RD+K N++L++ K+ DFGL + EG + +T T GTP Y
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEY 161
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
L PE N D + GVV+ E++ G+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQA---EVELLMRAH-HKNLTI 584
RVLGKG FG V L + AVK+L + + E +L A H LT
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 585 LVGYCDENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI-ATESA 642
L C + ++ V EF+ G+L H I + D+ R + A E
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEA-------RARFYAAEIT 106
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
L +LHD I++RD+K N+LL+ + KLADFG+ + G + ++T GTP
Sbjct: 107 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPD 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y+ PE D ++ GV+L E++ G
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 528 NFERVLGKGGFGTVYH-GYLDDKQ-VAVKML--SPSSVQGYKQFQAEVELLMRAHHKNLT 583
N V G+G +G V + + Q VA+K S K E+ +L + H+NL
Sbjct: 5 NLGLV-GEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L+ ++ LV+EF+ + +L L P ++ K QI +
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHT-----VLDDLEKYPNGLDESR---VRKYLFQIL----R 111
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
G+E+ H I+HRD+K NIL+++ KL DFG +R + V T V T Y
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWY 166
Query: 704 LDPEYYISN-RLTEKSDVYSFGVVLLELITGQP 735
PE + + + D+++ G ++ E++TG+P
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLTILVGYC 589
LG+G + TV+ G L + VA+K + +G EV LL H N+ L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
+ + LV+E++ + +L+ ++ +D I+S + +GL Y H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYM-----------DDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 650 DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYY 709
+ ++HRD+K N+L+NE+ + KLADFGL+R V ++ + V T Y P+
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 710 I-SNRLTEKSDVYSFGVVLLELITGQPV 736
+ S+ + + D++ G + E+ +G+P+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 39/230 (16%)
Query: 531 RVLGKGGFGTVYHGYLDDK----QVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLT 583
R++GKGG G VY Y D +VA+K + + K+F E ++ H +
Sbjct: 8 RLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 584 ILVGYCDENTKMGLVYEFMA--NGNLQAHLLA---QLAILPTDAEDKTGILSWKGRLQIA 638
+ C + VY M G LL Q L + +KT + L I
Sbjct: 66 PVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIF 119
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI------------FP 686
+ +EY+H ++HRD+K NILL + + D+G +
Sbjct: 120 HKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 687 VEGGSHVSTT----VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ S T +VGTP Y+ PE + +E +D+Y+ GV+L +++T
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 41/223 (18%)
Query: 532 VLGKGGFGTVYHGYLDD--KQVAVKM--LSPSSVQGYKQFQ--------AEVELLMRAHH 579
++GKG +G VY + +AVK L + + Q +E+E L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ--- 636
N+ +G+ + + E++ G++ + L GR +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGS------------------CLRTYGRFEEQL 109
Query: 637 ---IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+ +GL YLH I+HRD+K+ N+L++ K++DFG+S+ +
Sbjct: 110 VRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 694 STTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQ 734
+ ++ G+ ++ PE S + K D++S G V+LE+ G+
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 519 YANVLKITNNFERV--LGKGGFGTVYHGY--LDDKQVAVK-MLSP-SSVQGYKQFQAEVE 572
+ V +ITN + + +G G FG V L + VA+K ++ P S+ K+ E++
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 573 LLMRAHHKNLTILVGYCD----ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI 628
LL H+N+ + D + V E + L +L +
Sbjct: 62 LLKHLRHENI---ISLSDIFISPLEDIYFVTELLGTD------LHRLL--------TSRP 104
Query: 629 LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
L + + +GL+Y+H +VHRD+K +NIL+NE K+ DFGL+RI
Sbjct: 105 LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI---- 157
Query: 689 GGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPV 736
T V T Y PE ++ + + D++S G + E++ G+P+
Sbjct: 158 -QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 528 NFE--RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHHK 580
+FE +V+G+G FG V L DK A+K+L+ + + F+ E ++L+ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+T L + + LV ++ G+L L LP D + + IA +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYLAEMVIAID 116
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
S L Y VHRD+K NIL++ +LADFG S + +E G+ S+ VGT
Sbjct: 117 SVHQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGT 166
Query: 701 PGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQ 734
P Y+ PE + + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 24/178 (13%)
Query: 570 EVELLMRAHHKNLT----ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDK 625
E+ +L++ H N+ ++VG K+ +V E++ + +L++ L+ + +E K
Sbjct: 54 EINILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVK 109
Query: 626 TGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685
+L Q+ G+ +LHD I+HRD+K++N+LLN + K+ DFGL+R +
Sbjct: 110 CLML------QLL----SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156
Query: 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPE 742
+ T +V T Y PE + + + D++S G + EL+T +P+ E
Sbjct: 157 GSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 532 VLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
++G+GGFG VY D K A+K L + K Q E L +L + G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSL-VSTGDC 56
Query: 590 ----------DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
K+ + + M G+L HL + G+ S K AT
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL------------SQHGVFSEKEMRFYAT 104
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
E GLE++H+ +V+RD+K ANILL+E +++D GL+ F + H S VG
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHAS---VG 157
Query: 700 TPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQ 734
T GY+ PE + S D +S G +L +L+ G
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAE-VE---LLMRAHH 579
NF VLGKG FG V D+ A+K+L V + VE L ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
LT L ++ V E++ G+L H+ + G + A
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI------------QQVGKFKEPQAVFYAA 108
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
E + GL +LH + I++RD+K N++L+ + K+ADFG+ + V+G + + T G
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCG 163
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP Y+ PE + D +++GV+L E++ GQP
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLTILVGYC 589
LG+G + TV+ G L + VA+K + +G EV LL H N+ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT-ESAQGLEYL 648
+ LV+E++ + +L+ +L D G L ++I + +GL Y
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL------------DNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
H K I+HRD+K N+L+NEK + KLADFGL+R V ++ + V T Y P+
Sbjct: 120 H---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 174
Query: 709 YI-SNRLTEKSDVYSFGVVLLELITGQPV 736
+ S + D++ G +L E+ TG+P+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLTILVGY 588
+G+G +G VY G + VA+K + S + A E+ LL H N+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAE-DKTGILSWKGRLQIATESAQGLEY 647
+ +++ L++EF L L L LP D + S+ QI QG+ +
Sbjct: 68 LMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSY--LYQIL----QGILF 116
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGSHVSTTVVGTPGYLD 705
H ++HRD+K N+L++ K KLADFGL+R F PV V T V T Y
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRA 169
Query: 706 PEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
PE + S R + D++S G + E+ T +P+ E
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAE-VELLM--------- 575
NF VLGKG FG V D+ A+K+L + Q + VE M
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-----IQDDDVECTMVEKRVLALP 57
Query: 576 -RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
+ LT L ++ V E++ G+L H+ + G
Sbjct: 58 GKPPF--LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------------QQVGKFKEPHA 103
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
+ A E A GL +LH I++RD+K N++L+ + K+ADFG+ + G + +
Sbjct: 104 VFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--T 158
Query: 695 TTVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
T GTP Y+ PE I+ + KS D ++FGV+L E++ GQP
Sbjct: 159 RTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 47/248 (18%)
Query: 527 NNFE--RVLGKGGFGTVY---HGYLDDKQ-VAVKMLSPSSVQGYKQFQ---AEVELLMRA 577
+FE +++ G +G VY H + +Q A+K ++ ++ Q Q E ++L A
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHK--ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA 58
Query: 578 HHKNLTILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+N ++ +C TK + +V E++ G+ A LL + LP D R+
Sbjct: 59 --ENPFVVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDM----------ARM 105
Query: 636 QIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI---------- 684
A E+ LEYLH+ G IVHRD+K N+L+ KL DFGLS+I
Sbjct: 106 YFA-ETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160
Query: 685 ---FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKT 740
+ + V GTP Y+ PE + + D ++ G++L E + G P T
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
Query: 741 PERTLIGQ 748
PE L GQ
Sbjct: 221 PEE-LFGQ 227
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLTILVGYC 589
LG+G + TVY G L D VA+K + +G EV LL H N+ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH 649
+ LV+E++ + +L+ +L +D ++ + +GL Y H
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYL-----------DDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 650 DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYY 709
+ ++HRD+K N+L+NE+ + KLADFGL+R + ++ + V T Y P+
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 710 I-SNRLTEKSDVYSFGVVLLELITGQPV 736
+ S + + D++ G + E+ TG+P+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 528 NFE--RVLGKGGFGTVY-----HGYLDDKQVAVKMLSPSS-VQGYKQFQ---AEVELLMR 576
NFE RVLG G +G V+ G+ K A+K+L ++ VQ K + E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 577 AHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ + Y +TK+ L+ +++ G L HL + ++ R+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV-----------RV 109
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
IA E L++LH + I++RD+K NILL+ + L DFGLS+ F E +
Sbjct: 110 YIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AY 164
Query: 696 TVVGTPGYLDPEYYISNRLT----EKSDVYSFGVVLLELITG 733
+ GT Y+ PE + + + D +S GV+ EL+TG
Sbjct: 165 SFCGTIEYMAPE--VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 38/197 (19%)
Query: 549 KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608
+QVAVKM+ Q + EV ++ H+N+ + ++ ++ EF+ G L
Sbjct: 47 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL- 105
Query: 609 AHLLAQLAILPTDAEDKTGILSWKGRL---QIAT--ESA-QGLEYLHDGCKPPIVHRDVK 662
T I+S + RL QIAT ES Q L YLH ++HRD+K
Sbjct: 106 -----------------TDIVS-QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIK 144
Query: 663 SANILLNEKFQAKLADFG----LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKS 718
S +ILL + KL+DFG +S+ P ++VGTP ++ PE +
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPYGTEV 198
Query: 719 DVYSFGVVLLELITGQP 735
D++S G++++E++ G+P
Sbjct: 199 DIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 29/215 (13%)
Query: 533 LGKGGFGTVYHGYLDDK---QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
+G G +GTV LD + +VA+K L Y+ FQ+E L + ++ L +L
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKL-------YRPFQSE--LFAKRAYRELRLLKHMK 72
Query: 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK----GRLQ-IATESAQG 644
EN +GL+ F + +L L ++P D ++ + R+Q + + +G
Sbjct: 73 HENV-IGLLDVFTPDLSLDRFHDFYL-VMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
L+Y+H I+HRD+K N+ +NE + K+ DFGL+R + S ++ VV T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV-TRWYR 182
Query: 705 DPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQ 738
PE ++ T+ D++S G ++ E++TG+P+ +
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 531 RVLGKGGFGTVYHG-YLDDKQ-----VAVKML-SPSSVQGYKQFQAEVELLMRAHHKNLT 583
+VLG G FGTVY G ++ + + VA+K L +S + K+ E ++ + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG---ILSWKGRLQIATE 640
L+G C +T + L+ + M G L ++ + +D G +L+W +
Sbjct: 73 RLLGICLTST-VQLITQLMPFGCLLDYV--------REHKDNIGSQYLLNW------CVQ 117
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A+G+ YL + +VHRD+ + N+L+ K+ DFGL+++ + + +
Sbjct: 118 IAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
++ E + T +SDV+S+GV + EL+T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 531 RVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
++LGKG FG V K A+K+L + + E +L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ ++ V E+ G L HL + +ED+ R A E L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVF----SEDRA-------RFYGA-EIVSAL 108
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST--TVVGTPGY 703
YLH +V+RD+K N++L++ K+ DFGL + EG S +T T GTP Y
Sbjct: 109 GYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEY 161
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
L PE N D + GVV+ E++ G+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTIL 585
RVLGKGGFG V + K A K L ++ G E +L + + + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + LV M G+L+ H+ + D+ + + A E GL
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYN----MGNPGFDEQRAIFY------AAELCCGL 115
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
E L + IV+RD+K NILL+++ +++D GL+ P EG VGT GY+
Sbjct: 116 EDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EG--ETVRGRVGTVGYMA 169
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743
PE + + T D + G ++ E+I GQ +K ER
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHKNLT 583
N E+ LG+G + TVY G ++ + VA+K++S + +G F A E LL H N+
Sbjct: 9 NLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV 66
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+L + V+E+M LAQ + G+ + RL + +
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD------LAQYM-----IQHPGGLHPYNVRL-FMFQLLR 114
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL Y+H I+HRD+K N+L++ + KLADFGL+R + ++ S V T Y
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWY 169
Query: 704 LDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 736
P+ + + + D++ G + +E++ GQP
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 541 VYHGYLDDKQVAVKMLSPSSVQGYK----QFQAEVELLMRAHHKNLTILVGY----CDEN 592
+Y G ++K+V ++ +G+K + E++ L R N+ + G+ D+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC 652
++ L+ E+ G L+ L DK LS+K +L +A + +GL L+
Sbjct: 95 PRLSLILEYCTRGYLREVL------------DKEKDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYY--I 710
P ++++ S + L+ E ++ K+ GL +I +V+ V Y + I
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDI 195
Query: 711 SNRLTEKSDVYSFGVVLLELITG 733
+ T K D+YS GVVL E+ TG
Sbjct: 196 FSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 533 LGKGGFGTVYHGYLDDKQ-----VAVKMLSPSSVQGY---KQFQAEVELLMRAHHKNLTI 584
+G+GG+G V+ L K+ VA+K + S + + E ++L + L
Sbjct: 9 VGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L+ ++ + L E++ G+ + LL L +L D R +A E +
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSED----------HARFYMA-EMFEA 113
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
++ LH + +HRD+K N L++ KL DFGLS+ G + +VVG+P Y+
Sbjct: 114 VDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYM 165
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE D +S G +L E + G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 43/222 (19%)
Query: 528 NFERV--LGKGGFGTVYHG--YLDDKQVAVKMLS--------PSSVQGYKQFQAEVELLM 575
NF++V +G+G +G VY L + VA+K + PS+ E+ LL
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI------REISLLK 54
Query: 576 RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI-LSW-KG 633
+H N+ L+ K+ LV+EF+ + +L+ + DA +GI L K
Sbjct: 55 ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---------DASPLSGIPLPLIKS 104
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGS 691
L + QGL + H ++HRD+K N+L+N + KLADFGL+R F PV +
Sbjct: 105 YLF---QLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158
Query: 692 HVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELIT 732
H VV T Y PE + + + D++S G + E++T
Sbjct: 159 H---EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 533 LGKGGFGTVY--------HGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLM--------R 576
LG G FG VY L K++ V +P+ + ++ + ++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVH--NPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H N+ EN ++ +V + + L H + E++ W +Q
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI----WNIFVQ 121
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
+ L YLH + IVHRD+ NI+L E + + DFGL++ + T+
Sbjct: 122 MVL----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTS 172
Query: 697 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740
VVGT Y PE + EK+DV++FG +L ++ T QP T
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 2e-11
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKNLT 583
+ +G G +G V ++VA+K +S + K+ E++LL H+N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENII 62
Query: 584 --ILVGYCDENTKMG---LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+ + +V E M TD ++ K +
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM----------------ETDLHK---VI--KSPQPLT 101
Query: 639 TESAQ--------GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEG 689
+ Q GL+YLH ++HRD+K +NIL+N K+ DFGL+R + P E
Sbjct: 102 DDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 690 GSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 735
T V T Y PE +S +R T+ D++S G + EL+T +P
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 32/214 (14%)
Query: 531 RVLGKGGFGTVY-----HGYLDDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLT 583
+VLG+G FG V+ G + A+K+L ++ V+ + + E ++L +H +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L K+ L+ +F+ G+L L ++ D + +A E A
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-----------KFYLA-ELAL 109
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT--VVGTP 701
L++LH I++RD+K NILL+E+ KL DFGLS+ E H GT
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTV 162
Query: 702 GYLDPEYYISNRL--TEKSDVYSFGVVLLELITG 733
Y+ PE + NR T+ +D +SFGV++ E++TG
Sbjct: 163 EYMAPE--VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 570 EVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL 629
E+ +L + H NL L+ K+ LV+E+ + +L +L P G+
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT-----VLNELEKNP------RGVP 98
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 689
+ +I ++ Q + + H K +HRDVK NIL+ ++ Q KL DFG +RI + G
Sbjct: 99 EHLIK-KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTG 152
Query: 690 GSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPV 736
T V T Y PE + + + DV++ G V EL+TGQP+
Sbjct: 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 531 RVLGKGGFGTVYHGYLDDKQ----VAVKMLSPSSVQGYKQFQ-AEVELLMRAHHKNL-TI 584
+G+G +G V K VA+K +SP Q + Q E+++L R H+N+ I
Sbjct: 11 SYIGEGAYGMVCSAT--HKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 585 L----VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAED--KTGILSWKGRLQIA 638
L + + +V E M TD KT LS
Sbjct: 69 LDIIRPPSFESFNDVYIVQELM----------------ETDLYKLIKTQHLSNDHIQYFL 112
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF-PVEGGSHVSTTV 697
+ +GL+Y+H ++HRD+K +N+LLN K+ DFGL+RI P + T
Sbjct: 113 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 698 VGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQPV 736
V T Y PE ++++ K+ D++S G +L E+++ +P+
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 40/233 (17%)
Query: 533 LGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILVG-Y 588
+GKG +G V+ + + AVK+L P ++ +AE +L + H N+ G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 589 CDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ------IA 638
++ K G LV E G++ TD G L R++ I
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSV------------TDL--VKGFLKRGERMEEPIIAYIL 130
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
E+ GL++LH +HRDVK NILL + KL DFG+S + T V
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSV 185
Query: 699 GTPGYLDPEYY-----ISNRLTEKSDVYSFGVVLLELITGQPVIQKT-PERTL 745
GTP ++ PE + + + DV+S G+ +EL G P + P R L
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 531 RVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTIL 585
RVLGKGGFG V K A K L ++ G E ++L + + + + L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + LV M G+L+ H+ + +++ + A E GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVF-------YAAEITCGL 115
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
E LH + IV+RD+K NILL++ +++D GL+ P EG VGT GY+
Sbjct: 116 EDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EG--ETIRGRVGTVGYMA 169
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743
PE + R T D + G ++ E+I G+ ++ E+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 24/190 (12%)
Query: 549 KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608
KQVAVK + Q + EV ++ HH+N+ + ++ +V EF+ G L
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL- 106
Query: 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGLEYLHDGCKPPIVHRDVKSAN 665
TD T + QIAT + L YLH+ ++HRD+KS +
Sbjct: 107 -----------TDIVTHTRM----NEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDS 148
Query: 666 ILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGV 725
ILL + KL+DFG E S +VGTP ++ PE + D++S G+
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 726 VLLELITGQP 735
+++E+I G+P
Sbjct: 207 MVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 533 LGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTILVG 587
+GKG FG VY D + A+K+LS + K+ E +L+R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 588 Y---CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK-GRLQIATESAQ 643
++ + LV ++M+ G L HL K G S + IA E
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL------------QKEGRFSEDRAKFYIA-ELVL 107
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
LE+LH K IV+RD+K NILL+ L DFGLS+ + + T GT Y
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEY 162
Query: 704 LDPEYYISNR-LTEKSDVYSFGVVLLELITG 733
L PE + + T+ D +S GV++ E+ G
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVE----LLMRAHHKNLTI 584
+VLGKG FG V L D+ A+K+L + + L + A H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 585 LVGYCDENTKMGL--VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L +C TK L V E++ G+L I + D+ + R A E
Sbjct: 61 L--HCCFQTKDRLFFVMEYVNGGDLM------FQIQRSRKFDEP-----RSRF-YAAEVT 106
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVVGT 700
L +LH + +++RD+K NILL+ + KLADFG+ + EG +TT GT
Sbjct: 107 LALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGT 159
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745
P Y+ PE D ++ GV++ E++ GQP + E L
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 532 VLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
++G+GGFG VY D K A+K L + K Q E L +L + G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSL-VSTGDC 56
Query: 590 ----------DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
K+ + + M G+L HL + G+ S A
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------------SQHGVFSEAEMRFYAA 104
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
E GLE++H+ +V+RD+K ANILL+E +++D GL+ F + H S VG
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHAS---VG 157
Query: 700 TPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQ 734
T GY+ PE + S D +S G +L +L+ G
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 72/255 (28%), Positives = 110/255 (43%), Gaps = 32/255 (12%)
Query: 508 GSLELKNRKLSYANVLKITNNFERV--LGKGGFGTVYH--GYLDDKQVAVKMLSPSSVQG 563
G + L ++ T+ +E + +GKG +G VY D AVK+L P S
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD 62
Query: 564 YKQFQAEVELLMR-AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDA 622
++ +AE +L +H N+ G+ Y+ Q L+ +L +
Sbjct: 63 -EEIEAEYNILQSLPNHPNVVKF---------YGMFYKADKLVGGQLWLVLELCNGGSVT 112
Query: 623 EDKTGILSWKGRLQ------IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676
E G+L RL I + GL++LH+ I+HRDVK NILL + KL
Sbjct: 113 ELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL 169
Query: 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKS-----DVYSFGVVLLELI 731
DFG+S + T VGTP ++ PE + + S DV+S G+ +EL
Sbjct: 170 VDFGVSA--QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227
Query: 732 TGQ-PVIQKTPERTL 745
G P+ P +TL
Sbjct: 228 DGDPPLFDMHPVKTL 242
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF---PVEGGSHVSTTVVGT 700
GL+Y+H ++HRD+K N+L+N + K+ DFGL+R F P E + T V T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 701 PGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQPV 736
Y PE +S + K+ DV+S G +L EL+ +PV
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAE-VE---LLMRAHHKN 581
NF VLGKG FG V D+ A+K+L V + VE L +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
LT L ++ V E++ G+L + + G + A E
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI------------QQVGRFKEPHAVFYAAEI 110
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
A GL +LH I++RD+K N++L+ + K+ADFG+ + +G + + T GTP
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTP 165
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745
Y+ PE + D ++FGV+L E++ GQ + E L
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 533 LGKGGFGTVYHGYLD----DKQVAVKML-SPSSVQGYK-QFQAEVELLMRAHHKNLTILV 586
LG G FGTV G +K VAVK+L + ++ K + E ++ + + + ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C+ + M LV E G L L K ++ K ++ + + G++
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFL------------QKNKHVTEKNITELVHQVSMGMK 109
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLD 705
YL + VHRD+ + N+LL + AK++DFGLS+ + + + T P +
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 706 PEYYISNRLTEKSDVYSFGVVLLE 729
PE + + KSDV+SFGV++ E
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 68/268 (25%), Positives = 105/268 (39%), Gaps = 72/268 (26%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQG-YKQFQAEVELLMR-AHH 579
+ LG+G FG V + VAVKML + YK E+++L+ HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 580 KNLTILVGYCDENTKMG----LVYEFMANGNLQAHLLAQL-AILPTDAEDKTGILSW--- 631
N+ L+G C TK G ++ E+ GNL +L ++ P +
Sbjct: 71 LNVVNLLGAC---TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 632 --KGRLQIATES-------------------------------------------AQGLE 646
K RL + S A+G+E
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVSTTVVGTP-GYL 704
+L +HRD+ + NILL+E K+ DFGL+R I+ + +V P ++
Sbjct: 188 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARLPLKWM 242
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE T +SDV+SFGV+L E+ +
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 530 ERVLGKGGFGTVYHGYLD--DKQ---VAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLT 583
ER+LG G FG + G L K+ VA+ L S + + F AE L + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L G M +V E+M+NG L + L G L + + A
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL-----------RKHEGQLVAGQLMGMLPGLAS 118
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
G++YL + VH+ + + +L+N K++ F R + + TT+ G
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPV 172
Query: 704 L--DPEYYISNRLTEKSDVYSFGVVLLELIT 732
L PE + + SDV+SFG+V+ E+++
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 528 NFE--RVLGKGGFGTVY-----HGYLDDKQVAVKMLSPSS-VQGYK---QFQAEVELLMR 576
NFE +VLG G +G V+ G+ K A+K+L ++ VQ K + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 577 AHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ + Y +TK+ L+ +++ G L HL + + + +G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-------- 112
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
E LE+LH K I++RD+K NILL+ L DFGLS+ F E +
Sbjct: 113 ----EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAY 164
Query: 696 TVVGTPGYLDPEYYISNRLTEKS--DVYSFGVVLLELITG 733
+ GT Y+ P+ D +S GV++ EL+TG
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 533 LGKGGFGTVYHGY--LDDKQ--VAVKMLSPSSVQGYK-QFQAEVELLMRAHHKNLTILVG 587
LG G FG V G + KQ VA+K+L + + + + E E++ + + + ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C+ M LV E + G L L + + +++ + + G++Y
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-----------NVVELMHQVSMGMKY 110
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
L VHRD+ + N+LL + AK++DFGLS+ + + + + P + P
Sbjct: 111 LEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 707 EYYISNRLTEKSDVYSFGVVLLE 729
E + + +SDV+S+G+ + E
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 38/102 (37%), Positives = 59/102 (57%), Gaps = 8/102 (7%)
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
G++ IA +GL YL + K I+HRDVK +NIL+N + + KL DFG+S
Sbjct: 106 GKVSIAV--LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DS 157
Query: 693 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
++ + VGT Y+ PE + +SD++S G+ L+EL G+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 531 RVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSV---QGYKQFQAEVELLMR-AHHKNLTI 584
+V+GKG FG V ++K AVK+L ++ + K +E +L++ H L
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L K+ V +++ G L HL + L A A E A
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR------------FYAAEIASA 108
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
L YLH IV+RD+K NILL+ + L DFGL + G+ ++T GTP YL
Sbjct: 109 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYL 163
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE D + G VL E++ G P
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 43/224 (19%)
Query: 528 NFERVLGKGGFGTV---YHGYLDDKQVAVKMLS-P-SSVQGYKQFQAEVELLMRAHHKNL 582
+G G +G V + K VA+K LS P S K+ E+ LL H+N+
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRK-VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 583 TIL--VGYCDEN----TKMGLVYEFMANGNLQAHLLAQL-AILPTDA--EDKTGILSWKG 633
L V + + LV M A L I+ +D L +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMG---------ADLNNIVKCQKLSDDHIQFLVY-- 125
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
QI +GL+Y+H I+HRD+K +NI +NE + K+ DFGL+R E
Sbjct: 126 --QIL----RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----- 171
Query: 694 STTVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 735
T V T Y PE + N + + D++S G ++ EL+TG+
Sbjct: 172 MTGYVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 52/239 (21%)
Query: 528 NFERVLGKGGFGTVYHGYLDD----KQVAVKMLSPSSVQGYKQFQA---EVELLMRAHHK 580
E +G+G +G VY + K+ A+K Q Q+ E+ LL H+
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 581 NLTILVGYCDENT--KMGLVYEFMANGNLQAHLLAQLAILPTDAE-DKTGILSW---KGR 634
N+ LV E+ + L++++ AE D I+ + R
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDY--------------------AEHDLWQIIKFHRQAKR 102
Query: 635 LQIAT---ESA-----QGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFGLS 682
+ I +S G+ YLH ++HRD+K ANIL+ E+ K+ D GL+
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 683 RIF--PVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 738
R+F P++ + + VV T Y PE + R T+ D+++ G + EL+T +P+ +
Sbjct: 160 RLFNAPLKPLADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 41/107 (38%), Positives = 56/107 (52%), Gaps = 19/107 (17%)
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG----S 691
+IA + LEYLH ++HRDVK +N+L+N Q KL DFG+S G S
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 692 HVSTTVVGTPGYLDPEYYISNRLTE-----KSDVYSFGVVLLELITG 733
T G Y+ PE I+ L + KSDV+S G+ ++EL TG
Sbjct: 158 VAKTIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 64/255 (25%)
Query: 527 NNFE--RVLGKGGFGTV--YHGYLDDKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHH 579
++FE +V+G+G FG V A+K L S + +Q +AE ++L A
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD- 59
Query: 580 KNLTILVGYC---DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
N ++ Y DEN + L+ E++ G++ LL + E++T R
Sbjct: 60 -NPWVVKLYYSFQDENY-LYLIMEYLPGGDMMT-LLMKKDTF---TEEET-------RFY 106
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-------------R 683
IA E+ ++ +H K +HRD+K N+LL+ K KL+DFGL
Sbjct: 107 IA-ETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 684 IFPVEGGSHVSTT-----------------------VVGTPGYLDPEYYISNRLTEKSDV 720
+ + + VGTP Y+ PE ++ ++ D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 721 YSFGVVLLELITGQP 735
+S GV++ E++ G P
Sbjct: 223 WSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 533 LGKGGFGTVYHG--------YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTI 584
+G+G +G V+ ++ K+V V+ + A + L H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 585 LVGYC-----DENTKMGLVYEFMANGNLQAHL--LAQLAILPTDAEDKTGILSWKGRLQI 637
L C D TK+ LV+E + + +L +L + + + +D +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD------------M 115
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ +GL++LH +VHRD+K NIL+ Q KLADFGL+RI+ + T+V
Sbjct: 116 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSV 169
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
V T Y PE + + D++S G + E+ +P+ + + + +G+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 48/222 (21%)
Query: 533 LGKGGFGTVY---HGYLDDKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGY 588
+G+G FGTV H +AVK + + + K+ +++++MR+
Sbjct: 12 IGRGAFGTVNKMLHKPSG-TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD--------- 61
Query: 589 CDENTKM-GLVY---------EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
C K G ++ E M ++ + + IL G++ +A
Sbjct: 62 CPYIVKFYGALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEIL---GKIAVA 115
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG----SHVS 694
T A L YL + K I+HRDVK +NILL+ KL DFG+S G S
Sbjct: 116 TVKA--LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSIAK 164
Query: 695 TTVVGTPGYLDPEYYISNRLTE---KSDVYSFGVVLLELITG 733
T G Y+ PE + +SDV+S G+ L E+ TG
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 71/228 (31%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 533 LGKGGFGTVYHGY----LDDKQVAVKML-SPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+G G FG V G QV VK L +SVQ +F E + H NL +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C E T LV EF G+L+ +L + AE T + R+ A E A GL +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRK-----AELMTPDPTTLQRM--ACEIALGLLH 115
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
LH K +H D+ N LL K+ D+GLS E +V+ + P ++ P
Sbjct: 116 LH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVPLRWIAP 171
Query: 707 EYYI---SNRL----TEKSDVYSFGVVLLEL--ITGQPVIQKTPERTL 745
E N L T++S+V+S GV + EL + QP + E+ L
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 8/102 (7%)
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
G++ IA +GL YL + K I+HRDVK +NIL+N + + KL DFG+S
Sbjct: 106 GKVSIAV--IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DS 157
Query: 693 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
++ + VGT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 531 RVLGKGGFGTV--YHGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTIL 585
++LGKG FG V + A+K+L + + E +L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ ++ V E+ G L HL + E++ E L
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVF----TEERARFY--------GAEIVSAL 108
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST--TVVGTPGY 703
EYLH +V+RD+K N++L++ K+ DFGL + EG S +T T GTP Y
Sbjct: 109 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEY 161
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPER 743
L PE N D + GVV+ E++ G+ P + ER
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 51/224 (22%)
Query: 533 LGKGGFGTVYHGYLDDKQ--VAVKMLS--------PSSVQGYKQFQAEVELLMRAHHKNL 582
+G+G +GTV+ + VA+K + PSS E+ LL HKN+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 61
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L + K+ LV+E+ D + K S G + +
Sbjct: 62 VRLYDVLHSDKKLTLVFEY------------------CDQDLKKYFDSCNGDIDPEIVKS 103
Query: 643 ------QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGSHVS 694
+GL + H ++HRD+K N+L+N+ + KLADFGL+R F PV S
Sbjct: 104 FMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA-- 158
Query: 695 TTVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELIT-GQPV 736
VV T Y P+ +L S D++S G + EL G+P+
Sbjct: 159 -EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 529 FERV--LGKGGFGTVYHG--YLDDKQVAVKMLS--------PSSVQGYKQFQAEVELLMR 576
+++V +G+G +G VY L + VA+K + PS+ E+ LL
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKE 54
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+H N+ L+ K+ LV+EF L L + P D I S+ +L
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQL- 108
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF--PVEGGSHVS 694
QG+ Y H ++HRD+K N+L++ + KLADFGL+R F PV +H
Sbjct: 109 -----LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH-- 158
Query: 695 TTVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
VV T Y PE + +R D++S G + E++ +P
Sbjct: 159 -EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTIL 585
+V+GKG FG V D AVK+L ++ K+ AE +L++ +
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 586 VGYCDENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+ Y + K+ V +++ G L HL + L A A E A
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRAR------------FYAAEVASA 108
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVVGTPG 702
+ YLH I++RD+K NILL+ + L DFGL + EG ++T GTP
Sbjct: 109 IGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPE 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
YL PE D + G VL E++ G P
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 528 NFE--RVLGKGGFGTVY-----HGYLDDKQVAVKMLSPSS-VQGYK---QFQAEVELLMR 576
NFE +VLG G +G V+ G+ K A+K+L ++ VQ K + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 577 AHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ + Y K+ L+ ++++ G + HL + +ED+ S G +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF----SEDEVRFYS--GEI 114
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
+A LE+LH K IV+RD+K NILL+ + L DFGLS+ F E +
Sbjct: 115 ILA------LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TY 164
Query: 696 TVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITG 733
+ GT Y+ PE K+ D +S G+++ EL+TG
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 32/109 (29%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI---FPVEGGSHVSTTVVGT 700
GL+Y+H ++HRD+K +N+L+NE + ++ DFG++R P E + T V T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM-TEYVAT 174
Query: 701 PGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
Y PE +S T D++S G + E++ + + P + + Q
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF---PGKNYVHQ 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 8e-10
Identities = 71/243 (29%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 518 SYANVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLS-PSSVQGY-KQFQAEVEL 573
S VLK N + +G G G V Y + D+ VA+K LS P Q + K+ E+ L
Sbjct: 11 STFTVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 574 LMRAHHKNLTILVGY------CDENTKMGLVYEFM-ANGNLQAHLLAQLAILPTDAEDKT 626
+ +HKN+ L+ +E + LV E M AN L Q+ + D E +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-------LCQVIQMELDHERMS 122
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
+L + G+++LH I+HRD+K +NI++ K+ DFGL+R
Sbjct: 123 YLL---------YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 167
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
G S + T V T Y PE + E D++S G ++ E++ + + P R I
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF---PGRDYI 224
Query: 747 GQW 749
QW
Sbjct: 225 DQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
+GL+YLH I+HRD+K N+L+N K+ DFGL+R+ + H++ VV T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 703 YLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 738
Y PE + S T D++S G + EL+ + + Q
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 531 RVLGKGGFGTVYHGYLDDKQV----AVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLT 583
++LGKG FG V + +K A+K+L + + E +L + H LT
Sbjct: 1 KLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L + ++ V E+ G L HL + +ED+ E
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF----SEDRARFY--------GAEIVS 106
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
L+YLH + +V+RD+K N++L++ K+ DFGL + +G + T GTP Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
L PE N D + GVV+ E++ G+
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 533 LGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNLTILVG 587
+GKG FG V D Q A+K + + + + AE +L + + + L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS-WKGRLQIATESAQGLE 646
K+ LV F+ G L HL + G + R A E LE
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL------------QREGRFDLSRARFYTA-ELLCALE 107
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
LH K +++RD+K NILL+ + L DFGL ++ + + T GTP YL P
Sbjct: 108 NLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAP 162
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITGQP 735
E + + T+ D ++ GV+L E++TG P
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 533 LGKGGFGTVYHGYLDDKQVAVKM------LSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
LGKG +G+VY V + M L S + Q E+++L H +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK---FNQIIMELDIL---HKAVSPYIV 62
Query: 587 GYCDENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+ G VY E+M G+L T + +I +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDK---------LYAGGVATEGIPEDVLRRITYAVVK 113
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL++L + + I+HRDVK N+L+N Q KL DFG+S + ++ T +G Y
Sbjct: 114 GLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV----ASLAKTNIGCQSY 167
Query: 704 LDPEYYISNRLTE------KSDVYSFGVVLLELITG 733
+ PE S + +SDV+S G+ +LE+ G
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 65/242 (26%), Positives = 90/242 (37%), Gaps = 59/242 (24%)
Query: 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTIL 585
++LGKG G V+ L K A+K+L + K+ E E+L H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI------AT 639
T + LV ++ G L L Q P L A
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQ----P------------GKCLSEEVARFYAA 110
Query: 640 ESAQGLEYLH-DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--------- 689
E LEYLH G IV+RD+K NILL+E L+DF LS+ VE
Sbjct: 111 EVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 690 ------------------GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 731
S S + VGT Y+ PE + D ++ G++L E++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 732 TG 733
G
Sbjct: 227 YG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 528 NFERVLGKGGFGTVY---HGYLDDKQV-AVKMLSPSSV--QGYKQFQAEVELLMRAHHKN 581
+ +V+G+G FG V H KQV A+K+LS + + F E +M AH +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHK--SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM-AHANS 102
Query: 582 LTILVGYC--DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
I+ + ++ + +V E+M G+L +L++ I P W R A
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDI-PEK---------W-ARFYTA- 149
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
E L+ +H +HRDVK N+LL++ KLADFG G T VG
Sbjct: 150 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR-CDTAVG 205
Query: 700 TPGYLDPEYYISNRLT----EKSDVYSFGVVLLELITGQP 735
TP Y+ PE S + D +S GV L E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHK 580
+++E++ LG+G + TVY G ++ K VA+K++ +G F A E LL H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ +L + LV+E++ Q + G L + +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQY------------MDKHPGGLHPENVKLFLFQ 111
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL Y+H + I+HRD+K N+L+++ + KLADFGL+R V SH + V T
Sbjct: 112 LLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVT 166
Query: 701 PGYLDPEYYISNRLTEKS---DVYSFGVVLLELITG 733
Y P+ + + TE S D++ G + +E+I G
Sbjct: 167 LWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 533 LGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTILVG 587
LGKGGFG V + + K A K L ++ G K E E+L + + + L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ T + LV M G+L+ H+ + + ++ + QI G+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN----VGERGLEMERVIHYSA--QITC----GILH 110
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH IV+RD+K N+LL+++ +L+D GL+ ++ G + T GT GY+ PE
Sbjct: 111 LHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPE 164
Query: 708 YYISNRLTEKSDVYSFGVVLLELITGQ 734
+ D ++ G + E++ G+
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 18/187 (9%)
Query: 549 KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608
K VAVK + Q + EV ++ H+N+ + ++ +V EF+ G L
Sbjct: 46 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL- 104
Query: 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668
TD T + QIA L+ L ++HRD+KS +ILL
Sbjct: 105 -----------TDIVTHTRM----NEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149
Query: 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 728
+ KL+DFG V ++VGTP ++ PE + D++S G++++
Sbjct: 150 THDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 207
Query: 729 ELITGQP 735
E++ G+P
Sbjct: 208 EMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 70/243 (28%), Positives = 109/243 (44%), Gaps = 37/243 (15%)
Query: 518 SYANVLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLS-PSSVQGY-KQFQAEVEL 573
S VLK N + +G G G V Y + ++ VA+K LS P Q + K+ E+ L
Sbjct: 18 STFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 574 LMRAHHKNLTILVGY------CDENTKMGLVYEFM-ANGNLQAHLLAQLAILPTDAEDKT 626
+ +HKN+ L+ +E + +V E M AN L Q+ + D E +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-------LCQVIQMELDHERMS 129
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
+L + G+++LH I+HRD+K +NI++ K+ DFGL+R
Sbjct: 130 YLL---------YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 174
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
G S + T V T Y PE + E D++S G ++ E+I G + P I
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF---PGTDHI 231
Query: 747 GQW 749
QW
Sbjct: 232 DQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL+Y+H ++HRD+K +N+LLN K+ DFGL+R +G T V T Y
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWY 174
Query: 704 LDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQ 738
PE ++ + T DV+S G + EL+ +P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 70/239 (29%), Positives = 107/239 (44%), Gaps = 37/239 (15%)
Query: 522 VLKITNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLS-P-SSVQGYKQFQAEVELLMRA 577
VLK N + +G G G V Y + + VA+K LS P +V K+ E+ L+
Sbjct: 14 VLKRYQNL-KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV 72
Query: 578 HHKNLTILVGY------CDENTKMGLVYEFM-ANGNLQAHLLAQLAILPTDAEDKTGILS 630
+HKN+ L+ +E + LV E M AN L Q+ + D E + +L
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN-------LCQVIQMDLDHERMSYLL- 124
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
+ G+++LH I+HRD+K +NI++ K+ DFGL+R G
Sbjct: 125 --------YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGT 170
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQW 749
S + T V T Y PE + E D++S G ++ E+I G + P I QW
Sbjct: 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF---PGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 31/229 (13%)
Query: 513 KNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQ---VAVKMLSPSSVQGYKQFQ- 568
+ K+ Y + NF R LG G FG V ++ VA+K S + KQ
Sbjct: 23 RKNKMKYEDF-----NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 569 --AEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT 626
+E ++L +H L G + + + LV EF+ G L + P D
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPND----V 132
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
G + ++ + E Q L IV+RD+K N+LL++ K+ DFG +++
Sbjct: 133 GCF-YAAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T+ GTP Y+ PE ++ + +D ++ G+ + E++ G P
Sbjct: 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 65/265 (24%), Positives = 104/265 (39%), Gaps = 66/265 (24%)
Query: 531 RVLGKGGFGTVYHGYLDDKQV--AVKMLSPSSVQGYKQF---QAEVELLMRAHHKNLTIL 585
+ LG G FG V D + A+K L V Q +AE ++L A ++ + L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + V +++ G++ + LL ++ I P D + L A ES +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLAR-----FYIAELTCAVESVHKM 120
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP-------VEGGSHV----- 693
+ +HRD+K NIL++ KL DFGL F + G HV
Sbjct: 121 GF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 694 ---------------------------------STTVVGTPGYLDPEYYISNRLTEKSDV 720
+ ++VGTP Y+ PE + T+ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 721 YSFGVVLLELITGQ-PVIQKTPERT 744
+S GV+L E++ GQ P + +TP T
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTPLET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 61/258 (23%), Positives = 113/258 (43%), Gaps = 56/258 (21%)
Query: 528 NFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQ---FQAEVELLMRAHHK 580
+FE +V+G+G FG V D A+K+L + + +Q +AE ++L+ A
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ + + + L+ EF+ G++ L+ + T E++T + IA E
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEET-------QFYIA-E 109
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG----------------LSRI 684
+ ++ +H + +HRD+K N+LL+ K KL+DFG L+
Sbjct: 110 TVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 685 FPVE-----------------GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVL 727
P + ++ + VGTP Y+ PE ++ + D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 728 LELITG-QPVIQKTPERT 744
E++ G P +TP+ T
Sbjct: 227 YEMLIGYPPFCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 66/263 (25%)
Query: 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTIL 585
+ +G G FG V D A+K L + V Q +AE ++L A ++ + L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + V +++ G++ + LL +L I D R IA E +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDL----------ARFYIA-ELTCAI 114
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL---------SRIFPVEGGSH---- 692
E +H K +HRD+K NIL++ KL DFGL S+ + + G H
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY--QKGDHHRQD 169
Query: 693 ------------------------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYS 722
++ ++VGTP Y+ PE + T+ D +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 723 FGVVLLELITGQ-PVIQKTPERT 744
GV+L E++ GQ P + TP T
Sbjct: 230 VGVILYEMLVGQPPFLADTPAET 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 66/265 (24%), Positives = 104/265 (39%), Gaps = 66/265 (24%)
Query: 531 RVLGKGGFGTVYHGYLDDKQV--AVKMLSPSSVQGYKQF---QAEVELLMRAHHKNLTIL 585
+ LG G FG V D A+K L V Q +AE ++L A ++ + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + V +++ G++ + LL ++ + P R IA E +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVL----------ARFYIA-ELTLAI 114
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP-------VEGGSHV----- 693
E +H K +HRD+K NIL++ KL DFGL F + GSH+
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 694 ---------------------------------STTVVGTPGYLDPEYYISNRLTEKSDV 720
+ ++VGTP Y+ PE + T+ D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 721 YSFGVVLLELITGQ-PVIQKTPERT 744
+S GV+L E++ GQ P + TP T
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
+GL YLH I+HRDVK+ NI +N+ Q + D G ++ FPV + + + GT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVE 221
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744
PE ++ K+D++S G+VL E++ I + P T
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 44/226 (19%)
Query: 529 FERV--LGKGGFGTVYHGY--LDDKQVAVKMLS--------PSSVQGYKQFQAEVELLMR 576
+E+V +G+G +G VY + ++ +A+K + PS+ E+ LL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLKE 57
Query: 577 AHHKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
H N+ L V + ++ ++ LV+E+ L L + P A++ I ++
Sbjct: 58 MQHGNIVRLQDVVHSEK--RLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTY--L 108
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA-KLADFGLSRIF--PVEGGS 691
QI +G+ Y H ++HRD+K N+L++ + A KLADFGL+R F PV +
Sbjct: 109 YQIL----RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
Query: 692 HVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPV 736
H V T Y PE + +R + D++S G + E++ +P+
Sbjct: 162 H----EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 44/235 (18%)
Query: 529 FERVLGK----GGFGTVYHGYLDDKQVAVKM--LSPSSVQGYKQFQAEVELLMRAHHKNL 582
++GK + + VAVK L S + K Q E+ + H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 583 TILVGYCDENTKMGLVYEFMANGN----LQAHL---LAQLAILPTDAEDKTGILSWKGRL 635
V ++++ +V MA G+ L+ H L +LAI
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA----------------- 104
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
I + L+Y+H +HR VK+++ILL+ + L+ S ++ G
Sbjct: 105 FILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKR-QR 159
Query: 696 TVVGTPGY-------LDPEYYISNRL--TEKSDVYSFGVVLLELITGQPVIQKTP 741
V P L PE N EKSD+YS G+ EL G + P
Sbjct: 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 551 VAVKMLS-PSSVQGY-KQFQAEVELLMRAHHKNLTILVGY------CDENTKMGLVYEFM 602
VAVK LS P Q + K+ E+ LL +HKN+ L+ +E + LV E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 603 -ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661
AN L Q+ + D E + +L Q+ G+++LH I+HRD+
Sbjct: 109 DAN-------LCQVIHMELDHERMSYLL-----YQMLC----GIKHLHSA---GIIHRDL 149
Query: 662 KSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVY 721
K +NI++ K+ DFGL+R + + T V T Y PE + E D++
Sbjct: 150 KPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIW 206
Query: 722 SFGVVLLELITGQPVIQKTPERTLIGQW 749
S G ++ EL+ G + Q T I QW
Sbjct: 207 SVGCIMGELVKGSVIFQGTDH---IDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 42/202 (20%)
Query: 566 QFQAEVELLMRAHHKNLTILVGYCDE-----NTKMGLVYEFMANGNLQAHLLAQLAILPT 620
Q EV ++ HKN+ V Y D N K+ ++ EF G+L ++ +
Sbjct: 58 QLVIEVNVMRELKHKNI---VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF-- 112
Query: 621 DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP----IVHRDVKSANILL-------- 668
G + + I + L Y H+ P ++HRD+K NI L
Sbjct: 113 ------GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166
Query: 669 ---------NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI--SNRLTEK 717
N + AK+ DFGLS+ +E +H + VGTP Y PE + + +K
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDK 223
Query: 718 SDVYSFGVVLLELITGQPVIQK 739
SD+++ G ++ EL +G+ K
Sbjct: 224 SDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 527 NNFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQ---FQAEVELLMRAHH 579
++FE +V+G+G FG V + + A+K+L+ + + F+ E +L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 580 KNLTIL-VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+ +T L + DEN + LV ++ G+L L LP D + + +A
Sbjct: 61 QWITTLHYAFQDEN-YLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYIAEMVLA 114
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
S L Y VHRD+K N+LL+ +LADFG S + + G+ S+ V
Sbjct: 115 IHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAV 164
Query: 699 GTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQ 734
GTP Y+ PE + + + D +S GV + E++ G+
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 527 NNFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQFQA----EVELLMRAH 578
N FE V+G+G +G V + + VA+K S + ++ + E+++L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+N+ L K+ LV+E+ ++ ++L L +P G+ K R I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEY-----VEKNMLELLEEMPN------GVPPEKVRSYIY 107
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
Q ++ +H K IVHRD+K N+L++ KL DFG +R EG + T V
Sbjct: 108 ----QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYV 162
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736
T Y PE + + D++S G +L EL GQP+
Sbjct: 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 533 LGKGGFGTVYHGYLDDK---QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
+G G +G+V +D + +VA+K LS + FQ+E+ RA+ + LT+L
Sbjct: 23 VGSGAYGSVCSA-IDKRTGEKVAIKKLS-------RPFQSEI-FAKRAY-RELTLLKHMQ 72
Query: 590 DENTKMGLVYEFMAN---GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ-IATESAQGL 645
EN +GL+ F + Q L + + TD + G + ++Q + + GL
Sbjct: 73 HENV-IGLLDVFTSAVSGDEFQDFYLV-MPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
+Y+H I+HRD+K N+ +NE + K+ DFGL+R E T V T Y
Sbjct: 131 KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRA 182
Query: 706 PEYYIS-NRLTEKSDVYSFGVVLLELITGQ 734
PE ++ + D++S G ++ E++TG+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 532 VLGKGGFGTVYHGYLDDKQV----AVKMLSPSSVQGYK---QFQAEVELLMRAHHKNLTI 584
++G+G FG V + +K A+K++ S + + F+ E ++L ++ +
Sbjct: 8 LVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L + + LV E+ G+L + LL + D D+ + L +A S
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLS-LLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV-STTVVGTPGY 703
+ Y VHRD+K N+L++ KLADFG + V S VGTP Y
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANK--MVNSKLPVGTPDY 169
Query: 704 LDPEYYISNRLTEKS------DVYSFGVVLLELITGQ-PVIQKTPERT 744
+ PE + K D +S GV+ E+I G+ P + T +T
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 533 LGKGGFGTVYHGYLDDK---QVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+G G +G+V + D K +VAVK LS S+ K+ E+ LL H+N+ +G
Sbjct: 25 VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV---IG 80
Query: 588 YCDENTKMGLVYEFMANGNLQAHL----LAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
D T + EF + L HL L + +D L + QI +
Sbjct: 81 LLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QIL----R 131
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL+Y+H I+HRD+K +N+ +NE + K+ DFGL+R E T V T Y
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 183
Query: 704 LDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740
PE ++ + D++S G ++ EL+TG+ + T
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 62/259 (23%), Positives = 114/259 (44%), Gaps = 56/259 (21%)
Query: 527 NNFE--RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQ---FQAEVELLMRAHH 579
++FE +V+G+G FG V D A+K+L + + +Q +AE ++L+ A
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ + + + L+ EF+ G++ L+ + T +E+ T + IA
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEAT-------QFYIA- 108
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-------RIFPVEGGSH 692
E+ ++ +H + +HRD+K N+LL+ K KL+DFGL R +H
Sbjct: 109 ETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 693 --------------------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVV 726
++ + VGTP Y+ PE ++ + D +S GV+
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 727 LLELITG-QPVIQKTPERT 744
+ E++ G P +TP+ T
Sbjct: 226 MYEMLIGYPPFCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS-TTVVGTP 701
+ L+Y+H + HRD+K NIL N + K+ DFGL+R+ + + + T V T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 702 GYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPV 736
Y PE S ++ T D++S G + E++TG+P+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 533 LGKGGFGTVYHGYL----DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL--V 586
+G+G +G VY DD+ A+K + + + E+ LL H N+ L V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 66
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ-IATESAQGL 645
+ K+ L++++ + L + +K + +G ++ + + G+
Sbjct: 67 FLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 646 EYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIF--PVEGGSHVSTTVVG 699
YLH ++HRD+K ANIL+ E+ + K+AD G +R+F P++ + + VV
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 177
Query: 700 TPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 738
T Y PE + R T+ D+++ G + EL+T +P+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 47/230 (20%)
Query: 527 NNFE--RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQ--------------FQAE 570
++FE +V+G+G FG V VKM + V K F+ E
Sbjct: 1 DDFEILKVIGRGAFGEV---------AVVKMKNTGQVYAMKILNKWEMLKRAETACFREE 51
Query: 571 VELLMRAHHKNLTIL-VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL 629
++L+ + +T L + DEN + LV ++ G+L L LP D
Sbjct: 52 RDVLVNGDRRWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----- 105
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 689
+ + +A +S L Y VHRD+K N+LL++ +LADFG S + +
Sbjct: 106 FYLAEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLAD 155
Query: 690 GSHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQ 734
G+ S VGTP Y+ PE + R + D +S GV + E++ G+
Sbjct: 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQF---QAEVELLMRAHHKNLTIL 585
RV+G+G + V L +D+ A+K++ V + Q E + +A +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 586 VGYCDENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+ C + T ++ LV E++ G+L H+ Q LP + R A E
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK-LPEE----------HARF-YAAEICIA 108
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVVGTPG 702
L +LH+ I++RD+K N+LL+ KL D+G+ + EG ++T GTP
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPN 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP---VIQKTPE 742
Y+ PE D ++ GV++ E++ G+ +I P+
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 340 VIMILFLYLFMH--------IKISVDAIMNIKSKYELLRDWQGDPCAPNDY-LWQGLNCS 390
+ M+ FL+L + +S + +N KY L +W + D LWQG+ C
Sbjct: 13 IFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKY--LSNWN----SSADVCLWQGITC- 65
Query: 391 YDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQF-LRV 449
N + R+ S++LS I+G+I IF L I++++LSNN L+G +P+ + LR
Sbjct: 66 ---NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 450 LVDGNPNL 457
L N N
Sbjct: 123 LNLSNNNF 130
|
Length = 968 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 533 LGKGGFGTVYHGYL----DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL--V 586
+G+G +G VY D+K+ A+K + + + E+ LL H N+ L V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ K+ L++++ A +L + A + A K L + + G+
Sbjct: 67 FLSHSDRKVWLLFDY-AEHDLWHIIKFHRA---SKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 647 YLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIF--PVEGGSHVSTTVVGT 700
YLH ++HRD+K ANIL+ E+ + K+AD G +R+F P++ + + VV T
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 178
Query: 701 PGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 738
Y PE + R T+ D+++ G + EL+T +P+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 68/284 (23%), Positives = 108/284 (38%), Gaps = 96/284 (33%)
Query: 529 FERVLGKGGFGTVYH------GYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMR----- 576
F + LG G FG V G D+ +VAVKML S+ E E LM
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA------HTDEREALMSELKIL 95
Query: 577 ---AHHKNLTILVGYCDENTKMGLVYEFMANGNL-------QAHLLAQLAILPTDAEDK- 625
HKN+ L+G C + ++ E+ G+L L + LP +E
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSS 155
Query: 626 ---------------TGILS-------------------------------WKGRL---- 635
+G S W L
Sbjct: 156 DYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLL 215
Query: 636 QIATESAQGLEYL-HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI------FPVE 688
+ +++ AQG+++L C +HRDV + N+LL + AK+ DFGL+R + V+
Sbjct: 216 RFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
G + + ++ PE T +SDV+S+G++L E+ +
Sbjct: 272 GNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 533 LGKGGFGTVYHGYLDDK---QVAVKMLS---PSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+G G +G+V Y D + +VAVK LS S + + ++ E+ LL H+N+ L+
Sbjct: 23 VGSGAYGSVCSAY-DTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLL 80
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
T + E NL L + +++ L + + +GL+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY--------QLLRGLK 132
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
Y+H I+HRD+K +N+ +NE + ++ DFGL+R E T V T Y P
Sbjct: 133 YIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAP 184
Query: 707 EYYIS-NRLTEKSDVYSFGVVLLELITGQ 734
E ++ + D++S G ++ EL+ G+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQF---QAEVELLMRAHHKNLTIL 585
RV+G+G + V L ++ A+K++ V + Q E + +A + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 586 VGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+ C +++ V E++ G+L H+ Q LP + R A E +
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEE----------HARFYSA-EISLA 108
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT--VVGTPG 702
L YLH+ I++RD+K N+LL+ + KL D+G+ + EG TT GTP
Sbjct: 109 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPN 161
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y+ PE D ++ GV++ E++ G+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+G+ + H K ++HRD+K N+L++ +K K+AD GL R F + S+ V T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TL 175
Query: 702 GYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 736
Y PE + S + D++S G + E+ QP+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 10/124 (8%)
Query: 617 ILPTDAEDKTGILSWKGRLQI----ATESA--QGLEYLHDGCKPPIVHRDVKSANILLNE 670
ILP D L+ K + I A E + + ++YLH+ I+HRD+K+ NI +N
Sbjct: 161 ILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINH 217
Query: 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
L DFG + FPV+ ++ GT PE + D++S G+VL E+
Sbjct: 218 PGDVCLGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
Query: 731 ITGQ 734
T
Sbjct: 277 ATCH 280
|
Length = 391 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 531 RVLGKGGFGTV--YHGYLDDKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTIL 585
+V+G+G FG V K A+K+LS + F E +++ A+ + L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
++ + +V E+M G+L +L++ + A+ T E L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTA------------EVVLAL 155
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
+ +H ++HRDVK N+LL++ KLADFG G T VGTP Y+
Sbjct: 156 DAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYIS 211
Query: 706 PEYYISN----RLTEKSDVYSFGVVLLELITG 733
PE S + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 65/263 (24%), Positives = 105/263 (39%), Gaps = 71/263 (26%)
Query: 527 NNFE--RVLGKGGFGTV--YHGYLDDKQVAVKMLSPSSVQGYKQFQ-----AEVELLMRA 577
+F +V+GKG FG V K A+K L S + +K+ Q AE ++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAES 58
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+ L + + L+ EF+ G+L L+ T +ED T R +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVT-------RFYM 107
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF-----------P 686
A E +E +H K +HRD+K NIL++ KL+DFGLS F
Sbjct: 108 A-ECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 687 VEGGSHVST----------------------------------TVVGTPGYLDPEYYISN 712
++G S+ + + VGTP Y+ PE ++
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 713 RLTEKSDVYSFGVVLLELITGQP 735
++ D +S G ++ E + G P
Sbjct: 224 GYGQECDWWSLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 37/112 (33%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 628 ILSWKGRLQIATESAQGLEYL-HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
LS+ + + + A G+E+L C VHRD+ + N+L+ E K+ DFGL+R
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI- 289
Query: 687 VEGGSHVSTTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ +++S P ++ PE +N T SDV+SFG++L E+ T G P
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 531 RVLGKGGFGTVY---HGYLDDKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTI 584
+V+G+G FG V H K A+K+LS + F E +++ A+ +
Sbjct: 49 KVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L ++ + +V E+M G+L +L++ D +K W R A E
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLMSNY-----DVPEK-----W-ARFYTA-EVVLA 154
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
L+ +H +HRDVK N+LL++ KLADFG EG T VGTP Y+
Sbjct: 155 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYI 210
Query: 705 DPEYYISN----RLTEKSDVYSFGVVLLELITG 733
PE S + D +S GV L E++ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQF---QAEVELLMRAHHKNLTIL 585
RV+G+G + V L + A+K++ V + Q E + A N L
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA--SNHPFL 58
Query: 586 VGY--CDENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
VG C + ++ V EF++ G+L H+ Q LP + R + E +
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK-LPEE----------HARF-YSAEIS 106
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVVGT 700
L +LH+ I++RD+K N+LL+ + KL D+G+ + EG ++T GT
Sbjct: 107 LALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGT 159
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
P Y+ PE D ++ GV++ E++ G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 22/162 (13%)
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ L Y + LV + G L +H+ L I P + + W A E
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI-PEEC-----VKRW------AAE 93
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG-LSRIFPVEGGSHVSTTVVG 699
L+ LH + IV RD+ NILL+++ +L F S + G V
Sbjct: 94 MVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--- 147
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741
Y PE + TE D +S G +L EL+TG+ +++ P
Sbjct: 148 ---YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 24/49 (48%), Positives = 34/49 (69%)
Query: 402 LNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
L L + ++G I P IFSL + SLDLS+NSL+G +PE + +LQ L +L
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313
|
Length = 968 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 26/158 (16%)
Query: 535 KGGFGTVYHGY--LDDKQVAVK------MLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+G FG VY G + K AVK M++ + V Q QAE + L + + L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLY 70
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ LV E++ G++++ L I E+ ++ +E A L+
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKS----LLHIYGYFDEEMA--------VKYISEVALALD 118
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
YLH + I+HRD+K N+L++ + KL DFGLS++
Sbjct: 119 YLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVSTTVVGT 700
A+G+E+L +HRD+ + NILL+E K+ DFGL+R I+ + +V
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGSARL 238
Query: 701 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P ++ PE T +SDV+SFGV+L E+ +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVSTTVVGT 700
A+G+E+L +HRD+ + NILL+E K+ DFGL+R I+ + +V
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY--KDPDYVRKGDARL 243
Query: 701 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P ++ PE T +SDV+SFGV+L E+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
L + A+G+E+L VHRD+ + N+LL + K+ DFGL+R + ++VS
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI-MHDSNYVS 295
Query: 695 TTVVGTP-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P ++ PE N T SDV+S+G++L E+ +
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 63/239 (26%)
Query: 531 RVLGKGGFGTVYHGYL-----DDKQVAVKML-----SPSSVQGYKQFQAEVELLMRA--H 578
++LGK G GT K A+K + S V ++ QA +R
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-----LRRLSP 56
Query: 579 HKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H N+ L V + + ++ LV+E M + NL + + LP E + + S+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP---EKR--VKSYMYQL- 109
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
+ L+++H + I HRD+K NIL+ + KLADFG R
Sbjct: 110 -----LKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR------------G 148
Query: 697 VVGTPGYLDPEYYISNR--------LTE-----KSDVYSFGVVLLELITGQPVIQKTPE 742
+ P Y + YIS R LT+ K D+++ G V E+++ P+ T E
Sbjct: 149 IYSKPPYTE---YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 38/180 (21%)
Query: 566 QFQAEVELLMRAHHKNLTIL--VGYCDENTKMGL------VYEFMANGNLQAHLLAQLAI 617
Q + E+ L R +H+N+ + + + NT M +Y FM +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------- 260
Query: 618 LPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677
K L + R I + +EY+HD ++HRD+K NI LN + L
Sbjct: 261 -------KDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLG 309
Query: 678 DFGLSRIF-----PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
DFG + F + G VGT PE + E +D++S G++LL++++
Sbjct: 310 DFGTAMPFEKEREAFDYGW------VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 10/92 (10%)
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
L LH K I+H D+K N+L + K + L D+GL +I + GT
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPSCYDGTLD 171
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
Y PE + D ++ GV+ EL+TG+
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 520 ANVLKITNNFERVLGKGGFGTVY----HGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLM 575
A+V+++ N L G G V+ HG K+V VK +V G K E+++L
Sbjct: 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVK-----AVTGGKTPGREIDILK 141
Query: 576 RAHHKNLTILV-GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
H+ + L+ Y ++T M + L + D++G L +
Sbjct: 142 TISHRAIINLIHAYRWKSTVC------MVMPKYKCDLFTYV--------DRSGPLPLEQA 187
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
+ I + L YLH I+HRDVK+ NI L+E A L DFG + + +H
Sbjct: 188 ITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA----CKLDAHPD 240
Query: 695 TTV----VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLEL 730
T GT PE + K+D++S G+VL E+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 12/113 (10%)
Query: 635 LQIATESAQGLEYL-HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
L + + A+G+ +L C +HRD+ + NILL K+ DFGL+R + V
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-------GQPVIQK 739
++ PE + T +SDV+S+G++L E+ + G PV K
Sbjct: 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 54/226 (23%)
Query: 533 LGKGGFGTVYHGYLDDK--------------QVAVKMLSPSSVQGYKQFQAEVELLMRAH 578
LG+G +Y G L+ K +V +K+L PS F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
HK++ +L G C + + +V EF+ G L + + +L T WK ++A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT---------PWK--FKVA 111
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
+ A L YL D +VH +V + NIL LA G+ E G + +
Sbjct: 112 KQLASALSYLED---KDLVHGNVCTKNIL--------LAREGIDG----ECGPFIKLSDP 156
Query: 699 GTP-------------GYLDPEYYISNR-LTEKSDVYSFGVVLLEL 730
G P ++ PE ++ L+ +D +SFG L E+
Sbjct: 157 GIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 57/244 (23%)
Query: 533 LGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQF-QAEV---ELLMRAHHKNLTILVGY 588
LG+G FG VY L +KQ + ++ ++ E+ E + RA + V
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKE--GKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYG 197
Query: 589 CDENTK------MGLV---------YEFMANG----NLQAHLLAQLAILPTDAEDKTGIL 629
E LV + M + N++ +LL ++ LP E + I+
Sbjct: 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA-KLADFGLSRIFPVE 688
I + L+ LH IVHRDVK NI+ +E + K+ D G + V
Sbjct: 258 Q-----TIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV- 308
Query: 689 GGSHVSTTVVGTPGYLDPEYYISNRLT----------------------EKSDVYSFGVV 726
G +++ + P Y PE YI + T ++ D+YS G++
Sbjct: 309 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368
Query: 727 LLEL 730
L++
Sbjct: 369 FLQM 372
|
Length = 566 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 633 GRLQIATESAQ---GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 689
G Q+ + Q ++Y+H I+HRD+K+ N+L+N L DFG +
Sbjct: 258 GLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR--- 311
Query: 690 GSHVSTTVVGTPGYLD---PEYYISNRLTEKSDVYSFGVVLLE 729
GS + G G +D PE + T D++S G+V+ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 25/217 (11%)
Query: 533 LGKGGFGTVYHG--YLDD--KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVG 587
+G G FG V Y D +V VK L + S + +F + + H N+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C E LV+E+ G+L+++L + + ++A E A G+ +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE--------QWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
+H K +H D+ N L K+ D+G+ E +L PE
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 708 Y-------YISNRLTEKSDVYSFGVVLLELI--TGQP 735
I+ T+ S+V++ GV L EL QP
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 40/209 (19%)
Query: 548 DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607
+ +V +K+L PS F L+ + H +L + G C ++ +V EF+ +G L
Sbjct: 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667
L + +P +WK + +A + A L YL D +VH +V + NIL
Sbjct: 104 DVCLRKEKGRVPV---------AWK--ITVAQQLASALSYLED---KNLVHGNVCAKNIL 149
Query: 668 LNEKFQA-------KLADFG-----LSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRL 714
L A KL+D G LSR VE P ++ PE N L
Sbjct: 150 LARLGLAEGTSPFIKLSDPGVSFTALSREERVER----------IP-WIAPECVPGGNSL 198
Query: 715 TEKSDVYSFGVVLLEL-ITGQ-PVIQKTP 741
+ +D +SFG LLE+ G+ P+ ++TP
Sbjct: 199 STAADKWSFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 21/55 (38%), Positives = 33/55 (60%)
Query: 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
P +++L+LS++ ++GEI I S +S++ LDL N L G +P L L L L
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193
|
Length = 968 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 41/222 (18%)
Query: 532 VLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589
++G G FG VY D ++VA+K + +Q + E+ ++ +H N+ L Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 590 --------DENTKMGLVYEFMANG--NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
++N + +V EF+ H LP +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL--------------FLVKL 174
Query: 640 ESAQ---GLEYLHDGCKPPIVHRDVKSANILLNEKFQA-KLADFGLSRIFPVEGGSHVST 695
S Q L Y+H I HRD+K N+L++ KL DFG ++ S
Sbjct: 175 YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL---AGQRSV 228
Query: 696 TVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPV 736
+ + + Y PE + + T D++S G ++ E+I G P+
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270
|
Length = 440 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 16/116 (13%)
Query: 643 QGLEYLH-DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+GL YLH +G +HR++K+++IL++ L+ GLS ++ + + V P
Sbjct: 112 RGLNYLHQNGY----IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFP 165
Query: 702 GY-------LDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
+ L PE + KSD+YS G+ EL TG+ Q ++ Q
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 749 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.62 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.01 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.01 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 98.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.6 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.58 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.4 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.93 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.91 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.74 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.68 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 97.57 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.45 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.34 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.34 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 97.24 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.17 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 96.89 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 96.79 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 96.68 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 96.57 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 96.52 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 96.51 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 96.5 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 96.49 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.33 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 96.29 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 96.19 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.12 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-79 Score=707.37 Aligned_cols=430 Identities=25% Similarity=0.406 Sum_probs=342.0
Q ss_pred CeeeecCCCCCCCcccCCCceEEecCCccccCCCceeccccccccccccccccccccc--cCccceeeecccCCCCeeEE
Q 037623 1 FISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSEFNKEITERQFSNLRSFP--EGIRNCYTLKPDSDHEKFLI 78 (749)
Q Consensus 1 f~sidCg~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~~~~~~~~~~~~~tlR~Fp--~~~~nCy~~~~~~~~~~ylv 78 (749)
+++||||++.+. .+|. +|++|++|..|+. |....++.. ....++|+|+|+|| +|++|||+| |+.++|||||
T Consensus 25 ~~~I~CGs~~~~-~~d~-~~~~w~~D~~~~~-~~~~~~~~~---~~~~~~~~t~R~F~~~~g~~~cY~~-~~~~~g~ylV 97 (623)
T PLN03150 25 TMRISCGARVNV-RTAP-TNTLWYKDFAYTG-GIPANATRP---SFIAPPLKTLRYFPLSDGPENCYNI-NRVPKGHYSV 97 (623)
T ss_pred cEEEeCCCCCCc-ccCC-CCCEEcCCccccc-CccccccCc---ccccchhhccccCCcccccccceEe-eecCCCcEEE
Confidence 589999986442 1455 8999999999864 333333211 23567899999999 688999999 5559999999
Q ss_pred EEEEeeccCCCCCCCCceeEEecceeEEEEEcCC--CCCcEEEEEEEeccCCceEEEEeecCCCCceeeeeeeeeCCCCc
Q 037623 79 RARFMYGNYNGQDKPPSFNLMLEADVWDSVQFPD--SGSIVSKEIIHIPKREYIHVCLVNTDSGTPFISALELRPLPNLT 156 (749)
Q Consensus 79 R~~f~ygnyd~~~~~p~fd~~~~~~~w~~v~~~~--~~~~~~~e~~~~~~~~~~~vCl~~t~~~~Pfis~lEl~~l~~~~ 156 (749)
|++|+|||||+++++|.|||++|+|+|.+|+.+. ++..+++|+|+++++++++|||+++++|+||||+||||||++.+
T Consensus 98 Rl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~l~~~~ 177 (623)
T PLN03150 98 RVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKA 177 (623)
T ss_pred EEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEEcCccc
Confidence 9999999999999999999999999999998643 45568899999999999999999999999999999999999977
Q ss_pred cC-----CCCcceEeEEeeecCCCC-CccccCCCCCC--CCccccCCC---CCceeeccccccC--CCCCCCCcHHHHhh
Q 037623 157 YM-----TQSGSLSRYGRWDVGSTT-NKTFRYPDDVY--DRIWFPHNF---YSWAQISTSSNMK--STGNFQPPSTVMQS 223 (749)
Q Consensus 157 y~-----~~~~~l~~~~R~~~G~~~-~~~~ryp~D~~--dR~W~p~~~---~~~~~~st~~~~~--~~~~~~~P~~v~~t 223 (749)
|. .++..|+++.|.|+|+.. ...+|||||+| ||+|.|+.. ..|..+++...+. ....+.+|+.||||
T Consensus 178 y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqT 257 (623)
T PLN03150 178 YNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQS 257 (623)
T ss_pred ccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhh
Confidence 73 224569999999999864 34689999999 999998654 4578888775444 23456779999999
Q ss_pred ceecCCCCcceEEEecCCCCccceEEEEeeeccccccccCcceEEEEEECCeeccCCCCcccc-----eeeeEEeccccc
Q 037623 224 AVIPANGGSSLMLSWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYL-----DTDTVFSTTPTM 298 (749)
Q Consensus 224 A~~~~~~~~~l~~~w~~~~~~~~~~~~~~Faei~~~~~~~~~Rvf~i~lng~~~~~~~~p~~~-----~~~~l~~~~~~~ 298 (749)
|+++.++...+.++|+. ++...|+|++||+|++......+.|+|+|+|||+.+...+++... ...+..... .+
T Consensus 258 A~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v-~~ 335 (623)
T PLN03150 258 ALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTV-AV 335 (623)
T ss_pred hccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEE-ee
Confidence 99887655455555542 345689999999999753445578999999999987776554221 122221111 23
Q ss_pred CCceeEEEEEeCCCCCCCcchhheeeeeeecccccccCccceeeEeeeehhhccchhHHHHHHHHHhcccC--CCCCCCC
Q 037623 299 NRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDAIMNIKSKYELL--RDWQGDP 376 (749)
Q Consensus 299 ~~~~~~isl~~t~~s~lpPiinA~Ei~~~~~~~~~~t~~~dv~~~~~~~~~~~~~~~~~~l~~~k~~~~~~--~~W~~dp 376 (749)
.++.++|++.|+.++ +|||||+|||++++ .+..|.+.|+ .||+++|..++.. .+|+|||
T Consensus 336 ~~g~l~isl~p~~~s--~pilNaiEI~~~~~-~~~~t~~~~~----------------~aL~~~k~~~~~~~~~~W~g~~ 396 (623)
T PLN03150 336 SGRTLTIVLQPKKGT--HAIINAIEVFEIIT-AESKTLLEEV----------------SALQTLKSSLGLPLRFGWNGDP 396 (623)
T ss_pred cCCeEEEEEeeCCCC--cceeeeeeeeeccc-cccccCchHH----------------HHHHHHHHhcCCcccCCCCCCC
Confidence 347799999998765 69999999999998 4566676666 8999999998754 3899999
Q ss_pred CCCCCCcceeeecCCCC-------------------------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCC
Q 037623 377 CAPNDYLWQGLNCSYDA-------------------------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNN 431 (749)
Q Consensus 377 c~p~~~~w~Gv~C~~~~-------------------------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N 431 (749)
|.|..+.|.||.|+.+. ..+++|+.|+|++|+|+|.||+++++|++|+.|+|++|
T Consensus 397 C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N 476 (623)
T PLN03150 397 CVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476 (623)
T ss_pred CCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCC
Confidence 99998999999995321 13478899999999999999888999999999999999
Q ss_pred ccccCcchhhhhhhchhccccCCCCcc
Q 037623 432 SLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 432 ~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+|+|.+|+.++++++|+.|.+++|++.
T Consensus 477 ~lsg~iP~~l~~L~~L~~L~Ls~N~l~ 503 (623)
T PLN03150 477 SFNGSIPESLGQLTSLRILNLNGNSLS 503 (623)
T ss_pred CCCCCCchHHhcCCCCCEEECcCCccc
Confidence 999999999999998888877666544
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-70 Score=592.54 Aligned_cols=323 Identities=44% Similarity=0.751 Sum_probs=272.6
Q ss_pred eecCCCCCCC-cccCCCceEEecCCccccCCCceecccc--ccccccccccccccccccCccceeeecccC-CCCeeEEE
Q 037623 4 IDCGIPENAN-YTDSITGINYVSDASNIDTGVSHKISSE--FNKEITERQFSNLRSFPEGIRNCYTLKPDS-DHEKFLIR 79 (749)
Q Consensus 4 idCg~~~~~~-~~~~~~~~~~~~D~~~~~~g~~~~~~~~--~~~~~~~~~~~tlR~Fp~~~~nCy~~~~~~-~~~~ylvR 79 (749)
||||++.+.+ |+|+.|||+|++|.+|+++|+++.|++. .......++|+|+|+||+|.||||+|++.. +|+|||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR 80 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR 80 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence 8999988887 9999999999999999999999999422 234567899999999999999999995432 57799999
Q ss_pred EEEeeccCCCCC-----CCCceeEEecceeEEEEEcCCC-CCcEEEE-EEEeccCCceEEEEeecCCCC-ceeeeeeeee
Q 037623 80 ARFMYGNYNGQD-----KPPSFNLMLEADVWDSVQFPDS-GSIVSKE-IIHIPKREYIHVCLVNTDSGT-PFISALELRP 151 (749)
Q Consensus 80 ~~f~ygnyd~~~-----~~p~fd~~~~~~~w~~v~~~~~-~~~~~~e-~~~~~~~~~~~vCl~~t~~~~-Pfis~lEl~~ 151 (749)
+.|+||||||++ ++|.|||++|+|.|.+|+++++ ...+++| +|++.++++++|||+++++|+ ||||+|||||
T Consensus 81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~ 160 (347)
T PF12819_consen 81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP 160 (347)
T ss_pred EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence 999999999984 3788999999999999998873 2468899 555666899999999999999 9999999999
Q ss_pred CCCCccC----CCCcceEeEEeeecCCCCCccccCCCCCCCCccccCC-CCCceeeccc-ccc-C-CCCCCCCcHHHHhh
Q 037623 152 LPNLTYM----TQSGSLSRYGRWDVGSTTNKTFRYPDDVYDRIWFPHN-FYSWAQISTS-SNM-K-STGNFQPPSTVMQS 223 (749)
Q Consensus 152 l~~~~y~----~~~~~l~~~~R~~~G~~~~~~~ryp~D~~dR~W~p~~-~~~~~~~st~-~~~-~-~~~~~~~P~~v~~t 223 (749)
|++.+|. ..+.+|.++.|+|+|+..+ .+|||+|+|||+|+|+. ...|..++|+ ++. . ....|.||.+||||
T Consensus 161 lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~T 239 (347)
T PF12819_consen 161 LPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQT 239 (347)
T ss_pred CCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHh
Confidence 9996662 3456799999999997654 39999999999999974 5779999987 433 2 56789999999999
Q ss_pred ceecCCCCcceEEEecCCCCccceEEEEeeeccccccccCcceEEEEEECCeeccCCCCcccceeeeE--Eeccc--ccC
Q 037623 224 AVIPANGGSSLMLSWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDTDTV--FSTTP--TMN 299 (749)
Q Consensus 224 A~~~~~~~~~l~~~w~~~~~~~~~~~~~~Faei~~~~~~~~~Rvf~i~lng~~~~~~~~p~~~~~~~l--~~~~~--~~~ 299 (749)
|+++.+++.+++++|.+++....|||+||||||+......+.|+|+|+|||+.+.+++.|.+.....+ +...+ ...
T Consensus 240 A~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 319 (347)
T PF12819_consen 240 ARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPD 319 (347)
T ss_pred hhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecC
Confidence 99999988789999999777788999999999996333444799999999999988899877666554 32222 123
Q ss_pred CceeEEEEEeCCCCCCCcchhheeeeee
Q 037623 300 RDRHDIIINTTENSALPPILNALEIYQV 327 (749)
Q Consensus 300 ~~~~~isl~~t~~s~lpPiinA~Ei~~~ 327 (749)
++.++|+|.++.+|+|||||||+|||++
T Consensus 320 ~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 320 SGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred CCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 4578999999999999999999999985
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=399.50 Aligned_cols=217 Identities=56% Similarity=0.910 Sum_probs=191.9
Q ss_pred cccccCHHHHHHHhhccc--ccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEE
Q 037623 513 KNRKLSYANVLKITNNFE--RVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC 589 (749)
Q Consensus 513 ~~~~~~~~~l~~~t~~f~--~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~ 589 (749)
..+.|++.++..+|++|. +.||+|+||.||+|.+.+ +.||||++.....+..++|.+|++++.+++|+|+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 457799999999999998 699999999999999987 88999988766543146699999999999999999999999
Q ss_pred ecCC-eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 590 DENT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 590 ~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
.+.+ +.+||||||++|+|.++|+... .. .++|..|++||.++|+||+|||..+.|+||||||||+||||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~---------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKK---------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCC---------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 9988 5999999999999999997531 11 78999999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+++++||+|||+|+..+.. .........||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99999999999999765431 112111117999999999999999999999999999999999999998864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=348.28 Aligned_cols=200 Identities=28% Similarity=0.521 Sum_probs=178.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||+||+|+.. +..||||.+... .....+....|+.+|+.++|||||.|++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445677999999999999984 488999998776 5556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC------CcEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK------FQAKL 676 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~------~~~kL 676 (749)
.+|+|..+++. .+.+++..+..++.|+|.||++||++ +||||||||.||||+.. -.+||
T Consensus 92 ~gGDLs~yi~~------------~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 92 NGGDLSDYIRR------------RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEe
Confidence 99999999964 34799999999999999999999999 99999999999999864 46899
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+|||+|+.+.. .......+|++-|||||++...+|+.|+|+||.|++|||+++|++||+.....+
T Consensus 157 ADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 157 ADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred cccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99999998863 334456789999999999999999999999999999999999999999554433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=402.98 Aligned_cols=318 Identities=27% Similarity=0.444 Sum_probs=226.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc-----------------
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL----------------- 457 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l----------------- 457 (749)
.+++|+.|+|++|.|+|.+|..+++|++|+.|+|++|+++|.+|..+.+++.|+.|.+++|.+
T Consensus 521 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~ 600 (968)
T PLN00113 521 SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600 (968)
T ss_pred CccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhh
Confidence 466788888888888888877788888888888888888888888888888887776555544
Q ss_pred -------ccC------cccCCC-CcceEEeeeehhhHHHH--HHHHHHHhhhhcccccccccCCC-CCcccc------cc
Q 037623 458 -------CLS------ASCKGK-KNKFIVPLLASVVSFSV--LLAALAILRSLRRRKQELCPVGK-KGSLEL------KN 514 (749)
Q Consensus 458 -------~~~------~~c~~~-~~~~iii~i~~~v~~~~--l~~~l~~~~~~rrr~~~~~~~~~-~~~~~~------~~ 514 (749)
|+. ++|... +.....+.+++++++++ ++++++++++++|++++...... .+..+. ..
T Consensus 601 ~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (968)
T PLN00113 601 VAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVS 680 (968)
T ss_pred hcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccc
Confidence 432 123221 11111111111111111 22222222222222111111111 111111 01
Q ss_pred cccCHHHHHHHhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecC
Q 037623 515 RKLSYANVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN 592 (749)
Q Consensus 515 ~~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~ 592 (749)
..++++++... ....++||+|+||.||+|+. ++..||||++...... ..+|++++++++|||||+++|+|.+.
T Consensus 681 ~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 681 KSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 23445555433 33457899999999999986 4588999998754322 23568899999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
+..++||||+++|+|.++++ .++|..+.+++.|+|+||+|||+.+.++|+||||||+||++++++
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~---------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~ 820 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR---------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh---------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence 99999999999999999983 278999999999999999999987778999999999999999998
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.+++. ||.+...... ....++..|+|||++.+..++.|+|||||||++|||+||+.||..
T Consensus 821 ~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 821 EPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 88876 6665433211 223578999999999999999999999999999999999999854
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=352.80 Aligned_cols=198 Identities=42% Similarity=0.640 Sum_probs=175.5
Q ss_pred cccccccCceEEEEEEECCcc-cEEEEecCCchhh--HHHHHHHHHHHHhcCCCceeEEEEEEecCC-eeEEEEeeCCCC
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQ-VAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTILVGYCDENT-KMGLVYEFMANG 605 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~-VAVK~l~~~~~~~--~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~~~g 605 (749)
.+.||+|+||+||+|.+.++. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 356999999999999999977 9999998654322 568999999999999999999999999887 799999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceeeCCCCCcEEEcCCC-cEEEEecCCCc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP-IVHRDVKSANILLNEKF-QAKLADFGLSR 683 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g-IiHrDLkp~NILl~~~~-~~kL~DFGla~ 683 (749)
+|..+|+.. ....+++..++++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++
T Consensus 126 sL~~~l~~~----------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 126 SLSVLLHKK----------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred cHHHHHhhc----------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 999999752 356799999999999999999999998 6 99999999999999997 99999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYI--SNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
...... ...+...||..|||||++. ...++.|+|||||||+||||+||+.||.....
T Consensus 193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred eecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 754321 2334468999999999999 56999999999999999999999999987653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=329.17 Aligned_cols=200 Identities=31% Similarity=0.486 Sum_probs=177.7
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.++.++||+|+||+||.++..+ +.+|+|++++... .+.+...+|..+|.+++||.||++...+++.+.++||+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 3456899999999999998644 7899999987633 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+.||.|..+|. +.+.+++..+.-.+.+|+.||.|||+. +||||||||+|||||++|+++|+|||+
T Consensus 107 ~~GGeLf~hL~------------~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 107 LNGGELFYHLQ------------REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred cCCccHHHHHH------------hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999994 456789998889999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
++..... .......+||+.|||||++.+..++..+|.||+|+++|||++|.+||...+..
T Consensus 172 ~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 172 CKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred chhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 9964332 23345578999999999999999999999999999999999999999887643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=344.42 Aligned_cols=205 Identities=31% Similarity=0.514 Sum_probs=178.3
Q ss_pred hcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
..+.+.||+|.||.|+.|.+++ .+||+|.++..... .+.|.+|+.+|++++|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3455899999999999999988 59999999876433 478999999999999999999999999988999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.++|.. .....++..+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+..
T Consensus 287 sLl~yLr~----------~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 287 SLLDYLRT----------REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred cHHHHhhh----------cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 99999964 2456788999999999999999999999 9999999999999999999999999999944
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~l 746 (749)
. ++.........-...|.|||.+..++++.|+|||||||+||||+| |+.|+.+-...+.+
T Consensus 354 ~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~ 414 (468)
T KOG0197|consen 354 G-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL 414 (468)
T ss_pred C-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence 3 222223333345668999999999999999999999999999998 99999876554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=356.31 Aligned_cols=217 Identities=33% Similarity=0.501 Sum_probs=185.4
Q ss_pred hcccccccccCceEEEEEEECC-------cccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
-.+.+.||+|+||+||+|+..+ ..||||.+++.... ..++|++|+++++.++|||||+|+|+|.+++.++||
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 3456899999999999998643 56999999987554 778999999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCC--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTD--AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~--~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|||..|||.++|.......... ..+....++..+.+.||.|||.||+||-++ .+|||||.++|.|+.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 99999999999997653322111 111245699999999999999999999998 8999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~l 746 (749)
+|||+++.....+..+....-.-..+||+||.|..++++.++|||||||+||||++ |+.||.+...++++
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999998766554444333345679999999999999999999999999999998 99999987666554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.60 Aligned_cols=203 Identities=32% Similarity=0.466 Sum_probs=179.5
Q ss_pred cccCHHHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEec
Q 037623 515 RKLSYANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE 591 (749)
Q Consensus 515 ~~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~ 591 (749)
..++..|+... +.||+|..|+|||+++. ++.+|+|.+... +....+++.+|++++++.+||+||.++|.|..
T Consensus 74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34666677655 78999999999999985 578999999544 44556889999999999999999999999998
Q ss_pred CC-eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 592 NT-KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 592 ~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.. +..++||||++|+|+..+.. .+.+++...-+|+.++++||.|||+. .+||||||||+|||++.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~------------~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNs 214 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKR------------VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNS 214 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeecc
Confidence 88 59999999999999999943 36789999999999999999999963 29999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.|++||||||.++.+... ...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||-..
T Consensus 215 kGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 215 KGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred CCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 999999999999877432 445678999999999999999999999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=340.19 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=181.9
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+|...+.||+|||+.+|+++. .+..||+|++.+.. ....+...+|+++.++++|||||++++++++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4566678999999999999987 46899999998743 233467889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
|+|++++|..++. ..+.+++.+++.+..||+.||.|||+. +|||||||..|+||++++++||+||
T Consensus 98 ELC~~~sL~el~K------------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 98 ELCHRGSLMELLK------------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred EecCCccHHHHHH------------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccc
Confidence 9999999999984 456799999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+|..+..+ .+.....+||+.|+|||++....++..+||||+||+||-|+.|++||+..+-++
T Consensus 163 GLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke 225 (592)
T KOG0575|consen 163 GLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE 225 (592)
T ss_pred ceeeeecCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH
Confidence 999988644 234456789999999999999999999999999999999999999998765433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.38 Aligned_cols=201 Identities=28% Similarity=0.473 Sum_probs=172.2
Q ss_pred HHHhhcccccccccCceEEEEEEE--CCcccEEEEecCCchh-------hHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ-------GYKQFQAEVELLMRAHHKNLTILVGYCDENT 593 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~-------~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~ 593 (749)
....|-+.+.||+|+||.|-+|.. +++.||||++++.... .....++|+++|.+++|||||++.++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445566789999999999999986 4589999999764221 1233579999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC--
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-- 671 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-- 671 (749)
..|||+|||+||+|.+.+-. .+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~------------nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA------------NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAE 314 (475)
T ss_pred ceEEEEEEecCccHHHHHHh------------ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCc
Confidence 99999999999999999954 34566667788999999999999999 99999999999999766
Q ss_pred -CcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 672 -FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 672 -~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
..+||+|||+|+..+ ....+...+||+.|.|||++.++. +..+.|+||+||+||-+++|.+||.+..
T Consensus 315 ~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred ceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 789999999999864 345667789999999999997654 3348899999999999999999998754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=305.65 Aligned_cols=207 Identities=26% Similarity=0.398 Sum_probs=177.1
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEE-EEecCCe-eEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVG-YCDENTK-MGLV 598 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g-~~~~~~~-~~LV 598 (749)
+.+.+.++||+|.||+|||+.. ++..||.|.+.-. +.+..+....|+.+|++++|||||+.++ -+.++.+ +.||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3455678999999999999975 6688999988733 4455667899999999999999999988 3444444 8899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CceeeCCCCCcEEEcCCCcEEEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKP-PIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~-gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|||+..|+|...+..-+ ...+.++++.++++..|+++||.++|+.... -|+||||||.||+|+.+|.+||+
T Consensus 99 mE~c~~GDLsqmIk~~K--------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFK--------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred HHhhcccCHHHHHHHHH--------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 99999999999996543 3567899999999999999999999984211 38999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||+++.+... .....+.+|||.||+||.+.+..++.|+||||+||++|||..-++||.+.+
T Consensus 171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 99999987543 333456789999999999999999999999999999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.23 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=177.3
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
+.|.+.||.|+|++|++|+. .++++|||++.+... ...+-...|-++|.+| .||.|++|+..+.++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 45779999999999999987 458999999876532 2234467888999999 99999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.++++ +.+.|++...+..+.+|+.||+|||++ |||||||||+|||||+||++||.|||
T Consensus 155 ~A~nGdll~~i~------------K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 155 YAPNGDLLDLIK------------KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred ecCCCcHHHHHH------------HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecc
Confidence 999999999995 346789999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCc---------ee--eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 681 LSRIFPVEGGS---------HV--STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 681 la~~~~~~~~~---------~~--~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
.|+.+...... .. ....+||..|++||++.++..+..+|+|+|||+||.|+.|++||.+.++-
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 99988643221 11 14468999999999999999999999999999999999999999987653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=297.67 Aligned_cols=195 Identities=30% Similarity=0.428 Sum_probs=175.7
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
++.+.||.|+||+|..++. ++..+|+|++.+...- ..+...+|..+|..+.||.+++|.+.+.+.+..+|||||+
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 3458999999999999987 4578999999876443 3455678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+||.|.++|+ +.++++++.++-.|.||+.||+|||+. +|++|||||+|||+|.+|.+||.|||+|
T Consensus 127 ~GGElFS~Lr------------k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 127 PGGELFSYLR------------KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred CCccHHHHHH------------hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccce
Confidence 9999999995 457799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+.+.. ..-+.+||+.|+|||.+..+.+...+|.|||||++|||+.|.+||...+.
T Consensus 192 K~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 192 KRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 98642 24567899999999999999999999999999999999999999987654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.08 Aligned_cols=213 Identities=31% Similarity=0.550 Sum_probs=179.0
Q ss_pred cccccCHHHHHHHhhcccccccccCceEEEEEEECCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEe
Q 037623 513 KNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590 (749)
Q Consensus 513 ~~~~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~ 590 (749)
+...+.+++++ +.+.||+|.||+||+|++-| .||||++... ..+..+.|++|+.++++-+|.||+-++|+|.
T Consensus 385 ~~WeIp~~ev~-----l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIPPEEVL-----LGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccCHHHhh-----ccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 34455555554 34789999999999999865 6999999765 3456788999999999999999999999998
Q ss_pred cCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 591 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.... .+|+-+|+|-+|..+||-. ...|+..+.+.||.|||+||.|||.+ +|||||||+.||++.+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~-----------etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQ-----------ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHE 523 (678)
T ss_pred CCce-eeeehhccCchhhhhccch-----------hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEcc
Confidence 8766 9999999999999999753 35688899999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l 746 (749)
++.+||+|||++..-..-..........|...|||||+++. .++++++||||||+|+|||+||..||...+.+.++
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence 99999999999975433323333334457889999999964 46899999999999999999999999965555443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=320.46 Aligned_cols=196 Identities=32% Similarity=0.509 Sum_probs=177.3
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|.||.||||+.++ +.||+|.+.+.. ..+.+...+|++++++++||||+.+++.++...++++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 3445889999999999998755 789999987653 344677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
.| +|+.+|. ..+.+++..+..|+.++..||.|||+. +|+|||+||.|||++.++.+|+||||+|
T Consensus 84 ~g-~L~~il~------------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 84 VG-DLFTILE------------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred hh-hHHHHHH------------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhh
Confidence 77 9999994 346789999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+.+.. +..+.+.+.||+-|||||.+.+..++..+|+||+||++||+++|++||-..
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 98753 466777889999999999999999999999999999999999999999654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.08 Aligned_cols=199 Identities=29% Similarity=0.407 Sum_probs=172.8
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEEeeCC
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVYEFMA 603 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~~ 603 (749)
.++||+|.||.||||+. +++.||+|++.... .....-..+||.+|++++||||++|.+...+. ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 36899999999999987 45889999987553 33345568999999999999999999999876 68999999998
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.-++. ...-.|+..++..+++|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+
T Consensus 202 h-DL~GLl~-----------~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 202 H-DLSGLLS-----------SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred c-hhhhhhc-----------CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 7 7877773 2345789999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
++..... ...+..+.|.-|.|||.+.+. .|+...|+||.||||.||++|++.|++..+-+
T Consensus 267 ~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 267 FYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred eccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 8765532 235566789999999999876 59999999999999999999999999876644
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.36 Aligned_cols=193 Identities=33% Similarity=0.525 Sum_probs=166.5
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHh--cCCCceeEEEEEEecCC----eeEEEEeeCC
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR--AHHKNLTILVGYCDENT----KMGLVYEFMA 603 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--l~H~nIv~l~g~~~~~~----~~~LV~Ey~~ 603 (749)
.++||+|+||.||||++.++.||||++... ..+.|++|-+|.+. ++|+||++++++-.... +.+||+||.+
T Consensus 215 ~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 478999999999999999999999999854 44678888888776 48999999999876655 8899999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG------CKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~------~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
.|+|.++|. ...++|....+|+..+++||+|||+. ++|+|+|||||++|||+.+|+++.|+
T Consensus 292 kGsL~dyL~-------------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 292 KGSLCDYLK-------------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred CCcHHHHHH-------------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 999999994 34789999999999999999999965 57899999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCC-C-----CCchhHHHHHHHHHHHHcCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-L-----TEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~-----s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
|||+|.++.+..........+||.+|||||++.+.. + =.+.||||+|.|||||++.-..++
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999999987654444444578999999999997543 2 247899999999999999766553
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.62 Aligned_cols=207 Identities=29% Similarity=0.468 Sum_probs=180.9
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.--|.++||+|.||.|.++...+ ..||||+++..... ..++|.+|+++|.+++||||+.|+|+|..++.+++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 33456899999999999999988 89999999976544 45899999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.++|.++.. ..++-....+|+.|||.||+||.+. .+|||||.++|+|++.++++||+|||+++
T Consensus 619 nGDLnqFl~ahea----------pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL----------PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCcHHHHHHhccC----------cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence 9999999976522 1244556678999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCcccc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPERTL 745 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt--G~~pf~~~~~~~~ 745 (749)
-+...+..+......-..+|||||.+..++++.++|||+||+.+||+++ .+.||....++..
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 8776666666655667789999999999999999999999999999885 7889987555443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.51 Aligned_cols=202 Identities=29% Similarity=0.480 Sum_probs=177.6
Q ss_pred ccccCHHHHHHHhhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Q 037623 514 NRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT 593 (749)
Q Consensus 514 ~~~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~ 593 (749)
...+.|++|... +-||+|+.|.||+|++.++.||||+++.-. +.+++.|++++|+||+.+.|+|....
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 467778887766 569999999999999999999999876322 45788999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++|||||+.|-|.+.|+. ...+.-.....+.++||.||.|||.+ .|||||||+-||||..+..
T Consensus 186 cyCIiMEfCa~GqL~~VLka------------~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~ 250 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKA------------GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDV 250 (904)
T ss_pred eeEEeeeccccccHHHHHhc------------cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccce
Confidence 99999999999999999953 45567777889999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
+||+|||-++.+... ......+||..|||||++.+...++|+||||||||||||+||+-||..-+.-.+
T Consensus 251 VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 251 VKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred EEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 999999999876422 233456899999999999999999999999999999999999999987654443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.49 Aligned_cols=200 Identities=25% Similarity=0.407 Sum_probs=173.3
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
-++||+|+||.||.++- ++..+|+|+++++... ..+..+.|..+|...+++.||+|+..+++.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 37899999999999976 4588999999987543 345678999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|++..+|. +...|++..+...+.+++-|++-||+. |+|||||||+|+|||..|++||+||||+.-
T Consensus 226 GD~mTLL~------------~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 226 GDMMTLLM------------RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred ccHHHHHH------------hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 99999994 456788999999999999999999999 999999999999999999999999999854
Q ss_pred ccCC----------------------CCc----ee-------------------eeccccCCcccCccccccCCCCCchh
Q 037623 685 FPVE----------------------GGS----HV-------------------STTVVGTPGYLDPEYYISNRLTEKSD 719 (749)
Q Consensus 685 ~~~~----------------------~~~----~~-------------------~~~~~gt~~y~APE~~~~~~~s~k~D 719 (749)
+... +.. .. ....+|||.|||||++.+..++..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 000 00 01246999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 720 VYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 720 VwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
.||+|||+|||+.|.+||.+.+..+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~ 395 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQE 395 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999998876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=338.08 Aligned_cols=214 Identities=33% Similarity=0.472 Sum_probs=180.8
Q ss_pred HHhhcccccccccCceEEEEEEECC-------cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM 595 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~ 595 (749)
...-.+.+.||+|+||.||+|...+ ..||||.+++. +.+...+|.+|..+|++++|||||+++|+|-+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3344556899999999999998743 23899998876 567788999999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++++|||++|+|..+|...+. .......+...+.+.++.|||+|+.||+++ ++|||||.++|+||++...+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~-----~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRP-----APFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred EEEehhcccCcHHHHHHhccc-----ccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 999999999999999975422 122356789999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTL 745 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~ 745 (749)
|+|||+|+.+...+..+......-..+|||||.+.++.++.|+|||||||+||||+| |..||...+..++
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v 913 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV 913 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence 999999995544332222222223468999999999999999999999999999998 9999987665544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.72 Aligned_cols=201 Identities=30% Similarity=0.463 Sum_probs=174.9
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCC----ch-hhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS----SV-QGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~----~~-~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~ 596 (749)
..|.+.+.||+|.||+|+.|+. ++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++......+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3566779999999999999976 5689999976653 12 23456678999999998 999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAK 675 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~k 675 (749)
+||||+.+|+|.+++.. .+.+.+..+.+++.|++.|++|+|++ +|+||||||+|||++.+ +++|
T Consensus 97 ivmEy~~gGdL~~~i~~------------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN------------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCccHHHHHHH------------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999953 45688899999999999999999999 99999999999999999 9999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LT-EKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||++.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+.
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~ 228 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV 228 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH
Confidence 99999999764 1223445678999999999999877 75 889999999999999999999997553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.16 Aligned_cols=216 Identities=28% Similarity=0.466 Sum_probs=182.3
Q ss_pred ccccCHHHHHHHhhcc-----------cccccccCceEEEEEEEC--C---cccEEEEecCCch-hhHHHHHHHHHHHHh
Q 037623 514 NRKLSYANVLKITNNF-----------ERVLGKGGFGTVYHGYLD--D---KQVAVKMLSPSSV-QGYKQFQAEVELLMR 576 (749)
Q Consensus 514 ~~~~~~~~l~~~t~~f-----------~~~LG~G~fG~Vykg~~~--~---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~ 576 (749)
...++|+|--++..+| +++||.|.||.||+|+++ + ..||||.++.... ....+|+.|+.||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3567777766665554 468999999999999984 2 5699999998744 445789999999999
Q ss_pred cCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 037623 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPI 656 (749)
Q Consensus 577 l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gI 656 (749)
+.||||++|.|+........+|.|||+||+|+.+|..+ .+.+.+.+..-+.++||.||+||.+. ++
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~-----------DGqftviQLVgMLrGIAsGMkYLsdm---~Y 752 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN-----------DGQFTVIQLVGMLRGIASGMKYLSDM---NY 752 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc-----------CCceEeehHHHHHHHHHHHhHHHhhc---Cc
Confidence 99999999999999999999999999999999999653 34589999999999999999999998 99
Q ss_pred eeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccc--cCCcccCccccccCCCCCchhHHHHHHHHHHHHc-C
Q 037623 657 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV--GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-G 733 (749)
Q Consensus 657 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G 733 (749)
|||||.++|||++.+..+|++|||++|.+..+. ....+... -..+|.|||.+...+++.++|||||||+|||.++ |
T Consensus 753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 999999999999999999999999999774432 11112222 3469999999999999999999999999999886 9
Q ss_pred CCCCCCCCccc
Q 037623 734 QPVIQKTPERT 744 (749)
Q Consensus 734 ~~pf~~~~~~~ 744 (749)
++||=.-...+
T Consensus 832 ERPYWdmSNQd 842 (996)
T KOG0196|consen 832 ERPYWDMSNQD 842 (996)
T ss_pred CCcccccchHH
Confidence 99986544333
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.20 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=177.6
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
..+.++||+|.||+|+++.+.+ +.+|||++++.. ..+.+..+.|.+|+... +||.+++|+.++...++.+.|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 3467899999999999998854 789999998763 34456778888888777 59999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+.||++..+. ....+++..+.-+|.+++.||+|||++ +||+||||.+|||||.+|++||+|||
T Consensus 450 y~~Ggdm~~~~-------------~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 450 YVAGGDLMHHI-------------HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred ecCCCcEEEEE-------------ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence 99999943332 456799999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l 746 (749)
+++..... .....+..||+.|||||++.+..|+..+|.|||||+||||+.|+.||.+.+|+++.
T Consensus 514 lcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 514 LCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred cccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99975322 33456778999999999999999999999999999999999999999998887764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=290.19 Aligned_cols=197 Identities=24% Similarity=0.367 Sum_probs=170.4
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
..+|+|+||+|||++.. ++.||||++.++.. .-.+-.++|+++|++++|+|+|.|+.+|.....+.||+||++..=
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 47899999999999874 58899999987633 334567899999999999999999999999999999999998755
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
|.++= .....++...+.+++.|+++|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+.
T Consensus 88 L~eLe------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 88 LHELE------------RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred HHHHH------------hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 54432 2345678888999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
.. ...-+..+.|..|.|||.+.+ .+|+...||||.||++.||++|++.|-+.++-+
T Consensus 153 ~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 153 AP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred CC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 43 233456678999999999987 789999999999999999999999998876543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=299.49 Aligned_cols=197 Identities=29% Similarity=0.477 Sum_probs=168.7
Q ss_pred ccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC--eeEEEEeeCCC
Q 037623 529 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT--KMGLVYEFMAN 604 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~--~~~LV~Ey~~~ 604 (749)
..+.||+|.||.||++... +...|||.....+....+.+.+|+.+|.+++|||||+.+|.....+ ...+.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4589999999999999985 4889999987664444677899999999999999999999855444 68899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecCCCc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSR 683 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFGla~ 683 (749)
|+|.+++... .. .+++..+.+...||++||+|||++ +||||||||+|||++. ++.+||+|||+++
T Consensus 101 GsL~~~~~~~----------g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 101 GSLSDLIKRY----------GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred CcHHHHHHHc----------CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 9999999642 22 699999999999999999999999 9999999999999999 7999999999998
Q ss_pred cccCC-CCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 684 IFPVE-GGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 684 ~~~~~-~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
..... ..........||+.|||||++..+ ....++|||||||+++||+||++||..
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 76531 112233456799999999999854 445699999999999999999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.85 Aligned_cols=201 Identities=24% Similarity=0.422 Sum_probs=171.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+++.. ++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 345689999999999999874 4789999987542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 83 LPGGDMMTLLMK------------KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccC
Confidence 999999999853 34688999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCc---------------------------------eeeeccccCCcccCccccccCCCCCchhHHHHHHHHH
Q 037623 682 SRIFPVEGGS---------------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 728 (749)
Q Consensus 682 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ 728 (749)
++.+...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 9765321100 0012346999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCc
Q 037623 729 ELITGQPVIQKTPE 742 (749)
Q Consensus 729 ElltG~~pf~~~~~ 742 (749)
||++|+.||.+...
T Consensus 228 ell~G~~Pf~~~~~ 241 (363)
T cd05628 228 EMLIGYPPFCSETP 241 (363)
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.49 Aligned_cols=200 Identities=30% Similarity=0.414 Sum_probs=171.9
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+...+.||+|+||.||++.. +++.||+|.+.... ......+.+|++++.+++|+|++++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34568899999999999987 45889999986542 22335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|..++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~~g~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 82 MNGGDLKFHIYNM----------GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHhh----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999888532 234588999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+
T Consensus 149 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 149 AVQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred cEEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 9865322 112344689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=277.64 Aligned_cols=201 Identities=29% Similarity=0.426 Sum_probs=174.3
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCchh--hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ--GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.-.+.||+|.||.||+|+. +++.||||+++..... -.....+|++.|+.++|+||+.|++++...+.+.||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 44457899999999999987 4588999999866432 1345789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+. +|+..++ ++...++..++..++.++.+||+|||++ .|+||||||.|+|++++|.+||+|||+|
T Consensus 84 ~t-dLe~vIk-----------d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 84 PT-DLEVVIK-----------DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred cc-cHHHHhc-----------ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccch
Confidence 64 8998885 3567889999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+.+...... .+..+-|.-|.|||.+.+. .|+...||||.||++.||+-|.+.|.+.++-+
T Consensus 149 r~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 149 RFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred hccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 988655322 2333678899999999875 59999999999999999999999999876644
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.67 Aligned_cols=214 Identities=28% Similarity=0.414 Sum_probs=171.1
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC-Ce
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN-TK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~-~~ 594 (749)
..+.+.+.||+|+||.||+|... +..||||++.... ....+.+.+|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 34567789999999999999741 2579999987543 23456789999999999 899999999998764 45
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCC--------------------------------------------------CccC
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPT--------------------------------------------------DAED 624 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~--------------------------------------------------~~~~ 624 (749)
.++||||+++|+|.+++......... ....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999999653211000 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCccc
Q 037623 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704 (749)
Q Consensus 625 ~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 704 (749)
....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...............++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 124588999999999999999999998 99999999999999999999999999998654322211222334667899
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 705 DPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 705 APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999999999997 999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.46 Aligned_cols=191 Identities=28% Similarity=0.456 Sum_probs=172.6
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
+.||+|+.|.||.++. .++.||||++........+-..+|+.+|+..+|+|||.++..+..+++++.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 6799999999999976 44889999998776666677899999999999999999999998889999999999999998
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 688 (749)
+.+ ....+++.++..|++++++||+|||.+ +|||||||.+|||++.++.+||+|||++..+...
T Consensus 359 DvV-------------t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 359 DVV-------------TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred hhh-------------hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 888 334589999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
. .......||+.|||||++..+.|++|.||||||++++||+.|++||-.
T Consensus 423 ~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 423 Q--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred c--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 2 233466899999999999999999999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.45 Aligned_cols=195 Identities=28% Similarity=0.392 Sum_probs=169.0
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+++.. ++.||+|++.... ......+.+|++++.+++|+||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 4789999987542 233456789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR------------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99998843 34688999999999999999999999 9999999999999999999999999998753
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 200 (323)
T cd05571 146 ISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred ccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH
Confidence 221 1122345689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.32 Aligned_cols=195 Identities=28% Similarity=0.402 Sum_probs=168.6
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+++.. ++.||+|++.... ......+.+|++++.+++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 5889999987542 234456788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR------------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988843 34688999999999999999999998 9999999999999999999999999998753
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 146 ISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred cCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 222 1112335689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=311.14 Aligned_cols=196 Identities=30% Similarity=0.424 Sum_probs=170.0
Q ss_pred cccccccCceEEEEEEECC-----cc-cEEEEecC---CchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 530 ERVLGKGGFGTVYHGYLDD-----KQ-VAVKMLSP---SSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~-----~~-VAVK~l~~---~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.++||+|+||.||+|++.. .. ||||..+. ......++|.+|++++++++|+|||+++|++..+.++++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4899999999999998732 23 89999885 345667899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
+|.||+|.++|.. ....++..++++++.++|.||+|||++ ++|||||.++|+|++.++.+||+|||
T Consensus 242 l~~gGsL~~~L~k-----------~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 242 LCNGGSLDDYLKK-----------NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred ecCCCcHHHHHHh-----------CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999964 233689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeee-ccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVST-TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+++.-. ...... ...-..+|+|||.+..+.++.++|||||||++||+++ |..||.+...
T Consensus 308 Ls~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 308 LSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred cccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 988542 111111 2235679999999999999999999999999999998 8999987653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.33 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=169.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+|+.. ++.+|+|++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345688999999999999874 4789999987542 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 83 ~~gg~L~~~l~~------------~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 83 IPGGDMMSLLIR------------MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred CCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 999999999853 24578889999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCc---------------------------------------------eeeeccccCCcccCccccccCCCCC
Q 037623 682 SRIFPVEGGS---------------------------------------------HVSTTVVGTPGYLDPEYYISNRLTE 716 (749)
Q Consensus 682 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ 716 (749)
++.+...... .......||+.|+|||.+.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 8643211000 0012346999999999999989999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 717 KSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 717 k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++|||||||++|||++|+.||...+
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCC
Confidence 9999999999999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.21 Aligned_cols=193 Identities=29% Similarity=0.404 Sum_probs=168.1
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||+|+||.||+++.. ++.||+|++... .....+.+.+|++++.+++|+||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999874 478999998653 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 81 FHHLQR------------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred HHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 999853 34588999999999999999999998 999999999999999999999999999985432
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
. ........||+.|+|||++.+..++.++|||||||+++||++|+.||...+.
T Consensus 146 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~ 198 (312)
T cd05585 146 D--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV 198 (312)
T ss_pred C--CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH
Confidence 2 1222345689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.76 Aligned_cols=196 Identities=27% Similarity=0.393 Sum_probs=171.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999885 5889999986542 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~~~L~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 83 VPGGELFSYLRN------------SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred CCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCc
Confidence 999999999843 34588899999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9865321 1234689999999999998999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.76 Aligned_cols=195 Identities=29% Similarity=0.422 Sum_probs=169.0
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+++.. ++.||+|++... .....+.+.+|++++++++|+||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 588999998754 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR------------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99988843 34689999999999999999999998 9999999999999999999999999998753
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 146 ITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred CCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 221 1122335689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.99 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=172.2
Q ss_pred hhcccccccccCceEEEEEEECC---cccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD---KQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~---~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+..+ ..||+|++.... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 46677999999999999998643 579999986432 233467889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 111 Ey~~~g~L~~~i~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 111 EFVIGGEFFTFLRR------------NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred eCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 99999999999853 34588999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 999865321 1245689999999999998899999999999999999999999987543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=289.04 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=176.4
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..|++.++||.|..++||+|+. .+..||||++.-..... .+.+++|+..++.++||||+..+..|..+.++++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 3467789999999999999987 45889999998654433 58899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
|.+|++.+.++.. -...+++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.
T Consensus 106 Ma~GS~ldIik~~----------~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 106 MAGGSLLDIIKTY----------YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred hcCCcHHHHHHHH----------ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999764 234489999999999999999999999 999999999999999999999999998
Q ss_pred CccccCCCCcee-e-eccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHV-S-TTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~-~-~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+--+...+.... . ....|++.|||||++.. .-|+.|+|||||||...||.+|..||...+.
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 765543321111 1 34579999999999643 3589999999999999999999999987653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=309.06 Aligned_cols=201 Identities=27% Similarity=0.403 Sum_probs=170.2
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++.+++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 44568999999999999987 45789999986532 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~------------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 83 LPGGDLMTMLIK------------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred CCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccc
Confidence 999999999843 34578889999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCc-----------e----------------------------------eeeccccCCcccCccccccCCCCC
Q 037623 682 SRIFPVEGGS-----------H----------------------------------VSTTVVGTPGYLDPEYYISNRLTE 716 (749)
Q Consensus 682 a~~~~~~~~~-----------~----------------------------------~~~~~~gt~~y~APE~~~~~~~s~ 716 (749)
++.+...... . ......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9643211000 0 001245899999999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 717 KSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 717 k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++|||||||++|||++|+.||...+.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCH
Confidence 99999999999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.51 Aligned_cols=196 Identities=28% Similarity=0.446 Sum_probs=171.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3566789999999999999984 4789999987542 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 99 ~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 99 FVVGGELFTHLRK------------AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred CCCCChHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999853 24578888999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 164 FAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred CceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 99865322 123468999999999999999999999999999999999999997654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=312.56 Aligned_cols=205 Identities=23% Similarity=0.339 Sum_probs=176.2
Q ss_pred hcccccccccCceEEEEEEEC---CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||.||+|... +..||+|.+..........+.+|++++++++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667789999999999999763 46788887765555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 149 gg~L~~~l~~~~--------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 149 GGDLNKQIKQRL--------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred CCCHHHHHHHHH--------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 999999886431 1344688999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 76433222223345699999999999999999999999999999999999999986543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.60 Aligned_cols=196 Identities=26% Similarity=0.414 Sum_probs=172.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|++++.+++|+||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999984 4789999987542 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~g~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 83 VPGGDFRTLLNN------------LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred CCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence 999999999943 34578999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 986532 22345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=307.73 Aligned_cols=200 Identities=27% Similarity=0.399 Sum_probs=169.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+|+.. ++.+|+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345689999999999999874 4789999987542 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~------------~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 83 IPGGDMMSLLIR------------MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred CCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 999999999843 24578888999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCC---------------------------------------------ceeeeccccCCcccCccccccCCCCC
Q 037623 682 SRIFPVEGG---------------------------------------------SHVSTTVVGTPGYLDPEYYISNRLTE 716 (749)
Q Consensus 682 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ 716 (749)
++.+..... ........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 754321000 00011246899999999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 717 KSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 717 k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++|||||||++|||++|++||...+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.32 Aligned_cols=207 Identities=27% Similarity=0.459 Sum_probs=183.4
Q ss_pred HHHhhcccccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
++-.|++.+.||+|.||.|-++.. .++.||||.+++. +.++.-.+.+|+++|..++||||+.++.+|+..+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345677789999999999999975 5699999998765 44555678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||..+|.|.+++. ..+.+++.++.++..||..|+.|+|.+ +++|||||.+|||+|+++++||+
T Consensus 131 vMEYaS~GeLYDYiS------------er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS------------ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred EEEecCCccHHHHHH------------HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeee
Confidence 999999999999994 456799999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCcccccC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERTLIG 747 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l~ 747 (749)
|||++-.+.. .......+|++-|.+||.+.+..| ++..|-||+||+||-|+.|..||++.+-..+++
T Consensus 196 DFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 196 DFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred ccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 9999988753 334556789999999999999887 588999999999999999999999876554443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=281.90 Aligned_cols=198 Identities=27% Similarity=0.385 Sum_probs=169.8
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCch-hh-HHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QG-YKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~ 604 (749)
+.|++|.||.||+|+++ +..||+|+++.... .+ --.-++|+.+|.+++|||||.+-.+... -+..+||||||++
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 67999999999999984 58899999975432 11 1235899999999999999999988754 4679999999987
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
+|.+.+.. -.+.+...++.-+..|+++|++|||+. .|+|||||++|+|+.+.|.+||+|||+|+.
T Consensus 162 -DLksl~d~-----------m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 162 -DLKSLMET-----------MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred -hHHHHHHh-----------ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 89999954 236788999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
+... ....+..+-|.-|.|||.+.+. .|+...||||+|||+.||+++++.|.+..+-+.
T Consensus 227 ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ 286 (419)
T KOG0663|consen 227 YGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ 286 (419)
T ss_pred hcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH
Confidence 8644 2334566789999999999876 599999999999999999999999998776443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.71 Aligned_cols=214 Identities=28% Similarity=0.418 Sum_probs=173.3
Q ss_pred HhhcccccccccCceEEEEEEECC------------------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD------------------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTIL 585 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~------------------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l 585 (749)
..+.+.+.||+|+||.||++.+.+ ..||+|.+.... ....++|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 345667899999999999997532 359999987653 3345679999999999999999999
Q ss_pred EEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCC-------CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 037623 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPT-------DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVH 658 (749)
Q Consensus 586 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~-------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiH 658 (749)
++++.+.+..++||||+++|+|.+++......... ........++|..+++++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999998643211000 0012234688999999999999999999998 9999
Q ss_pred eCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCC
Q 037623 659 RDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPV 736 (749)
Q Consensus 659 rDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt--G~~p 736 (749)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986643322222223346789999999999999999999999999999986 5678
Q ss_pred CCCCC
Q 037623 737 IQKTP 741 (749)
Q Consensus 737 f~~~~ 741 (749)
|....
T Consensus 242 ~~~~~ 246 (304)
T cd05096 242 YGELT 246 (304)
T ss_pred CCcCC
Confidence 87543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.13 Aligned_cols=200 Identities=25% Similarity=0.409 Sum_probs=171.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+++.. ++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 445689999999999999874 5789999987542 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~g~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 83 LPGGDMMTLLMK------------KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred CCCcHHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999853 23589999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCce------------------------------------eeeccccCCcccCccccccCCCCCchhHHHHHH
Q 037623 682 SRIFPVEGGSH------------------------------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGV 725 (749)
Q Consensus 682 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGv 725 (749)
++.+....... ......||+.|+|||++....++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87653211000 001235899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 037623 726 VLLELITGQPVIQKTP 741 (749)
Q Consensus 726 vL~ElltG~~pf~~~~ 741 (749)
+++||++|+.||...+
T Consensus 228 il~el~~G~~Pf~~~~ 243 (364)
T cd05599 228 IMYEMLVGYPPFCSDN 243 (364)
T ss_pred HHHHhhcCCCCCCCCC
Confidence 9999999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.08 Aligned_cols=193 Identities=22% Similarity=0.356 Sum_probs=167.0
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhh---HHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTILVGYCDE----NTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 603 (749)
..||+|++|.||+|+++++.||||.+....... .+.|.+|+.++.+++||||++++|++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999987653322 4678899999999999999999999866 356789999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.. .+.+++...++++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++
T Consensus 106 ~g~L~~~l~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 106 RGYLREVLDK------------EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CCcHHHHHhh------------CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 9999999953 346889999999999999999999732 67899999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+.... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 653221 23357889999999976 6899999999999999999999999987653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=282.70 Aligned_cols=203 Identities=31% Similarity=0.379 Sum_probs=176.6
Q ss_pred cccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 530 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.||+|.-|+||++.+.+ ...|+|++.+... ....+.+.|.+||+.++||.+..|++.++.+...+||||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 3789999999999999977 7899999987643 3456678899999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..+++++ ..+.+++..+.-.|.++.-||+|||.. |||.|||||+||||.++|++-|+||.++..
T Consensus 162 GdL~~LrqkQ----------p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 162 GDLHSLRQKQ----------PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred ccHHHHHhhC----------CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999765 567899999999999999999999999 999999999999999999999999999754
Q ss_pred ccCC--------------------------------CCc----------------------eeeeccccCCcccCccccc
Q 037623 685 FPVE--------------------------------GGS----------------------HVSTTVVGTPGYLDPEYYI 710 (749)
Q Consensus 685 ~~~~--------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~ 710 (749)
.... ... ..+...+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 3210 000 1112346899999999999
Q ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 711 SNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 711 ~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
+.-.+.++|.|+|||++|||+.|+.||.+.+.++.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T 343 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET 343 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence 99999999999999999999999999999776543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.84 Aligned_cols=201 Identities=28% Similarity=0.432 Sum_probs=176.8
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.||+|+.|.|-.|+. +|+.+|||++.+.. ......+++|+.+|+.+.|||+++|++++++..++|||.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 3468899999999999987 67999999987652 222456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|.|+++|. ..+.+.+.++.++..||..|+.|+|.. +|+||||||+|+|||.+.++||+|||+|
T Consensus 95 ~gGELFdylv------------~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 95 PGGELFDYLV------------RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred CCchhHHHHH------------hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecccee
Confidence 9999999995 346788999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l 746 (749)
.+... ......-+|++.|.|||++.+.+| +.++||||.||||+.|+||+.||++.+.+.++
T Consensus 160 sLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 160 SLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred ecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 87532 233445679999999999999987 47899999999999999999999987765544
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=304.23 Aligned_cols=200 Identities=28% Similarity=0.365 Sum_probs=169.9
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
..+.+.+.||+|+||.||+++.. ++.+|+|++... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34566789999999999999874 478999998643 2223456789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 123 Ey~~gg~L~~~l~~-------------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 123 EYMPGGDLVNLMSN-------------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred cCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEec
Confidence 99999999998842 2467888999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+++.+.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 187 GTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 9998764321 1122345699999999998754 37889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=306.21 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=170.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||.||+++.. ++.||||++..... ...+.+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456689999999999999874 47899999865422 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~g~L~~~i~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 83 IPGGDMMSLLIR------------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred CCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999843 34578888899999999999999998 999999999999999999999999999
Q ss_pred CccccCCCC-----------------------------------------ceeeeccccCCcccCccccccCCCCCchhH
Q 037623 682 SRIFPVEGG-----------------------------------------SHVSTTVVGTPGYLDPEYYISNRLTEKSDV 720 (749)
Q Consensus 682 a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DV 720 (749)
+..+..... ........||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 853311000 000112468999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCc
Q 037623 721 YSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 721 wSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||||++|||++|+.||...+.
T Consensus 228 wSlGvilyell~G~~Pf~~~~~ 249 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTP 249 (376)
T ss_pred eeccceeeehhhCCCCCCCCCH
Confidence 9999999999999999987553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.54 Aligned_cols=195 Identities=31% Similarity=0.466 Sum_probs=167.2
Q ss_pred ccccccCceEEEEEEE-----CCcccEEEEecCCc----hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 531 RVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS----VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.||+|+||.||+++. .++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 34779999987532 22335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+.+..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~~~~L~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 146 (323)
T cd05584 82 LSGGELFMHLER------------EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL 146 (323)
T ss_pred CCCchHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence 999999998843 34577888889999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 147 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~ 205 (323)
T cd05584 147 CKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR 205 (323)
T ss_pred CeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH
Confidence 87542221 122335689999999999998899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.60 Aligned_cols=196 Identities=30% Similarity=0.433 Sum_probs=168.1
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|+..+ +.||+|++.... ....+.+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998854 789999987542 23345677889988876 899999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|...+.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 81 GDLMFQIQR------------SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 999988843 34588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...++.
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 202 (321)
T cd05591 146 GILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202 (321)
T ss_pred cccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH
Confidence 43221 1223446899999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=294.91 Aligned_cols=200 Identities=30% Similarity=0.436 Sum_probs=169.5
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhcCCC-ceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHK-NLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~-nIv~l~g~~~~~~~~~LV~E 600 (749)
+.+.+.||+|+||.||+|+..+ +.||||++.... ....+.+..|++++..++|+ +|+.+.+++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 4567899999999999998854 679999987532 23456778899999999664 68889999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~g~L~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 82 YVNGGDLMYHIQQ------------VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred CCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 9999999998843 34578999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+++...... .......|++.|+|||++.+..++.++|||||||++|||+||+.||...+..
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (324)
T cd05587 147 MCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207 (324)
T ss_pred cceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 987532211 1223456899999999999999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=298.85 Aligned_cols=195 Identities=28% Similarity=0.395 Sum_probs=167.9
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+++. +++.||+|++.... ......+.+|++++.+++|+||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 45789999987542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
+|..++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 81 ELFFHLSR------------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred cHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 99988842 3468999999999999999999997 6 899999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 146 GIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred cCCC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 3222 1112334689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.90 Aligned_cols=196 Identities=31% Similarity=0.452 Sum_probs=165.8
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|+..+ +.||+|+++... ....+.+..|.+++... +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998854 679999987542 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 81 GDLMFHIQS------------SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 999988843 23588899999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 43221 2223456899999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.28 Aligned_cols=200 Identities=29% Similarity=0.417 Sum_probs=169.4
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
+.+.+.||+|+||.||+|+..+ +.||+|++.... ....+.+..|..++..+ +|++++++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 4567899999999999998754 689999987542 22334567788888777 68999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~g~L~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 82 YVNGGDLMYQIQQ------------VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred CCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 9999999988843 34588999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+++...... .......|++.|+|||++.+..++.++|||||||++|||+||+.||...+..
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 147 MCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred CceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 987543221 1223456899999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.10 Aligned_cols=203 Identities=28% Similarity=0.358 Sum_probs=174.4
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchh-hHHHHHHHHHHHHhcC-CCceeEEEEEEecCC-eeEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAH-HKNLTILVGYCDENT-KMGLVY 599 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~-~~~LV~ 599 (749)
.+|...++||.|.||.||+|+- ++..||||+++..-.. +...-++|++.|++++ ||||++|..++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 3466678999999999999986 4588999999865322 2223478999999998 999999999998877 999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
|||+ .+|.++++. +.+.+++..++.|+.||++||+|+|.+ |+.||||||+|||+.....+||+||
T Consensus 90 E~Md-~NLYqLmK~-----------R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKD-----------RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred Hhhh-hhHHHHHhh-----------cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 9995 599999853 577899999999999999999999999 9999999999999998889999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
|+||.+... ..-+..+.|.-|.|||++. .+.|+.+.||||+|||++|+.+-++.|-+.+|-+.
T Consensus 155 GLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq 218 (538)
T KOG0661|consen 155 GLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ 218 (538)
T ss_pred ccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence 999987533 2335567889999999985 56799999999999999999999999998876543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=285.68 Aligned_cols=196 Identities=27% Similarity=0.415 Sum_probs=168.3
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||+|+||+||++... ++.+|+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999874 57899999875422 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
..++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVD--------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhcc--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 98885321 2345689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 150 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 150 GQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11233468999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=295.40 Aligned_cols=196 Identities=31% Similarity=0.432 Sum_probs=167.8
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||+||+++.. ++.||||++.... ....+.+..|.+++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 4789999987532 23345677888888876 799999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~i~~------------~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 81 GDLMFHIQK------------SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred chHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 999988843 34588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 146 GIFN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred cCcC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 4222 11223456899999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=286.89 Aligned_cols=202 Identities=36% Similarity=0.571 Sum_probs=170.0
Q ss_pred ccccccccCceEEEEEEEC------CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 529 FERVLGKGGFGTVYHGYLD------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.||.|.||.||+|.+. +..|+||.++.. .....++|.+|++.+.+++|+||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 377999999664 334578899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.++|... ....+++..+.+++.|+++||+|||+. +++|+||+++|||+++++.+||+|||+
T Consensus 83 ~~~g~L~~~L~~~----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 83 CPGGSLDDYLKSK----------NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp -TTEBHHHHHHHT----------CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred ccccccccccccc----------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 9999999999753 345689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
++...................|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~ 212 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE 212 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 987632222222333457779999999999999999999999999999999 78999765443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=295.34 Aligned_cols=199 Identities=30% Similarity=0.453 Sum_probs=169.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~E 600 (749)
+++.+.||+|+||+||+++.. ++.||+|++.... ....+.+..|..++..+. |++|+++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456789999999999999874 5789999987532 233456778888988885 5778889999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 82 y~~~g~L~~~i~~------------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 82 YVNGGDLMYHIQQ------------VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred CCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 9999999998843 34588999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 147 MCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred cccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 987543221 122344689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=286.82 Aligned_cols=196 Identities=26% Similarity=0.423 Sum_probs=161.6
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeEEEEeeC
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT-----KMGLVYEFM 602 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~-----~~~LV~Ey~ 602 (749)
.+++|+|+||.||+|++. ++.||||+.-..... --+|+.+|++++|||||+|+.++.... ...||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 489999999999999984 488999997644321 147899999999999999999885422 334899999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~DFGl 681 (749)
+. +|...++... .....++...+.-...||.+||+|||+. +|+||||||.|+|+|.+ +.+||||||.
T Consensus 105 P~-tL~~~~r~~~--------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 105 PE-TLYRVIRHYT--------RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred hH-HHHHHHHHHh--------hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 76 8888885421 2345567777778899999999999997 99999999999999965 8999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+.+...+ ...+...|..|.|||.+.+. +|+.+.||||.|||+.||+-|++.|.+.+..+
T Consensus 173 AK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d 233 (364)
T KOG0658|consen 173 AKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD 233 (364)
T ss_pred ceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH
Confidence 99875443 22456688999999999875 69999999999999999999999999866543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=302.10 Aligned_cols=201 Identities=25% Similarity=0.428 Sum_probs=171.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+++.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|+.++.+++|+|++++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345689999999999999874 4789999987532 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 83 LPGGDMMTLLMK------------KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CCCccHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccC
Confidence 999999999843 34588999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCc---------------------------------eeeeccccCCcccCccccccCCCCCchhHHHHHHHHH
Q 037623 682 SRIFPVEGGS---------------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 728 (749)
Q Consensus 682 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ 728 (749)
++.+...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 0011346899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCc
Q 037623 729 ELITGQPVIQKTPE 742 (749)
Q Consensus 729 ElltG~~pf~~~~~ 742 (749)
||++|+.||.....
T Consensus 228 el~tG~~Pf~~~~~ 241 (360)
T cd05627 228 EMLIGYPPFCSETP 241 (360)
T ss_pred ecccCCCCCCCCCH
Confidence 99999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=300.93 Aligned_cols=201 Identities=27% Similarity=0.354 Sum_probs=169.6
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
..+.+.+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34566789999999999999874 4789999986432 223455788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ..++...+..++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 123 Ey~~gg~L~~~l~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 123 EYMPGGDLVNLMSN-------------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred cCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEec
Confidence 99999999998842 2367788889999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++...... ........||+.|+|||++... .++.++|||||||++|||++|+.||...+.
T Consensus 187 G~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 187 GTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred cceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 9998654321 1112345699999999998653 478999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=292.79 Aligned_cols=195 Identities=31% Similarity=0.458 Sum_probs=166.2
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|+..+ +.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999854 789999987542 22345567788888764 999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~l~~------------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 81 GDLMFHIQS------------CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 999999843 34578999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 146 NMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred CCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 32211 122345689999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=293.98 Aligned_cols=197 Identities=28% Similarity=0.421 Sum_probs=166.6
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHH---HhcCCCceeEEEEEEecCCeeEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELL---MRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL---~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.||+|+||.||+|... ++.||||+++... ....+.+.+|++++ .+++|+||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999874 5889999987542 22334566666555 5668999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|..++. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 82 E~~~~~~L~~~~~-------------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 82 EYAAGGDLMMHIH-------------TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred cCCCCCcHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 9999999988873 23589999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++..... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 g~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 146 GLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred cCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 998753222 1222345689999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=299.49 Aligned_cols=201 Identities=28% Similarity=0.349 Sum_probs=170.3
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
..+.+.+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.+....++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45666789999999999999885 4789999986432 223456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||+++++++||+||
T Consensus 123 Ey~~gg~L~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 123 EYMPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred cCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999998842 2367888899999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++.+.... ........||+.|+|||++... .++.++|||||||++|||++|+.||...+.
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 9998764321 1122345699999999998654 378999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=298.14 Aligned_cols=214 Identities=27% Similarity=0.426 Sum_probs=173.0
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||.||+|+.. ...||||++.... ....+.+.+|+++++++ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 34567799999999999999752 1469999997543 33356788999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCC-------------------------------------------------------
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPT------------------------------------------------------- 620 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~------------------------------------------------------- 620 (749)
++||||+++|+|.+++.........
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999999654211000
Q ss_pred ---CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeecc
Q 037623 621 ---DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697 (749)
Q Consensus 621 ---~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 697 (749)
........+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 0011224588999999999999999999998 9999999999999999999999999999865433221222223
Q ss_pred ccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 698 ~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 35678999999999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=295.69 Aligned_cols=195 Identities=33% Similarity=0.411 Sum_probs=165.0
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVE-LLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||+||+++.. ++.+|+|++.... ....+++..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999874 5789999986542 223345566655 46778999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~l~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 81 GELFFHLQR------------ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 999988842 34688999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 146 GIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred CCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 3221 1122345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=295.58 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=170.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|..++..++|+||+++.+++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999875 4779999986532 22345578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 83 YVGGDLLTLLSKF-----------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred CCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccc
Confidence 9999999999542 24578899999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++...... ........|++.|+|||++.+ +.++.++|||||||++|||++|+.||...+
T Consensus 149 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 149 CLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 98664322 112223468999999999875 567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=292.64 Aligned_cols=196 Identities=31% Similarity=0.442 Sum_probs=166.8
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|+.. ++.||+|+++... ....+.+..|..++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999884 4789999987542 12345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~i~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 81 GDLMFHIQD------------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 999998843 24578899999999999999999998 999999999999999999999999999874
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 146 NVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred cccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 3221 12223456899999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=292.63 Aligned_cols=192 Identities=25% Similarity=0.400 Sum_probs=166.4
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
++||+|+||.||+++.. ++.||+|+++... ....+.+..|..++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999874 4789999997542 23345678899999988 799999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~~~~------------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQR------------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999988843 34689999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 146 GIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 3221 1122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=292.87 Aligned_cols=198 Identities=27% Similarity=0.379 Sum_probs=168.0
Q ss_pred hcccccccccCceEEEEEEE-----CCcccEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS----VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~ 596 (749)
+.+.+.||+|+||.||+++. .++.||+|++.... ....+.+.+|+.++.++ +|+||+++.+++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45678999999999999875 34789999986532 22345678899999999 5999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 82 lv~e~~~~g~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ------------RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred EEEeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 99999999999999853 34588999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|||+++.+..... .......||..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 147 ~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 147 TDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred eeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 99999986533221 122345689999999999865 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=291.38 Aligned_cols=192 Identities=26% Similarity=0.395 Sum_probs=166.4
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+++.. ++.+|+|++.... ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 4789999997642 23345688999999888 699999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 81 GDLMFHMQR------------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 999988843 34589999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 146 GLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 3221 1122345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=300.62 Aligned_cols=200 Identities=27% Similarity=0.406 Sum_probs=173.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||+||+|+.. ++.||+|++.... ....+.+.+|++++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456789999999999999985 6889999987542 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~~~L~~~l~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 83 MPGGDLMNLLIR------------KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred CCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999953 24688999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCC---------------------------ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCC
Q 037623 682 SRIFPVEGG---------------------------SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734 (749)
Q Consensus 682 a~~~~~~~~---------------------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~ 734 (749)
++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 986643320 01122346899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 037623 735 PVIQKTP 741 (749)
Q Consensus 735 ~pf~~~~ 741 (749)
.||....
T Consensus 228 ~Pf~~~~ 234 (350)
T cd05573 228 PPFYSDT 234 (350)
T ss_pred CCCCCCC
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=293.23 Aligned_cols=191 Identities=26% Similarity=0.429 Sum_probs=165.2
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+++.. ++.+|+|++... .....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999874 478999998754 223345678899888877 899999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 81 GDLMFHMQR------------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 999888742 34688999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 146 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 32221 12234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=293.97 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=169.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||+||+++.. ++.||+|++... .....+.+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456789999999999999874 478999998643 222345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~g~~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 83 YVGGDLLTLLSK-----------FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred CCCCcHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999853 234578899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..+.... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 149 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 149 CLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 87654322 111223458999999999863 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=285.73 Aligned_cols=199 Identities=28% Similarity=0.404 Sum_probs=167.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||.||+|+.. +..||+|+++.... .....+.+|+.++++++|+||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 556789999999999999874 47899999875432 234567899999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 87 ~-~l~~~l~~-----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 87 S-DLKQYLDN-----------CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred c-CHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCccee
Confidence 4 89888843 233578899999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
...... .......+++.|+|||.+.+ ..++.++||||+||++|||+||++||...+.
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 152 AKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred eccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 643221 11223457899999999865 5689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=282.90 Aligned_cols=204 Identities=25% Similarity=0.383 Sum_probs=170.9
Q ss_pred HHhhcccccccccCceEEEEEEEC-----CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
...+.+.+.||+|+||.||+|.+. +..||+|.++... ....+.|.+|+.++.+++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 345667899999999999999763 3579999987653 3334678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++|+|.+++.. ....+++..+++++.|++.||+|||+. +++||||||+|||+++++.+|++
T Consensus 84 v~e~~~~~~L~~~l~~-----------~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~ 149 (266)
T cd05064 84 VTEYMSNGALDSFLRK-----------HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKIS 149 (266)
T ss_pred EEEeCCCCcHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEEC
Confidence 9999999999999853 234689999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|||.+....... ........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....
T Consensus 150 dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 150 GFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred CCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 999876532211 111112235678999999999999999999999999999875 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=294.20 Aligned_cols=195 Identities=32% Similarity=0.413 Sum_probs=164.5
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVE-LLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||+||+|+.. ++.||+|++.... ....+++.+|.. ++..++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999984 5889999987542 222344555554 45779999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 81 GELFFHLQR------------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 999998843 34578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 146 GIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred cccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence 3221 1222344689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=294.16 Aligned_cols=200 Identities=26% Similarity=0.383 Sum_probs=169.4
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+++..+ +.+|+|++.+.. ....+.+.+|+.++..++|++|+++.+++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 4567899999999999999854 779999986432 22234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~g~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 83 YVGGDLLTLLSKF-----------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence 9999999999542 24588999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..+.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 149 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 149 CLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred heecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 87653322 12223346899999999986 3467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=293.60 Aligned_cols=195 Identities=30% Similarity=0.399 Sum_probs=163.8
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVE-LLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~-iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
++||+|+||.||+|+.. ++.||+|++..... ...+++.+|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999984 47899999875422 22344555554 57889999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 81 GELFFHLQR------------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 999888842 34578888899999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 146 GVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred CCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 3221 1122344689999999999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=284.84 Aligned_cols=200 Identities=30% Similarity=0.419 Sum_probs=171.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
++..+.||+|+||+||++... ++.||+|++..... .....+.+|+.++++++|+||+++.+++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 455688999999999999874 58899999875432 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 82 MNGGDLKFHIYNM----------GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999888532 234689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 149 AVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 98653221 11234688999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=290.97 Aligned_cols=198 Identities=26% Similarity=0.347 Sum_probs=171.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+...+.||+|+||.||+++.. +..+|+|.+... .....+++.+|++++.+++|+||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 3455688999999999999985 477899988754 2334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|.+++.. ...+++..+.+++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++
T Consensus 86 ~~~~L~~~l~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 86 DGGSLDQVLKE------------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 99999999853 235789999999999999999999852 6999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 152 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 152 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865321 1233468999999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=285.57 Aligned_cols=199 Identities=24% Similarity=0.328 Sum_probs=169.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|++++.+++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456789999999999999985 4789999987542 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 83 EKNMLELLEE------------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCCHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 9877654431 234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+....... .......|+..|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 148 RNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 87643221 11223468899999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=297.68 Aligned_cols=213 Identities=27% Similarity=0.410 Sum_probs=172.3
Q ss_pred hhcccccccccCceEEEEEEE-------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~-------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.+.||+|+||.||+|+. .+..||||+++... ....+.+.+|++++..+ +||||++++++|...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 456679999999999999974 12579999987543 33456788999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCC--------------------------------------------------------
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPT-------------------------------------------------------- 620 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~-------------------------------------------------------- 620 (749)
+||||+++|+|.+++.........
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 999999999999999653210000
Q ss_pred -------CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCcee
Q 037623 621 -------DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693 (749)
Q Consensus 621 -------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 693 (749)
........++|..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 0001123588999999999999999999998 999999999999999999999999999986543322112
Q ss_pred eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 694 ~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 222335668999999999999999999999999999998 899997643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=292.26 Aligned_cols=195 Identities=31% Similarity=0.411 Sum_probs=163.0
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHH-HHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEV-ELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei-~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||+||+++.. ++.+|+|++..... .....+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999874 36799999875321 2223444444 456778999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ...+.+..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 81 GELFYHLQR------------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 999998843 23577888889999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 146 NIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred cccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 4222 1122345689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=295.40 Aligned_cols=200 Identities=24% Similarity=0.327 Sum_probs=171.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+++.. ++.||+|+++... ....+.+.+|+.++.+++|+||+++.+++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456789999999999999874 5789999987542 23446688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 83 QPGGDLLSLLNRY-----------EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred CCCCCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence 9999999998542 24688999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI------SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..+.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 149 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 149 AARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred CeECCCCC-ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 98764332 12223346899999999986 4567899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=304.78 Aligned_cols=206 Identities=27% Similarity=0.388 Sum_probs=173.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC--------
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT-------- 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~-------- 593 (749)
.|.+.+.||+|+||+||+++. +++.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 566789999999999999986 4588999998654 3344567889999999999999999987764332
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~--------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRA--------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 3679999999999999996432 2345688999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999876433222223345699999999999999999999999999999999999999986543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=294.00 Aligned_cols=194 Identities=29% Similarity=0.405 Sum_probs=168.1
Q ss_pred ccccccCceEEEEEEE-----CCcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.||+|+||.||+++. .++.+|+|++..... .....+.+|++++.+++|+||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 347899999875432 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 82 GGDLFTRLSK------------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 146 (318)
T ss_pred CCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence 9999999843 34589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 147 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 147 ESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 653221 22234568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=268.50 Aligned_cols=201 Identities=30% Similarity=0.448 Sum_probs=176.0
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.++.+.||+|.||.||.|+.+. -.||+|++.++.. +...++.+|+++-+.++||||+++++++.+....+|++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 3567999999999999998754 6799999876532 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
.++|+|...|... ....+++......+.|+|.||.|+|.. .||||||||+|+|++.++.+||+|||-
T Consensus 104 a~~gel~k~L~~~----------~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 104 APRGELYKDLQEG----------RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred cCCchHHHHHHhc----------ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999753 455678888889999999999999998 999999999999999999999999997
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+..-+ ........||..|.+||...+..++...|+|++|++.+|++.|.+||......+
T Consensus 171 sV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 171 SVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred eeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 76432 222345679999999999999999999999999999999999999998766444
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=275.82 Aligned_cols=201 Identities=29% Similarity=0.400 Sum_probs=169.3
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCCchh--hHHHHHHHHHHHHhcCCCc-eeEEEEEEecCC------eeEEE
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ--GYKQFQAEVELLMRAHHKN-LTILVGYCDENT------KMGLV 598 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~l~H~n-Iv~l~g~~~~~~------~~~LV 598 (749)
.+.||+|+||+||+|+. +++.||+|++.....+ --....+|+.++.+++|+| |+.|.+++...+ ..+||
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 35699999999999986 5689999999766442 2244689999999999999 999999998877 78899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||++ -+|..++..... ....++-..+..++.||++||+|||++ +|+||||||.|||++++|.+||+|
T Consensus 96 fe~~d-~DL~~ymd~~~~--------~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 96 FEFLD-RDLKKYMDSLPK--------KPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred EEeec-ccHHHHHHhccc--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 99994 589999954311 114566688999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
||+|+....+. ...+...+|.-|.|||++.+. .|+...||||+||++.||+++++.|.+..+.+
T Consensus 164 FGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ 228 (323)
T KOG0594|consen 164 FGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID 228 (323)
T ss_pred cchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH
Confidence 99999765332 223455688899999999887 69999999999999999999999999876643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=289.69 Aligned_cols=199 Identities=26% Similarity=0.407 Sum_probs=165.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~L 597 (749)
|.+.+.||+|+||.||+|+.. +..||||++... ......++.+|++++++++||||+++.+++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999874 488999998743 223446788999999999999999999988543 35799
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||++ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 82 v~e~~~-~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 82 VFELME-SDLHQVIKA------------NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred EEecCC-CCHHHHHHh------------cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEc
Confidence 999995 689888842 34589999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCc-eeeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||+++........ .......|+..|+|||++.+ ..++.++|||||||++|||++|++||.+.+
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999865322211 11233468999999999865 678999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.81 Aligned_cols=195 Identities=31% Similarity=0.467 Sum_probs=167.3
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||+||+++.. ++.||||++.... ....+.+..|.+++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999885 4789999987542 23345677889999887 799999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~L~~~~~~------------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 81 GDLMFHIQR------------SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 999988843 34689999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~ 201 (318)
T cd05570 146 GILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201 (318)
T ss_pred cCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence 32211 112234589999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.50 Aligned_cols=201 Identities=26% Similarity=0.421 Sum_probs=168.5
Q ss_pred hhcccccccccCceEEEEEEEC--Cc----ccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~----~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.+...+.||+|+||.||+|++. +. .||+|++.... ....+++.+|+.++++++|+||++++|+|... ...++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 4555689999999999999862 22 38999987543 34457889999999999999999999999764 57799
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++|+|.+++... ...+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 87 ~e~~~~g~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 87 TQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred eecCCCCCHHHHHHhc-----------cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 9999999999998542 34588999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred ccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999987654322222222234678999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=281.10 Aligned_cols=215 Identities=32% Similarity=0.464 Sum_probs=177.0
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
.++.+.+.||+|+||.||+|+.. +..||||.+...... ..+.+.+|++++.+++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45666789999999999999763 267999998765444 4578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCC--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTD--AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~--~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
+||||+++++|.+++.......... .......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996532111000 112345689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |+.||...+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999986533222222223346788999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=283.89 Aligned_cols=198 Identities=27% Similarity=0.392 Sum_probs=166.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++++++|+||+++.+++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3556789999999999999884 57899999875432 22346788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 86 ~-~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 86 H-TDLCQYMDK-----------HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred C-cCHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 5 688887743 234578889999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+...... .......+++.|+|||++.+ ..++.++|||||||+++||++|+.||.+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 151 RAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred eeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7543221 11233457899999999865 45889999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=288.38 Aligned_cols=200 Identities=26% Similarity=0.360 Sum_probs=171.8
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
...|++.+.||+|+||.||++... +..+|+|.+... .....+.+.+|++++.+++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 345667789999999999999885 477899987754 23345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||
T Consensus 84 ~~~~~~L~~~l~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 84 HMDGGSLDQVLKK------------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred cCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999853 235788899999999999999999742 69999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++..+... ......++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 98765321 1223468899999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=284.20 Aligned_cols=201 Identities=29% Similarity=0.453 Sum_probs=165.3
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchh--------------hHHHHHHHHHHHHhcCCCceeEEEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ--------------GYKQFQAEVELLMRAHHKNLTILVGYC 589 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~--------------~~~~f~~Ei~iL~~l~H~nIv~l~g~~ 589 (749)
.|.+.+.||+|.||.|-+|+. +++.||||++.+.... ..+...+|+.+|++++|+|||+|+.+.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 345568999999999999987 4588999999764211 125788999999999999999999998
Q ss_pred ec--CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 590 DE--NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI-LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 590 ~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~-l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
.+ .+.+|||+|||..|.+...- ..+. ++..++++++.++..||+|||.+ +||||||||+|+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-------------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL 241 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-------------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL 241 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-------------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence 65 57899999999988763221 2223 89999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEecCCCccccCCCC---ceeeeccccCCcccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 667 LLNEKFQAKLADFGLSRIFPVEGG---SHVSTTVVGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 667 Ll~~~~~~kL~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~----~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
||++++++||+|||.+........ ........||+.|+|||.+.++. .+.+.||||+||.||-|+.|+.||.+
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 999999999999999886532211 11223357999999999998743 46789999999999999999999987
Q ss_pred CCc
Q 037623 740 TPE 742 (749)
Q Consensus 740 ~~~ 742 (749)
..+
T Consensus 322 ~~~ 324 (576)
T KOG0585|consen 322 DFE 324 (576)
T ss_pred chH
Confidence 654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=279.95 Aligned_cols=213 Identities=29% Similarity=0.486 Sum_probs=174.1
Q ss_pred hhcccccccccCceEEEEEEE------CCcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
...+.+.||+|+||+||+|+. .+..+++|.+... ..+..+++.+|++++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 456678999999999999985 2367999998754 334457789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCC-----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 599 YEFMANGNLQAHLLAQLAILPT-----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~-----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
|||+++++|.+++......... ........+++.+++.++.|++.||+|||++ +++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 9999999999998643211000 0011234588999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999987643322222233345678999999998899999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=279.33 Aligned_cols=213 Identities=27% Similarity=0.411 Sum_probs=173.6
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
..+.+.+.||+|+||.||+|...+ ..||+|++.... .....++.+|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 346677899999999999998642 469999886542 334567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++......... ......+++..++.++.|+++||+|||+. +++||||||+||++++++.++|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMEN--NPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999653221110 11234578999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+|||+++...............++..|+|||.+.++.++.++|||||||+++||++ |+.||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999986543322221222345778999999999999999999999999999999 7899976543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=283.07 Aligned_cols=199 Identities=28% Similarity=0.412 Sum_probs=164.0
Q ss_pred hcccccccccCceEEEEEEEC---CcccEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeEEEEEEe-----cCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSV--QGYKQFQAEVELLMRA---HHKNLTILVGYCD-----ENT 593 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l---~H~nIv~l~g~~~-----~~~ 593 (749)
|.+.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|+.++.++ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 556789999999999999862 36799998865422 2234566777777665 6999999999985 245
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++|+||++ ++|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV----------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 6889999996 6899988532 234588999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+||+|||+++..... .......|++.|+|||.+....++.++|||||||++|||++|++||.+..+
T Consensus 149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 999999999865322 222344689999999999988999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=277.10 Aligned_cols=192 Identities=27% Similarity=0.405 Sum_probs=165.4
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||+|+||.||+++.. ++.+|+|.+..... ...+.+..|++++.+++|+||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999874 58899999864321 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV----------GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9888542 234588999999999999999999998 999999999999999999999999999886532
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
. .......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 148 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 148 G---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred C---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 1223346889999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=279.11 Aligned_cols=213 Identities=31% Similarity=0.511 Sum_probs=174.2
Q ss_pred hcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
+.+.+.||+|+||.||+|...+ ..||+|.+.... ....++|.+|++++.+++|+||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 4456899999999999998643 459999987543 33456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCC----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTD----AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
|||+++|+|.+++.......... .......+++..++.++.|+++||+|||+. +++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 99999999999996532111000 011225689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999986543322222233456788999999999999999999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=309.53 Aligned_cols=211 Identities=24% Similarity=0.386 Sum_probs=173.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.++||+|+||.||+|+.. ++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456789999999999999874 5889999987532 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++....... .........+++..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 84 ~eGGSL~~lL~s~~~~~-~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred CCCCCHHHHHHHhhhcc-ccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999986432110 00111234567888999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCc----------------eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGS----------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~----------------~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++........ .......||+.|+|||++.+..++.++|||||||+++||+||+.||....
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9866211100 01112458999999999999999999999999999999999999997643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=292.18 Aligned_cols=212 Identities=27% Similarity=0.418 Sum_probs=171.7
Q ss_pred hhcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.+.||+|+||.||+|+..+ ..||||++.... ....+.+.+|++++.+++ ||||++++++|.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 34456899999999999998632 359999997543 333467899999999996 999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCC-------------------------------------------------------
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTD------------------------------------------------------- 621 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~------------------------------------------------------- 621 (749)
|||||+++|+|.++|+.........
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999999997643210000
Q ss_pred -----------------------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 622 -----------------------------AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 622 -----------------------------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
.......+++..+++++.|+++||+|||+. +|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 000123588999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKT 740 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~ 740 (749)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999986543322212223346778999999999999999999999999999997 99998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=280.55 Aligned_cols=214 Identities=30% Similarity=0.474 Sum_probs=176.8
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.+.+.+.||+|+||.||+|+.. ...+++|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 3455689999999999999752 245899998877666667899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccC----CCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 599 YEFMANGNLQAHLLAQLAIL----PTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~----~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
|||+++++|.+++....... ..........+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999996542110 011112234689999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+|+|||+++...............++..|+|||.+....++.++|||||||+++||+| |+.||...+.
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999986543322222233456788999999999999999999999999999999 9999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=279.00 Aligned_cols=214 Identities=31% Similarity=0.451 Sum_probs=176.1
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.+.+.+.||+|+||.||++... +..+|+|.+........+.+.+|++++.+++|+|++++++++...+..++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3456789999999999999751 245899998876666667899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCC-CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPT-DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~-~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|||+++++|.+++......... ........+++..+++++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 9999999999999654211111 1112334689999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |++||.....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999986543322222223345778999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=277.56 Aligned_cols=201 Identities=27% Similarity=0.327 Sum_probs=162.8
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+|...+ ..+++|.+.... ......|.+|+++++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997532 468888776543 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++..... ......++...++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRG-------MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccc-------cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence 99999965421 1223457888899999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeeeccccCCcccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.............++..|+|||++.. ...+.++|||||||++|||++ |+.||....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 33221111122345678999998743 356889999999999999999 788987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.14 Aligned_cols=207 Identities=28% Similarity=0.390 Sum_probs=177.3
Q ss_pred HHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcC-C-----CceeEEEEEEec
Q 037623 520 ANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-H-----KNLTILVGYCDE 591 (749)
Q Consensus 520 ~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H-----~nIv~l~g~~~~ 591 (749)
.|....+|.+.+.||+|.||+|-||... ++.||||+++... .-..+-..|+.+|..++ | -|+|++++++..
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 3444447788899999999999999874 5889999998653 33456688999999996 3 489999999999
Q ss_pred CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC
Q 037623 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK 671 (749)
Q Consensus 592 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~ 671 (749)
.++.+||+|.+ ..+|.++|+.. +...++...++.|+.||++||.+||+. +|||+||||+||||.+-
T Consensus 260 r~HlciVfELL-~~NLYellK~n----------~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~ 325 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNN----------KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDP 325 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccC
Confidence 99999999988 56999999754 556799999999999999999999998 99999999999999753
Q ss_pred --CcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 037623 672 --FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746 (749)
Q Consensus 672 --~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l 746 (749)
..+||+|||.++..... ......+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+.+
T Consensus 326 ~r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 326 KRSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred CcCceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 47999999999975322 22556788999999999999999999999999999999999999998876554
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=275.77 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=169.9
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecC--CchhhHHHHHHHHHHHHhcCCCceeEEEEEEec-----CCeeEEEEe
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-----NTKMGLVYE 600 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~--~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-----~~~~~LV~E 600 (749)
.+.||+|+||.|++++. +++.||+|++.. .+....++-.+|+++|+.++|+||+.+...+.. -...++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 36899999999999987 458899999984 345556788999999999999999999998854 467899999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
+| +.+|...++. .+.++......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||
T Consensus 107 lM-etDL~~iik~------------~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS------------QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred HH-hhHHHHHHHc------------CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 99 6689888843 34488888999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|+...........+....|.-|.|||.+.. ..++...||||.||++.||++|++.|.+.+.
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 9998754322334466778999999999864 5799999999999999999999999988764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=274.15 Aligned_cols=201 Identities=30% Similarity=0.485 Sum_probs=170.7
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||++...+ ..+|+|.+..... ..+++.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 34567889999999999998865 5799998764432 346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++.
T Consensus 84 ~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 84 GCLLNYLRQR-----------QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccc
Confidence 9999988532 23588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
..... ........++..|+|||.+....++.++||||||+++|||++ |+.||...+.
T Consensus 150 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 150 VLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred cCCCc-eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 53221 111122335668999999998889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=283.66 Aligned_cols=197 Identities=30% Similarity=0.412 Sum_probs=174.1
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
-++||+|+||.||-++. +++.+|.|++.+.. .++....++|..+|.+++.+.||.|-..++..+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 47999999999998765 56889999886543 34455678999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.-||... ....+++..++-.|.+|+.||++||.. .||.|||||+|||+|+.|+++|+|.|+|..
T Consensus 270 GDLkfHiyn~----------g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 270 GDLKFHIYNH----------GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CceeEEeecc----------CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999998643 346799999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++.. ...+..+||.+|||||++.++.|+...|.||+||+||||+.|+.||+...+
T Consensus 337 i~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 337 IPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred cCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 7532 233445899999999999999999999999999999999999999986543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.02 Aligned_cols=188 Identities=31% Similarity=0.508 Sum_probs=157.4
Q ss_pred ccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHh--cCCCceeEEEEEEecC----CeeEEEEeeC
Q 037623 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR--AHHKNLTILVGYCDEN----TKMGLVYEFM 602 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--l~H~nIv~l~g~~~~~----~~~~LV~Ey~ 602 (749)
+.+.||+|.||.||+|.+.|..||||++...+. +.+.+|.++... ++|+||+.+++.-..+ .+++||.+|.
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 457899999999999999999999999975543 456788888866 4999999999876443 4788999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG-----CKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~-----~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
++|||.++|. ...++....++++..+|.||++||.. .+|.|.|||||+.|||+.+++.+.|+
T Consensus 292 e~GSL~DyL~-------------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 292 EHGSLYDYLN-------------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred cCCcHHHHHh-------------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 9999999994 35789999999999999999999954 67899999999999999999999999
Q ss_pred ecCCCccccCCCCc--eeeeccccCCcccCccccccCC----C--CCchhHHHHHHHHHHHHc
Q 037623 678 DFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISNR----L--TEKSDVYSFGVVLLELIT 732 (749)
Q Consensus 678 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~----~--s~k~DVwSfGvvL~Ellt 732 (749)
|+|+|-......+. ......+||.+|||||++...- + -..+||||||.|+||+.-
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999876544211 1224557999999999985432 1 246899999999999874
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=274.79 Aligned_cols=201 Identities=29% Similarity=0.353 Sum_probs=164.4
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+|+..+ ..+|+|.+.... ......+.+|+.++++++|+|++++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 468999887543 334457889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++..... ......++..+++++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~-------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 81 DLKGYLRSCRK-------AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred cHHHHHHHhhh-------cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccc
Confidence 99999965421 1223567888899999999999999998 9999999999999999999999999999754
Q ss_pred cCCCCceeeeccccCCcccCccccccC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISN-------RLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.............++..|+|||++... .++.++|+||||++++||++ |+.||....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 322211112233467889999998642 35789999999999999996 999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-33 Score=269.95 Aligned_cols=202 Identities=28% Similarity=0.458 Sum_probs=173.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.+++.++||+|.|+.||++.. +++.+|+|++... +..+.+++.+|+.+.+.++|||||+|.....+....+||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 355568999999999998865 4678888877543 334678889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC---CcEEEEe
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---FQAKLAD 678 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~---~~~kL~D 678 (749)
|+|++|..-+-.. ..+++..+-..+.||+++|+|+|.+ +|||||+||+|+|+... --+||+|
T Consensus 92 m~G~dl~~eIV~R------------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 92 VTGGELFEDIVAR------------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ccchHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecc
Confidence 9999998877432 3567888889999999999999999 99999999999999643 3589999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
||+|..+. +.......+||++|||||++...+++..+|||+.||+|+-|+.|.+||.+.+.+.+
T Consensus 157 FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl 220 (355)
T KOG0033|consen 157 FGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 220 (355)
T ss_pred cceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH
Confidence 99999876 23444566899999999999999999999999999999999999999988665444
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.52 Aligned_cols=204 Identities=30% Similarity=0.484 Sum_probs=172.9
Q ss_pred HHhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
...+.+.+.||+|++|.||+|...+ +.||+|.++.... ..+++.+|+.++++++|+|++++.+++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3456778999999999999998754 6799999875542 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++... ....+++..+.+++.+++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 84 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 84 KYGSLLEYLQGG----------AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred cCCcHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 999999998532 234689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+...... .........+..|+|||++.+..++.++||||||++++||+| |+.||.+...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 151 RVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred EEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 8764221 111111223457999999999999999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=273.68 Aligned_cols=201 Identities=29% Similarity=0.504 Sum_probs=171.7
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|...+ ..||+|.+..... ..+.+.+|+.++++++|+|++++++.+...+..+++|||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 45567899999999999998755 7799998765433 357889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.++|+|||+++.
T Consensus 86 ~~L~~~l~~~----------~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 86 GSLLDFLKSD----------EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred CcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcccee
Confidence 9999999643 334678999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
..... ........++..|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 153 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 153 IEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred cCCCc-eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 54221 111122345678999999998899999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.19 Aligned_cols=190 Identities=30% Similarity=0.429 Sum_probs=160.3
Q ss_pred ccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 529 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 3478999999999999874 5889999986543 233567899999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.... ..++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 158 ~L~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 158 SLEGTH----------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred cccccc----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 985422 345677889999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCceeeeccccCCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.... .......|+..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 219 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 219 AQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 4221 11233468999999998743 2345689999999999999999999974
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.94 Aligned_cols=198 Identities=30% Similarity=0.409 Sum_probs=170.4
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
...+.||+|+||+||++... ++.+|+|.+..... ...+.+.+|++++.+++|+|++++.+++..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34578999999999999884 47899999865432 22345788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|..++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 83 NGGDLKFHIYNM----------GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred cCccHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 999999888542 234689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......|+..|+|||++.+..++.++|+|||||+++||++|+.||....
T Consensus 150 ~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 150 VKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred eecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 765322 11223468999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.98 Aligned_cols=198 Identities=31% Similarity=0.426 Sum_probs=169.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+...+.||+|+||.||++... ++.+|||.+..... ...+.+.+|+.++.+++|++++++.+.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345578999999999999874 47899999865422 2235578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 82 ~~g~~L~~~l~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 82 MNGGDLKFHIYHM----------GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999988542 234588999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 149 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred eeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 87643221 112346899999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.51 Aligned_cols=201 Identities=30% Similarity=0.455 Sum_probs=171.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|++|.||+|... ++.||+|.+.... ...+++.+|++++.+++|+|++++++++..++..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4556789999999999999875 4789999987543 345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 86 ~~~L~~~~~~~----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 86 YGNLLDYLREC----------NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCcHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 99999998542 234689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
...... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.+
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 153 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred ccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 754321 111112234568999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=290.01 Aligned_cols=191 Identities=22% Similarity=0.255 Sum_probs=163.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||.||++... ++.||+|... .+.+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 3566789999999999999874 4789999743 2356889999999999999999999999999999999985
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|..++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 167 -~~L~~~l~~------------~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 167 -TDLYCYLAA------------KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred -CCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 788888742 24578999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||-.
T Consensus 231 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 231 FPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 542211 1122345699999999999999999999999999999999999987643
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=277.32 Aligned_cols=214 Identities=25% Similarity=0.415 Sum_probs=173.8
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.+.+.+.||+|+||.||+|+.. +..||+|++...... ..+.+.+|+.++.+++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556689999999999999863 267999998755432 34668899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCC----CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 598 VYEFMANGNLQAHLLAQLAILP----TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
++||+++++|.+++........ .........+++..+++++.|+++||+|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999999964321100 01112234688999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++ |..||.+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999886543322222223346778999999998899999999999999999998 8889976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.08 Aligned_cols=200 Identities=25% Similarity=0.388 Sum_probs=166.5
Q ss_pred hcccccccccCceEEEEEEEC--Cc----ccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~----~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+.+.+.||+|+||+||+|++. +. .+++|.+.... .....++..|+..+++++|+||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 344588999999999999873 33 47788876443 2344678888999999999999999999864 5577899
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 88 e~~~~gsL~~~l~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 88 QLSPLGSLLDHVRQ-----------HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred EeCCCCcHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCC
Confidence 99999999999954 234689999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||.+..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99987643322222233456778999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.14 Aligned_cols=214 Identities=27% Similarity=0.395 Sum_probs=171.7
Q ss_pred HhhcccccccccCceEEEEEEECC----------------cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD----------------KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVG 587 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~----------------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g 587 (749)
..+.+.+.||+|+||.||+++..+ ..||+|.+... .......|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345667899999999999987532 24899998754 3334567999999999999999999999
Q ss_pred EEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEE
Q 037623 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 588 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
++...+..++||||+++++|.+++.................+++..+++++.|+++||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999995431100001111223578999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCC
Q 037623 668 LNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTP 741 (749)
Q Consensus 668 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt--G~~pf~~~~ 741 (749)
+++++.+||+|||+++...............++..|+|||.+..+.++.++|||||||+++||++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999986543322222222345678999999999999999999999999999998 667887644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=272.26 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=169.1
Q ss_pred cccccccccCceEEEEEEECC-----cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe------
Q 037623 528 NFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK------ 594 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~------ 594 (749)
.+.+.||+|+||.||+|+... ..||+|+++.. .....+++.+|++.+++++|+|++++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356889999999999998742 56999998754 23445678999999999999999999999866554
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++++||+++|+|..++..... ......+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRL------GGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhc------cCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeE
Confidence 7899999999999999865321 11234689999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
||+|||+++.+..............+..|+|||.+.+..++.++|||||||+++||++ |..||....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999987643322111122235678999999988899999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.16 Aligned_cols=202 Identities=29% Similarity=0.439 Sum_probs=171.7
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|++.. ..||||.+.... ....++|.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 35567899999999999998742 468999987543 334567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++... ...+++..+++++.|++.||+|||+. +|+|+||||+|||+++++.++|+||
T Consensus 85 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 85 EYMENGSLDKFLREN-----------DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred EcCCCCCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence 999999999998532 23689999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 99987752222222222345678999999999999999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.34 Aligned_cols=197 Identities=29% Similarity=0.439 Sum_probs=165.4
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
+.||+|+||.||+|+. +++.+|+|...... ......+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999987 45889999876542 34456799999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++.. ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 81 LTFLRT-----------EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred HHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence 999853 234578999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
............+..|+|||.+.++.++.++||||||+++|||++ |..||....
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 111100111123457999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=283.65 Aligned_cols=203 Identities=31% Similarity=0.471 Sum_probs=178.7
Q ss_pred HHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchh---hHHHHHHHHHHHHhcC-CCceeEEEEEEecCCee
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAH-HKNLTILVGYCDENTKM 595 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~ 595 (749)
-....|.+.+.||+|.||.||+++.. ++.+|+|.+.+.... ..+...+|+.+|+++. |||||.+.+.++.....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 33445777799999999999999874 588999999876443 3468899999999998 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC----
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---- 671 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~---- 671 (749)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+. +|+||||||+|+|+...
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred EEEEEecCCchHHHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCC
Confidence 9999999999999999531 389999999999999999999998 99999999999999643
Q ss_pred CcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 672 FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 672 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+.+|++|||++..... .......+||+.|+|||++....++.++||||+||++|.|++|.+||.+..+.
T Consensus 176 ~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred CcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 4799999999998754 33445678999999999999999999999999999999999999999886643
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=290.39 Aligned_cols=199 Identities=25% Similarity=0.333 Sum_probs=169.9
Q ss_pred HHHHhhcccccccccCceEEEEEEECC----cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLDD----KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
+....+.+.+.||+|+||.||++...+ ..||+|.+... +...+|++++++++|+||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 334467778999999999999997633 56899987643 345689999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|||++. ++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.++|+
T Consensus 164 v~e~~~-~~l~~~l~------------~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 164 VMPKYK-CDLFTYVD------------RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred EehhcC-CCHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence 999985 68888883 335689999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||+++.+.............||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999986643322222334569999999999999999999999999999999999999997643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=283.60 Aligned_cols=196 Identities=32% Similarity=0.493 Sum_probs=172.3
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
.+.||+|.||.||||.+. ++.||+|++... .....++.++|+.+|.+++++||.+.+|.+..+..+.++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 478999999999999985 488999999754 44556788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
+.+.|.. ...+++..+.-|+.++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+-.+.
T Consensus 98 v~~lL~~------------~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 98 VLDLLKS------------GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred hhhhhcc------------CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999942 33446667777899999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
... ......+||+.|||||++....|+.|+|+||||+..+||.+|.+|+.+...
T Consensus 163 ~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 163 NTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred chh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 432 222567899999999999988999999999999999999999999987543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=288.52 Aligned_cols=193 Identities=30% Similarity=0.415 Sum_probs=161.5
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhc---CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRA---HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l---~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
||+|+||+||+|+.. ++.||||++..... .....+..|..++.+. +|+||+++.+.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999874 58899999865322 2233455677777665 799999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~l~~------------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 81 GELFWHLQK------------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred ChHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 999988842 34588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.... ........||..|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 146 NLTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred CCCC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 4222 1122345689999999998765 478999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.45 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=174.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||+++.. ++.|++|.+... .....+++.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345689999999999999874 488999988643 3345677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++... ....+++..+.+++.+++.||.|||+. +++|+||||+||++++++.++|+|||++
T Consensus 82 ~~~~L~~~l~~~----------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 82 ENGDLHKLLKMQ----------RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 999999999642 235688999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+.+.... .......++..|+|||+..+..++.++|+||||++++||++|+.||...+.
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 149 KLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred eeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 8664322 112234578899999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=283.20 Aligned_cols=212 Identities=28% Similarity=0.439 Sum_probs=170.5
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEec-CCee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDE-NTKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~-~~~~ 595 (749)
.+.+.+.||+|+||.||+|... ++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4667799999999999999742 2579999987543 33446788899999999 89999999998864 4568
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCC-------------------------------------------------CccCCC
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPT-------------------------------------------------DAEDKT 626 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~-------------------------------------------------~~~~~~ 626 (749)
++++||+++++|.+++......... ......
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999998653211000 000012
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCc
Q 037623 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706 (749)
Q Consensus 627 ~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 706 (749)
..++|..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 3689999999999999999999998 9999999999999999999999999999876433221222234466789999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 037623 707 EYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKT 740 (749)
Q Consensus 707 E~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~ 740 (749)
|++.+..++.++|||||||+++||++ |+.||...
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.04 Aligned_cols=212 Identities=30% Similarity=0.455 Sum_probs=174.2
Q ss_pred hcccccccccCceEEEEEEEC-------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
..+.++||+|+||.||++... +..+|+|.+........+.+.+|++++.+++|+||+++++++......++++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345689999999999999742 3578999988776666778999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCC---CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 600 EFMANGNLQAHLLAQLAILP---TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~---~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
||+++++|.+++........ .........+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999965421110 01111234689999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++||....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 99999976543221111222335678999999999999999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=271.77 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=167.1
Q ss_pred ccccccccCceEEEEEEECC----cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------CeeE
Q 037623 529 FERVLGKGGFGTVYHGYLDD----KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKMG 596 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~~ 596 (749)
+.+.||+|+||.||+|+..+ ..+|+|.++.. +....+.+.+|++++.+++|+||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 46889999999999999754 25899987654 344467889999999999999999999988532 2468
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+++||+++|+|.+++..... ......+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRL------GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcc------cCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 99999999999998853211 12334689999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+|||+++.+.............++..|+|||......++.++||||||+++|||++ |+.||....
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987643321111122345678999999999999999999999999999999 899997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=274.56 Aligned_cols=212 Identities=27% Similarity=0.411 Sum_probs=172.1
Q ss_pred cccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.||+|+||.||+|+... ..+++|.+.... ....+++.+|+.++++++|+||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 456889999999999998632 468888887553 334567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCC------------CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEE
Q 037623 600 EFMANGNLQAHLLAQLAILPT------------DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~------------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
||+++|+|.+++......... ........+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 999999999998643211000 0112234689999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 668 LNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 668 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.+...
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999986543322111222345678999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=270.41 Aligned_cols=199 Identities=31% Similarity=0.490 Sum_probs=168.6
Q ss_pred hcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
..+.+.||+|+||.||++...+ ..+|+|++..... ...+|.+|++++++++|+|++++++++...+..++|+||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 4567899999999999998755 6799999865433 2357889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 85 ~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 85 CLLNYLRER-----------KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred CHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceec
Confidence 999998542 23689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 151 ~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 151 LDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred cccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 3221 111111224457999999999999999999999999999999 899997644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=273.08 Aligned_cols=212 Identities=27% Similarity=0.410 Sum_probs=174.7
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
..+.+.+.||+|+||.||+|...+ ..||+|.+.... ......+.+|+.++.+++|+|++++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 345567899999999999998743 569999987553 344567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++....... ........+++..+++++.|++.||.|||+. +++||||||+|||+++++.+||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEA--ENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEecCCCCCHHHHHHhcccch--hhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 9999999999999996532110 0011234588999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+|||+++.+.............++..|+|||.+..+.++.++|||||||++|||++ |+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99999986543322222223346788999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=296.78 Aligned_cols=206 Identities=25% Similarity=0.358 Sum_probs=172.0
Q ss_pred cccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEE-Eec------CCeeEE
Q 037623 528 NFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGY-CDE------NTKMGL 597 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~-~~~------~~~~~L 597 (749)
.+++.|.+|||+.||.+.+.+ .++|+|++-..+....+...+|+++|++|+ |+|||.+++. ... .-+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 456899999999999999843 799999998888888899999999999996 9999999993 211 246789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
.||||++|.|-+++... ....|++.++++|+.++++|+++||.. +|+|||||||-+||||..+++.|||
T Consensus 120 LmEyC~gg~Lvd~mn~R----------lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTR----------LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred ehhhccCCcHHHHHHHH----------HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 99999999999999653 234499999999999999999999985 7889999999999999999999999
Q ss_pred ecCCCccccCCC-Ccee------eeccccCCcccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 678 DFGLSRIFPVEG-GSHV------STTVVGTPGYLDPEYY---ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 678 DFGla~~~~~~~-~~~~------~~~~~gt~~y~APE~~---~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|||.|....... .... .....-|+-|.|||++ .+..+++|+|||||||+||-|+....||.....-.
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 999987543221 1110 0112378999999998 46789999999999999999999999998764433
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.81 Aligned_cols=198 Identities=28% Similarity=0.407 Sum_probs=166.5
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeEEE
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT-----KMGLV 598 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~-----~~~LV 598 (749)
+..+.||+|+||.||++.. +++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3458899999999999986 4588999998653 2334567889999999999999999999998766 78999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+. ++|.+.+. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 83 ~e~~~-~~l~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 83 TELMQ-SDLHKIIV------------SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred eeccc-cCHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 99996 57877773 334689999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+++...... ........++..|+|||.+.+. .++.++|||||||+++||++|+.||...+.
T Consensus 147 fg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 147 FGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred ccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 99998654322 1122334578899999998774 478999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=271.24 Aligned_cols=203 Identities=32% Similarity=0.511 Sum_probs=175.8
Q ss_pred HhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
..+.+.+.||+|+||.||+|...+ ..+++|.+.........++.+|+.++++++|+|++++++++...+..++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 345667899999999999999865 7899999887766566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++... ....+++..+++++.+++.||+|||+. +++|+||||+||++++++.+||+|||.+.
T Consensus 86 ~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 86 KGSLLAFLRSP----------EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred cCCHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchh
Confidence 99999999542 335689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
.+.... .......++..|+|||.+....++.++||||||++++||++ |+.||...+.
T Consensus 153 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 153 LIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred hcCCcc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 664321 11123345678999999998899999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=269.60 Aligned_cols=200 Identities=28% Similarity=0.462 Sum_probs=170.5
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||+||+|+..+ ..+|+|.+..... ..++|.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 34567899999999999998866 5699998875433 346789999999999999999999999998999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++... ...+++..+++++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.
T Consensus 84 ~~l~~~i~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 84 GCLLNYLREH-----------GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCcccee
Confidence 9999998532 23689999999999999999999998 999999999999999999999999999886
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
..... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus 150 ~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 150 VLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred cCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 53321 111122335678999999998889999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=277.96 Aligned_cols=198 Identities=26% Similarity=0.416 Sum_probs=166.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|...+.||+|+||.||+|+.. ++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 555689999999999999874 47799999875432 233467889999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 88 ~-~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 88 K-DLKQYMDD-----------CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred C-CHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccce
Confidence 5 88888743 234578899999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+.+ ..++.++|||||||+++||+||++||...+
T Consensus 153 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 153 AKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred ecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 643221 11123457889999999865 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=270.34 Aligned_cols=198 Identities=28% Similarity=0.427 Sum_probs=169.5
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|+. +++.||+|++........+.+.+|+.++.+++|+|++++++++..++..++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 456678999999999999997 347899999876554555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 90 ~~~L~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 90 GGSLQDIYHV------------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence 9999998843 23578999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.+.... .......++..|+|||.+. ...++.++|||||||+++||++|+.||...
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 155 KITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred eecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 653221 1112345788999999984 345788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=285.72 Aligned_cols=214 Identities=27% Similarity=0.408 Sum_probs=172.4
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSV-QGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~ 595 (749)
....+.+.||+|+||.||+|++.+ ..||+|++..... ...+.+.+|++++.++. |+||++++++|......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 334456899999999999998632 5799999976532 33457889999999997 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCC-------------------------------------------------------
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPT------------------------------------------------------- 620 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~------------------------------------------------------- 620 (749)
++|+||+++|+|.++++........
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999999999999764321000
Q ss_pred -------------------------------CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 621 -------------------------------DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 621 -------------------------------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
........+++..+++++.|++.||+|||+. +++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 0001223578899999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999986533221111122346788999999998899999999999999999998 899997543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=271.91 Aligned_cols=201 Identities=28% Similarity=0.461 Sum_probs=167.1
Q ss_pred hhcccccccccCceEEEEEEE--CCc----ccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDK----QVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
...+.+.||+|+||+||+|+. ++. .||+|++... .....+++.+|+.++.+++|+|++++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 344568999999999999986 333 4799998754 33445678899999999999999999999975 457799
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++|+|.+++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 87 ~~~~~~g~l~~~l~~-----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 87 TQLMPYGCLLDYVRE-----------NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred EEcCCCCCHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECC
Confidence 999999999999853 234689999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||+...
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999987643322111122235678999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=285.27 Aligned_cols=204 Identities=30% Similarity=0.466 Sum_probs=179.4
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe-eEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK-MGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~-~~LV~Ey 601 (749)
|...+++|+|+||.++..+. +++.+++|.+.-.. ....+..++|+.++++++|||||...+.+.+++. .++||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 45568999999999987765 45889999886543 3334567899999999999999999999998888 9999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++||+|.+.+..+ +...+++..+.++..|++.|+.|||++ .|+|||||+.||+++.+..+||+|||+
T Consensus 86 ~eGg~l~~~i~~~----------k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQ----------KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred cCCCCHHHHHHHH----------hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 9999999999765 356789999999999999999999988 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
|+.+..+. .....+.||+.||.||.+.+.+|..|+|+|||||++|||++=+++|+..+-..+
T Consensus 153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 99986543 244567899999999999999999999999999999999999999998765443
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=271.93 Aligned_cols=207 Identities=31% Similarity=0.459 Sum_probs=169.2
Q ss_pred hcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
+.+.+.||+|++|.||+|...+ ..||+|...... ......|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 4456899999999999998743 568888876443 33456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---cEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---QAK 675 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---~~k 675 (749)
|||+++++|.+++..... .......+++..+++++.|+++||+|||+. +++||||||+|||+++++ .+|
T Consensus 88 ~e~~~g~~L~~~i~~~~~-----~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 88 LELMAGGDLKSFLRENRP-----RPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EecCCCCCHHHHHHHhCC-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 999999999999965421 111234689999999999999999999998 999999999999998654 699
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999987632211111112223568999999999999999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=276.15 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=172.4
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+...+.||+|++|.||+|+. .++.|++|.+........+.+.+|+.++++++|+|++++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 345567899999999999986 458899999887665566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 101 ~~~L~~~~~~-------------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 101 GGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred CCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 9999998842 2478899999999999999999998 99999999999999999999999999988
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......+++.|+|||.+.+...+.++|||||||+++||++|+.||....
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 653321 11223458889999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=284.71 Aligned_cols=206 Identities=30% Similarity=0.448 Sum_probs=176.1
Q ss_pred HHHHHhhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
|+.+..-.+.++||.|.||.||.|+++. ..||||.+++..+ ..++|+.|+.+|..++|||+|+|+|+|..+...|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3333333456899999999999999976 7799999986654 468999999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+|||.+|+|.++|... ....++--..+.+|.||+.||+||..+ .+|||||.++|.|+.++..+||+|
T Consensus 342 TEfM~yGNLLdYLRec----------nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC----------NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred EecccCccHHHHHHHh----------chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeec
Confidence 9999999999999754 334456667889999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
||+++++..+. ........-.+.|.|||.+....++.|+|||+|||+||||.| |-.||-+.+
T Consensus 409 FGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 409 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred cchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 99999875432 222222234678999999999999999999999999999998 999997754
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=275.09 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=171.6
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||.||++... ...||||+++... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34566789999999999999751 2469999887553 33356789999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+++|+|.+++... ....+++.++++++.+++.||+|||+. +|+|+||||+|||+++++.++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK----------RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 9999999999999998542 223489999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 999999986643322112222345678999999999999999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=270.95 Aligned_cols=202 Identities=30% Similarity=0.467 Sum_probs=169.9
Q ss_pred HhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
..+.+.+.||+|+||.||+|+..+ ..||+|++..... ..+++.+|++++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 456778999999999999998855 6799999875433 3467899999999999999999999875 456789999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++... ....+++..+++++.|+++||+|||+. +++||||||+||++++++.+||+|||.++
T Consensus 84 ~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 84 KGSLLDFLKGE----------MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CCcHHHHHhhc----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence 99999999542 234678999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
.+..... .......++..|+|||+..+..++.++||||||++++||+| |+.||.....
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 6543221 11122346678999999999999999999999999999999 8889976543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=267.60 Aligned_cols=195 Identities=26% Similarity=0.451 Sum_probs=163.1
Q ss_pred cccccCceEEEEEEEC----CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 532 VLGKGGFGTVYHGYLD----DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~----~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
.||+|+||.||+|++. +..||+|++..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 24599999876533 33467899999999999999999999885 457889999999999
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
|.+++.. ....+++..+++++.|+++||+|||++ +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 L~~~l~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 81 LNKFLSG-----------KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred HHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 9999853 234689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCcee-eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 687 VEGGSHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 687 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
....... .....++..|+|||.+....++.++|||||||++||+++ |+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 3322111 111224578999999998889999999999999999996 999997644
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=281.85 Aligned_cols=202 Identities=30% Similarity=0.457 Sum_probs=173.7
Q ss_pred ccccccccCceEEEEEEECC------cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 529 FERVLGKGGFGTVYHGYLDD------KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..++||.|.||.||+|+..+ -.||||..+.. .....+.|.+|..+|++++||||++|+|+|.+ ...++|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 35789999999999998743 24899988763 55667889999999999999999999999975 578999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++-|.|+++|.. ....++.......+.||+.||+|||+. .+|||||.++|||+....-+||+|||+
T Consensus 472 ~~~GELr~yLq~-----------nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 472 APLGELREYLQQ-----------NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ccchhHHHHHHh-----------ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 999999999964 345688888999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~l 746 (749)
++.+..+...+. ....-...|||||.+.-..++.++|||.|||++|||++ |..||++-...+++
T Consensus 538 SR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI 602 (974)
T KOG4257|consen 538 SRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI 602 (974)
T ss_pred hhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence 998764433222 23345678999999999999999999999999999997 99999986554443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=273.04 Aligned_cols=213 Identities=26% Similarity=0.398 Sum_probs=172.0
Q ss_pred HHhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM 595 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~ 595 (749)
...+.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++|+|++++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345667789999999999999753 2469999876543 23345688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+++|+|.+++....... ........+++..+++++.|++.||+|||+. +|+||||||+|||+++++.++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhcccc--ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999996532110 0111234567888999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+|||+++...............++..|+|||.+.++.++.++|||||||+++||++ |+.||.+..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999986543222111122235678999999999999999999999999999998 788997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=274.31 Aligned_cols=213 Identities=31% Similarity=0.458 Sum_probs=174.5
Q ss_pred hhcccccccccCceEEEEEEECC------------------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD------------------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILV 586 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~------------------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~ 586 (749)
.+.+.+.||+|+||.||+++..+ ..||+|.+.... ....+++.+|++++.+++|+|+++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 45667899999999999987643 348999987653 34467889999999999999999999
Q ss_pred EEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 587 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
+++..++..++++||+++++|.+++.......... ......+++..++.++.|+++||+|||+. +++||||||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 99999999999999999999999996542211110 12234689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCc
Q 037623 667 LLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPE 742 (749)
Q Consensus 667 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt--G~~pf~~~~~ 742 (749)
++++++.++|+|||+++...............++..|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999986543322222234456788999999998899999999999999999998 7788876443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=294.34 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=175.6
Q ss_pred cccccccCceEEEEEEE--CC----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 530 ERVLGKGGFGTVYHGYL--DD----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.++||+|+||+||||.+ ++ -+||+|++... ..+..+++..|+-+|.+++|+|+++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47999999999999987 22 56999998765 4455688999999999999999999999998765 88999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+.|+|.++++.+ ...+.-+..+.+..|||+||.|||.+ .++||||.++|||+.+-.++||.|||++
T Consensus 780 P~G~LlDyvr~h-----------r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 780 PLGCLLDYVREH-----------RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred ccchHHHHHHHh-----------hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchh
Confidence 999999999754 34577788999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
+.+..++.+.......-.+.|||-|.+....++.++|||||||.+||++| |..|+++...++
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 99987765554444445678999999999999999999999999999998 999999866543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=270.42 Aligned_cols=198 Identities=27% Similarity=0.448 Sum_probs=169.9
Q ss_pred cccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 528 NFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
++.+.||+|+||.||+|...+ ..+++|.+........+.+.+|++++++++|+|++++++++......++|+||++++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 445789999999999999854 678999887766666778999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|..++.. ....+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 88 ~l~~~~~~-----------~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 88 AVDAVMLE-----------LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred cHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 99988753 234689999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
... ........++..|+|||++. +..++.++|||||||++|||++|++||...+
T Consensus 154 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 154 TRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 322 11223346889999999984 4457789999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=291.70 Aligned_cols=197 Identities=23% Similarity=0.391 Sum_probs=159.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--------~~~ 595 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++.... ....+|+.++++++|+||+++.+++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3556789999999999999874 4789999885432 2345799999999999999999876421 246
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QA 674 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~ 674 (749)
++||||+++ +|.+++.... .....+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~--------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYA--------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred EEEEecCCc-cHHHHHHHHh--------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence 689999975 7777764321 2345689999999999999999999998 999999999999999664 79
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|||+++.+.... ......|++.|+|||++.+. .++.++|||||||++|||++|++||.+..
T Consensus 211 kL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred eeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998664321 12234689999999998764 68999999999999999999999998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=275.52 Aligned_cols=203 Identities=26% Similarity=0.387 Sum_probs=161.5
Q ss_pred cccccccCceEEEEEEEC----CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEEeeCC
Q 037623 530 ERVLGKGGFGTVYHGYLD----DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGLVYEFMA 603 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~----~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~ 603 (749)
.+.||+|+||+||+|+.. ++.+|+|.+..... ...+.+|++++++++|+||+++++++.. ....++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999863 36799999875432 2457889999999999999999998854 456789999985
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE----cCCCcEEEEec
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADF 679 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl----~~~~~~kL~DF 679 (749)
++|.+++...... ........+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 84 -~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 84 -HDLWHIIKFHRAS---KANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred -CCHHHHHHhcccc---cccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 5888887533211 0112234588999999999999999999998 99999999999999 45678999999
Q ss_pred CCCccccCCCCc-eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+++........ .......+|+.|+|||++.+. .++.++||||+||+++||++|++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 999876432111 112345689999999999774 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=267.52 Aligned_cols=195 Identities=28% Similarity=0.440 Sum_probs=163.7
Q ss_pred ccccccCceEEEEEEE----CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYL----DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~----~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
++||+|+||.||+|.+ ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999975 24779999986543 334577899999999999999999999985 4567899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ...+++..+++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 80 ~~L~~~l~~------------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~ 144 (257)
T cd05116 80 GPLNKFLQK------------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 144 (257)
T ss_pred CcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccc
Confidence 999999843 23588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCcee-eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+........ .....++..|+|||.+....++.++|+|||||++|||++ |+.||....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 145 LGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred cCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 643322111 112234578999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=275.84 Aligned_cols=216 Identities=30% Similarity=0.417 Sum_probs=173.2
Q ss_pred HHhhcccccccccCceEEEEEEECC---------cccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDD---------KQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN 592 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~ 592 (749)
...+.+.+.||+|+||.||+++..+ ..+|+|.+.... .....++.+|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3456778999999999999997522 359999987542 33456788999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCC----CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILP----TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
+..++||||+++|+|.+++........ .........+++.++++++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999965421100 00001224589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999986532211111112234568999999999999999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=289.04 Aligned_cols=191 Identities=25% Similarity=0.288 Sum_probs=163.3
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||+|+||.||++.... +.||||... ...+.+|++++++++|+||+++++++..++..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 4556899999999999999854 779999633 2345789999999999999999999999999999999994
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|..++.. ....++|..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 244 ~~L~~~l~~-----------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 244 SDLYTYLGA-----------RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred CCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 788888743 234689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
+.............||..|+|||++.+..++.++|||||||+||||++|..|+-
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 643222222234569999999999999999999999999999999999886543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=267.81 Aligned_cols=190 Identities=28% Similarity=0.428 Sum_probs=161.2
Q ss_pred ccccccCceEEEEEEECC--------------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 531 RVLGKGGFGTVYHGYLDD--------------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--------------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
+.||+|+||.||+|+... ..|++|.+........+.|.+|+.++.+++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 248889887665555668899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc---
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--- 673 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~--- 673 (749)
+||||+++|+|..++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR-----------KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred EEEecccCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCC
Confidence 99999999999988853 234589999999999999999999998 9999999999999986653
Q ss_pred ----EEEEecCCCccccCCCCceeeeccccCCcccCccccc-cCCCCCchhHHHHHHHHHHHH-cCCCCCCCC
Q 037623 674 ----AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELI-TGQPVIQKT 740 (749)
Q Consensus 674 ----~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~k~DVwSfGvvL~Ell-tG~~pf~~~ 740 (749)
++++|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|+.|+...
T Consensus 147 ~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 147 CGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 899999998754321 2235778899999987 466899999999999999998 688998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=268.87 Aligned_cols=200 Identities=30% Similarity=0.484 Sum_probs=168.5
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|...+ ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 45667899999999999998755 6799999876433 3467899999999999999999999885 4568899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..+++++.+++.||+|||+. +++||||||+||++++++.++|+|||++..
T Consensus 85 ~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 85 GSLLDFLKDG----------EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred CcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 9999998542 234589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+..... .......++..|+|||.+.+..++.++|+||||++++||++ |+.||...+
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 152 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred ccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 543221 11112235568999999998899999999999999999999 899997644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=266.62 Aligned_cols=199 Identities=30% Similarity=0.493 Sum_probs=169.1
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS-----VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+...+.||+|++|.||++.. +++.+|+|.+.... ....+.+.+|++++.+++|+||+++++++.+.+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 34568999999999999986 35889999876432 123457889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++.. ...+++..+.+++.|++.||+|||+. +++||||+|+||++++++.++|+||
T Consensus 84 e~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 84 EYMPGGSVKDQLKA------------YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EECCCCcHHHHHHH------------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 99999999999853 23578889999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCcee-eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 680 Gla~~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 99976543211111 12345778999999999999999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=268.42 Aligned_cols=205 Identities=30% Similarity=0.468 Sum_probs=173.1
Q ss_pred HHHHhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
+....+++.+.||+|+||.||+|...+ +.||+|.+..... ..+++.+|+.++++++|+|++++.+++. .+..++++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 445667788999999999999998754 8899999875543 3467899999999999999999999874 567899999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||
T Consensus 81 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 81 YMENGSLVDFLKTP----------EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred cCCCCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCc
Confidence 99999999998542 344689999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
++....... ........++..|+|||++....++.++||||||++++||++ |+.||...+.
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 148 LARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred ceeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 998654221 111223345678999999998899999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=265.73 Aligned_cols=197 Identities=30% Similarity=0.504 Sum_probs=173.3
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.+.+.+.||+|+||.||+|...++.||+|.+..... ..+++.+|+.++.+++|+|++++++++......++||||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 445678999999999999999999999999986654 5678999999999999999999999999899999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++..
T Consensus 86 ~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 86 SLVDYLRSR----------GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred cHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccc
Confidence 999998542 223689999999999999999999998 9999999999999999999999999999875
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.... .....+..|+|||++..+.++.++||||||++++||++ |+.||....
T Consensus 153 ~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 153 SQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred cccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 3211 12234568999999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=272.71 Aligned_cols=199 Identities=25% Similarity=0.402 Sum_probs=173.5
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..+.+.+.||+|++|.||+++. .++.||+|.+........+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3455678999999999999986 45889999998766555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.. ..+++.++.+++.++++||.|||+. +++||||||+|||+++++.++|+|||++
T Consensus 99 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 99 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred CCCCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 99999998842 3478889999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
....... .......+++.|+|||.+.+..++.++|+|||||+++||++|+.||...+
T Consensus 163 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 163 AQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred eEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7654321 11223457889999999999989999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=289.01 Aligned_cols=195 Identities=33% Similarity=0.482 Sum_probs=168.3
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------CeeEEEEe
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKMGLVYE 600 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~~LV~E 600 (749)
.+.||+|+||.||+|+. .|+.||||.++.. .....+...+|+++|++++|+|||++.+.-++. +...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 47899999999999985 5689999999875 334456678999999999999999999886543 35679999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC--CC--cEEE
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--KF--QAKL 676 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--~~--~~kL 676 (749)
||.+|||+..|... +....|++.+.+.+..+++.||.|||++ +|+||||||.||++-. ++ .-||
T Consensus 98 yC~gGsL~~~L~~P---------EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP---------ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred ecCCCcHHHHhcCc---------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEee
Confidence 99999999999532 3566799999999999999999999998 9999999999999953 23 4799
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+|||.|+.+... ....+..||..|.|||.... +.++..+|.|||||++||.+||..||..
T Consensus 166 tDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 166 TDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999999987532 35567889999999999985 8899999999999999999999999975
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=274.01 Aligned_cols=202 Identities=27% Similarity=0.400 Sum_probs=161.1
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe--cCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD--ENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~--~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|+..+ ..||+|.+..... ...+.+|++++++++|+||+++.+++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998643 6799998875432 246788999999999999999999885 35678899999864
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE----cCCCcEEEEecC
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFG 680 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl----~~~~~~kL~DFG 680 (749)
+|.+++...... ........+++..+.+++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||
T Consensus 85 -~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 85 -DLWHIIKFHRAS---KANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred -cHHHHHHhhhcc---ccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 788877533211 0112334688999999999999999999998 99999999999999 466789999999
Q ss_pred CCccccCCCCc-eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++........ .......+|+.|+|||++.+. .++.++|||||||++|||+||++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99876432211 112334688999999998764 57999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=280.69 Aligned_cols=196 Identities=29% Similarity=0.359 Sum_probs=164.5
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Ce
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~ 594 (749)
..|...+.||+|+||.||+++.. +..||||++... .....+.+.+|+.++.+++|+||+++++++... ..
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 34666789999999999999874 588999998653 233456788999999999999999999998643 35
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++||||+++ +|...+. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+
T Consensus 101 ~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred eEEEEeCCCc-CHHHHHh--------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence 7899999965 5666552 1367888899999999999999999 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|||+++..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||.+.+
T Consensus 163 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 163 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred EEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999754321 12233468899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=268.22 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=169.8
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|.... ..||||.+... .....++|..|+.++++++|+|++++.+++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 45678999999999999998743 35999998765 3444578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++.. ....+++.++++++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 85 e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 85 EFMENGALDSFLRQ-----------NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ecCCCCcHHHHHhh-----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 99999999999853 234589999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeee-ccc--cCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVST-TVV--GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~-~~~--gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|++..+.......... ... .+..|+|||.+....++.++|||||||+++||++ |+.||...+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 9988654322111111 111 2457999999999999999999999999999886 999997644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=268.98 Aligned_cols=189 Identities=32% Similarity=0.489 Sum_probs=165.0
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.||+|+||.||+|+. +++.||+|++... .....+++.+|++++.+++|+|++++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4568899999999999987 4478999998654 334456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||++..
T Consensus 84 ~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 84 GSLDVYR----------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CChHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9986442 357888899999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.... ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 145 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 145 LVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred cccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 5322 12234688999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=268.54 Aligned_cols=198 Identities=28% Similarity=0.435 Sum_probs=170.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|+.. ++.||+|.++.........+.+|+.+++.++|+|++++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4455688999999999999874 48899999876655556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. .+.+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~L~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 90 GGSLQDIYHV------------TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 9999998843 34588999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
..... ........|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 155 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred EccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 65322 11123346889999999974 456889999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=273.86 Aligned_cols=218 Identities=28% Similarity=0.395 Sum_probs=175.3
Q ss_pred HHHHhhcccccccccCceEEEEEEEC---------CcccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEe
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCD 590 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~ 590 (749)
+....+.+.+.||+|+||.||+++.. +..||+|..... .....+++.+|+.++.++ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34455667799999999999999741 136899988754 234457789999999999 8999999999999
Q ss_pred cCCeeEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 591 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
.....++||||+++|+|.+++......... ........+++.++++++.|+++||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999999754221000 0011234689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 667 LLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 667 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||...+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999987643322222223345678999999998899999999999999999998 8888876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=273.17 Aligned_cols=209 Identities=31% Similarity=0.478 Sum_probs=169.0
Q ss_pred hcccccccccCceEEEEEEECC----cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD----KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
+.+.+.||+|+||.||+|+..+ ..+++|.++.. .....+.+.+|++++.++ +||||+++++++......++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567899999999999998743 24688888743 334456789999999999 79999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 601 FMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
|+++++|.+++......... ........+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 99999999999653211100 0111234689999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+|||++...... ........+..|+|||++.+..++.++|||||||+++||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 161 ADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred CCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999998743211 11111223567999999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=268.76 Aligned_cols=203 Identities=29% Similarity=0.458 Sum_probs=169.9
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+...+.||+|+||.||+|+... ..+|+|.+.... ....+++.+|++++.+++|+|++++.+++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 34557899999999999998742 368999887552 334567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++.. ....+++..+.+++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 86 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 151 (268)
T cd05063 86 EYMENGALDKYLRD-----------HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF 151 (268)
T ss_pred EcCCCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence 99999999999853 234689999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceee-eccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVS-TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|++............ .....+..|+|||++....++.++|||||||++|||++ |+.||.....
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 999866432211111 11223457999999998899999999999999999997 9999975443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=265.66 Aligned_cols=205 Identities=34% Similarity=0.511 Sum_probs=173.3
Q ss_pred ccccccCceEEEEEEEC-----CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD-----DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|... +..+++|.+...... ..+.+.+|++++.+++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999999885 578999998866443 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++....... .......+++..+.+++.|+++||+|||+. +++|+||||+||++++++.+||+|||.+..
T Consensus 81 ~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 81 GDLLDYLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred CcHHHHHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 99999995421000 001136789999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
..............++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 754332222334457889999999988899999999999999999999 699997653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=273.75 Aligned_cols=196 Identities=27% Similarity=0.364 Sum_probs=168.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||+|+||.||+++.. +..+|+|.+... .....+++.+|++++.+++|+||+++++++..++..++|+||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 455689999999999999874 467888887654 23344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ...+++..+..++.|+++||.|||+.+ +++|+||||+|||+++++.+||+|||++.
T Consensus 83 ~~~L~~~l~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 83 GGSLDQVLKK------------AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 9999999953 245789999999999999999999732 89999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
..... ......++..|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus 149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 149 QLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 65321 123346888999999998888999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=270.62 Aligned_cols=199 Identities=28% Similarity=0.424 Sum_probs=170.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|+.. +..+++|.+........+.+.+|+.++++++|+|++++++.+..+...++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 3455688999999999999874 47899999987776667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|..++.. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~l~~~~~~-----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 93 GGAVDAIMLE-----------LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CCcHHHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999888743 234589999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
..... ........++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 159 KNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 54322 11122345788999999984 345688999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=266.66 Aligned_cols=196 Identities=30% Similarity=0.476 Sum_probs=168.3
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe-cCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD-ENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~-~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||++...+..+|+|...... ..+.+.+|+.++++++|+|++++++++. .++..++|+||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 45667899999999999999999999999986543 2467899999999999999999999764 45678999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..+++++.+++.||+|||++ +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 85 GSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred CcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence 9999998542 234588999999999999999999998 999999999999999999999999999885
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
..... .....+..|+|||++....++.++|||||||++|||++ |+.||....
T Consensus 152 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 152 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 43221 12234568999999998899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=269.65 Aligned_cols=211 Identities=27% Similarity=0.381 Sum_probs=173.8
Q ss_pred HHhhcccccccccCceEEEEEEECC------cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDD------KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKM 595 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~ 595 (749)
...+.+.+.||+|+||.||+|...+ ..|++|.+... .....+.+.+|+.++++++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3456677999999999999998743 67899988754 33445678899999999999999999998866 5678
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++++||+++|+|.+++..... ........+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRL----GEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccc----cccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 899999999999999864311 0011235689999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||...+
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 999999987644322222223346778999999998889999999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=258.66 Aligned_cols=194 Identities=28% Similarity=0.448 Sum_probs=167.4
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCch--------hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV--------QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
+.-++.||+|..++|-++.. ++++.|+|++..... .-.+.-.+|+++|+++ .||+|+.+.++++.....
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 33457899999999998876 458899998864311 1123457899999998 799999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++|+|.|+.|.|.++|- ..-.++++...+|+.|+.+|++|||.. .||||||||+|||++++.++|
T Consensus 99 FlVFdl~prGELFDyLt------------s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLT------------SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred hhhhhhcccchHHHHhh------------hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence 99999999999999994 345789999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccC------CCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN------RLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
|+|||+++.+.+. ...+..+||++|+|||.+... -|+...|+||.||+||-|+.|.+||-
T Consensus 164 isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 164 ISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred EeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9999999987643 334567899999999998643 47889999999999999999999984
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=286.39 Aligned_cols=193 Identities=30% Similarity=0.544 Sum_probs=163.2
Q ss_pred ccccccccCceEEEEEEECC--cccEE---EEecC-CchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe--eEEEEe
Q 037623 529 FERVLGKGGFGTVYHGYLDD--KQVAV---KMLSP-SSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK--MGLVYE 600 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~~--~~VAV---K~l~~-~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~--~~LV~E 600 (749)
|..+||+|+|-+||||.++. .+||= |.-.. .+....++|..|+++|+.|+|+||++++.+..+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 45789999999999999854 34432 22111 234455889999999999999999999999876544 779999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEec
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADF 679 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~DF 679 (749)
.|..|+|+.++.+ .+.++.+.+.++++||++||.|||++ .|+|||||||.+||+|+.+ |.+||+|+
T Consensus 124 L~TSGtLr~Y~kk------------~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 124 LFTSGTLREYRKK------------HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred cccCCcHHHHHHH------------hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence 9999999999964 45678889999999999999999996 7899999999999999854 79999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|+|..+... ....+.|||.|||||... ..|++.+||||||++|+||+|+.-||..
T Consensus 191 GLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 191 GLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred hHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 999987432 223478999999999987 8899999999999999999999999974
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=275.28 Aligned_cols=210 Identities=30% Similarity=0.466 Sum_probs=169.6
Q ss_pred hhcccccccccCceEEEEEEECC----cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD----KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|.... ..+++|.+... .....+++.+|++++.++ +|+||+++++++..++..++|+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 45667899999999999998643 34677777643 334456789999999999 8999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 600 EFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
||+++++|.+++......... ........+++..++.++.|+++||+|||+. +++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 999999999999754221100 0012234689999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+|||+++..... ........+..|+|||.+.+..++.++|||||||+++||+| |..||...+
T Consensus 165 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 165 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred eCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999998643211 11112234668999999988889999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=271.95 Aligned_cols=213 Identities=27% Similarity=0.423 Sum_probs=172.5
Q ss_pred hhcccccccccCceEEEEEEEC------------------CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD------------------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILV 586 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~------------------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~ 586 (749)
.+.+.+.||+|+||.||++... ...+|+|++... .....+++.+|++++.+++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3566789999999999998532 135899998754 334456899999999999999999999
Q ss_pred EEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 587 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
+++...+..++||||+++|+|.+++...... ..........+++.++.+++.|++.||+|||+. +++||||||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQ-EAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcc-cccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999654211 111112334688999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCc
Q 037623 667 LLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQPVIQKTPE 742 (749)
Q Consensus 667 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt--G~~pf~~~~~ 742 (749)
|+++++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999986543322111222234678999999988899999999999999999998 7789876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=266.86 Aligned_cols=202 Identities=29% Similarity=0.467 Sum_probs=169.0
Q ss_pred HhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
..+.+.+.||+|++|.||++...+ ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 346677899999999999998865 5799998765432 3467889999999999999999999875 456889999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++
T Consensus 84 ~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 84 KGSLLDFLKEG----------DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CCCHHHHHhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 99999999542 234578999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
....... .......++..|+|||...+..++.++||||||+++|||+| |+.||.+...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred EccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6533211 11122345678999999998999999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=271.67 Aligned_cols=197 Identities=25% Similarity=0.406 Sum_probs=172.3
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||.|++|.||+|+. +++.|++|.+........+.+.+|++++++++|+|++++++++...+..++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 44567899999999999986 4588999998766555567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ..+++.+++.++.+++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 101 ~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 101 GSLTDVVTE-------------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred CcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999998832 2478999999999999999999999 999999999999999999999999999886
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 165 ITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred ccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54322 11223458889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=266.22 Aligned_cols=197 Identities=35% Similarity=0.562 Sum_probs=171.9
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCchhhHH--HHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYK--QFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~--~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||+||+++..+ +.+|+|++......... ...+|+.++.+++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3567899999999999999865 57999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.. ...+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+
T Consensus 81 ~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 81 PGGSLQDYLQK------------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp TTEBHHHHHHH------------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccc------------cccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999999952 34679999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.... ..........++..|+|||.+. ....+.++||||+|++++||++|+.||...
T Consensus 146 ~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 146 VKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp EEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 7641 1223334556889999999998 888999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=265.95 Aligned_cols=197 Identities=28% Similarity=0.418 Sum_probs=169.5
Q ss_pred ccccccCceEEEEEEECC-----cccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|++|.||+|.+.. ..||+|.+..... ...+++.+|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998732 3589999987765 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 80 ~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~ 146 (257)
T cd05040 80 GSLLDRLRKD----------ALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRA 146 (257)
T ss_pred CcHHHHHHhc----------ccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccc
Confidence 9999998642 114689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+....... ......++..|+|||++.+..++.++|||||||+++||++ |+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 65432211 1123457789999999999999999999999999999999 999996543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=265.70 Aligned_cols=201 Identities=26% Similarity=0.424 Sum_probs=171.1
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+. +++.||||.+... .....+.+.+|++++++++|+|++++++++...+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 45678999999999999987 4588999987643 233446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.... .....+++..+.+++.|+++||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 84 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 84 ADAGDLSQMIKYFK--------KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred cCCCcHHHHHHHhh--------hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcccc
Confidence 99999999885421 1334678999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+....... .......++..|+|||.+.+...+.++|+||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 153 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 88654321 1112345788999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=269.16 Aligned_cols=190 Identities=29% Similarity=0.410 Sum_probs=159.4
Q ss_pred cccccCceEEEEEEECC--------------------------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEE
Q 037623 532 VLGKGGFGTVYHGYLDD--------------------------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~~--------------------------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l 585 (749)
.||+|+||.||+|++.. ..|++|++.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997411 3488998876655555678899999999999999999
Q ss_pred EEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCc
Q 037623 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSAN 665 (749)
Q Consensus 586 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~N 665 (749)
+++|.+....++||||+++|+|..++.. ....+++..+++++.|+++||+|||+. +|+||||||+|
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~N 147 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-----------EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKN 147 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCccc
Confidence 9999999999999999999999988853 234678999999999999999999998 99999999999
Q ss_pred EEEcCCC-------cEEEEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHH-cCCCC
Q 037623 666 ILLNEKF-------QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELI-TGQPV 736 (749)
Q Consensus 666 ILl~~~~-------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~Ell-tG~~p 736 (749)
||+++.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred EEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9997643 3899999988643211 12346788999998865 56899999999999999994 79999
Q ss_pred CCCCC
Q 037623 737 IQKTP 741 (749)
Q Consensus 737 f~~~~ 741 (749)
|....
T Consensus 222 ~~~~~ 226 (274)
T cd05076 222 LKERT 226 (274)
T ss_pred ccccC
Confidence 97643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=261.54 Aligned_cols=196 Identities=30% Similarity=0.434 Sum_probs=165.8
Q ss_pred ccccccCceEEEEEEECC-cccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
++||+|+||.||+|...+ +.+|+|.+..... .....+.+|++++.+++|+|++++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999998754 7799999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 688 (749)
+++.. ....+++..++.++.+++.||.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 81 SFLRK-----------KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred HHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 98853 223578999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
. ........++..|+|||++.+..++.++||||||++++||++ |..||....
T Consensus 147 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 147 I-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred c-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 1 111112234568999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=267.55 Aligned_cols=201 Identities=27% Similarity=0.438 Sum_probs=169.2
Q ss_pred hhcccccccccCceEEEEEEECC------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.+.+.+.||+|+||.||+|.... ..+|+|.+.... .....++.+|+.++.+++|+|+++++++|.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 45567899999999999998632 258999887654 3445678999999999999999999999987 788999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++|+|.+++... ...+++..+++++.|+++||+|||+. +++||||||+|||+++++.+||+|
T Consensus 87 ~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 87 TQLMPLGCLLDYVRNH-----------KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred EecCCCCcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 9999999999998532 33589999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
||+++.+.............++..|+|||.+....++.++|+||||++++|+++ |+.||....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred CcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 999987653322221112224568999999988899999999999999999998 999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=267.06 Aligned_cols=199 Identities=31% Similarity=0.478 Sum_probs=167.0
Q ss_pred hcccccccccCceEEEEEEE------CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~LV 598 (749)
+.+.+.||+|+||.||++.. .+..||+|.+........+.+.+|++++.+++|+|++++.+++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 44568999999999999975 246799999987766667889999999999999999999998754 3468899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 86 ~e~~~~~~L~~~l~~-----------~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~d 151 (284)
T cd05081 86 MEYLPYGSLRDYLQK-----------HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD 151 (284)
T ss_pred EEecCCCCHHHHHHh-----------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECC
Confidence 999999999999853 223589999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCcee-eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 679 FGla~~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
||+++.+........ .....++..|+|||++.+..++.++|||||||+++||++|..++..
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 999987643322111 1112234569999999988999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=266.35 Aligned_cols=202 Identities=29% Similarity=0.462 Sum_probs=169.5
Q ss_pred hhcccccccccCceEEEEEEEC--C---cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--D---KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+.. + ..+|+|.+.... ....+.+.+|+.++.+++||||+++.+++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4556789999999999999863 2 368999887543 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++.. ....+++.++++++.|++.||+|||+. +++||||||+|||+++++.++|+||
T Consensus 85 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 85 EYMENGSLDAFLRK-----------HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred EcCCCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 99999999999953 224589999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceee-eccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVS-TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|++..+......... ....++..|+|||.+.+..++.++|+||||++++|+++ |+.||....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 999876433211111 11223568999999999899999999999999999886 999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=260.91 Aligned_cols=205 Identities=26% Similarity=0.453 Sum_probs=174.7
Q ss_pred CHHHHHHHhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 037623 518 SYANVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTK 594 (749)
Q Consensus 518 ~~~~l~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~ 594 (749)
+++|+-+.|. +.||+|+++.|--++. ++.++|||++.+.......+..+|++++.+. .|+||+.|+.++++++.
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3677777765 8899999999987753 7799999999988767778899999999998 69999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC--
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-- 672 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-- 672 (749)
.|||||-|.||+|..++++ .+.+++.++.++.++||.||.+||.+ ||.||||||+|||-.+-.
T Consensus 151 FYLVfEKm~GGplLshI~~------------~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK------------RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred EEEEEecccCchHHHHHHH------------hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 9999999999999999964 45689999999999999999999999 999999999999997544
Q ss_pred -cEEEEecCCCccccCCCC-----ceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 673 -QAKLADFGLSRIFPVEGG-----SHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 673 -~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
-+|||||.+..-+..... ........|+..|||||+.. ...|+.++|.||||||||-|++|.+||.+.
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 489999998865432211 11223456888999999873 345899999999999999999999999863
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=272.43 Aligned_cols=214 Identities=30% Similarity=0.424 Sum_probs=171.9
Q ss_pred HhhcccccccccCceEEEEEEEC---------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENT 593 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~ 593 (749)
..+.+.+.||+|+||.||+++.. ...+|+|.+.... .....++.+|++++.++ +|+||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34556789999999999999752 2468999887542 34456788999999999 6999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
..++|+||+++|+|.+++......... ........+++.++++++.|++.||+|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999999999999654211100 0111234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999986543221111112234567999999999999999999999999999999 899987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=266.13 Aligned_cols=200 Identities=23% Similarity=0.293 Sum_probs=159.9
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+|...+ ..+++|.+.... ....+.|.+|+.++++++|+|++++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997532 345667665443 344578999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++..... .....++..+..++.|+++||+|||+. +++||||||+|||+++++.+||+|||++...
T Consensus 81 ~L~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~ 149 (268)
T cd05086 81 DLKSYLSQEQW--------HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR 149 (268)
T ss_pred cHHHHHHhhhc--------ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence 99999965321 233567778889999999999999998 9999999999999999999999999998643
Q ss_pred cCCCCceeeeccccCCcccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.............++..|+|||++.. ...+.++|||||||++|||++ |+.||....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred CcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22111111223457889999999753 245789999999999999997 577886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=284.41 Aligned_cols=199 Identities=28% Similarity=0.398 Sum_probs=174.1
Q ss_pred cccccccCceEEEEEEECC-----cccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 530 ERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.++||+|.||.|++|.++. ..||||.+...... ....|++|+.+|.+++|+|+++|+|+.-+ ....||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 3789999999999999853 46999999876543 67899999999999999999999999987 78889999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
.|+|.+.|++. ....|-....-.++.|||.||.||.++ ++|||||.++|+|+-....+||+|||+.+
T Consensus 194 lGSLldrLrka----------~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 194 LGSLLDRLRKA----------KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred cchHHHHHhhc----------cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence 99999999752 345667777889999999999999999 99999999999999999899999999999
Q ss_pred cccCCCCceeeecc-ccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTV-VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
.+...++...+... .-...|+|||.+...+++.++|||+|||.+|||+| |+.||.+...
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 98776655544332 34568999999999999999999999999999998 8999987543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=270.96 Aligned_cols=198 Identities=31% Similarity=0.421 Sum_probs=162.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeEEEEEEec-----CCe
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRA---HHKNLTILVGYCDE-----NTK 594 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l---~H~nIv~l~g~~~~-----~~~ 594 (749)
|.+.+.||+|+||+||+|+.. ++.||+|.+..... .....+.+|++++.++ +|+||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456789999999999999874 47899998875422 1223456677777665 79999999998854 345
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++|+||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV----------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 789999997 4898888532 234589999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|||+++..... .......++..|+|||++.+..++.++|||||||+++||++|++||....
T Consensus 148 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 148 KLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred EECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 99999999865322 11223457889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=268.87 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=171.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||+|++|.||+++.. +..+|+|..........+.|.+|++++++++|+|++++++.+......++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 455688999999999999874 478999998877666677899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ....+++..+.+++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 87 ~~L~~~~~~-----------~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 87 GALDSIMLE-----------LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred CcHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999853 234689999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
..... .......++..|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 153 NKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred hcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 53221 1122345888999999975 3446789999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=266.24 Aligned_cols=204 Identities=31% Similarity=0.508 Sum_probs=172.7
Q ss_pred HHhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
...+.+.+.||+|+||.||++...+ +.+|||.+..... ..+++.+|+.++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3455677899999999999998755 7799999875433 3467899999999999999999999999889999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++... ....+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+|||++
T Consensus 84 ~~~~L~~~i~~~----------~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 84 SKGSLLDFLKSG----------EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred CCCCHHHHHhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 999999999542 234689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+.+.... .........+..|+|||.+.+..++.++||||||++++||++ |+.||.+...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 151 RLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred eeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 8654221 111112234568999999999899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=270.41 Aligned_cols=213 Identities=31% Similarity=0.446 Sum_probs=173.2
Q ss_pred hhcccccccccCceEEEEEEECC-------cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.+.||+|+||.||++...+ ..+|+|.+... ......++.+|++++.++ +|+||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 34556899999999999998632 56899988754 333456788999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
++|||+++|+|..++......... ........+++..+++++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCC
Confidence 999999999999999653211000 0112345789999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999987643322111222335678999999999999999999999999999997 999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=263.72 Aligned_cols=196 Identities=30% Similarity=0.453 Sum_probs=164.7
Q ss_pred ccccccCceEEEEEEECC-----cccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
++||+|+||.||+|+... ..+|+|.+..... ...+++.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998632 5699999876544 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ...+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++.
T Consensus 80 ~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 80 GPLLKYLKK------------RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred CcHHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccce
Confidence 999999953 23678999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCcee-eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+........ .....++..|+|||.+....++.++||||||+++|||++ |+.||...+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 643322111 111224568999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=263.37 Aligned_cols=200 Identities=29% Similarity=0.449 Sum_probs=172.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||+|+||.||+++.. ++.+|+|.+... .....+.+.+|+.++++++|+|++++.+.+..++..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999874 588999988643 33445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++... ....+++..+++++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++
T Consensus 82 ~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 82 GGDLMQKIKLQ----------RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred CCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999988532 334578899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||++.+...+.++|+||||++++||++|+.||...+
T Consensus 149 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 149 LLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred eecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 654321 12233468889999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=269.75 Aligned_cols=213 Identities=32% Similarity=0.461 Sum_probs=172.4
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.+.+.+.||+|+||.||++... +..||+|++.... ....+++.+|+.++.+++|+|++++++++..++..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 3455689999999999999863 3679999987553 3445679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCC----------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTD----------AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~----------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
|+||+++|+|.+++.......... .......+++..+++++.|++.||+|||+. +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999996532111100 011224588999999999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 668 LNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 668 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+++++.++|+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999876543221111222335668999999998999999999999999999997 888986543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=267.21 Aligned_cols=196 Identities=31% Similarity=0.439 Sum_probs=164.3
Q ss_pred cccccccccCceEEEEEEE------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEE
Q 037623 528 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLV 598 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV 598 (749)
.+.+.||+|+||+||++.. .++.||+|.+.... ....+.|.+|++++++++|+||+++.+++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5568999999999988653 34679999987653 23456788999999999999999999998653 457899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++++|.+++.. ..+++.+++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 87 ~e~~~~~~l~~~~~~-------------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 87 MEYVPLGSLRDYLPK-------------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred ecCCCCCCHHHHHHH-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEee
Confidence 999999999999842 2489999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 679 FGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 679 FGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
||+++......... ......++..|+|||.+.....+.++||||||++++||+||+.|+..
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 99998764322111 11222356679999999988999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.26 Aligned_cols=195 Identities=30% Similarity=0.461 Sum_probs=171.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|++|.||+++.. ++.+|+|++.... ....+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999884 4889999987542 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+|||+++++.+||+|||+
T Consensus 83 ~~~~~L~~~~~~------------~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 83 VPGGELFSHLRK------------SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred CCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999853 34688999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++..... .....+++.|+|||.+.+...+.++||||||++++||++|+.||...+
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875432 223458899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=264.00 Aligned_cols=199 Identities=28% Similarity=0.462 Sum_probs=165.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-----SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~L 597 (749)
+...+.||+|+||.||+|+.. +..||+|.+... .....+.+.+|+.++.+++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345689999999999999874 478999987532 123346788999999999999999999988653 46789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
+|||+++++|.+++.. ...+++...++++.|++.||+|||+. +++|+||||+||++++++.++|+
T Consensus 84 v~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 84 FMEHMPGGSIKDQLKS------------YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred EEEecCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEEC
Confidence 9999999999999843 23478888999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCC-ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGG-SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++....... ........++..|+|||.+.+...+.++|||||||++|||++|+.||...
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 9999986532211 11122345888999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=276.20 Aligned_cols=213 Identities=27% Similarity=0.414 Sum_probs=169.2
Q ss_pred HhhcccccccccCceEEEEEEE-------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEec-CCe
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDE-NTK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~-------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~-~~~ 594 (749)
..+.+.+.||+|+||.||+|+. .++.||||+++... ....+.+.+|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4567789999999999999974 23679999997543 23456788999999999 78999999998865 456
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCC------------------------------------------------------
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPT------------------------------------------------------ 620 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~------------------------------------------------------ 620 (749)
.++||||+++|+|.+++.........
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999999653211000
Q ss_pred -CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeecccc
Q 037623 621 -DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699 (749)
Q Consensus 621 -~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 699 (749)
........+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0000123578999999999999999999998 999999999999999999999999999986533221111222345
Q ss_pred CCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 037623 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKT 740 (749)
Q Consensus 700 t~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~ 740 (749)
+..|+|||.+.+..++.++||||||++++||++ |..||...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 678999999999999999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=264.42 Aligned_cols=188 Identities=29% Similarity=0.416 Sum_probs=160.5
Q ss_pred ccccccCceEEEEEEECCc------------ccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 531 RVLGKGGFGTVYHGYLDDK------------QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~------------~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
+.||+|+||.||+|...+. .+++|.+...... ...|.+|+.++++++|+|++++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4699999999999998542 3778877654433 6788999999999999999999999988 778999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC------
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF------ 672 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~------ 672 (749)
+||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 79 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~ 144 (259)
T cd05037 79 EEYVKFGPLDVFLHRE-----------KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYV 144 (259)
T ss_pred EEcCCCCcHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCc
Confidence 9999999999998542 22688999999999999999999998 999999999999999887
Q ss_pred -cEEEEecCCCccccCCCCceeeeccccCCcccCccccccC--CCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 037623 673 -QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELIT-GQPVIQKT 740 (749)
Q Consensus 673 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DVwSfGvvL~Ellt-G~~pf~~~ 740 (749)
.+||+|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..||...
T Consensus 145 ~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 145 PFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred eeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 799999999986532 1223466789999999876 78999999999999999999 57888665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=264.79 Aligned_cols=198 Identities=28% Similarity=0.470 Sum_probs=168.5
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCchh---------hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ---------GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~---------~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.||+|++|.||+|... ++.+|+|.+...... ..+.+.+|+.++.+++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45678999999999999873 478999988654221 2356889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||
T Consensus 83 lv~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 83 IFLEYVPGGSVAALLNN------------YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEecCCCCHHHHHHh------------ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEe
Confidence 99999999999999943 24578889999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCc----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGS----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 677 ~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|||+++........ .......++..|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 999999876422111 1112235788999999999989999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.31 Aligned_cols=201 Identities=26% Similarity=0.414 Sum_probs=172.0
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|++|.||+++. ++..+|||.+.... ....+++.+|+.++++++|+|++++++++.+.+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 45568999999999999986 45889999876532 23446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.... .....+++..+.+++.++++||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 84 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 84 ADAGDLSRMIKHFK--------KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred cCCCCHHHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchh
Confidence 99999999885421 1345689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+..+.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.+.
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 153 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 88654321 1122345888999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=275.26 Aligned_cols=218 Identities=29% Similarity=0.408 Sum_probs=174.3
Q ss_pred HHHHhhcccccccccCceEEEEEEECC---------cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEe
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLDD---------KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCD 590 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~ 590 (749)
+....+.+.+.||+|+||.||+++..+ ..||+|.+... .....+++.+|++++.++ +|+||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 344567778999999999999997521 35899988754 233457889999999999 8999999999999
Q ss_pred cCCeeEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 591 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
.....++++||+++|+|.+++......... ........+++..+++++.|+++||+|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 999999999999999999999653211000 0011234689999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 667 LLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 667 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999986533211111122234567999999999999999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=278.76 Aligned_cols=195 Identities=27% Similarity=0.368 Sum_probs=164.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~ 595 (749)
.|.+.+.||+|+||.||++... ++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4566789999999999999874 478999998753 233456788999999999999999999987543 357
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+++ +|...+.. .+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+|
T Consensus 105 ~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred EEEEeCCCC-CHHHHHHh--------------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEE
Confidence 899999965 67776631 367888999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 167 L~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 167 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred EEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999865321 12234468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=267.21 Aligned_cols=203 Identities=32% Similarity=0.459 Sum_probs=168.0
Q ss_pred ccccccCceEEEEEEECC--------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 531 RVLGKGGFGTVYHGYLDD--------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.||+|+||.||+|+..+ ..+|+|.+.... .....++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998743 468999876543 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-----cEEE
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-----QAKL 676 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-----~~kL 676 (749)
+++++|.+++...... ......+++.+++.++.|+++||+|||+. +++|+||||+||+++++. .++|
T Consensus 81 ~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 81 MEGGDLLSYLRDARVE-----RFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred cCCCcHHHHHHHhhhc-----ccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999654210 01234578999999999999999999998 999999999999999877 8999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||....
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 99999976543221111222345678999999999999999999999999999998 999997543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=265.58 Aligned_cols=202 Identities=27% Similarity=0.385 Sum_probs=168.7
Q ss_pred HhhcccccccccCceEEEEEEECC-----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
..+.+.+.||+|+||.||+|...+ ..|++|...... ....+.+.+|+.++++++|+|++++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 345567899999999999998633 368999887654 4456789999999999999999999999875 567899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++.. ....+++..++.++.+++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 85 ~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 85 MELAPLGELRSYLQV-----------NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred EEcCCCCcHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence 999999999999953 223589999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+++...... ........++..|+|||.+....++.++||||||++++|+++ |+.||.....
T Consensus 151 ~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 151 FGLSRYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred Cceeeeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99998654331 111222234568999999988889999999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=265.33 Aligned_cols=205 Identities=31% Similarity=0.466 Sum_probs=165.9
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|++.+ ..+++|.++.. .....+.+.+|++++.++ +|+|++++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998744 24688888753 334456789999999999 899999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 605 GNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+|.+++......... ........+++.++++++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999999654211000 0112234688999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
++...... ........+..|+|||++....++.++|||||||+++||++ |+.||...+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 98632211 11111234567999999988889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=264.41 Aligned_cols=197 Identities=28% Similarity=0.474 Sum_probs=165.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC------CeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN------TKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~------~~~~L 597 (749)
+.+.+.||+|+||.||+|... ++.||+|++.... ....++.+|+.++.++ +|+|++++++++... ...++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 445678999999999999874 4789999986543 3346788999999998 799999999998652 46789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++++|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+
T Consensus 87 v~e~~~~~~L~~~l~~~----------~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 87 VMEFCGAGSVTDLIKNT----------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred EEEcCCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 99999999999998542 334688999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|||++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998653221 1223456889999999986 34578899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=263.74 Aligned_cols=196 Identities=28% Similarity=0.419 Sum_probs=166.1
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
..||+|+||.||+|+..+ ..|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 589999999999998743 679999988776666788999999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecCCCccccC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPV 687 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~ 687 (749)
+++.... .....++..+..++.|+++||+|||+. +|+||||||+||+++. ++.++|+|||++.....
T Consensus 94 ~~l~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 94 ALLRSKW---------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred HHHHHhc---------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9996431 111227888899999999999999998 9999999999999986 67999999999876532
Q ss_pred CCCceeeeccccCCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.. .......++..|+|||++.... ++.++||||||++++||++|+.||...
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 21 1122335788999999986654 788999999999999999999999753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=289.22 Aligned_cols=195 Identities=23% Similarity=0.350 Sum_probs=159.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCC------CceeEEEEEEecC-CeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH------KNLTILVGYCDEN-TKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H------~nIv~l~g~~~~~-~~~~ 596 (749)
.|.+.+.||+|+||+||+|+.. ++.||||+++.... ..+++..|+.++.+++| .+++.+++++... ...+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4566789999999999999874 47899999865322 23455677777777755 4588888888654 5788
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCC---
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKF--- 672 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~--- 672 (749)
+|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK------------HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEEecc-CCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 999987 7789888843 3468999999999999999999997 5 899999999999998765
Q ss_pred -------------cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 673 -------------QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 673 -------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999886432 122345789999999999999999999999999999999999999987
Q ss_pred CCc
Q 037623 740 TPE 742 (749)
Q Consensus 740 ~~~ 742 (749)
.+.
T Consensus 348 ~~~ 350 (467)
T PTZ00284 348 HDN 350 (467)
T ss_pred CCh
Confidence 554
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=264.35 Aligned_cols=204 Identities=27% Similarity=0.455 Sum_probs=171.3
Q ss_pred HHHhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
....+.+.+.||+|+||.||++...+ ..+|+|.+.... ...+.+.+|++++++++|+|++++.+++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34556778999999999999998754 679999887543 335678999999999999999999999887 778999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.
T Consensus 82 ~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 82 MAKGSLLDFLKSD----------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred CCCCcHHHHHHhC----------CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcc
Confidence 9999999999542 234678999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+....... ........++..|+|||++....++.++|+|||||+++|++| |+.||...+.
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 149 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred eeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 97653221 111122335678999999998889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=277.83 Aligned_cols=195 Identities=27% Similarity=0.356 Sum_probs=163.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~ 595 (749)
.|...+.||+|+||.||++... ++.||||++... .....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4556789999999999999864 578999998754 233446778999999999999999999988543 357
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+++ +|...+. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+|
T Consensus 98 ~lv~e~~~~-~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred EEEhhhhcc-cHHHHHh--------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEE
Confidence 899999965 6766652 1377888999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++..... .......++..|+|||++.+..++.++|||||||+++||++|+.||.+.+
T Consensus 160 l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 160 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred EeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999864321 12234468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=272.50 Aligned_cols=199 Identities=22% Similarity=0.257 Sum_probs=163.8
Q ss_pred cccccccc--CceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 529 FERVLGKG--GFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 529 f~~~LG~G--~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.++||+| +|++||+++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999874 4889999987542 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|.+++... ....+++..+++++.|+++||+|||+. +|+||||||+|||++.++.++++||+.+
T Consensus 82 ~~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 82 AYGSAKDLICTH----------FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred CCCcHHHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchh
Confidence 999999998542 223588999999999999999999998 9999999999999999999999999865
Q ss_pred ccccCCCCce-----eeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSH-----VSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.......... ......++..|+|||++.+ ..++.++|||||||+++||++|+.||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 4432111100 0112246678999999976 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=253.34 Aligned_cols=206 Identities=25% Similarity=0.318 Sum_probs=174.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec-----CCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-----NTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-----~~~~~LV 598 (749)
+|.+.+.||+|||+-||.++. +++.+|+|++...+.++.+..++|++..++++|||++++++++.. ..+.+|+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 467789999999999998874 558899999988887888899999999999999999999988743 3458999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
++|...|+|.+.+.... .+...+++.+.+.|+.++++||++||+. .|+++||||||.|||+.+.+.++|.|
T Consensus 102 ~Pyy~~Gsl~d~i~~~k--------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLK--------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eehhccccHHHHHHHHh--------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 99999999999996543 3556899999999999999999999987 45699999999999999999999999
Q ss_pred cCCCccccCCCCce-------eeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSH-------VSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 679 FGla~~~~~~~~~~-------~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
||.++..+..-... .......|..|.|||.+. +...++++|||||||+||+|+.|..||...
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 99998664321111 012235889999999985 445789999999999999999999999753
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=265.51 Aligned_cols=197 Identities=31% Similarity=0.482 Sum_probs=171.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||.|++|.||+|+.. ++.+|+|.+.... ......+.+|++++++++|+|++++.+++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 455688999999999999874 4789999987543 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++
T Consensus 83 ~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 83 GGSCLDLLKP-------------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CCcHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999842 2688999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.+.... .......++..|+|||.+.+..++.++||||||+++|||+||+.||...+
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 765331 12233457889999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=261.87 Aligned_cols=201 Identities=30% Similarity=0.408 Sum_probs=173.1
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||.|+||.||.++. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45668999999999988876 4578999987654 3445577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++... ....+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 82 NGGTLYDKIVRQ----------KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CCCcHHHHHHhc----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 999999998542 234689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
........ ......+++.|+|||.+.+...+.++||||||++++||++|+.||.....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 86643321 22344688999999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=270.44 Aligned_cols=200 Identities=25% Similarity=0.398 Sum_probs=168.8
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||++.... +.|++|.+..... ...+.+.+|++++++++|+||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 4556899999999999998754 7899999876532 3345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ...+++..+..++.++++||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~g~~L~~~l~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 83 VEGGDCATLLKN------------IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred CCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999943 24588999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCC-------------ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGG-------------SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++....... ........++..|+|||.+....++.++|+||||+++|||++|+.||.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 874211100 001112347788999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=260.61 Aligned_cols=197 Identities=29% Similarity=0.470 Sum_probs=172.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||+|+||.||+|+.. +..+++|.+..... .+++.+|++++++++|+|++++++++......++++||+++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 455688999999999999985 47899999875533 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ....+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 83 ~~L~~~l~~-----------~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 83 GSVSDIMKI-----------TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred CcHHHHHHh-----------CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999853 235689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
..... .......++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 149 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 149 LTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred cccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 64322 12233457889999999999999999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=261.16 Aligned_cols=200 Identities=29% Similarity=0.449 Sum_probs=173.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+++.. ++.+++|.+........+.+.+|++++++++|+|++++++++......+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 3556789999999999999874 47899999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 84 ~~~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 84 GGSLQDIYQVT-----------RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred CCcHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 99999988532 24588999999999999999999998 99999999999999999999999999988
Q ss_pred cccCCCCceeeeccccCCcccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+... .++.++||||||++++||+||+.||....
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred hhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 654321 112234578899999999776 88999999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=267.75 Aligned_cols=196 Identities=31% Similarity=0.466 Sum_probs=169.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+...+.||+|+||.||+|... +..||+|.+.... ....+.+.+|++++++++|+||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 444578999999999999874 4789999987543 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 86 ~~~L~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 86 GGSALDLLK-------------PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CCcHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 999998873 23578899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.+.... .......++..|+|||++.+..++.++|||||||+++||++|+.|+...
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred cccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 654321 1112345788999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=265.58 Aligned_cols=200 Identities=28% Similarity=0.398 Sum_probs=167.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||+|+.. +..||+|++.... ....+.+.+|+.++.+++|+|++++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345688999999999999874 5889999986442 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+ ++|.+++... .....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 82 ~-~~l~~~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 82 S-MDLKKYLDSL---------PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred C-CCHHHHHhcC---------CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 7 6898887432 1235689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
....... .......+++.|+|||.+.+. .++.++|||||||+++||+||++||....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 7653321 112233568899999988654 47889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=278.28 Aligned_cols=194 Identities=27% Similarity=0.408 Sum_probs=163.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~ 595 (749)
.|...+.||+|+||+||+|... ++.||||++.... ....+.+.+|++++++++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 3555689999999999999874 4789999987542 23345678999999999999999999887532 456
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++++|++ +++|..++. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+|
T Consensus 96 ~~~~~~~-~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-------------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred EEEeecC-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEE
Confidence 8999987 788987762 23588999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||+++||++|+.||...+
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999865321 223468899999999876 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=263.66 Aligned_cols=199 Identities=28% Similarity=0.463 Sum_probs=166.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-----VQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~L 597 (749)
+...+.||+|+||.||+|... +..|++|++.... .+..+.+.+|+.++++++|+||+++.+++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345689999999999999874 5789999876432 2334568899999999999999999998865 356789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
++||+++++|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 84 ~~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 84 FMEYMPGGSVKDQLKA------------YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 9999999999999853 23478899999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCC-ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGG-SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++.+..... ........++..|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 9999986532211 11112345788999999999988999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=259.29 Aligned_cols=197 Identities=31% Similarity=0.456 Sum_probs=167.4
Q ss_pred ccccccCceEEEEEEEC-CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
++||+|+||.||++... ++.||+|........ ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999986 588999998765443 5578999999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 688 (749)
+++.. ....+++..++.++.++++||+|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~l~~-----------~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 81 TFLRK-----------KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred HHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99853 223578999999999999999999998 9999999999999999999999999999865321
Q ss_pred CCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
...........+..|+|||.+.++.++.++|+||||++++||+| |..||....
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 11111112234567999999998899999999999999999999 889987643
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=272.68 Aligned_cols=193 Identities=26% Similarity=0.397 Sum_probs=168.5
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
..||+|+||.||++.. +++.||+|.+........+.+.+|+.++..++|+|++++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 5799999999999987 45889999987655555577889999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 688 (749)
.++. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 107 ~~~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 107 DIVS-------------QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred HHHh-------------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 8773 23578999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
. .......++..|+|||++.+..++.++|||||||+++||++|+.||....
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 171 V--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred c--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11233468899999999998899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=297.38 Aligned_cols=208 Identities=26% Similarity=0.413 Sum_probs=169.0
Q ss_pred HHHhhcccccccccCceEEEEEEECC--cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeE
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMG 596 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~ 596 (749)
....|.+.+.||+|+||+||+++... ..+|+|.+... .......|..|+.++.+++||||+++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 33456778999999999999998744 67899988654 23345678999999999999999999998754 45688
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceeeCCCCCcEEEcCC-
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCK----PPIVHRDVKSANILLNEK- 671 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~----~gIiHrDLkp~NILl~~~- 671 (749)
|||||+++|+|.++|.... .....+++..++.|+.||+.||+|||+... .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~--------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCY--------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 9999999999999996432 123568999999999999999999998521 259999999999999643
Q ss_pred ----------------CcEEEEecCCCccccCCCCceeeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcC
Q 037623 672 ----------------FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITG 733 (749)
Q Consensus 672 ----------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG 733 (749)
..+||+|||+++.+... .......||+.|+|||++.. ..++.++|||||||+||||+||
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 34899999999865322 12234568999999999854 4588999999999999999999
Q ss_pred CCCCCCCC
Q 037623 734 QPVIQKTP 741 (749)
Q Consensus 734 ~~pf~~~~ 741 (749)
+.||...+
T Consensus 240 k~PF~~~~ 247 (1021)
T PTZ00266 240 KTPFHKAN 247 (1021)
T ss_pred CCCCCcCC
Confidence 99997543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=262.00 Aligned_cols=196 Identities=34% Similarity=0.494 Sum_probs=160.5
Q ss_pred ccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEe-cCCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCD-ENTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~-~~~~~~LV~Ey~~ 603 (749)
+.||+|+||.||+|+..+ ..||+|.+... .....+.+.+|+.+++.++|+|++++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998632 46999988643 3344678889999999999999999999875 4556789999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++... ...+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~ 146 (262)
T cd05058 81 HGDLRNFIRSE-----------THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146 (262)
T ss_pred CCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccc
Confidence 99999998532 23467888899999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCce--eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCC
Q 037623 684 IFPVEGGSH--VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG-~~pf~~~ 740 (749)
.+....... ......++..|+|||.+....++.++|||||||++|||++| .+||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 653221111 11123456789999999988999999999999999999995 6667543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=260.90 Aligned_cols=202 Identities=27% Similarity=0.416 Sum_probs=172.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|++|.||+|... ++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3566789999999999999984 588999988643 23335678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|..++.... .....+++.++++++.++++||+|||+. +++||||+|+||++++++.++|+|||
T Consensus 83 ~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 83 LADAGDLSRMIKHFK--------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred cCCCCCHHHHHHHhc--------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 999999999985421 2345688999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++..+..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 152 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 9876543211 112345788999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=282.94 Aligned_cols=193 Identities=31% Similarity=0.475 Sum_probs=169.2
Q ss_pred cccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHH
Q 037623 532 VLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQA 609 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 609 (749)
+||+|.||+||-|++.+ ..+|||.+...+.+..+-..+|+.+-++++|+|||+.+|.|.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999865 5689999988877777888999999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc-CCCcEEEEecCCCcccc
Q 037623 610 HLLAQLAILPTDAEDKTGIL--SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFP 686 (749)
Q Consensus 610 ~L~~~~~~~~~~~~~~~~~l--~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~-~~~~~kL~DFGla~~~~ 686 (749)
+|... -+++ ++.++-..-+||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++.+.
T Consensus 662 LLrsk-----------WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 662 LLRSK-----------WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred HHHhc-----------cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 99643 3334 6667777889999999999999 999999999999997 56899999999998774
Q ss_pred CCCCceeeeccccCCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.- ........||..|||||++..+. |+.++|||||||.+.||.||++||-..
T Consensus 728 gi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 728 GI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred cC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 32 23344567999999999998765 889999999999999999999999753
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=263.44 Aligned_cols=197 Identities=29% Similarity=0.464 Sum_probs=170.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+...+.||.|+||.||+|... +..||+|.+.... ....+.+.+|+.++++++|+|++++++++.+....++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 344578999999999999874 4789999987543 3456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 86 ~~~L~~~i~~-------------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 86 GGSALDLLRA-------------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccce
Confidence 9999998832 3478888999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+.+...+.++|||||||+++||++|+.||....
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 150 QLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred eccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 654321 11223457889999999998899999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=265.52 Aligned_cols=198 Identities=28% Similarity=0.383 Sum_probs=168.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+++.+.||+|++|.||+|+.. ++.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 456688999999999999884 5889999886542 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+++.|..++. ....+++..+++++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 83 ~~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 83 DHTVLNELEK------------NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CccHHHHHHh------------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccc
Confidence 9988877763 234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.||.+..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 87643321 1223357788999999876 457899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=269.06 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=166.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||.||+|+.. ++.||+|.+.... ......+.+|+.++++++|+||+++++++......++|+||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 456688999999999999874 4789999986543 2233467889999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|.+++.. ....+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||++.
T Consensus 88 -~~l~~~l~~-----------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 88 -KDLKQYLDD-----------CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred -cCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 589888853 234578999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......+++.|+|||.+.+. .++.++|||||||+++||++|++||...+
T Consensus 153 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 153 AKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred ccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 643221 111233568899999998654 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=266.65 Aligned_cols=198 Identities=28% Similarity=0.365 Sum_probs=170.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||+||++... ++.+|+|++.... ....+++.+|++++..++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 4455689999999999999875 5789999876543 334578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.. .+.+++..+.+++.+++.||.|||+.+ +++||||||+||++++++.++|+|||++
T Consensus 86 ~~~~L~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 86 DCGSLDRIYKK------------GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred CCCCHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 99999988843 245889999999999999999999732 7999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... ......++..|+|||++.+..++.++|+|||||+++||++|+.||....
T Consensus 152 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 152 GELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred cchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 754221 1123468899999999988899999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=261.25 Aligned_cols=198 Identities=31% Similarity=0.529 Sum_probs=168.2
Q ss_pred cccccccccCceEEEEEEE-CCcccEEEEecCCc------hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 528 NFERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSS------VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~-~~~~VAVK~l~~~~------~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
...+.||+|+||.||+|.. +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 3457899999999999987 44779999876432 2234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||
T Consensus 83 ~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 83 FVPGGSISSILNR------------FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred cCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence 9999999999843 23578899999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCC----ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGG----SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++........ ........++..|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 9876532111 11122345888999999999988999999999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=259.01 Aligned_cols=200 Identities=29% Similarity=0.445 Sum_probs=170.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~LV~Ey 601 (749)
|.+.+.||+|++|.||+++.. ++.+|+|++... .....+.+.+|++++++++|+|++++.+.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999874 478999998653 23445678899999999999999999988764 4467899999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++... ....+++.++.+++.+++.||++||+. +++||||||+||++++++.++|+|||+
T Consensus 82 ~~~~~l~~~l~~~----------~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 82 CEGGDLYHKLKEQ----------KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred cCCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccc
Confidence 9999999998542 334689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..+.... .......+++.|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 149 ARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred eEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 98663321 12233457889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=260.74 Aligned_cols=195 Identities=32% Similarity=0.511 Sum_probs=167.2
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.+.+.+.||+|+||.||++...++.+|+|...... ..+.+.+|+.++.+++|+|++++.+++... ..++||||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 35667899999999999999888999999986543 236789999999999999999999998654 578999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++... ....+++..+++++.|+++||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 ~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 84 NLVNFLRTR----------GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred CHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceec
Confidence 999999542 234578999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
... ......+..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 151 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 151 SMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred ccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 221 112234567999999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=264.65 Aligned_cols=198 Identities=31% Similarity=0.482 Sum_probs=166.4
Q ss_pred hhcccccccccCceEEEEEEE------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~ 596 (749)
.+...+.||+|+||.||+++. .+..||+|.+.... ....+.+.+|++++++++|+|++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 345568899999999999974 24779999987553 34456799999999999999999999998765 5688
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 lv~e~~~g~~L~~~l~~-----------~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR-----------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred EEEEccCCCCHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEE
Confidence 99999999999999853 223589999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 037623 677 ADFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 737 (749)
Q Consensus 677 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf 737 (749)
+|||+++.+...... .......++..|+|||++.+..++.++||||||++++||+|++.|.
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999999876433221 1112344677899999999889999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=259.48 Aligned_cols=196 Identities=31% Similarity=0.465 Sum_probs=169.7
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-----VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
...+.||+|++|.||+|... +..|++|.+.... .+..+.+.+|++++++++|+|++++.+++......++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 44578999999999999884 5889999886543 2345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 83 ~~~~~~L~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 83 LVPGGSLAKLLKK------------YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999843 23578999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++....... ......++..|+|||.+.... ++.++|+||||++++||++|+.||....
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 988654322 223445888999999997776 8999999999999999999999997543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=265.35 Aligned_cols=199 Identities=27% Similarity=0.386 Sum_probs=168.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+++.+.||+|+||.||+++.. +..+|+|.+... .....+++.+|++++.+++|+||+++++.+...+..++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456689999999999999985 588999988654 33445788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|..++... .....+++..+.+++.++++||.|||+.+ +|+|+||||+||++++++.+||+|||++.
T Consensus 83 ~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 83 AGSLDKLYAGG---------VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred CCCHHHHHHhc---------cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999888532 11346899999999999999999999632 89999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.+... ......++..|+|||.+.+.. ++.++|+|||||+++||++|+.||...
T Consensus 152 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 152 NLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred cccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 65321 122345788999999986543 488999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=296.88 Aligned_cols=198 Identities=27% Similarity=0.377 Sum_probs=172.8
Q ss_pred hhcccccccccCceEEEEEEECC--cccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.++||+|+||.|..++..+ +.+|+|++.+- ....-..|..|.++|..-+.+-|+.|...+.+..++|||||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 34456899999999999998854 78999999863 23344678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
||+||+|-.++.. ...+++..+...+.+|.-||+-||+. |+|||||||+|||||..|++||+|||
T Consensus 156 Y~pGGDlltLlSk------------~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSK------------FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cccCchHHHHHhh------------cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 9999999999943 33688888899999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccc----c-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYI----S-NRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.+-.+..++ .-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||..
T Consensus 221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 998876543 33345567999999999984 3 6799999999999999999999999964
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=260.09 Aligned_cols=200 Identities=30% Similarity=0.534 Sum_probs=169.7
Q ss_pred hhcccccccccCceEEEEEEEC-CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||++... +..+|+|.+..... ...+|.+|++++++++|+|++++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 3456789999999999999875 57899998875433 346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ....+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~~L~~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 84 GCLSDYLRA-----------QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred CcHHHHHHh-----------CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceee
Confidence 999999853 223578999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
..... ........++.+|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 150 ~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 150 VLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred cccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 53221 111112235678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=266.57 Aligned_cols=199 Identities=26% Similarity=0.415 Sum_probs=172.4
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||++.. +++.|++|.+........+.+.+|+.++++++|+|++++.+.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 455668999999999999986 457899999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ..+++..+..++.++++||.|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 100 ~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 100 GGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred CCcHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 9999998842 2478889999999999999999999 99999999999999999999999999887
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
....... ......+++.|+|||.+....++.++||||||+++||+++|+.||...+.
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 6543321 12234588899999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=268.31 Aligned_cols=193 Identities=27% Similarity=0.415 Sum_probs=168.7
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
..||+|+||.||++.. ++..||||.+........+.+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999987 45889999987665556677899999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 688 (749)
+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 108 ~~~~-------------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 108 DIVT-------------HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred HHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 9873 23478899999999999999999998 9999999999999999999999999998765322
Q ss_pred CCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
. .......++..|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus 172 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 172 V--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred c--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11223458889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.54 Aligned_cols=198 Identities=28% Similarity=0.457 Sum_probs=164.1
Q ss_pred ccccccccCceEEEEEEEC--Cc----ccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 529 FERVLGKGGFGTVYHGYLD--DK----QVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~--~~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..+.||+|+||.||+|+.. +. .||+|.+..... ....++.+|+.++++++|+||++++++|... ...+++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3478999999999999863 33 478888875432 3345788999999999999999999998754 46799999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 90 ~~~g~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 90 MPHGCLLDYVHE-----------HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred cCCCCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence 999999999853 233578999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 987643322211222345678999999999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=268.52 Aligned_cols=203 Identities=31% Similarity=0.379 Sum_probs=172.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
++..+.||+|++|.||++... ++.+|+|.+..... ...+.+.+|++++.+++|+||+++++.+......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 445688999999999999884 48899999876532 2456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||+
T Consensus 83 ~~~~~L~~~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 83 CPGGELFRLLQRQ----------PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred cCCCCHHHHHHhC----------CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence 9999999998532 235689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCc---------------------------eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCC
Q 037623 682 SRIFPVEGGS---------------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734 (749)
Q Consensus 682 a~~~~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~ 734 (749)
+......... .......|+..|+|||++.+..++.++||||||+++|||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 8755322110 0011235788999999999988999999999999999999999
Q ss_pred CCCCCCCc
Q 037623 735 PVIQKTPE 742 (749)
Q Consensus 735 ~pf~~~~~ 742 (749)
.||...+.
T Consensus 230 ~pf~~~~~ 237 (316)
T cd05574 230 TPFKGSNR 237 (316)
T ss_pred CCCCCCch
Confidence 99976543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=261.35 Aligned_cols=199 Identities=29% Similarity=0.477 Sum_probs=167.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-----SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~L 597 (749)
+.+.+.||+|+||.||+|... +..||+|.+... ..+..+.+.+|++++++++|+||+++++++... ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999873 478999987432 223456789999999999999999999998654 45789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
++||+++++|.+++.. ...+++..+.+++.|++.||.|||+. +++|+||||+||++++++.++|+
T Consensus 84 v~e~~~~~~L~~~~~~------------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 84 FVEYMPGGSIKDQLKA------------YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEEeCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence 9999999999999843 23478899999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCC-ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGG-SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++....... ........++..|+|||.+.+...+.++|+|||||+++||++|+.||...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 9999986532111 11112345888999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=259.50 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=173.3
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||.|+||+||+|.. ++..+++|++.... ....+.+.+|++++++++|+|++++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 45678999999999999987 34789999987543 2356788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.
T Consensus 83 ~~~l~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 83 GGSLLDIMKSSY---------PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred CCcHHHHHHHhc---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 999999996431 124689999999999999999999998 99999999999999999999999999988
Q ss_pred cccCCCCce--eeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSH--VSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.+....... ......++..|+|||++... ..+.++|+|||||+++||++|+.||...+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 765432221 22334588899999998877 78999999999999999999999997654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=262.75 Aligned_cols=190 Identities=24% Similarity=0.392 Sum_probs=160.9
Q ss_pred ccccccCceEEEEEEECC---------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 531 RVLGKGGFGTVYHGYLDD---------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.||+|+||.||+|.... ..+++|.+........+++.+|+.++.+++|+|++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997632 34888888766555567889999999999999999999999998999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc--------
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-------- 673 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~-------- 673 (749)
+++|+|.+++... ...+++..+++++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 81 ~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~ 146 (258)
T cd05078 81 VKFGSLDTYLKKN-----------KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPF 146 (258)
T ss_pred CCCCcHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCce
Confidence 9999999998532 23688999999999999999999998 9999999999999987765
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCC-CCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQ-PVIQKT 740 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~-~pf~~~ 740 (749)
++++|||++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...
T Consensus 147 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 147 IKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred EEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 699999988754321 224577889999999864 5789999999999999999994 666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=260.46 Aligned_cols=197 Identities=25% Similarity=0.414 Sum_probs=166.1
Q ss_pred ccccccccCceEEEEEEE--CCcccEEEEecCCch----------hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV----------QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~----------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
..+.||+|+||.||+|+. +++.+|+|.+..... ...+.+.+|+.++.+++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 457899999999999986 458899998753211 11346788999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|
T Consensus 85 lv~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 85 IFLEYVPGGSIGSCLRT------------YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred EEEecCCCCcHHHHHhh------------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence 99999999999999843 24688899999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|||+++...............++..|+|||.+.... ++.++||||||++++|+++|+.||...
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 9999998653221122223345888999999987655 789999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=257.28 Aligned_cols=199 Identities=33% Similarity=0.530 Sum_probs=170.6
Q ss_pred ccccccccCceEEEEEEECC------cccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 529 FERVLGKGGFGTVYHGYLDD------KQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.||+|+||.||+++..+ ..||+|.+...... ..+.+.+|++++.+++|+|++++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999999854 67999999766443 567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+
T Consensus 83 ~~~~~l~~~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~ 149 (258)
T smart00219 83 MEGGDLLDYLRKN----------RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGL 149 (258)
T ss_pred cCCCCHHHHHHhh----------hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCC
Confidence 9999999999643 112289999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
++......... .....++..|+|||.+.+..++.++||||+|++++||++ |++||....
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 150 SRDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ceecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 98764332111 112236789999999988889999999999999999998 889987543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=263.24 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=170.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|++|.||+|+.. ++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456789999999999999873 5889999987654 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+++|.+++.. ....+++.+++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++
T Consensus 82 -~~~L~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 82 -PSDLSEVLRD-----------EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred -CCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 9999999853 225689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
........ .......++..|+|||.+.+. .++.++||||+|++++||++|++||....
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 87643321 112234588899999998654 46899999999999999999998887644
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=262.23 Aligned_cols=201 Identities=28% Similarity=0.402 Sum_probs=165.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEe-----cCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCD-----ENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~-----~~~~~~LV 598 (749)
+.+.+.||+|+||.||+++.. ++.+|+|++..... ...++.+|+.++.++ +|+|++++++++. .+...++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 445689999999999999874 47899998765332 235688899999999 7999999999884 34568999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++++|.+++.... .....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|
T Consensus 99 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 99 LELCNGGSVTDLVKGFL--------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred EeecCCCCHHHHHHHhh--------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 99999999999885431 1335688999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+++.+.... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 168 FGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99988654321 11223468899999999853 447889999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=261.77 Aligned_cols=207 Identities=27% Similarity=0.397 Sum_probs=169.9
Q ss_pred cccccccccCceEEEEEEEC-------CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
...+.||+|+||.||+|+.. .+.|++|.+...... ..+++.+|++++++++|+|++++++++.+.+..++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 34578999999999999863 256999988765443 4578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++..... .........+++..+..++.|+++||+|||+. +|+||||||+||++++++.++++||
T Consensus 88 e~~~~~~L~~~i~~~~~---~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 88 EYTDLGDLKQFLRATKS---KDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EecCCCcHHHHHHhccc---ccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999964321 00011223689999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+++...... ........++..|+|||.+.+...+.++||||||++++||++ |..||....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 9987543221 111122345678999999988889999999999999999998 888997543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=272.77 Aligned_cols=189 Identities=24% Similarity=0.334 Sum_probs=160.7
Q ss_pred HhhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..|.+.+.||+|+||.||+|+..+ ..||+|+.... ....|+.++.+++|+||+++++++......++|+|++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 346677899999999999999854 67899975432 2356899999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
. ++|.+++.. ....+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 140 ~-~~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 140 S-SDLYTYLTK-----------RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred C-CcHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 4 688888853 335689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 737 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf 737 (749)
+..... .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 205 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 205 QFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 753221 1123456899999999999999999999999999999999865443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=271.01 Aligned_cols=194 Identities=31% Similarity=0.480 Sum_probs=168.0
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.++||+|.||+||-|+. +++.||||++.+.. .....+.++|+.||.+++||.||.|...|+..+..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47999999999999986 56999999987642 23346789999999999999999999999999999999999954
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC---CcEEEEecCCC
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---FQAKLADFGLS 682 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~---~~~kL~DFGla 682 (749)
+..+.+... ..+++++..-..++.||+.||.|||.+ +|+|+||||+|||+.+. -++||||||.|
T Consensus 648 DMLEMILSs----------EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 648 DMLEMILSS----------EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred hHHHHHHHh----------hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence 555555332 456788888888999999999999999 99999999999999754 37999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++++. ....+.+.||+.|+|||++.++-|...-|+||.||++|--++|..||+..
T Consensus 715 RiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 715 RIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred eecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 98753 34456788999999999999999999999999999999999999999854
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=260.74 Aligned_cols=193 Identities=27% Similarity=0.399 Sum_probs=165.8
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||+|+||+||++... ++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 5789999986542 22345677899999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++... ....+++..++.++.|+++||.|||+. +++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~~l~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNV----------GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHc----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 9998643 224689999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
. .......++..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 148 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 148 G---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred C---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 1 11223457789999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=258.91 Aligned_cols=199 Identities=30% Similarity=0.406 Sum_probs=173.2
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+|-++||+|.||.|-.++- .++.+|+|++++. .+.....-..|-++|...+||.+..|-..++..+.++.||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 3558999999999998876 4588999999875 3334455678899999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
.||.|.-+|. ..+.+++....-.-.+|..||.|||++ +||.||||.+|.|+|.+|++||.|||++
T Consensus 251 nGGeLf~HLs------------rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 251 NGGELFFHLS------------RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred cCceEeeehh------------hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccc
Confidence 9999999984 445678887788889999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+.--. ........+||+.|+|||++.+..|+...|.|.+||++|||+.|+.||...+.+
T Consensus 316 KE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 316 KEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred hhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 85322 233445678999999999999999999999999999999999999999876543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.87 Aligned_cols=199 Identities=29% Similarity=0.396 Sum_probs=171.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|...+.||+|+||.||+|+.. ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 445689999999999999874 48899999876544 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.. ...+++..+.+++.++++||+|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~~L~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 82 SGGTLEELLEH------------GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred CCCcHHHHHhh------------cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999843 23578889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCcee--eeccccCCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHV--STTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~---~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
........... .....++..|+|||++.... .+.++||||||++++||++|+.||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 87644322111 11245788999999998766 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=259.96 Aligned_cols=205 Identities=30% Similarity=0.429 Sum_probs=166.3
Q ss_pred cccccccccCceEEEEEEEC-----CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC------e
Q 037623 528 NFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT------K 594 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~------~ 594 (749)
.+.+.||+|+||.||+|.+. +..||||++... .....+++.+|+.++++++|+|++++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999863 367999998754 3344677899999999999999999999886532 2
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++++||+++|+|..++..... ......+++..+++++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRI------GEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCE
Confidence 3688999999999988854311 11233578999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
||+|||+++.+.............++..|++||.+....++.++||||||+++|||++ |++||...+
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999987643321111222335678999999998889999999999999999999 899987654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=274.01 Aligned_cols=200 Identities=28% Similarity=0.479 Sum_probs=175.1
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|.|++|..|+. ++..||+|.+.+... ...+.+.+|+++|..++|||||+++.+......+++||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 45568999999999999986 568999999987632 33355889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
.+|.++++|..+ ..+....+..+..|+..|++|||++ .|+|||||++||||+.++++||+|||++
T Consensus 138 ~~ge~~~yl~~~------------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 138 SGGELFDYLVKH------------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred cCchhHHHHHhc------------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence 999999999643 4455578888999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
..+.. ........|++.|.|||++.+.++ ++++|+||+|++||-|+.|..||++..-++
T Consensus 203 ~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 203 TFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred eeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 98752 344556789999999999998875 589999999999999999999999865443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.83 Aligned_cols=191 Identities=27% Similarity=0.418 Sum_probs=167.7
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||.|++|.||+++.. ++.+|+|++.... ....+.+.+|+.++++++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 6889999987543 23446789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||+++....
T Consensus 81 ~~~l~~------------~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD------------RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999953 23478899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.. ......++..|++||.+....++.++|+||||+++|||++|+.||....
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 21 1223457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=260.56 Aligned_cols=190 Identities=31% Similarity=0.467 Sum_probs=157.0
Q ss_pred cccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHh---cCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 532 VLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMR---AHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~---l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.||+|+||.||++... ++.+|+|.+..... ...+.+.+|..++.. .+|+|++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 47899998865421 222334455444433 479999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++.
T Consensus 81 ~~~L~~~i~~------------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 81 GGDLHYHLSQ------------HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred CCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 9999998843 24589999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
..... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...
T Consensus 146 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 146 DFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred ecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 54321 1123458999999999864 55889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=259.57 Aligned_cols=198 Identities=26% Similarity=0.461 Sum_probs=168.3
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCCc------hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS------VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~------~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
...+.||+|++|.||+++. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457899999999999986 45889999986532 123467899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEEEe
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLAD 678 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL~D 678 (749)
||+++++|.+++.. ...+++..+.+++.|+++||+|||+. +++|+||||+||+++.++ .+||+|
T Consensus 83 e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 83 EWMAGGSVSHLLSK------------YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCCcHHHHHHH------------hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence 99999999999853 23578999999999999999999999 999999999999998775 699999
Q ss_pred cCCCccccCCCCc--eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 679 FGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 679 FGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
||++..+...... .......++..|+|||.+.+..++.++||||+|++++||++|+.||...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9999876433111 1112345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=258.68 Aligned_cols=200 Identities=29% Similarity=0.420 Sum_probs=171.6
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||.||+++. +++.+|+|.+... .....+++.+|+.++++++|+|++++.+++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 45678999999999999987 4588999998643 2334568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++... ....+++.++++++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~~l~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 82 EGGDLYKKINAQ----------RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 999999988542 234578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
....... .......++..|+|||++.+...+.++|+|||||+++||++|+.||...+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 149 RVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred eecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 8654321 11223457889999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.54 Aligned_cols=198 Identities=26% Similarity=0.403 Sum_probs=164.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||.||+|... ++.||+|++...... ....+.+|++++++++|+||+++.+++..++..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 455689999999999999874 588999998654322 23467889999999999999999999999999999999995
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|.+.+.. ....+.+..+..++.|+++||+|||+. +|+|+||||+|||++.++.+||+|||+++
T Consensus 87 -~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 87 -TDLAQYMIQ-----------HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred -CCHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccc
Confidence 678777643 223577888899999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||....
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 152 AKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 643221 111233468899999998764 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=261.59 Aligned_cols=200 Identities=30% Similarity=0.495 Sum_probs=169.5
Q ss_pred hcccccccccCceEEEEEEEC------CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD------DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~------~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~L 597 (749)
+.+.+.||+|+||.||+++.. +..+|||++...... ..+.|.+|++++++++|+|++++.+++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 445588999999999999864 367999998866443 46789999999999999999999999877 567899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+
T Consensus 86 v~e~~~~~~l~~~l~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 151 (284)
T cd05038 86 IMEYLPSGSLRDYLQRH-----------RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKIS 151 (284)
T ss_pred EEecCCCCCHHHHHHhC-----------ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence 99999999999999542 23589999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||++.......... ......++..|+|||.+....++.++||||||++++||++|+.|+...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 999998765322211 111233556799999999889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=259.34 Aligned_cols=196 Identities=31% Similarity=0.482 Sum_probs=169.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||+|+||.||+|... +..+|+|...... ....+.+.+|+.++.+++|+|++++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 445678999999999999863 4789999876543 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++. ...+++..+..++.+++.|+.|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 86 ~~~l~~~i~-------------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 86 GGSALDLLE-------------PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred CCcHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 999998883 23578999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.+.... .......++..|+|||.+.+...+.++|+|||||+++||++|+.||...
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred ecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 654321 1122345788999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=264.98 Aligned_cols=202 Identities=27% Similarity=0.414 Sum_probs=176.5
Q ss_pred hhcccccccccCceEEEEEE--ECCcccEEEEecCCchhh--HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~--~~~~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
-|++++.||+|.|..|-.++ ++|..||||++.+..... ...+.+|++.|..++|||||+|+.+......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 46677999999999999886 589999999998775443 45678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFG 680 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFG 680 (749)
=.+|+|.+++-++ ...+++....+...||..|+.|+|+. .+|||||||+||.+-+ -|-+||.|||
T Consensus 99 GD~GDl~DyImKH-----------e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH-----------EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred cCCchHHHHHHhh-----------hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 9999999999654 34588889999999999999999999 8999999999998865 5789999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
++-.+.+.. .....+|+..|-|||.+.+..|+ ++.||||+|||||.|+.|++||+..++.+
T Consensus 165 FSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 165 FSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred ccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 998776542 33456799999999999999886 67899999999999999999999876654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=265.80 Aligned_cols=199 Identities=28% Similarity=0.398 Sum_probs=167.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchh-----hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-----GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+.+.+.||+|++|.||+|... ++.||+|.+...... ....+..|++++++++|+|++++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 455678999999999999874 588999998765322 2355778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+ +|+|.+++... ...+++..+++++.|+++||+|||+. +|+|+||||+||+++.++.++|+||
T Consensus 82 e~~-~~~L~~~i~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 82 EFM-ETDLEKVIKDK-----------SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ccc-CCCHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 999 99999998431 13689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++...... .......++..|+|||.+.+ ..++.++|||||||+++||++|.+||....+
T Consensus 147 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 147 GLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred eeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 9998764322 11122346778999998854 4578999999999999999999888876443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.57 Aligned_cols=197 Identities=28% Similarity=0.484 Sum_probs=168.3
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC-chhhHHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAH---HKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~---H~nIv~l~g~~~~~~~~~LV~E 600 (749)
|...+.||+|+||.||+|+. +++.+|+|.+... .....+++.+|+.++++++ |+|++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 34457899999999999997 3488999998654 3344567889999999997 9999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.. ..+++..++.++.++++||.|||+. +|+|+||+|+||++++++.++|+|||
T Consensus 83 ~~~~~~L~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 83 YAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred cCCCCcHHHHHHc-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 9999999988732 2588999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++..+.... .......|+..|+|||.+.++ .++.++||||||+++|||++|+.||....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764332 112334688899999998754 46899999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=266.86 Aligned_cols=206 Identities=29% Similarity=0.428 Sum_probs=175.6
Q ss_pred HHhhcccccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~L 597 (749)
....+|..+||+|+||.|.++...+ ..+|||++++.-. .+.+--..|-++|+.. +-|.+++|..+++.-+.++.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3456888999999999999998765 6799999986522 2233345677777766 67899999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+.||+|-.++. ..+.+.++.+.-.|.+||-||-+||++ |||.||||..|||+|.+|++||+
T Consensus 428 VMEyvnGGDLMyhiQ------------Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ------------QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred EEEEecCchhhhHHH------------HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence 999999999998884 345677788889999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l 746 (749)
|||+++.--.+ ........||+.|+|||.+...+|+..+|.|||||+||||+.|++||++.+++++.
T Consensus 493 DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 493 DFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred ecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999854322 22345678999999999999999999999999999999999999999999887764
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=256.55 Aligned_cols=199 Identities=28% Similarity=0.418 Sum_probs=170.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|++|.||++... ++.+|+|.+... .....+.+.+|++++++++|+|++++++.+..++..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456789999999999999874 478999998654 2344578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~DFGl 681 (749)
++++|.+++... ....+++..+.+++.++++||+|||++ +++|+||||+||+++++ ..+||+|||+
T Consensus 82 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 82 PGGTLAEYIQKR----------CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CCCCHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 999999999642 234588999999999999999999998 99999999999999855 4689999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+....... ......++..|+|||.+.+...+.++||||||++++||++|+.||...+
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 98764321 1223457889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.82 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=168.0
Q ss_pred hcccccccccCceEEEEEEE----CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYL----DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~----~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~L 597 (749)
+.+.+.||+|++|.||+|+. .+..||+|.+.... ....+.+.+|+.++.+++|+|++++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 45668899999999999997 34789999988632 33346678899999999999999999999887 88999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC----CCc
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE----KFQ 673 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~----~~~ 673 (749)
||||+++ +|.+.+..... .....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 82 v~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQ-------AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred EEeCCCc-CHHHHHHhhcc-------CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccce
Confidence 9999975 77777643321 1224688999999999999999999998 9999999999999999 899
Q ss_pred EEEEecCCCccccCCCCc-eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+||+|||+++........ .......++..|+|||.+.+. .++.++|||||||+++||++|++||.....
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999999999876433221 112234578899999988764 578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=274.87 Aligned_cols=187 Identities=33% Similarity=0.477 Sum_probs=165.9
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||.|.||.||-+++ +...||||++.-+ +...+.++..|+..|.+++|||++..-|++-.+...+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 6799999999999987 4488999999754 4456788999999999999999999999999999999999999 45
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+-.+.+.-+ .+.+.+-.+..|..+.++||+|||+. +.||||||+.|||+++.|.+||+|||.|.+.
T Consensus 111 SAsDlleVh-----------kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 111 SASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred cHHHHHHHH-----------hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 777877433 35678888999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
.+. ...+||+.|||||++. .+.|+-|+||||+||...||...++|+-
T Consensus 177 ~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 177 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred Cch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 543 4678999999999984 6789999999999999999999999964
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=264.54 Aligned_cols=198 Identities=26% Similarity=0.403 Sum_probs=167.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+++.+.||+|+||.||+|... ++.+|+|++..... ...+.+.+|++++++++|+|++++++++..++..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456689999999999999985 48899998765422 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+++.|..+.. ....+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 83 ~~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 83 DHTVLDDLEK------------YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CccHHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence 9998887663 223489999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
..+.... .......++..|+|||++.+ ..++.++||||||++++||++|++||....
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 148 RTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred eeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 8654322 22223457889999999875 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.39 Aligned_cols=198 Identities=27% Similarity=0.410 Sum_probs=165.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||+|++|.||+|+.. ++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 455689999999999999874 588999998654322 23456789999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 87 ~-~L~~~~~~-----------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 87 T-DLKQYMDD-----------CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred C-CHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccc
Confidence 4 99998853 223678999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 152 AKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 543221 11122346788999999875 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=260.53 Aligned_cols=197 Identities=28% Similarity=0.405 Sum_probs=172.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||.|+||.||+++.. ++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999985 5889999987542 23457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~~~L~~~l~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 82 LLGGDLRYHLSQ------------KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred CCCCCHHHHHHh------------cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 999999999843 24678999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+....... ......++..|+|||.+.+...+.++|+||||++++||++|+.||....
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 88754322 1233457889999999998889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=256.45 Aligned_cols=202 Identities=28% Similarity=0.390 Sum_probs=168.8
Q ss_pred hcccccccccCceEEEEEEECC---cccEEEEecCC----------chhhHHHHHHHHHHHHh-cCCCceeEEEEEEecC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD---KQVAVKMLSPS----------SVQGYKQFQAEVELLMR-AHHKNLTILVGYCDEN 592 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~---~~VAVK~l~~~----------~~~~~~~f~~Ei~iL~~-l~H~nIv~l~g~~~~~ 592 (749)
+.+.+.||+|+||.||+|...+ +.+|+|.+... ......++.+|+.++.+ ++|+|++++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999999854 77999987532 22234567788888875 7999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
+..+++|||+++++|.+++.... .....+++..+++++.|++.||.|||+.. +++|+||+|+||++++++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLK--------EKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHH--------hccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCC
Confidence 99999999999999999885421 13456889999999999999999999631 899999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99999999998654322 2234568889999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=255.27 Aligned_cols=205 Identities=27% Similarity=0.382 Sum_probs=171.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~LV~E 600 (749)
|++.+.||+|+||.||++... ++.+|+|.+... .....+++.+|++++++++|+|++++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 455688999999999999874 478999988654 33445678899999999999999999998753 456789999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC--KPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|+++++|.+++.... .....+++..++.++.++++||+|||..+ ..+++|+||||+||++++++.+||+|
T Consensus 82 ~~~~~~L~~~l~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 82 YCEGGDLAQLIQKCK--------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred hccCCCHHHHHHHHh--------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 999999999996532 13456899999999999999999999332 33999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||++....... .......++..|+|||.+....++.++|+||||++++||++|+.||...+
T Consensus 154 ~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 154 FGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 99998764332 11233468899999999999899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=254.93 Aligned_cols=198 Identities=29% Similarity=0.414 Sum_probs=173.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+++.+.||+|++|.||+++.. ++.|++|++..... ...+.+.+|+..+.+++|+|++++.+++......++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345689999999999999885 58899999876644 446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+++|.+++.. ...+++..+..++.|+++||+|||+ . +++|+||+|+||++++++.++|+|||++
T Consensus 83 ~~~L~~~l~~------------~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 83 GGSLADLLKK------------VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999953 2568899999999999999999999 8 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 876433211 123457889999999999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=260.38 Aligned_cols=194 Identities=25% Similarity=0.386 Sum_probs=169.0
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.+.||+|++|.||++... ++.+++|++........+.+.+|+.++++++|+|++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 368999999999999864 478999998766555567789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 104 ~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 104 TDIVTH-------------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred HHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 998842 3578899999999999999999998 999999999999999999999999998875532
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.. .......++..|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 168 EV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred CC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 21 11223458889999999988889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=260.52 Aligned_cols=201 Identities=30% Similarity=0.397 Sum_probs=165.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC-----CeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN-----TKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~-----~~~~LV 598 (749)
+.+.+.||+|+||.||++... ++.+|+|.+..... ..+++.+|+.++.++ +|+|++++++++... ...++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 344678999999999999874 47899999865432 245678899999998 899999999998653 358899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 103 ~ey~~~~sL~~~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 103 LELCNGGSVTELVKGLL--------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred EEECCCCcHHHHHHHhh--------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 99999999999886431 1345688999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCC-----CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-----LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+++...... .......++..|+|||.+.... ++.++|||||||++|||++|+.||....
T Consensus 172 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 172 FGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 99988654321 1122345788999999986443 6889999999999999999999997643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=255.28 Aligned_cols=206 Identities=28% Similarity=0.383 Sum_probs=170.6
Q ss_pred hhcccccccccCceEEEEEEECC------cccEEEEecCCchh-h-HHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD------KQVAVKMLSPSSVQ-G-YKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~~~~-~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~ 596 (749)
.|+....||+|.||.||||+-.+ +.+|+|+++..... + -....+|+.+++.++|+|++.|..++-+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 35567889999999999996522 37899998765322 1 2456799999999999999999998866 78899
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC----C
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK----F 672 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~----~ 672 (749)
|++||.+. +|...++.++. .+.+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |
T Consensus 105 l~fdYAEh-DL~~II~fHr~-------~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRA-------SKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred EEehhhhh-hHHHHHHHhcc-------chhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 99999987 89999876643 2446788999999999999999999998 79999999999999877 8
Q ss_pred cEEEEecCCCccccCCCCce-eeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 673 QAKLADFGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+||+|+|+++++...-..- ....++-|.-|.|||.+.+.+ |+.+.||||.||++.||+|-++.|.+.++
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 99999999999885432211 223456789999999998864 89999999999999999999999987543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=262.21 Aligned_cols=198 Identities=27% Similarity=0.388 Sum_probs=166.4
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+..+.||+|++|.||+|+.. ++.||||++.... ....+.+.+|++++++++|+|++++++++.+.+..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45678999999999999874 5889999886442 2234578899999999999999999999999999999999995
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|.+++... ....+++..+.+++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 83 -~~l~~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 83 -QDLKKFMDAS----------PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred -cCHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 6898888542 335689999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+.+.. ++.++||||||++++||+||+.||...+
T Consensus 149 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 149 AFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred hcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 654321 1112334678899999887654 6889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=260.46 Aligned_cols=198 Identities=27% Similarity=0.386 Sum_probs=168.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+++.+.||+|++|.||+|+.. ++.||+|++... .....+.+.+|++++++++|+|++++++++...+..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 556789999999999999885 478999988654 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+++.+..+.. ....+++..+..++.++++||+|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 83 ~~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 83 ERTLLELLEA------------SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCCHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 9877665542 234578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
........ .......++..|+|||++.+. .++.++||||||++++||++|++||...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87654321 122234578889999999888 8899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=257.80 Aligned_cols=190 Identities=29% Similarity=0.459 Sum_probs=157.7
Q ss_pred cccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHH---HHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 532 VLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVEL---LMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~i---L~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.||+|+||.||++... ++.||+|.+..... .....+..|..+ +...+|++++.+.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 47899999875422 122234444443 444589999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 81 g~~L~~~l~~------------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 81 GGDLHYHLSQ------------HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 9999988842 34689999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.+... ......|+..|+|||.+.++ .++.++|+|||||+++||++|+.||...
T Consensus 146 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 146 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 65322 11234688999999999754 6899999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=257.84 Aligned_cols=194 Identities=28% Similarity=0.459 Sum_probs=167.7
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||+|+||.||+++.. ++.+++|.+..... ...+.+.+|++++.+++|+|++++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999985 58899999875533 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++... ..+++..+.+++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENV------------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9998532 3689999999999999999999998 999999999999999999999999999876533
Q ss_pred CCC------ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGG------SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~------~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
... ........++..|+|||.......+.++||||||++++||++|+.||....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 211 112233457889999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=258.00 Aligned_cols=198 Identities=29% Similarity=0.365 Sum_probs=168.4
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEEeeC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVYEFM 602 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~Ey~ 602 (749)
...+.||.|++|.||++... ++.+|+|.+..... ....++.+|++++++++|+||+++++++... ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 44578999999999999984 48899999875432 4457789999999999999999999998653 4689999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.... .....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 84 ~~~~L~~~l~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 84 EGGSLDSIYKKVK--------KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CCCCHHHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 9999999885432 1345688899999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 7653221 12335778899999999999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=261.40 Aligned_cols=195 Identities=25% Similarity=0.349 Sum_probs=163.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||.||+|+.. ++.+|+|.+..... ...+.+.+|++++++++|+|++++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 455688999999999999984 57899999865322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+ ++|.+++.. ....+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~-~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 82 D-QDLKKYFDS-----------CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred C-CCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 7 578887743 234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
+...... .......++..|+|||.+.+.. ++.++|||||||+++||+||+.|+.
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 8654321 1112345788999999987654 6899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=259.27 Aligned_cols=197 Identities=27% Similarity=0.383 Sum_probs=165.6
Q ss_pred hcccccccccCceEEEEEEE-----CCcccEEEEecCCch----hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSV----QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~ 596 (749)
+.+.+.||+|+||.||+++. ++..||+|++..... ...+.+.+|+.++.++ +|+||+++.+++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34568899999999999986 457899999875422 2346678899999999 6999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|+||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+|||+++++.+||
T Consensus 82 lv~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 82 LILDYINGGELFTHLSQ------------RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred EEEecCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 99999999999999853 23578888999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+|||+++...... ........++..|+|||.+... ..+.++||||||++++||++|+.||..
T Consensus 147 ~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 147 TDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred eeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 9999998653321 1112234588899999998753 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=257.33 Aligned_cols=194 Identities=27% Similarity=0.447 Sum_probs=172.8
Q ss_pred ccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
+.++||+|.||.|||+.. .++.+|+|.+...+ +.+++..|+.++.+.+.+++|+.+|.+.....+++|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 357899999999999976 46889999987543 35788999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
..+.+.. +.+.+++.++..++...++||+|||.. .=||||||+.|||++-+|.+||+|||.|..+.
T Consensus 115 iSDI~R~-----------R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 115 ISDIMRA-----------RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred HHHHHHH-----------hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999864 567899999999999999999999998 78999999999999999999999999997653
Q ss_pred CCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.. ......+.||+.|||||++..--|+.++|+||+|+...||..|++||...
T Consensus 181 DT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 181 DT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred hh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 21 22234678999999999999999999999999999999999999999864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=259.20 Aligned_cols=193 Identities=31% Similarity=0.442 Sum_probs=164.5
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+...+.||+|+||.||+|+. +++.||+|++.... ....+++.+|++++++++|+|++++.++|...+..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 55568899999999999987 45889999886432 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++ |+|.+.+.. ....+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||+
T Consensus 97 ~~-g~l~~~~~~-----------~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 97 CL-GSASDILEV-----------HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred hC-CCHHHHHHH-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCc
Confidence 96 577777642 223589999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+...... ....++..|+|||.+. ...++.++||||||+++|||+||+.||...
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 8764322 2345788999999884 456889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=258.21 Aligned_cols=201 Identities=27% Similarity=0.440 Sum_probs=168.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+.+.||+|++|.||+|+.. +..||||++...... ..+.+.+|++++++++|+|++++++++...+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 455689999999999999984 578999998765332 34567889999999999999999999999999999999998
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.+++... .....+++..+.+++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 82 ~-~l~~~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 82 K-DLKKYMDTH---------GVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred c-cHHHHHHhc---------CCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 5 888887532 1234689999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
...... .......++..|++||.+.+. .++.++||||||++++||++|+.||...+.
T Consensus 149 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 149 AFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred hhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 653221 111233568899999998654 568899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=254.10 Aligned_cols=191 Identities=29% Similarity=0.435 Sum_probs=161.0
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchh---hHHHHHHHHHHH-HhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ---GYKQFQAEVELL-MRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~---~~~~f~~Ei~iL-~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|+. .++.||+|.+...... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999987 4578999998755322 223345555444 445899999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ...+++..+.+++.|+++||.|||+. +++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 82 GDCASLIKT------------LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 999999843 23578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
... .....++..|+|||.+.+..++.++||||||++++||++|+.||...+.
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 432 1234578899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=260.51 Aligned_cols=193 Identities=25% Similarity=0.391 Sum_probs=168.5
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
..||+|+||.||++.. ++..||+|++........+.+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 6799999999999987 45889999987655555677899999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 688 (749)
+++. ...+++.....++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 106 ~~~~-------------~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 106 DIVT-------------HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred HHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 8773 23478999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
. .......++..|+|||.+.+..++.++|+||||++++||++|+.||....
T Consensus 170 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 170 V--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred c--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11233457889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=248.83 Aligned_cols=196 Identities=33% Similarity=0.532 Sum_probs=173.6
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
...+.||+|++|.||+++.. +..+++|++........+.+.+|++++++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45688999999999999985 5789999998766556678999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++... ...+++..+..++.++++||++||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 83 ~L~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 83 SLKDLLKST-----------NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred cHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 999998532 25689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
..... .....++..|++||.+.....+.++||||||++++||++|+.||...
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 44321 23445788999999999888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=256.54 Aligned_cols=199 Identities=27% Similarity=0.345 Sum_probs=162.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHH-HHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVEL-LMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~i-L~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|+||.||+++.. ++.||+|++.... .....++..|+.+ ++..+|+|++++++++..+...+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 345688999999999999874 5889999987542 2334456667665 55679999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+ |+|.+++.... .....+++..+.+++.|++.||+|||+++ +++||||||+||++++++.+||+|||++
T Consensus 83 ~-~~l~~~l~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 83 D-TSLDKFYKKVY--------DKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred c-ccHHHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 6 68888875431 13356899999999999999999999743 7999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCcccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYIS----NRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+..... .......++..|+|||.+.+ ..++.++|+|||||+++||++|+.||..
T Consensus 152 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 152 GYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 865321 11223457889999998865 4468899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=257.63 Aligned_cols=198 Identities=28% Similarity=0.433 Sum_probs=172.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||+|++|.||+|... ++.+++|++..... ..+.+.+|++++++++|+|++++++++......++|+||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 344578999999999999986 58899999986654 557789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ...+++..+..++.++++||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 100 ~~L~~~l~~~-----------~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 100 GSLTDIITQN-----------FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred CcHHHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 9999999542 13689999999999999999999998 999999999999999999999999998876
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 543211 1123347789999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=256.13 Aligned_cols=195 Identities=32% Similarity=0.439 Sum_probs=170.1
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.||+|++|.||++... ++.+|+|.+.... ....+++.+|++++++++|+||+++++.+......++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45578999999999999985 5889999987653 34556789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|.+++... ...+++..+.+++.|+++||+|||+ . +++|+||||+||++++++.++|+|||.+.
T Consensus 84 ~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 84 GSLDKILKEV-----------QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred CcHHHHHHHc-----------cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccch
Confidence 9999998532 2568889999999999999999999 7 99999999999999999999999999987
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
...... .....++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 150 ~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 150 QLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 653221 11256788999999999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=256.10 Aligned_cols=199 Identities=28% Similarity=0.468 Sum_probs=164.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEec------CCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDE------NTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~------~~~~~ 596 (749)
.+.+.+.||+|+||.||+|+.. ++.+|+|+..... ....++..|+.++.++ +|+|++++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4455689999999999999984 4789999886543 3346788999999998 79999999999853 46789
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|
T Consensus 96 iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT----------KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred EEEEeCCCCcHHHHHHHc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 999999999999998542 234578888999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999987653221 1122345888999999986 346788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=249.77 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=173.0
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEEee
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVYEF 601 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~Ey 601 (749)
...+.||+|++|.||+|+.. ++.|++|++..... ...+.+.+|++++++++|+|++++++.+... ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999986 58899999876542 4567899999999999999999999999888 899999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ...+++..+..++.++++||+|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~~~~L~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 83 VSGGSLSSLLKK------------FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred cCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccccc
Confidence 999999999853 22789999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+................++..|+|||.+.....+.++||||||++++||++|+.||...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 987654322111234458889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=254.68 Aligned_cols=200 Identities=30% Similarity=0.465 Sum_probs=170.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|+||.||+|... +..+|+|.+.... ....+.+.+|++++++++|+|++++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456688999999999999984 4789999986542 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL~DFGl 681 (749)
++++|.+++... ....+++..++.++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.
T Consensus 82 ~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 82 DGGDLMKRINRQ----------RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 999999998542 234579999999999999999999998 999999999999999875 579999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+....... .......|+..|+|||+..+..++.++||||||++++||++|+.||...+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 149 ARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred chhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 98764321 12223458889999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=258.28 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=165.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+.. ++.+++|.++.... .....+.+|+.++.+++|+||+++.+++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3455689999999999999985 47899999875432 2234567899999999999999999998776 8899999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||++ ++|.+++... ...+++..+++++.|+++||+|||+. +++|+||||+||++++++.+||+||
T Consensus 86 e~~~-~~L~~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 86 EYVE-HDLKSLMETM-----------KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred hhcC-cCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeec
Confidence 9997 5898888532 23689999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+++...... .......++..|+|||.+.+. ..+.++|+||||++++||++|+.||....
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 151 GLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998764331 111233477889999998764 46899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=254.84 Aligned_cols=201 Identities=28% Similarity=0.457 Sum_probs=167.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCC------eeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENT------KMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~------~~~ 596 (749)
.+.+.+.||+|++|.||+|+.. ++.+++|++..... ..+++.+|+++++++ +|+|++++++++.... ..+
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 4556789999999999999984 47799999876543 346789999999999 7999999999996544 489
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++++|.+++.... .....+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||
T Consensus 86 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLR--------KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred EEEEcCCCCcHHHHHHHHh--------hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 9999999999999985431 1245689999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|||++....... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||...
T Consensus 155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9999987653221 11223458889999998753 34678999999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=260.25 Aligned_cols=203 Identities=19% Similarity=0.208 Sum_probs=152.0
Q ss_pred HHHHhhcccccccccCceEEEEEEECC-----cccEEEEecCCchhhH-----------HHHHHHHHHHHhcCCCceeEE
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSSVQGY-----------KQFQAEVELLMRAHHKNLTIL 585 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~~~~~-----------~~f~~Ei~iL~~l~H~nIv~l 585 (749)
+....+.+.+.||+|+||+||+|...+ ..+|+|+......... .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 333456778999999999999998754 3566665432221110 112233344566789999999
Q ss_pred EEEEecCC----eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 586 VGYCDENT----KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 586 ~g~~~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
++++.... ..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+. +|+||||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDi 152 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR------------IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDI 152 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh------------hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99765443 3467777663 366665532 12346788899999999999999998 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
||+|||+++++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.|
T Consensus 153 Kp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 153 KPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred CHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999876432211 111234699999999999999999999999999999999999999
Q ss_pred CCCC
Q 037623 737 IQKT 740 (749)
Q Consensus 737 f~~~ 740 (749)
|...
T Consensus 233 ~~~~ 236 (294)
T PHA02882 233 WKGF 236 (294)
T ss_pred CCcc
Confidence 9875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=284.18 Aligned_cols=209 Identities=30% Similarity=0.455 Sum_probs=172.3
Q ss_pred cccccccccCceEEEEEEEC---------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeE
Q 037623 528 NFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.||+|+||.|++|... ...||||.++... ....+.+..|+++|..+ +|+|++.++|+|..+...+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45569999999999999853 2469999998653 34567899999999998 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhcc--CCCCccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 597 LVYEFMANGNLQAHLLAQLAI--LPTDAEDKT--GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~--~~~~~~~~~--~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
+|.||++.|+|.++|...+.. ......... ..+.....+.++.|||.||+||++. ++|||||.++|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 999999999999999876500 000000111 3489999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeecc-ccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTV-VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQK 739 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~ 739 (749)
.+||+|||+|+.....+........ .-..+|||||.+....++.|+|||||||+||||+| |..||.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999976544333222111 12457999999999999999999999999999998 8899976
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=260.16 Aligned_cols=193 Identities=33% Similarity=0.454 Sum_probs=163.8
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+...+.||+|+||.||+++.. +..+|+|++.... ....+++.+|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 444578999999999999873 4789999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++ |+|.+.+.. ....+++.++..++.+++.||.|||+. +|+||||+|+||++++++.+||+|||+
T Consensus 107 ~~-g~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 107 CL-GSASDLLEV-----------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CC-CCHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 96 578777743 234589999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+...... ....++..|+|||.+. .+.++.++|||||||+++||++|+.||...
T Consensus 172 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 172 ASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 8754321 2335788999999974 456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=278.91 Aligned_cols=203 Identities=23% Similarity=0.288 Sum_probs=158.5
Q ss_pred HHHhhcccccccccCceEEEEEEECC---cccEEE------------------EecCCchhhHHHHHHHHHHHHhcCCCc
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLDD---KQVAVK------------------MLSPSSVQGYKQFQAEVELLMRAHHKN 581 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~~---~~VAVK------------------~l~~~~~~~~~~f~~Ei~iL~~l~H~n 581 (749)
....|.+.+.||+|+||+||++.... ...+.| .+. ........+++|++++.+++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34567778999999999999987532 111211 111 11223456889999999999999
Q ss_pred eeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 582 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
|+++++++...+..++|+|++. ++|.+++..... ..........+.+++.|++.||+|||++ +|+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDL 293 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAF-------DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDI 293 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccc-------cccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9999999999999999999984 577777743211 1122234566788999999999999998 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCC-CCC
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP-VIQ 738 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~-pf~ 738 (749)
||+|||+++++.+||+|||+++.+.... ........|+..|+|||++.+..++.++|||||||++|||++|+. |+.
T Consensus 294 KP~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 294 KLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CHHHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999999998764321 122234568999999999999999999999999999999999885 444
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-28 Score=256.22 Aligned_cols=202 Identities=24% Similarity=0.304 Sum_probs=164.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe-----eE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTK-----MG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~-----~~ 596 (749)
+...+.||+|+||.||+|... ++.||+|+...... .....+.+|+.++.++ +|+|++++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455688999999999999874 57899998765422 2335788899999999 56999999999876655 89
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAK 675 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~k 675 (749)
+||||+++ +|.+++..... .....+++..++.++.|+++||+|||+. +|+||||||+||+++. ++.+|
T Consensus 83 lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGR-------GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEeeccCc-CHHHHHHHhcc-------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 99999985 89888864321 1234689999999999999999999998 9999999999999998 88999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++.+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999865332111 122346788999998865 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=256.27 Aligned_cols=198 Identities=29% Similarity=0.408 Sum_probs=166.9
Q ss_pred cccccccccCceEEEEEEECC--cccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEEee
Q 037623 528 NFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVYEF 601 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~Ey 601 (749)
.+.+.||+|++|.||+|+..+ +.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 456889999999999998854 889999998663 33346788999999999999999999999887 899999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++ +|.+++.. ....+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 82 MDH-DLTGLLDS-----------PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred ccc-cHHHHHhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccc
Confidence 975 88888742 224689999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.||...+
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 987644321 11223356788999998765 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=255.40 Aligned_cols=198 Identities=26% Similarity=0.376 Sum_probs=165.9
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.||.|++|.||+|.. ++..||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 3457899999999999987 45889999987543 2233568899999999999999999999999999999999995
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|.+++... ....+++..+++++.|+++||+|||+. +++||||+|+||++++++.++|+|||+++
T Consensus 82 -~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 82 -LDLKKYMDSS----------PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred -cCHHHHHhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 6899988542 224689999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.+..... ......++..|+|||++.+. .++.++||||||+++|||++|++||...+
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6532211 11223467899999988664 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=248.25 Aligned_cols=197 Identities=30% Similarity=0.498 Sum_probs=172.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||+++.. ++.+++|.+..... ...+.+.+|++++.+++|+|++++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 445689999999999999874 47899999977654 45678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 82 ~~~~L~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 82 ENGSLRQIIKK------------FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred CCCcHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 99999999843 24689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
........ ......++..|+|||...+...+.++||||+|++++||++|+.||...
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 147 TKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred eecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 87643321 123345788999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=244.53 Aligned_cols=193 Identities=27% Similarity=0.413 Sum_probs=164.2
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCC-chhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPS-SVQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
..||+|..|+|++++... ..+|||.+..+ +..+.++++..++++.+-+ .|.||+.+||+..+....+.||.|. ..
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 679999999999998855 88999998766 5566788888888887775 8999999999999999999999984 45
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
++.+|... .+.+++..+-++...+.+||.||.+++ +|||||+||+|||+|+.|++|+||||++..+-
T Consensus 177 ~ekLlkri-----------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 177 AEKLLKRI-----------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHh-----------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 66666432 345777778889999999999999875 99999999999999999999999999998764
Q ss_pred CCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
. ....+..+|.+.|||||.+. ..+|+.++||||||+.|+||.||+-||.+.
T Consensus 244 d---SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 244 D---SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred c---ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 2 33445567999999999995 346899999999999999999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=261.51 Aligned_cols=197 Identities=26% Similarity=0.376 Sum_probs=167.6
Q ss_pred hcccccccccCceEEEEEEECC-cccEEEEecC--CchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSP--SSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~--~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|+..++||+||.+.||++...+ +.+|+|++.. .+.+....|.+|+..|.++ .|.+|++|++|-..++.+||||||=
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 4455889999999999999876 6788887643 4566678899999999999 5899999999999999999999975
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
.-+|...|... .....+| .+..+..|+++|+.++|++ ||||.||||.|+|+-++ .+||+|||+|
T Consensus 443 -d~DL~kiL~k~----------~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA 506 (677)
T KOG0596|consen 443 -DIDLNKILKKK----------KSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIA 506 (677)
T ss_pred -cccHHHHHHhc----------cCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechh
Confidence 56999999643 2223345 6778999999999999999 99999999999999876 8999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccC-----------CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISN-----------RLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
..+..+...-.....+||+.||+||.+... +.+.++||||+||+||+|+.|++||..
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 998877656566677899999999998532 367899999999999999999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=264.05 Aligned_cols=199 Identities=31% Similarity=0.484 Sum_probs=164.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC--CeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN--TKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~--~~~~LV 598 (749)
.+.+.+.||+|+||.||+|... ++.+|+|++... .......+.+|+.++.++ +|+||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4556789999999999999874 578999988542 233445678899999999 999999999998643 468999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||++ ++|..++.. ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 88 ~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 88 FEYME-TDLHAVIRA-------------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ecccc-cCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 99997 589888732 2678999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCc---eeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGS---HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+++........ .......++..|+|||.+.+ ...+.++||||||+++|||++|+.||....
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876433221 12223458889999998765 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=251.77 Aligned_cols=187 Identities=24% Similarity=0.314 Sum_probs=156.0
Q ss_pred cccc--ccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 529 FERV--LGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 529 f~~~--LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+.+. ||+|+||.||+++.. +..+|+|......... .|+.....+ +|+|++++++.+...+..++||||++
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~ 92 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92 (267)
T ss_pred cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence 4444 599999999999874 4778999886542221 122222222 79999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEEEecCCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADFGLS 682 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL~DFGla 682 (749)
+++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++
T Consensus 93 ~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 93 DGDLFDLLKK------------EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999853 23789999999999999999999998 999999999999999988 9999999998
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..... ....++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 765322 12357889999999999899999999999999999999999998543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=249.76 Aligned_cols=202 Identities=30% Similarity=0.447 Sum_probs=175.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||++... +..+++|++..... ...+++.+|++++++++|+|++++.+.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345688999999999999986 58899999876533 45677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.... .....+++..+..++.++++||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 82 DGGDLSQKIKKQK--------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred CCCcHHHHHHHhh--------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 9999999996532 1246789999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
....... .......+++.|+|||......++.++||||+|++++||++|+.||...+
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 151 KVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred eecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 8654332 12233468889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=259.13 Aligned_cols=199 Identities=24% Similarity=0.271 Sum_probs=165.9
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.+.+|.|+++.||+++.+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 355666777777888778899999998754 344567899999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.+..+..
T Consensus 87 ~~~l~~~----------~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 87 EDLLKTH----------FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred HHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 9999643 233578889999999999999999999 999999999999999999999999998876532
Q ss_pred CCCc-----eeeeccccCCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGS-----HVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~-----~~~~~~~gt~~y~APE~~~~~--~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.... .......++..|+|||++... .++.++|||||||+++||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2111 111223467789999998763 57889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=255.11 Aligned_cols=199 Identities=24% Similarity=0.374 Sum_probs=163.2
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||+|+.. ++.||+|.+..... ...+.+.+|++++++++|+|++++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456689999999999999874 47899998865422 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFGl 681 (749)
+ ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++ ++.+||+|||+
T Consensus 84 ~-~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 84 D-LDLKKHMDSS----------PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred c-ccHHHHHHhC----------CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccc
Confidence 6 5788877432 223457888889999999999999998 9999999999999985 56799999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+....... .......++..|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 150 ARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred ccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 97653321 111233567899999998664 57899999999999999999999997543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=252.32 Aligned_cols=195 Identities=26% Similarity=0.332 Sum_probs=161.2
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeEEEEEEecC--CeeEEEEee
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV-QGYKQFQAEVELLMRAH-HKNLTILVGYCDEN--TKMGLVYEF 601 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~--~~~~LV~Ey 601 (749)
.+.+.||+|+||.||+|+. +++.+|+|+++.... .......+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4568899999999999987 458899999875422 22234457888898885 99999999999877 889999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++ |+|.+.+.. ....+++..+..++.|+++||+|||+. +++||||||+||++++ +.+||+|||+
T Consensus 82 ~~-~~l~~~l~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 82 MD-MNLYELIKG-----------RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred CC-ccHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccc
Confidence 96 588888743 234689999999999999999999998 9999999999999999 9999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++.+..... .....++..|+|||.+.. +..+.++|||||||+++||++|+.||.+.+
T Consensus 146 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 146 CRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 987643211 122357889999998654 557889999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=258.18 Aligned_cols=200 Identities=28% Similarity=0.364 Sum_probs=164.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~ 599 (749)
.+++.+.||+|+||.||+|+.. ++.||+|.+..... .....+.+|+.++.+++|+|++++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 3456688999999999999874 58899999864422 1223567899999999999999999998654 5689999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||++ ++|.+++.. ....+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+||
T Consensus 88 e~~~-~~l~~~l~~-----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 88 EYCE-QDLASLLDN-----------MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred ecCC-CCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 9996 488888743 125689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|++||...+.
T Consensus 153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 153 GLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred ceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99987643321 1122345778999999865 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=256.14 Aligned_cols=200 Identities=28% Similarity=0.398 Sum_probs=162.8
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCC--------e
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENT--------K 594 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~--------~ 594 (749)
+.+.+.||+|+||.||+|+.. ++.||||.+..... .....+.+|++++++++|+||++++++|.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 566789999999999999874 58899998864322 22345678999999999999999999986544 4
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++||||++ ++|.+.+.. ....+++..+.+++.|+++||+|||+. +++|+||||+||++++++.+
T Consensus 94 ~~lv~e~~~-~~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSN-----------KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL 158 (310)
T ss_pred EEEEEcCCC-cCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence 599999996 478877742 233589999999999999999999998 99999999999999999999
Q ss_pred EEEecCCCccccCCCCc--eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|||++..+...... .......++..|+|||.+.+. .++.++||||||++++||++|++||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999866432211 111233477889999988665 36889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=262.11 Aligned_cols=198 Identities=27% Similarity=0.414 Sum_probs=162.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~L 597 (749)
.+.+.+.||+|+||.||+|+. +++.||+|++.... ......+.+|+.++.+++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 355678999999999999987 45889999986432 23446688999999999999999999987543 35789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|+||+++ +|...+. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 86 v~e~~~~-~l~~~~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 86 VQELMET-DLYKLIK-------------TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred Eehhccc-CHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEC
Confidence 9999964 7877762 24589999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCc-eeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999865432111 11123457889999998755 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=261.66 Aligned_cols=196 Identities=28% Similarity=0.368 Sum_probs=164.3
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Ce
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~ 594 (749)
..+...+.||+|+||.||+++. +++.||+|.+... .....+++.+|+.++.+++|+|++++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 3455668999999999999987 4588999998643 333446778899999999999999999988543 35
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 96 ~~lv~e~~~-~~l~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM--------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred EEEEEeccC-CCHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 689999995 588877731 178888999999999999999998 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|||+++..... .......++..|+|||.+.+..++.++|||||||+++||++|+.||...+
T Consensus 158 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 158 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred EEccCccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99999999865322 11223457889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=254.23 Aligned_cols=197 Identities=28% Similarity=0.381 Sum_probs=166.2
Q ss_pred hcccccccccCceEEEEEEE-----CCcccEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS----VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~ 596 (749)
+.+.+.||+|++|.||+++. ++..||||.++... ....+.+.+|++++.++ +|+|++++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 34568899999999999975 23679999987542 22345688999999999 6999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|
T Consensus 82 lv~e~~~~~~L~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 82 LILDYVNGGELFTHLYQ------------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred EEEecCCCCcHHHHHhh------------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 99999999999999843 24578999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+|||+++....... .......++..|+|||.+.+.. .+.++||||||++++||++|+.||..
T Consensus 147 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 147 TDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred EECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999886543321 1122345788999999987765 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=252.41 Aligned_cols=198 Identities=26% Similarity=0.341 Sum_probs=161.9
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.+.||+|+||.||+++.. ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||++ +
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~ 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence 478999999999999874 4889999987543 234567889999999996 9999999999999899999999986 4
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
++.++...... .....+++..+.+++.++++||+|||+.+ +++||||||+||++++++.+||+|||+++.+
T Consensus 88 ~l~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 88 SLDKFYKYVYE-------VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred CHHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 66554321100 12356899999999999999999999742 8999999999999999999999999999765
Q ss_pred cCCCCceeeeccccCCcccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.... ......++..|+|||.+.+. .++.++|||||||+++||++|+.||...
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 159 VDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred ccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 3221 11233578899999999776 6899999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=255.20 Aligned_cols=201 Identities=30% Similarity=0.406 Sum_probs=164.6
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC-------
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT------- 593 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~------- 593 (749)
..+.+.+.||+|+||.||+|+.. ++.||+|++.... ......+.+|++++++++|+|++++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 34566789999999999999984 4789999986542 223356788999999999999999999987654
Q ss_pred ---eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 594 ---KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 594 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
..++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+. +|+|+||||+||++++
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~ 151 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLES-----------GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNN 151 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 78999999976 67666632 234689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++.+||+|||++..+..... .......++..|+|||.+.+. ..+.++|||||||+++||++|++||...+
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 152 KGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred CCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999987643321 111223457789999988653 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=248.70 Aligned_cols=201 Identities=28% Similarity=0.433 Sum_probs=173.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||+++.. ++.+++|.+.... .....++.+|++++++++|+||+++.+++......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345688999999999999874 4789999987542 334567789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++.... .....+++..+..++.++++||+|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 82 PFGDLSKAISKRK--------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred CCCCHHHHHHHHH--------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 9999999986532 1345689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+..... ......++..|++||.+.+..++.++|+||||++++||++|+.||...+.
T Consensus 151 ~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 151 KVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred hhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 876433 22234578899999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=267.81 Aligned_cols=196 Identities=27% Similarity=0.436 Sum_probs=170.8
Q ss_pred cccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
...||.|+||.|||++... ...|.|++...+....+.|.-|++||+.++||+||+|++.+..++.++++.|||.||-.
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 3579999999999998765 34677888877888889999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
+..+.. -...|.+.++.-++++++.||.|||++ .|||||||+.|||++-+|.++|+|||.+-....
T Consensus 117 DaimlE-----------L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 117 DAIMLE-----------LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred hHHHHH-----------hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 888743 456789999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
. -.......||+.|||||++. +.+|+.++||||||+.|.||..+.+|-...+
T Consensus 183 t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 183 T--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred H--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 2 12234568999999999975 4579999999999999999999999986543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=259.29 Aligned_cols=197 Identities=29% Similarity=0.368 Sum_probs=163.0
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCCchhh--------------HHHHHHHHHHHHhcCCCceeEEEEEEecCC
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQG--------------YKQFQAEVELLMRAHHKNLTILVGYCDENT 593 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~--------------~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~ 593 (749)
.+.||+|+||+||+|+.. ++.||||++....... ...+.+|++++.+++|+|++++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999864 5889999986543221 125778999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++||||++ |+|.+++.. ...+++.....++.|+++||+|||+. +++|+||+|+||++++++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~------------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR------------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 9999999996 689888842 34588999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCccccCCCC------------ceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGG------------SHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+||+|||+++....... ........++..|+|||.+.+. .++.++|||||||+++||++|++||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999986541110 0111223467889999998764 4689999999999999999999999765
Q ss_pred Cc
Q 037623 741 PE 742 (749)
Q Consensus 741 ~~ 742 (749)
++
T Consensus 238 ~~ 239 (335)
T PTZ00024 238 NE 239 (335)
T ss_pred CH
Confidence 43
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=258.11 Aligned_cols=198 Identities=24% Similarity=0.282 Sum_probs=161.9
Q ss_pred cccccc--CceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKG--GFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G--~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+| +||+||+++. .++.||+|++.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999987 56899999987542 33457788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++++||+.+..
T Consensus 84 ~~l~~~l~~~----------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTY----------FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 9999988543 223588999999999999999999998 999999999999999999999999986543
Q ss_pred ccCCCCce-e----eeccccCCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSH-V----STTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~-~----~~~~~gt~~y~APE~~~~~--~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
........ . .....++..|+|||++.+. .++.++|||||||+++||++|+.||....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 32211110 0 0112245679999999764 47899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=252.26 Aligned_cols=198 Identities=30% Similarity=0.421 Sum_probs=164.4
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeEEEEEEecCCe-----e
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRA---HHKNLTILVGYCDENTK-----M 595 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l---~H~nIv~l~g~~~~~~~-----~ 595 (749)
++.+.||+|+||.||+|+.. ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45688999999999999985 58899999874422 2234566788777666 69999999999987776 8
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
+++|||+. ++|.+++... ....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+|
T Consensus 82 ~l~~e~~~-~~l~~~l~~~----------~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKC----------PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred EEEehhcc-cCHHHHHHHc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEE
Confidence 99999997 4898888542 223589999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||++..+..... .....++..|+|||.+.+..++.++|+|||||+++||++|++||....+
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 999999987643211 1223478899999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=232.75 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=164.6
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
..||+|++|.|=+-++ +++..|+|.+... ..+..++.++|+++..+. .+|.+|.++|....+...++.||.| ..|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence 5799999999866655 6788999998765 445667888999887665 8999999999999999999999999 457
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
|+.+-.... +....+++...-+||..+..||.|||++. .+||||+||+|||++.+|++|+||||++..+.
T Consensus 131 ldkfy~~v~--------~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 131 LDKFYRKVL--------KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHHHHHHH--------hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 876654332 46778899999999999999999999874 89999999999999999999999999998763
Q ss_pred CCCCceeeeccccCCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
. +-..+...|...|||||.+..+ .|+-|+||||||+.+.||.+++.||...
T Consensus 201 d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 201 D---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred h---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 2 2223335688899999998543 5889999999999999999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=252.53 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=171.6
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~E 600 (749)
|.+.+.||+|++|.||+++. +++.||+|++... .....+.+.+|++++.+++ |+||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 45678999999999999988 4588999998753 2233467889999999998 9999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||
T Consensus 83 ~~~~~~L~~~l~~------------~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 83 YAPNGELLQYIRK------------YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred CCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999843 23689999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCc------------------eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGS------------------HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~------------------~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++......... .......++..|+|||.......+.++|+||||++++|+++|+.||....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 98866432211 11123357889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=246.19 Aligned_cols=192 Identities=34% Similarity=0.490 Sum_probs=167.5
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
||+|+||.||+++.. ++.+++|.+..... ...+.+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999985 58899999875432 2456789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~------------~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK------------EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999853 23588999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.. .......++..|+|||...+...+.++|+||||++++||++|+.||...+
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 21 12234457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=248.26 Aligned_cols=209 Identities=26% Similarity=0.362 Sum_probs=169.5
Q ss_pred cccCHHHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeEEEEEEe
Q 037623 515 RKLSYANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRA-HHKNLTILVGYCD 590 (749)
Q Consensus 515 ~~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~ 590 (749)
..|+-.++... ..||.|+||+|+|-..+ ++..|||+++.... .+.++++.|.+...+- +.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 45555555544 57999999999998774 58899999986543 5667889999876665 8999999999999
Q ss_pred cCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 591 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.++.-++.||.| .-||+.+-..-.. -....+++.-.-+|......||.||.... .|||||+||+|||++.
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~-------vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYS-------VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDR 203 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHH-------HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEec
Confidence 999999999999 4577665432211 24456788888889999999999998764 8999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.|.+||||||++..+. ++...+.-+|...|||||.+... -++.++||||||+.|+|+.||+.|+++.+
T Consensus 204 ~G~vKLCDFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred CCCEeeecccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 9999999999987653 22334455789999999999643 48899999999999999999999998754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=242.44 Aligned_cols=189 Identities=26% Similarity=0.386 Sum_probs=161.5
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEec----CCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDE----NTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 603 (749)
++||-|-.|.|-.+.. +++.+|+|++.+. ...++|+++--+. .|+|||.++++++. ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 6899999999998876 4588999998755 3346788776554 79999999999854 567889999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEEEEecC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAKLADFG 680 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~kL~DFG 680 (749)
||.|++.+..+ ..+.++++++-.|+.||+.|+.|||+. .|.||||||+|+|... |-.+||+|||
T Consensus 143 GGeLfsriq~~----------g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 143 GGELFSRIQDR----------GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred chHHHHHHHHc----------ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 99999999653 456799999999999999999999999 9999999999999974 4579999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|+.-.. .........|+.|.|||++-.++++..+|+||+||++|-|+.|.+||...
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 9986432 22234556899999999999999999999999999999999999999764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=258.43 Aligned_cols=195 Identities=29% Similarity=0.457 Sum_probs=166.8
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCchh---hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||-|+||.|.++.-.+ ..+|.|.+.+.+.- .....+.|.+||+..+.+-||+|+..+.+++.+|.||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 579999999999997544 67899998876543 2345789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
++-++|. +.+.+.+..++..+.++..|+++.|.. |+|||||||+|||||.+|++||.||||+.-+
T Consensus 715 DmMSLLI------------rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 715 DMMSLLI------------RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred cHHHHHH------------HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 9999995 346788888888899999999999988 9999999999999999999999999998644
Q ss_pred c--------CCCCc-----------------e---------------eeeccccCCcccCccccccCCCCCchhHHHHHH
Q 037623 686 P--------VEGGS-----------------H---------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGV 725 (749)
Q Consensus 686 ~--------~~~~~-----------------~---------------~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGv 725 (749)
. ..++. . .....+||..|+|||++...-++.-+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1 00000 0 001346999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 037623 726 VLLELITGQPVIQKT 740 (749)
Q Consensus 726 vL~ElltG~~pf~~~ 740 (749)
||+||+.|++||-..
T Consensus 860 il~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLAD 874 (1034)
T ss_pred HHHHHhhCCCCccCC
Confidence 999999999999753
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=289.83 Aligned_cols=197 Identities=28% Similarity=0.408 Sum_probs=165.8
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
..||.|.||.||-|.. +|.-.|+|-+... .....+...+|+.++..++|||+|+.+|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 5899999999999986 4467899976543 33445678899999999999999999999999999999999999999
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
|.+.+. ..+..++.....+-.|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|..+.
T Consensus 1321 La~ll~------------~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1321 LASLLE------------HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHH------------hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999994 344566666677889999999999999 99999999999999999999999999999875
Q ss_pred CCCCc--eeeeccccCCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 687 VEGGS--HVSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 687 ~~~~~--~~~~~~~gt~~y~APE~~~~~~---~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
..... .......||+-|||||++.+.+ ..-++||||+|||.+||+||++||..-+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 43110 1112456999999999997543 55689999999999999999999986543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=253.90 Aligned_cols=194 Identities=31% Similarity=0.434 Sum_probs=163.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
++...+.||+|+||.||+|+.. +..+|+|.+... .....+++.+|++++++++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3444578999999999999874 477999988642 22345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+. |+|.+.+.. ....+++..+..++.+++.||.|||+. +++||||||+||++++++.++|+|||
T Consensus 96 ~~~-~~l~~~~~~-----------~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 96 YCL-GSASDLLEV-----------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred ccC-CCHHHHHHH-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 996 688777743 223578999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++...... ....++..|+|||.+. .+..+.++|||||||+++||++|+.||...
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 161 SASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred cceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 98765322 2335788999999974 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=250.64 Aligned_cols=197 Identities=29% Similarity=0.386 Sum_probs=165.5
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.||+|++|+||+|+.. ++.|++|++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45688999999999999984 47899999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++... ....+++..++.++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||+++
T Consensus 81 ~~~l~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 81 EGNLYQLMKDR----------KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred CCCHHHHHHhc----------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 88999988542 234689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... ......++..|+|||.+. ...++.++|+||||++++||++|++||....
T Consensus 148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 148 EIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred eccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 653221 112345788999999885 4557899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=249.38 Aligned_cols=191 Identities=32% Similarity=0.456 Sum_probs=162.2
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.||+|+||+||+|+. .++.|++|++.... ....+.+.+|++++++++|+|++++++++.+.+..++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 46799999999999987 45789999986432 2334578899999999999999999999999999999999995
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+.+.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 105 ~~l~~~l~~-----------~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 105 GSASDLLEV-----------HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 578777743 234588999999999999999999998 999999999999999999999999998864
Q ss_pred ccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
... .....++..|+|||++. ...++.++|||||||+++||++|+.||...+
T Consensus 171 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 171 SSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred cCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 12345788999999984 4568889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=258.30 Aligned_cols=192 Identities=29% Similarity=0.420 Sum_probs=159.6
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------CeeEE
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKMGL 597 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~~L 597 (749)
...+.||+|+||.||+|.. +++.||+|++... .....+.+.+|++++.+++|+||+++.+++... ...++
T Consensus 20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 3457899999999999986 3578999998754 223346788999999999999999999988542 34678
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
+++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 100 v~~~~-~~~L~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 100 VTHLM-GADLNNIVK-------------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred Eehhc-ccCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 88876 789988773 23588999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...+
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998864221 223457889999999866 568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=250.96 Aligned_cols=196 Identities=26% Similarity=0.380 Sum_probs=161.8
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|++|.||+|+.. ++.||||.++.... ....++..|+.++.+.+ |+||+++++++.+....++||||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 455689999999999999986 68899999875432 33456777887777775 999999999999999999999998
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+ ++|.+.+.. ....+++..+.+++.++++||+|||+.+ +|+||||+|+||++++++.+||+|||++
T Consensus 97 ~-~~l~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 97 S-TCLDKLLKR-----------IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred C-cCHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccc
Confidence 5 477776643 1236899999999999999999999731 8999999999999999999999999998
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
..+.... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 163 GRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred hhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 7653221 112234778999999987654 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=258.15 Aligned_cols=199 Identities=23% Similarity=0.349 Sum_probs=164.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDE----NTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----~~~~~L 597 (749)
.+.+.+.||+|++|.||+|+.. +..||+|++.... ....+.+.+|+.++.+++|+||+++.+++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 3455688999999999999874 5889999987542 2345677889999999999999999988753 356899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|+||+. ++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 86 v~e~~~-~~l~~~~~------------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 86 VMDLME-SDLHHIIH------------SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred EEehhh-hhHHHHhc------------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEec
Confidence 999995 68888873 234589999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCc--eeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 99999765432211 11123468889999999865 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=249.70 Aligned_cols=197 Identities=28% Similarity=0.374 Sum_probs=167.8
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
...+.||+|++|.||+++.. ++.+++|.+..... .....+.+|++++++++|+|++++++++..++..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999874 57899999875533 245678899999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.+++.. ....+++..+..++.++++||+|||+. +|+|+||||+||++++++.++|+|||.+.
T Consensus 82 ~-~l~~~l~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 82 T-DLYKLIKD-----------RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred C-CHHHHHHh-----------hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 5 88888753 224689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......++..|+|||.+.+. ..+.++|+||||++++||+||+.||...+
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764432 112234577889999998876 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=257.60 Aligned_cols=199 Identities=28% Similarity=0.420 Sum_probs=169.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC-----eeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT-----KMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~-----~~~L 597 (749)
+.+.+.||+|++|.||+|+.. ++.+|+|++.... ....+.+.+|++++++++|+||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999974 4889999987653 344577899999999999999999999987765 7899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||++ ++|.+++. ....+++..++.++.++++||+|||+. +|+||||||+|||+++++.++|+
T Consensus 82 v~e~~~-~~l~~~l~------------~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 82 VTELME-TDLHKVIK------------SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred Eecchh-hhHHHHHh------------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 999997 57888874 233789999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCc-eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||++......... .......++..|+|||.+.+. .++.++|+||||++++||++|+.||...+
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 99999876443210 112234578889999999888 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=255.43 Aligned_cols=199 Identities=29% Similarity=0.399 Sum_probs=161.9
Q ss_pred hcccccccccCceEEEEEEEC----CcccEEEEecCC--chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC----Cee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD----DKQVAVKMLSPS--SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN----TKM 595 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~----~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~----~~~ 595 (749)
+.+.+.||+|+||.||+++.. +..+|+|++... .....+.+.+|++++.++ +|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456789999999999999974 457999988643 222346788999999999 599999999875432 456
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++++||+. ++|.+.+. ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 82 ~~~~e~~~-~~L~~~l~------------~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 82 YLYEELME-ADLHQIIR------------SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred EEEEeccc-CCHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 78888885 68988884 234688999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCc--eeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++.+...... .......|+..|+|||.+.+ ..++.++|+|||||+++||++|++||...+
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9999999865432211 11123458899999998765 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=256.63 Aligned_cols=196 Identities=27% Similarity=0.429 Sum_probs=163.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~L 597 (749)
|...+.||+|+||+||+++.. ++.||||.+... .....+.+.+|+.++.+++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 455689999999999999874 588999998753 233345678899999999999999999987643 35799
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|+||+. ++|.+++. ....+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+
T Consensus 87 v~e~~~-~~L~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 87 VYELMD-TDLHQIIR------------SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEeCCC-CCHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence 999995 68888873 234689999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++...... .......++..|+|||.+.. ..++.++|||||||+++||++|++||.+.
T Consensus 151 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 151 DFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 999998654321 12233457889999998865 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=254.85 Aligned_cols=194 Identities=29% Similarity=0.407 Sum_probs=162.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC------ee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT------KM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~------~~ 595 (749)
.|...+.||+|+||.||++... +..||||++... .....+.+.+|++++++++|+||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3455688999999999999874 588999998643 2233456889999999999999999999986543 45
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+ +++|..++. ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 96 ~lv~e~~-~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK-------------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred EEEEecC-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence 8999998 778988773 23588999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||++++||++|+.||...+
T Consensus 159 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 159 ILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred EeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999865321 123357889999999876 458899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=249.61 Aligned_cols=197 Identities=31% Similarity=0.416 Sum_probs=168.0
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.||+|++|.||+|+.. ++.+|+|++.... ....+.+..|++++++++|+|++++.+++...+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34578999999999999885 5889999988653 3334678899999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++|.+++... ...+++..+.+++.++++||+|||+. +|+||||+|+||++++++.+||+|||+++
T Consensus 82 -~~l~~~i~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 82 -MDLKKYLDKR-----------PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred -cCHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 5899998542 14689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
....... ......++..|+|||.+... .++.++|||||||+++||++|++||....
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 6543221 11223456789999998776 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=254.70 Aligned_cols=192 Identities=28% Similarity=0.399 Sum_probs=158.9
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------CeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~~ 596 (749)
+...+.||+|+||.||+|+. +++.||||++.... ......+.+|+.++++++|+||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 34458999999999999986 45889999986532 22235678999999999999999999998654 3468
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|+||+.. +|..++ ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||
T Consensus 97 lv~e~~~~-~l~~~~--------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 97 LVMPYMQT-DLQKIM--------------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred EEeccccc-CHHHHH--------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 99999964 665544 12478899999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.+.+
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998864321 123356788999999876 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=258.93 Aligned_cols=194 Identities=25% Similarity=0.390 Sum_probs=172.1
Q ss_pred ccccccCceEEEEEEECCcc--cEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~--VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
..||-|+||.|=..+..++. .|+|++++.. ....+....|-.+|...+.+.||+|+-.+.+....||.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 57999999999998887644 7888887653 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
.|+..|. ..+.++......++..+.+|++|||++ +||.|||||+|.+++.+|-+||.|||+|+.+
T Consensus 506 ElWTiLr------------dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 506 ELWTILR------------DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhhhh------------hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999994 456788888889999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
... ...-..+||+.|+|||.+.++-.+..+|.||+|++++||++|++||++.+.
T Consensus 571 ~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 571 GSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred ccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 543 233457899999999999999999999999999999999999999998654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=252.06 Aligned_cols=201 Identities=28% Similarity=0.393 Sum_probs=162.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecC--------C
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDEN--------T 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--------~ 593 (749)
.+.+.+.||+|++|.||+|+.. ++.+|+|++..... .....+.+|++++++++|+||+++++++.+. .
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 4556789999999999999874 47899998864422 2234678899999999999999999887543 3
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++|+||+++ +|...+.. ....+++..+..++.|+++||+|||+. +|+|+||||+||++++++.
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~-----------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLEN-----------PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGI 153 (311)
T ss_pred eEEEEEecCCc-CHHHHHhc-----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 46899999965 67776632 234689999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCce---------eeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSH---------VSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+||+|||+++......... ......+++.|+|||.+.+. .++.++|||||||+++||++|++||.+.+
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998654322111 11223467889999988654 57899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=245.26 Aligned_cols=200 Identities=27% Similarity=0.391 Sum_probs=165.8
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPS-----SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
|.+.+.||+|+||.||+++... ..+++|+++.. ......++..|+.++++++|||++++++++.+.+..++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999998753 45666665532 1223345678999999999999999999999889999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++.... .....+++..++.++.|+++||.|||+. +++|+||||+||+++++ .++|+||
T Consensus 82 e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~ 149 (260)
T cd08222 82 EYCEGRDLDCKLEELK--------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDF 149 (260)
T ss_pred EeCCCCCHHHHHHHHh--------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeeccc
Confidence 9999999999986432 2345789999999999999999999998 99999999999999864 6999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+++...... .......++..|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus 150 g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 150 GVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9988664321 2223345788999999998888899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=221.98 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=167.6
Q ss_pred cccccccCceEEEEEEECC--cccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 530 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.++||+|.+|+||||+..+ +.||+|.....+ ..--....+|+-+++.++|+|||++++....+....||+||+. -
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 3689999999999998754 779999886542 2223567899999999999999999999999999999999994 4
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|..+... -.+.++...+..++.|+.+||.++|++ .+.|||+||.|.|++.+|++|++|||+++.+
T Consensus 86 dlkkyfds-----------lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 86 DLKKYFDS-----------LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred HHHHHHHh-----------cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 77777642 456788899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHc-CCCCCCCCCccccc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~l 746 (749)
... ...-....-|.-|.+|.++.+.+ ++...|+||-||++.|+.. |++.|.+.+..+.+
T Consensus 152 gip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 152 GIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred CCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 543 12223345788999999998765 7899999999999999995 88888887655443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=250.22 Aligned_cols=192 Identities=28% Similarity=0.395 Sum_probs=160.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~LV~Ey 601 (749)
|.+.+.||+|+||.||++... ++.||+|++... .....+.+.+|++++.+++|||++++.+++.. ....++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 445689999999999999864 478999987643 22334678899999999999999999998865 5678899999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+ +++|..++. ...+++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||+
T Consensus 92 ~-~~~L~~~~~-------------~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 92 L-GTDLHRLLT-------------SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred h-ccCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 8 568888773 23467888889999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+...... .....++..|+|||.+.+ ..++.++||||||++++||++|++||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8754221 122356788999999866 56899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=255.44 Aligned_cols=199 Identities=29% Similarity=0.423 Sum_probs=162.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----------
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN----------- 592 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~----------- 592 (749)
.+.+.+.||.|+||.||+|... ++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4556789999999999999874 478999998776666667889999999999999999999776543
Q ss_pred ---CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 593 ---TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 593 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
...++|+||++ ++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE-------------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH-------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 35789999997 58887773 23578999999999999999999998 999999999999997
Q ss_pred -CCCcEEEEecCCCccccCCCCce-eeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 670 -EKFQAKLADFGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 670 -~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++..+||+|||+++.+....... ......++..|+|||.+.. ..++.++|||||||+++||++|+.||...+
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 45679999999998653221111 1122347888999998754 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=238.06 Aligned_cols=179 Identities=24% Similarity=0.248 Sum_probs=152.7
Q ss_pred cCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHH
Q 037623 536 GGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLA 613 (749)
Q Consensus 536 G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 613 (749)
|.+|.||+++. +++.+|+|++.... .+.+|...+....|+|++++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999987 45889999987553 234455556666899999999999999999999999999999999853
Q ss_pred hhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCcee
Q 037623 614 QLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693 (749)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 693 (749)
. ..+++..+.+++.|+++||+|||+. +|+||||||+||++++++.++++|||.+......
T Consensus 79 ~------------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 79 F------------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred h------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 2 3488999999999999999999998 9999999999999999999999999987654321
Q ss_pred eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 694 ~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.....++..|+|||.+....++.++||||+|++++||++|+.|+..
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 1223456789999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=271.36 Aligned_cols=142 Identities=30% Similarity=0.427 Sum_probs=126.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||.||+|... ++.||||++.... ......+.+|+.++..++|+||+++++++......+|||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999986 5889999987543 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ...+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~g~~L~~li~~------------~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 86 LIGGDVKSLLHI------------YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred CCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999853 23578889999999999999999998 999999999999999999999999999
Q ss_pred Cc
Q 037623 682 SR 683 (749)
Q Consensus 682 a~ 683 (749)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 86
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=245.59 Aligned_cols=203 Identities=28% Similarity=0.447 Sum_probs=167.6
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCC--chhh-----HHHHHHHHHHHHhcCCCceeEEEEEEe-cCCe
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQG-----YKQFQAEVELLMRAHHKNLTILVGYCD-ENTK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~-----~~~f~~Ei~iL~~l~H~nIv~l~g~~~-~~~~ 594 (749)
..|-+-.+||+|+|+.|||+.+ ..+-||||+-... .... .+...+|.+|-..+.||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3344457899999999999986 4588999986533 1111 234578999999999999999999986 4567
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---C
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---K 671 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~ 671 (749)
.+-|.|||+|.+|+-+|+. .+.++++++..|+.||+.||.||... +|+|||-||||.|||+-+ -
T Consensus 543 FCTVLEYceGNDLDFYLKQ------------hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ------------HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred ceeeeeecCCCchhHHHHh------------hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 8899999999999999954 45689999999999999999999986 789999999999999965 4
Q ss_pred CcEEEEecCCCccccCCCCc-----eeeeccccCCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 672 FQAKLADFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISN----RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 672 ~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~----~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|.+||.|||+++++..+... ......+||..|++||.+.-+ +++.|+||||.||++|..+.|+.||...
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 78999999999998655333 223445799999999998533 5789999999999999999999999764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=252.52 Aligned_cols=193 Identities=29% Similarity=0.418 Sum_probs=162.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe------eE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK------MG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~------~~ 596 (749)
|.+.+.||+|++|.||+|+.. ++.||+|++... +....+.+.+|+.++++++|+|++++.+++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 455689999999999999984 478999998653 23334667889999999999999999988765554 89
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|+||+ +++|.+++. ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||
T Consensus 97 lv~e~~-~~~L~~~~~-------------~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL 159 (343)
T cd07851 97 LVTHLM-GADLNNIVK-------------CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKI 159 (343)
T ss_pred EEEecC-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 999998 679988883 24589999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+|||++...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...+
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999865322 223457888999999865 367899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=231.23 Aligned_cols=197 Identities=35% Similarity=0.497 Sum_probs=170.2
Q ss_pred cccccccccCceEEEEEEECC--cccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 528 NFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.||+|++|.||++...+ +.+++|........ ..+.+.+|++.+.+++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999999854 88999999876554 567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ...+++..+..++.++++++.+||+. +++|+|++++||+++.++.++|+|||.+..
T Consensus 82 ~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 82 GDLFDYLRKK-----------GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred CCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 9999998542 11178999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~-~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
...... .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 148 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 654321 112234577889999998 666788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=255.86 Aligned_cols=208 Identities=21% Similarity=0.280 Sum_probs=152.7
Q ss_pred hcccccccccCceEEEEEEE------------------CCcccEEEEecCCchhhHHH--------------HHHHHHHH
Q 037623 527 NNFERVLGKGGFGTVYHGYL------------------DDKQVAVKMLSPSSVQGYKQ--------------FQAEVELL 574 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~------------------~~~~VAVK~l~~~~~~~~~~--------------f~~Ei~iL 574 (749)
+.+.++||+|+||+||+|.+ .++.||||++........++ +..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 45568999999999999964 12569999987543322233 34477778
Q ss_pred HhcCCCce-----eEEEEEEec--------CCeeEEEEeeCCCCCHHHHHHHhhccCCCC------------ccCCCCCC
Q 037623 575 MRAHHKNL-----TILVGYCDE--------NTKMGLVYEFMANGNLQAHLLAQLAILPTD------------AEDKTGIL 629 (749)
Q Consensus 575 ~~l~H~nI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~------------~~~~~~~l 629 (749)
.+++|.++ +.++++|.. +...+|||||+++++|.++++......... .......+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 88877655 667777753 356899999999999999997532211100 01122346
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCcccc
Q 037623 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYY 709 (749)
Q Consensus 630 ~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~ 709 (749)
+|..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+..... .......+++.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhh
Confidence 8889999999999999999998 999999999999999999999999999976533211 111122357899999998
Q ss_pred ccCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCC
Q 037623 710 ISNRL----------------------TEKSDVYSFGVVLLELITGQP-VIQ 738 (749)
Q Consensus 710 ~~~~~----------------------s~k~DVwSfGvvL~ElltG~~-pf~ 738 (749)
..... ..+.||||+||+++||++|.. |+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 54321 134799999999999999985 765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=245.42 Aligned_cols=209 Identities=22% Similarity=0.337 Sum_probs=173.4
Q ss_pred cCHHHHHHHhhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCC--C----ceeEEEEE
Q 037623 517 LSYANVLKITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHH--K----NLTILVGY 588 (749)
Q Consensus 517 ~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H--~----nIv~l~g~ 588 (749)
+...|.+...|.+.+.+|+|.||.|-++.+.. ..||||+++..... .+..+-|+++|.++.+ | -+|.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 44556666777788999999999999998744 78999998765433 2455789999999932 2 37788888
Q ss_pred EecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 589 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
+.-.++.++|+|.| |-|+.++|... ....++...+..|+.|+++++++||+. +++|.||||+|||+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N----------~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf 225 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKEN----------NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF 225 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccC----------CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence 99999999999988 66999999542 456788899999999999999999999 99999999999999
Q ss_pred cC--------------------CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHH
Q 037623 669 NE--------------------KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 728 (749)
Q Consensus 669 ~~--------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ 728 (749)
.+ +..+||+|||.|+.-. .....++.|..|.|||++.+-.++.++||||+||||.
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 42 2358999999998632 1224567899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCcccc
Q 037623 729 ELITGQPVIQKTPERTL 745 (749)
Q Consensus 729 ElltG~~pf~~~~~~~~ 745 (749)
|+.||...|+..++.++
T Consensus 301 ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 301 ELYTGETLFQTHENLEH 317 (415)
T ss_pred EeeccceecccCCcHHH
Confidence 99999999998776553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=250.93 Aligned_cols=193 Identities=28% Similarity=0.419 Sum_probs=162.4
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+...+|.|+|+.|-++.. +++..+||++.+... +-.+|+.++.+. +|+|++++.+.+.+..+.++|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 345667899999999998876 458899999986632 234677666655 8999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE-cCCCcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL-NEKFQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl-~~~~~~kL~DFGl 681 (749)
.++-|.+.+... ..+. ..+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.
T Consensus 399 ~g~ell~ri~~~------------~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 399 DGGELLRRIRSK------------PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred cccHHHHHHHhc------------chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence 999888887532 2223 67778999999999999998 99999999999999 5889999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
++..... ....+-|..|.|||++....+++++|+||||++||||++|+.||...+..
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 9976533 22335678999999999999999999999999999999999999876544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-27 Score=232.64 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=163.2
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecC-Cchhh-HHHHHHHHHHHHhcCCCceeEEEEEEec--------CCeeEE
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSP-SSVQG-YKQFQAEVELLMRAHHKNLTILVGYCDE--------NTKMGL 597 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~-~~~~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--------~~~~~L 597 (749)
..+||+|.||.||+|+.. ++.||+|+.-- ..+.+ -....+|+++|..++|+|++.++..|.. ....+|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 357999999999999874 47788886532 22222 2456899999999999999999998843 345789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|+++++. +|...|. .....++...+.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+
T Consensus 102 Vf~~ceh-DLaGlLs-----------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLS-----------NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred eHHHhhh-hHHHHhc-----------CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 9999976 7888773 3446789999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCc--eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 678 DFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 678 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|||+++.+...++. ..-+..+.|..|.+||.+.+. .++++.|||+-||++.||+||.+.+++..+.
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 99999877543322 122344568899999999764 6999999999999999999999999987654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=232.23 Aligned_cols=209 Identities=26% Similarity=0.347 Sum_probs=175.4
Q ss_pred cccccccCceEEEEEEEC------C-cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEEe
Q 037623 530 ERVLGKGGFGTVYHGYLD------D-KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMGLVYE 600 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~------~-~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~LV~E 600 (749)
..++-+|.||.||+|.+. + +.|.||.++.. +.-....+..|...+..+.|+|+.+..+++.+ .+..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 457889999999999763 2 56888877654 44456778999999999999999999999865 566788899
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
++.-|+|..+|.-.+. +.....+.+...+...++.|++.||+|||.. ++||.||.++|.+||+..++||+|=.
T Consensus 369 ~~~~gNLK~FL~~Cr~----~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRG----DDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred ccCcchHHHHHHHhcc----CCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccch
Confidence 9999999999964332 2223456788888999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTL 745 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~ 745 (749)
++|.+-+.+............+||+||.+.+..++..+|||||||+||||+| |+.|+...+..++
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9998877665554444556789999999999999999999999999999998 9999988765543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=230.36 Aligned_cols=194 Identities=24% Similarity=0.393 Sum_probs=167.3
Q ss_pred ccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 529 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+-++||+|.|.+|..+++. ++.+|+|++++. +.++.+-.+.|-.+..+. +||.+|-|..++..+..++.|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3479999999999999874 477999998764 233344567788888776 8999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|--++.. .+.+++..+.....+|.-||.|||++ |||.||||..|||+|..|++||.|+|++
T Consensus 334 ~ggdlmfhmqr------------qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 334 NGGDLMFHMQR------------QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred cCcceeeehhh------------hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence 99999777743 34578888888899999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+.--.+ ........||+.|+|||.+.+..|+...|.|++||+++||+.|+.||+-
T Consensus 399 ke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 399 KEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 864322 3344567899999999999999999999999999999999999999973
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=261.67 Aligned_cols=187 Identities=32% Similarity=0.480 Sum_probs=141.1
Q ss_pred ccccccCceEEEEEE--ECCcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee------------
Q 037623 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM------------ 595 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~--~~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~------------ 595 (749)
+.||+||||.|||++ ++++.+|||++... +........+|+.+|++++|||||+.+....+....
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 589999999999997 47899999998765 344456788999999999999999987654221111
Q ss_pred --------------------------------------------------------------------------------
Q 037623 596 -------------------------------------------------------------------------------- 595 (749)
Q Consensus 596 -------------------------------------------------------------------------------- 595 (749)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------------------EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCC-CHHHHHHHHHHHHHHHHH
Q 037623 596 ---------------------------GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL-SWKGRLQIATESAQGLEY 647 (749)
Q Consensus 596 ---------------------------~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l-~~~~~l~ia~~ia~gL~y 647 (749)
|+=||||+...|.+.+... ... ......++..+|++||.|
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N------------~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN------------HFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc------------ccchhhHHHHHHHHHHHHHHHH
Confidence 2233333333333333111 001 234567899999999999
Q ss_pred HHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC----------------CCCceeeeccccCCcccCcccccc
Q 037623 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV----------------EGGSHVSTTVVGTPGYLDPEYYIS 711 (749)
Q Consensus 648 LH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~----------------~~~~~~~~~~~gt~~y~APE~~~~ 711 (749)
+|++ |||||||||.||+++++..+||+|||+|+.... .......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 999999999999999999999999999987310 001113456679999999999976
Q ss_pred C---CCCCchhHHHHHHHHHHHHc
Q 037623 712 N---RLTEKSDVYSFGVVLLELIT 732 (749)
Q Consensus 712 ~---~~s~k~DVwSfGvvL~Ellt 732 (749)
. +|+.|+|+||+|||++||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 5 49999999999999999984
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=248.26 Aligned_cols=197 Identities=28% Similarity=0.493 Sum_probs=168.9
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEe-----cCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCD-----ENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~-----~~~~~~LV 598 (749)
..|.++||.|.+|.||+++. .++.+|+|++.... ...++.+.|.++|+.. +|||++..+|++. .+++++||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 45678999999999998875 56889999987553 3346778899999887 8999999999984 36899999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
||||.+|+.-++++.- ....+.|..+.-|+.+++.|+.+||.. .++|||||-.|||++.++.+||+|
T Consensus 100 MEfC~gGSVTDLVKn~----------~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNT----------KGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred eeccCCccHHHHHhhh----------cccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 9999999999999653 366799999999999999999999998 899999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
||.+..+... ........||+.|||||++... .++.++|+||+|++..||--|.+|+..
T Consensus 167 FGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 167 FGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred eeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9998876433 2233456799999999999654 477899999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=224.44 Aligned_cols=185 Identities=37% Similarity=0.576 Sum_probs=163.6
Q ss_pred CceEEEEEEECC--cccEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHH
Q 037623 537 GFGTVYHGYLDD--KQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLA 613 (749)
Q Consensus 537 ~fG~Vykg~~~~--~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 613 (749)
+||.||+|+..+ +.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999854 889999998765544 67899999999999999999999999999999999999999999999853
Q ss_pred hhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCcee
Q 037623 614 QLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693 (749)
Q Consensus 614 ~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 693 (749)
. ..+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~------------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 81 R------------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred c------------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 2 1288999999999999999999998 99999999999999999999999999998764331 2
Q ss_pred eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 694 ~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.....++..|++||.+....++.++||||||++++||++|+.||..
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2344578899999999988899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=241.10 Aligned_cols=190 Identities=22% Similarity=0.350 Sum_probs=162.2
Q ss_pred cccccccCceEEEEEEECC--cccEEEEecCCchhh--------HHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeE
Q 037623 530 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQG--------YKQFQAEVELLMRAH---HKNLTILVGYCDENTKMG 596 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~l~---H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+|.|+||.|+.+..+. ..|+||.+.+...-. .-..-.|+.||.+++ |+||++++.++++++..+
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 4689999999999998854 779999887653211 123457999999997 999999999999999999
Q ss_pred EEEeeC-CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 597 LVYEFM-ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 597 LV~Ey~-~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
|+||-. ++-+|++++ +....+++..+..|.+|++.|+++||++ +|||||||-+||.++.+|-+|
T Consensus 646 l~te~hg~gIDLFd~I------------E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFI------------EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred EEecCCCCCcchhhhh------------hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEE
Confidence 999964 566899988 3556789999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
|+|||.|....... -...+||.+|.|||++.+.+| +..-|+|++|++||.++..+.||.
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999997653321 234579999999999998876 567899999999999999999885
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=249.88 Aligned_cols=205 Identities=23% Similarity=0.280 Sum_probs=138.3
Q ss_pred hhcccccccccCceEEEEEEEC------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEE------EecCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY------CDENT 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~------~~~~~ 593 (749)
.+.+.+.||+|+||.||+|++. +..||||++...... +.+..| .+.+..+.++..++.. +....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 3456789999999999999874 468999987643221 111111 1111122222211111 34567
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCC------C--CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILP------T--DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSAN 665 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~------~--~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~N 665 (749)
..++||||+++++|.+++........ . .............+..++.|+++||+|||+. +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 89999999999999999864310000 0 0000111223345668999999999999998 99999999999
Q ss_pred EEEcC-CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC----------------------CCCCchhHHH
Q 037623 666 ILLNE-KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN----------------------RLTEKSDVYS 722 (749)
Q Consensus 666 ILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~k~DVwS 722 (749)
||+++ ++.+||+|||+|+.+.... ........++++|+|||.+... .++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 5799999999998654322 2223345689999999965322 2345679999
Q ss_pred HHHHHHHHHcCCCCCC
Q 037623 723 FGVVLLELITGQPVIQ 738 (749)
Q Consensus 723 fGvvL~ElltG~~pf~ 738 (749)
|||+||||+++..++.
T Consensus 365 lGviL~el~~~~~~~~ 380 (566)
T PLN03225 365 AGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHhCcCCCc
Confidence 9999999999876654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=227.74 Aligned_cols=195 Identities=27% Similarity=0.420 Sum_probs=160.2
Q ss_pred cccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeEEEEe
Q 037623 530 ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMGLVYE 600 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~LV~E 600 (749)
.+.||-|+||.||...+ +++.||+|++... +....+.+.+|+++|...+|.|++..++..... +++|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 37899999999999987 4588999998754 334567899999999999999999988876542 35667788
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
.|. .+|...+ -..+.++-..+.-+..||.+||.|||+. +|.||||||.|.|++.+..+||||||
T Consensus 138 LmQ-SDLHKII------------VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 138 LMQ-SDLHKII------------VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHH-hhhhhee------------ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence 774 3666555 2455677777788899999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+|+.-..++ ...++...-|..|.|||.+.+. .|+...||||.||++.|++..+-.|+..+
T Consensus 202 LARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 202 LARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred cccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 999754433 2333455678899999999876 58999999999999999999888887644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=211.53 Aligned_cols=190 Identities=21% Similarity=0.395 Sum_probs=158.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEecC--CeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDEN--TKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~--~~~~LV~E 600 (749)
.|++.+.+|+|.++.||.|.. ++..++||++++.. .+.+.+|+.+|..++ |+||+.|++...+. ....||+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 455668999999999999984 56889999998654 467889999999996 99999999998654 45679999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEec
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADF 679 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~DF 679 (749)
|+.+.+...+- ..++...+...+.++++||.|+|+. ||+|||+||+|+++|.. ..++|+|+
T Consensus 116 ~v~n~Dfk~ly---------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 116 YVNNTDFKQLY---------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred hhccccHHHHh---------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 99998886655 2466677888999999999999999 99999999999999954 57999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|+|..+.+..... ....+..|.-||.+.+ ..++..-|+|||||+|.+|+..+.||-.
T Consensus 178 GLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 178 GLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred chHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 9999887653222 2345667889999865 4588899999999999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=245.94 Aligned_cols=197 Identities=29% Similarity=0.431 Sum_probs=160.3
Q ss_pred ccccccCceE-EEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGT-VYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~-Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
+++|.|+.|+ ||+|..+++.||||++-... .+-.++|+..|+.- +|+|||+.++.-.+.+..|+..|.| ..+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 6799998876 59999999999999986443 24457899999887 7999999998888899999999999 46999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---C--CcEEEEecCCCc
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---K--FQAKLADFGLSR 683 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~--~~~kL~DFGla~ 683 (749)
+++... . .+. .... -...+.+..|++.||++||+. +||||||||.||||+. + .+++|+|||+++
T Consensus 591 dlie~~-~---~d~-~~~~---~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 591 DLIESS-G---LDV-EMQS---DIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred HHHhcc-c---cch-hhcc---cccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 999653 0 000 0111 134567889999999999998 9999999999999975 2 589999999999
Q ss_pred cccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCc
Q 037623 684 IFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG-~~pf~~~~~ 742 (749)
++..+..+- ......||-+|+|||++....-+..+|+||+||++|+.++| ..||.+.-+
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 987654322 23456799999999999998888999999999999999986 899987543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=218.88 Aligned_cols=188 Identities=29% Similarity=0.390 Sum_probs=158.1
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec------CCeeEEEEe
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE------NTKMGLVYE 600 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------~~~~~LV~E 600 (749)
+.+|.|+- .|..+.+ .+++||+|++... .....++..+|..++..++|+|+++++.++.- ..+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777776 5665544 4688999987654 33446778899999999999999999999854 356789999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
+| .++|...++. .++...+..|..|++.|++|||+. +|+||||||+||++..++.+||.|||
T Consensus 102 ~m-~~nl~~vi~~--------------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 102 LM-DANLCQVILM--------------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hh-hhHHHHHHHH--------------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 99 5689888853 367778889999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|+.-.. ....+....|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.
T Consensus 164 ~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 164 LARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred hhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 9986432 23556678899999999999888999999999999999999999999854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=229.66 Aligned_cols=214 Identities=24% Similarity=0.288 Sum_probs=179.6
Q ss_pred cccCHHHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcC------CCceeEEE
Q 037623 515 RKLSYANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH------HKNLTILV 586 (749)
Q Consensus 515 ~~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~------H~nIv~l~ 586 (749)
.++.+.|++...|.+.-..|+|-|++|.+|... +..||||++.....- .+.=+.|+++|.+|+ .-+.++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 356788999999999999999999999999874 478999999876432 244578999999994 23678888
Q ss_pred EEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 587 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
-.|...++++||+|-+ ..+|.+.|..- ...-.|..+.+...+.|+.-||..|-.+ +|+|.||||.||
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKy---------G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi 567 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKY---------GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI 567 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHh---------CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence 8889999999999977 66999999754 3556788899999999999999999998 999999999999
Q ss_pred EEcCC-CcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 667 LLNEK-FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 667 Ll~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
|+++. ..+||||||.|..... ...+....+..|.|||++.+..|+...|+||.||+||||.||+-.|.+.....+
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASE----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred EeccCcceeeeccCcccccccc----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 99975 4689999999987532 223344556789999999999999999999999999999999999988655444
Q ss_pred c
Q 037623 746 I 746 (749)
Q Consensus 746 l 746 (749)
|
T Consensus 644 L 644 (752)
T KOG0670|consen 644 L 644 (752)
T ss_pred H
Confidence 3
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=199.93 Aligned_cols=182 Identities=40% Similarity=0.668 Sum_probs=158.1
Q ss_pred ccccCceEEEEEEEC--CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHH
Q 037623 533 LGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQA 609 (749)
Q Consensus 533 LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 609 (749)
||+|.+|.||+++.. ++.+++|++...... ..+.+.+|++.+.+++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999987 688999998866443 34678999999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecCCCccccCC
Q 037623 610 HLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPVE 688 (749)
Q Consensus 610 ~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~ 688 (749)
++... ...+++..+..++.++++++++||+. +++|+||+|.||++++ ++.++|+|||.+......
T Consensus 81 ~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKEN-----------EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 98532 14688999999999999999999999 9999999999999999 899999999999866433
Q ss_pred CCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHH
Q 037623 689 GGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLEL 730 (749)
Q Consensus 689 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~El 730 (749)
.. ......+...|++||..... ..+.+.|+|++|++++||
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 21 12234577889999999887 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-24 Score=208.74 Aligned_cols=193 Identities=21% Similarity=0.378 Sum_probs=153.6
Q ss_pred hhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEE-EecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGY-CDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~-~~~~~~~~LV~Ey 601 (749)
.|++.+.||+|.||.+-++...+ +.+++|.+.... ...++|.+|..---.+ .|.||+.-++. ++..+..+.++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 35567899999999999998865 778999887543 3357888888654444 68888876654 5667788899999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc--CCCcEEEEec
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN--EKFQAKLADF 679 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~--~~~~~kL~DF 679 (749)
++.|+|.+.+ ....+.+....+++.|++.|+.|||++ .+||||||.+|||+- +..++|||||
T Consensus 104 aP~gdL~snv-------------~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 104 APRGDLRSNV-------------EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred Cccchhhhhc-------------CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 9999998877 234577888899999999999999999 999999999999994 3448999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+.+..+.. ......+..|.+||..... ...+.+|+|.||++++.++||+.||+..
T Consensus 168 G~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 168 GLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 999865321 1122345679999987533 3577899999999999999999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=211.96 Aligned_cols=139 Identities=25% Similarity=0.399 Sum_probs=115.9
Q ss_pred ccCHHHHHH-HhhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcC-----C---CceeE
Q 037623 516 KLSYANVLK-ITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAH-----H---KNLTI 584 (749)
Q Consensus 516 ~~~~~~l~~-~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-----H---~nIv~ 584 (749)
.+...|+.. .+|.+.++||-|.|++||++.+.. +-||+|+.+-.. .-.+..+.||++|.+++ | ..||+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 445566666 778888999999999999998754 789999986432 22355688999999883 3 46999
Q ss_pred EEEEEec----CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeC
Q 037623 585 LVGYCDE----NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRD 660 (749)
Q Consensus 585 l~g~~~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrD 660 (749)
|+++|.. +.+.+||+|++ |.+|..++... ..+.++...+.+|+.|++.||.|||.+| +|||.|
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s----------~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTD 213 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS----------NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTD 213 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHh----------CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccC
Confidence 9999854 67899999998 77898888653 5567899999999999999999999998 999999
Q ss_pred CCCCcEEE
Q 037623 661 VKSANILL 668 (749)
Q Consensus 661 Lkp~NILl 668 (749)
|||+|||+
T Consensus 214 lKPENvLl 221 (590)
T KOG1290|consen 214 LKPENVLL 221 (590)
T ss_pred CCcceeee
Confidence 99999999
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=210.54 Aligned_cols=162 Identities=20% Similarity=0.194 Sum_probs=124.7
Q ss_pred hhcccccccccCceEEEEEEEC---CcccEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPS-----SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++... .....+.|.+|+++|.+++|+|+++.+..+ ...+|
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEE
Confidence 4667789999999999999863 466799987533 122346689999999999999998643322 45799
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC-CCCcEEEcCCCcEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV-KSANILLNEKFQAKL 676 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL-kp~NILl~~~~~~kL 676 (749)
||||+++++|.. +. ... ..+++.+++++|+|||+. +|+|||| ||+|||++.++.+||
T Consensus 96 VmE~~~G~~L~~-~~------------~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 96 VRGWTEGVPLHL-AR------------PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred EEEccCCCCHHH-hC------------ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEE
Confidence 999999999962 21 000 135788999999999998 9999999 999999999999999
Q ss_pred EecCCCccccCCCCcee------eeccccCCcccCccccccC
Q 037623 677 ADFGLSRIFPVEGGSHV------STTVVGTPGYLDPEYYISN 712 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~ 712 (749)
+|||+|+.+........ .+...+++.|+|||.+...
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999997754432111 1345688899999998644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=205.88 Aligned_cols=192 Identities=29% Similarity=0.445 Sum_probs=159.6
Q ss_pred ccccccccCceEEEEEEE-----CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 529 FERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..++||.|.|++||++++ .+..||+|.+...+.. ....+|+++|.++ .+.||+++.+++...+...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 357899999999999976 2367999998776543 5688999999998 6899999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFGl 681 (749)
++....++.. .++...+...+..+.+||.++|+. |||||||||+|+|.+. .+.-.|+|||+
T Consensus 118 ~H~~f~~l~~---------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 118 EHDRFRDLYR---------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CccCHHHHHh---------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 9999988873 356788889999999999999999 9999999999999985 45789999999
Q ss_pred Ccccc-----------------C-CC---------------C---------ceeeeccccCCcccCcccccc-CCCCCch
Q 037623 682 SRIFP-----------------V-EG---------------G---------SHVSTTVVGTPGYLDPEYYIS-NRLTEKS 718 (749)
Q Consensus 682 a~~~~-----------------~-~~---------------~---------~~~~~~~~gt~~y~APE~~~~-~~~s~k~ 718 (749)
|.... . .+ + .......+||+||.|||++.. ..-+.+.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221 0 00 0 001123469999999999864 5578899
Q ss_pred hHHHHHHHHHHHHcCCCCCCCC
Q 037623 719 DVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 719 DVwSfGvvL~ElltG~~pf~~~ 740 (749)
||||-||+++-+++++.||-..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeeccceeehhhccccccccC
Confidence 9999999999999999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-22 Score=219.77 Aligned_cols=194 Identities=29% Similarity=0.446 Sum_probs=167.6
Q ss_pred cccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.-..+|+|.+|.|||++. .++..|||+++-......+-.++|+-+++..+|+||+.++|-+-..+..++.|||+.+|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 3447899999999999987 45889999998776666777889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+.-+ ....+++.++..++++..+|++|||+. +=+|||||-.|||+++.+.+|++|||.+-.+
T Consensus 98 slQdiy~------------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 98 SLQDIYH------------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred cccceee------------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 9987764 456789999999999999999999998 8899999999999999999999999988655
Q ss_pred cCCCCceeeeccccCCcccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYY---ISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~---~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
...- -......||+.|||||+. ..+-+.+++|+|+.|+...|+-.-++|..
T Consensus 163 tati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 163 TATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred hhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 3221 122356799999999987 45668999999999999999988777754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=198.51 Aligned_cols=202 Identities=23% Similarity=0.310 Sum_probs=164.0
Q ss_pred hhcccccccccCceEEEEEEECC---cccEEEEecCCchhhHHHHHHHHHHHHhcCC----CceeEEEEEE-ecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD---KQVAVKMLSPSSVQGYKQFQAEVELLMRAHH----KNLTILVGYC-DENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~---~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H----~nIv~l~g~~-~~~~~~~L 597 (749)
.+.+.+.||+|+||.||++.... ..+|+|............+..|+.++..+.+ .++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 45667999999999999999755 3588888766543333367889999988863 5788888888 57778999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-----C
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-----F 672 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-----~ 672 (749)
||+.+ |.+|.++.... ..+.++..+.++|+.|+..+|++||+. |++||||||.|+++... .
T Consensus 99 VM~l~-G~sL~dl~~~~----------~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN----------PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred EEecc-CccHHHHHHhC----------CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccc
Confidence 99976 88999977432 246799999999999999999999999 99999999999999854 4
Q ss_pred cEEEEecCCCc--cccCCCCc--ee----eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 673 QAKLADFGLSR--IFPVEGGS--HV----STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 673 ~~kL~DFGla~--~~~~~~~~--~~----~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.+.|.|||+++ .+...... .. .....||.+|.+++...+.+.+.+.|+||++.++.|++.|..||....
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 69999999999 43222211 11 123459999999999999999999999999999999999999997654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=228.20 Aligned_cols=149 Identities=17% Similarity=0.168 Sum_probs=113.0
Q ss_pred hcCC-CceeEEEEEE-------ecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHH
Q 037623 576 RAHH-KNLTILVGYC-------DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647 (749)
Q Consensus 576 ~l~H-~nIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~y 647 (749)
.++| +||++++++| .+.+..++++|++ +++|.++|.. ....+++..++.++.||++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~ 95 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-----------PDRSVDAFECFHVFRQIVEIVNA 95 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-----------ccccccHHHHHHHHHHHHHHHHH
Confidence 3444 5777777776 2334677888987 6699999942 23458999999999999999999
Q ss_pred HHhCCCCCceeeCCCCCcEEEcCC-------------------CcEEEEecCCCccccCCCC--------------ceee
Q 037623 648 LHDGCKPPIVHRDVKSANILLNEK-------------------FQAKLADFGLSRIFPVEGG--------------SHVS 694 (749)
Q Consensus 648 LH~~~~~gIiHrDLkp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~--------------~~~~ 694 (749)
||++ +|+||||||+||||+.. +.+|++|||+++....... ....
T Consensus 96 lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (793)
T PLN00181 96 AHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ 172 (793)
T ss_pred HHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence 9998 99999999999999653 4556666666653211000 0000
Q ss_pred eccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 695 ~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
....||+.|||||++.+..++.++|||||||+||||++|.+|+..
T Consensus 173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 113478889999999999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.6e-19 Score=186.85 Aligned_cols=201 Identities=36% Similarity=0.584 Sum_probs=168.4
Q ss_pred cccccccccCceEEEEEEECCcccEEEEecCCchh---hHHHHHHHHHHHHhcCCC-ceeEEEEEEecCCeeEEEEeeCC
Q 037623 528 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQ---GYKQFQAEVELLMRAHHK-NLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~l~H~-nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++...+......++++|++.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 45678999999999999988 78899988765332 367899999999999988 79999999977777899999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEEEecCCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADFGLS 682 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL~DFGla 682 (749)
++++.+.+..... . ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||++
T Consensus 82 ~~~l~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 82 GGSLEDLLKKIGR--------K-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred CCcHHHHHHhccc--------c-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 9999966643210 0 3688889999999999999999999 899999999999999988 7999999999
Q ss_pred ccccCCCCce----eeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSH----VSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~----~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+.+....... ......++..|+|||.+.. .......|+|++|++++++++|+.||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8654332211 2345679999999999987 578899999999999999999999976654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-20 Score=177.99 Aligned_cols=200 Identities=23% Similarity=0.301 Sum_probs=165.1
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCC-CceeEEEEEEecCCeeEEEEee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH-KNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H-~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..+.+.+.||+|+||.+|.|.. .+..||+|+-+.... ..+...|..+.+.++| ..|..+..+..++..-.||||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3566779999999999999975 568999999665433 3567788999999865 4566667777888899999998
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC---CcEEEEe
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---FQAKLAD 678 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~---~~~kL~D 678 (749)
+ |-+|++++.- -.+.++.++++-+|-|+..-++|+|.+ ++|||||||+|+|..-+ ..+.++|
T Consensus 93 L-GPsLEdLfnf-----------C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 93 L-GPSLEDLFNF-----------CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred c-CccHHHHHHH-----------HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 8 8899998843 345688999999999999999999999 99999999999999743 3689999
Q ss_pred cCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|+.+...... .......||.+|.+-....+.+-+.+.|+=|+|.+|..+--|..||++..
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 9999987533211 12245569999999999888888999999999999999999999999853
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=180.62 Aligned_cols=200 Identities=19% Similarity=0.303 Sum_probs=166.5
Q ss_pred hhcccccccccCceEEEEEE--ECCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~--~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.++||+|.||.++.|+ ++++.||||.-...+. ..+...|.+..+.| ..++|...+.+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 45667999999999999997 4789999998654432 34667777777777 5678888887778888889999988
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-----CCcEEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-----KFQAKLA 677 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-----~~~~kL~ 677 (749)
|-+|+++..- ..+.++.+++..+|.|+..-++|+|++ .+|.|||||+|+||.. ...+.|+
T Consensus 107 -GPSLEDLFD~-----------CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 107 -GPSLEDLFDL-----------CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred -CcCHHHHHHH-----------hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 7899998843 346799999999999999999999999 9999999999999963 3368999
Q ss_pred ecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||+|+.+...... +......||.+||+-....+.+-+.+.|+=|+|-+++..+-|..||++...
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 99999988544321 223455699999999999999999999999999999999999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=182.30 Aligned_cols=175 Identities=14% Similarity=0.147 Sum_probs=134.2
Q ss_pred HHHHHHHhhcccccccccCceEEEEEEECCcccEEEEecCCchhhHH---H------HHHHHHHHHhcCCCceeEEEEEE
Q 037623 519 YANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYK---Q------FQAEVELLMRAHHKNLTILVGYC 589 (749)
Q Consensus 519 ~~~l~~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~---~------f~~Ei~iL~~l~H~nIv~l~g~~ 589 (749)
..+++...+...+++|.|+||.||....++..+|+|++.+......+ . +++|+..+.+++|++|.....++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34555667777899999999999997776789999999765333222 2 68999999999999999998875
Q ss_pred ecC--------CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 590 DEN--------TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 590 ~~~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
... ...+|||||++|.+|.+... ++. ....+++++|..+|+. |++|||+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH~~---gi~H~Di 161 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------------ISE----DVKAKIKASIESLHQH---GMVSGDP 161 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh----------------ccH----HHHHHHHHHHHHHHHc---CCccCCC
Confidence 432 35789999999999977631 111 2456899999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHH
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 731 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ell 731 (749)
||+||++++++ ++|+|||.......+... ..++....+..++|+|+||+.+..+.
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999988 999999988754221110 11334445667999999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.8e-19 Score=173.98 Aligned_cols=138 Identities=21% Similarity=0.194 Sum_probs=105.4
Q ss_pred cccccccCceEEEEEEEC-CcccEEEEecCCchh--h-------HHH-----------------HHHHHHHHHhcCCCce
Q 037623 530 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQ--G-------YKQ-----------------FQAEVELLMRAHHKNL 582 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~--~-------~~~-----------------f~~Ei~iL~~l~H~nI 582 (749)
.+.||+|+||.||+|... ++.||||+++..... . ... ..+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 368999999999999874 689999998754211 0 112 2359999999987776
Q ss_pred eEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceeeCC
Q 037623 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL-HDGCKPPIVHRDV 661 (749)
Q Consensus 583 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~~gIiHrDL 661 (749)
.....+.. ...+|||||++++++..... ....++.....+++.|++.+|.++ |+. +|+||||
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL------------KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh------------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 33222221 23489999999887754431 123578899999999999999999 677 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccc
Q 037623 662 KSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~ 685 (749)
||+|||+++ +.++|+|||+|...
T Consensus 145 kP~NIli~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEEC-CcEEEEEccccccC
Confidence 999999984 68999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-19 Score=177.71 Aligned_cols=194 Identities=20% Similarity=0.351 Sum_probs=157.6
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
..+|.....|..|+|++.+..+++|++.... ....+.|..|.-.|+-..||||++++|.|....+..++..||+.|+|
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3567888899999999999888889886542 23346789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
...||.+ ..-..+..++.+++.++|+|++|||+. .|-|.---|.++.+++|++.+++|+- +-+++
T Consensus 275 ynvlhe~----------t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf--- 339 (448)
T KOG0195|consen 275 YNVLHEQ----------TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF--- 339 (448)
T ss_pred HHHHhcC----------ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee---
Confidence 9999864 455678889999999999999999987 44455667999999999999888752 11111
Q ss_pred CCCceeeeccccCCcccCccccccCCC---CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRL---TEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~---s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+.......-.+.||+||.++.++- -..+|+|||.+++||+.|.+.||...+
T Consensus 340 ---sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 340 ---SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ---eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 011122345678999999987753 357999999999999999999998754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.1e-18 Score=167.81 Aligned_cols=187 Identities=17% Similarity=0.137 Sum_probs=140.9
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCchhh----HHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG----YKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~----~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
...|++|+||+||.+...+.+++.+.+....... ...|.+|+++|.+++ |+++..++++ ...+++|||++|
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4789999999999887777888888776553311 235889999999995 5788888886 346899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC-CCCcEEEcCCCcEEEEecCCCc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV-KSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL-kp~NILl~~~~~~kL~DFGla~ 683 (749)
.+|...+.. ....++.|++++|+++|+. ||+|||| ||+|||+++++.++|+|||+|.
T Consensus 83 ~~L~~~~~~-------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 83 AAMYQRPPR-------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred ccHHhhhhh-------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 988654310 0134678999999999999 9999999 7999999999999999999998
Q ss_pred cccCCCCc----e---e----eeccccCCcccCccccccC-CCC-CchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGS----H---V----STTVVGTPGYLDPEYYISN-RLT-EKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~----~---~----~~~~~gt~~y~APE~~~~~-~~s-~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
........ . . ......++.|++|+...-. ..+ ...+.++-|.-+|.++||+.+.-+..+
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 65432210 0 0 0112367788888764322 223 567999999999999999988755444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=169.11 Aligned_cols=107 Identities=26% Similarity=0.264 Sum_probs=93.5
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ....++|..+++++.|+++||+|||+. + ||+|||+++++.+|+ ||+++.
T Consensus 1 GsL~~~l~~-----------~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEV-----------RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHH-----------hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEe
Confidence 688888853 234699999999999999999999998 4 999999999999999 999886
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.... ...|++.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 59 ~~~~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 59 KTPE-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred eccc-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 5322 125789999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=168.89 Aligned_cols=139 Identities=20% Similarity=0.226 Sum_probs=108.4
Q ss_pred cccccccCceEEEEEEEC-CcccEEEEecCCchh---------------------h-----HHHHHHHHHHHHhcCCCce
Q 037623 530 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQ---------------------G-----YKQFQAEVELLMRAHHKNL 582 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~---------------------~-----~~~f~~Ei~iL~~l~H~nI 582 (749)
.+.||+|++|+||+|+.. ++.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 367999999999999875 789999998764211 0 1224678999999999987
Q ss_pred eEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCC
Q 037623 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDV 661 (749)
Q Consensus 583 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDL 661 (749)
.....+... ..+|||||++++++..... ....++.....+++.+++.++.+||+ . ||+||||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl 144 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL------------KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL 144 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh------------hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence 544333322 2489999999886544321 11346778889999999999999999 7 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCcccc
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
||+|||++ ++.++|+|||+++.+.
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999 7899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-17 Score=187.79 Aligned_cols=347 Identities=16% Similarity=0.170 Sum_probs=206.8
Q ss_pred eeecCCCCC---CCcccCCC--ceEEecCCccccCCCceeccc--ccc----cc--ccccccccccccccCc-cceeeec
Q 037623 3 SIDCGIPEN---ANYTDSIT--GINYVSDASNIDTGVSHKISS--EFN----KE--ITERQFSNLRSFPEGI-RNCYTLK 68 (749)
Q Consensus 3 sidCg~~~~---~~~~~~~~--~~~~~~D~~~~~~g~~~~~~~--~~~----~~--~~~~~~~tlR~Fp~~~-~nCy~~~ 68 (749)
.|+||+... ..|.|+.- .+.|.+|..|.. +....++. ..+ .+ .+...|+|.|.+-++. .-.|+++
T Consensus 195 R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~-~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~ 273 (623)
T PLN03150 195 RLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGS-GSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMD 273 (623)
T ss_pred EEEecCcccccccCCCCCcccCccccCcCcccCC-CcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEee
Confidence 589997542 23444433 688999998863 22222211 111 11 1334699999986543 4599994
Q ss_pred ccCCCCeeEEEEEEeeccCCC-CCCCCceeEEecceeEEE-EEc---C-CCCCcEEEEEEEeccCCceEEEEeecCCCCc
Q 037623 69 PDSDHEKFLIRARFMYGNYNG-QDKPPSFNLMLEADVWDS-VQF---P-DSGSIVSKEIIHIPKREYIHVCLVNTDSGTP 142 (749)
Q Consensus 69 ~~~~~~~ylvR~~f~ygnyd~-~~~~p~fd~~~~~~~w~~-v~~---~-~~~~~~~~e~~~~~~~~~~~vCl~~t~~~~P 142 (749)
+.++++|+||..|.-=.... ....-+||++++|..+.. +++ + .....++.+..+.+.++.+.|.|+.+....|
T Consensus 274 -v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s~p 352 (623)
T PLN03150 274 -VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHA 352 (623)
T ss_pred -cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCCcc
Confidence 55899999999996543211 223347999999976643 222 1 1234566677776667889999998765569
Q ss_pred eeeeeeeeeCCCCccCCCCcceEeEEeeecCCCCCccccCCCCCCCCccccCCCCCceeeccccccCCCCCCCCcHHHHh
Q 037623 143 FISALELRPLPNLTYMTQSGSLSRYGRWDVGSTTNKTFRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQ 222 (749)
Q Consensus 143 fis~lEl~~l~~~~y~~~~~~l~~~~R~~~G~~~~~~~ryp~D~~dR~W~p~~~~~~~~~st~~~~~~~~~~~~P~~v~~ 222 (749)
||++||+..+... +.... |. ....|+
T Consensus 353 ilNaiEI~~~~~~-----------------~~~t~-----~~--------------------------------~~~aL~ 378 (623)
T PLN03150 353 IINAIEVFEIITA-----------------ESKTL-----LE--------------------------------EVSALQ 378 (623)
T ss_pred eeeeeeeeecccc-----------------ccccC-----ch--------------------------------HHHHHH
Confidence 9999999876531 00000 00 001111
Q ss_pred ---hceecCCCCcceEEEecCCCCccceEEEEeeecccccccc--CcceEEEEEECCeeccCCCCcccceeeeEEecccc
Q 037623 223 ---SAVIPANGGSSLMLSWKPANRMIKNYVYFYFSEFESERAK--NQTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPT 297 (749)
Q Consensus 223 ---tA~~~~~~~~~l~~~w~~~~~~~~~~~~~~Faei~~~~~~--~~~Rvf~i~lng~~~~~~~~p~~~~~~~l~~~~~~ 297 (749)
.+.. .+...+|..+++.... +.|.++.|.... ...++..+.+.+..+.|.+|+....+..+..
T Consensus 379 ~~k~~~~-----~~~~~~W~g~~C~p~~---~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~---- 446 (623)
T PLN03150 379 TLKSSLG-----LPLRFGWNGDPCVPQQ---HPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS---- 446 (623)
T ss_pred HHHHhcC-----CcccCCCCCCCCCCcc---cccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE----
Confidence 1110 0111367654332221 469999994322 1246778888887777777766555443333
Q ss_pred cCCceeEEEEEeCCCCCCCcchhheeeeeeecccccccCccceeeEeeeehhhccchhHHHHHHHHHhcccCCCCCCCCC
Q 037623 298 MNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDVIMILFLYLFMHIKISVDAIMNIKSKYELLRDWQGDPC 377 (749)
Q Consensus 298 ~~~~~~~isl~~t~~s~lpPiinA~Ei~~~~~~~~~~t~~~dv~~~~~~~~~~~~~~~~~~l~~~k~~~~~~~~W~~dpc 377 (749)
++++ .+...+.|+.
T Consensus 447 -----L~Ls----~N~l~g~iP~--------------------------------------------------------- 460 (623)
T PLN03150 447 -----INLS----GNSIRGNIPP--------------------------------------------------------- 460 (623)
T ss_pred -----EECC----CCcccCcCCh---------------------------------------------------------
Confidence 2222 2222222222
Q ss_pred CCCCCcceeeecCCCCCCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhh-chhcc-ccCCC
Q 037623 378 APNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQ-FLRVL-VDGNP 455 (749)
Q Consensus 378 ~p~~~~w~Gv~C~~~~~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~-~l~~l-~~~n~ 455 (749)
....+++|+.|||++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|+.++.+. ++..+ +.+|+
T Consensus 461 --------------~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 461 --------------SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred --------------HHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 012367899999999999999999999999999999999999999999987642 33334 56778
Q ss_pred CcccCc---ccCCCCcceEEeeeehhhHHHHHHHHHHHhhhhccc
Q 037623 456 NLCLSA---SCKGKKNKFIVPLLASVVSFSVLLAALAILRSLRRR 497 (749)
Q Consensus 456 ~l~~~~---~c~~~~~~~iii~i~~~v~~~~l~~~l~~~~~~rrr 497 (749)
.+|+.+ .|..+.....++.++++++++++++++.++++++||
T Consensus 527 ~lc~~p~l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~~~~r 571 (623)
T PLN03150 527 GLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571 (623)
T ss_pred cccCCCCCCCCcccCCCceEEEEEhHHHHHHHHHHHHHhhheeeh
Confidence 899863 575433333344444333333333333333333333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=159.81 Aligned_cols=136 Identities=19% Similarity=0.253 Sum_probs=104.4
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhc-----CCCceeEEEEEEecCC---eeE-EEEe
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-----HHKNLTILVGYCDENT---KMG-LVYE 600 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-----~H~nIv~l~g~~~~~~---~~~-LV~E 600 (749)
.+.||+|+||.||. .-.....+||+.........+++.+|+.++.++ .|+||++++|+++++. ..+ +|+|
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred cceecCCCceEEEE-CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 36899999999996 222333478988765444567899999999999 5799999999998763 333 7899
Q ss_pred e--CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceeeCCCCCcEEEcC----CCc
Q 037623 601 F--MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL-EYLHDGCKPPIVHRDVKSANILLNE----KFQ 673 (749)
Q Consensus 601 y--~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL-~yLH~~~~~gIiHrDLkp~NILl~~----~~~ 673 (749)
| +++|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..
T Consensus 86 ~~G~~~~tL~~~l~~-------------~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 86 FDGKPSITLTEFAEQ-------------CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred CCCCcchhHHHHHHc-------------ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 9 568999999942 124444 35577777777 999999 9999999999999974 347
Q ss_pred EEEEe-cCCCcc
Q 037623 674 AKLAD-FGLSRI 684 (749)
Q Consensus 674 ~kL~D-FGla~~ 684 (749)
++|+| ||....
T Consensus 148 ~~LiDg~G~~~~ 159 (210)
T PRK10345 148 PVVCDNIGESTF 159 (210)
T ss_pred EEEEECCCCcce
Confidence 99999 554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=159.23 Aligned_cols=135 Identities=19% Similarity=0.349 Sum_probs=114.4
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchh--------hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQ--------GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.||+|++|.||+|...+..|++|+....... ....+.+|++++.+++|+++.....++...+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999998899999986643211 1245788999999999999887777777777889999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+|++|.+.+... .+ .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||.+
T Consensus 82 ~G~~L~~~~~~~---------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 82 EGEPLKDLINSN---------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCcCHHHHHHhc---------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 999999988421 11 7789999999999999998 999999999999999 779999999998
Q ss_pred ccc
Q 037623 683 RIF 685 (749)
Q Consensus 683 ~~~ 685 (749)
+..
T Consensus 142 ~~~ 144 (211)
T PRK14879 142 EFS 144 (211)
T ss_pred cCC
Confidence 853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-17 Score=192.91 Aligned_cols=196 Identities=25% Similarity=0.343 Sum_probs=154.4
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEec----CC-ch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLS----PS-SV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~----~~-~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
++++|.|++|.|+..... ....+.|... .. .. +....+..|..+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 478999999977766542 1223333221 11 11 1122256677777889999998877777776666666999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++ +|...+- ....+....+-.+.+|+..|++|||+. ||.|||+|++|++++.++.+||+|||.
T Consensus 403 ~~~-Dlf~~~~------------~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 403 CPY-DLFSLVM------------SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred ccH-HHHHHHh------------cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence 999 9999983 224677888889999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCc--eeeeccccCCcccCccccccCCCCC-chhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGS--HVSTTVVGTPGYLDPEYYISNRLTE-KSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~-k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+.....+... .......|+..|+|||.+...++++ ..||||.|+++..|++|+.||....
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 9877655433 4555677999999999999999876 4799999999999999999998643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-17 Score=183.31 Aligned_cols=185 Identities=30% Similarity=0.335 Sum_probs=153.7
Q ss_pred cccccCceEEEEEE-----ECCcccEEEEecCCchhh--HHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCC
Q 037623 532 VLGKGGFGTVYHGY-----LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 532 ~LG~G~fG~Vykg~-----~~~~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
++|+|.||.|+... ..+.-+|+|++++..... ......|..++..++ |+.+|.+...++.+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47899999998653 344667888876553211 124567888899987 9999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|..++. ....++.........+++-+++++|+. +|+|||+|++||+++.+|++++.|||+++
T Consensus 81 gg~lft~l~------------~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 81 GGDLFTRLS------------KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSK 145 (612)
T ss_pred cchhhhccc------------cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhh
Confidence 999998883 345566777777888999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
..-... ...||..|||||++. .....+|.||||++++||+||..||..
T Consensus 146 e~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 146 EAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred HhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 653221 117899999999998 556789999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-16 Score=156.24 Aligned_cols=131 Identities=24% Similarity=0.327 Sum_probs=107.7
Q ss_pred cccccCceEEEEEEECCcccEEEEecCCch--------hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 532 VLGKGGFGTVYHGYLDDKQVAVKMLSPSSV--------QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.||+|+||.||+|...+..|++|....... ...+++.+|++++.+++|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 489999999999999889999998654321 123567889999999998876555555556667789999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+.+... .. .++.+++++|.+||+. +++|+|++|+||+++ ++.++++|||+++
T Consensus 81 g~~l~~~~~~~------------~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 81 GKPLKDVIEEG------------ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CccHHHHHhhc------------HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999887321 00 7899999999999998 999999999999999 7899999999988
Q ss_pred cc
Q 037623 684 IF 685 (749)
Q Consensus 684 ~~ 685 (749)
..
T Consensus 138 ~~ 139 (199)
T TIGR03724 138 YS 139 (199)
T ss_pred CC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.6e-16 Score=177.77 Aligned_cols=133 Identities=23% Similarity=0.340 Sum_probs=111.9
Q ss_pred ccccccccCceEEEEEEECCcccEEEEecCCc--------hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSS--------VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
..+.||+|+||+||+|.+.+..+++|+..... ....+++.+|++++.+++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 35789999999999999988766666543221 1123568899999999999999988888877778899999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++. .+.+++.+++++|.+||+. +++||||||+|||+ +++.++|+|||
T Consensus 417 ~~~g~~L~~~l~--------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 417 YIGGKDLKDVLE--------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred ecCCCcHHHHHH--------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 999999998873 2467899999999999998 99999999999999 56799999999
Q ss_pred CCccc
Q 037623 681 LSRIF 685 (749)
Q Consensus 681 la~~~ 685 (749)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-16 Score=185.62 Aligned_cols=197 Identities=20% Similarity=0.183 Sum_probs=153.2
Q ss_pred HHHHHhhcccccccccCceEEEEEEEC-CcccEEEEecCCchhhHHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeE
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH---HKNLTILVGYCDENTKMG 596 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~---H~nIv~l~g~~~~~~~~~ 596 (749)
++....+.+.+.||+|+||+||+|... ++.||+|+-+.....+ |.--.+++.||+ -+-|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 333445566789999999999999875 4889999988776542 222233444444 112222333333456778
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC------
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE------ 670 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~------ 670 (749)
||+||.+.|+|.+++. ..+.++|...+.++.|+++.+++||.. +|||+||||+|.||..
T Consensus 771 lv~ey~~~Gtlld~~N------------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN------------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred eeeeccccccHHHhhc------------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCC
Confidence 9999999999999983 567899999999999999999999999 9999999999999952
Q ss_pred -CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 037623 671 -KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735 (749)
Q Consensus 671 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~ 735 (749)
..-++|+|||.+..+..-.....-....+|-.+-.+|...+...+.+.|.|+++-+++-|+.|+-
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34699999999876654433434445678889999999999999999999999999999999973
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-16 Score=158.12 Aligned_cols=140 Identities=20% Similarity=0.238 Sum_probs=106.6
Q ss_pred hcccccccccCceEEEEEE-E--CCcccEEEEecCCchh------------------------hHHHHHHHHHHHHhcCC
Q 037623 527 NNFERVLGKGGFGTVYHGY-L--DDKQVAVKMLSPSSVQ------------------------GYKQFQAEVELLMRAHH 579 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~-~--~~~~VAVK~l~~~~~~------------------------~~~~f~~Ei~iL~~l~H 579 (749)
+.+.+.||+|++|.||+|. . +++.||+|++...... ....+..|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3456899999999999998 2 5689999998753210 01235689999999976
Q ss_pred Cc--eeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-c
Q 037623 580 KN--LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP-I 656 (749)
Q Consensus 580 ~n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g-I 656 (749)
.. +...+++ ...++||||+++++|..... ....+......+++.|+++++++||+. + |
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL------------KDVEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc------------ccCCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 43 3344433 23589999999988765431 112345556788999999999999999 8 9
Q ss_pred eeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 657 VHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 657 iHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
+||||||+||+++ ++.++|+|||.+....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 7899999999988643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-16 Score=184.03 Aligned_cols=196 Identities=23% Similarity=0.278 Sum_probs=149.8
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCch-hhHHHH---HHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSV-QGYKQF---QAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~-~~~~~f---~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
...+++.||++.|=+|.+|+.+...|+||++.+... ...+.| ..|++ ...++|||.+++.-........+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 345678999999999999999888899999876642 223344 44444 5556999999988776667777888888
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+.+ +|.++| .....+...+..-|+.|+..||.-+|.. ||+|||||.+|||++.=.-+.|+||..
T Consensus 103 vkh-nLyDRl------------STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 103 VKH-NLYDRL------------STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred Hhh-hhhhhh------------ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 865 888888 3455677777888999999999999999 999999999999999988999999987
Q ss_pred CccccCCCC--ceee---eccccCCcccCccccccC----------C-CCCchhHHHHHHHHHHHHc-CCCCCC
Q 037623 682 SRIFPVEGG--SHVS---TTVVGTPGYLDPEYYISN----------R-LTEKSDVYSFGVVLLELIT-GQPVIQ 738 (749)
Q Consensus 682 a~~~~~~~~--~~~~---~~~~gt~~y~APE~~~~~----------~-~s~k~DVwSfGvvL~Ellt-G~~pf~ 738 (749)
-+.....++ .... .....-..|+|||.+... . .+++-||||+||++.||++ |++||.
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 653322211 1111 111222369999987431 2 6789999999999999997 789985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=155.80 Aligned_cols=198 Identities=22% Similarity=0.267 Sum_probs=129.6
Q ss_pred cccccccCceEEEEEEECC--cccEEEEecCC---chhhHHHHHHHHHHHHhcCC-----------CceeEEEEEE----
Q 037623 530 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSPS---SVQGYKQFQAEVELLMRAHH-----------KNLTILVGYC---- 589 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H-----------~nIv~l~g~~---- 589 (749)
.+.||.|+++.||.+++.. +++|||+..-. .....+++++|.-....+.+ .-++++.-.-
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4789999999999999955 88999987533 33456777777655544322 2222221111
Q ss_pred ----ecC---C-----eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 037623 590 ----DEN---T-----KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIV 657 (749)
Q Consensus 590 ----~~~---~-----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIi 657 (749)
... . +.+++|+-+ .++|...+..-... ......+....++.+..|+.+.+++||+. |++
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~-----~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSR-----AQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHH-----TTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhc-----ccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 111 1 235677776 56898886432110 01123355566778889999999999999 999
Q ss_pred eeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCcccccc--------CCCCCchhHHHHHHHHHH
Q 037623 658 HRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS--------NRLTEKSDVYSFGVVLLE 729 (749)
Q Consensus 658 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~k~DVwSfGvvL~E 729 (749)
|+||||+|++++++|.++|+||+.....+ ..... ...+..|.+||.... -.++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAG----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETT----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecC----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999998776532 22221 345578999997743 247889999999999999
Q ss_pred HHcCCCCCCCCC
Q 037623 730 LITGQPVIQKTP 741 (749)
Q Consensus 730 lltG~~pf~~~~ 741 (749)
|.+|+.||....
T Consensus 243 lWC~~lPf~~~~ 254 (288)
T PF14531_consen 243 LWCGRLPFGLSS 254 (288)
T ss_dssp HHHSS-STCCCG
T ss_pred HHHccCCCCCCC
Confidence 999999998653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=147.99 Aligned_cols=135 Identities=16% Similarity=0.179 Sum_probs=105.1
Q ss_pred hcccccccccCceEEEEEEE-CCcccEEEEecCCch----------------------hhHHHHHHHHHHHHhcCCCc--
Q 037623 527 NNFERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSV----------------------QGYKQFQAEVELLMRAHHKN-- 581 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~-~~~~VAVK~l~~~~~----------------------~~~~~f~~Ei~iL~~l~H~n-- 581 (749)
+.+.+.||+|+||.||++.. +++.||||++..... .....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55678999999999999988 468999998654320 01123677888999998874
Q ss_pred eeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 582 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
+...++. ...++||||+++++|..... . ....+++.++++++.++|+. +|+||||
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~------------~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRV------------L------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhccc------------c------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 4444432 34589999999998865431 0 23457889999999999998 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCcccc
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-14 Score=134.82 Aligned_cols=134 Identities=19% Similarity=0.165 Sum_probs=114.4
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCC--CceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH--KNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H--~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.+.||+|.++.||++...+..+++|....... ...+.+|+.++..++| ..+.+++++....+..++++||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 36799999999999999888999999866543 4678899999999976 4888999888888889999999988765
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
... +......++.++++++++||.....+++|+|++|+||++++++.++++|||.++.
T Consensus 81 ~~~-------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 321 4556678899999999999987556899999999999999989999999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=6e-14 Score=144.69 Aligned_cols=135 Identities=21% Similarity=0.192 Sum_probs=105.8
Q ss_pred cccc-ccCceEEEEEEECCcccEEEEecCCc-------------hhhHHHHHHHHHHHHhcCCCce--eEEEEEEecCC-
Q 037623 531 RVLG-KGGFGTVYHGYLDDKQVAVKMLSPSS-------------VQGYKQFQAEVELLMRAHHKNL--TILVGYCDENT- 593 (749)
Q Consensus 531 ~~LG-~G~fG~Vykg~~~~~~VAVK~l~~~~-------------~~~~~~f~~Ei~iL~~l~H~nI--v~l~g~~~~~~- 593 (749)
..|| .|+.|+||+....+..++||...... ......+.+|++++.+++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 5788 89999999999989999999875421 1223567889999999998875 66777654322
Q ss_pred ---eeEEEEeeCCC-CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 594 ---KMGLVYEFMAN-GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 594 ---~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
..++|+|++++ .+|.+++.. ..++.. .+.+++++|.+||+. ||+||||||+|||++
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~-------------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~ 176 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE-------------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLD 176 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc-------------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEc
Confidence 22599999997 689888732 123332 357899999999999 999999999999999
Q ss_pred CCCcEEEEecCCCccc
Q 037623 670 EKFQAKLADFGLSRIF 685 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~ 685 (749)
.++.++|+|||.++..
T Consensus 177 ~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 177 PDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCEEEEECCCcccC
Confidence 9889999999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=159.13 Aligned_cols=153 Identities=27% Similarity=0.470 Sum_probs=127.8
Q ss_pred HHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037623 574 LMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCK 653 (749)
Q Consensus 574 L~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~ 653 (749)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+.. ....++|.-...++++++.||+|||+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-----------~~~~~d~~F~~s~~rdi~~Gl~ylh~s-- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-----------EDIKLDYFFILSFIRDISKGLAYLHNS-- 67 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-----------cccCccHHHHHHHHHHHHHHHHHHhcC--
Confidence 3568899999999999999999999999999999999953 356789999999999999999999987
Q ss_pred CCc-eeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC-------CCCCchhHHHHHH
Q 037623 654 PPI-VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-------RLTEKSDVYSFGV 725 (749)
Q Consensus 654 ~gI-iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~s~k~DVwSfGv 725 (749)
+| .|+.++++|.++|....+||.|||+....................-|.|||.+... ..+.++|+||||+
T Consensus 68 -~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i 146 (484)
T KOG1023|consen 68 -PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI 146 (484)
T ss_pred -cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence 55 89999999999999999999999998876421111111122244579999998663 1577899999999
Q ss_pred HHHHHHcCCCCCCCC
Q 037623 726 VLLELITGQPVIQKT 740 (749)
Q Consensus 726 vL~ElltG~~pf~~~ 740 (749)
+++||++.+.||...
T Consensus 147 i~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 147 IMYEILFRSGPFDLR 161 (484)
T ss_pred HHHHHHhccCccccc
Confidence 999999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=137.22 Aligned_cols=135 Identities=20% Similarity=0.215 Sum_probs=96.6
Q ss_pred cccccccCceEEEEEEEC-CcccEEEEecCCchh--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 037623 530 ERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQ--GYKQ----------------------FQAEVELLMRAHHKN--L 582 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~--~~~~----------------------f~~Ei~iL~~l~H~n--I 582 (749)
.+.||+|+||+||+|... ++.||||++...... .... ...|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999886 689999988653211 1111 135666666665443 3
Q ss_pred eEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCC
Q 037623 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDV 661 (749)
Q Consensus 583 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDL 661 (749)
.+.+++ ...++||||++++.+....... . ... ....+++.+++.++.++|+ . +|+|+||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----------~--~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl 141 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----------V--RLL-EDPEELYDQILELMRKLYREA---GLVHGDL 141 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh----------h--hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCC
Confidence 344433 2458999999996543221110 0 001 5567899999999999998 6 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccc
Q 037623 662 KSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~ 685 (749)
||+||+++ ++.++|+|||.+...
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccc
Confidence 99999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-14 Score=165.21 Aligned_cols=167 Identities=28% Similarity=0.441 Sum_probs=119.6
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.|.|..|++|.||..+.+ .+.+|+|+-+.+.. .+- ++.....+.+| |+-
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~li------lRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI------LRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccchh------hhc--cccccCCccee---------------------chh
Confidence 478999999999999775 47788844221110 000 23333333333 343
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
...++ ..+.++ .+++.+++|||+. +|+|||+||+|.||+.-|++|+.|||+.+..-.
T Consensus 139 ~tllk------------~~g~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 139 ATLLK------------NIGPLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred hhhcc------------cCCCCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 34442 112222 1237789999998 999999999999999999999999999875421
Q ss_pred CCC-------------ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccccCC
Q 037623 688 EGG-------------SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748 (749)
Q Consensus 688 ~~~-------------~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~l~q 748 (749)
... +-....+.||+.|+|||++...-|+..+|+|++|+++||.+-|+.||.+...++++.|
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~ 269 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 269 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence 100 0011245799999999999999999999999999999999999999999877776654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.9e-13 Score=139.36 Aligned_cols=147 Identities=22% Similarity=0.235 Sum_probs=109.0
Q ss_pred CCCceeEEEEEEec---------------------------CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCC
Q 037623 578 HHKNLTILVGYCDE---------------------------NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630 (749)
Q Consensus 578 ~H~nIv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~ 630 (749)
+|||||++.+++.+ ...+++||...+ -+|+++|.. ...+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-------------~~~s 339 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-------------RHRS 339 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-------------CCCc
Confidence 69999998887632 345678888764 489999853 3456
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc--CCC--cEEEEecCCCccccCC----CCceeeeccccCCc
Q 037623 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN--EKF--QAKLADFGLSRIFPVE----GGSHVSTTVVGTPG 702 (749)
Q Consensus 631 ~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~--~~~--~~kL~DFGla~~~~~~----~~~~~~~~~~gt~~ 702 (749)
...+.-++.|+.+|+.|||.+ ||.|||+|++|||+. +|. .+.|+|||++-.-..- ..........|...
T Consensus 340 ~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~ 416 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK 416 (598)
T ss_pred hHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence 667778999999999999999 999999999999994 443 5789999976431110 00111123346778
Q ss_pred ccCccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 703 YLDPEYYISNR------LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 703 y~APE~~~~~~------~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
-||||+....+ .-.|+|.|+.|-+.||+++...||.+..
T Consensus 417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 89999975332 2358999999999999999999998743
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.3e-14 Score=153.27 Aligned_cols=125 Identities=28% Similarity=0.417 Sum_probs=107.4
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
..+++.|++++..+|.++|.+. ......++...+.++.|++.|++| + +.+|+|+||.||+...+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr---------~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~ 393 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR---------RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDD 393 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC---------CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccch
Confidence 3577999999999999999543 244567888899999999999999 5 899999999999999999
Q ss_pred cEEEEecCCCccccCCC----CceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc
Q 037623 673 QAKLADFGLSRIFPVEG----GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt 732 (749)
.+||.|||+...+.... .....+...||..||+||.+.+..++.|+|+||||++|+|++.
T Consensus 394 q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 394 QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999999998765443 1123345679999999999999999999999999999999997
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.9e-12 Score=139.60 Aligned_cols=139 Identities=20% Similarity=0.202 Sum_probs=98.5
Q ss_pred ccccccCceEEEEEEE-CCcccEEEEecCCchhhH----------------------------------------HHHHH
Q 037623 531 RVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSVQGY----------------------------------------KQFQA 569 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~-~~~~VAVK~l~~~~~~~~----------------------------------------~~f~~ 569 (749)
+.||.|++|+||+|++ +|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 468999999876421100 02455
Q ss_pred HHHHHHhcC----CCceeEEEEEE-ecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHH-
Q 037623 570 EVELLMRAH----HKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ- 643 (749)
Q Consensus 570 Ei~iL~~l~----H~nIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~- 643 (749)
|++.+.+++ |.+-+..-..+ ......+|||||++|++|.+...... ... .+.+++..+++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----------~~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----------AGL---DRKALAENLARS 268 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----------cCC---CHHHHHHHHHHH
Confidence 666665552 32223332233 33456799999999999988764321 011 23456666666
Q ss_pred HHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 644 gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
.+..+|.. |++|+|+||.||+++++++++++|||++..+.
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 46778887 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.6e-13 Score=158.46 Aligned_cols=202 Identities=24% Similarity=0.356 Sum_probs=159.3
Q ss_pred hhcccccccccCceEEEEEEECC---cccEEEEecCCc--hhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD---KQVAVKMLSPSS--VQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~---~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+|+.|-.....+ ..+|+|.+.... ....+....|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34556779999999998776532 456666665443 222334445676666675 999999999999999999999
Q ss_pred eeCCCCCHHHHH-HHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceeeCCCCCcEEEcCCC-cEEE
Q 037623 600 EFMANGNLQAHL-LAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH-DGCKPPIVHRDVKSANILLNEKF-QAKL 676 (749)
Q Consensus 600 Ey~~~gsL~~~L-~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH-~~~~~gIiHrDLkp~NILl~~~~-~~kL 676 (749)
||.+++++...+ +. .....+-...-....|+..++.|+| .. ++.|+|+||+|.+++..+ ..++
T Consensus 101 ~~s~g~~~f~~i~~~-----------~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP-----------DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred CcccccccccccccC-----------CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence 999999998776 22 1113344456678899999999999 66 999999999999999999 9999
Q ss_pred EecCCCccccC-CCCceeeecccc-CCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 677 ADFGLSRIFPV-EGGSHVSTTVVG-TPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+|||+|..+.. .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 99999998877 444455555668 9999999999884 56788999999999999999999997643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.2e-11 Score=116.55 Aligned_cols=131 Identities=19% Similarity=0.138 Sum_probs=97.4
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHH
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAH 610 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 610 (749)
+.|+.|.++.||++...++.+++|....... ....+..|++++..+.+.++++-+-.+. ....++||||+++.++...
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCccccc
Confidence 5688999999999999889999999765432 1235678999999987666554333332 2345799999999876432
Q ss_pred HHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 611 LLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC--KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 611 L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
- .....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~--------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D--------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c--------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 011245678999999999872 22369999999999999 56899999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-10 Score=106.75 Aligned_cols=131 Identities=21% Similarity=0.302 Sum_probs=104.0
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCch---h-----hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSV---Q-----GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~---~-----~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..+++|+-+.+|.+.+-+.++.+|.-.+... . ...+-.+|+.++.+++--.|..-.-+..+.....++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4678999999999988777777776544321 1 1234578999999987766665555666778889999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+|..|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++.++. +.++|||++
T Consensus 82 ~G~~lkd~l~~~-------------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 82 EGELLKDALEEA-------------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CChhHHHHHHhc-------------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence 999999888421 256777888888999999 999999999999998874 999999999
Q ss_pred cc
Q 037623 683 RI 684 (749)
Q Consensus 683 ~~ 684 (749)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 85
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-09 Score=107.14 Aligned_cols=135 Identities=19% Similarity=0.177 Sum_probs=95.8
Q ss_pred ccccccCceEEEEEEECC--------cccEEEEecCCc-----h-----------------hhHHHH----HHHHHHHHh
Q 037623 531 RVLGKGGFGTVYHGYLDD--------KQVAVKMLSPSS-----V-----------------QGYKQF----QAEVELLMR 576 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--------~~VAVK~l~~~~-----~-----------------~~~~~f----~~Ei~iL~~ 576 (749)
..||.|--+.||.|...+ ..+|||+.+... . ...+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997642 689999875321 0 001223 389999998
Q ss_pred cCCC--ceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCC
Q 037623 577 AHHK--NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL-HDGCK 653 (749)
Q Consensus 577 l~H~--nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~ 653 (749)
++.. ++...+++ ...++||||+.++.+..... +...++..+...+..+++.+|..| |+.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L------------kd~~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL------------KDAKLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh------------hccccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 8543 44455543 46789999997754422111 111234455677889999999998 777
Q ss_pred CCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 654 PPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 654 ~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
++||+||++.|||+++ +.++|+|||.+...
T Consensus 145 -glVHGDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 145 -NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred -CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999999999975 58999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.7e-09 Score=100.82 Aligned_cols=142 Identities=20% Similarity=0.267 Sum_probs=106.5
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCc--------hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSS--------VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..|-+|+-+.|+++.+.++...||.-.... .-..++-.+|++.|.+++--.|..-.-++.+...-.|+|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 578899999999999999888888643221 112456789999999987666665555555666778999999
Q ss_pred CC-CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---cEEEEe
Q 037623 603 AN-GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---QAKLAD 678 (749)
Q Consensus 603 ~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---~~kL~D 678 (749)
++ -++.+++..... .. ..-.....++..|-+.+.-||.. +|||+||.++||++.+++ .+.++|
T Consensus 93 ~g~~~vk~~i~~~~~---------~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 93 DGASTVKDFILSTME---------DE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred cchhHHHHHHHHHcc---------Cc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEe
Confidence 76 478888865421 11 11222367889999999999999 999999999999997665 458999
Q ss_pred cCCCccc
Q 037623 679 FGLSRIF 685 (749)
Q Consensus 679 FGla~~~ 685 (749)
||++..-
T Consensus 160 fgls~~s 166 (229)
T KOG3087|consen 160 FGLSSVS 166 (229)
T ss_pred ecchhcc
Confidence 9998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-09 Score=108.76 Aligned_cols=141 Identities=21% Similarity=0.283 Sum_probs=103.2
Q ss_pred ccccccCceEEEEEEECC-cccEEEEecCCch-hhHHHHHHHHHHHHhcCCCc--eeEEEEEEecCC---eeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKN--LTILVGYCDENT---KMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~~~~~~---~~~LV~Ey~~ 603 (749)
+.|+.|..+.||++...+ +.+++|....... ....++.+|++++..+++.+ +.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998876 8899999765432 23457889999999997644 566777766542 5689999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG-------------------------------- 651 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~-------------------------------- 651 (749)
+.++...+. ...++..++.+++.+++++|..||+.
T Consensus 84 G~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 84 GRVLRDRLL-------------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred CEecCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 987755431 02345555566666666666666642
Q ss_pred ---------------------CCCCceeeCCCCCcEEEcC--CCcEEEEecCCCcc
Q 037623 652 ---------------------CKPPIVHRDVKSANILLNE--KFQAKLADFGLSRI 684 (749)
Q Consensus 652 ---------------------~~~gIiHrDLkp~NILl~~--~~~~kL~DFGla~~ 684 (749)
....++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-09 Score=122.92 Aligned_cols=141 Identities=16% Similarity=0.167 Sum_probs=90.0
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCchh---------------------------------h-H------HHHH
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ---------------------------------G-Y------KQFQ 568 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~---------------------------------~-~------~~f~ 568 (749)
+.||+|++|+||+|++. |+.||||+..+.-.. + . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 57999999999999984 689999999754210 0 0 1244
Q ss_pred HHHHHHHhcC----CCceeEEEEEEec-CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHH
Q 037623 569 AEVELLMRAH----HKNLTILVGYCDE-NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643 (749)
Q Consensus 569 ~Ei~iL~~l~----H~nIv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~ 643 (749)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-... ......+.......++.|+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~------g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA------GTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc------CCCHHHHHHHHHHHHHHHH--
Confidence 5555555552 4444443333332 5678899999999999774211100 0000112222222223332
Q ss_pred HHHHHHhCCCCCceeeCCCCCcEEEcCCC----cEEEEecCCCccccC
Q 037623 644 GLEYLHDGCKPPIVHRDVKSANILLNEKF----QAKLADFGLSRIFPV 687 (749)
Q Consensus 644 gL~yLH~~~~~gIiHrDLkp~NILl~~~~----~~kL~DFGla~~~~~ 687 (749)
+.. |++|+|+||.||+++.++ +++++|||++..+..
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999888 999999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.8e-09 Score=119.34 Aligned_cols=164 Identities=21% Similarity=0.214 Sum_probs=123.3
Q ss_pred CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCC
Q 037623 547 DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT 626 (749)
Q Consensus 547 ~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~ 626 (749)
.+.+|.|...+...........+-++.|+.+|||||++++...+++...|||+|-+. .|..++...
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------------ 101 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------------ 101 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------------
Confidence 457888888876655334556778899999999999999999999999999999873 576677432
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCc
Q 037623 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706 (749)
Q Consensus 627 ~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 706 (749)
......-.+.||+.||.+||+.| +++|++|.-..|++++.|+.||++|..+........ ......--..|..|
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDP 174 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccCh
Confidence 23344556899999999999765 899999999999999999999999998765322111 01111122246667
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHcC
Q 037623 707 EYYISNRLTEKSDVYSFGVVLLELITG 733 (749)
Q Consensus 707 E~~~~~~~s~k~DVwSfGvvL~ElltG 733 (749)
+.+.... ...|.|.||++++|++.|
T Consensus 175 ~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCccc--cchhhhhHHHHHHHHhCc
Confidence 6553333 457999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.9e-10 Score=114.30 Aligned_cols=155 Identities=24% Similarity=0.407 Sum_probs=118.0
Q ss_pred HHHHhcCCCceeEEEEEEec-----CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHH
Q 037623 572 ELLMRAHHKNLTILVGYCDE-----NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646 (749)
Q Consensus 572 ~iL~~l~H~nIv~l~g~~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~ 646 (749)
+-|-++.|.|||+++.|+.+ ......+.|||+.|+|..+|++.+. ....+......+++.||..||.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--------~~~a~~~~~wkkw~tqIlsal~ 190 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--------NQKALFQKAWKKWCTQILSALS 190 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--------hhhhhhHHHHHHHHHHHHhhhh
Confidence 44556689999999998754 3456789999999999999976532 4456777888899999999999
Q ss_pred HHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCC--CceeeeccccCCcccCccccccCCCCCchhHHHHH
Q 037623 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFG 724 (749)
Q Consensus 647 yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfG 724 (749)
|||+ |.|+|+|+++..+-|++..++-+|++--.-......-. .........+-++|.|||+-.....+-.+|||+||
T Consensus 191 yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 191 YLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred hhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 9998 58999999999999999999888875422111110000 00011122367899999998888888899999999
Q ss_pred HHHHHHHcCCC
Q 037623 725 VVLLELITGQP 735 (749)
Q Consensus 725 vvL~ElltG~~ 735 (749)
+..+||.-|+-
T Consensus 270 mcAlemailEi 280 (458)
T KOG1266|consen 270 MCALEMAILEI 280 (458)
T ss_pred HHHHHHHHhee
Confidence 99999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-09 Score=120.12 Aligned_cols=203 Identities=24% Similarity=0.206 Sum_probs=150.5
Q ss_pred HHHHHhhcccccccc--cCceEEEEEEEC----CcccEEEEecCC--chhhHHHHHHHHHHHHhc-CCCceeEEEEEEec
Q 037623 521 NVLKITNNFERVLGK--GGFGTVYHGYLD----DKQVAVKMLSPS--SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDE 591 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~--G~fG~Vykg~~~----~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~ 591 (749)
+.......+.+-+|. |.+|.||++... ...+|+|+-+.. ..+....=.+|.....++ .|+|.++......+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344455566788999 999999999872 367888874332 222223335666666666 59999998888888
Q ss_pred CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceeeCCCCCcEE
Q 037623 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ----GLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 592 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~----gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
.+..++-+|++ +.+|.++.+. ....++.........+..+ ||.++|+. .++|-|+||.||+
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~-----------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~ 254 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHT-----------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIF 254 (524)
T ss_pred CCcceeeeccc-cchhHHhhhc-----------ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhhee
Confidence 89999999987 4677777643 2333445555566666666 99999998 9999999999999
Q ss_pred EcCC-CcEEEEecCCCccccCCCCc---eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 668 LNEK-FQAKLADFGLSRIFPVEGGS---HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 668 l~~~-~~~kL~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+.++ ...++.|||+...+....-. .......+...|++||.. .+.++...|+|++|.+.+|..+|..+...
T Consensus 255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccC
Confidence 9999 89999999999887644311 122223578899999986 45568899999999999999998766544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.3e-08 Score=100.37 Aligned_cols=135 Identities=16% Similarity=0.088 Sum_probs=98.3
Q ss_pred CceEEEEEEECCcccEEEEecCCchh-hHH----------HHHHHHHHHHhcCCCc--eeEEEEEEec-----CCeeEEE
Q 037623 537 GFGTVYHGYLDDKQVAVKMLSPSSVQ-GYK----------QFQAEVELLMRAHHKN--LTILVGYCDE-----NTKMGLV 598 (749)
Q Consensus 537 ~fG~Vykg~~~~~~VAVK~l~~~~~~-~~~----------~f~~Ei~iL~~l~H~n--Iv~l~g~~~~-----~~~~~LV 598 (749)
....|++..+.++.+.||........ ..+ .+.+|...+.++...+ ....+++.+. ...-+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33457788888889999977543311 111 3778998888884333 3344555543 2356799
Q ss_pred EeeCCCC-CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-------
Q 037623 599 YEFMANG-NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE------- 670 (749)
Q Consensus 599 ~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~------- 670 (749)
+|++++. +|.+++... .....+...+.+++.++++.+.-||+. ||+|+|++++|||++.
T Consensus 114 te~l~~~~sL~~~~~~~----------~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 114 TEDLAPTISLEDYCADW----------ATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred EeeCCCCccHHHHHHhh----------cccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 9999986 898887421 112344566778999999999999999 9999999999999985
Q ss_pred CCcEEEEecCCCcc
Q 037623 671 KFQAKLADFGLSRI 684 (749)
Q Consensus 671 ~~~~kL~DFGla~~ 684 (749)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.5e-09 Score=129.22 Aligned_cols=100 Identities=32% Similarity=0.585 Sum_probs=73.7
Q ss_pred cchhHHHHHHHHHhcc----cCCCCC-CCCCCCCCCcceeeecCCCCCCCCceeEEEccCCcceeecccCccCCCCCCeE
Q 037623 352 IKISVDAIMNIKSKYE----LLRDWQ-GDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESL 426 (749)
Q Consensus 352 ~~~~~~~l~~~k~~~~----~~~~W~-~dpc~p~~~~w~Gv~C~~~~~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l 426 (749)
.+.|..||++||+.+. .+.+|+ ++.| |.|.||+|+. ..+++.|||++|+++|.+|+.++.+++|+.|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~----c~w~gv~c~~----~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L 98 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADV----CLWQGITCNN----SSRVVSIDLSGKNISGKISSAIFRLPYIQTI 98 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCC----CcCcceecCC----CCcEEEEEecCCCccccCChHHhCCCCCCEE
Confidence 4478999999999874 356795 3344 3799999974 2467788888888777777777777778888
Q ss_pred ECcCCccccCcchhhh-hhhchhccccCCCCccc
Q 037623 427 DLSNNSLTGSVPEFLA-ELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 427 ~ls~N~l~G~iP~~l~-~~~~l~~l~~~n~~l~~ 459 (749)
+|++|+++|.+|..+. .+++|+.|.+++|++.+
T Consensus 99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~ 132 (968)
T PLN00113 99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132 (968)
T ss_pred ECCCCccCCcCChHHhccCCCCCEEECcCCcccc
Confidence 8887777777777655 67777777766666643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5e-09 Score=121.95 Aligned_cols=197 Identities=23% Similarity=0.332 Sum_probs=134.0
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+-+-+|.++.++.+.-.+ ...+.|+..... ....+....+-.++...+||-++....-+.......|+++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 356678888887664322 222333322211 111223333334444445666654444445567889999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|...|+.. ...+..-.......+.++++|||.. .+.|+|++|.|+|...+++.++.|||.....
T Consensus 890 ~~~Skl~~~------------~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 890 DLPSKLHNS------------GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CchhhhhcC------------CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 999998643 1233333344556788899999987 6999999999999999999999999844332
Q ss_pred cCC---------------------C--------CceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 686 PVE---------------------G--------GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 686 ~~~---------------------~--------~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
... . .........+|+.|.+||...+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0 00112234589999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 037623 737 IQKTPE 742 (749)
Q Consensus 737 f~~~~~ 742 (749)
|+....
T Consensus 1035 ~na~tp 1040 (1205)
T KOG0606|consen 1035 FNAETP 1040 (1205)
T ss_pred CCCcch
Confidence 986543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.7e-08 Score=112.19 Aligned_cols=189 Identities=22% Similarity=0.240 Sum_probs=139.4
Q ss_pred cccccccccCceEEEEEEEC---CcccEEEEecCCchhhHHH--HHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEee
Q 037623 528 NFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSVQGYKQ--FQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~~~~~~~~--f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.....||.|.|+.|++...+ +..+++|.+.+.......+ -..|+-+...+ .|.+++.....+...++.++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34578999999999987653 4778888876653322222 23455555544 577777766666677788889999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEecC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADFG 680 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~DFG 680 (749)
++++++..... ....++...++++..+++.++.++|+. .++|+|+||+||++..+ +..++.|||
T Consensus 348 ~~~~s~~l~~~------------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 348 CEGGSSSLRSV------------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred hcCcchhhhhH------------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 99999877762 234567777889999999999999987 99999999999999886 789999999
Q ss_pred CCccccCCCCceeeeccccCCccc--CccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYL--DPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
.+..+.... ......-+++ +++......+-.+.|+++||.-+.|.++|...
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 987532211 1112333444 55555667788999999999999999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.6e-07 Score=91.30 Aligned_cols=124 Identities=23% Similarity=0.247 Sum_probs=79.0
Q ss_pred EEEEEEEC-CcccEEEEecCCc---------------------h-----hhHHHHHHHHHHHHhcCCCc--eeEEEEEEe
Q 037623 540 TVYHGYLD-DKQVAVKMLSPSS---------------------V-----QGYKQFQAEVELLMRAHHKN--LTILVGYCD 590 (749)
Q Consensus 540 ~Vykg~~~-~~~VAVK~l~~~~---------------------~-----~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~~~ 590 (749)
.||.|... +..+|||+..... . ......++|.+.|.++...+ +...+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999874 5789999875420 0 01234678999999997764 4445444
Q ss_pred cCCeeEEEEeeCC--CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceeeCCCCCcEE
Q 037623 591 ENTKMGLVYEFMA--NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY-LHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 591 ~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~y-LH~~~~~gIiHrDLkp~NIL 667 (749)
....+||||++ +..+..+.... ++......++.++.+.+.. +|.. ||+|+||.+.|||
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~--------------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD--------------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG--------------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc--------------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 24579999998 55554433110 1123345677777776665 4676 9999999999999
Q ss_pred EcCCCcEEEEecCCCccc
Q 037623 668 LNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 668 l~~~~~~kL~DFGla~~~ 685 (749)
++++ .+.|+|||.+...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9988 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.3e-07 Score=96.50 Aligned_cols=176 Identities=16% Similarity=0.187 Sum_probs=128.3
Q ss_pred ceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe----cCCeeEEEEeeCCC-CCHHHH
Q 037623 538 FGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD----ENTKMGLVYEFMAN-GNLQAH 610 (749)
Q Consensus 538 fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~----~~~~~~LV~Ey~~~-gsL~~~ 610 (749)
-.+.||+.. +|..+++|+++....+....-..-++.++++.|.|+|++..++. .+..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357788875 56888999984433322222234578899999999999998875 35678899999886 567666
Q ss_pred HHHhhccCCC---CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 611 LLAQLAILPT---DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 611 L~~~~~~~~~---~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
-........+ ..-......++...+.++.|+..||.++|+. |+..+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432211100 0112334577888999999999999999999 999999999999999999999999887776654
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~ 735 (749)
+.... + +--++-|.=.||.+++.|.||..
T Consensus 446 d~~~~----------------l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPTEP----------------L---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCcc----------------h---hHHhhhhHHHHHHHHHHHhhccc
Confidence 32111 1 11356799999999999999964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=9e-07 Score=89.34 Aligned_cols=106 Identities=23% Similarity=0.221 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHhcCCC--ceeEEEEEEecC----CeeEEEEeeCCCC-CHHHHHHHhhccCCCCccCCCCCCCHHHHHHH
Q 037623 565 KQFQAEVELLMRAHHK--NLTILVGYCDEN----TKMGLVYEFMANG-NLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637 (749)
Q Consensus 565 ~~f~~Ei~iL~~l~H~--nIv~l~g~~~~~----~~~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~i 637 (749)
....+|...+.+++.. .....+++.+.. ...++|+|++++. +|.+++... ...+......+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~------------~~~~~~~~~~l 123 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW------------EQLDPSQRREL 123 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh------------cccchhhHHHH
Confidence 4577888888777433 344566665542 2457999999884 798888532 11555667889
Q ss_pred HHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---cEEEEecCCCccc
Q 037623 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---QAKLADFGLSRIF 685 (749)
Q Consensus 638 a~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---~~kL~DFGla~~~ 685 (749)
+.++++.++-||+. ||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 124 l~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 124 LRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999 999999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.6e-06 Score=83.83 Aligned_cols=138 Identities=18% Similarity=0.134 Sum_probs=103.0
Q ss_pred ccccCceEEEEEEECCcccEEEEecCC---c---hhhHHHHHHHHHHHHhcCCCc--eeEEEEEEe-c----CCeeEEEE
Q 037623 533 LGKGGFGTVYHGYLDDKQVAVKMLSPS---S---VQGYKQFQAEVELLMRAHHKN--LTILVGYCD-E----NTKMGLVY 599 (749)
Q Consensus 533 LG~G~fG~Vykg~~~~~~VAVK~l~~~---~---~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~~~-~----~~~~~LV~ 599 (749)
-|+||-+-|++-.+.++.+-+|.-... + +.+...|.+|...|.++...+ +.+.+ ++. . .-.-.||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 356899999999888888889976521 1 335678999999999885332 33344 332 1 22456999
Q ss_pred eeCCC-CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc--EEE
Q 037623 600 EFMAN-GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--AKL 676 (749)
Q Consensus 600 Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~--~kL 676 (749)
|-+++ -+|.+++... .....+...+..++.++++.++-||+. |+.|+|+.+.|||++.++. +++
T Consensus 105 e~L~g~~~L~~~l~~~----------~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 105 EDMAGFISIADWYAQH----------AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred EeCCCCccHHHHHhcC----------CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence 97764 5888887431 223456777889999999999999999 9999999999999986556 999
Q ss_pred EecCCCcc
Q 037623 677 ADFGLSRI 684 (749)
Q Consensus 677 ~DFGla~~ 684 (749)
+||.-++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99987664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.3e-06 Score=89.17 Aligned_cols=195 Identities=18% Similarity=0.235 Sum_probs=128.6
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEE-------ecCCeeEEEEee
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYC-------DENTKMGLVYEF 601 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~-------~~~~~~~LV~Ey 601 (749)
.+.||+|+.+.+|-.--- ...+.|+.......... +.++.|... .||-+-.-+.+= ....-..+.|..
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchh-hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 578999999999943211 22344666544332222 223333333 455332212221 112225567777
Q ss_pred CCCCCH-HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 602 MANGNL-QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 602 ~~~gsL-~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
+++..- ..++ .+..........+|.-.++.+..+|.+.+-||.. |.+-+|+.++|+|+.++..+.|.|=.
T Consensus 92 v~g~~pI~~~y------~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 92 VSGKEPIHMIY------SPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred CCCccchhhhc------CchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 765421 1111 1122234566789999999999999999999999 99999999999999999999999865
Q ss_pred CCccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcC-CCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITG-QPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG-~~pf~~~ 740 (749)
.-... .+........|...|.+||.-. +...+...|-|.+||++++++.| +.||.+.
T Consensus 163 sfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 163 SFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 43322 1233334456888999999754 34567789999999999999986 9999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.3e-06 Score=87.20 Aligned_cols=133 Identities=20% Similarity=0.196 Sum_probs=92.1
Q ss_pred cccccccccCceEEEEEEEC-CcccEEEEecCCch----------------------hhHHHHHHHHHHHHhcCCC--ce
Q 037623 528 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV----------------------QGYKQFQAEVELLMRAHHK--NL 582 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~----------------------~~~~~f~~Ei~iL~~l~H~--nI 582 (749)
.+.+.||-|--+.||.|... +.++|||.-+.... -.....++|.+.|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45688999999999999986 68999996543210 0123457889999998655 45
Q ss_pred eEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCC
Q 037623 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVK 662 (749)
Q Consensus 583 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLk 662 (749)
...+++ +...+|||++++-.|...- ++....-.++..|.+-+.-+-.. ||||+|++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----------------~~~en~~~il~~il~~~~~~~~~---GiVHGDlS 229 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----------------LDVENPDEILDKILEEVRKAYRR---GIVHGDLS 229 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----------------CcccCHHHHHHHHHHHHHHHHHc---CccccCCc
Confidence 555543 4567999999886553221 11222233444444444444455 99999999
Q ss_pred CCcEEEcCCCcEEEEecCCCcc
Q 037623 663 SANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 663 p~NILl~~~~~~kL~DFGla~~ 684 (749)
+-||+++++|.+.++||-.+..
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred hheEEEecCCCEEEEeCccccc
Confidence 9999999999999999976654
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.5e-06 Score=81.69 Aligned_cols=138 Identities=19% Similarity=0.340 Sum_probs=74.7
Q ss_pred eeeecCCCCCCCcccCCCceEEecCCccccCCCc-----------eeccccccccccccccccccccccCccceeeeccc
Q 037623 2 ISIDCGIPENANYTDSITGINYVSDASNIDTGVS-----------HKISSEFNKEITERQFSNLRSFPEGIRNCYTLKPD 70 (749)
Q Consensus 2 ~sidCg~~~~~~~~~~~~~~~~~~D~~~~~~g~~-----------~~~~~~~~~~~~~~~~~tlR~Fp~~~~nCy~~~~~ 70 (749)
+.|+||. ..|+|. .|+.|.+|..|...+.. .............+.|+|-|+=|. .-.|.+ |.
T Consensus 3 ~~IN~Gg---~~~~~~-~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~i-p~ 75 (174)
T PF11721_consen 3 LRINAGG---PAYTDS-SGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDI-PV 75 (174)
T ss_dssp EEEEETS---SSEEET-TTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEE-E-
T ss_pred EEEECCC---CcccCC-CCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEE-ec
Confidence 5799996 344444 89999999999644330 111222222333566899999332 458999 65
Q ss_pred CCCCeeEEEEEEe---eccCCCCCCC---CceeEEeccee-EEEEEcCC-CCC---cEEEEE-EEeccCCceEEEEee--
Q 037623 71 SDHEKFLIRARFM---YGNYNGQDKP---PSFNLMLEADV-WDSVQFPD-SGS---IVSKEI-IHIPKREYIHVCLVN-- 136 (749)
Q Consensus 71 ~~~~~ylvR~~f~---ygnyd~~~~~---p~fd~~~~~~~-w~~v~~~~-~~~---~~~~e~-~~~~~~~~~~vCl~~-- 136 (749)
.+.|.|-||+.|. ++. ++.... =+||++++|+. ...+++-. .+. ....+. -+.+.++.+.++|..
T Consensus 76 ~~~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~ 154 (174)
T PF11721_consen 76 VPNGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAG 154 (174)
T ss_dssp -S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE-
T ss_pred CCCcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecC
Confidence 5999999999993 333 222222 26999999954 33444221 111 344444 234588899999986
Q ss_pred ---------cCCCCceeeee
Q 037623 137 ---------TDSGTPFISAL 147 (749)
Q Consensus 137 ---------t~~~~Pfis~l 147 (749)
...|.|.||+|
T Consensus 155 ~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 155 KGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp -SEEEEEEESSSSSSSEEEE
T ss_pred CCcEEeeccccCCCcEEeeC
Confidence 44666888886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.3e-06 Score=93.42 Aligned_cols=139 Identities=18% Similarity=0.236 Sum_probs=90.8
Q ss_pred ccccccCceEEEEEEEC-CcccEEEEecCCchhh------------------------------HH----------HHHH
Q 037623 531 RVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQG------------------------------YK----------QFQA 569 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~~------------------------------~~----------~f~~ 569 (749)
+.|+.++-|+||+|++. |+.||||+.++.-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999997 6999999987631110 01 2344
Q ss_pred HHHHHHhc-----CCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHH
Q 037623 570 EVELLMRA-----HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644 (749)
Q Consensus 570 Ei~iL~~l-----~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~g 644 (749)
|...+.++ +.+++.--.=|.+-.....|+|||++|-.+.+..... ...++.+ .++..++++
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-----------~~g~d~k---~ia~~~~~~ 276 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-----------SAGIDRK---ELAELLVRA 276 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-----------hcCCCHH---HHHHHHHHH
Confidence 55555554 2333332222223356789999999998888775321 1233422 333333332
Q ss_pred H-HHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 645 L-EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 645 L-~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
. ..+-.. |+.|.|.+|.||+++.++++.+.|||+...+.
T Consensus 277 f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 277 FLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 1 111112 89999999999999999999999999987764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.6e-07 Score=70.75 Aligned_cols=60 Identities=43% Similarity=0.618 Sum_probs=53.3
Q ss_pred CceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 397 PRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
|+|+.|+|++|+|+ .||+. +..+++|++|+|++|+++.--|..+..+++|+.|.+++|++
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999 67765 88999999999999999965567889999999999998875
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.4e-05 Score=80.11 Aligned_cols=148 Identities=15% Similarity=0.258 Sum_probs=86.1
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCce--eEEEEEEecCCeeEEEEeeCCCCC-H
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL--TILVGYCDENTKMGLVYEFMANGN-L 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nI--v~l~g~~~~~~~~~LV~Ey~~~gs-L 607 (749)
..||+|..+.||+. .+...++|...... ......+|.+++..+..-.+ .+.++++...+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 35567788876543 22456889999988865444 456777777777889999999863 2
Q ss_pred H--------------HHHHHhhccCCCCccCCCCCCCH-HHHH--HH------HHHHHH-HHHHHHhC-CCCCceeeCCC
Q 037623 608 Q--------------AHLLAQLAILPTDAEDKTGILSW-KGRL--QI------ATESAQ-GLEYLHDG-CKPPIVHRDVK 662 (749)
Q Consensus 608 ~--------------~~L~~~~~~~~~~~~~~~~~l~~-~~~l--~i------a~~ia~-gL~yLH~~-~~~gIiHrDLk 662 (749)
. ..+......+..-.... ..+.. ..++ .+ ...+.+ ...+|... ..+.++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~-~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT-STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC-CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1 11111000011100000 00100 0000 00 000111 12233322 23457899999
Q ss_pred CCcEEEcCCCcEEEEecCCCcc
Q 037623 663 SANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 663 p~NILl~~~~~~kL~DFGla~~ 684 (749)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999987 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.3e-05 Score=74.92 Aligned_cols=139 Identities=14% Similarity=0.123 Sum_probs=89.7
Q ss_pred HHHHhhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHH---------HHHHHHHHhcCCC---ceeEEEEEE
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQF---------QAEVELLMRAHHK---NLTILVGYC 589 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f---------~~Ei~iL~~l~H~---nIv~l~g~~ 589 (749)
+....+...+++-.....-|.+-..+++...+|.........++.| .+++..+.+++.. .....+.+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3333444446666666667777777888899998876544333322 2344444444322 222222222
Q ss_pred -----ecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCC
Q 037623 590 -----DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSA 664 (749)
Q Consensus 590 -----~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~ 664 (749)
.-....+|+|||++|..|.+... ++. .++..+++++.-||+. |+.|+|..|.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpg 164 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPG 164 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcC
Confidence 22345679999999987755431 111 2556677889999999 9999999999
Q ss_pred cEEEcCCCcEEEEecCCCcc
Q 037623 665 NILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 665 NILl~~~~~~kL~DFGla~~ 684 (749)
|++++++ .++++||+..+.
T Consensus 165 NFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 165 NFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred cEEEECC-cEEEEECccccc
Confidence 9999976 599999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.4e-05 Score=77.83 Aligned_cols=148 Identities=16% Similarity=0.110 Sum_probs=86.1
Q ss_pred ccccCc-eEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCCCCHHHH
Q 037623 533 LGKGGF-GTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMANGNLQAH 610 (749)
Q Consensus 533 LG~G~f-G~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 610 (749)
|-.|.. ..||+...++..+.||+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 334444 8899998777778888876543 345678888888874 33344667766666678899999999887654
Q ss_pred HH------------HhhccCCCCccCCCCCCC-H-HHHHHHH--------------------HHHHHHHHHHHh----CC
Q 037623 611 LL------------AQLAILPTDAEDKTGILS-W-KGRLQIA--------------------TESAQGLEYLHD----GC 652 (749)
Q Consensus 611 L~------------~~~~~~~~~~~~~~~~l~-~-~~~l~ia--------------------~~ia~gL~yLH~----~~ 652 (749)
.. .....+..-..... .+. + ...+... ..+...++.|-. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADC-PFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccC-CcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 21 00000010000000 110 0 0000000 001112222211 12
Q ss_pred CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 ~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35689999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.9e-05 Score=72.37 Aligned_cols=128 Identities=22% Similarity=0.225 Sum_probs=89.6
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHHH
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQA 609 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 609 (749)
.+.|++|.+|.||+|.+.+..+|+|+-...++. ..++.|+++|..+.-.++-+=+-.+.+ ..+.|||+.|-.|.+
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~ 101 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhcccccEEEEeeccCceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhh
Confidence 478999999999999999999999997765543 678999999999988777765444332 234599999988876
Q ss_pred HHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCC-CC-cEEEcCCCcEEEEecCCCccc
Q 037623 610 HLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVK-SA-NILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 610 ~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLk-p~-NILl~~~~~~kL~DFGla~~~ 685 (749)
.-.. .+-...++ +++.---|... ||-|+.|. |. ||++.+ ..+.|+||..|+.-
T Consensus 102 ~~~~---------------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k 156 (201)
T COG2112 102 LEIG---------------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATFK 156 (201)
T ss_pred hhhc---------------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence 6521 12223333 33332223333 88888875 34 555544 49999999999843
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.5e-05 Score=76.49 Aligned_cols=148 Identities=19% Similarity=0.242 Sum_probs=85.9
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeEEEEEEec---CCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN--LTILVGYCDE---NTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~~~~---~~~~~LV~Ey~~~g 605 (749)
+.|+.|..+.||+...+++.+++|..... .......+|..++..+.... +..++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56889999999999998889999997654 34567788888888885433 3455554422 33568999999998
Q ss_pred CHHH----------------HHHHhhccCCCCccCCCCCCCHH--------HHHHH------------HHHHHH-HHHHH
Q 037623 606 NLQA----------------HLLAQLAILPTDAEDKTGILSWK--------GRLQI------------ATESAQ-GLEYL 648 (749)
Q Consensus 606 sL~~----------------~L~~~~~~~~~~~~~~~~~l~~~--------~~l~i------------a~~ia~-gL~yL 648 (749)
.+.. .+..-.. ..........+. ..... ...+.+ .++.+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQ----VPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHH----SHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhccc----ccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 8877 1111000 000000000000 00000 112222 33333
Q ss_pred Hh----CCCCCceeeCCCCCcEEEc-CCCcEEEEecCCCcc
Q 037623 649 HD----GCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRI 684 (749)
Q Consensus 649 H~----~~~~gIiHrDLkp~NILl~-~~~~~kL~DFGla~~ 684 (749)
++ .....++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 32 2345799999999999999 666678999997764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.1e-06 Score=97.16 Aligned_cols=100 Identities=26% Similarity=0.440 Sum_probs=77.9
Q ss_pred HHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCC-------ceeeeccccCCcccCcccccc
Q 037623 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG-------SHVSTTVVGTPGYLDPEYYIS 711 (749)
Q Consensus 639 ~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~~~~gt~~y~APE~~~~ 711 (749)
.+++.||.|+|.. +++||++|.|++|.++.++..||+.|+.+........ ............|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999976 5899999999999999999999999998765432111 111112235567999999999
Q ss_pred CCCCCchhHHHHHHHHHHHH-cCCCCCCCC
Q 037623 712 NRLTEKSDVYSFGVVLLELI-TGQPVIQKT 740 (749)
Q Consensus 712 ~~~s~k~DVwSfGvvL~Ell-tG~~pf~~~ 740 (749)
...+.++|+||+|++++-+. .|+..+...
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc
Confidence 88999999999999999999 566666543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.6e-06 Score=60.19 Aligned_cols=40 Identities=30% Similarity=0.629 Sum_probs=34.0
Q ss_pred CceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcc
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVP 438 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP 438 (749)
++|+.|+|++|+++ .||+++++|++|+.|+|++|+++ .||
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 46899999999999 79888999999999999999998 454
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.5e-06 Score=93.36 Aligned_cols=181 Identities=22% Similarity=0.205 Sum_probs=131.1
Q ss_pred ccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCc-eeEEEEEEecCCeeEEEEeeCCCC-CH
Q 037623 531 RVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN-LTILVGYCDENTKMGLVYEFMANG-NL 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n-Iv~l~g~~~~~~~~~LV~Ey~~~g-sL 607 (749)
+-.++|+++.++|.+-.. +...++.+... ....-++++|.+++||| .+.-++-++.++...++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 446789999999887644 22334443322 34466889999999999 666666677777888999988776 11
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccC
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 687 (749)
... .......+...+...+...-.+++++||+. .=+|+| ||+..+ ...|..||+.+..+..
T Consensus 323 ~~~-----------~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 323 ALE-----------MTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred ccc-----------CChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCc
Confidence 110 011223345556667778888999999987 458998 887776 4889999998887643
Q ss_pred CCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
.. ..+...+++.++|||+.....+..+.|+|+.|+-..++.-|-+|-.
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 32 3345679999999999999999999999999987778877776654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00014 Score=72.16 Aligned_cols=105 Identities=24% Similarity=0.207 Sum_probs=82.1
Q ss_pred HHHHHHHHhcCC-CceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHH
Q 037623 568 QAEVELLMRAHH-KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646 (749)
Q Consensus 568 ~~Ei~iL~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~ 646 (749)
..|.-++..+++ +++.+++|+|. .++|.||...+++...-.. -.....-+|..|.+||.++++.+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~---------l~~~~~~~w~~R~~iA~~lL~~l~ 73 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP---------LSQFLQSPWEQRAKIALQLLELLE 73 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc---------cccccccCHHHHHHHHHHHHHHHH
Confidence 457888888876 58999999994 3679999987766422000 011224689999999999999999
Q ss_pred HHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 647 yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|++...-.+.-.|++++|+-+++++++|++|...+...
T Consensus 74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999864446778999999999999999999999977654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00034 Score=70.98 Aligned_cols=135 Identities=21% Similarity=0.227 Sum_probs=88.0
Q ss_pred cccccCceEEEEEEEC-CcccEEEEecCCchhhH------------------------HHHHHHHHHHHhcCCC--ceeE
Q 037623 532 VLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGY------------------------KQFQAEVELLMRAHHK--NLTI 584 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~~~------------------------~~f~~Ei~iL~~l~H~--nIv~ 584 (749)
.|..|.-+.||+|... +..+|||+......... .-..+|..-|.++... .+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 6778999999999864 58899999865321110 0124566667666322 2233
Q ss_pred EEEEEecCCeeEEEEeeCCCCCH-HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCC
Q 037623 585 LVGYCDENTKMGLVYEFMANGNL-QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKS 663 (749)
Q Consensus 585 l~g~~~~~~~~~LV~Ey~~~gsL-~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp 663 (749)
-+++ .+..|||||+...-. .-.| +.-.+.......+..++.+.+.-|-..+ ++||+||+.
T Consensus 135 Pi~~----~~nVLvMEfIg~~g~pAP~L-------------kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSE 195 (268)
T COG1718 135 PIAF----RNNVLVMEFIGDDGLPAPRL-------------KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSE 195 (268)
T ss_pred ceee----cCCeEEEEeccCCCCCCCCc-------------ccCCcCchhHHHHHHHHHHHHHHHHHhc--Ccccccchh
Confidence 3333 245699999965311 0000 1111122256667778888888777622 999999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccc
Q 037623 664 ANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 664 ~NILl~~~~~~kL~DFGla~~~~ 686 (749)
=|||+. ++.+.|+|||.|....
T Consensus 196 yNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hheEEE-CCeEEEEECccccccC
Confidence 999999 7799999999887654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00029 Score=79.88 Aligned_cols=140 Identities=21% Similarity=0.218 Sum_probs=89.0
Q ss_pred ccccccCceEEEEEEECC-cccEEEEecCCchhh-------------------------------------HHHHHHHHH
Q 037623 531 RVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQG-------------------------------------YKQFQAEVE 572 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~-------------------------------------~~~f~~Ei~ 572 (749)
+.||.-..|+||+|++.+ +.||||+-++.-... .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999965 779999976531111 012445554
Q ss_pred HHHhc----CCCc---eeEEEEEE-ecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHH
Q 037623 573 LLMRA----HHKN---LTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644 (749)
Q Consensus 573 iL~~l----~H~n---Iv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~g 644 (749)
-..+. +|-+ -|..=.++ .-.....|+||||+|..+.+.-.-. ...++-. .++..+.++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-----------~~gi~~~---~i~~~l~~~ 312 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-----------KRGISPH---DILNKLVEA 312 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-----------HcCCCHH---HHHHHHHHH
Confidence 44333 4444 11122222 2245789999999998776664221 1223333 344444443
Q ss_pred HHHHHhCCCCCceeeCCCCCcEEEcC----CCcEEEEecCCCcccc
Q 037623 645 LEYLHDGCKPPIVHRDVKSANILLNE----KFQAKLADFGLSRIFP 686 (749)
Q Consensus 645 L~yLH~~~~~gIiHrDLkp~NILl~~----~~~~kL~DFGla~~~~ 686 (749)
|+++....|++|+|=+|.||+++. ++++.+-|||+...+.
T Consensus 313 --~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 313 --YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 333333349999999999999994 6789999999987653
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=97.57 E-value=4.7e-05 Score=74.55 Aligned_cols=103 Identities=19% Similarity=0.245 Sum_probs=53.9
Q ss_pred EEeeecCCCCCccccCCCCCCCCccccCCC---CCceeeccc------cccCCCCCCCCcHHHHhhceecCCCCcceEEE
Q 037623 167 YGRWDVGSTTNKTFRYPDDVYDRIWFPHNF---YSWAQISTS------SNMKSTGNFQPPSTVMQSAVIPANGGSSLMLS 237 (749)
Q Consensus 167 ~~R~~~G~~~~~~~ryp~D~~dR~W~p~~~---~~~~~~st~------~~~~~~~~~~~P~~v~~tA~~~~~~~~~l~~~ 237 (749)
+.|.|+|+. .| +|.-++.|.++.. ..|.-.... ...........+..++||+-... . .++
T Consensus 2 ~~~IN~Gg~-----~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~--~f~ 70 (174)
T PF11721_consen 2 VLRINAGGP-----AY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---S--SFS 70 (174)
T ss_dssp EEEEEETSS-----SE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---S--SEE
T ss_pred EEEEECCCC-----cc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---C--ceE
Confidence 469999964 24 8888999988543 334111100 01112222334779999997622 2 345
Q ss_pred ecCC-CCccceEEEEeeecccccccc------CcceEEEEEECCeeccCCCC
Q 037623 238 WKPA-NRMIKNYVYFYFSEFESERAK------NQTRDLNIYINGKLWYGPLS 282 (749)
Q Consensus 238 w~~~-~~~~~~~~~~~Faei~~~~~~------~~~Rvf~i~lng~~~~~~~~ 282 (749)
|..+ ...-.|-|.|||||+.. .. ...|+|+|+|||+.+...+.
T Consensus 71 Y~ip~~~~G~Y~V~L~FaE~~~--~~~~~~~~~G~RvFdV~v~g~~vl~~~D 120 (174)
T PF11721_consen 71 YDIPVVPNGTYTVRLHFAELYF--GASGGASGPGQRVFDVYVNGETVLKNFD 120 (174)
T ss_dssp EEEE--S-EEEEEEEEEE-SSS----------SSSS-EEEEETTEEEEEEE-
T ss_pred EEEecCCCcEEEEEEEeccccc--cccccccCCCceEEEEEecceEEEeccC
Confidence 5544 33345779999999975 34 56899999999987655443
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.001 Score=66.04 Aligned_cols=125 Identities=26% Similarity=0.334 Sum_probs=88.9
Q ss_pred HhhcccccccccCc-eEEEEEEECCcccEEEEecC---Cch------------------hhHHHHHHHHHHHHhcC---C
Q 037623 525 ITNNFERVLGKGGF-GTVYHGYLDDKQVAVKMLSP---SSV------------------QGYKQFQAEVELLMRAH---H 579 (749)
Q Consensus 525 ~t~~f~~~LG~G~f-G~Vykg~~~~~~VAVK~l~~---~~~------------------~~~~~f~~Ei~iL~~l~---H 579 (749)
...+|-+.||.|.. |.|||++..++.+|+|+... ... .....|..|.+..++++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 34556789999999 99999999999999999321 000 11235889999988884 4
Q ss_pred Cce--eEEEEEEecC------------------CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHH
Q 037623 580 KNL--TILVGYCDEN------------------TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639 (749)
Q Consensus 580 ~nI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~ 639 (749)
+++ |+.+||..-. ....+|.||++... .+ ..+-+.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------------~~----~~~~~~ 171 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------------PL----QIRDIP 171 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------------cc----chhHHH
Confidence 556 8899987321 11346777765432 11 223456
Q ss_pred HHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 640 ~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++.+-|..+|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 172 ~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 677778889988 9999999999985 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00069 Score=82.61 Aligned_cols=155 Identities=15% Similarity=0.244 Sum_probs=92.0
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCCc-hhhHHHHHHHHHHHHhcC-CCce--eEEEEEEecC---CeeEEEE
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAH-HKNL--TILVGYCDEN---TKMGLVY 599 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~-H~nI--v~l~g~~~~~---~~~~LV~ 599 (749)
+.++.|.+..+|+....+ ..+++|+..... ......+.+|.+++..+. |.++ .+.+++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 568899999999987754 357777764432 123356889999999995 6664 6777887654 4578999
Q ss_pred eeCCCCCHHHH----------------HHHhhccCCC-Cc-----cCCCCCCC--------HHHHHHH---------HHH
Q 037623 600 EFMANGNLQAH----------------LLAQLAILPT-DA-----EDKTGILS--------WKGRLQI---------ATE 640 (749)
Q Consensus 600 Ey~~~gsL~~~----------------L~~~~~~~~~-~~-----~~~~~~l~--------~~~~l~i---------a~~ 640 (749)
||+++..+.+. +......+.. +. .......+ |.....- ...
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99987643210 0000000000 00 00001111 1111000 122
Q ss_pred HHHHHHHHHhCC--------CCCceeeCCCCCcEEEcCC-C-cEEEEecCCCccc
Q 037623 641 SAQGLEYLHDGC--------KPPIVHRDVKSANILLNEK-F-QAKLADFGLSRIF 685 (749)
Q Consensus 641 ia~gL~yLH~~~--------~~gIiHrDLkp~NILl~~~-~-~~kL~DFGla~~~ 685 (749)
+.+.+++|..+. .+.+||+|+++.|||++.+ . ..-|.||.++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 445567775432 1359999999999999853 3 3579999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0015 Score=65.24 Aligned_cols=127 Identities=25% Similarity=0.393 Sum_probs=88.0
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCc----------------hhhHHHHHHHHHHHHhcC------CCceeEEEEE
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSS----------------VQGYKQFQAEVELLMRAH------HKNLTILVGY 588 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~----------------~~~~~~f~~Ei~iL~~l~------H~nIv~l~g~ 588 (749)
..||+|+.-.||.-- .+....||+..... ....++..+|+.-..++. +..|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 579999999999532 33567788877655 123456677777666665 7889999999
Q ss_pred EecCCeeEEEEeeCCC------CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCC
Q 037623 589 CDENTKMGLVYEFMAN------GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVK 662 (749)
Q Consensus 589 ~~~~~~~~LV~Ey~~~------gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLk 662 (749)
.+++....+|+|.+.+ -+|.+++.. ..++. ...+ .+-+-.+||-+. .|+.+|++
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------------~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~ 145 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE-------------GGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLN 145 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc-------------CCccH-HHHH---HHHHHHHHHHHc---CCeecCCC
Confidence 9999999999998753 246666632 23443 2333 333444566666 89999999
Q ss_pred CCcEEEcCC---C-cEEEEe
Q 037623 663 SANILLNEK---F-QAKLAD 678 (749)
Q Consensus 663 p~NILl~~~---~-~~kL~D 678 (749)
|+||++... . .+.|+|
T Consensus 146 ~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cccEEEEecCCCceEEEEEe
Confidence 999999633 2 566776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=70.14 Aligned_cols=75 Identities=12% Similarity=0.030 Sum_probs=56.2
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCC---CceeEEEEEEec---CCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH---KNLTILVGYCDE---NTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H---~nIv~l~g~~~~---~~~~~LV~Ey~~~ 604 (749)
+.||.|..+.||+....+..+.+|..+... ....|..|.+.|+.+.. -.+.+.+++|.. .+..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 579999999999988776677777754311 22578899999988853 246678887754 3568999999998
Q ss_pred CCH
Q 037623 605 GNL 607 (749)
Q Consensus 605 gsL 607 (749)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0012 Score=67.85 Aligned_cols=73 Identities=15% Similarity=0.178 Sum_probs=43.6
Q ss_pred ccccccCce-EEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCC---ceeEEEEEEecC---CeeEEEEeeCC
Q 037623 531 RVLGKGGFG-TVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHK---NLTILVGYCDEN---TKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG-~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~---nIv~l~g~~~~~---~~~~LV~Ey~~ 603 (749)
+.|+.|+.. .||+. +..+++|...... ....+.+|.+++..+... -+...++..... ...+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 356666665 58875 3456677654322 235788899999887532 223334333322 13478999999
Q ss_pred CCCHH
Q 037623 604 NGNLQ 608 (749)
Q Consensus 604 ~gsL~ 608 (749)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0023 Score=65.71 Aligned_cols=72 Identities=17% Similarity=0.200 Sum_probs=47.6
Q ss_pred ccccccCceEEEEEEEC---CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeE-EEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTI-LVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~-l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
+.|..|-...+|+.... ++.+++|+....... .....+|+.++..+...++++ +++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 45777888899998876 467888876543222 123357888888885544544 333322 248999999876
Q ss_pred H
Q 037623 607 L 607 (749)
Q Consensus 607 L 607 (749)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0028 Score=67.57 Aligned_cols=150 Identities=16% Similarity=0.185 Sum_probs=88.7
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeEEEEE------EecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN--LTILVGY------CDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~------~~~~~~~~LV~Ey~ 602 (749)
+.|..|....+|+...++..+++|+.... ...+...|++++..+++.+ +.+.+.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 46777888899998887788999987642 2345667888887775433 3344332 12234567999999
Q ss_pred CCCCHHH-----------H---HHHhhccCCCCccCCCCCCCHHHHH----------HHHHHHHHHHHHHHh----CCCC
Q 037623 603 ANGNLQA-----------H---LLAQLAILPTDAEDKTGILSWKGRL----------QIATESAQGLEYLHD----GCKP 654 (749)
Q Consensus 603 ~~gsL~~-----------~---L~~~~~~~~~~~~~~~~~l~~~~~l----------~ia~~ia~gL~yLH~----~~~~ 654 (749)
+|..+.. . +|......... ........|.... .....+..++.++.+ ....
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGE-RNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCcc-CCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 9876421 1 11110000000 0111222333221 111223344555543 2234
Q ss_pred CceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 655 PIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 655 gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
+++|+|+.|.|||++++....|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999987789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0026 Score=66.39 Aligned_cols=147 Identities=18% Similarity=0.087 Sum_probs=82.0
Q ss_pred cccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeE-EEEEEecCCeeEEEEeeCCCCCHHHH
Q 037623 532 VLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTI-LVGYCDENTKMGLVYEFMANGNLQAH 610 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~-l~g~~~~~~~~~LV~Ey~~~gsL~~~ 610 (749)
.+..|-...+|+...+++.+++|..........-...+|.+++..+....+++ +++.+. ..+|+||++|..+...
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 35568888999988777888888765443221123578888898886544443 343332 3689999998665321
Q ss_pred ----------HHHhhccCCCCccCCCCCCCHHHHH-HHH---------HHHHHHHHHHHhC-----CCCCceeeCCCCCc
Q 037623 611 ----------LLAQLAILPTDAEDKTGILSWKGRL-QIA---------TESAQGLEYLHDG-----CKPPIVHRDVKSAN 665 (749)
Q Consensus 611 ----------L~~~~~~~~~~~~~~~~~l~~~~~l-~ia---------~~ia~gL~yLH~~-----~~~gIiHrDLkp~N 665 (749)
+......+..... ....++....+ ... ..+.+.+..+-.. ..+.++|+|+.|.|
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1111111111100 01112221111 110 1111222222211 12358999999999
Q ss_pred EEEcCCCcEEEEecCCCcc
Q 037623 666 ILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 666 ILl~~~~~~kL~DFGla~~ 684 (749)
|++++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0038 Score=67.07 Aligned_cols=152 Identities=14% Similarity=0.167 Sum_probs=84.9
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeEEEEEE------ecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN--LTILVGYC------DENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~~------~~~~~~~LV~Ey~ 602 (749)
+.++.|....+|+...++..+++|+...... .++...|.+++..+.... +.+.+... ...+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4577777789999887777788887654321 234456677777664322 23333321 1235568999999
Q ss_pred CCCCHH-----------HH---HHHhhccCCCCccCCCCCCCHHHHH------------HHHHHHHHHHHHHHh----CC
Q 037623 603 ANGNLQ-----------AH---LLAQLAILPTDAEDKTGILSWKGRL------------QIATESAQGLEYLHD----GC 652 (749)
Q Consensus 603 ~~gsL~-----------~~---L~~~~~~~~~~~~~~~~~l~~~~~l------------~ia~~ia~gL~yLH~----~~ 652 (749)
+|..+. .. +|................-.|.... .....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 885432 11 1111110000000000111222111 112223445555543 23
Q ss_pred CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 ~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
..+++|+|+++.||++++++...|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 45899999999999999987778999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=5.1e-05 Score=71.71 Aligned_cols=64 Identities=31% Similarity=0.467 Sum_probs=57.1
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
..+++.|-||+|.|+ .+||.|+.|.+|+.|+|+||+++ .+|.++++++.|+.|..+-|.|...+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lp 95 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILP 95 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCc
Confidence 567888999999998 88999999999999999999999 79999999999999988877776543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00029 Score=51.82 Aligned_cols=33 Identities=30% Similarity=0.885 Sum_probs=23.5
Q ss_pred chhHHHHHHHHHhcc-----cCCCCCC----CCCCCCCCcceeeecC
Q 037623 353 KISVDAIMNIKSKYE-----LLRDWQG----DPCAPNDYLWQGLNCS 390 (749)
Q Consensus 353 ~~~~~~l~~~k~~~~-----~~~~W~~----dpc~p~~~~w~Gv~C~ 390 (749)
..|++||++||+.+. .+.+|+. +|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-----~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-----SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-----CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-----eeccEEeC
Confidence 467899999999875 3678963 566 69999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0087 Score=64.57 Aligned_cols=150 Identities=13% Similarity=0.162 Sum_probs=79.5
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeEEEE------EEecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN--LTILVG------YCDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g------~~~~~~~~~LV~Ey~ 602 (749)
+.|+.|....+|+...++..+++|+..... .+....|+.++..+...+ +.+.+. +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 456677778999988777789999876222 233344555555553222 222222 112245678999999
Q ss_pred CCCCHH-----------HHH---HHhhccCCCCccCCCCCCCH-HHHHH-------------HHHHHHHHHHHHHh----
Q 037623 603 ANGNLQ-----------AHL---LAQLAILPTDAEDKTGILSW-KGRLQ-------------IATESAQGLEYLHD---- 650 (749)
Q Consensus 603 ~~gsL~-----------~~L---~~~~~~~~~~~~~~~~~l~~-~~~l~-------------ia~~ia~gL~yLH~---- 650 (749)
+|..+. ..| |......... ......+.| ..... +...+...++.+.+
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLE-RPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCcc-CCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 987431 111 1111000000 001111222 11111 11112222233321
Q ss_pred CCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 651 GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 651 ~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
....++||+|+.+.|||++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1345899999999999999775568999998864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.01 Score=65.59 Aligned_cols=74 Identities=19% Similarity=0.190 Sum_probs=51.5
Q ss_pred ccccccCceEEEEEEECCc--ccEEEEecCC-----c--hhhHHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeEEE
Q 037623 531 RVLGKGGFGTVYHGYLDDK--QVAVKMLSPS-----S--VQGYKQFQAEVELLMRAH---HKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~--~VAVK~l~~~-----~--~~~~~~f~~Ei~iL~~l~---H~nIv~l~g~~~~~~~~~LV 598 (749)
+.||.|.+..||+....+. .+.||.-.+. . ....+++..|.+.|..+. ...+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998764 8999985421 1 123456778888887762 2344555555 34567899
Q ss_pred EeeCCCCC
Q 037623 599 YEFMANGN 606 (749)
Q Consensus 599 ~Ey~~~gs 606 (749)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0072 Score=64.63 Aligned_cols=150 Identities=23% Similarity=0.267 Sum_probs=84.6
Q ss_pred ccccccCceEEEEEEECC--------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEee
Q 037623 531 RVLGKGGFGTVYHGYLDD--------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~Ey 601 (749)
+.+..|-...+|+....+ +.+++|+...... ......+|.+++..+....+. ++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345567777899887653 6788888765432 223457888888888544444 34544432 368999
Q ss_pred CCCCCHHHHH----------HHhhccCCCCccCC------CCCCCHHHHH--------------------------HHHH
Q 037623 602 MANGNLQAHL----------LAQLAILPTDAEDK------TGILSWKGRL--------------------------QIAT 639 (749)
Q Consensus 602 ~~~gsL~~~L----------~~~~~~~~~~~~~~------~~~l~~~~~l--------------------------~ia~ 639 (749)
++|..+.... ......+....... ....-|.... .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887664311 01111111110000 0011111110 1122
Q ss_pred HHHHHHHHHHh------CCCCCceeeCCCCCcEEEcCC----CcEEEEecCCCccc
Q 037623 640 ESAQGLEYLHD------GCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIF 685 (749)
Q Consensus 640 ~ia~gL~yLH~------~~~~gIiHrDLkp~NILl~~~----~~~kL~DFGla~~~ 685 (749)
.+.+.+..|.. .....++|+|+.+.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233444432 234578999999999999984 78999999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00061 Score=50.32 Aligned_cols=38 Identities=37% Similarity=0.451 Sum_probs=33.2
Q ss_pred CCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 421 TSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 421 ~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
++|++|+|++|+++ .||+.+++|++|+.|.+++|.+..
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 57999999999999 799999999999999999998864
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.001 Score=64.87 Aligned_cols=61 Identities=30% Similarity=0.405 Sum_probs=27.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhh-hhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFL-AELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l-~~~~~l~~l~~~n~~l~~ 459 (749)
+.+|+.||||+|+++ .| +.+..|+.|+.|+|++|+++ .|++.+ ..++.|+.|++++|++..
T Consensus 41 l~~L~~L~Ls~N~I~-~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~ 102 (175)
T PF14580_consen 41 LDKLEVLDLSNNQIT-KL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD 102 (175)
T ss_dssp -TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S
T ss_pred hcCCCEEECCCCCCc-cc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC
Confidence 567899999999998 46 56888999999999999998 476555 468899999999988854
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.015 Score=63.59 Aligned_cols=148 Identities=12% Similarity=0.178 Sum_probs=89.8
Q ss_pred eeecCCCC-CCCcccCCCceEEecC---CccccCCCceecc---ccccccccccccccccccccCccceeee--cccCCC
Q 037623 3 SIDCGIPE-NANYTDSITGINYVSD---ASNIDTGVSHKIS---SEFNKEITERQFSNLRSFPEGIRNCYTL--KPDSDH 73 (749)
Q Consensus 3 sidCg~~~-~~~~~~~~~~~~~~~D---~~~~~~g~~~~~~---~~~~~~~~~~~~~tlR~Fp~~~~nCy~~--~~~~~~ 73 (749)
.++||... ...|.|+.-.+.|.+. .++.+-..+..|. ..-....+...|+|.|.=.....+ ++| ..+.++
T Consensus 182 R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~-~nltw~~~~~~ 260 (347)
T PF12819_consen 182 RLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDP-LNLTWSFVDPG 260 (347)
T ss_pred eecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhcccccccc-eEEEeccCCCC
Confidence 48999854 2678888889999963 2332222222232 110112344558898887755422 444 235588
Q ss_pred CeeEEEEEEeeccCCCCCC-CCceeEEecceeEEEEEcCC----C-CCcEEEEEEE-eccCCceEEEEeecCCC--Ccee
Q 037623 74 EKFLIRARFMYGNYNGQDK-PPSFNLMLEADVWDSVQFPD----S-GSIVSKEIIH-IPKREYIHVCLVNTDSG--TPFI 144 (749)
Q Consensus 74 ~~ylvR~~f~ygnyd~~~~-~p~fd~~~~~~~w~~v~~~~----~-~~~~~~e~~~-~~~~~~~~vCl~~t~~~--~Pfi 144 (749)
..|+||..|-==-.-..+. .-.||+++++..|.. .++- . ...++...++ +..+..+.|.|..+... .|+|
T Consensus 261 ~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lppiL 339 (347)
T PF12819_consen 261 FSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPPIL 339 (347)
T ss_pred ccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCcCcee
Confidence 8999999995222111122 357999999999974 3222 1 2222344444 44456789999988654 5999
Q ss_pred eeeeeeeC
Q 037623 145 SALELRPL 152 (749)
Q Consensus 145 s~lEl~~l 152 (749)
++||+..+
T Consensus 340 NalEIy~v 347 (347)
T PF12819_consen 340 NALEIYKV 347 (347)
T ss_pred EeeeeEeC
Confidence 99999754
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.00055 Score=79.85 Aligned_cols=62 Identities=29% Similarity=0.375 Sum_probs=55.9
Q ss_pred CCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.++|+.|+|++|.|. ++|.+ +.+|..|+.|+||+|+|+ .||+++.++..|++|...+|++..
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~ 444 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS 444 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee
Confidence 678999999999996 89887 999999999999999999 799999999999999888777643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.00054 Score=64.93 Aligned_cols=63 Identities=29% Similarity=0.314 Sum_probs=52.7
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+.+|+.|+|++|++. .+|++|+.|+.|+.|+++-|+|. .+|..++.++.|+.|++..|+|.-
T Consensus 54 ~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e 116 (264)
T KOG0617|consen 54 ELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE 116 (264)
T ss_pred Hhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccc
Confidence 4667888889888887 78888888999999999988888 578888888888888888877754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.00093 Score=74.62 Aligned_cols=62 Identities=35% Similarity=0.369 Sum_probs=53.0
Q ss_pred CCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
...++..|+||+|++- +||.+ +.+|+.|-+||||+|+|. .+|+.+..|..|+.|.++||.|-
T Consensus 124 ~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 124 YAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred hhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 3456788999999987 88877 778999999999999998 79999999999999988887653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.001 Score=70.97 Aligned_cols=65 Identities=28% Similarity=0.433 Sum_probs=54.5
Q ss_pred CCCceeEEEccCCcce----------------------eecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccc
Q 037623 395 QAPRIKSLNLSSSGIA----------------------GEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLV 451 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~----------------------G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~ 451 (749)
++-+|+.||||+|+|. |.++++ +.+|.+|..|||.+|.+. .||+.+++|.+|+.|.
T Consensus 456 ~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLe 534 (565)
T KOG0472|consen 456 SLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLE 534 (565)
T ss_pred hhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEE
Confidence 4456777777776543 678888 999999999999999998 7999999999999999
Q ss_pred cCCCCcccC
Q 037623 452 DGNPNLCLS 460 (749)
Q Consensus 452 ~~n~~l~~~ 460 (749)
+.+|.+.-+
T Consensus 535 L~gNpfr~P 543 (565)
T KOG0472|consen 535 LDGNPFRQP 543 (565)
T ss_pred ecCCccCCC
Confidence 998888743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0025 Score=50.55 Aligned_cols=39 Identities=36% Similarity=0.637 Sum_probs=34.3
Q ss_pred CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCcc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSL 433 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l 433 (749)
..+++|+.|+|++|.++ .||+. +..|++|++|+|++|+|
T Consensus 22 ~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 22 SNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred cCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence 45789999999999998 55564 89999999999999986
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.00086 Score=74.88 Aligned_cols=61 Identities=31% Similarity=0.394 Sum_probs=35.7
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+++|+.|+||+|.++ .+...++...+|++|+||.|+|+ .+|+.+++|+.|+.|+.+||.|.
T Consensus 244 l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 455566666666665 33233455556666666666666 46666666666666666666554
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.039 Score=60.28 Aligned_cols=149 Identities=15% Similarity=0.182 Sum_probs=81.8
Q ss_pred cccccCceEEEEEEECC------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEeeCCC
Q 037623 532 VLGKGGFGTVYHGYLDD------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~~------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.|-.|-.-.+|+....+ +.+++|+.......... -.+|..++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44457778889887532 56888887655332222 36788888888655555 345554322 58999987
Q ss_pred CCHHHH----------HHHhhccCCCCccCCCC-CCCHHHHHHHHH-----------------HHHHHHHHHH----h-C
Q 037623 605 GNLQAH----------LLAQLAILPTDAEDKTG-ILSWKGRLQIAT-----------------ESAQGLEYLH----D-G 651 (749)
Q Consensus 605 gsL~~~----------L~~~~~~~~~~~~~~~~-~l~~~~~l~ia~-----------------~ia~gL~yLH----~-~ 651 (749)
.+|... +......++........ ..-|....+... .+...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 11111111111100111 111222222211 1122222222 1 2
Q ss_pred CCCCceeeCCCCCcEEEcC-CCcEEEEecCCCccc
Q 037623 652 CKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIF 685 (749)
Q Consensus 652 ~~~gIiHrDLkp~NILl~~-~~~~kL~DFGla~~~ 685 (749)
....++|+|+++.|||+++ ++.++++||..+..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2346799999999999986 468999999988754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.042 Score=58.86 Aligned_cols=31 Identities=29% Similarity=0.399 Sum_probs=26.6
Q ss_pred CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 ~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
..+++|+|+.+.||++++ +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 358999999999999998 5789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0049 Score=65.81 Aligned_cols=73 Identities=26% Similarity=0.379 Sum_probs=59.4
Q ss_pred eeecCCCC------CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhcc-ccCCCCc
Q 037623 386 GLNCSYDA------NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNL 457 (749)
Q Consensus 386 Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l-~~~n~~l 457 (749)
-|.|+..+ ..++..+.|+|..|+++ .||+. ++.+++|+.||||+|+++--=|+.+..+..|..| ..+||++
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 37887532 24567799999999999 89887 9999999999999999997779999888887766 5566776
Q ss_pred cc
Q 037623 458 CL 459 (749)
Q Consensus 458 ~~ 459 (749)
.-
T Consensus 129 ~~ 130 (498)
T KOG4237|consen 129 TD 130 (498)
T ss_pred hh
Confidence 53
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.0019 Score=68.95 Aligned_cols=53 Identities=34% Similarity=0.500 Sum_probs=30.9
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLV 451 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~ 451 (749)
+++|-.|||.+|+|. ++|.++.-|.+|..||||||.++| +|.+++++ .|+.|-
T Consensus 251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~ 303 (565)
T KOG0472|consen 251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLA 303 (565)
T ss_pred cccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehh
Confidence 455566666666665 555555566666666666666663 55566665 555553
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.071 Score=57.56 Aligned_cols=149 Identities=17% Similarity=0.236 Sum_probs=83.3
Q ss_pred ccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCC---CceeE---EEEEE--ecCC--eeEEEEeeC
Q 037623 533 LGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH---KNLTI---LVGYC--DENT--KMGLVYEFM 602 (749)
Q Consensus 533 LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H---~nIv~---l~g~~--~~~~--~~~LV~Ey~ 602 (749)
|.+ .-..+|+...+++..++|+.... ....+...|+..+..+.- +-.++ +-|-. .-.. ..+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 45678999888877788888765 333556667777766632 21122 22211 1123 677899999
Q ss_pred CCCCHHH---------------HHHHhhccCCCCccCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC---
Q 037623 603 ANGNLQA---------------HLLAQLAILPTDAEDKTGILSWKG-------------RLQIATESAQGLEYLHDG--- 651 (749)
Q Consensus 603 ~~gsL~~---------------~L~~~~~~~~~~~~~~~~~l~~~~-------------~l~ia~~ia~gL~yLH~~--- 651 (749)
+|..+.. .||......+-..........|.. ......++...++.+.+.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9987772 111111100100001112233430 111233344444444432
Q ss_pred -CCCC---ceeeCCCCCcEEEcCCCc-EEEEecCCCcc
Q 037623 652 -CKPP---IVHRDVKSANILLNEKFQ-AKLADFGLSRI 684 (749)
Q Consensus 652 -~~~g---IiHrDLkp~NILl~~~~~-~kL~DFGla~~ 684 (749)
.... +||+|+.+.||+++++.. ..++||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1123 899999999999999875 89999998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 749 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-126
Identities = 102/239 (42%), Positives = 149/239 (62%), Gaps = 14/239 (5%)
Query: 508 GSLELKNRKLSYANVLKITNNF--ERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGY 564
+ ++ ++ ++ + TNNF + ++G G FG VY G L D +VA+K +P S QG
Sbjct: 20 YLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI 79
Query: 565 KQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAED 624
++F+ E+E L H +L L+G+CDE +M L+Y++M NGNL+ HL ++
Sbjct: 80 EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--------GSDL 131
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
T +SW+ RL+I +A+GL YLH I+HRDVKS NILL+E F K+ DFG+S+
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743
+H+ST V GT GY+DPEY+I RLTEKSDVYSFGVVL E++ + I ++ R
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-105
Identities = 90/249 (36%), Positives = 143/249 (57%), Gaps = 26/249 (10%)
Query: 511 ELKNRKLSYANVLKITNNFER--------VLGKGGFGTVYHGYLDDKQVAVKMLS----P 558
+ + S+ + +TNNF+ +G+GGFG VY GY+++ VAVK L+
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI 68
Query: 559 SSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAIL 618
++ + +QF E++++ + H+NL L+G+ + + LVY +M NG+L L
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC----- 123
Query: 619 PTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678
D T LSW R +IA +A G+ +LH+ +HRD+KSANILL+E F AK++D
Sbjct: 124 ----LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738
FGL+R + +++ +VGT Y+ PE + +T KSD+YSFGVVLLE+ITG P +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 739 KT-PERTLI 746
+ + L+
Sbjct: 236 EHREPQLLL 244
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-102
Identities = 100/227 (44%), Positives = 142/227 (62%), Gaps = 13/227 (5%)
Query: 515 RKLSYANVLKITNNF--ERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYK-QFQAE 570
++ S + ++NF + +LG+GGFG VY G L D VAVK L QG + QFQ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 571 VELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630
VE++ A H+NL L G+C T+ LVY +MANG++ + L + + L
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR--------ERPESQPPLD 129
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
W R +IA SA+GL YLHD C P I+HRDVK+ANILL+E+F+A + DFGL+++
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKD 188
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 737
+HV+T V GT G++ PEY + + +EK+DV+ +GV+LLELITGQ
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-72
Identities = 70/244 (28%), Positives = 102/244 (41%), Gaps = 32/244 (13%)
Query: 517 LSYANVLKITNNFE--RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELL 574
L N+ + + V +G FG V+ L ++ VAVK+ Q + Q + EV L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVYSL 72
Query: 575 MRAHHKNLTILVGYCDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630
H+N+ +G T + L+ F G+L L K ++S
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-------------KANVVS 119
Query: 631 WKGRLQIATESAQGLEYLH-------DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
W IA A+GL YLH DG KP I HRD+KS N+LL A +ADFGL+
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 684 IFPVEGGSHVSTTVVGTPGYLDPEY-----YISNRLTEKSDVYSFGVVLLELITGQPVIQ 738
F + + VGT Y+ PE + D+Y+ G+VL EL +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 739 KTPE 742
+
Sbjct: 240 GPVD 243
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-64
Identities = 73/208 (35%), Positives = 108/208 (51%), Gaps = 14/208 (6%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTILV 586
+ +G G FGTV+ VAVK+L +F EV ++ R H N+ + +
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G + + +V E+++ G+L L A L + RL +A + A+G+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---------LDERRRLSMAYDVAKGMN 151
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YLH PPIVHR++KS N+L+++K+ K+ DFGLSR+ S S + GTP ++ P
Sbjct: 152 YLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAP 208
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITGQ 734
E EKSDVYSFGV+L EL T Q
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-60
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
E V+G+G FG V K VA+K + S + K F E+ L R +H N+ L G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
C + LV E+ G+L L + + + + +QG+ YL
Sbjct: 70 CLNP--VCLVMEYAEGGSLYNVLHGA---------EPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
H ++HRD+K N+LL K+ DFG + T G+ ++ PE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPE 173
Query: 708 YYISNRLTEKSDVYSFGVVLLELITGQ 734
+ + +EK DV+S+G++L E+IT +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRR 200
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-59
Identities = 72/222 (32%), Positives = 110/222 (49%), Gaps = 35/222 (15%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQG-------YKQFQAEVELLMRAHH 579
+E+ +GKGGFG V+ G L D VA+K L +G +++FQ EV ++ +H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
N+ L G +V EF+ G+L LL DK + W +L++
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL-----------DKAHPIKWSVKLRLML 129
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-----FQAKLADFGLSRIFPVEGGSHVS 694
+ A G+EY+ PPIVHRD++S NI L AK+ADFGLS+ H
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSV 183
Query: 695 TTVVGTPGYLDPE--YYISNRLTEKSDVYSFGVVLLELITGQ 734
+ ++G ++ PE TEK+D YSF ++L ++TG+
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-58
Identities = 44/214 (20%), Positives = 85/214 (39%), Gaps = 25/214 (11%)
Query: 528 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTIL 585
NF L + G ++ G + VK+L + F E L H N+ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 586 VGYCDE--NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+G C L+ +M G+L L E ++ ++ A + A+
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLH----------EGTNFVVDQSQAVKFALDMAR 122
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
G+ +LH +P I + S +++++E A+++ + F S + P +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAW 174
Query: 704 LDPE---YYISNRLTEKSDVYSFGVVLLELITGQ 734
+ PE + +D++SF V+L EL+T +
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-58
Identities = 70/211 (33%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTILV 586
+ +G G FGTVY G VAVKML+ ++ + F+ EV +L + H N+ + +
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
GY ++ +V ++ +L HL K + IA ++A+G++
Sbjct: 87 GYSTAP-QLAIVTQWCEGSSLYHHL-----------HASETKFEMKKLIDIARQTARGMD 134
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YLH I+HRD+KS NI L+E K+ DFGL+ GSH + G+ ++ P
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 707 E---YYISNRLTEKSDVYSFGVVLLELITGQ 734
E SN + +SDVY+FG+VL EL+TGQ
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-58
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQ----GYKQFQAEVELLMRAHHKNLTI 584
E ++G GGFG VY + +VAVK + + + E +L H N+
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L G C + + LV EF G L L + + + A + A+G
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGK-------------RIPPDILVNWAVQIARG 117
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQ--------AKLADFGLSRIFPVEGGSHVSTT 696
+ YLHD PI+HRD+KS+NIL+ +K + K+ DFGL+R + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMS 173
Query: 697 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
G ++ PE ++ ++ SDV+S+GV+L EL+TG+
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 38/229 (16%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
++G+G +G VY G LD++ VAVK+ S ++ Q + + + + H N+ +
Sbjct: 17 LLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVG 75
Query: 589 CDENTKMG-----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+ T G LV E+ NG+L +L W ++A +
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYL-------------SLHTSDWVSSCRLAHSVTR 122
Query: 644 GLEYLH------DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF------PVEGGS 691
GL YLH D KP I HRD+ S N+L+ ++DFGLS
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 692 HVSTTVVGTPGYLDPEY-------YISNRLTEKSDVYSFGVVLLELITG 733
+ + + VGT Y+ PE ++ D+Y+ G++ E+
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 35/233 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVEL--LMRAHHKNLTILV 586
+GKG +G V+ G + VAVK+ S + K + E EL + H+N+ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 587 GYC----DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+T++ L+ + G+L +L + L L+I A
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVSCLRIVLSIA 115
Query: 643 QGLEYLH-----DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV--ST 695
GL +LH KP I HRD+KS NIL+ + Q +AD GL+ + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 696 TVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
VGT Y+ PE ++ D+++FG+VL E+ +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-55
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 35/233 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVE--LLMRAHHKNLTILV 586
+ +GKG +G V+ G ++VAVK+ + E E + H+N+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 587 GYC----DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
T++ L+ ++ NG+L +L K+ L K L++A S
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL-------------KSTTLDAKSMLKLAYSSV 144
Query: 643 QGLEYLH-----DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH--VST 695
GL +LH KP I HRD+KS NIL+ + +AD GL+ F +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 696 TVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
T VGT Y+ PE + +D+YSFG++L E+ E
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 30/220 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTILV 586
++GKG FG VYHG +VA++++ K F+ EV + H+N+ + +
Sbjct: 37 IGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C + ++ L + + D +L QIA E +G+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVR-----------DAKIVLDVNKTRQIAQEIVKGMG 144
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS---TTVVGTPGY 703
YLH I+H+D+KS N+ + + + DFGL I V G +
Sbjct: 145 YLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 704 LDPEYYISNRL---------TEKSDVYSFGVVLLELITGQ 734
L PE ++ SDV++ G + EL +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVE--LLMRAHHKNLTILV 586
+ +GKG FG V+ G ++VAVK+ S + + + E E + H+N+ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 587 GYC----DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
T++ LV ++ +G+L +L ++ +G +++A +A
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-------------NRYTVTVEGMIKLALSTA 149
Query: 643 QGLEYLH-----DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH--VST 695
GL +LH KP I HRD+KS NIL+ + +AD GL+ +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 696 TVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
VGT Y+ PE +++D+Y+ G+V E+ + +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-53
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
VLGKG FG + + +K L + + F EV+++ H N+ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G ++ ++ + E++ G L+ + W R+ A + A G+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIK-----------SMDSQYPWSQRVSFAKDIASGMA 122
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGS------------HVS 694
YLH I+HRD+ S N L+ E +ADFGL+R+ E
Sbjct: 123 YLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TVVG P ++ PE EK DV+SFG+VL E+I
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVK--MLSPSSVQGYKQFQAEVELLMRAHHKNLTI 584
F+ +G+G F TVY G +VA + ++F+ E E+L H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 585 LVGY----CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ LV E M +G L+ +L + ++ K +
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL------------KRFKVMKIKVLRSWCRQ 137
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGSHVSTTVVG 699
+GL++LH PPI+HRD+K NI + K+ D GL+ + + + V+G
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIG 192
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP ++ PE Y + E DVY+FG+ +LE+ T +
Sbjct: 193 TPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEY 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN 581
+R LG+G FG V+ D VAVK L ++ K FQ E ELL H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 582 LTILVGYCDENTKMGLVYEFMANGN----LQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+ G C + + +V+E+M +G+ L+AH + ++ G L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A++ A G+ YL VHRD+ + N L+ K+ DFG+SR V
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRD--VYST---DYYR 190
Query: 698 VGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
VG L PE + + T +SDV+SFGV+L E+ T QP
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKNLTIL 585
+G+G FG V+ G L D+ VAVK +F E +L + H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+G C + + +V E + G+ L + L K LQ+ ++A G+
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL-----------RTEGARLRVKTLLQMVGDAAAGM 226
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG------ 699
EYL +HRD+ + N L+ EK K++DFG+SR G + ++ +
Sbjct: 227 EYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKW 281
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
T PE R + +SDV+SFG++L E +
Sbjct: 282 TA----PEALNYGRYSSESDVWSFGILLWETFS 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKM--LSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+G G +G D K + K + + +EV LL H N+ V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI---V 68
Query: 587 GYCD-----ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
Y D NT + +V E+ G+L + + E+ +L Q+
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF--VLRV--MTQLT--- 121
Query: 642 AQGLEYLHDGCKPP--IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
L+ H ++HRD+K AN+ L+ K KL DFGL+RI + + T VG
Sbjct: 122 -LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP Y+ PE EKSD++S G +L EL P
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 69/224 (30%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN 581
+ LG+G FG V+ D VAVK L +S + FQ E ELL H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLA---QLAILPTDAEDKTGILSWKGRLQIA 638
+ G C E + +V+E+M +G+L L + +L + G L L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
++ A G+ YL VHRD+ + N L+ + K+ DFG+SR V
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-----STDYYRV 216
Query: 699 GTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G L PE + + T +SDV+SFGVVL E+ T QP
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ------VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL 582
F + LGKG FG+V D Q VAVK L S+ + + F+ E+E+L H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 583 TILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
G C + + L+ E++ G+L+ +L + + LQ ++
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----------QKHKERIDHIKLLQYTSQ 122
Query: 641 SAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+G+EYL +HRD+ + NIL+ + + K+ DFGL+++ P +
Sbjct: 123 ICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK---- 174
Query: 700 TPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PG PE ++ + SDV+SFGVVL EL T
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-36
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 35/212 (16%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+ +GKG FG V G +VAVK + + + F AE ++ + H NL L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 589 C-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+E + +V E+MA G+L +L +L L+ + + + +EY
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-------T 700
L VHRD+ + N+L++E AK++DFGL++ S+T T
Sbjct: 305 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWT 353
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + + KSDV+SFG++L E+ +
Sbjct: 354 A----PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 33/218 (15%)
Query: 529 FERVLGKGGFGTVYHGYLD------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL 582
F + LGKG FG+V D + VAVK L S+ + + F+ E+E+L H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 583 TILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
G C + + L+ E++ G+L+ +L + + LQ ++
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----------QKHKERIDHIKLLQYTSQ 153
Query: 641 SAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+G+EYL +HRD+ + NIL+ + + K+ DFGL+++ P + V
Sbjct: 154 ICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVK 205
Query: 700 TPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PG PE ++ + SDV+SFGVVL EL T
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-36
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ--VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+ LG G +G VY G VAVK L +++ ++F E ++ H NL L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C ++ EFM GNL +L E +S L +AT+ + +E
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR----------ECNRQEVSAVVLLYMATQISSAME 332
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLD 705
YL +HR++ + N L+ E K+ADFGLSR+ + G ++ + P +
Sbjct: 333 YLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 387
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELIT 732
PE N+ + KSDV++FGV+L E+ T
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKN 581
++LG+G FG+V G L + +VAVK + SS + ++F +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 582 LTILVGYCDENTKMG-----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+ L+G C E + G ++ FM G+L +LL E + + L+
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS------RLETGPKHIPLQTLLK 151
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVST 695
+ A G+EYL + +HRD+ + N +L + +ADFGLS+ I+
Sbjct: 152 FMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIY------SGDY 202
Query: 696 TVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G + E T KSDV++FGV + E+ T P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL 582
+ LGKG FG+V D VAVK L S + FQ E+++L H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 583 TILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
G + + LV E++ +G L+ L + L L +++
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQ 135
Query: 641 SAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+G+EYL C VHRD+ + NIL+ + K+ADFGL+++ P++ VV
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVR 187
Query: 700 TPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PG PE N + +SDV+SFGVVL EL T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ------VAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
R LG+G FG V D + VAVK L P S + E+E+L +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 582 LTILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ G C E+ + L+ EF+ +G+L+ +L ++ K +L+ A
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----------PKNKNKINLKQQLKYAV 133
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
+ +G++YL VHRD+ + N+L+ + Q K+ DFGL++ + V
Sbjct: 134 QICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTV 185
Query: 699 GTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + ++ SDV+SFGV L EL+T
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+ +GKG FG V G +VAVK + + + F AE ++ + H NL L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 589 C-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+E + +V E+MA G+L +L +L L+ + + + +EY
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL----------RSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 648 LHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG------- 699
L VHRD+ + N+L++E AK++DFGL++ S+T
Sbjct: 133 LEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKW 180
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
T PE + + KSDV+SFG++L E+ +
Sbjct: 181 TA----PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
R LG+G FG VY G +VA+K ++ +S++ +F E ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
++ L+G + ++ E M G+L+++L + S +Q+A E
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP--AMANNPVLAPPSLSKMIQMAGE 146
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A G+ YL+ VHRD+ + N ++ E F K+ DFG++R + G
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET---DYYRKGG 198
Query: 701 PGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G L PE T SDV+SFGVVL E+ T QP
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
+VLG G FGTVY G + VA+K L +S + K+ E ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C +T L+ + M G L ++ + + +L+W +QIA
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY-----LLNWC--VQIAK-- 128
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-- 699
G+ YL D +VHRD+ + N+L+ K+ DFGL+++ + G
Sbjct: 129 --GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKV 181
Query: 700 ----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
E + T +SDV+S+GV + EL+T
Sbjct: 182 PIKWMA----LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVK---MLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
+ +G+G F VY LD VA+K + + E++LL + +H N+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV--- 94
Query: 586 VGYCD---ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+ Y E+ ++ +V E G+L + E + + +
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT--VWKY------FVQLC 146
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
LE++H ++HRD+K AN+ + KL D GL R F + + ++VGTP
Sbjct: 147 SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPY 201
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE N KSD++S G +L E+ Q
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 63/228 (27%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKN 581
R+LGKG FG+V L + +VAVKML + ++F E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 582 LTILVGYC------DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ LVG ++ FM +G+L A LLA + + L + +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA------SRIGENPFNLPLQTLV 140
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFPVEGGSHVS 694
+ + A G+EYL +HRD+ + N +L E +ADFGLSR I+
Sbjct: 141 RFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIY------SGD 191
Query: 695 TTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G L E N T SDV++FGV + E++T P
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 527 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKM--LSPSSVQGYKQFQAEVELLMRAHHK 580
+ + +G+G FG D +Q +K +S S + ++ + EV +L H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 581 NLTILVGYCD---ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
N+ V Y + EN + +V ++ G+L + AQ +L ED+ IL W
Sbjct: 84 NI---VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ--EDQ--ILDW------ 130
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ L+++HD I+HRD+KS NI L + +L DFG++R+ ++
Sbjct: 131 FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARAC 185
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+GTP YL PE + KSD+++ G VL EL T +
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-35
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
E LG+G FG V+ G + +VA+K L P ++ + F E +++ + H+ L L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
E +V E+M+ G+L L + L + +A + A G+ Y
Sbjct: 247 VVSEEPIY-IVTEYMSKGSLLDFLK----------GETGKYLRLPQLVDMAAQIASGMAY 295
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
+ VHRD+++ANIL+ E K+ADFGL+R+ +E + + P + P
Sbjct: 296 VERMN---YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAP 350
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + R T KSDV+SFG++L EL T
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 55/223 (24%), Positives = 82/223 (36%), Gaps = 27/223 (12%)
Query: 529 FERVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
F + LG+GGF V G D A+K + Q ++ Q E ++ +H N+ LV
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 587 GYCDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
YC L+ F G L + ED+ L +
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI--------LWLLLGIC 144
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS-------T 695
+GLE +H HRD+K NILL ++ Q L D G +
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 696 TVVGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 735
T Y PE + E++DV+S G VL ++ G+
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
F + +G G FG V+ GY +K +VA+K + ++ + F E E++M+ H L L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C E + LV EFM +G L +L + G+ + + L + + +G+ Y
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL-----------RTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-------T 700
L + C ++HRD+ + N L+ E K++DFG++R T+ G
Sbjct: 120 LEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPVKWA 172
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + +R + KSDV+SFGV++ E+ +
Sbjct: 173 S----PEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
R LG+G FG V D VAVK L + Q ++ E+++L +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 582 LTILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ G C++ + LV E++ G+L+ +L + L A
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------------PRHSIGLAQLLLFAQ 141
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
+ +G+ YLH +HRD+ + N+LL+ K+ DFGL++ P V
Sbjct: 142 QICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRV 193
Query: 699 GTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT 732
G PE + SDV+SFGV L EL+T
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDDK--QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
+ LG G +G VY G VAVK L +++ ++F E ++ H NL L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C ++ EFM GNL +L E +S L +AT+ + +E
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLR----------ECNRQEVSAVVLLYMATQISSAME 125
Query: 647 YLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT-----VVGT 700
YL +HRD+ + N L+ E K+ADFGLSR+ + G ++ + + T
Sbjct: 126 YLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWT 179
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE N+ + KSDV++FGV+L E+ T
Sbjct: 180 A----PESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 41/225 (18%)
Query: 531 RVLGKGGFGTVYHGYLDDKQ-VAVKM-----LSPSSVQGYKQFQAEVELLMRAHHKNLTI 584
+ +G GG V+ + KQ A+K ++ Y+ E+ L + + I
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKI 90
Query: 585 --LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L Y + + +V E N +L L + + + WK +
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDL-NSWLKKKKSID---PWERKSY-WK---NML---- 137
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+ + +H G IVH D+K AN L+ + KL DFG++ + S V + VGT
Sbjct: 138 EAVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 702 GYLDPE-----------YYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE ++++ KSDV+S G +L + G+
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
E LG+G FG V+ G + +VA+K L P ++ + F E +++ + H+ L L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
E +V E+M+ G+L L + L + +A + A G+ Y
Sbjct: 330 VVSEEPIY-IVTEYMSKGSLLDFLK----------GETGKYLRLPQLVDMAAQIASGMAY 378
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP-GYLDP 706
+ VHRD+++ANIL+ E K+ADFGL+R+ +E + + P + P
Sbjct: 379 VERMN---YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAP 433
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + R T KSDV+SFG++L EL T
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 56/210 (26%), Positives = 82/210 (39%), Gaps = 24/210 (11%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVK--MLSPSSVQGYKQFQAEVELLMR-AHHKNLTIL 585
LG G +G V+ D + AVK M + + AEV + H L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+E + L E +LQ H A A LP E + + + ++ L
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLP---EAQ--VWGY------LRDTLLAL 170
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
+LH +VH DVK ANI L + + KL DFGL G + G P Y+
Sbjct: 171 AHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAGAGEVQEGDPRYMA 224
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + +DV+S G+ +LE+
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 29/227 (12%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
F LG+ FG VY G+L + VA+K L + ++F+ E L R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 581 NLTILVGYCDENTKMGLVYEFMANGN----LQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
N+ L+G ++ + +++ + ++G+ L D L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 637 IATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
+ + A G+EYL VH+D+ + N+L+ +K K++D GL R V
Sbjct: 133 LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFRE--VYAA---DY 183
Query: 696 TVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ L PE + + + SD++S+GVVL E+ + QP
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 63/230 (27%), Positives = 95/230 (41%), Gaps = 32/230 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELL-MRAHH 579
F + LG G FG V VAVKML PS + + +E+++L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHL------LAQLAILPTDAEDKTGILSWKG 633
N+ L+G C ++ E+ G+L L P ED L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 634 RLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
L + + A+G+ +L C +HRD+ + NILL K+ DFGL+R +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 693 VSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
VV L PE + T +SDV+S+G+ L EL + P
Sbjct: 200 --NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 59/213 (27%), Positives = 80/213 (37%), Gaps = 24/213 (11%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSP---SSVQGYKQFQAEVELLMRAHHK 580
LG G FG V G D VAVK L P S + F EV + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
NL L G +V E G+L L G + A +
Sbjct: 82 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR-----------KHQGHFLLGTLSRYAVQ 129
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A+G+ YL +HRD+ + N+LL + K+ DFGL R P +V
Sbjct: 130 VAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 701 P-GYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P + PE + + SD + FGV L E+ T
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
F + LG G FG V +G + VA+KM+ S+ +F E +++M H+ L L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C + + ++ E+MANG L +L + + L++ + + +EY
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL-----------REMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-------T 700
L +HRD+ + N L+N++ K++DFGLSR T+ VG +
Sbjct: 136 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFPVRWS 188
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
P PE + ++ + KSD+++FGV++ E+ +
Sbjct: 189 P----PEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+ LG G FG V G + VAVKM+ S+ +F E + +M+ H L G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
C + + +V E+++NG L +L L L++ + +G+ +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL-----------RSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 648 LHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG------- 699
L +HRD+ + N L++ K++DFG++R V +VS+ G
Sbjct: 120 LESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTKFPVKW 171
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ PE + + + KSDV++FG+++ E+ +
Sbjct: 172 SA----PEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 56/238 (23%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ----VAVKMLSP-SSVQGYKQFQAEVELLMR-AHHKNL 582
F+ V+G+G FG V + A+K + +S ++ F E+E+L + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLA----QLAILPTDAEDKTGILSWKGRLQIA 638
L+G C+ + L E+ +GNL L + A LS + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 639 TESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ A+G++YL +HRD+ + NIL+ E + AK+ADFGLSR
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 698 VGTPGYLDPEYYIS------------------NRLTEKSDVYSFGVVLLELIT--GQP 735
E Y+ + T SDV+S+GV+L E+++ G P
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDD---------KQVAVKMLSP-SSVQGYKQFQAEVELLMR-A 577
+ LG+G FG V VAVKML ++ + +E+E++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLA----QLAILPTDAEDKTGILSWKG 633
HKN+ L+G C ++ + ++ E+ + GNL+ +L A + +++K
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+ + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R + +
Sbjct: 159 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYY 213
Query: 694 STTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
T G L PE T +SDV+SFGV++ E+ T G P
Sbjct: 214 ---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKNL 582
+RV+GKG FG VYHG D+ Q A+K LS + +Q + F E L+ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 583 TILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
L+G ++ +M +G+L + + K + +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI-----------RSPQRNPTVKDLISFGLQV 133
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVEGGSHVS 694
A+G+EYL + VHRD+ + N +L+E F K+ADFGL+R + V+ H
Sbjct: 134 ARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
V T E + R T KSDV+SFGV+L EL+T P
Sbjct: 190 LPVKWTA----LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 38/218 (17%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNL 582
R+LG+G FG VY G + VAVK K+ F +E ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L+G +E ++ E G L +L E L + + +
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYL-----------ERNKNSLKVLTLVLYSLQIC 123
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-- 699
+ + YL C VHRD+ NIL+ KL DFGLSR +E + +
Sbjct: 124 KAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VTR 175
Query: 700 -----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE R T SDV+ F V + E+++
Sbjct: 176 LPIKWMS----PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSP-SSVQGYKQFQAEVELLMR-AHH 579
+ LG+G FG V + VAVKML ++ ++ +E+++L+ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 580 KNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLA----QLAILPTDAEDKTGILSWKGR 634
N+ L+G C + ++ EF GNL +L + + + L+ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
+ + + A+G+E+L +HRD+ + NILL+EK K+ DFGL+R +
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD--------IY 199
Query: 695 TT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
V L PE T +SDV+SFGV+L E+ + P
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 35/218 (16%)
Query: 529 FERVLGKGGFGTVYHGYL-----DDKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKNL 582
E+++G G G V +G L D VA+K L + + + F +E ++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L G +V E+M NG+L L G + + +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-----------RTHDGQFTIMQLVGMLRGVG 161
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-- 699
G+ YL D G VHRD+ + N+L++ K++DFGLSR+ +E + T G
Sbjct: 162 AGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGK 215
Query: 700 -----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
T PE + SDV+SFGVV+ E++
Sbjct: 216 IPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-34
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
E+ LG G FG V+ + +VAVK + P S+ + F AE ++ H L L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ ++ EFMA G+L L D+ + + + A+G+ +
Sbjct: 251 VVTKEPIY-IITEFMAKGSLLDFL----------KSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT-----VVGTPG 702
+ +HRD+++ANIL++ K+ADFGL+R+ +E + + + T
Sbjct: 300 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA- 353
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE T KSDV+SFG++L+E++T
Sbjct: 354 ---PEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNL 582
R +G+G FG V+ G VA+K + ++ F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L+G EN ++ E G L++ L + L + A + +
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQ-----------VRKYSLDLASLILYAYQLS 126
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT----- 696
L YL VHRD+ + N+L++ KL DFGLSR +E ++ +
Sbjct: 127 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP 180
Query: 697 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
+ PE R T SDV+ FGV + E++
Sbjct: 181 IKWMA----PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKML-SPSSVQGYKQFQAEVELLMRAHHKN 581
+VLG G FGTV+ G + V +K++ S Q ++ + + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C ++ LV +++ G+L H+ G L + L +
Sbjct: 77 IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR-----------QHRGALGPQLLLNWGVQI 124
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-- 699
A+G+ YL + +VHR++ + N+LL Q ++ADFG++ + +
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL--LPPDDKQLLYSEAKT 179
Query: 700 ----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
E + T +SDV+S+GV + EL+T
Sbjct: 180 PIKWMA----LESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 41/237 (17%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
+ LG+G FG V VAVKML +S + +E +L + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLA------------QLAILPTDAEDKTGI 628
++ L G C ++ + L+ E+ G+L+ L +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 629 LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
L+ + A + +QG++YL + +VHRD+ + NIL+ E + K++DFGLSR
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSR----- 198
Query: 689 GGSHVSTT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
V V + G + E + T +SDV+SFGV+L E++T G P
Sbjct: 199 ---DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 41/225 (18%)
Query: 531 RVLGKGGFGTVYHGYLDDKQ-VAVKM-----LSPSSVQGYKQFQAEVELLMRAHHKNLTI 584
+ +G GG V+ + KQ A+K ++ Y+ E+ L + + I
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKI 71
Query: 585 --LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L Y + + +V E N +L + L K + R
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWL------------KKKKSIDPWERKSYWKNML 118
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+ + +H G IVH D+K AN L+ + KL DFG++ + S V + VGT
Sbjct: 119 EAVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 702 GYLDPE-----------YYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE ++++ KSDV+S G +L + G+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-QVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
LG G FG V+ GY + +VAVK L S+ F AE L+ + H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ ++ E+M NG+L L L+ L +A + A+G+ +
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFL----------KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-------T 700
+ + +HRD+++ANIL+++ K+ADFGL+R+ +E + T G T
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWT 177
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE T KSDV+SFG++L E++T
Sbjct: 178 A----PEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 54/263 (20%), Positives = 97/263 (36%), Gaps = 41/263 (15%)
Query: 493 SLRRRKQELCPVGKKGSLELKNRKLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQ-V 551
R+ + +G + + +V + + +G GG V+ + KQ
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY 83
Query: 552 AVKM-----LSPSSVQGYKQFQAEVELLMRAHHKNLTI--LVGYCDENTKMGLVYEFMAN 604
A+K ++ Y+ E+ L + + I L Y + + +V E N
Sbjct: 84 AIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 139
Query: 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKS 663
+L + L K + R + + +H G IVH D+K
Sbjct: 140 IDLNSWL------------KKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKP 183
Query: 664 ANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE-----------YYISN 712
AN L+ + KL DFG++ + S V + VG Y+ PE +
Sbjct: 184 ANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 713 RLTEKSDVYSFGVVLLELITGQP 735
+++ KSDV+S G +L + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKT 265
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDD---------KQVAVKMLSP-SSVQGYKQFQAEVELLMR-A 577
+ LG+G FG V VAVKML ++ + +E+E++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLA----QLAILPTDAEDKTGILSWKG 633
HKN+ L+G C ++ + ++ E+ + GNL+ +L A + +++K
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+ + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R + +
Sbjct: 205 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYY 259
Query: 694 STTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
T G L PE T +SDV+SFGV++ E+ T G P
Sbjct: 260 ---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 528 NFERVLGKGGFGTVYHGYLDDK-----QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
+F V+G+G FG VYHG L D AVK L+ + + QF E ++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 582 LTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ L+G C +V +M +G+L+ + ++T + K + +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----------RNETHNPTVKDLIGFGLQ 136
Query: 641 SAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR------IFPVEGGSHV 693
A+G++YL VHRD+ + N +L+EKF K+ADFGL+R + V +
Sbjct: 137 VAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
V E + + T KSDV+SFGV+L EL+T P
Sbjct: 193 KLPVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELLMR-AHH 579
F + LG G FG V +VAVKML + + +E++++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTD--AEDKTGILSWKGRLQI 637
+N+ L+G C + ++ E+ G+L L + +L TD S + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 638 ATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
+++ AQG+ +L C +HRDV + N+LL AK+ DFGL+R + S
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND-----SNY 220
Query: 697 VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+V L PE T +SDV+S+G++L E+ + P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 530 ERVLGKGGFGTVYHGYLDDK----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTI 584
+ LG G FG+V G + VA+K+L + + + E +++ + + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L+G C M LV E G L L+ K + ++ + + G
Sbjct: 75 LIGVCQAEALM-LVMEMAGGGPLHKFLV-----------GKREEIPVSNVAELLHQVSMG 122
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG----- 699
++YL + VHRD+ + N+LL + AK++DFGLS+ + + + +
Sbjct: 123 MKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPL 177
Query: 700 --TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + + +SDV+S+GV + E ++
Sbjct: 178 KWYA----PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 530 ERVLGKGGFGTVYHGYLDDK----QVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKNLT 583
++ LG G FGTV GY K VAVK+L + + AE ++ + + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
++G C+ + M LV E G L +L + + K +++ + +
Sbjct: 82 RMIGICEAESWM-LVMEMAELGPLNKYLQ------------QNRHVKDKNIIELVHQVSM 128
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG---- 699
G++YL + VHRD+ + N+LL + AK++DFGLS+ + +
Sbjct: 129 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWP 183
Query: 700 ---TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + + KSDV+SFGV++ E +
Sbjct: 184 VKWYA----PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 529 FERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNL 582
++V+G G FG V G L + VA+K L + ++ F E ++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L G ++ + +V E+M NG+L + L + + + A
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-----------RKHDAQFTVIQLVGMLRGIA 157
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-- 699
G++YL D G VHRD+ + NIL+N K++DFGL R+ +E + T G
Sbjct: 158 SGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGK 211
Query: 700 -----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
T PE + T SDV+S+G+VL E+++
Sbjct: 212 IPIRWTS----PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 529 FERVLGKGGFGTVYHGYLDDK------QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
+VLG G FGTVY G + VA+K L +S + K+ E ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+G C +T L+ + M G L ++ + + + L +
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-----------EHKDNIGSQYLLNWCVQI 126
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG-- 699
A+G+ YL D +VHRD+ + N+L+ K+ DFGL+++ + G
Sbjct: 127 AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKV 181
Query: 700 ----TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
E + T +SDV+S+GV + EL+T
Sbjct: 182 PIKWMA----LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDD---------KQVAVKMLSP-SSVQGYKQFQAEVELLMR-A 577
+ LG+G FG V +VAVKML ++ + +E+E++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLA----QLAILPTDAEDKTGILSWKG 633
HKN+ L+G C ++ + ++ E+ + GNL+ +L A L + + LS K
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+ A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R H+
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHI 244
Query: 694 STTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
T G L PE T +SDV+SFGV+L E+ T G P
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 47/231 (20%), Positives = 92/231 (39%), Gaps = 33/231 (14%)
Query: 527 NNFE--RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYK-----------------QF 567
N++ R L +G F + D+K A+K S ++ + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 568 QAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG 627
+ E++++ ++ G ++ ++YE+M N ++ + ++ T
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL----DKNYTC 146
Query: 628 ILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687
+ + I Y+H+ + I HRDVK +NIL+++ + KL+DFG S
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203
Query: 688 EGGSHVSTTVVGTPGYLDPEYYISNRLT---EKSDVYSFGVVLLELITGQP 735
GT ++ PE + SN + K D++S G+ L +
Sbjct: 204 ---DKKIKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 529 FERVLGKGGFGTVYHGYL------DDKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
++V+G G FG VY G L + VA+K L + + F E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L G + M ++ E+M NG L L +K G S + +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL-----------REKDGEFSVLQLVGMLRGI 156
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG- 699
A G++YL + VHRD+ + NIL+N K++DFGLSR+ +E + T G
Sbjct: 157 AAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGG 210
Query: 700 ------TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
T PE + T SDV+SFG+V+ E++T
Sbjct: 211 KIPIRWTA----PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-------QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
R LG G FG VY G + QVAVK L S Q F E ++ + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ +G ++ ++ E MA G+L++ L P ++ + L+ L +A +
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET---RPRPSQPSS--LAMLDLLHVARD 148
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSR-IFPVEGGSHVSTT 696
A G +YL + +HRD+ + N LL AK+ DFG++R I+ S
Sbjct: 149 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYY 199
Query: 697 VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G L PE ++ T K+D +SFGV+L E+ + P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 531 RVLGKGGFGTVYHGY-LDDKQ-VAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
VLGKG +G VY G L ++ +A+K + + + E+ L HKN+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
EN + + E + G+L A L ++ L + E G + QI +GL+YL
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYT----KQI----LEGLKYL 138
Query: 649 HDGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
HD IVHRD+K N+L+N K++DFG S+ + G + + T GT Y+ PE
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPE 193
Query: 708 YYISNRL--TEKSDVYSFGVVLLELITGQP 735
+ +D++S G ++E+ TG+P
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 41/237 (17%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELLMR-AHH 579
F +VLG G FG V + QVAVKML + +E++++ + H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHL-----------LAQLAILPTDAEDKTGI 628
+N+ L+G C + + L++E+ G+L +L + + E+ +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 629 LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
L+++ L A + A+G+E+L VHRD+ + N+L+ K+ DFGL+R
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR----- 220
Query: 689 GGSHVSTT---VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ + VV L PE T KSDV+S+G++L E+ + P
Sbjct: 221 ---DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 70/236 (29%), Positives = 102/236 (43%), Gaps = 39/236 (16%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
+ R +G+G FG V+ VAVKML +S FQ E L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLA------------QLAILPTDAEDKTGI 628
N+ L+G C M L++E+MA G+L L + L+ +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 629 LSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSR-IFP 686
LS +L IA + A G+ YL + VHRD+ + N L+ E K+ADFGLSR I+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNIY- 225
Query: 687 VEGGSHVSTTVVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ PE NR T +SDV+++GVVL E+ + QP
Sbjct: 226 -----SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 35/224 (15%)
Query: 528 NFERVLGKGGFGTVYHGYLDDK-----QVAVKMLSP-SSVQGYKQFQAEVELLMRAHHKN 581
+F V+G+G FG VYHG L D AVK L+ + + QF E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 582 LTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ L+G C +V +M +G+L+ + ++T + K + +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----------RNETHNPTVKDLIGFGLQ 200
Query: 641 SAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
A+G+++L VHRD+ + N +L+EKF K+ADFGL+R + V
Sbjct: 201 VAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 700 ------TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
E + + T KSDV+SFGV+L EL+T P
Sbjct: 257 KLPVKWMA----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 57/247 (23%)
Query: 523 LKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH 578
L+ ++FE VLG+G FG V LD + A+K + + + +EV LL +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 579 HKNLTILVG-YCDEN------------TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDK 625
H+ + + + + + + E+ NG L + ++ D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--- 117
Query: 626 TGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
W+ QI + L Y+H G I+HRD+K NI ++E K+ DFGL++
Sbjct: 118 ----YWRLFRQIL----EALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 685 F------------PVEGGSHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVV 726
+ G S T+ +GT Y+ E +Y EK D+YS G++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGII 220
Query: 727 LLELITG 733
E+I
Sbjct: 221 FFEMIYP 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 69/217 (31%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQ-VAVKMLSPSSVQGYK---QFQAEVELLMRAHH 579
+FE R LGKG FG VY K +A+K+L + ++ Q + EVE+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
N+ L GY + T++ L+ E+ G + L K + T
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL------------QKLSKFDEQRTATYIT 116
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
E A L Y H ++HRD+K N+LL + K+ADFG S V S T + G
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCG 169
Query: 700 TPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
T YL PE I R+ EK D++S GV+ E + G+P
Sbjct: 170 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 33/226 (14%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSP-SSVQGYKQFQAEVELLMRAHHK 580
R LG G FG VY G + QVAVK L S Q F E ++ + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ +G ++ ++ E MA G+L++ L P ++ + L+ L +A +
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSS--LAMLDLLHVARD 189
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLN---EKFQAKLADFGLSR-IFPVEGGSHVSTT 696
A G +YL + +HRD+ + N LL AK+ DFG++R I+
Sbjct: 190 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RAGYY 240
Query: 697 VVGTPGYL-----DPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
G L PE ++ T K+D +SFGV+L E+ + P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 40/232 (17%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH 579
+ +F+ ++G GGFG V+ +D K +K + ++ ++ + EV+ L + H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63
Query: 580 KN-------------LTILVGYCDENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAE 623
N +K ++ EF G L+ + + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD--K 121
Query: 624 DKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
L + +G++Y+H +++RD+K +NI L + Q K+ DFGL
Sbjct: 122 VL--ALEL------FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T GT Y+ PE S ++ D+Y+ G++L EL+
Sbjct: 171 SL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-32
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNL 582
R +G+G FG V+ G VA+K + ++ F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L+G EN ++ E G L++ L + + L + A + +
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFL-----------QVRKFSLDLASLILYAYQLS 501
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
L YL VHRD+ + N+L++ KL DFGLSR +E ++ + P
Sbjct: 502 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLP 555
Query: 702 -GYLDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
++ PE R T SDV+ FGV + E++ +P
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 36/216 (16%)
Query: 530 ERVLGKGGFGTVYHGY---LDDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNL-TI 584
+ + GG G +Y ++ + V +K L S + AE + L H ++ I
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 585 L-VGYCDENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ + Y E++ +L+ +L +A + E
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP--VAEA------------IAYLLE 190
Query: 641 SAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
L YLH G +V+ D+K NI+L E+ Q KL D G G + G
Sbjct: 191 ILPALSYLHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYG 239
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TPG+ PE + T +D+Y+ G L L P
Sbjct: 240 TPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 530 ERVLGKGGFGTVYHGYLD---DKQVAVKMLSP--SSVQGYKQ-FQAEVELLMRAHHKNLT 583
R++G+GG G VY D ++ VA+K++S SS ++ Q E R ++
Sbjct: 39 RRLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
+ + + + ++ + + +L A L Q + P A + I +
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------------VAIVRQIGS 145
Query: 644 GLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT--VVGT 700
L+ H G HRDVK NIL++ A L DFG++ ++ VGT
Sbjct: 146 ALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASAT---TDEKLTQLGNTVGT 198
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE + + T ++D+Y+ VL E +TG P
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 62/234 (26%)
Query: 529 FERVLGKGGFGTVYHGYLDDK---------QVAVKMLSPSSVQGYKQFQAEVELLMRAHH 579
F LG+G F ++ G + +V +K+L + + F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
K+L + G C + LV EF+ G+L +L + ++ +L++A
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-----------KKNKNCINILWKLEVAK 120
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--------AKLADFGLSRIFPVEGGS 691
+ A + +L + ++H +V + NILL + KL+D G+S
Sbjct: 121 QLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------ 171
Query: 692 HVSTTVVGTPGYLDPEYY-----------ISN--RLTEKSDVYSFGVVLLELIT 732
L + I N L +D +SFG L E+ +
Sbjct: 172 ------------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 45/236 (19%)
Query: 527 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLS-PSSVQGYKQFQAEVELLMRAHHKN 581
+FE + LG+GGFG V+ +DD A+K + P+ ++ EV+ L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 582 LTILVGYCD------------ENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAEDKT 626
I V Y + ++ +Y + NL+ + + I +
Sbjct: 65 --I-VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV-- 119
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI-- 684
L LQIA + +E+LH ++HRD+K +NI K+ DFGL
Sbjct: 120 -CLHI--FLQIA----EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 685 --------FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
T VGT Y+ PE N + K D++S G++L EL+
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 527 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYK---QFQAEVELLMRAHH 579
+F+ +LGKG F VY +VA+KM+ ++ + Q EV++ + H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR---LQ 636
++ L Y +++ + LV E NG + +L ++ E++ R Q
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEA-------RHFMHQ 120
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
I G+ YLH I+HRD+ +N+LL K+ADFGL+ + H T
Sbjct: 121 II----TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YT 171
Query: 697 VVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
+ GTP Y+ PE + +SDV+S G + L+ G+P
Sbjct: 172 LCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-31
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 530 ERVLGKGGFGTVYHGYLDDK----QVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTI 584
+ LG G FG+V G + VA+K+L + + + E +++ + + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L+G C M LV E G L L+ K + ++ + + G
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLV-----------GKREEIPVSNVAELLHQVSMG 448
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT-----VVG 699
++YL + VHR++ + N+LL + AK++DFGLS+ + + + + +
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
PE + + +SDV+S+GV + E ++
Sbjct: 506 YA----PECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 8e-31
Identities = 21/234 (8%), Positives = 50/234 (21%), Gaps = 35/234 (14%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLT 583
L G V+ + A+K+ + + ++ R ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 584 ILVGYC--------------DENTKMGLVYEFMANGN------LQAHLLAQLAILPTDAE 623
++ + A N + L L
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 624 DKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
G + + + L +VH N+ + + L D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 735
Y E+ ++ T + + G+ + +
Sbjct: 243 KV-----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 26/241 (10%), Positives = 59/241 (24%), Gaps = 45/241 (18%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLS----------------------------PSS 560
VLG+ + V +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 561 VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPT 620
+ + +F +L+ K + + + + + + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL---- 199
Query: 621 DAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADF 679
L RLQ+ + + L LH G +VH ++ +I+L+++ L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPE-----YYISNRLTEKSDVYSFGVVLLELITGQ 734
P + +T D ++ G+ + +
Sbjct: 256 EHLVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 735 P 735
Sbjct: 315 L 315
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 32/225 (14%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTI 584
+LG+G V+ G A+K+ + S E E+L + +HKN+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 585 LVGYCDENTKMG--LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L +E T L+ EF G+L L L L + +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP---------SNAYGLPESEFLIVLRDVV 122
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
G+ +L + IVHR++K NI+ + + KL DFG +R ++
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLY 176
Query: 699 GTPGYLDPEYYISNRL--------TEKSDVYSFGVVLLELITGQP 735
GT YL P+ Y L D++S GV TG
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 64/244 (26%), Positives = 102/244 (41%), Gaps = 33/244 (13%)
Query: 504 VGKKGSLELKNRKLSYANVL--KITNNFERVLGKGGFGTVYH-GYLDDKQVAVKMLSPSS 560
+G SLE + + V+ KI+ + VLG G GT+ + G D++ VAVK + P
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC 60
Query: 561 VQGYKQFQAEVELLMR-AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILP 619
+ EV+LL H N+ + + E A LQ ++
Sbjct: 61 FSFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV-------- 108
Query: 620 TDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEK-----FQ 673
E K + + ++ GL +LH IVHRD+K NIL++ +
Sbjct: 109 ---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIK 161
Query: 674 AKLADFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISN---RLTEKSDVYSFGVVLLE 729
A ++DFGL + V S + V GT G++ PE + T D++S G V
Sbjct: 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221
Query: 730 LITG 733
+I+
Sbjct: 222 VISE 225
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 39/232 (16%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILV 586
RVL +GGF VY ++ A+K L + + + EV + + + H N+ V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI---V 89
Query: 587 GYCD--------ENTKMGLVYEFM--ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+C +T G L L + G LS L+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES---------RGPLSCDTVLK 140
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST- 695
I ++ + ++++H KPPI+HRD+K N+LL+ + KL DFG + S
Sbjct: 141 IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 696 ---------TVVGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 735
T TP Y PE Y + + EK D+++ G +L L Q
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 59/274 (21%), Positives = 96/274 (35%), Gaps = 48/274 (17%)
Query: 506 KKGSLELKNRKLSYANVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKM-----L 556
S +N ++L++ + +G+G +G V A+K+ +
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 557 SPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLA 616
+ + ++ + EV L+ + HH N+ L ++ + LV E G+L L +
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 617 ILPTDAEDKTGILSWKGRLQIA-------------------TESA---------QGLEYL 648
+ E L YL
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 649 HD-GCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPV--EGGSHVSTTVVGTPGY 703
H+ G I HRD+K N L + KL DFGLS+ F G + TT GTP +
Sbjct: 185 HNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 704 LDPE--YYISNRLTEKSDVYSFGVVLLELITGQP 735
+ PE + K D +S GV+L L+ G
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSP---SSVQGYKQFQAEVELLMRAHHKNL-T 583
+LG GG V+ D + VAVK+L Y +F+ E + +H +
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 584 IL-VGYCDENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ G E L Y E++ L+ + G ++ K +++
Sbjct: 77 VYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV------------HTEGPMTPKRAIEVIA 123
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-TV 697
++ Q L + H G I+HRDVK ANI+++ K+ DFG++R G S T V
Sbjct: 124 DACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+GT YL PE + + +SDVYS G VL E++TG+P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 26/209 (12%)
Query: 533 LGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
+G+G FG V+ Q AVK + + E+ + L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 120
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD 650
E + + E + G+L L+ Q+ LP ED+ ++ +GLEYLH
Sbjct: 121 EGPWVNIFMELLEGGSL-GQLIKQMGCLP---EDRALY--------YLGQALEGLEYLHT 168
Query: 651 GCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGSHVST---TVVGTPGYLDP 706
I+H DVK+ N+LL+ +A L DFG + +G + GT ++ P
Sbjct: 169 RR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 707 EYYISNRLTEKSDVYSFGVVLLELITGQP 735
E + K D++S ++L ++ G
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTI 584
LG GG TVY + + +VA+K + + K+F+ EV + H+N+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-- 73
Query: 585 LVGYCDENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
V D + + Y E++ L ++ + G LS + +
Sbjct: 74 -VSMIDVDEEDDCYYLVMEYIEGPTLSEYI------------ESHGPLSVDTAINFTNQI 120
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-TVVG 699
G+++ HD IVHRD+K NIL++ K+ DFG+++ + S T V+G
Sbjct: 121 LDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLG 174
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T Y PE E +D+YS G+VL E++ G+P
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 49/241 (20%)
Query: 532 VLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTILVGY 588
+GKG FG V+ G K VA+K++ + + Q E+ +L + +T G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGL 645
++TK+ ++ E++ G+ LL + G L QIAT E +GL
Sbjct: 89 YLKDTKLWIIMEYLGGGSAL-DLL------------EPGPLD---ETQIATILREILKGL 132
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST-----TVVGT 700
+YLH K +HRD+K+AN+LL+E + KLADFG++ G T T VGT
Sbjct: 133 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGT 182
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP---------VIQKTPER---TLIGQ 748
P ++ PE + K+D++S G+ +EL G+P V+ P+ TL G
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN 242
Query: 749 W 749
+
Sbjct: 243 Y 243
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 44/221 (19%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYK---QFQAEVELLMRAHHKNLTIL 585
R LGKGGF + + A K++ S + + E+ + H+++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL---------- 635
G+ ++N + +V E +L + L
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKR------------------RKALTEPEARYYLR 122
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
QI G +YLH ++HRD+K N+ LNE + K+ DFGL+ +G
Sbjct: 123 QIVL----GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--K 173
Query: 696 TVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
+ GTP Y+ PE +S + + + DV+S G ++ L+ G+P
Sbjct: 174 VLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 53/225 (23%), Positives = 83/225 (36%), Gaps = 32/225 (14%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTI 584
+LG+G V+ G A+K+ + S E E+L + +HKN+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 585 LVGYCDENTKMG--LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L +E T L+ EF G+L L + L L + +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVL---------EEPSNAYGLPESEFLIVLRDVV 122
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
G+ +L + IVHR++K NI+ + + KL DFG +R ++
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLY 176
Query: 699 GTPGYLDPEYYISNRL--------TEKSDVYSFGVVLLELITGQP 735
GT YL P+ Y L D++S GV TG
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQ-VAVKMLSPSSVQGYK---QFQAEVELLMRAHH 579
++F+ R LGKG FG VY +K +A+K+L S ++ Q + E+E+ H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS-WKGRLQIA 638
N+ + Y + ++ L+ EF G L L K G + +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ------------KHGRFDEQRSATFME 121
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
E A L Y H + ++HRD+K N+L+ K + K+ADFG S P S T+
Sbjct: 122 -ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMC 173
Query: 699 GTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
GT YL PE I + EK D++ GV+ E + G P
Sbjct: 174 GTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 44/221 (19%)
Query: 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYK---QFQAEVELLMRAHHKNLTIL 585
R LGKGGF + D + A K++ S + + E+ + H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL---------- 635
G+ ++N + +V E +L + L
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKR------------------RKALTEPEARYYLR 148
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
QI G +YLH ++HRD+K N+ LNE + K+ DFGL+ +G
Sbjct: 149 QIVL----GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--K 199
Query: 696 TVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
+ GTP Y+ PE +S + + + DV+S G ++ L+ G+P
Sbjct: 200 VLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
LG G FG VY A K++ S + + + E+E+L H + L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGL 645
+ K+ ++ EF G + A +L L E QI + + L
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EP-----------QIQVVCRQMLEAL 130
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
+LH +HRD+K+ N+L+ + +LADFG+S + +GTP ++
Sbjct: 131 NFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMA 185
Query: 706 PEYYISNRLTE-----KSDVYSFGVVLLELITGQP 735
PE + + + K+D++S G+ L+E+ +P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 31/247 (12%), Positives = 66/247 (26%), Gaps = 56/247 (22%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLS----------------------------PSS 560
VLG+ + V +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 561 VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPT 620
+ + +F +L+ K + + + + + + + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL----L 194
Query: 621 DAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADF 679
L RLQ+ + + L LH G +VH ++ +I+L+++ L F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEY-----------YISNRLTEKSDVYSFGVVLL 728
V G+ + G+ PE +T D ++ G+V+
Sbjct: 251 EHL----VRDGA--RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 729 ELITGQP 735
+
Sbjct: 305 WIWCADL 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 532 VLGKGGFGTVYHGYL--DDKQVAVK-MLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
LG G G V+ +A K + Q E+++L + + G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYL 648
+ ++ + E M G+L +L + +P E G ++ +GL YL
Sbjct: 100 FYSDGEISICMEHMDGGSL-DQVLKKAGRIP---EQILGK--------VSIAVIKGLTYL 147
Query: 649 HDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
+ K I+HRDVK +NIL+N + + KL DFG+S ++ + VGT Y+ PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 201
Query: 709 YISNRLTEKSDVYSFGVVLLELITGQP 735
+ +SD++S G+ L+E+ G+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRY 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTIL 585
+ LG GGFG V +QVA+K ++ + E++++ + +H N+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 586 VGYCDENTKMG------LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
D K+ L E+ G+L+ +L + + L + +
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---------NQFENCCGLKEGPIRTLLS 128
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGSHVSTT 696
+ + L YLH+ I+HRD+K NI+L Q K+ D G ++ + T
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTE 182
Query: 697 VVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
VGT YL PE + T D +SFG + E ITG
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 37/225 (16%), Positives = 67/225 (29%), Gaps = 28/225 (12%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN 581
+LG+G F VY D ++ +K+ P++ + +E L +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
LV E + G L + ++ + A
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY-------KNTPEKVMPQGLVISFAMRM 181
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA-----------KLADFGLSRIFPVEGG 690
+E +HD I+H D+K N +L F L D G S +
Sbjct: 182 LYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T T G+ E + + D + + ++ G
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 532 VLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNLTILVGY 588
V+G G V Y ++VA+K ++ Q E++ + + HH N+
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGL 645
++ LV + ++ G++ ++ + E K+G+L IAT E +GL
Sbjct: 82 FVVKDELWLVMKLLSGGSVL-DIIK---HIVAKGEHKSGVLD---ESTIATILREVLEGL 134
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS-RIFPVEGGSHVS--TTVVGTPG 702
EYLH + +HRDVK+ NILL E ++ADFG+S + + T VGTP
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 703 YLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
++ PE Y K+D++SFG+ +EL TG
Sbjct: 192 WMAPEVMEQVRGY-----DFKADIWSFGITAIELATGAA 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 532 VLGKGGFGTVYHGYL--DDKQVAVK-MLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVG 587
LG+G +G V + +AVK + + + Q K+ ++++ MR G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 588 YCDENTKMGLVYEFMANG--NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ + E M ++ + +P ED G IA + L
Sbjct: 74 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP---EDILGK--------IAVSIVKAL 122
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
E+LH ++HRDVK +N+L+N Q K+ DFG+S G Y+
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMA 177
Query: 706 PEYYISNRLTE-----KSDVYSFGVVLLELITGQP 735
PE I+ L + KSD++S G+ ++EL +
Sbjct: 178 PE-RINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
+G+G GTVY ++VA++ ++ + E+ ++ + N+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQGLEY 647
++ +V E++A G+L TD +T + QIA E Q LE+
Sbjct: 88 VGDELWVVMEYLAGGSL------------TDVVTETCM----DEGQIAAVCRECLQALEF 131
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
LH +HRD+KS NILL KL DFG E +T+VGTP ++ PE
Sbjct: 132 LHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186
Query: 708 YYISNRLTEKSDVYSFGVVLLELITGQP 735
K D++S G++ +E+I G+P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 54/240 (22%), Positives = 90/240 (37%), Gaps = 36/240 (15%)
Query: 518 SYANVLKITNNFERVLGKGGFGTVYH-GYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR 576
++ LK E++LG G GTV G + VAVK + E++LL
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTE 64
Query: 577 -AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
H N+ + + + E N NLQ L +++ + +
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQ-----DLVESKNVSDENLKLQKEYNPI 118
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-------------FQAKLADFGLS 682
+ + A G+ +LH I+HRD+K NIL++ + ++DFGL
Sbjct: 119 SLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 683 RIFPVEGGSHVST--TVVGTPGYLDPE-------YYISNRLTEKSDVYSFGVVLLELITG 733
+ S + GT G+ PE RLT D++S G V +++
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
LG+G +G+VY + VA+K + ++ E+ ++ + ++ G
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESAQG 644
+NT + +V E+ G++ + + L ED +IAT + +G
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT---ED-----------EIATILQSTLKG 137
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
LEYLH +HRD+K+ NILLN + AKLADFG++ TV+GTP ++
Sbjct: 138 LEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWM 192
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE +D++S G+ +E+ G+P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 40/215 (18%)
Query: 533 LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD 590
+G+G G V +QVAVKM+ Q + EV ++ H N+ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL---QIAT---ESAQG 644
++ ++ EF+ G L TD + + RL QIAT Q
Sbjct: 113 VGEELWVLMEFLQGGAL------------TD-------IVSQVRLNEEQIATVCEAVLQA 153
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG----LSRIFPVEGGSHVSTTVVGT 700
L YLH ++HRD+KS +ILL + KL+DFG +S+ P ++VGT
Sbjct: 154 LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------KRKSLVGT 204
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
P ++ PE + + D++S G++++E++ G+P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 21/212 (9%)
Query: 532 VLGKGGFGTVYHGYL--DDKQVAVKMLSP-SSVQGYKQFQAEVELLMRA-HHKNLTILVG 587
+G+G +G+V + +AVK + + KQ +++++MR+ + G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ E M+ + + + E+ G I + + L +
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK--------ITLATVKALNH 140
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
L + K I+HRD+K +NILL+ KL DFG+S S T G Y+ PE
Sbjct: 141 LKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPE 195
Query: 708 ----YYISNRLTEKSDVYSFGVVLLELITGQP 735
+SDV+S G+ L EL TG+
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 43/240 (17%), Positives = 79/240 (32%), Gaps = 46/240 (19%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVK--MLSPSSVQGYKQFQAEVELLMR- 576
+ T F +G G FG+V+ LD A+K + + EV
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H ++ E+ M + E+ G+L + I+ E + + LQ
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE--LKDLL--LQ 123
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-------------------KFQAKLA 677
+ +GL Y+H +VH D+K +NI ++ K K+
Sbjct: 124 VG----RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 735
D G G +L E + K+D+++ + ++ +P
Sbjct: 177 DLGHVTRIS------SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEP 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLT---- 583
++G G +G VY G + A+K++ + ++ + E+ +L + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 584 --ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT-- 639
I + ++ LV EF G++ L+ E+ IA
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLK-EE-----------WIAYIC 135
Query: 640 -ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
E +GL +LH +HRD+K N+LL E + KL DFG+S G T +
Sbjct: 136 REILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFI 190
Query: 699 GTPGYLDPEYYISNRLTE-----KSDVYSFGVVLLELITGQP 735
GTP ++ PE + + KSD++S G+ +E+ G P
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 532 VLGKGGFGTVYHGYL--DDKQVAVK-MLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVG 587
+G G G V+ +AVK M + + K+ ++++++++H + G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
NT + + E M + +P E G + + L Y
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIP---ERILGK--------MTVAIVKALYY 139
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
L + ++HRDVK +NILL+E+ Q KL DFG+S G Y+ PE
Sbjct: 140 LKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPE 194
Query: 708 YYISNRLTE-----KSDVYSFGVVLLELITGQP 735
T+ ++DV+S G+ L+EL TGQ
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNL 582
+RVLGKG FG V + ++ AVK++S V+ + EV+LL + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L + ++ LV E G L ++++ S +I +
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------------KRFSEVDAARIIRQVL 136
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
G+ Y+H IVHRD+K N+LL ++ ++ DFGLS F S +G
Sbjct: 137 SGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIG 190
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T Y+ PE + EK DV+S GV+L L++G P
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 39/218 (17%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLS---PSSVQGYKQFQAEVELLMRAHHKNLTIL 585
R +G G FG VY + + VA+K +S S + ++ EV L + H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESA 642
G LV E+ E L ++IA +
Sbjct: 120 RGCYLREHTAWLVMEYCLGS------------ASDLLEVHKKPLQ---EVEIAAVTHGAL 164
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS--TTVVGT 700
QGL YLH +HRDVK+ NILL+E KL DFG + S ++ + VGT
Sbjct: 165 QGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGT 213
Query: 701 PGYLDPEYYISNRLTE---KSDVYSFGVVLLELITGQP 735
P ++ PE ++ + K DV+S G+ +EL +P
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTI 584
+ LG G +G V + + A+K++ +SV + EV +L H N+
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L + ++ LV E G L ++ + + I + G
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHR------------MKFNEVDAAVIIKQVLSG 148
Query: 645 LEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+ YLH IVHRD+K N+LL + K+ DFGLS +F +GT
Sbjct: 149 VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTA 202
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE + + EK DV+S GV+L L+ G P
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 50/220 (22%), Positives = 80/220 (36%), Gaps = 32/220 (14%)
Query: 532 VLGKG--GFGTVYHGY--LDDKQVAVKM--LSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
V+GKG TV + V V+ L S + Q E+ + +H N+
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT---ESA 642
+ ++ +V FMA G+ + L+ T + L IA
Sbjct: 92 RATFIADNELWVVTSFMAYGSAK-DLI------------CTHFMDGMNELAIAYILQGVL 138
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG-----SHVSTTV 697
+ L+Y+H VHR VK+++IL++ + L+ + G
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 698 VGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 735
V +L PE N KSD+YS G+ EL G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
F VLG G F V+ L K A+K + S + E+ +L + H+N+ L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ T LV + ++ G L +L + G+ + K + + +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILER------------GVYTEKDASLVIQQVLSAV 119
Query: 646 EYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
+YLH+ G IVHRD+K N+L E + + DFGLS++ + + +T GTP
Sbjct: 120 KYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTP 171
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GY+ PE ++ D +S GV+ L+ G P
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 528 NFERVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHHKNL 582
F ++LG+G F TV ++ A+K+L + + E +++ R H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS-WKGRLQIATES 641
L ++ K+ + NG L ++ K G R A E
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYI------------RKIGSFDETCTRFYTA-EI 139
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
LEYLH G I+HRD+K NILLNE ++ DFG +++ E + + VGT
Sbjct: 140 VSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE + SD+++ G ++ +L+ G P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLT 583
N +LGKG FG V + ++ AVK+++ +S + EVELL + H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L ++++ +V E G L ++ + S +I +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFS 132
Query: 644 GLEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
G+ Y+H IVHRD+K NILL + K+ DFGLS F + +G
Sbjct: 133 GITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIG 185
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T Y+ PE + EK DV+S GV+L L++G P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 49/231 (21%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--------YKQFQAEVELLMRA 577
+ LG G G V + K+VA++++S + E+E+L +
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNL------QAHLLAQLAILPTDAEDKTGILSW 631
+H + + + D +V E M G L L E +
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRL----------KEATCKLYF- 245
Query: 632 KGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPV 687
Q+ ++YLH+ G I+HRD+K N+LL+ + K+ DFG S+I
Sbjct: 246 ---YQML----LAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 292
Query: 688 EGGSHVSTTVVGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 735
G + + T+ GTP YL PE + D +S GV+L ++G P
Sbjct: 293 -GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 59/226 (26%), Positives = 86/226 (38%), Gaps = 39/226 (17%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-------------KQFQAEVEL 573
R LG G +G V + A+K++ S ++ E+ L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 574 LMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
L H N+ L ++ LV EF G L ++ +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR------------HKFDECD 147
Query: 634 RLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEG 689
I + G+ YLH IVHRD+K NILL N K+ DFGLS F
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---S 200
Query: 690 GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ +GT Y+ PE + + EK DV+S GV++ L+ G P
Sbjct: 201 KDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 58/235 (24%), Positives = 88/235 (37%), Gaps = 56/235 (23%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ---------FQAEVELLMR- 576
+ +LG+G V K+ AVK++ + + EV++L +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+ H N+ L + NT LV++ M G L D + K L
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELF---------------DY--LTE-KVTL- 121
Query: 637 IATESA---------QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
+E + + LH IVHRD+K NILL++ KL DFG S
Sbjct: 122 --SEKETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL- 174
Query: 687 VEGGSHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
V GTP YL PE ++ D++S GV++ L+ G P
Sbjct: 175 --DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTI 584
F+R LG G FG V+ + +K ++ Q +Q +AE+E+L H N+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+ ++ M +V E G L +++ + + LS ++ +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSA--------QARGKALSEGYVAELMKQMMNA 136
Query: 645 LEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
L Y H +VH+D+K NIL + K+ DFGL+ +F ST GT
Sbjct: 137 LAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGT 189
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE +T K D++S GVV+ L+TG
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 26/214 (12%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
E +G+G +G V + A K + V+ +F+ E+E++ H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
++NT + LV E G L + + +I + +
Sbjct: 72 YETFEDNTDIYLVMELCTGGEL------------FERVVHKRVFRESDAARIMKDVLSAV 119
Query: 646 EYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
Y H + HRD+K N L + KL DFGL+ F + T VGTP
Sbjct: 120 AYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTP 172
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ P+ + + D +S GV++ L+ G P
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 44/225 (19%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQ----GYKQFQAEVELLMRAHHKNL 582
+LG+G +G V + AVK+L ++ G + E++LL R HKN+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 583 TIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL----- 635
L V Y +E KM +V E+ G + +L + + R
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP---------------EKRFPVCQA 111
Query: 636 -----QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
Q+ GLEYLH IVH+D+K N+LL K++ G++
Sbjct: 112 HGYFCQLID----GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
T G+P + PE K D++S GV L + TG
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 55/234 (23%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--------YKQFQAEVELLMR-A 577
+ V+G+G V + AVK++ ++ + + + E +L + A
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H ++ L+ + ++ M LV++ M G L D + K L
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELF---------------DY--LTE-KVAL-- 197
Query: 638 ATESA---------QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPV 687
+E + + +LH IVHRD+K NILL++ Q +L+DFG S
Sbjct: 198 -SEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHL-- 250
Query: 688 EGGSHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
+ GTPGYL PE ++ D+++ GV+L L+ G P
Sbjct: 251 -EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 23/213 (10%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
+ LG G FG V+ + K ++ + E+ ++ + HH L L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
++ +M L+ EF++ G L + A+ + E + Q +GL
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVINYM----RQAC----EGL 162
Query: 646 EYLHD-GCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGSHVSTTVVGTPG 702
+++H+ IVH D+K NI+ K + K+ DFGL+ + T
Sbjct: 163 KHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAE 215
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ PE + +D+++ GV+ L++G
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLT 583
N +LGKG FG V + ++ AVK+++ +S + EVELL + H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L ++++ +V E G L D K S +I +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL------------FDEIIKRKRFSEHDAARIIKQVFS 132
Query: 644 GLEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
G+ Y+H IVHRD+K NILL + K+ DFGLS F + +G
Sbjct: 133 GITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIG 185
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T Y+ PE + EK DV+S GV+L L++G P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 30/216 (13%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTI 584
+ +G G + + + AVK++ S E+E+L+R H N+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L D+ + +V E M G L +L Q S + + +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQ------------KFFSEREASAVLFTITKT 128
Query: 645 LEYLHD-GCKPPIVHRDVKSANILLNEKFQA----KLADFGLSRIFPVEGGSHVSTTVVG 699
+EYLH G +VHRD+K +NIL ++ ++ DFG ++ + + T
Sbjct: 129 VEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTPCY 182
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T ++ PE D++S GV+L ++TG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/233 (25%), Positives = 93/233 (39%), Gaps = 53/233 (22%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--------YKQFQAEVELLMRA 577
+ LG G G V + K+VA+K++S + E+E+L +
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+H + + + D +V E M G L DK ++ RL
Sbjct: 73 NHPCIIKIKNFFDAE-DYYIVLELMEGGELF---------------DK--VVG-NKRL-- 111
Query: 638 ATESA---------QGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIF 685
E+ ++YLH+ I+HRD+K N+LL E K+ DFG S+I
Sbjct: 112 -KEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 686 PVEGGSHVSTTVVGTPGYLDPE---YYISNRLTEKSDVYSFGVVLLELITGQP 735
G + + T+ GTP YL PE + D +S GV+L ++G P
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTIL 585
+ LG+G +G V + ++ VAVK++ + + E+ + +H+N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL---------- 635
G+ E L E+ + G L + +
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEP------------------DIGMPEPDAQRFFH 112
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
Q+ G+ YLH I HRD+K N+LL+E+ K++DFGL+ +F +
Sbjct: 113 QLMA----GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 696 TVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITG 733
+ GT Y+ PE + R E DV+S G+VL ++ G
Sbjct: 166 KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSV---QGYKQFQAEVELLMRAHH 579
+ F RVLG+GGFG V+ ++ A K L+ + +GY+ E ++L + H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 580 KNLTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+ + L Y E T + LV M G+++ H+ P E + A
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
+ GLE+LH + I++RD+K N+LL++ +++D GL+ +
Sbjct: 297 -QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GTPG++ PE + D ++ GV L E+I +
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/270 (20%), Positives = 85/270 (31%), Gaps = 66/270 (24%)
Query: 527 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLS-PSSVQGYKQFQAEVELLMRAHHKN 581
+FE + +G+GGFG V+ +DD A+K + P+ ++ EV+ L + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGI------------- 628
+ E E L+ I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 629 ----LSWKGRLQIATESAQG-------------------------------LEYLHDGCK 653
S K L I + + +E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 654 PPIVHRDVKSANILLNEKFQAKLADFGLSRI----------FPVEGGSHVSTTVVGTPGY 703
++HRD+K +NI K+ DFGL T VGT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITG 733
+ PE N + K D++S G++L EL+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKM-----LSPSSVQGYKQFQAEVELLMRAHHKN 581
V+GKG F V +Q AVK+ + S + + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+ + + +V+EFM +L ++ + +E QI
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QIL--- 140
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ L Y HD I+HRDVK +LL KL FG++ G V+
Sbjct: 141 -EALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGR 193
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
VGTP ++ PE + DV+ GV+L L++G
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLT 583
+ + LGKG F V + A K+++ + +++ + E + + H N+
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA- 642
L E + LV++ + G L + I++ + +E+
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELF---------------ED--IVA-REFY---SEADA 107
Query: 643 --------QGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGG 690
+ + Y H G IVHR++K N+LL K + KLADFGL+
Sbjct: 108 SHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---ND 160
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
S GTPGYL PE + ++ D+++ GV+L L+ G P
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 23/213 (10%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
+ LG G FG V+ A K + + + E++ + H L L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+++ +M ++YEFM+ G L + D+ +S ++ + +GL
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVA-----------DEHNKMSEDEAVEYMRQVCKGL 268
Query: 646 EYLHD-GCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGSHVSTTVVGTPG 702
++H+ VH D+K NI+ K KL DFGL+ GT
Sbjct: 269 CHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAE 321
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ PE + +D++S GV+ L++G
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 36/223 (16%)
Query: 528 NFERVLGKGGFGTVYHGYLDDK----QVAVKMLSPSSVQG------YKQFQAEVELLMRA 577
+ LG G F V +K + A K + + ++ + EV +L +
Sbjct: 15 DIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H N+ L + T + L+ E ++ G L L + ++ +A QI
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--------QI 124
Query: 638 ATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIFPVEGGSH 692
G+ YLH I H D+K NI+L +K KL DFGL+
Sbjct: 125 L----DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGV 173
Query: 693 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ GTP ++ PE L ++D++S GV+ L++G
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG------YKQFQAEVELLMRAHH 579
LG G F V K+ A K + + ++ + EV +L H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
N+ L + T + L+ E ++ G L L + ++ +A QI
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL--------KQIL- 118
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA----KLADFGLSRIFPVEGGSHVS 694
G+ YLH I H D+K NI+L +K KL DFG++ +
Sbjct: 119 ---DGVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEF 168
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ GTP ++ PE L ++D++S GV+ L++G
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILV 586
++ LG+G F ++ AVK++S Q E+ L H N+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLH 72
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ LV E + G L + + S I + +
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKK------------KHFSETEASYIMRKLVSAVS 120
Query: 647 YLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
++HD G +VHRD+K N+L N+ + K+ DFG +R+ P + T T
Sbjct: 121 HMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLH 174
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y PE N E D++S GV+L +++GQ
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 45/221 (20%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQ--GYKQFQAEVELLMRAHHKNLTI 584
+ +GKG F V L ++VA+K++ + + ++ EV ++ +H N+
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL--------- 635
L + + L+ E+ + G + +L+A GR+
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVA------------------HGRMKEKEARSKF 120
Query: 636 -QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
QI + ++Y H IVHRD+K+ N+LL+ K+ADFG S F G +
Sbjct: 121 RQIVS----AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLD 171
Query: 695 TTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
G P Y PE + + + DV+S GV+L L++G
Sbjct: 172 AF-CGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTIL 585
+ LG+G +G V + ++ VAVK++ + + E+ + +H+N+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL---------- 635
G+ E L E+ + G L + +
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEP------------------DIGMPEPDAQRFFH 112
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
Q+ G+ YLH I HRD+K N+LL+E+ K++DFGL+ +F +
Sbjct: 113 QLMA----GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 696 TVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITG 733
+ GT Y+ PE + R E DV+S G+VL ++ G
Sbjct: 166 KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 38/224 (16%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL----DDKQV-AVKMLSPSSVQGYKQFQ---AEVELLMR 576
++FE R +GKG FG V + D K++ A+K ++ + + E++++
Sbjct: 15 DHFEILRAIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 577 AHHKNLTILVGYC--DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
H L L Y DE M +V + + G+L+ HL Q E+ +
Sbjct: 72 LEHPFLVNLW-YSFQDE-EDMFMVVDLLLGGDLRYHL-QQNVHFK---EETV-------K 118
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
L I E L+YL I+HRD+K NILL+E + DF ++ + P
Sbjct: 119 LFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQI 171
Query: 695 TTVVGTPGYLDPEYYISNRLTEKS---DVYSFGVVLLELITGQP 735
TT+ GT Y+ PE + S + S D +S GV EL+ G+
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 55/229 (24%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHKNLTI 584
+ LGKG F V + A K+++ + +++ + E + + H N+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 585 LVGYCDENTKMGLVYEFMANGNL--------------QAHLLAQLAILPTDAEDKTGILS 630
L E + LV++ + G L +H + Q+
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-------------- 138
Query: 631 WKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFP 686
+ + Y H G IVHR++K N+LL K + KLADFGL+
Sbjct: 139 ------------ESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 181
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
S GTPGYL PE + ++ D+++ GV+L L+ G P
Sbjct: 182 --NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+LG G FG V+ ++A K++ ++ ++ + E+ ++ + H NL L
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ + LV E++ G L ++ + L E T + QI +G+ +
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLT---ELDTILFM----KQIC----EGIRH 202
Query: 648 LHD-GCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
+H I+H D+K NIL + K+ DFGL+R + GTP +L
Sbjct: 203 MHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFL 255
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + ++ +D++S GV+ L++G
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 56/242 (23%), Positives = 100/242 (41%), Gaps = 29/242 (11%)
Query: 506 KKGSLELKNRKLSYANVLKITNNFE---RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSS 560
++L L + ++ N + + LG+G F V ++ A K L
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66
Query: 561 VQG--YKQFQAEVELLMR-AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAI 617
+ E+ +L + L + +++ L+ E+ A G + + L +LA
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 618 LPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILL---NEKFQ 673
+ ++ + I QI +G+ YLH IVH D+K NILL
Sbjct: 127 MVSENDVIRLIK------QIL----EGVYYLHQNN----IVHLDLKPQNILLSSIYPLGD 172
Query: 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 733
K+ DFG+SR G + ++GTP YL PE + +T +D+++ G++ L+T
Sbjct: 173 IKIVDFGMSRKI---GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
Query: 734 QP 735
Sbjct: 230 TS 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ------FQAEVELLMRAHH 579
+ LG G F V + A K + + ++ + EV +L + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
N+ L + T + L+ E ++ G L L + ++ +A QI
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--------QIL- 125
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIFPVEGGSHVS 694
G+ YLH I H D+K NI+L +K KL DFGL+
Sbjct: 126 ---DGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEF 175
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ GTP ++ PE L ++D++S GV+ L++G
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-23
Identities = 52/229 (22%), Positives = 84/229 (36%), Gaps = 54/229 (23%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ--FQAEVELLMRAHHKNLTI 584
LGKG F V L ++ A +++ + + E + H N+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 585 LVGYCDENTKMGLVYEFMANGNL--------------QAHLLAQLAILPTDAEDKTGILS 630
L E L+++ + G L +H + Q+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL-------------- 120
Query: 631 WKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFP 686
+ + + H G +VHR++K N+LL K + KLADFGL+
Sbjct: 121 ------------EAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV- 163
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
EG GTPGYL PE + + D+++ GV+L L+ G P
Sbjct: 164 -EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILV 586
E VLG+G V + ++ AVK++ + EVE+L + H+N+ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ +E + LV+E M G++ +H+ + + + + A L+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKR------------RHFNELEASVVVQDVASALD 125
Query: 647 YLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVS-----TTV 697
+LH+ G I HRD+K NIL N+ K+ DF L + G T
Sbjct: 126 FLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 698 VGTPGYLDPE-----YYISNRLTEKSDVYSFGVVLLELITGQP 735
G+ Y+ PE ++ ++ D++S GV+L L++G P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQFQ---AEVELLMRAHH 579
N+F R++G+GGFG VY D ++ A+K L ++ + E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 580 KNLTILVG--YCDE-NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+ +V Y K+ + + M G+L HL + G+ S
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------------SQHGVFSEADMRF 296
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
A E GLE++H +V+RD+K ANILL+E +++D GL+ +
Sbjct: 297 YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHA 349
Query: 697 VVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
VGT GY+ PE + S D +S G +L +L+ G
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 46/221 (20%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTI 584
LG G FG V G L +VAVK+L+ ++ + + E++ L H ++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL--------- 635
L T +V E+++ G L ++ GR+
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICK------------------HGRVEEMEARRLF 117
Query: 636 -QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
QI + ++Y H + +VHRD+K N+LL+ AK+ADFGLS + G +
Sbjct: 118 QQILS----AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLR 168
Query: 695 TTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
T+ G+P Y PE IS RL + D++S GV+L L+ G
Sbjct: 169 TS-CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSV---QGYKQFQAEVELLMRAHH 579
N F RVLGKGGFG V ++ A K L + +G E ++L + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 580 KNLTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+ + L Y E + LV M G+L+ H+ E + A
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHI--YHMGQAGFPEARA-------VFYAA 293
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
E GLE LH + IV+RD+K NILL++ +++D GL+ P V
Sbjct: 294 -EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV 346
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GT GY+ PE + R T D ++ G +L E+I GQ
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 42/260 (16%)
Query: 493 SLRRRK--QELCPVGKKGSLELKNRKLSYANVLKITNNFE--RVLGKGGFGTVYHGYL-- 546
LRR K E K + ++K +L +FE +V+G+G FG V +
Sbjct: 45 PLRREKNILEYLEWAKPFTSKVKQMRLH-------REDFEILKVIGRGAFGEVA---VVK 94
Query: 547 --DDKQV-AVKMLSPSSVQGYKQ---FQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600
+ +V A+K+L+ + + F+ E ++L+ K +T L ++ + LV +
Sbjct: 95 LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154
Query: 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRD 660
+ G+L L LP E+ R +A E ++ +H + VHRD
Sbjct: 155 YYVGGDLLTLLSKFEDRLP---EEMA-------RFYLA-EMVIAIDSVH---QLHYVHRD 200
Query: 661 VKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKS-- 718
+K NIL++ +LADFG +E G+ S+ VGTP Y+ PE + +
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG 259
Query: 719 ---DVYSFGVVLLELITGQP 735
D +S GV + E++ G+
Sbjct: 260 PECDWWSLGVCMYEMLYGET 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 54/227 (23%), Positives = 81/227 (35%), Gaps = 52/227 (22%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV--------QGYKQFQAEVELLMRAHH 579
LG G FG V+ +K+V VK + V + E+ +L R H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGN-LQAHLLAQLAILPTDAEDKTGILSWKGRL--- 635
N+ ++ + LV E +G L A + RL
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR------------------HPRLDEP 130
Query: 636 -------QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
Q+ + + YL I+HRD+K NI++ E F KL DFG + E
Sbjct: 131 LASYIFRQLVS----AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--E 181
Query: 689 GGSHVSTTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
G T GT Y PE + + +++S GV L L+
Sbjct: 182 RGKLFYTF-CGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 57/248 (22%), Positives = 92/248 (37%), Gaps = 73/248 (29%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA------------------- 569
+GKG +G V Y D+ A+K+LS + F
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 570 -------EVELLMRAHHKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPT 620
E+ +L + H N+ L V + +V+E + G + + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------MEVPT- 130
Query: 621 DAEDKTGILSWKGRL----------QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670
L + G+EYLH I+HRD+K +N+L+ E
Sbjct: 131 -----------LKPLSEDQARFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGE 172
Query: 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTE----KSDVYSFGVV 726
K+ADFG+S F +G + + VGTP ++ PE +S DV++ GV
Sbjct: 173 DGHIKIADFGVSNEF--KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVT 229
Query: 727 LLELITGQ 734
L + GQ
Sbjct: 230 LYCFVFGQ 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 46/249 (18%)
Query: 506 KKGSLELKNRKLSYANVLKITNNFE--RVLGKGGFGTVYHGYL----DDKQV-AVKMLSP 558
+ + LK +L ++FE +V+G+G F V + QV A+K+++
Sbjct: 47 EPIVVRLKEVRLQ-------RDDFEILKVIGRGAFSEVA---VVKMKQTGQVYAMKIMNK 96
Query: 559 SSVQGYKQ---FQAEVELLMRAHHKNLTILVGYC--DENTKMGLVYEFMANGNLQAHLLA 613
+ + F+ E ++L+ + +T L + DEN + LV E+ G+L L
Sbjct: 97 WDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDEN-YLYLVMEYYVGGDLLTLLSK 154
Query: 614 QLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673
+P + R +A E ++ +H + VHRD+K NILL+
Sbjct: 155 FGERIP---AEMA-------RFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGH 200
Query: 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVY-------SFGVV 726
+LADFG +G S VGTP YL PE + + Y + GV
Sbjct: 201 IRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259
Query: 727 LLELITGQP 735
E+ GQ
Sbjct: 260 AYEMFYGQT 268
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 54/229 (23%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA------EVELLMRAHHK 580
+LG GGFG+VY G D+ VA+K + + + + EV LL +
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 581 NLTI--LVGYCDENTKMGLVYEFMAN-GNLQAHLLAQLAILPTDAEDKTGILSWKGRL-- 635
+ L+ + + L+ E +L + +G L
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE------------------RGALQE 148
Query: 636 --------QIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFP 686
Q+ + + + H+ ++HRD+K NIL++ + + KL DFG +
Sbjct: 149 ELARSFFWQVL----EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK 201
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
+ + GT Y PE +I + V+S G++L +++ G
Sbjct: 202 ---DTVYTDF-DGTRVYSPPE-WIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG------YKQFQAEVELLMRAHH 579
+ LG G F V Q A K + + + + EV +L H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
N+ L + T + L+ E +A G L L + ++ +A + QI
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL--------KQIL- 124
Query: 640 ESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA----KLADFGLSRIFPVEGGSHVS 694
G+ YLH I H D+K NI+L ++ K+ DFGL+ +
Sbjct: 125 ---NGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEF 174
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ GTP ++ PE L ++D++S GV+ L++G
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 40/213 (18%), Positives = 86/213 (40%), Gaps = 24/213 (11%)
Query: 528 NFERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
LG+G FG V+ K K + + E+ +L A H+N+ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHL 66
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ ++ +++EF++ ++ + L + E + + Q+ + L
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFEL-NEREIVSYVH------QVC----EAL 115
Query: 646 EYLHD-GCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGSHVSTTVVGTPG 702
++LH I H D++ NI+ + + K+ +FG +R + P
Sbjct: 116 QFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPE 168
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y PE + + ++ +D++S G ++ L++G
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 56/230 (24%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA------EVELLMRAH--- 578
+LGKGGFGTV+ G+ D QVA+K++ + V G+ EV LL +
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 579 -HKNLTILVGYCDENTKMGLVYEFMANGN-LQAHLLAQLAILPTDAEDKTGILSWKGRL- 635
H + L+ + + LV E L ++ KG L
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE------------------KGPLG 137
Query: 636 ---------QIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIF 685
Q+ +++ H +VHRD+K NIL++ + AKL DFG +
Sbjct: 138 EGPSRCFFGQV----VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
+ GT Y PE +IS + V+S G++L +++ G
Sbjct: 191 H---DEPYTDF-DGTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
E LG+G VY K A+K+L + + K + E+ +L+R H N+ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES----- 641
+ T++ LV E + G L D+ I+ KG +E
Sbjct: 115 EIFETPTEISLVLELVTGGELF---------------DR--IVE-KGYY---SERDAADA 153
Query: 642 ----AQGLEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHV 693
+ + YLH+ G IVHRD+K N+L K+ADFGLS+I +
Sbjct: 154 VKQILEAVAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVL 206
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TV GTPGY PE + D++S G++ L+ G
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 71/274 (25%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKML-SPSSVQGYKQFQAEVELLMRA-HH 579
+ LG+G FG V + VAVKML ++ ++ +E+++L+ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 580 KNLTILVGYCDENT----------KMGLVYEFMAN----------------------GNL 607
N+ L+G C + K G + ++ + G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 608 QAHLLAQLAILPTDAEDKT-----------------------GILSWKGRLQIATESAQG 644
L +L + + + L+ + + + + A+G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG-Y 703
+E+L +HRD+ + NILL+EK K+ DFGL+R + +V P +
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDARLPLKW 261
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELIT--GQP 735
+ PE T +SDV+SFGV+L E+ + P
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILV 586
++VLG G G V + ++ A+K+L S + + EV+ + + ++ ++
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 587 GYCDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
+ ++ E M G L + + + T+ E +I +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA----------EIMRDIG 138
Query: 643 QGLEYLHD-GCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIFPVEGGSHVSTTVV 698
+++LH I HRDVK N+L + KL DFG ++ + T
Sbjct: 139 TAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPC 190
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP Y+ PE + + D++S GV++ L+ G P
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYK---QFQAEVELLMRAHHKNLTI 584
LG+G FG V ++VA+K +S ++ + + E+ L H ++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL--------- 635
L T + +V E+ A G L +++ K R+
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIVE------------------KKRMTEDEGRRFF 114
Query: 636 -QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
QI +EY H + IVHRD+K N+LL++ K+ADFGLS I G+ +
Sbjct: 115 QQIIC----AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLK 165
Query: 695 TTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
T+ G+P Y PE I+ +L + DV+S G+VL ++ G
Sbjct: 166 TS-CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTIL 585
+VLG G G V + ++ A+KML + + EVEL R + ++ +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 586 VGYCDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
V + +V E + G L + + + T+ E + I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM------KSI---- 170
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGSHVSTTV 697
+ ++YLH I HRDVK N+L K KL DFG ++ + TT
Sbjct: 171 GEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTP 223
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP Y+ PE + + D++S GV++ L+ G P
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 46/221 (20%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTI 584
LG G FG V G L +VAVK+L+ ++ + + E++ L H ++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL--------- 635
L + + +V E+++ G L ++ GRL
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICK------------------NGRLDEKESRRLF 122
Query: 636 -QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
QI + G++Y H + +VHRD+K N+LL+ AK+ADFGLS + G +
Sbjct: 123 QQILS----GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLR 173
Query: 695 TTVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
T+ G+P Y PE IS RL + D++S GV+L L+ G
Sbjct: 174 TS-CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 28/213 (13%), Positives = 57/213 (26%), Gaps = 55/213 (25%)
Query: 530 ERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLT 583
G + D D+QVA+ + P V ++ + L R +
Sbjct: 36 LIFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
++ +V E++ G+LQ +A + P A ++ A
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGA------------IRAMQSLAA 140
Query: 644 GLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
+ H G + + + ++ LA P
Sbjct: 141 AADAAHRAG----VALSIDHPSRVRVSIDGDVVLAY----------------------PA 174
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ + D+ G L L+ +
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 50/220 (22%), Positives = 81/220 (36%), Gaps = 46/220 (20%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+ +G G FG L + VAVK + + + Q E+ H N+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKE 83
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL----------QI 637
T + ++ E+ + G L + GR Q+
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN------------------AGRFSEDEARFFFQQL 125
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA--KLADFGLSRIFPVEGGSHVST 695
+ G+ Y H I HRD+K N LL+ K+ DFG S+ +
Sbjct: 126 LS----GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--- 175
Query: 696 TVVGTPGYLDPEYYISNRLTE--KSDVYSFGVVLLELITG 733
+ VGTP Y+ PE + + + +DV+S GV L ++ G
Sbjct: 176 STVGTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 527 NNFE--RVLGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQFQ---AEVELLMRAHH 579
+ F+ + LG G FG V A+K+L V KQ + E +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
L L +N+ + +V E++A G + +HL + G S A
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL------------RRIGRFSEPHARFYAA 148
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+ EYLH +++RD+K N+L++++ ++ DFG ++ + T+ G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCG 200
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP L PE +S + D ++ GV++ E+ G P
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 70/280 (25%), Positives = 112/280 (40%), Gaps = 47/280 (16%)
Query: 477 SVVSFSVLLAALAIL------RSLRRRKQELCPVGKKGSLELKNRKLSYANVLKITNNFE 530
S V+ LL L L +LR+ K + + K R L ++E
Sbjct: 18 SEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMK-----AEDYE 72
Query: 531 --RVLGKGGFGTVYHGYL----DDKQV-AVKMLSPSSVQGYKQ---FQAEVELLMRAHHK 580
+V+G+G FG V L ++V A+K+LS + F E +++ A+
Sbjct: 73 VVKVIGRGAFGEVQ---LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ L ++ + +V E+M G+L + + R A E
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM------------SNYDVPEKWARFYTA-E 176
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
L+ +H +HRDVK N+LL++ KLADFG EG T VGT
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
Query: 701 PGYLDPEYYISNRLTEKS-----DVYSFGVVLLELITGQP 735
P Y+ PE + ++ + D +S GV L E++ G
Sbjct: 233 PDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 62/241 (25%), Positives = 113/241 (46%), Gaps = 29/241 (12%)
Query: 505 GKKGSLELKNRKLSYANVLKITN-NFERVLGKGGFGTVY----HGYLDDKQV-AVKMLSP 558
G + + + + +VLG+G FG V+ D +Q+ A+K+L
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 62
Query: 559 SSVQGYKQFQ--AEVELLMRAHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQL 615
++++ + + E ++L+ +H + L Y K+ L+ +F+ G+L L ++
Sbjct: 63 ATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-SKE 120
Query: 616 AILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA 674
+ E+ + +A E A L++LH G I++RD+K NILL+E+
Sbjct: 121 VMFT---EEDV-------KFYLA-ELALALDHLHSLG----IIYRDLKPENILLDEEGHI 165
Query: 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
KL DFGLS+ + + GT Y+ PE T+ +D +SFGV++ E++TG
Sbjct: 166 KLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
Query: 735 P 735
Sbjct: 224 L 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 499 QELCPVGKKGSLELKNRKLSYANVLKITN-NFERVLGKGGFGTVYHG-YLDDKQV-AVKM 555
+ P G+ E++ + + + + ++LGKG FG V + A+K+
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 556 LSPSSVQGYKQF---QAEVELLMRAHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHL 611
L + + E +L + H LT L Y + ++ V E+ G L HL
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL 239
Query: 612 LAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK 671
++ + ED+ R A E L+YLH + +V+RD+K N++L++
Sbjct: 240 -SRERVFS---EDRA-------RFYGA-EIVSALDYLHS--EKNVVYRDLKLENLMLDKD 285
Query: 672 FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELI 731
K+ DFGL + +G + T GTP YL PE N D + GVV+ E++
Sbjct: 286 GHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
Query: 732 TGQP 735
G+
Sbjct: 344 CGRL 347
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 527 NNFE--RVLGKGGFGTVY----HGYLDDKQV-AVKMLSPSS-VQGYKQF---QAEVELLM 575
FE RVLGKGG+G V+ + ++ A+K+L + V+ K +AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 576 RAHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
H + L+ Y K+ L+ E+++ G L L + I ED
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-EREGIFM---EDTA-------C 124
Query: 635 LQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+A E + L +LH G I++RD+K NI+LN + KL DFGL + +G
Sbjct: 125 FYLA-EISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV-- 177
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T GT Y+ PE + + D +S G ++ +++TG P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSVQGYKQFQ---AEVELLMR 576
+F+ R LG G FG V+ L + + A+K+L V KQ + E +L
Sbjct: 6 QDFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS-WKGRL 635
H + + G + ++ ++ +++ G L + L K+ +
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL------------RKSQRFPNPVAKF 110
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
A E LEYLH I++RD+K NILL++ K+ DFG ++ P V+
Sbjct: 111 YAA-EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTY 161
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T+ GTP Y+ PE + + D +SFG+++ E++ G
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 43/229 (18%)
Query: 524 KIT-NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQF---QAEVELLM 575
K+T N+F+ ++LGKG FG V + A+K+L + + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 576 RAHHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
H LT L Y + ++ V E+ G L HL S +
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL------------------SRERV 101
Query: 635 LQI------ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
E LEYLH +V+RD+K N++L++ K+ DFGL + E
Sbjct: 102 FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK----E 154
Query: 689 G--GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
G T GTP YL PE N D + GVV+ E++ G+
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 28/239 (11%)
Query: 506 KKGSLELKNRKLSYANVLKITN-NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQ 562
K+ S E ++ +N L I N F RVLGKG FG V + + AVK+L +
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 563 GYKQF---QAEVELLMRA-HHKNLTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAI 617
E +L A +H LT L C + ++ V EF+ G+L H+
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI------ 115
Query: 618 LPTDAEDKTGILSWKGRLQI-ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676
K+ + R + A E L +LHD I++RD+K N+LL+ + KL
Sbjct: 116 ------QKSRRFD-EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKL 165
Query: 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
ADFG+ + G + + T GTP Y+ PE D ++ GV+L E++ G
Sbjct: 166 ADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 527 NNFE--RVLGKGGFGTVY----HGYLDDKQV-AVKMLSPSS-VQGYKQF---QAEVELLM 575
NFE +VLG G +G V+ D ++ A+K+L ++ VQ K + E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 576 RA-HHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
L L Y TK+ L+ +++ G L HL +Q E +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-SQRERFT---EHEV------- 161
Query: 634 RLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
++ + E LE+LH G I++RD+K NILL+ L DFGLS+ F V +
Sbjct: 162 QIYVG-EIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETE 215
Query: 693 VSTTVVGTPGYLDPEYYISNRL--TEKSDVYSFGVVLLELITGQP 735
+ GT Y+ P+ + D +S GV++ EL+TG
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ---FQA--EVELLMRA 577
+E++ LG+G F TVY ++ VA+K + K A E++LL
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H N+ L+ + + LV++FM +L ++ +++ T + K +L
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM-ETDL-EVIIKDNSLVLTPSHIKAYML------MT 121
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
QGLEYLH I+HRD+K N+LL+E KLADFGL++ F ++ T
Sbjct: 122 L----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQ 172
Query: 698 VGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
V T Y PE Y D+++ G +L EL+ P
Sbjct: 173 VVTRWYRAPELLFGARMY-----GVGVDMWAVGCILAELLLRVP 211
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHK 580
+ ++ LG+G + TVY G L D VA+K + +G A EV LL H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHA 60
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ L + LV+E++ + +L L + K + Q+
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL-DKDL-KQYLDDCGNIINMHNVKLFLF------QLL-- 110
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL Y H ++HRD+K N+L+NE+ + KLADFGL+R + ++ V T
Sbjct: 111 --RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVT 163
Query: 701 PGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 735
Y P+ + S + + D++ G + E+ TG+P
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA--EVELLMRAHHK 580
+ F+++ LG G + TVY G VA+K + S +G A E+ L+ H+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-STAIREISLMKELKHE 63
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ L K+ LV+EFM + +L+ ++ ++ + + ++ Q+
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ--WQLL-- 118
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
QGL + H+ I+HRD+K N+L+N++ Q KL DFGL+R F + + ++ V T
Sbjct: 119 --QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVT 171
Query: 701 PGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
Y P+ Y + D++S G +L E+ITG+P
Sbjct: 172 LWYRAPDVLMGSRTY-----STSIDIWSCGCILAEMITGKP 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 45/226 (19%)
Query: 527 NNFERV--LGKGGFGTVYHGY-LDDKQVAVKMLS--------PSSVQGYKQFQA--EVEL 573
++++ +G+G +G VY + VA+K + PS+ A E+ L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST--------AIREISL 72
Query: 574 LMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
L HH N+ L+ + LV+EFM L ++ ++ L
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFME------KDLKKVL------DENKTGLQ--- 117
Query: 634 RLQIATESAQ---GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG 690
QI Q G+ + H I+HRD+K N+L+N KLADFGL+R F +
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-- 172
Query: 691 SHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 735
T V T Y P+ + S + + D++S G + E+ITG+P
Sbjct: 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 3e-17
Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 34/255 (13%)
Query: 493 SLRRRKQELCPVGKKGSLELKNRKLSYANVLKITN-NFERVLGKGGFGTVYHG-YLDDKQ 550
+ + P K + K + +K+T+ NF VLGKG FG V +
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 551 V-AVKMLSPSSVQGYKQFQAEVE--------LLMRAHHKNLTILVGYC-DENTKMGLVYE 600
+ AVK+L V +VE L + LT L C ++ V E
Sbjct: 368 LYAVKILKKDVVIQDD----DVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVME 422
Query: 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRD 660
++ G+L H+ + G + A E A GL +L I++RD
Sbjct: 423 YVNGGDLMYHI------------QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRD 467
Query: 661 VKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDV 720
+K N++L+ + K+ADFG+ + +G + + T GTP Y+ PE + D
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 721 YSFGVVLLELITGQP 735
++FGV+L E++ GQ
Sbjct: 526 WAFGVLLYEMLAGQA 540
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 67/239 (28%), Positives = 101/239 (42%), Gaps = 38/239 (15%)
Query: 511 ELKNRKLSYANVLKITN-NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQF 567
EL + S LKI + ++LGKG FG V+ + Q A+K L V
Sbjct: 2 ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-- 59
Query: 568 QAEVE--------LLMRAHHKNLTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAIL 618
+VE L + H LT + + + V E++ G+L H+
Sbjct: 60 --DVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI-QSCHKF 115
Query: 619 PTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678
+ A E GL++LH IV+RD+K NILL++ K+AD
Sbjct: 116 D---LSRA-------TFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIAD 161
Query: 679 FGLSRIFPVEG--GSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
FG+ + E G + T GTP Y+ PE + + D +SFGV+L E++ GQ
Sbjct: 162 FGMCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 525 ITNNFERV--LGKGGFGTVYHGYLDDKQ----VAVK-MLSPSSVQGYKQFQA--EVELLM 575
+ +E++ +G+G +G V+ ++ VA+K L K A E+ +L
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLK 57
Query: 576 RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ H NL L+ ++ LV+E+ + + H L + + K+
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVL-HELDRYQRGVPEHLVKSITW------ 109
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
Q Q + + H +HRDVK NIL+ + KL DFG +R+ +
Sbjct: 110 QTL----QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--D 160
Query: 696 TVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITGQP 735
V T Y PE + + DV++ G V EL++G P
Sbjct: 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 528 NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQFQAEVE--------LLMRA 577
+F +V+GKG FG V + ++ AVK+L ++ K E + LL
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK----EEKHIMSERNVLLKNV 96
Query: 578 HHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H L L + K+ V +++ G L HL + E + R
Sbjct: 97 KHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHL-QRERCFL---EPRA-------RFY 144
Query: 637 IATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
A E A L YLH IV+RD+K NILL+ + L DFGL + + ++
Sbjct: 145 AA-EIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TS 197
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T GTP YL PE D + G VL E++ G P
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 527 NNFERV--LGKGGFGTVYHGYLDDKQ----VAVK-MLSPSSVQGYKQFQA--EVELLMRA 577
+E + +G+G +G V +K VA+K L + K A E++LL +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQL 81
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H+NL L+ C + + LV+EF+ + + L L + + QI
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLD-YQVVQKYLF------QI 133
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
G+ + H I+HRD+K NIL+++ KL DFG +R G +
Sbjct: 134 I----NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDE 184
Query: 698 VGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQP 735
V T Y PE + + + DV++ G ++ E+ G+P
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 39/222 (17%)
Query: 528 NFERVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQFQAEVE--------LLMRA 577
NF VLGKG FG V ++ AVK+L V +VE L +
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD----DVECTMVEKRVLALPG 78
Query: 578 HHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS-WKGRL 635
LT L C ++ V E++ G+L H+ + G
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI------------QQVGRFKEPHAVF 125
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG--GSHV 693
A E A GL +L I++RD+K N++L+ + K+ADFG+ + E
Sbjct: 126 YAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVT 177
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T GTP Y+ PE + D ++FGV+L E++ GQ
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQF---QAEVELLMRA-H 578
+F+ RV+G+G + V ++ A+K++ V + Q E + +A +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 579 HKNLTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H L L C + +++ V E++ G+L H+ + LP E+ R
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP---EEHA-------RFYS 116
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A E + L YLH + I++RD+K N+LL+ + KL D+G+ + G + ++T
Sbjct: 117 A-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTF 170
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GTP Y+ PE D ++ GV++ E++ G+
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 53/230 (23%)
Query: 527 NNFERV--LGKGGFGTVYHGYLDDKQ---VAVKMLS--------PSSVQGYKQFQA--EV 571
+ + +G+G +G VY + A+K + PS+ E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPST--------TIREI 51
Query: 572 ELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSW 631
+L H N+ L ++ LV+E + + +L LL K+ +L
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDL-KKLLDVCEGGLESVTAKSFLL-- 107
Query: 632 KGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGS 691
Q+ G+ Y HD ++HRD+K N+L+N + + K+ADFGL+R F +
Sbjct: 108 ----QLL----NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 692 HVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T + T Y P+ Y + D++S G + E++ G P
Sbjct: 157 Y--THEIVTLWYRAPDVLMGSKKY-----STTIDIWSVGCIFAEMVNGTP 199
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 56/246 (22%)
Query: 524 KITNNFERV---LGKGGFGTVYHG----YLDDKQVAVKM-----LSPSSVQGYKQFQAEV 571
++ + FE +G+G +G VY DDK A+K +S S+ + E+
Sbjct: 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EI 69
Query: 572 ELLMRAHHKNLTILVGYCDENT--KMGLVYEFMANGNLQAHLLAQL--AILPTDAEDKTG 627
LL H N+ L + K+ L++++ H L + + A K
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE------HDLWHIIKFHRASKANKKPV 123
Query: 628 ILSWKGRLQIATESAQ---GLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADFG 680
L R + + Q G+ YLH ++HRD+K ANIL+ E+ + K+AD G
Sbjct: 124 QLP---RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 681 LSRIF--PVEGGSHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELIT 732
+R+F P++ + + VV T Y PE +Y T+ D+++ G + EL+T
Sbjct: 178 FARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLT 231
Query: 733 GQPVIQ 738
+P+
Sbjct: 232 SEPIFH 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 58/242 (23%)
Query: 527 NNFERV--LGKGGFGTVYHG--YLDDKQVAVKMLS--------PSSVQGYKQFQA--EVE 572
+ +E++ +G+G FG V+ ++VA+K + P + A E++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--------ALREIK 68
Query: 573 LLMRAHHKNLTILVGYCDENTKMG--------LVYEFMANGNLQAHLLAQLAILPTDAED 624
+L H+N+ L+ C LV++F + +L A LL+ + + T +E
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL-AGLLSNVLVKFTLSEI 126
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
K + + GL Y+H I+HRD+K+AN+L+ KLADFGL+R
Sbjct: 127 KRVMQ------MLL----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 685 F--PVEGGSHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQPV 736
F + T V T Y PE Y D++ G ++ E+ T P+
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRSPI 228
Query: 737 IQ 738
+Q
Sbjct: 229 MQ 230
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLS-PSSVQGYKQFQA----EVELLMR- 576
+ +E V +G G +GTVY VA+K + P+ G EV LL R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 577 --AHHKN----LTILVG-YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL 629
H N + + D K+ LV+E + +L+ +L K +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG 689
Q +GL++LH C IVHRD+K NIL+ KLADFGL+RI+
Sbjct: 128 ------QFL----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---- 170
Query: 690 GSHVS-TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738
++ T VV T Y PE + + D++S G + E+ +P+
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 50/233 (21%)
Query: 527 NNFERV--LGKGGFGTVY---HGYLDDKQVAVKMLS--------PSSVQGYKQFQA--EV 571
+E V +G+G +G V+ + VA+K + P S EV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--------TIREV 62
Query: 572 ELLM---RAHHKN----LTILVG-YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAE 623
+L H N + D TK+ LV+E + + +L L ++ E
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDL-TTYLDKVPEPGVPTE 120
Query: 624 DKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
++ Q+ +GL++LH +VHRD+K NIL+ Q KLADFGL+R
Sbjct: 121 TIKDMM-----FQLL----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 684 IFPVEGGSHVS-TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
I+ ++ T+VV T Y PE + + D++S G + E+ +P
Sbjct: 169 IY----SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 527 NNFE--RVLGKGGFGTVYHG-YLDDKQV-AVKMLSPSSVQGYKQF---QAEVELLMRA-H 578
+F+ RV+G+G + V ++ A++++ V + Q E + +A +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 579 HKNLTILVGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H L L C + +++ V E++ G+L H+ + LP E+ R
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP---EEHA-------RFYS 159
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A E + L YLH + I++RD+K N+LL+ + KL D+G+ + G + ++T
Sbjct: 160 A-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTF 213
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GTP Y+ PE D ++ GV++ E++ G+
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 7e-16
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 41/225 (18%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLS--------PSSVQGYKQFQA--EVE 572
+E++ +G+G +GTV+ + VA+K + PSS A E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--------ALREIC 53
Query: 573 LLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK 632
LL HKN+ L + K+ LV+EF + +L K+ +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDL-KKYFDSCNGDLDPEIVKSFLF--- 108
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
Q+ +GL + H ++HRD+K N+L+N + KLA+FGL+R F + +
Sbjct: 109 ---QLL----KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158
Query: 693 VSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELIT-GQP 735
+ V T Y P+ + + D++S G + EL G+P
Sbjct: 159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSP--SSVQGYKQFQAEVELLMRAHHKNLTILV 586
+ +G G G V Y + D+ VA+K LS + K+ E+ L+ +HKN+ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 587 ------GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+E + LV E M + NL + +L ++ L + Q+
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELD------HERMSYLLY----QML-- 174
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
G+++LH I+HRD+K +NI++ K+ DFGL+R G S + T V T
Sbjct: 175 --CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 226
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQW 749
Y PE + E D++S G ++ E++ + + P R I QW
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF---PGRDYIDQW 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/237 (21%), Positives = 86/237 (36%), Gaps = 38/237 (16%)
Query: 519 YANVLKITNNFE--RVLGKGGFGTVYHGY-LDDKQVAVKMLSPSSVQGYKQ--FQA---- 569
A + + + + R + G +G V G + VA+K + + G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 570 -----EVELLMRAHHKNLT-----ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILP 619
E+ LL HH N+ + K+ LV E M +L + Q ++
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI- 131
Query: 620 TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679
+ + + I GL LH+ +VHRD+ NILL + + DF
Sbjct: 132 SPQHIQYFMY------HIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDF 178
Query: 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 735
L+R + T V Y PE + T+ D++S G V+ E+ +
Sbjct: 179 NLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 52/232 (22%), Positives = 97/232 (41%), Gaps = 46/232 (19%)
Query: 527 NNFERV--LGKGGFGTVYHGY--LDDKQVAVKMLS--------PSSVQGYKQFQA--EVE 572
+ + R+ LG+G +G VY + ++ VA+K + P + A EV
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT--------AIREVS 85
Query: 573 LLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK 632
LL H+N+ L N ++ L++E+ N +L+ ++ + K+ +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM--RVIKSFLY--- 139
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA-----KLADFGLSRIFPV 687
Q+ G+ + H +HRD+K N+LL+ + K+ DFGL+R F +
Sbjct: 140 ---QLI----NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
Query: 688 EGGSHVSTTVVGTPGYLDPEYYI-SNRLTEKSDVYSFGVVLLELITGQPVIQ 738
T + T Y PE + S + D++S + E++ P+
Sbjct: 190 PIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 48/236 (20%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EVELLMRAHH 579
+ +G G G V Y + ++ VA+K LS + FQ E+ L+ +H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 580 KNLTILV------GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
KN+ L+ +E + +V E M + NL + +L ++ L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELD------HERMSYLLY-- 134
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
Q+ G+++LH I+HRD+K +NI++ K+ DFGL+R +
Sbjct: 135 --QML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 182
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQW 749
T V T Y PE + E D++S G ++ E+I G + P I QW
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF---PGTDHIDQW 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 43/223 (19%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EVELLMRAHH 579
+G+G +G V Y L+ +VA+K +SP F+ E+++L+R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRH 84
Query: 580 KNLTILV-----GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
+N+ + ++ + +V + M +L L Q L ++ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ--HL-SNDHICYFLY----- 135
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI-FPVEGGSHV 693
QI +GL+Y+H ++HRD+K +N+LLN K+ DFGL+R+ P +
Sbjct: 136 -QIL----RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 694 STTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 735
T V T Y PE ++ T+ D++S G +L E+++ +P
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 48/223 (21%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EVELLMRAHH 579
+G G +G+V ++VA+K LS + FQ+ E+ LL H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQH 82
Query: 580 KNLTILV------GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
+N+ L+ LV FM +LQ + + + E+K L +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFS------EEKIQYLVY-- 133
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
Q+ +GL+Y+H +VHRD+K N+ +NE + K+ DFGL+R
Sbjct: 134 --QML----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA-----DAE 179
Query: 694 STTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
T V T Y PE +S + D++S G ++ E++TG+
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 53/243 (21%), Positives = 87/243 (35%), Gaps = 63/243 (25%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQ---------AE 570
K + F+ R+ G+G FGTV G VA+K K Q
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQI 69
Query: 571 VELLMRAHHKNLTIL------VGYCDEN-TKMGLVYEFMANGNLQAHLLAQLAILPTDAE 623
++ L HH N+ L +G D + +V E++ P
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV----------------PDTL- 112
Query: 624 DKTGILSWKGRLQIATES---------AQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQ 673
++ R + + LH + HRD+K N+L+NE
Sbjct: 113 -HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGT 170
Query: 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELIT 732
KL DFG ++ +V+ + + Y PE N+ T D++S G + E++
Sbjct: 171 LKLCDFGSAKKL-SPSEPNVAY--ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 733 GQP 735
G+P
Sbjct: 228 GEP 230
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 54/236 (22%), Positives = 85/236 (36%), Gaps = 70/236 (29%)
Query: 530 ERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSVQGYKQFQA------EVELLMRAHHKNL 582
+V+G G FG V+ L + +VA+K K Q E++++ H N+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNV 94
Query: 583 TIL------VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
L G + + LV E++ P + Q
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV----------------PETV--YRASRHYAKLKQ 136
Query: 637 IATES---------AQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIF- 685
+ L Y+H I HRD+K N+LL+ KL DFG ++I
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
Query: 686 PVEGGSHVSTTVVGTPGYLDPE------YYISNRLTEKSDVYSFGVVLLELITGQP 735
E + + + + Y PE Y T D++S G V+ EL+ GQP
Sbjct: 194 AGE----PNVSYICSRYYRAPELIFGATNY-----TTNIDIWSTGCVMAELMQGQP 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 56/234 (23%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL--- 585
+ LG GG G V+ DK+VA+K + + Q K E++++ R H N+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 586 -----------VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAED--KTGILSWK 632
VG E + +V E+M TD + + G L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM----------------ETDLANVLEQGPLL-- 118
Query: 633 GRLQIATESAQ--------GLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSR 683
E A+ GL+Y+H ++HRD+K AN+ +N E K+ DFGL+R
Sbjct: 119 ------EEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 684 IF-PVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQP 735
I P + + T Y P +S N T+ D+++ G + E++TG+
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 58/243 (23%), Positives = 86/243 (35%), Gaps = 83/243 (34%)
Query: 530 ERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQA------EVELLMRAHHKN 581
+V+G G FG VY L D + VA+K K Q E++++ + H N
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCN 108
Query: 582 LTIL------VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ L G + + LV +++ P +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV----------------PETV--YRVARHYSRAK 150
Query: 636 QIATES---------AQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIF 685
Q + L Y+H I HRD+K N+LL+ + KL DFG ++
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRL-------------TEKSDVYSFGVVLLELIT 732
V G +VS YI +R T DV+S G VL EL+
Sbjct: 208 -VRGEPNVS--------------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 733 GQP 735
GQP
Sbjct: 253 GQP 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 54/232 (23%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EVELLMRAHH 579
+LG+G +G V + VA+K + P F E+++L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKH 68
Query: 580 KNLT-----ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
+N+ + ++ ++ E M +L + Q +L +D + I
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ--ML-SDDHIQYFIY----- 119
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
Q + ++ LH ++HRD+K +N+L+N K+ DFGL+RI +
Sbjct: 120 -QTL----RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 695 TTV--------VGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQP 735
T V T Y PE + S + + DV+S G +L EL +P
Sbjct: 172 PTGQQSGMVEFVATRWYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 45/248 (18%), Positives = 87/248 (35%), Gaps = 47/248 (18%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQA-EVELLMRAH 578
+ + + LG G FG V + K+ A+K V +++ E++++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK-----VLQDPRYKNRELDIMKVLD 58
Query: 579 HKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTG--------- 627
H N+ L Y + + + L + + +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 628 ---------ILSWKGRLQIATES---------AQGLEYLHDGCKPPIVHRDVKSANILLN 669
+ S+ + + + + ++H I HRD+K N+L+N
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVN 175
Query: 670 -EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVL 727
+ KL DFG ++ + V+ + + Y PE + T D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKL-IPSEPSVAY--ICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 728 LELITGQP 735
ELI G+P
Sbjct: 233 GELILGKP 240
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL Y+H I+HRD+K N+ +NE + K+ DFGL+R T V T Y
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWY 191
Query: 704 LDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
PE ++ T+ D++S G ++ E+ITG+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 44/229 (19%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
R LG G F TV+ +++ VA+K++ + + E++LL R + + T
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 589 CDENTKMGLVYEFMANGNLQAHL----------LAQLAI------LPTDAEDKTGILSWK 632
+ + L+ F G H+ L L +P +
Sbjct: 84 GANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ------- 135
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE------KFQAKLADFGLSRIFP 686
I+ + GL+Y+H C I+H D+K N+L+ Q K+AD G + +
Sbjct: 136 ----ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACW- 187
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T + T Y PE + +D++S ++ ELITG
Sbjct: 188 ---YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 54/218 (24%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTIL 585
+VLG G G V + ++ A+KML + + EVEL R + ++ +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 586 VG-YCDENTKMGLVY---EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
V Y + + E + G L + + + T+ E + I
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK------SIG--- 127
Query: 642 AQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQA---KLADFGLSRIFPVEGGSHVSTTV 697
+ ++YLH I HRDVK N+L K KL DFG ++ G +
Sbjct: 128 -EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTGEKY----- 175
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ D++S GV++ L+ G P
Sbjct: 176 -----------------DKSCDMWSLGVIMYILLCGYP 196
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GL+Y+H I+HRD+K +N+ +NE + K+ DFGL+R + T V T Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 704 LDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
PE ++ + D++S G ++ EL+TG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 51/225 (22%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 518 SYANVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVEL 573
S+ ++++ R LG+G + V+ ++++V VK+L P + K+ E+++
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKI 83
Query: 574 L-MRAHHKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS 630
L N+ L + + LV+E + N + + L L TD + + +
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQTL----TDYDIRFYMY- 137
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEG 689
+I + L+Y H I+HRDVK N++++ E + +L D+GL+ F G
Sbjct: 138 -----EIL----KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPG 184
Query: 690 GSHVSTTVVGTPGYLDPEYYISNRLTEKS-DVYSFGVVLLELITG 733
+ V + + PE + ++ + S D++S G +L +I
Sbjct: 185 QEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/263 (19%), Positives = 88/263 (33%), Gaps = 86/263 (32%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EVELLMRAHH 579
++G+G +G VY Y +K VA+K ++ + F+ E+ +L R
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKS 84
Query: 580 KNLT-----ILVGYCDENTKMGLVYEFM---------ANGNLQ-AH---LLAQLAILPTD 621
+ I+ + ++ +V E L H +L
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN------- 137
Query: 622 AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681
+L G ++H+ I+HRD+K AN LLN+ K+ DFGL
Sbjct: 138 ------LL-------------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTE--------------------KS-DV 720
+R E +++ + + +LT KS D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 721 YSFGVVLLELITGQPVIQKTPER 743
+S G + EL+ P
Sbjct: 236 WSTGCIFAELLNMLQSHINDPTN 258
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 27/94 (28%)
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-------- 450
+ LNL + I+G I + L + LDLS+N L G +P+ ++ L L +
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 451 ----------------VDGNPNLC---LSASCKG 465
NP LC L
Sbjct: 718 GPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-09
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 16/88 (18%)
Query: 368 LLRDWQG--DPCAPNDYLWQGLNCSYDANQAPRIKSLNLSS---SGIAGEILPHIFSLTS 422
LL DW +PC + G+ C D ++ S++LSS + + + SLT
Sbjct: 29 LLPDWSSNKNPCT-----FDGVTCRDD-----KVTSIDLSSKPLNVGFSAVSSSLLSLTG 78
Query: 423 IESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ESL LSN+ + GSV F L L
Sbjct: 79 LESLFLSNSHINGSVSGF-KCSASLTSL 105
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 13/54 (24%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L++SS+ + I P + ++++ LD+S N L+G ++ L++L
Sbjct: 200 VNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLL 252
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 20/57 (35%), Positives = 32/57 (56%)
Query: 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
N ++ L L ++G G+I P + + + + SL LS N L+G++P L L LR L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 18/59 (30%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 393 ANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVP-EFLAELQFLRVL 450
+ + L+LS + G + P S + +ESL LS+N+ +G +P + L +++ L+VL
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 17/55 (30%), Positives = 33/55 (60%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLV 451
+++L L + + GEI + + T++ + LSNN LTG +P+++ L+ L +L
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 14/52 (26%), Positives = 30/52 (57%), Gaps = 1/52 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEF-LAELQFL 447
++ L++S + ++G+ I + T ++ L++S+N G +P L LQ+L
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYL 274
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 15/54 (27%), Positives = 28/54 (51%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+++ L L + + GEI + + ++E+L L N LTG +P L+ L +
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 15/52 (28%), Positives = 33/52 (63%)
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L++S + ++G I I S+ + L+L +N ++GS+P+ + +L+ L +L
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-07
Identities = 14/54 (25%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+K L +S + I+G++ + ++E LD+S+N+ + +P L + L+ L
Sbjct: 178 GELKHLAISGNKISGDV-D-VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHL 228
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-07
Identities = 14/54 (25%), Positives = 26/54 (48%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
N++S G P + S+ LD+S N L+G +P+ + + +L +L
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-07
Identities = 17/56 (30%), Positives = 29/56 (51%)
Query: 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ SL+LS + ++G I + SL+ + L L N L G +P+ L ++ L L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 21/56 (37%), Positives = 28/56 (50%), Gaps = 3/56 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEF--LAELQFLRVL 450
++SL LS+S I G + S+ SLDLS NSL+G V L L+ L
Sbjct: 77 TGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 131
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 393 ANQAPRIKSLNLSSSGIAGEILPHIF--SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
N + + +L+LSS+ +G ILP++ +++ L L NN TG +P L+ L L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 19/56 (33%), Positives = 30/56 (53%), Gaps = 2/56 (3%)
Query: 397 PRIKSLNLSSSGIAGEILP-HIFSLTSIESLDLSNNSLTGSVPEFLAELQF-LRVL 450
++SL LSS+ +GE+ + + ++ LDLS N +G +PE L L L L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-06
Identities = 15/57 (26%), Positives = 30/57 (52%), Gaps = 3/57 (5%)
Query: 397 PRIKSLNLSSSGIAGEI--LPHIFSLTSIESLDLSNNSLTGSVP-EFLAELQFLRVL 450
+ SL+LS + ++G + L + S + ++ L++S+N+L +L L VL
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 9e-06
Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 397 PRIKSLNLSSSGIAGEI-LPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLV 451
+K LN+SS+ + + L S+E LDLS NS++G+ L
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 18/51 (35%), Positives = 30/51 (58%)
Query: 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++LS++ + GEI I L ++ L LSNNS +G++P L + + L L
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 12/57 (21%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 397 PRIKSLNLSSSGIAGEILPHIF---SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L+LS++ I+G + ++ L +S N ++G V ++ L L
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFL 205
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 20/55 (36%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLA-ELQFLRVL 450
+K LN+SS+ G I P L S++ L L+ N TG +P+FL+ L L
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 17/57 (29%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLT-SIESLDLSNNSLTGSVPEFLAE--LQFLRVL 450
+K L+LS + +GE+ + +L+ S+ +LDLS+N+ +G + L + L+ L
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 12/51 (23%), Positives = 23/51 (45%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFL 447
+ L LS++ +G I + S+ LDL+ N G++P + +
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK 564
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 4/50 (8%), Positives = 13/50 (26%)
Query: 401 SLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ G + L++ ++++ G + L
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 58/240 (24%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EVELLMR-AH 578
+ LGKG +G V+ + VAVK + FQ E+ +L +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSG 67
Query: 579 HKNLTIL--VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H+N+ L V D + + LV+++M +L A + A IL + + Q
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--IL-EPVHKQYVVY------Q 117
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
+ + ++YLH G ++HRD+K +NILLN + K+ADFGLSR F +
Sbjct: 118 LI----KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 697 VVGTPGYLDPEY-------YI-------------SNRLTEKSDVYSFGVVLLELITGQPV 736
+ + + Y+ S + T+ D++S G +L E++ G+P+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 43/228 (18%), Positives = 82/228 (35%), Gaps = 72/228 (31%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQA---------EV 571
I + +E ++G G +G V Y L+ + VA+K + + F+ E+
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREI 103
Query: 572 ELLMRAHHKNLT-----ILVGYCDENTKMGLVYEFM---------ANGNLQ-AH---LLA 613
+L R +H ++ ++ ++ ++ +V E L H LL
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY 163
Query: 614 QLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673
+L G++Y+H I+HRD+K AN L+N+
Sbjct: 164 N-------------LL-------------VGVKYVHSA---GILHRDLKPANCLVNQDCS 194
Query: 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-----LTE 716
K+ DFGL+R + + ++ + + LT
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 37/229 (16%)
Query: 530 ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
+ +G GGFG +Y + ++ A ++ Q +E++ R K+
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 588 YCDENTKMGL--VYEFMANGNLQAH---LLAQLAILPTDAED---KTGILSWKGRLQIAT 639
+ +G+ Y ++ + L D + + G LQ+
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK--LADFGLSRIFPVEGGSHV---- 693
LEY+H+ VH D+K+AN+LL K + LAD+GLS + G+H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY-CPNGNHKQYQE 214
Query: 694 --STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 734
GT + S L+ +SDV G +L + G+
Sbjct: 215 NPRKGHNGTI------EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 57/231 (24%), Positives = 90/231 (38%), Gaps = 56/231 (24%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-KQFQAEVELL------------- 574
+V+GKG FG V Y + VA+KM+ + + + +Q E+ +L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 575 ---MRAH--HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL 629
M + +N + E M L YE + Q L +
Sbjct: 161 VIHMLENFTFRNHICMTF---ELLSMNL-YELIKKNKFQGFSLPLVR------------- 203
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPV 687
+ A Q L+ LH + I+H D+K NILL + + K+ DFG S
Sbjct: 204 ------KFAHSILQCLDALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--- 251
Query: 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738
E T + + Y PE + R D++S G +L EL+TG P++
Sbjct: 252 EHQRV--YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 5e-09
Identities = 37/198 (18%), Positives = 62/198 (31%), Gaps = 38/198 (19%)
Query: 526 TNNFERV--LGKGGFGTVYHGYLDDKQVAVKML---SPSSVQGYKQFQAEVELLMRAHHK 580
T +R +G+G FG V+ D VA+K++ P V G Q E L K
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 581 NLTILVGYCDENTK------------------MGLVYEFMANGN------------LQAH 610
L++L G T+ + ++ + Q
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 611 LLAQLAILPTDAED-KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669
++ + D E +T + S I + L HRD+ N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLK 196
Query: 670 EKFQAKLADFGLSRIFPV 687
+ KL + +
Sbjct: 197 KTSLKKLHYTLNGKSSTI 214
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 14/50 (28%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 401 SLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++L+ + +A ++ + ++ LDL NN + G++P+ L +L+FL L
Sbjct: 225 KIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 24/110 (21%), Positives = 43/110 (39%), Gaps = 31/110 (28%)
Query: 369 LRDWQGD-PCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIA----------------- 410
L W C W G+ C Q R+ +L+LS +
Sbjct: 24 LSSWLPTTDCCNRT--WLGVLCD-TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80
Query: 411 ----------GEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
G I P I LT + L +++ +++G++P+FL++++ L L
Sbjct: 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-07
Identities = 12/54 (22%), Positives = 31/54 (57%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L ++ + ++G I + + ++ +LD S N+L+G++P ++ L L +
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 10/51 (19%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEF--LAELQFL 447
+ ++LS + + G+ S + + + L+ NSL + + L L
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 11/51 (21%), Positives = 25/51 (49%)
Query: 402 LNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVD 452
L+ S + ++G + P I SL ++ + N ++G++P+ L +
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 16/59 (27%), Positives = 25/59 (42%), Gaps = 1/59 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTS-IESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454
P + + + I+G I S + S+ +S N LTG +P A L V + N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 6e-05
Identities = 12/52 (23%), Positives = 24/52 (46%), Gaps = 1/52 (1%)
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
S+ +S + + G+I P +L ++ +DLS N L G + + +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 47/243 (19%), Positives = 83/243 (34%), Gaps = 62/243 (25%)
Query: 530 ERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQ------GYKQFQAEVELLMR 576
+G+GGFG +Y + D VK+ + Y++ ++
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 577 AHHKNLTIL----VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK 632
+ L L + K G Y FM + +D + I
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI-----------MDRFGSDLQK---IYEAN 145
Query: 633 GR-------LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK--LADFGLSR 683
+ LQ++ LEY+H+ VH D+K++N+LLN K + L D+GL+
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
Query: 684 IFPVEGGSHV------STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELI 731
+ G H GT + S + + D+ G +++ +
Sbjct: 203 RY-CPEGVHKAYAADPKRCHDGTI------EFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
Query: 732 TGQ 734
TG
Sbjct: 256 TGH 258
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 58/267 (21%), Positives = 91/267 (34%), Gaps = 84/267 (31%)
Query: 533 LGKGGFGTVY--HGYLDDKQVAVKMLSPSSVQGYKQF-QAEVELLMR-----AHHKNLTI 584
LG G F TV+ K VA+K++ S + Y + E+ LL + N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 585 LVGYCDENTKMG-------LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+V D+ G +V+E + HLL + G+ + +I
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-----GHHLLKWIIKSNYQ-----GLPLPCVK-KI 151
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLN---------------------------- 669
+ QGL+YLH C+ I+H D+K NILL+
Sbjct: 152 IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 670 ---------------------EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEY 708
EK + K+AD G + T + T Y E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEV 264
Query: 709 YISNRLTEKSDVYSFGVVLLELITGQP 735
I + +D++S + EL TG
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDY 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 40/238 (16%), Positives = 80/238 (33%), Gaps = 52/238 (21%)
Query: 530 ERVLGKGGFGTVYHGY----------LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH 579
+ + G +Y ++ ++K+ + + E RA
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-----RLFNEQNFFQRAAK 101
Query: 580 KNLTILVGYCDENTKMGL----VYEFMANGNLQAHLLAQLAILPTDAED-----KTGILS 630
+ + + L F + + L+ L + +LS
Sbjct: 102 PLQ--VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLS 157
Query: 631 WKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK--LADFGLSRIFPVE 688
+ LQ+A LE+LH+ VH +V + NI ++ + Q++ LA +G + +
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY-CP 213
Query: 689 GGSHV------STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 734
G HV + G +IS + +SD+ S G +L+ + G
Sbjct: 214 SGKHVAYVEGSRSPHEGDL------EFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 30/225 (13%)
Query: 523 LKITNNF--ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-A 577
L++ N + R +G G FG +Y G ++VA+K+ + + Q E ++
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQ 62
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+ + E +V E L L L + S K L +
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVME------LLGPSLEDLF------NFCSRKFSLKTVLLL 110
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADFGLSRIF-PVEGGSHV 693
A + +EY+H +HRDVK N L+ + + DFGL++ + H+
Sbjct: 111 ADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167
Query: 694 ----STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
+ + GT Y ++ + + D+ S G VL+ G
Sbjct: 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 46/235 (19%), Positives = 83/235 (35%), Gaps = 44/235 (18%)
Query: 521 NVLKITNNF--ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR 576
VL + NF + +G G FG + G ++ VA+K+ S Q E +
Sbjct: 3 GVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQ 60
Query: 577 AHH-KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ + + +V E L L L + S K L
Sbjct: 61 LGSGDGIPQVYYFGPCGKYNAMVLE------LLGPSLEDLF------DLCDRTFSLKTVL 108
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILL-----NEKFQAKLADFGLSRIF-PVEG 689
IA + +EY+H +++RDVK N L+ + + DF L++ + E
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 690 GSHV----STTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 734
H+ ++ GT Y+S + + D+ + G + + + G
Sbjct: 166 KKHIPYREHKSLTGTA------RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 54/239 (22%)
Query: 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-KQFQAEVELL------------- 574
++GKG FG V Y ++ + VA+K++ + + + Q Q EV LL
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 575 ---MRAH--HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGIL 629
++ H +N LV E L Y+ + N N + L
Sbjct: 118 IVHLKRHFMFRNHLCLVF---EMLSYNL-YDLLRNTNFRGVSLNLTR------------- 160
Query: 630 SWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL--NEKFQAKLADFGLSRIFPV 687
+ A + L +L + I+H D+K NILL ++ K+ DFG S
Sbjct: 161 ------KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL- 211
Query: 688 EGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
+ + Y PE + D++S G +L+E+ TG+P+ E +
Sbjct: 212 ---GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 42/225 (18%), Positives = 78/225 (34%), Gaps = 42/225 (18%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH-KNLTIL 585
R +G+G FG ++ G L+++QVA+K S Q + E + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+ E LV + L L L + S K A + +
Sbjct: 72 YYFGQEGLHNVLVID------LLGPSLEDLL------DLCGRKFSVKTVAMAAKQMLARV 119
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAK-----LADFGLSRIF-PVEGGSHV----ST 695
+ +H+ +V+RD+K N L+ + DFG+ + + H+
Sbjct: 120 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 696 TVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQ 734
+ GT Y+S + + D+ + G V + + G
Sbjct: 177 NLSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 30/225 (13%)
Query: 523 LKITNNF--ERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-A 577
++ N F R +G G FG +Y G +++VA+K+ + + + Q E ++
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQ 60
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
+ + + E LV + L L L + LS K L +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMD------LLGPSLEDLF------NFCSRKLSLKTVLML 108
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK---LADFGLSRIF-PVEGGSHV 693
A + +E++H +HRD+K N L+ +A + DFGL++ + H+
Sbjct: 109 ADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 694 ----STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
+ + GT Y ++ + + D+ S G VL+ + G
Sbjct: 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 8/91 (8%)
Query: 371 DWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSN 430
+W + G++ N R+ L+L G +G + I LT +E L L +
Sbjct: 59 NWNFNKELDMWGAQPGVSL----NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 431 NSLTG----SVPEFLAELQFLRVLVDGNPNL 457
+ P+ ++ +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHY 145
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 10/61 (16%), Positives = 23/61 (37%), Gaps = 7/61 (11%)
Query: 397 PRIKSLNLS-------SSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRV 449
+ +++ S + P F ++ S++LSNN ++ E + L
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 450 L 450
+
Sbjct: 462 I 462
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 2/61 (3%)
Query: 402 LNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461
+ + E I S+ L + +N + + + L + NPN+ +
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLD--IKDNPNISIDL 604
Query: 462 S 462
S
Sbjct: 605 S 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 7/52 (13%), Positives = 20/52 (38%)
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ N + +L + +++ N +P FL L ++++
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 9/53 (16%), Positives = 20/53 (37%), Gaps = 2/53 (3%)
Query: 399 IKSLNLSSSGIA-GEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
I+ + + + + + + + + L+ N L G +P F L L
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASL 358
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 11/54 (20%), Positives = 23/54 (42%), Gaps = 1/54 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L + + G++ P S + SL+L+ N +T F + + L
Sbjct: 330 KKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L ++ + LP IF+ L ++ LDLS L P L L+VL
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 13/54 (24%), Positives = 24/54 (44%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L+LS + SL+S++ L++S+N+ L L+VL
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 12/55 (21%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIF-SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+++ L+ S + +F SL ++ LD+S+ + L L VL
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 11/54 (20%), Positives = 22/54 (40%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ +L L+ + I L L+S++ L +L + L+ L+ L
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 13/54 (24%), Positives = 23/54 (42%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
P ++ L+LS I SL+ + +L L+ N + + L L+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 13/54 (24%), Positives = 20/54 (37%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
K+L+LS + + FS ++ LDLS + L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 3/56 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSV-PEFLAELQFLRVL 450
+ L++S + IF+ L+S+E L ++ NS + P+ EL+ L L
Sbjct: 421 RNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 2/64 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAEL-QFLRVL-VDGN 454
++ LN+S + L S++ LD S N + S + L L L + N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 455 PNLC 458
C
Sbjct: 554 DFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 19/55 (34%), Positives = 29/55 (52%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+K LN++ + I LP FS LT++E LDLS+N + L L + +L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 13/55 (23%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVP-EFLAELQFLRVL 450
+K L+LS +G+ + + L +E LD +++L L+ L L
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 11/55 (20%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG-SVPEFLAELQFLRVL 450
++ L + +A I L +++ L++++N + +PE+ + L L L
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 12/55 (21%), Positives = 22/55 (40%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L+L + I E+ + L +I + LS N A + L+ L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 12/54 (22%), Positives = 20/54 (37%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ LNL S+G + L ++ +DL N+L L+ L
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 15/65 (23%), Positives = 29/65 (44%), Gaps = 4/65 (6%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPE-FLAELQFLRVL-VDG 453
+K ++L + + +F+ S++SL+L N +T + F + L L +
Sbjct: 560 FELKIIDLGLNNLNTLP-ASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 454 NPNLC 458
NP C
Sbjct: 619 NPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 16/56 (28%), Positives = 27/56 (48%), Gaps = 2/56 (3%)
Query: 397 PRIKSLNLSSSGIAG-EILPHIF-SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
P ++ L L + + P F L ++ LDLSNN++ + L L+ L +L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/54 (24%), Positives = 25/54 (46%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L+L S+ I ++ +LDLS+N L+ + +L+ L+ L
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 11/54 (20%), Positives = 23/54 (42%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ SL++ + I+ L ++ L+L +N L+ + A L L
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL 102
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 13/55 (23%), Positives = 25/55 (45%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
P +K LNL + ++ + F+ T++ L L +NS+ + + L L
Sbjct: 73 PMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQF--LRVL 450
+ +L+LS +G++ L L +++ L LSNN + E L L+ L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 14/59 (23%), Positives = 28/59 (47%), Gaps = 5/59 (8%)
Query: 397 PRIKSLNLSSSGIAGEILPHIF---SLTSIESLDLSNNSLTGSVPEFLAELQF--LRVL 450
R+ L L++ + + + + TSI +L LSN+ L+ + L++ L +L
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 11/56 (19%), Positives = 20/56 (35%)
Query: 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ + L+LS + + L +E L N++ L L +R L
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 397 PRIKSLNLSS---SGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L LS+ + E L IF+ +S++ L+LS+N + P + L L
Sbjct: 145 ENLQELLLSNNKIQALKSEEL-DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 399 IKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
I LNL+ + + + F+ + + SLD+ N+++ PE +L L+VL
Sbjct: 27 ITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVL 78
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 14/57 (24%), Positives = 23/57 (40%)
Query: 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ R+ L+L+ G G + I LT ++ L +S T S F E +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 10/51 (19%), Positives = 20/51 (39%)
Query: 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ N + +L + ++L N +P+FL +L L+ L
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 14/76 (18%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 383 LWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLT------- 434
+ ++CS D + ++ LS + I +F+ + I ++ LSNN +T
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSL 717
Query: 435 GSVPEFLAELQFLRVL 450
L +
Sbjct: 718 KPKDGNYKNTYLLTTI 733
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 69/463 (14%), Positives = 135/463 (29%), Gaps = 125/463 (26%)
Query: 40 SEFNKEI-TERQFSNLRSFPEGIRNCYTL------KPDSDHEKFLIRA-----RFMYGNY 87
+ K I ++ + ++ + + L K + +KF+ +F+
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 88 NGQDKPPSFNLMLEADVWDSVQFPDSGSIVSKEIIHIPKREYIHVCLVNTDSGTPFISAL 147
+ + PS + + D + + + +K ++ + + L + L
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLY--NDNQVFAK--YNVSRLQPYLK-LRQ--------ALL 145
Query: 148 ELRPLPNLTY--MTQSG--SLSRYGRWDVGSTTNKTFRYPDDVYDRIWFPHNFYSWAQIS 203
ELRP N+ + SG ++ DV + + ++ W +
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVAL----DVCLSYKVQCKMDFKIF-----------WLNL- 189
Query: 204 TSSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWKPANRMIKNYVYFYFSEFESERAKN 263
N P TV++ + + +W + N + +
Sbjct: 190 --------KNCNSPETVLE---MLQKLLYQIDPNWTSRSDHSSNI------KLRIHSIQA 232
Query: 264 QTRDLNIYINGKLWYGPLSPSYLDTDTVFSTTPTMNRDRHDI--------IINTTENSAL 315
+ R L L P L V ++ I+ TT +
Sbjct: 233 ELRRL-------LKSKPYENCLLVLLNV--------QNAKAWNAFNLSCKILLTTRFKQV 277
Query: 316 PPILNALEIYQV--KEFLQLLTNQQDVIMILFLYLFMHI--------KISVDAIMNIKSK 365
L+A + LT +V +L YL + + I
Sbjct: 278 TDFLSAATTTHISLDHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA-- 334
Query: 366 YELLRDWQGDPCAPN--DYLWQGLNCSYDANQAPRIKSLN-LSSSGIAGEILPH-----I 417
E +RD D W+ +NC D SLN L + E +
Sbjct: 335 -ESIRDG------LATWDN-WKHVNC--DKLTTIIESSLNVLEPA----EYRKMFDRLSV 380
Query: 418 FSL-TSIESLDLS---NNSLTGSVPEFLAELQFLRVLVDGNPN 456
F I ++ LS + + V + +L LV+ P
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH-KYSLVEKQPK 422
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 4e-05
Identities = 67/404 (16%), Positives = 130/404 (32%), Gaps = 117/404 (28%)
Query: 35 SHKISSEFNKEI---TERQFSNLRSFPEGIRN-CYTLKPD----SDH----------EKF 76
S+K+ + + +I + ++ + E ++ Y + P+ SDH +
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 77 LIRARFMYGNYNGQDKPPSFNLMLEADVWDS--VQ-FPDSGS--IV---SKEII-HIPKR 127
+R Y L+L +V ++ F + ++ K++ +
Sbjct: 233 ELRRLLKSKPY-----ENCL-LVLL-NVQNAKAWNAF-NLSCKILLTTRFKQVTDFLSAA 284
Query: 128 EYIHVCLVNTDSG-TP------FISALELRP--LP------NLTYMTQSGSLSRYG--RW 170
H+ L + TP + L+ RP LP N ++ R G W
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 171 DVGSTTNKTFRYPDDVYDRIWFPHNFYSWAQISTSSNMKSTGNFQPPS---------TVM 221
D + D++ ++ ++S+ N P+ +V
Sbjct: 345 D---------NWKHVNCDKL--------------TTIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 222 QSAV-IPANGGSSLMLSWKPANRMIKNYVYFYFSEFESER-AKNQTRDLNIYINGKLWYG 279
+ IP L L W +IK+ V ++ + Q ++ I I
Sbjct: 382 PPSAHIPT---ILLSLIW---FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI---- 431
Query: 280 PLSPSYLDTDTVFSTTPTMNR---DRHDIIINTTENSALPPILNALEIYQVKEFL--QLL 334
YL+ ++R D ++I + +PP L+ Y + L
Sbjct: 432 -----YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYS---HIGHHLK 482
Query: 335 TNQQDVIMILF--LYL---FMHIKISVD--AIMNIKSKYELLRD 371
+ M LF ++L F+ KI D A S L+
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 7e-04
Identities = 60/538 (11%), Positives = 142/538 (26%), Gaps = 157/538 (29%)
Query: 249 VYFYFSEFESERAKNQTRDLNIYINGKL-----W-YGPLSPSYLDTDTVFSTTPTMNRDR 302
F S Q + ++ L + P+ P+M
Sbjct: 64 TLRLFWTLLS----KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ--------PSMMTRM 111
Query: 303 HDIIINTTENSALPPILNALEIYQVKEFLQL---LTNQQDVIMILFLYLFMHI-----KI 354
+ + N + + +++ +L+L L + + + K
Sbjct: 112 YIEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAK-----NVLIDGVLGSGK- 163
Query: 355 SVDAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEIL 414
+ A+ ++ ++ W LN + ++ L I
Sbjct: 164 TWVAL-------DVCLSYKVQCKMDFKIFW--LNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 415 PHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLV--DG--NPNLCLSA---SCKGKK 467
++I+ L +S+ + L + L+ N +A SCK
Sbjct: 215 SRSDHSSNIK---LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCK--- 267
Query: 468 NKFIVPLLASVVSFSVLLAALAILRSLRRRKQELCPVGKKGSLELKNRKLSYANVLKITN 527
+L + V A + + L
Sbjct: 268 ------ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL--------------- 306
Query: 528 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH------KN 581
+ L + L + + + + +R K+
Sbjct: 307 -LLKYLD----------------CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 582 LTILVGYCDE-NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILS--WKGRL--- 635
+ CD+ T + + + + +L++ P A T +LS W +
Sbjct: 350 VN-----CDKLTTIIESSLNVLEPAEYR-KMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403
Query: 636 --QIATE----------SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--AKLAD-FG 680
+ + + + ++ ++K + L ++ + D +
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPS------IYLELK---VKLENEYALHRSIVDHYN 454
Query: 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEY---YI-----SNRLTEKSDVYSFGVVLLEL 730
+ + F + P YLD +Y +I + E+ + F +V L+
Sbjct: 455 IPKTFDSDDLI---------PPYLD-QYFYSHIGHHLKNIEHPERMTL--FRMVFLDF 500
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 53/259 (20%), Positives = 88/259 (33%), Gaps = 82/259 (31%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-KQFQAEVELL----- 574
+ N F R +G G FG V + K AVK++ +++ Y + + E ++L
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQN 90
Query: 575 ----------MRAH--HKNLTILVGYCDENTKMGL-VYEFMANGNLQAHLLAQLAILPTD 621
+ + L+ + +G +YE + N + +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLI--FE---PLGPSLYEIITRNNYNGFHIEDIK----- 140
Query: 622 AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA------- 674
E + L YL + H D+K NILL++ +
Sbjct: 141 --------------LYCIEILKALNYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVR 183
Query: 675 ------------------KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTE 716
KL DFG F + H +++ T Y PE ++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFG-CATF--KSDYH--GSIINTRQYRAPEVILNLGWDV 238
Query: 717 KSDVYSFGVVLLELITGQP 735
SD++SFG VL EL TG
Sbjct: 239 SSDMWSFGCVLAELYTGSL 257
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 16/54 (29%), Positives = 26/54 (48%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++SL L S+ I+ LP F ++ LD NN++ E ++ LQ L
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 13/55 (23%), Positives = 28/55 (50%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
P+++ L+L+ + + + F L ++ L+LS++ L S + L L+ L
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 10/54 (18%), Positives = 25/54 (46%), Gaps = 1/54 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L+L+++ ++ E+ + L++++ L LS N + L L
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 19/59 (32%), Positives = 32/59 (54%), Gaps = 2/59 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454
R++ L LS ++ I H F+ L + +DLS+N LT S E L+ L+ + + + N
Sbjct: 476 GRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 8/55 (14%), Positives = 21/55 (38%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
R+ +L L+++ + + S +++ L ++ L + L L
Sbjct: 81 HRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 11/53 (20%), Positives = 19/53 (35%), Gaps = 2/53 (3%)
Query: 399 IKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L S + + I FS L ++ LDL+ + + L L
Sbjct: 35 TECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTL 86
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 13/55 (23%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIF-SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L+L+ I I F S +++L L+ N L L+ + L+ L
Sbjct: 57 INLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 11/59 (18%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNL 457
+ L + + + +P++ LTS+ LD+S+++ S+ + L + + + N +
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 44/254 (17%), Positives = 77/254 (30%), Gaps = 76/254 (29%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY---LDDKQVAVKMLSPSSVQGY-KQFQAEVELL---- 574
+ +E LG+G FG V QVA+K++ +V Y + + E+ +L
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYREAARLEINVLKKIK 74
Query: 575 ------------MRAH--HKNLTILVGYCDENTKMGL-VYEFMANGNLQAHLLAQLAILP 619
M + + +G +EF+ N Q + L +
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIA--FE---LLGKNTFEFLKENNFQPYPLPHVR--- 126
Query: 620 TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679
+A + L +LH+ + + H D+K NIL L +
Sbjct: 127 ----------------HMAYQLCHALRFLHE-NQ--LTHTDLKPENILFVNSEFETLYNE 167
Query: 680 GLSRIFPVEGGSHV------STTVVGTPGYLDPEYYISNRL------------TEKSDVY 721
S + + S T ++ R + DV+
Sbjct: 168 HKSCEEKSVKNTSIRVADFGSATFDHEHHT----TIVATRHYRPPEVILELGWAQPCDVW 223
Query: 722 SFGVVLLELITGQP 735
S G +L E G
Sbjct: 224 SIGCILFEYYRGFT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 45/254 (17%), Positives = 84/254 (33%), Gaps = 76/254 (29%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY---LDDKQVAVKMLSPSSVQGY-KQFQAEVELL---- 574
++ +E LG+G FG V + VAVK++ +V Y + ++E+++L
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK--NVDRYCEAARSEIQVLEHLN 69
Query: 575 ------------MRAH--HKNLTILVGYCDENTKMGL-VYEFMANGNLQAHLLAQLAILP 619
M H +V + +GL Y+F+ L +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIV--FE---LLGLSTYDFIKENGFLPFRLDHIR--- 121
Query: 620 TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679
++A + + + +LH K + H D+K NIL + + +
Sbjct: 122 ----------------KMAYQICKSVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNP 162
Query: 680 GLSRIFPVEGGSHV------STTVVGTPGYLDPEYYISNRL------------TEKSDVY 721
+ R + S T +S R ++ DV+
Sbjct: 163 KIKRDERTLINPDIKVVDFGSATYDDEHHS----TLVSTRHYRAPEVILALGWSQPCDVW 218
Query: 722 SFGVVLLELITGQP 735
S G +L+E G
Sbjct: 219 SIGCILIEYYLGFT 232
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 13/58 (22%), Positives = 25/58 (43%), Gaps = 2/58 (3%)
Query: 394 NQAPRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L+LS + +I +F L ++ L++S+N+L +L L L
Sbjct: 470 ANTTNLTFLDLSKCQLE-QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP 455
R++ LN+S + + H L S+ +LD S N + S + L + N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 456 NLCLSASC 463
++ C
Sbjct: 557 ---VACIC 561
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 15/55 (27%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ +L L+ + I P FS LTS+E+L L + +L L+ L
Sbjct: 80 HHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 12/54 (22%), Positives = 20/54 (37%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L+LS I L + +L L+ N + P + L L L
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 11/55 (20%), Positives = 18/55 (32%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIF-SLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L+ S + F SL + LD+S + L L L
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNPNL 457
+ + + ++G+ E+ + +E+L L+ N L ++P +A L LR L + P L
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 1/55 (1%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L ++ + LP IF+ L ++ LDLS L P L L+VL
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 1e-04
Identities = 45/297 (15%), Positives = 90/297 (30%), Gaps = 32/297 (10%)
Query: 175 TTNKTFRYPDD----VYDRI---WFPHNFYSWAQISTSSNMKSTGNFQPPSTVMQ--SAV 225
N F P+D Y R + + + F P TV +
Sbjct: 215 VQNAFFTDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTL 274
Query: 226 IPANGGSSLMLSWKPANRMIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSY 285
+ + L + W+ + + + + + I +
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVI------------W 322
Query: 286 LDTDTVFSTTPTMNRDRHDIIINTTENSALPPILNALEIYQVKEFLQLLTNQQDV----- 340
+D+ +R + T+ L+ + ++ L+ Q++
Sbjct: 323 TGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENK 382
Query: 341 IMILFLYLFMHIKISVDAIMNIKSKYELLRDWQGDPCAPNDYLWQGLNCSYDAN--QAPR 398
+L + L M + + L+ A D L +
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD 442
Query: 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGN 454
++ L+L+ + +L H+ L + LDLS+N L ++P LA L+ L VL N
Sbjct: 443 VRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 496
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 3/60 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP 455
++K+L+LSS+ +A + P S + + L NN L + + L Q L + GN
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
R K ++ S + + L + +++ LDLS N L+ LA L +L
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 3/60 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP 455
++K+L+LSS+ +A + P S + + L NN L + + L Q L + GN
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
R K ++ S + + L + +++ LDLS N L+ LA L +L
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 14/53 (26%), Positives = 31/53 (58%), Gaps = 3/53 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRV 449
P ++ L +S++ + E LP + + + ++ +D+ NNSL +P+ L+F+
Sbjct: 131 PLLEYLGVSNNQL--EKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAA 180
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 17/60 (28%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP 455
++K LN+ S+ I+ + + +L+ + SL L+NN L E + L L L + N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 17/55 (30%), Positives = 27/55 (49%), Gaps = 3/55 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
++ L L + I I S L ++ L L NN L+ VP L +L+ L+V+
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 6/57 (10%)
Query: 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP 455
K L +S + + LP + + SL + N LT +PE L L + ++GNP
Sbjct: 244 KELMVSGNRL--TSLPM--LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 17/64 (26%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGN 454
+K L + +S ++ I + F L S+ L+L++N+L+ + L++L L + N
Sbjct: 242 SSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
Query: 455 PNLC 458
P C
Sbjct: 301 PWNC 304
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455
+++L + SG+ + P F + L+LS N+L + + L +++ GNP
Sbjct: 56 GELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNP 114
Query: 456 NLC 458
C
Sbjct: 115 LHC 117
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGN 454
++ L + S I I + F L S+ ++L++N+LT + L L + + N
Sbjct: 231 MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 455 PNLC 458
P C
Sbjct: 290 PWNC 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 14/55 (25%), Positives = 27/55 (49%), Gaps = 3/55 (5%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+ L LS + I+ + + + L L+NN L VP LA+ ++++V+
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 14/63 (22%), Positives = 26/63 (41%), Gaps = 3/63 (4%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL-VDGNP 455
PR++ L +S + + + LP + + +S N L L L+ + + NP
Sbjct: 451 PRLQELYISRNKL--KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508
Query: 456 NLC 458
C
Sbjct: 509 WDC 511
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 749 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.98 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.49 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.13 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.13 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.76 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.6 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.53 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.38 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.38 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 98.36 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.24 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.23 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.19 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.17 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.14 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.09 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.06 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 97.96 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 97.96 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 97.94 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 97.92 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 97.91 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 97.89 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 97.89 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 97.89 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 97.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 97.8 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 97.78 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 97.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 97.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.77 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 97.76 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 97.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 97.75 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 97.72 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 97.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 97.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 97.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 97.69 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 97.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 97.67 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 97.66 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.64 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 97.63 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 97.62 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 97.61 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 97.61 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 97.61 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 97.6 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 97.6 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 97.58 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 97.57 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 97.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 97.56 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 97.55 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 97.55 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 97.55 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 97.51 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 97.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 97.47 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 97.44 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 97.44 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 97.43 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 97.43 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 97.43 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 97.4 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 97.39 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 97.38 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 97.38 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 97.37 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 97.36 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 97.36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 97.35 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 97.34 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 97.34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 97.31 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 97.3 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 97.29 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 97.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 97.27 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 97.27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 97.26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 97.25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 97.25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 97.22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 97.2 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 97.2 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 97.19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 97.19 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.17 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 97.14 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 97.12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 97.11 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.1 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 97.08 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 97.08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 97.06 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 97.05 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 97.04 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 97.02 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 96.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 96.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 96.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.87 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 96.86 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 96.85 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 96.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 96.83 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 96.81 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 96.8 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 96.79 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 96.76 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 96.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 96.72 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 96.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 96.68 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 96.68 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 96.67 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 96.64 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 96.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.57 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 96.56 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 96.56 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 96.56 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 96.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.51 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 96.5 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 96.41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 96.4 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 96.33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 96.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.23 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 96.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.06 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 95.8 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 95.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.66 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 95.5 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 95.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 94.6 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 94.53 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 94.5 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 94.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.43 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 93.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.86 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 93.76 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 93.04 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 92.25 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 91.97 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 91.32 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 89.01 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 87.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.45 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 86.25 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 83.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.33 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=395.73 Aligned_cols=221 Identities=24% Similarity=0.408 Sum_probs=184.0
Q ss_pred HHHHHhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN 592 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~ 592 (749)
++...+..|.+.||+|+||+||+|++. ++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 333445678899999999999999873 3679999997653 33457899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
+..+||||||++|+|.++|......... ........++|..+++|+.|||+||+|||++ +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 9999999999999999999654211100 0112235699999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
++++.+||+|||+|+.+...+.........||++|||||++.++.++.++|||||||+||||+| |+.||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999997654433333445679999999999999999999999999999999999 899998765443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=391.13 Aligned_cols=215 Identities=31% Similarity=0.441 Sum_probs=181.0
Q ss_pred hcccccccccCceEEEEEEEC-------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+.+.+.||+|+||+||+|++. +..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 456789999999999999863 3679999999887777889999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccC-CCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 600 EFMANGNLQAHLLAQLAIL-PTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~-~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||++|+|.++|+...... ..........++|.++++++.|||+||+|||++ +||||||||+|||+++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 9999999999997532100 000112345799999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
||+|+...............||++|||||++.++.++.++|||||||+||||+| |+.||.+.+..+
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999987644332333334568999999999999999999999999999999999 999998765443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=392.77 Aligned_cols=213 Identities=30% Similarity=0.457 Sum_probs=173.5
Q ss_pred cccccccccCceEEEEEEEC-------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 528 NFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.++||+|+||+||+|++. ++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45689999999999999874 36799999998877778899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccC---CCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 601 FMANGNLQAHLLAQLAIL---PTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~---~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||++|+|.++|+...... ..........++|.++++|+.|+|+||+|||+. +||||||||+|||+++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 999999999997542110 001112345799999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 9999997654433334445679999999999999999999999999999999999 99999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=386.17 Aligned_cols=199 Identities=33% Similarity=0.575 Sum_probs=167.9
Q ss_pred cccccccccCceEEEEEEECCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 528 NFERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.+.+.||+|+||+||+|++.+ .||||+++.. +.+..++|.+|++++++++|||||+++|+|.+ +..+||||||++|
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG 116 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS 116 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred EEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence 467899999999999998765 5999998754 34556789999999999999999999999865 5689999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.++|+. ....++|.++++|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 117 sL~~~l~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 117 SLYKHLHV-----------QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp BHHHHHHT-----------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred CHHHHHhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999963 334699999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.............||+.|||||++.+ +.++.++|||||||+||||+||+.||.+.+.
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 54333334455679999999999964 4689999999999999999999999986543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=382.36 Aligned_cols=205 Identities=26% Similarity=0.435 Sum_probs=182.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..+||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3777899999999999999974 5889999997542 2335678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||
T Consensus 113 y~~gG~L~~~i~~------------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 113 YAKNGELLKYIRK------------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp CCTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred cCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 9999999999954 24689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
+|+.+.............||+.|||||++.+..++.++||||+||++|||+||+.||.+.+..++
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 242 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99987654434444567899999999999999999999999999999999999999987665443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=385.18 Aligned_cols=204 Identities=27% Similarity=0.406 Sum_probs=173.7
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++... .....+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3667789999999999999874 588999999754 334467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
|++|+|.++|... +...+++..++.++.||+.||+|||++ +||||||||+|||+++++.+||+|||+
T Consensus 105 ~~gg~L~~~i~~~----------~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 105 CEGGDLFKRINAQ----------KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp CTTCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCCCcHHHHHHHc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 9999999999643 345678999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+.+... ........||+.|||||++.+..++.++|||||||+||||+||+.||.+.+..+
T Consensus 172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 232 (350)
T 4b9d_A 172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232 (350)
T ss_dssp ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 9875321 122344579999999999999999999999999999999999999998765543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=383.17 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=178.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
|.+.+.||+|+||+||+|+.. ++.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 455678999999999999984 588999999766555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ..+++..+..++.||+.||+|||++ +||||||||+|||+++++++||+|||+|+.
T Consensus 156 g~L~~~l~~-------------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 156 GALTDIVTH-------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 999998842 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+... ........||+.|||||++.+..++.++|||||||++|||++|++||.+.+..
T Consensus 220 ~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 276 (346)
T 4fih_A 220 VSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 276 (346)
T ss_dssp CCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cCCC--CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 6433 22334568999999999999999999999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=368.26 Aligned_cols=196 Identities=30% Similarity=0.512 Sum_probs=167.9
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE----NTKMGLVY 599 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----~~~~~LV~ 599 (749)
.+.++||+|+||+||+|+.. +..||+|++... .....+.|.+|++++++++|||||++++++.. +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999985 478999998654 33445789999999999999999999999864 35689999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEe
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLAD 678 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~D 678 (749)
|||++|+|.+++.. ...+++..+..++.||++||+|||++ +++||||||||+|||+++ ++.+||+|
T Consensus 109 Ey~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR------------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp ECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred eCCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEe
Confidence 99999999999954 24689999999999999999999997 224999999999999984 78999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|+.... .......||+.|||||++.+ .++.++|||||||+||||+||+.||.+..
T Consensus 176 FGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 176 LGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999986432 22345679999999998864 69999999999999999999999997643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=384.86 Aligned_cols=198 Identities=25% Similarity=0.370 Sum_probs=178.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
|.+.+.||+|+||+||+|+.. ++.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556689999999999999984 588999999876666667799999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ..+++..+..++.||++||+|||++ +||||||||+||||+.++++||+|||+|+.
T Consensus 233 G~L~~~i~~-------------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 233 GALTDIVTH-------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred CcHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceE
Confidence 999999842 3489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+... ........||+.|||||++.+..++.++|||||||++|||++|++||.+.+.
T Consensus 297 ~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 297 VSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp CCSS--CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCC--CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 6433 2233456799999999999999999999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=372.38 Aligned_cols=200 Identities=27% Similarity=0.399 Sum_probs=164.1
Q ss_pred hcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC----eeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT----KMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~----~~~LV~Ey~ 602 (749)
+.+.+.||+|+||+||+|+++++.||||++...... ...++.|+..+.+++|||||+++|+|.+.+ ..+||||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 446789999999999999999999999999754322 223345666667889999999999997643 679999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG-----CKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~-----~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
++|+|.++|+. ..++|..+++++.|+|+||+|||++ +.++||||||||+|||+++++++||+
T Consensus 84 ~~gsL~~~l~~-------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 84 EHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp TTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCcHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 99999999953 2489999999999999999999986 35699999999999999999999999
Q ss_pred ecCCCccccCCCCce--eeeccccCCcccCccccccC------CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSH--VSTTVVGTPGYLDPEYYISN------RLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+|+......... ......||+.|||||++.+. .++.++|||||||+||||+||++||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 999998765433221 12245799999999999764 4678999999999999999998887543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.38 Aligned_cols=198 Identities=24% Similarity=0.317 Sum_probs=169.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||+|+||+||+|+.. ++.||||+++.... +.+|+.++++++|||||++++++.+++..+||||||++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 344578999999999999974 58899999975432 25799999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEEEecCCCc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSR 683 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL~DFGla~ 683 (749)
|+|.++|.. .+.+++..+..++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+
T Consensus 135 g~L~~~l~~------------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 135 GSLGQLIKQ------------MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp CBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999954 24689999999999999999999999 999999999999999887 69999999999
Q ss_pred cccCCCCce---eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 684 IFPVEGGSH---VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 684 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
.+....... ......||+.|||||++.+..++.++|||||||+||||+||+.||.+.+..+
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 775432211 1233579999999999999999999999999999999999999998765544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.46 Aligned_cols=216 Identities=27% Similarity=0.395 Sum_probs=180.3
Q ss_pred HHHhhcccccccccCceEEEEEEECC-------cccEEEEecCCch-hhHHHHHHHHHHHHhcCC-CceeEEEEEEec-C
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSV-QGYKQFQAEVELLMRAHH-KNLTILVGYCDE-N 592 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H-~nIv~l~g~~~~-~ 592 (749)
....+.+.+.||+|+||+||+|++.+ +.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+ +
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 34456677999999999999998743 4699999976543 445789999999999955 899999999976 4
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
+..+||||||++|+|.++|+........ ........++|..++.++.|||+||+|||++ +||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 5789999999999999999765321111 0112245689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
++++.+||+|||+|+.+.............||++|||||++.++.++.++|||||||+||||+| |+.||.+..
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999997765544444455679999999999999999999999999999999998 999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=374.00 Aligned_cols=202 Identities=28% Similarity=0.396 Sum_probs=170.3
Q ss_pred hhcccccccccCceEEEEEEE-----CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.|++.+.||+|+||+||+|+. .++.||||++.... .....++.+|+++|++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 467789999999999999986 23679999987542 22345788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
||||++|+|.+++.. .+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|
T Consensus 105 mEy~~gg~L~~~l~~------------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK------------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp ECCCTTCEEHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred EEcCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 999999999999954 24689999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
||+|+..... ........||+.|||||++.+..++.++|||||||+||||+||+.||.+.+..+
T Consensus 170 FGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 170 FGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp SEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccceeccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 9999865322 222345679999999999999999999999999999999999999998766544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=359.91 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=162.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4677899999999999999874 5889999987542 2334678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+ +|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||
T Consensus 94 y~-~g~L~~~l~~------------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 94 YA-GNELFDYIVQ------------RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp CC-CEEHHHHHHH------------SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred CC-CCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence 99 6899999853 34689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+|+..... .......||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.+..+
T Consensus 158 la~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 158 LSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99865422 22345679999999999998876 589999999999999999999998765433
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=351.02 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=158.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCC----------
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENT---------- 593 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~---------- 593 (749)
|++.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 566789999999999999874 58899999875433 34567999999999999999999999986543
Q ss_pred --eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC
Q 037623 594 --KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK 671 (749)
Q Consensus 594 --~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~ 671 (749)
..++||||+++|+|.+++... ......++..++.++.|+++||+|||++ +||||||||+|||++.+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~---------~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGR---------CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTC---------CSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CcEEEEEEecCCCCcHHHHHHhc---------CCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence 368999999999999999643 1233457788899999999999999999 99999999999999999
Q ss_pred CcEEEEecCCCccccCCCCce----------eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 672 FQAKLADFGLSRIFPVEGGSH----------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 672 ~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+.+||+|||+|+.+....... ......||+.|||||++.+..++.++|||||||++|||++ ||..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999999999999775432111 1233569999999999999999999999999999999996 7754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.13 Aligned_cols=201 Identities=23% Similarity=0.372 Sum_probs=171.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEec------CCeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDE------NTKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------~~~~~ 596 (749)
|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|+++|++++|||||++++++.. .+..+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 667789999999999999974 6889999997542 3445678999999999999999999999753 36789
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
||||||+ |+|.+++. ..+.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 136 ivmE~~~-g~L~~~i~------------~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 136 VVLDLME-SDLHQIIH------------SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp EEEECCS-EEHHHHHT------------SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEeCCC-CCHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEE
Confidence 9999996 68999883 345799999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCC--ceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 677 ADFGLSRIFPVEGG--SHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 677 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+|||+|+.+..... ........||+.|||||++.+. .++.++||||+||++|||++|++||.+.++.
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 99999987643221 2233456899999999998875 4699999999999999999999999876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.15 Aligned_cols=196 Identities=27% Similarity=0.367 Sum_probs=166.2
Q ss_pred hhcccccccccCceEEEEEEEC-----CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.|.+.+.||+|+||+||+|+.. ++.||+|++..... ..++.+|+++|.++ +||||+++++++.+.+..++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3667799999999999999752 36799999876543 35678999999998 7999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEe
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLAD 678 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~D 678 (749)
||+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 100 E~~~g~~L~~~~~---------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 100 PYLEHESFLDILN---------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ECCCCCCHHHHHT---------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred eCCCcccHHHHHc---------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 9999999999882 378999999999999999999999 99999999999999876 7999999
Q ss_pred cCCCccccCCCC--------------------------ceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHH
Q 037623 679 FGLSRIFPVEGG--------------------------SHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELI 731 (749)
Q Consensus 679 FGla~~~~~~~~--------------------------~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~Ell 731 (749)
||+|+....... ........||+.|||||++.+. .++.++||||+||+++||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999986532211 0112334699999999999876 4899999999999999999
Q ss_pred cCCCCCCCCC
Q 037623 732 TGQPVIQKTP 741 (749)
Q Consensus 732 tG~~pf~~~~ 741 (749)
+|+.||....
T Consensus 242 ~G~~Pf~~~~ 251 (361)
T 4f9c_A 242 SGRYPFYKAS 251 (361)
T ss_dssp HTCSSSSCCS
T ss_pred HCCCCCCCCC
Confidence 9999996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=361.85 Aligned_cols=196 Identities=29% Similarity=0.455 Sum_probs=168.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHH---HHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQF---QAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f---~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
+.+.++||+|+||+||+|+.. ++.||||++.+... ...... ..++.++..++|||||++++++.+.+..+||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 566799999999999999984 58899999965321 112223 3445666778999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
||||+||+|..+|.. ...+++..+..++.||+.||+|||++ +||||||||+||||++++++||+|
T Consensus 271 mEy~~GGdL~~~l~~------------~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ------------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp ECCCCSCBHHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred EecCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecc
Confidence 999999999999954 24689999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|+.+... ......||+.|||||++.+ ..++.++|+|||||+||||++|++||.+.+
T Consensus 336 FGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 336 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp CTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred cceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876432 2235679999999999975 579999999999999999999999997643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=360.68 Aligned_cols=202 Identities=23% Similarity=0.365 Sum_probs=180.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||+||+|+.. ++.||+|++........+.+.+|+++|++++|||||++++++.+....+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4677899999999999999984 58899999987766667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC--CcEEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK--FQAKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~--~~~kL~DFGl 681 (749)
+|+|.++|.. ....+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 238 gg~L~~~i~~-----------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 238 GGELFEKVAD-----------EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp CCBHHHHHTC-----------TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CCcHHHHHHH-----------hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999842 345689999999999999999999999 99999999999999854 7999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+.+... .......||+.|||||++.+..++.++||||+||+||||++|++||.+.+..+
T Consensus 304 a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 304 TAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp CEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred eeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 9987433 22345579999999999999999999999999999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.47 Aligned_cols=213 Identities=23% Similarity=0.338 Sum_probs=183.2
Q ss_pred cccccccCHHHHHHHhhc------------ccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHh
Q 037623 511 ELKNRKLSYANVLKITNN------------FERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMR 576 (749)
Q Consensus 511 ~~~~~~~~~~~l~~~t~~------------f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~ 576 (749)
..+...++++++..++.. ..+.||+|+||.||+|+.. ++.||||++........+.+.+|+.++++
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98 (321)
T ss_dssp ------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred eecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence 344567888888877653 3468999999999999984 58899999987666667789999999999
Q ss_pred cCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 037623 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPI 656 (749)
Q Consensus 577 l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gI 656 (749)
++|+||+++++++...+..++||||+++++|.+++. ...+++..+..++.|+++||+|||+. +|
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~---~i 162 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-------------QVRLNEEQIATVCEAVLQALAYLHAQ---GV 162 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-------------hcCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 999999999999999999999999999999999883 23589999999999999999999998 99
Q ss_pred eeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 657 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 657 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998764321 122345799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 037623 737 IQKTP 741 (749)
Q Consensus 737 f~~~~ 741 (749)
|....
T Consensus 241 f~~~~ 245 (321)
T 2c30_A 241 YFSDS 245 (321)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 97654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.78 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=176.0
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||+||+|+. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 355668999999999999986 458899999976655556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 101 GGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TCBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999843 2488999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp ECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764332 22334579999999999999999999999999999999999999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.88 Aligned_cols=218 Identities=41% Similarity=0.732 Sum_probs=188.7
Q ss_pred ccccCHHHHHHHhhccc--------ccccccCceEEEEEEECCcccEEEEecCC----chhhHHHHHHHHHHHHhcCCCc
Q 037623 514 NRKLSYANVLKITNNFE--------RVLGKGGFGTVYHGYLDDKQVAVKMLSPS----SVQGYKQFQAEVELLMRAHHKN 581 (749)
Q Consensus 514 ~~~~~~~~l~~~t~~f~--------~~LG~G~fG~Vykg~~~~~~VAVK~l~~~----~~~~~~~f~~Ei~iL~~l~H~n 581 (749)
...+++.++..++.+|. +.||+|+||.||+|+.+++.||||++... .....+.+.+|+.++.+++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 46789999999999886 46999999999999998899999998753 2334577999999999999999
Q ss_pred eeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 582 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
|+++++++...+..++||||+++|+|.+++... .....+++..+++++.|+++||+|||+. +|+||||
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl 159 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL---------DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDI 159 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG---------GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhc---------cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCC
Confidence 999999999999999999999999999999643 2345689999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|||+++++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999999999987654333333344568999999998764 58899999999999999999999998755
Q ss_pred ccc
Q 037623 742 ERT 744 (749)
Q Consensus 742 ~~~ 744 (749)
...
T Consensus 239 ~~~ 241 (307)
T 2nru_A 239 EPQ 241 (307)
T ss_dssp SSS
T ss_pred chH
Confidence 433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.15 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=173.8
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.++||+|+||+||+|+... +.||+|++..... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4456899999999999999854 7899999875322 1223488999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 156 ~~gg~L~~~l~~-----------~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 156 YVGGDLLTLLSK-----------FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CTTCBHHHHHHT-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCcHHHHHHH-----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999953 235689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 222 a~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 222 CLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 98764332 22334457999999999997 56789999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.63 Aligned_cols=200 Identities=27% Similarity=0.397 Sum_probs=175.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||+||+++.. ++.||+|++.... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3556789999999999999984 5889999997542 2345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 86 ~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 86 YANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeecc
Confidence 99999999998542 4588999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 151 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 151 LCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp TCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred chhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 99864322 1223455799999999999999999999999999999999999999987554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.12 Aligned_cols=201 Identities=18% Similarity=0.218 Sum_probs=173.5
Q ss_pred hhcccccccccCceEEEEEE-------ECCcccEEEEecCCchhhHHHHHHHHHHHHhcC---CCceeEEEEEEecCCee
Q 037623 526 TNNFERVLGKGGFGTVYHGY-------LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH---HKNLTILVGYCDENTKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~-------~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~---H~nIv~l~g~~~~~~~~ 595 (749)
.+.+.+.||+|+||+||+|. ..++.||||++..... .++..|++++.+++ |+|++.+++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 35567899999999999994 2458899999976543 46777888888776 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-----
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE----- 670 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~----- 670 (749)
++||||+++|+|.+++..... .....+++..++.++.|+++||+|||+. +|+||||||+|||++.
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKN-------TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHT-------STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred EEEEeccCCCcHHHHHHHhhc-------ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 999999999999999975422 1345699999999999999999999998 9999999999999998
Q ss_pred ------CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 671 ------KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 671 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999866433334445566799999999999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.53 Aligned_cols=203 Identities=34% Similarity=0.554 Sum_probs=168.9
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||+||+|+..++.||||++.... ....+++.+|++++.+++|+||+++++++...+..++||||++
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred HceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 45667899999999999999999999999987653 3445689999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP--IVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g--IiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+|+|.+++... .....+++..++.++.|+++||+|||+. + |+||||||+|||+++++.+||+|||+
T Consensus 118 ~~~L~~~l~~~---------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 118 RGSLYRLLHKS---------GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCBHHHHHHST---------THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCcHHHHHhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999532 1123489999999999999999999998 7 99999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus 186 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 186 SRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred Ccccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9864322 1222345699999999999999999999999999999999999999987554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.00 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=176.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||+||+|+.. ++.||+|++........+.|.+|++++.+++||||+++++++.+++..++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 3456789999999999999985 58899999987777778899999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 91 ~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 91 GGTLRGIIKS-----------MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TCBHHHHHHH-----------CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CCcHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccce
Confidence 9999999964 234689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCce------------eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSH------------VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~------------~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
......... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 764322111 1114569999999999999999999999999999999999999987643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=315.75 Aligned_cols=204 Identities=47% Similarity=0.796 Sum_probs=178.0
Q ss_pred cccccccccCceEEEEEEEC-CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 528 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
.+.+.||+|+||.||+|+.. ++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 44678999999999999975 58899999887766677889999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
|.+++.... .....++|..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 122 L~~~l~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 122 LKRHLYGSD--------LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp TGGGSSSSC--------CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred HHHHHhccC--------CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 998884321 1234689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 33323333445689999999999999999999999999999999999999976543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=316.34 Aligned_cols=198 Identities=27% Similarity=0.478 Sum_probs=174.8
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||.||+|+. +++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 55678999999999999997 4688999998754 3345677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 97 SGGEVFDYLVAH------------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp TTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999542 3588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+...... ......||+.|+|||++.+..+. .++|||||||+++||++|+.||.+.+.
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 162 NEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp GGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 8764322 23445799999999999888765 799999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.26 Aligned_cols=201 Identities=30% Similarity=0.409 Sum_probs=171.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|.+++.++ +||||+++++++.+.+..++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 4566789999999999999984 4789999997542 23346678999999988 7999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 104 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 104 EFVNGGDLMFHIQKS------------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccc
Confidence 999999999999542 4589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 169 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 169 GMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 999854322 22234557999999999999999999999999999999999999999876544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=318.48 Aligned_cols=216 Identities=28% Similarity=0.401 Sum_probs=177.7
Q ss_pred hhcccccccccCceEEEEEEEC---------CcccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTK 594 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~ 594 (749)
.+.+.+.||+|+||.||+|+.. +..||||+++.. .....+++.+|++++.++ +||||++++++|...+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 4556789999999999999862 145999999765 334457899999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.++||||+++|+|.+++......... ........+++..+++++.|+++||+|||++ +|+||||||+|||+++
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 99999999999999999754210000 0001234689999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999987643322222233457789999999999999999999999999999999 999998765443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.42 Aligned_cols=199 Identities=28% Similarity=0.365 Sum_probs=171.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+|+.. ++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 455689999999999999985 47899999865321 2234578999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 151 ~~gg~L~~~l~~-------------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 151 MPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp CTTEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCcHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999843 2478999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR----LTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 98764332 22233567999999999997665 78999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.04 Aligned_cols=203 Identities=33% Similarity=0.475 Sum_probs=171.4
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC----eeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT----KMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~----~~~LV~Ey 601 (749)
.+.+.+.||+|+||+||+|+..++.||||++...... ...+.+|+.++.+++||||+++++++.... ..++||||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hchhhheecccCceEEEEEEECCCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 3456789999999999999999999999999755433 345677899999999999999999997643 47999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCceeeCCCCCcEEEcCCCcE
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG-------CKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~-------~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
+++|+|.+++.. ..+++..+.+++.|+++||+|||+. +.++|+||||||+|||+++++.+
T Consensus 104 ~~~g~L~~~l~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 104 HEKGSLSDFLKA-------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp CTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 999999999953 2489999999999999999999976 24489999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-----RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||.+..+
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999876544332233345799999999999863 466788999999999999999999987544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.37 Aligned_cols=202 Identities=25% Similarity=0.342 Sum_probs=174.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+++.. ++.||||++.+... ...+.+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 445689999999999999984 58899999975322 2234588999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++++||+|||+
T Consensus 143 ~~gg~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 143 YVGGDLLTLLSKF-----------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CCSCBHHHHHHHH-----------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 9999999999642 23689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc-------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI-------SNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...+..
T Consensus 209 a~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 209 CLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp CEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred heeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 98764332 22223457999999999997 457899999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.41 Aligned_cols=197 Identities=25% Similarity=0.402 Sum_probs=171.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.++||+|+||+||+++.. ++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3566789999999999999985 4789999997542 22345678999999887 8999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 133 E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp ECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EcCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeec
Confidence 999999999999542 4589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 198 Gla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 198 GMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 999863222 2223456799999999999999999999999999999999999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.69 Aligned_cols=200 Identities=28% Similarity=0.451 Sum_probs=170.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+|+.. +..||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 4566789999999999999874 578999998543 33445789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 92 ~~~g~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 92 YIEGPTLSEYIESH------------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp CCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999542 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus 157 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 157 IAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred Ccccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764321 122234568999999999999999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=315.63 Aligned_cols=201 Identities=29% Similarity=0.444 Sum_probs=174.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+.. ++.||||+++... ....+.+..|.+++.++ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4556789999999999999984 5789999997542 23346678899999887 9999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 98 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp ECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEC
Confidence 999999999999542 3589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 163 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 163 GMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp TTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999864322 12234567999999999999999999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.66 Aligned_cols=197 Identities=25% Similarity=0.402 Sum_probs=174.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3566789999999999999984 5889999987542 2234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 87 ~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 87 YIEGGELFSLLRK------------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp CCCSCBHHHHHHH------------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecC
Confidence 9999999999953 34588999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99865321 2345799999999999999999999999999999999999999976543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.19 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=175.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchh------hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ------GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.|.+.+.||+|+||.||+++.. ++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4667789999999999999984 588999998765322 24678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC----c
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF----Q 673 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~----~ 673 (749)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++ .
T Consensus 93 v~e~~~gg~L~~~l~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 93 ILELVSGGELFDFLA------------QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEECCCSCBHHHHHT------------TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCC
T ss_pred EEEcCCCCcHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccC
Confidence 999999999999993 335689999999999999999999999 999999999999998876 7
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 158 vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~ 224 (361)
T 2yab_A 158 IKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (361)
T ss_dssp EEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred EEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999876432 1223456999999999999999999999999999999999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.63 Aligned_cols=201 Identities=29% Similarity=0.401 Sum_probs=175.1
Q ss_pred hhcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+..+ +.||||++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 45667899999999999999864 789999987542 23346788999999887 8999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 101 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQV------------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeC
Confidence 999999999999542 3589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 166 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 166 GMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp TTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 999864322 12234557999999999999999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.62 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=176.2
Q ss_pred HHHhhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
....|.+.+.||+|+||.||+|+.. ++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456778899999999999999984 588999999754 334457789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---cEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---QAK 675 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---~~k 675 (749)
|||+++|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+|
T Consensus 107 ~e~~~gg~L~~~l~------------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 107 FDLVTGGELFEDIV------------AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp ECCCCSCBHHHHHT------------TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred EecCCCCCHHHHHH------------HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence 99999999999983 334689999999999999999999999 999999999999998654 599
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 172 l~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 172 LADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp ECCCTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EeecCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999876432 122345799999999999999999999999999999999999999986543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=313.11 Aligned_cols=215 Identities=46% Similarity=0.781 Sum_probs=184.3
Q ss_pred cccCHHHHHHHhhcc--cccccccCceEEEEEEEC-CcccEEEEecCCchh-hHHHHHHHHHHHHhcCCCceeEEEEEEe
Q 037623 515 RKLSYANVLKITNNF--ERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQ-GYKQFQAEVELLMRAHHKNLTILVGYCD 590 (749)
Q Consensus 515 ~~~~~~~l~~~t~~f--~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~l~H~nIv~l~g~~~ 590 (749)
..+++.++.....++ .+.||+|+||.||+|+.. ++.||||++...... ....+.+|++++.+++|+||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 567778877776655 579999999999999874 588999998765332 2347899999999999999999999999
Q ss_pred cCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 591 ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 591 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
..+..++||||+++|+|.+++.... .....+++..+..++.|+++||+|||+.+.++|+||||||+|||+++
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERP--------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCS--------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred cCCceEEEEEeccCCCHHHHHHhcc--------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 9999999999999999999996431 23456999999999999999999999988889999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||+++||++|+.||.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp TCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999999998764332 233344569999999999999999999999999999999999999995
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=311.67 Aligned_cols=197 Identities=25% Similarity=0.407 Sum_probs=173.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+++.. ++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3556789999999999999985 478999999754 233456688999999988 8999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 90 e~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp CCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence 999999999999542 3589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 155 GMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp GGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 999864322 1223455799999999999999999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.74 Aligned_cols=205 Identities=27% Similarity=0.431 Sum_probs=173.7
Q ss_pred HHhhcccccccccCceEEEEEEEC-----CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
...+.+.+.||+|+||.||+|+.. +..||||++... .....+.|.+|++++.+++|+||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 345566789999999999999983 245999999865 34456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 128 v~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT-----------HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp EEECCTTCBHHHHHHT-----------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCCCCcHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEEC
Confidence 9999999999999953 234689999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999876443221 12223346778999999999999999999999999999999 9999976544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.20 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=165.3
Q ss_pred hhcccccccccCceEEEEEEE-----CCcccEEEEecCCc----hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS----VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.+.||+|+||.||+++. .++.||+|++.... ......+.+|++++++++|+||+++++++...+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 466779999999999999987 35789999997652 233456789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 98 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl 162 (327)
T 3a62_A 98 LILEYLSGGELFMQLERE------------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKL 162 (327)
T ss_dssp EEEECCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEE
T ss_pred EEEeCCCCCcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEE
Confidence 999999999999999542 3578999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus 163 ~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 163 TDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp CCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EeCCcccccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 999999864322 1223345699999999999999999999999999999999999999987554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=307.39 Aligned_cols=200 Identities=25% Similarity=0.369 Sum_probs=175.7
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCchh------hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ------GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
..|.+.+.||+|+||.||+++.. ++.||+|++...... ..+.+.+|+.++.+++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45777899999999999999985 588999998754321 3567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC----
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---- 672 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---- 672 (749)
+||||+++|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++
T Consensus 91 lv~e~~~~~~L~~~l~------------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 91 LILELVAGGELFDFLA------------EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEEECCCSCBHHHHHT------------TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred EEEEcCCCCCHHHHHH------------hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 9999999999999983 335689999999999999999999999 999999999999999887
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 89999999998764321 12345699999999999999999999999999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.82 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=175.6
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc-----hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-----VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
...|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 446788899999999999999874 5889999986432 123577899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc---
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--- 673 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~--- 673 (749)
+||||+++|+|.+.+.... .....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRA--------DAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEECCSSCBHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCCCCCHHHHHHHhc--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCc
Confidence 9999999999998886542 1334689999999999999999999999 9999999999999987654
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 172 vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 172 VKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EEEecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 999999999876432 22233456999999999999999999999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.33 Aligned_cols=202 Identities=25% Similarity=0.398 Sum_probs=172.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 3556789999999999999875 58899999865432 23466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 88 ~~~~L~~~l~------------~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 88 SGGELFDRIE------------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp TTEEGGGGSB------------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCcHHHHHh------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecc
Confidence 9999988873 344689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+.+.............||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 87644333333345679999999999987775 7899999999999999999999986543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.57 Aligned_cols=197 Identities=24% Similarity=0.393 Sum_probs=169.7
Q ss_pred cccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.+.||+|+||.||+|+.. ++.||+|++........+++.+|++++.+++|+||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999874 588999999887666778899999999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE--cCCCcEEEEecCCCccc
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL--NEKFQAKLADFGLSRIF 685 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl--~~~~~~kL~DFGla~~~ 685 (749)
.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+ ++++.+||+|||+++.+
T Consensus 174 ~~~l~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 174 FDRIID-----------ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp HHHHHH-----------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred HHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 999854 234589999999999999999999999 99999999999999 56789999999999876
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
.... ......||+.|+|||++....++.++|||||||++|||++|+.||.+.++.
T Consensus 240 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 294 (373)
T 2x4f_A 240 KPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294 (373)
T ss_dssp CTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4332 223346999999999999999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=314.22 Aligned_cols=197 Identities=27% Similarity=0.408 Sum_probs=172.6
Q ss_pred hhcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+++... +.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 45667899999999999999854 779999986542 2335678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|..++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 96 ~~~gg~L~~~l~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 96 LLLGGDLRYHLQ------------QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp CCTTEEHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCCCcHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence 999999999994 234689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+++.+... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 161 ~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 161 IAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp TCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred eeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 99876432 22345679999999999974 45899999999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.68 Aligned_cols=200 Identities=19% Similarity=0.319 Sum_probs=175.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||.||+|+.. ++.+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 3566789999999999999985 4789999987543 344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC--CCcEEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--KFQAKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--~~~~kL~DFGl 681 (749)
+|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 85 g~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 85 GLDIFERINT-----------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp CCBHHHHHTS-----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 9999999842 234689999999999999999999999 9999999999999997 78999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
++.+... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 151 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 209 (321)
T 1tki_A 151 ARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp CEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH
Confidence 9876432 2233456899999999999988999999999999999999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.43 Aligned_cols=197 Identities=25% Similarity=0.371 Sum_probs=174.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3556789999999999999984 5889999986542 2335678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 122 ~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 122 YVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp CCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence 99999999999542 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 99875322 2345699999999999999999999999999999999999999987554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=320.20 Aligned_cols=197 Identities=30% Similarity=0.478 Sum_probs=171.7
Q ss_pred hcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC-eeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT-KMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~~~g 605 (749)
+.+.+.||+|+||.||+|...++.||||+++... ..+.|.+|++++++++|+||+++++++.+.+ ..++||||+++|
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred eEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 4556899999999999999999999999998654 4578999999999999999999999987655 789999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++... ....+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 273 ~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 273 SLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp BHHHHHHHH----------CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999653 234578999999999999999999999 9999999999999999999999999999854
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
... .....++..|+|||.+.+..++.++|||||||++|||+| |+.||...+..
T Consensus 340 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 340 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred ccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 321 122357889999999999999999999999999999998 99999875443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.41 Aligned_cols=211 Identities=28% Similarity=0.420 Sum_probs=176.8
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
..+.+.+.||+|+||+||+|++. +..||||++... ......++.+|+.++.+++|+||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 34566789999999999999953 257999999754 3445567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---c
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---Q 673 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---~ 673 (749)
+||||+++|+|.+++..... .......+++..+++++.|+++||+|||+. +|+||||||+|||++.++ .
T Consensus 151 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRP-----RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSC-----CSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred EEEEeCCCCCHHHHHHhhcc-----ccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 99999999999999976422 112335689999999999999999999999 999999999999999554 5
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999986533222222334567899999999999999999999999999999998 99999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=320.13 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=174.7
Q ss_pred HHhhcccccccccCceEEEEEEE--CCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
...|.+.+.||+|+||.||+++. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 34577789999999999999987 45889999987653 334567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc---CCCcEEE
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN---EKFQAKL 676 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~---~~~~~kL 676 (749)
||+++|+|.+.+.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||
T Consensus 90 E~~~gg~L~~~i~~------------~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 90 DLVTGGELFEDIVA------------REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CCCBCCBHHHHHHH------------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred EeCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence 99999999999853 34589999999999999999999999 999999999999998 4578999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.
T Consensus 155 ~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 155 ADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp CCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 9999998764332 222345799999999999999999999999999999999999999976554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.79 Aligned_cols=203 Identities=28% Similarity=0.457 Sum_probs=162.8
Q ss_pred hhcccccccccCceEEEEEEEC-----CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+.. +..||||+++.. .....++|.+|+.++.+++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4556789999999999999864 367999999765 3345578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 126 e~~~~~sL~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 126 EYMENGSLDSFLRK-----------HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp ECCTTCBHHHHHHT-----------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eCCCCCcHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence 99999999999953 234689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9998764332111 1112235778999999999999999999999999999998 9999976543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.70 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=172.7
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+|+.. ++.||||+++... ....++|.+|++++.+++||||+++++++...+..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 3456789999999999999985 5889999987653 334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|.+++... ...+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 195 ~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 195 QGGDFLTFLRTE-----------GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp TTCBHHHHHHHH-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 999999999643 23588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+...............++..|+|||.+..+.++.++|||||||++|||+| |+.||.....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 86432111111112235678999999999999999999999999999998 9999986543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.89 Aligned_cols=203 Identities=28% Similarity=0.425 Sum_probs=167.4
Q ss_pred hhcccccccccCceEEEEEEEC--Cc----ccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DK----QVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.+.+.+.||+|+||+||+|+.. ++ +||+|.+... .....++|.+|+.++++++|+||++++++|.... .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 4566789999999999999873 33 3588887644 3345678999999999999999999999998754 7799
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 95 ~e~~~~g~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 160 (327)
T 3poz_A 95 TQLMPFGCLLDYVRE-----------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp EECCTTCBHHHHHHH-----------STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred EEecCCCcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence 999999999999964 234689999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
||+++...............+|..|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 999987754433333334457889999999999999999999999999999999 99999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.18 Aligned_cols=201 Identities=26% Similarity=0.405 Sum_probs=173.3
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 356678999999999999997 458899999865421 223578999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+ +|+|.+++... ..+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 90 ~~-~g~l~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 90 YA-GGELFDYIVEK------------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp CC-CEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred CC-CCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence 99 78999988542 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERTL 745 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~~~~ 745 (749)
+++..... .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......+.
T Consensus 154 ~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 154 LSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp CTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred cceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 99865432 22234569999999999988776 7899999999999999999999987654443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=312.93 Aligned_cols=200 Identities=22% Similarity=0.348 Sum_probs=176.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||.||+|+.. ++.||+|++..........+.+|++++.+++|+||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4667789999999999999984 57899999987766666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC--CCcEEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--KFQAKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--~~~~kL~DFGl 681 (749)
+|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 132 gg~L~~~l~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 132 GGELFDRIAA-----------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp CCBHHHHTTC-----------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CCcHHHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccc
Confidence 9999998842 234689999999999999999999999 9999999999999974 46899999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 98764332 22344699999999999999999999999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.96 Aligned_cols=201 Identities=27% Similarity=0.392 Sum_probs=169.6
Q ss_pred hhcccccccccCceEEEEEEEC-CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||+||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 3556789999999999999984 58899999875432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++ +|.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~-~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 102 EK-DLKKVLDE-----------NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp SE-EHHHHHHT-----------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CC-CHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCc
Confidence 74 88888743 334589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+...... .......+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+..+.
T Consensus 167 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 167 RAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp EETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred eecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 8764321 22234568999999999876 56899999999999999999999999875544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.59 Aligned_cols=214 Identities=31% Similarity=0.453 Sum_probs=175.8
Q ss_pred hhcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.+.+.+.||+|+||.||+|+..+ +.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 45567899999999999999853 679999998653 3445789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCC------------CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCc
Q 037623 598 VYEFMANGNLQAHLLAQLAILP------------TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSAN 665 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~------------~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~N 665 (749)
||||+++|+|.+++........ .........+++..++.++.|+++||+|||++ +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 9999999999999975321000 00001125789999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 666 ILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 666 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999999999999999986543322222334568889999999999999999999999999999999 9999987544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.40 Aligned_cols=215 Identities=27% Similarity=0.394 Sum_probs=176.1
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCC-e
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENT-K 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~-~ 594 (749)
..+.+.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 34566789999999999999852 2679999998653 34457799999999999 8999999999998754 4
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCC------------------------------------------------------
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPT------------------------------------------------------ 620 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~------------------------------------------------------ 620 (749)
.++||||+++|+|.+++.........
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 89999999999999999754221000
Q ss_pred CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccC
Q 037623 621 DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700 (749)
Q Consensus 621 ~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt 700 (749)
........+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...............+|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 0000122389999999999999999999999 9999999999999999999999999999876544333444456689
Q ss_pred CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 701 ~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 99999999999999999999999999999998 9999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.53 Aligned_cols=200 Identities=19% Similarity=0.276 Sum_probs=172.8
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+|+. +++.||||++..... .+++.+|++++.++ +|+||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 355678999999999999996 458899999875532 24688999999999 9999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc-----EEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-----AKLA 677 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~-----~kL~ 677 (749)
+++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++. +||+
T Consensus 88 -~~~L~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 88 -GPSLEDLFDLC-----------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp -CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred -CCCHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999542 34689999999999999999999999 9999999999999999887 9999
Q ss_pred ecCCCccccCCCCce-----eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSH-----VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 999998764432211 12345799999999999999999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.32 Aligned_cols=201 Identities=30% Similarity=0.477 Sum_probs=170.0
Q ss_pred HhhcccccccccCceEEEEEEE------CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~ 596 (749)
..+.+.+.||+|+||+||+|++ +++.||||++........+.+.+|++++.+++|+||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4566779999999999999985 347899999988777777889999999999999999999999865 35689
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++... ...+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 90 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH-----------KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp EEEECCTTCBHHHHHHHC-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred EEEEeCCCCCHHHHHHhc-----------ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEE
Confidence 999999999999999642 23589999999999999999999998 9999999999999999999999
Q ss_pred EecCCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 677 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||+||..|+..
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 999999876433211 122234577789999999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.42 Aligned_cols=201 Identities=26% Similarity=0.376 Sum_probs=171.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC--eeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT--KMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~--~~~LV~E 600 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++.+++|+||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 3556789999999999999985 5889999997543 234567889999999999999999999997655 7799999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE----cCCCcEEE
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKL 676 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl----~~~~~~kL 676 (749)
|+++|+|.+++... .....+++..++.++.|+++||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 90 ~~~~~~L~~~l~~~---------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 90 FCPCGSLYTVLEEP---------SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp CCTTCBHHHHHHSG---------GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred CCCCCCHHHHHHHh---------ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEE
Confidence 99999999999643 1233489999999999999999999999 99999999999999 78888999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccc--------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI--------SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 158 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 158 TDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998764332 223456899999999986 5778999999999999999999999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.70 Aligned_cols=201 Identities=30% Similarity=0.399 Sum_probs=165.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHH-HHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVEL-LMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~i-L~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+++.. ++.||||++..... ...+.+.+|..+ ++.++||||+++++++.+.+..++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4567799999999999999985 47799999976532 233456677776 46789999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 119 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 119 DYINGGELFYHLQRE------------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence 999999999999542 3578899999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 184 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 245 (373)
T 2r5t_A 184 GLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245 (373)
T ss_dssp CBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH
T ss_pred ccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999864322 12234557999999999999999999999999999999999999999875543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=324.68 Aligned_cols=199 Identities=27% Similarity=0.394 Sum_probs=164.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+.. ++.||||++... .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 556789999999999999874 578999998753 233446678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
+++|+|..++... ..+++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 230 ~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 230 ANGGELFFHLSRE------------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp CSSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred CCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCC
Confidence 9999999998542 458999999999999999999998 7 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 295 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 295 LCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 99864322 2223456799999999999999999999999999999999999999987554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.21 Aligned_cols=216 Identities=30% Similarity=0.414 Sum_probs=180.0
Q ss_pred HhhcccccccccCceEEEEEEECC---------cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD---------KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENT 593 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~ 593 (749)
..+.+.+.||+|+||.||+|+..+ ..||||++... .....+++.+|++++.++ +||||+++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 355677999999999999998632 46999999765 334457899999999999 9999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCC----CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILP----TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
..++||||+++|+|.+++........ .........+++..+++++.|+++||+|||+. +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 99999999999999999976421100 00112235699999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
+++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+++||++ |+.||...+..
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987654332233334457889999999999999999999999999999999 99999875543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.40 Aligned_cols=205 Identities=21% Similarity=0.264 Sum_probs=175.4
Q ss_pred hhccccccccc--CceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKG--GFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G--~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.|.+.+.||+| +||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 45677999999 99999999985 5889999987543 344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 106 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 106 SFMAYGSAKDLICTH----------FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp ECCTTCBHHHHHHHT----------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCG
T ss_pred EccCCCCHHHHHhhh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence 999999999999643 234589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCc-----eeeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 680 GLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 680 Gla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|.+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 998754322111 11122368899999999987 57999999999999999999999999875543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.63 Aligned_cols=202 Identities=29% Similarity=0.481 Sum_probs=165.8
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe----eE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK----MG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~----~~ 596 (749)
.|.+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|++++.+++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 466779999999999999997 45889999997642 3345678999999999999999999999876543 48
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++++|.+++... ..+++..+++++.|+++||+|||++ +|+||||||+|||++.++.+||
T Consensus 93 lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTE------------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEECCCEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEE
T ss_pred EEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEE
Confidence 999999999999999542 3589999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999876433221 122334689999999999999999999999999999999999999987553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=296.68 Aligned_cols=201 Identities=25% Similarity=0.420 Sum_probs=174.8
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|+..+ ..||+|++..... ..+++.+|++++.+++||||+++++++......++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 45667899999999999999876 5799999976543 346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 88 ~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 88 GCLLNYLRSH-----------GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp CBHHHHHHHH-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred CcHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcccee
Confidence 9999999643 33589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
..... ........+++.|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 154 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 154 VLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp CCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 64332 222233456778999999999899999999999999999999 9999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.29 Aligned_cols=202 Identities=30% Similarity=0.531 Sum_probs=174.5
Q ss_pred hhcccccccccCceEEEEEEE-CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|+. +++.||+|++..... ..+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 456678999999999999998 457899999986543 346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 90 ~~L~~~l~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 90 GCLSDYLRT-----------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp CBHHHHHHT-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CcHHHHHHh-----------cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccc
Confidence 999999953 234689999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
..... ........+++.|+|||.+.+..++.++||||||++++||++ |+.||......
T Consensus 156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 156 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 53221 111223456778999999999999999999999999999999 99999875543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.55 Aligned_cols=201 Identities=24% Similarity=0.345 Sum_probs=168.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC---------
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT--------- 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~--------- 593 (749)
.+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 4667789999999999999984 5889999987543 334578999999999999999999999986543
Q ss_pred ------------------------------------------------eeEEEEeeCCCCCHHHHHHHhhccCCCCccCC
Q 037623 594 ------------------------------------------------KMGLVYEFMANGNLQAHLLAQLAILPTDAEDK 625 (749)
Q Consensus 594 ------------------------------------------------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~ 625 (749)
..++||||+++|+|.+++... ..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------~~ 157 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR---------CS 157 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC---------CS
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc---------cC
Confidence 378999999999999999643 23
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCc----------eeee
Q 037623 626 TGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGS----------HVST 695 (749)
Q Consensus 626 ~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~ 695 (749)
....++..+++++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 34567888999999999999999999 9999999999999999999999999999876543211 1123
Q ss_pred ccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 696 ~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
...||+.|+|||.+.+..++.++|||||||+++||++|..|+.
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 3469999999999999999999999999999999999988764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=323.89 Aligned_cols=199 Identities=31% Similarity=0.414 Sum_probs=174.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 455689999999999999984 5889999986542 22346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|||+
T Consensus 266 ~~gg~L~~~l~~~----------~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 266 MNGGDLKFHIYHM----------GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp CCSCBHHHHHHSS----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccc
Confidence 9999999998532 234589999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 333 a~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 333 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 98764321 2234579999999999999999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.52 Aligned_cols=205 Identities=29% Similarity=0.424 Sum_probs=163.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 3455689999999999999874 58899999875432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
+ |+|.+++..... ......+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~-~~L~~~l~~~~~------~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 86 D-NDLKKYMDSRTV------GNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp C-CBHHHHHHHHHS------SSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred C-CCHHHHHHhccc------cccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 8 699999865421 12234689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.++
T Consensus 156 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 156 RAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp EETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 8764321 122344689999999999764 689999999999999999999999987554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.83 Aligned_cols=199 Identities=26% Similarity=0.412 Sum_probs=175.0
Q ss_pred HhhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..|.+.+.||+|+||.||+|+..+ ..||+|++........+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 356778999999999999999855 679999998765566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcEEEEec
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADF 679 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~kL~DF 679 (749)
++++|.+++... ..+++..+.+++.|+++||+|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 89 ~~~~L~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 89 TGGELFERVVHK------------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp CSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 999999998542 3589999999999999999999999 99999999999999 78889999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|++....... ......+|+.|+|||.+.+. ++.++||||||++++||++|+.||.....
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 9998764322 22345689999999998654 89999999999999999999999987544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=304.34 Aligned_cols=210 Identities=30% Similarity=0.411 Sum_probs=163.2
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee---
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM--- 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~--- 595 (749)
.+.+.+.||+|+||.||+|+... ..||||++... .....+++.+|++++++++|+||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 46667899999999999998743 27999998764 334567899999999999999999999999877665
Q ss_pred ---EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 596 ---GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 596 ---~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
++||||+++|+|.+++..... ......+++..+++++.|+++||+|||+. +|+||||||+|||+++++
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRI------GENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred CccEEEEEeccCCcHHHHHHhhhc------cccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 899999999999999965421 11233689999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 999999999987644332222334457789999999999999999999999999999999 999998765443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=323.10 Aligned_cols=203 Identities=30% Similarity=0.448 Sum_probs=176.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|++. +..||||+++.... ..++|.+|+.++.+++||||++++++|...+..++||||++
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 4566789999999999999986 57899999976543 35789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++... ....+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 300 ~g~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 300 YGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp TCBHHHHHHHS----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred CCCHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999642 335689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
...... ........++..|+|||.+....++.++|||||||+||||+| |+.||.+.+..
T Consensus 367 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 367 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp CCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 764321 122223346788999999999999999999999999999999 99999875543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.68 Aligned_cols=198 Identities=29% Similarity=0.455 Sum_probs=165.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch--------------------------hhHHHHHHHHHHHHhc
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--------------------------QGYKQFQAEVELLMRA 577 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--------------------------~~~~~f~~Ei~iL~~l 577 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++..... ...+++.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 3566789999999999999874 47899999875432 1235689999999999
Q ss_pred CCCceeEEEEEEec--CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 037623 578 HHKNLTILVGYCDE--NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP 655 (749)
Q Consensus 578 ~H~nIv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g 655 (749)
+||||+++++++.. .+..++||||+++++|.+++ ....+++..+..++.|+++||+|||+. +
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ 157 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------------TLKPLSEDQARFYFQDLIKGIEYLHYQ---K 157 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-------------CSSCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 99999999999986 67889999999999986643 334689999999999999999999999 9
Q ss_pred ceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCC---CCCchhHHHHHHHHHHHHc
Q 037623 656 IVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELIT 732 (749)
Q Consensus 656 IiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~k~DVwSfGvvL~Ellt 732 (749)
|+||||||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+.. .+.++|||||||++|||++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999999999876432 22233457999999999997765 4788999999999999999
Q ss_pred CCCCCCCCC
Q 037623 733 GQPVIQKTP 741 (749)
Q Consensus 733 G~~pf~~~~ 741 (749)
|+.||....
T Consensus 236 g~~pf~~~~ 244 (298)
T 2zv2_A 236 GQCPFMDER 244 (298)
T ss_dssp SSCSSCCSS
T ss_pred CCCCCCCcc
Confidence 999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=321.41 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=175.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||+||+++.. ++.||+|++..... ...+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 344578999999999999984 58899999975432 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|..++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 267 ~~gg~L~~~l~~~~--------~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 267 MNGGDIRYHIYNVD--------EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp CTTCBHHHHHHTSS--------TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCCCHHHHHHHhh--------cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecce
Confidence 99999999985421 1245689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 336 a~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 336 AVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred eeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 98764322 22234579999999999999999999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=300.74 Aligned_cols=195 Identities=29% Similarity=0.420 Sum_probs=164.3
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHh--cCCCceeEEEEEEec----CCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR--AHHKNLTILVGYCDE----NTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--l~H~nIv~l~g~~~~----~~~~~LV~ 599 (749)
.+.+.+.||+|+||+||+|+.+++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....++||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 4566789999999999999999999999998754 33556677777766 799999999998654 35688999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceeeCCCCCcEEEcCC
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH--------DGCKPPIVHRDVKSANILLNEK 671 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH--------~~~~~gIiHrDLkp~NILl~~~ 671 (749)
||+++|+|.+++. ...+++..+++++.|+++||+||| +. +|+||||||+|||++++
T Consensus 86 e~~~~g~L~~~l~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ-------------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN 149 (301)
T ss_dssp CCCTTCBHHHHHT-------------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT
T ss_pred hhccCCCHHHHHh-------------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC
Confidence 9999999999993 236899999999999999999999 66 99999999999999999
Q ss_pred CcEEEEecCCCccccCCCCcee--eeccccCCcccCccccccC------CCCCchhHHHHHHHHHHHHcC----------
Q 037623 672 FQAKLADFGLSRIFPVEGGSHV--STTVVGTPGYLDPEYYISN------RLTEKSDVYSFGVVLLELITG---------- 733 (749)
Q Consensus 672 ~~~kL~DFGla~~~~~~~~~~~--~~~~~gt~~y~APE~~~~~------~~s~k~DVwSfGvvL~ElltG---------- 733 (749)
+.+||+|||+++.......... .....||+.|+|||.+.+. .++.++|||||||++|||+||
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 9999999999986644322211 2234699999999999876 455799999999999999999
Q ss_pred CCCCCC
Q 037623 734 QPVIQK 739 (749)
Q Consensus 734 ~~pf~~ 739 (749)
+.||..
T Consensus 230 ~~pf~~ 235 (301)
T 3q4u_A 230 KPPFYD 235 (301)
T ss_dssp CCTTTT
T ss_pred cccccc
Confidence 888865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=295.75 Aligned_cols=199 Identities=32% Similarity=0.519 Sum_probs=162.6
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCch----hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSV----QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.+.+.+.||+|+||.||+|+..++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred heeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 355678999999999999999999999999875432 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC--------CCc
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--------KFQ 673 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--------~~~ 673 (749)
+++++|.+++. ...+++..+..++.|+++||+|||++...+|+||||||+|||+++ ++.
T Consensus 88 ~~~~~L~~~~~-------------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 88 ARGGPLNRVLS-------------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp CTTEEHHHHHT-------------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred CCCCCHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999882 346899999999999999999999983233999999999999986 678
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+||+|||+++...... .....|++.|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus 155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred eEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998654321 224468999999999999999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.12 Aligned_cols=215 Identities=28% Similarity=0.458 Sum_probs=175.3
Q ss_pred HhhcccccccccCceEEEEEEE-------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~-------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||.||+|+. .+..||||++.... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 4556678999999999999986 12579999997542 33457799999999999 999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCC-----------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCC
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTD-----------AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSA 664 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~-----------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~ 664 (749)
++||||+++|+|.+++.......... .......+++..++.++.|+++||+|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 99999999999999996542211000 011224589999999999999999999999 9999999999
Q ss_pred cEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 665 NILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 665 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999987754433333344567889999999999999999999999999999998 9999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.67 Aligned_cols=197 Identities=29% Similarity=0.460 Sum_probs=157.7
Q ss_pred hhcccccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|+..+ +.||||++.... ..+.+.+|++++.+++|+||+++++++...+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 35667899999999999999854 779999997653 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEEEEecC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAKLADFG 680 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~kL~DFG 680 (749)
+|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 132 ~~~L~~~l~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 132 GGELFDRIV------------EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp SCBHHHHHT------------TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred CCCHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 999999983 234589999999999999999999999 9999999999999975 8899999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 197 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 197 LSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred cccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 99865322 222345689999999999999999999999999999999999999976543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.74 Aligned_cols=215 Identities=28% Similarity=0.403 Sum_probs=178.5
Q ss_pred HhhcccccccccCceEEEEEEE-------CCcccEEEEecCCch-hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSV-QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~-------~~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||.||+|+. .++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 3456778999999999999985 236799999976533 4457899999999999 999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCC------CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILP------TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~------~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
++||||+++|+|.+++........ .........+++..+++++.|+++||+|||+. +|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 999999999999999975421100 00011234589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||+| |+.||.....
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999987755433333344557889999999999999999999999999999999 9999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.08 Aligned_cols=215 Identities=28% Similarity=0.408 Sum_probs=177.4
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.+.+.+.||+|+||.||+|+.. +..||||++... .....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 4556789999999999999862 267999999764 34456788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCC------------CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCc
Q 037623 598 VYEFMANGNLQAHLLAQLAILP------------TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSAN 665 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~------------~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~N 665 (749)
||||+++|+|.+++........ .........+++..+++++.|+++||+|||++ +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 9999999999999975422000 00001234589999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 666 ILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 666 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.||.+...+
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987654332222334457889999999999999999999999999999999 99999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=321.46 Aligned_cols=201 Identities=28% Similarity=0.465 Sum_probs=172.4
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|+..+ ..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 45567899999999999999864 789999998654 34678999999999999999999999987 5678999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++... ....+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 267 g~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 267 GSLLDFLKSD----------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CBHHHHHHSH----------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 9999999643 223578899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
..... ........++..|+|||++..+.++.++|||||||++|||+| |+.||.+...
T Consensus 334 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 334 IEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp BCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 53211 111123346778999999999999999999999999999999 9999987544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=305.45 Aligned_cols=201 Identities=26% Similarity=0.428 Sum_probs=168.5
Q ss_pred hcccccccccCceEEEEEEECC--cc----cEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQ----VAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+.+.+.||+|+||+||+|+... +. ||+|.+.... ....+.+.+|+.++.+++|+||+++++++. ++..++|+
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 4556899999999999998743 33 7788775442 333456789999999999999999999986 45688999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 94 e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 94 QYLPLGSLLDHVRQ-----------HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp ECCTTCBSHHHHHS-----------SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSC
T ss_pred EeCCCCCHHHHHHH-----------ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCC
Confidence 99999999999953 234688899999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++.+.............++..|+|||.+.+..++.++|||||||++|||+| |+.||.+...
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 99998755443333445568889999999999999999999999999999999 9999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.59 Aligned_cols=202 Identities=29% Similarity=0.468 Sum_probs=161.5
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcC-CCceeEEEEEEecC--CeeE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAH-HKNLTILVGYCDEN--TKMG 596 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~--~~~~ 596 (749)
...|.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+.++.++. |+||+++++++... ...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 345677899999999999999874 588999998653 3445567889999999997 99999999999754 3789
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+|||||+ |+|..++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||
T Consensus 88 lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-------------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEEECCS-EEHHHHHHH-------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEecccC-cCHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEe
Confidence 9999997 689888843 3588999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCC-------------------CceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 677 ADFGLSRIFPVEG-------------------GSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 677 ~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
+|||+++.+.... .........||+.|+|||++.+ ..++.++|||||||+++||++|++|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999998653211 1112234579999999999986 6789999999999999999999999
Q ss_pred CCCCCc
Q 037623 737 IQKTPE 742 (749)
Q Consensus 737 f~~~~~ 742 (749)
|.+.+.
T Consensus 231 f~~~~~ 236 (388)
T 3oz6_A 231 FPGSST 236 (388)
T ss_dssp CCCSSH
T ss_pred CCCCCH
Confidence 987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.53 Aligned_cols=191 Identities=27% Similarity=0.383 Sum_probs=149.9
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
+.||+|+||.||+|+.. ++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999985 588999998643 3456789999999997 99999999999999999999999999999
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---cEEEEecCCCcc
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF---QAKLADFGLSRI 684 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~---~~kL~DFGla~~ 684 (749)
.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 94 ~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 94 FERIKK------------KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp HHHHHH------------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred HHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999953 34689999999999999999999999 999999999999998665 899999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.... ........+|+.|+|||++.+..++.++|||||||+++||++|+.||...+
T Consensus 159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 5432 222234568999999999999999999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=296.58 Aligned_cols=201 Identities=25% Similarity=0.279 Sum_probs=167.5
Q ss_pred HHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 037623 520 ANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTK 594 (749)
Q Consensus 520 ~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~ 594 (749)
.++....+...+.||+|+||+||+|+.. ++.||||++.... .....++..|+..+.++ +|+||++++++|.+++.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 4556667888899999999999999985 5889999986542 23344556666666665 99999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++||||+ +++|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW-----------GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH-----------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCE
T ss_pred EEEEEecc-CCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence 99999999 77999988643 34689999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..
T Consensus 197 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 197 KLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred EEccceeeeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999865432 22234569999999998875 789999999999999999999766543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.18 Aligned_cols=199 Identities=25% Similarity=0.403 Sum_probs=167.7
Q ss_pred hcccccccccCceEEEEEEEC-CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||+||+|+.. ++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 556789999999999999985 58899999875532 224678899999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+ +|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~-~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 84 Q-DLKKLLDV-----------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp E-EHHHHHHT-----------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred C-CHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 5 89888853 235688999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
..... ........+|+.|+|||.+.+. .++.++|||||||+++||++|+.||.+.++
T Consensus 149 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 149 AFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65422 1122344689999999999764 589999999999999999999999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.39 Aligned_cols=197 Identities=29% Similarity=0.479 Sum_probs=164.0
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
.+.+.+.||+|+||.||+|+..++.||||++.... ..+.|.+|++++.+++||||+++++++.+ ..++||||+++|
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred HeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 35567899999999999999999999999987543 45789999999999999999999998873 478999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc-EEEEecCCCcc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-AKLADFGLSRI 684 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~-~kL~DFGla~~ 684 (749)
+|.+++... .....+++..+++++.|+++||+|||+.+..+|+||||||+|||+++++. +||+|||+++.
T Consensus 85 ~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 85 SLYNVLHGA---------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp BHHHHHHCS---------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred CHHHHHhcc---------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999542 12335789999999999999999999943339999999999999998876 79999999976
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
.... .....||+.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 5321 22345899999999999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=298.93 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=175.7
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchh------hHHHHHHHHHHHHhcCCCceeEEEEEEecCCee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ------GYKQFQAEVELLMRAHHKNLTILVGYCDENTKM 595 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~ 595 (749)
...|.+.+.||+|+||.||+|+.. ++.||+|++...... ..+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345778899999999999999984 588999998754321 356799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF--- 672 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~--- 672 (749)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++
T Consensus 91 ~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ------------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp EEEECCCCSCBHHHHHHT------------CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred EEEEEcCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCc
Confidence 999999999999999942 34688999999999999999999999 999999999999999887
Q ss_pred -cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 673 -QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 673 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp CCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 79999999998764321 22345689999999999999999999999999999999999999976543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.37 Aligned_cols=201 Identities=28% Similarity=0.459 Sum_probs=171.1
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+++..+ ..||+|++...... .+++.+|++++.+++|+||+++++++.+.+..++||||+++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 45667899999999999999876 57999999865433 46789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++.. ....+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 104 ~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 104 GCLLNYLRE-----------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp CBHHHHHHC-----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred CcHHHHHHH-----------hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccc
Confidence 999999953 234589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
..... ........+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 170 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 170 VLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp BCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 53221 111223346778999999999999999999999999999998 9999986543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.12 Aligned_cols=202 Identities=25% Similarity=0.322 Sum_probs=174.6
Q ss_pred HHHHHhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcC-----CCceeEEEEEEecCC
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-----HKNLTILVGYCDENT 593 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-----H~nIv~l~g~~~~~~ 593 (749)
++....|.+.+.||+|+||+||+|+. +++.||||++... ....+.+..|++++.+++ |+||+++++++...+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 33444566779999999999999998 4588999999754 334467788999999986 999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--- 670 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--- 670 (749)
..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRN----------NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 999999999 99999999643 334589999999999999999999999 9999999999999975
Q ss_pred ----------------------CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHH
Q 037623 671 ----------------------KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLL 728 (749)
Q Consensus 671 ----------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ 728 (749)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999864322 23456899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCc
Q 037623 729 ELITGQPVIQKTPE 742 (749)
Q Consensus 729 ElltG~~pf~~~~~ 742 (749)
||++|+.||...+.
T Consensus 251 ell~g~~pf~~~~~ 264 (360)
T 3llt_A 251 ELYTGSLLFRTHEH 264 (360)
T ss_dssp HHHHSSCSCCCSSH
T ss_pred HHHHCCCCCCCCcH
Confidence 99999999987554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.31 Aligned_cols=202 Identities=36% Similarity=0.567 Sum_probs=160.7
Q ss_pred HHhhcccccccccCceEEEEEEECCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
...+.+.+.||+|+||+||+|+..+ .||||+++.. .....+.|.+|++++++++|+||+++++++ .....++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 3445667899999999999998755 5999998754 344567899999999999999999999976 45668999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 101 ~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 101 CEGSSLYHHLHA-----------SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp CCEEEHHHHHTT-----------C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred cCCCcHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence 999999999842 345689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++...............||+.|+|||.+. ...++.++||||||++++||++|+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 98664333233334456899999999986 6678889999999999999999999998644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.16 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=162.3
Q ss_pred HhhcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
..+.+.+.||+|+||.||+|+... ..||+|++... .....+.+.+|+.++.+++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 356677899999999999998742 45999998764 3344577999999999999999999999985 5678899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 94 ~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 94 MELCTLGELRSFLQV-----------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EECCTTEEHHHHHHH-----------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred EecCCCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence 999999999999954 234589999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
||+++...... ........+++.|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 160 FGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cccccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 99998764321 112223356789999999999999999999999999999997 99999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.08 Aligned_cols=200 Identities=28% Similarity=0.462 Sum_probs=153.9
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 55678999999999999997 458899999865422 2246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 93 CHNGEMNRYLKN-----------RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp CTTEEHHHHHHT-----------CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred CCCCcHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecc
Confidence 999999999853 235689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+....... .......|++.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 159 ATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred eeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 98764321 112235689999999999999999999999999999999999999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.90 Aligned_cols=197 Identities=21% Similarity=0.350 Sum_probs=170.9
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--CeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~~~LV~Ey 601 (749)
.+.+.+.||+|+||.||+|+.+++.||||++... .....+.+.+|+.++.+++||||+++++++... ...++||||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred HhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 4566789999999999999999999999999765 334457899999999999999999999999876 788999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeeCCCCCcEEEcCCCcEEEEec
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP--IVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g--IiHrDLkp~NILl~~~~~~kL~DF 679 (749)
+++|+|.+++... ....+++..++.++.|+++||+|||+. + |+||||||+|||+++++.++|+||
T Consensus 91 ~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 91 MPYGSLYNVLHEG----------TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp CTTCBHHHHHHSC----------SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCcHHHHHhhc----------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEec
Confidence 9999999999532 233689999999999999999999997 6 999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTE---KSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~---k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|++..... ....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 98764322 2345889999999998766554 79999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.96 Aligned_cols=216 Identities=26% Similarity=0.357 Sum_probs=171.1
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCC-----chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-----SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
...|.+.+.||+|+||.||+|+.. +..||+|++... .....+.+.+|++++.+++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 345677899999999999999884 478999998643 2344578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCC----------------------------CCccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 037623 597 LVYEFMANGNLQAHLLAQLAILP----------------------------TDAEDKTGILSWKGRLQIATESAQGLEYL 648 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~----------------------------~~~~~~~~~l~~~~~l~ia~~ia~gL~yL 648 (749)
+||||+++|+|.+++........ .........+++..+..++.|+++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842111000 00001122346778889999999999999
Q ss_pred HhCCCCCceeeCCCCCcEEEcCCC--cEEEEecCCCccccCCCCc--eeeeccccCCcccCcccccc--CCCCCchhHHH
Q 037623 649 HDGCKPPIVHRDVKSANILLNEKF--QAKLADFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYS 722 (749)
Q Consensus 649 H~~~~~gIiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwS 722 (749)
|+. +|+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999 999999999999998776 8999999999876432211 12334569999999999975 67899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCc
Q 037623 723 FGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 723 fGvvL~ElltG~~pf~~~~~ 742 (749)
|||++|||++|+.||.....
T Consensus 262 lG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999987544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.61 Aligned_cols=201 Identities=31% Similarity=0.484 Sum_probs=168.3
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|...+ ..||||+++.... ..++|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 35567899999999999999976 6799999986543 34689999999999999999999999976 678999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++... ....+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 263 gsL~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 263 GSLLDFLKGE----------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp CBHHHHHSHH----------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 9999999542 224589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
..... ........++..|+|||.+..+.++.++|||||||++|||++ |+.||.+...
T Consensus 330 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 330 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 64321 111223346789999999999999999999999999999999 9999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=293.82 Aligned_cols=195 Identities=26% Similarity=0.354 Sum_probs=167.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++.+++|+||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 556789999999999999984 4789999987543 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++ +|.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~-~l~~~~~~-----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 84 DQ-DLKKYFDS-----------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SE-EHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CC-CHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 75 66666643 235689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
+..... ........+|+.|+|||.+.+.. ++.++|||||||+++||++|..||.
T Consensus 149 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 149 RAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp EECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 876432 12223456899999999998766 7999999999999999999888753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=302.06 Aligned_cols=195 Identities=31% Similarity=0.445 Sum_probs=169.8
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+...+.||+|+||+||+|+. +++.||||++.... ....+++.+|++++.+++||||+++++++...+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 456678999999999999996 45889999987542 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|++ |+|.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 135 ~~~-g~l~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 135 YCL-GSASDLLEVH-----------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp CCS-EEHHHHHHHH-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred cCC-CCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 997 6888888532 34689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++..... ....||+.|+|||++. .+.++.++|||||||+++||++|+.||...+
T Consensus 200 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp TCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865322 2346899999999984 5678999999999999999999999997644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.01 Aligned_cols=206 Identities=29% Similarity=0.398 Sum_probs=168.8
Q ss_pred HHHHHhhcccccccccCceEEEEEEE--CCcccEEEEecCCch-----hhHHHHHHHHHHHHhcC---CCceeEEEEEEe
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV-----QGYKQFQAEVELLMRAH---HKNLTILVGYCD 590 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~l~---H~nIv~l~g~~~ 590 (749)
++....|.+.+.||+|+||+||+|+. +++.||||++..... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34445677789999999999999996 458899999864321 11245677777777664 999999999997
Q ss_pred cCC-----eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCc
Q 037623 591 ENT-----KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSAN 665 (749)
Q Consensus 591 ~~~-----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~N 665 (749)
... ..++||||++ |+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~N 150 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA----------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPEN 150 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC----------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTT
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence 654 5789999997 6999998542 234489999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 666 ILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 666 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
||+++++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++.
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred EEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999876432 2224457899999999999999999999999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.61 Aligned_cols=198 Identities=26% Similarity=0.378 Sum_probs=162.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||+||+++.. ++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4667799999999999999984 58899999976533 23678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc--EEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--AKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~--~kL~DFGl 681 (749)
+|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~L~~~l~~~------------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 100 GGELYERICNA------------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp SCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred CCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 99999998542 3589999999999999999999999 9999999999999987765 99999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEK-SDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k-~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++..... .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.....
T Consensus 165 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 165 SKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 9853221 12234569999999999988887665 8999999999999999999986543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.54 Aligned_cols=196 Identities=24% Similarity=0.377 Sum_probs=169.7
Q ss_pred HhhcccccccccCceEEEEEEECC---------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD---------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||+||+|+... ..||+|++........+.+.+|++++.+++|+||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 345677899999999999998743 35999999877666678899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc--
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-- 673 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~-- 673 (749)
++||||+++|+|.+++... ...+++..+++++.|+++||+|||++ +|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN-----------KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred EEEEECCCCCCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 9999999999999999642 23489999999999999999999999 9999999999999998876
Q ss_pred ------EEEEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcC-CCCCCCC
Q 037623 674 ------AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITG-QPVIQKT 740 (749)
Q Consensus 674 ------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG-~~pf~~~ 740 (749)
+||+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++| .+|+...
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 99999999975422 123457889999999987 7799999999999999999995 4555443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=331.56 Aligned_cols=202 Identities=29% Similarity=0.399 Sum_probs=175.7
Q ss_pred hhcccccccccCceEEEEEEECC--cccEEEEecCCc---hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSS---VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+|+..+ +.||||+++... ....+.+..|..++..+ +|++|+.+++++.+.+..+|||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 45667899999999999999854 679999987532 23346778899999887 7999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|..++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++++||+||
T Consensus 422 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQV------------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCC
T ss_pred eCcCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeec
Confidence 999999999999642 3589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+++..... ........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+
T Consensus 487 Gla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~ 549 (674)
T 3pfq_A 487 GMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549 (674)
T ss_dssp TTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH
Confidence 999864322 222345679999999999999999999999999999999999999998765543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=292.11 Aligned_cols=202 Identities=29% Similarity=0.412 Sum_probs=170.2
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..+.+.+.||+|+||.||+++.. +..||+|++.... ....+.+.+|++++.+++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 35777899999999999999974 4789999987543 23457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcEEEEe
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLAD 678 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~kL~D 678 (749)
+++|+|.+++..... ....+++..+.+++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 102 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 102 CEGGELLERIVSAQA--------RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp CSCCBHHHHHHHHHH--------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CCCCcHHHHHHhhhh--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999965421 345689999999999999999999999 99999999999999 4567899999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+++..... .......|++.|+|||.+. +.++.++||||||++++||++|+.||.+..
T Consensus 171 fg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 171 FGLAELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp CCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 9999865432 2223456899999999875 568999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.14 Aligned_cols=197 Identities=24% Similarity=0.355 Sum_probs=163.6
Q ss_pred hcccccccccCceEEEEEEECC-cccEEEEecCC--chhhHHHHHHHHHHHHhcCC--CceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHH--KNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H--~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||.||++...+ +.||||++... .....+.+.+|++++.+++| +||+++++++...+..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 5567899999999999998754 77999998754 34455789999999999976 999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+.+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 90 ~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 90 CGNIDLNSWLKK------------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp CCSEEHHHHHHH------------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred CCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccc
Confidence 568899999953 34688999999999999999999999 999999999999997 56899999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----------NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 987654433333345579999999999865 67899999999999999999999999763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=292.85 Aligned_cols=199 Identities=20% Similarity=0.286 Sum_probs=172.1
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+|+. +++.||||++..... .+.+.+|++++.++ +|+|++++++++......++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 456678999999999999996 458899999865432 35678999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc-----EEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-----AKLA 677 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~-----~kL~ 677 (749)
+++|.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+|||++.++. +||+
T Consensus 89 -~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 89 -GPSLEDLLDLC-----------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp -CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred -CCCHHHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999542 34589999999999999999999998 9999999999999987766 9999
Q ss_pred ecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 99999876543221 12234569999999999999999999999999999999999999998743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=297.73 Aligned_cols=200 Identities=27% Similarity=0.430 Sum_probs=166.7
Q ss_pred hcc-cccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNF-ERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f-~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+ .+.||+|+||+||+|+. +++.||||++........+.+.+|++++.++ +|+||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 444 37899999999999986 4588999999876555567899999999985 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc---EEEEec
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ---AKLADF 679 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~---~kL~DF 679 (749)
++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 94 ~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 94 RGGSILSHIHKR------------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp TTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred CCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 999999999642 3588999999999999999999999 9999999999999998775 999999
Q ss_pred CCCccccCCCCc-----eeeeccccCCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYIS-----NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~-----~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+++........ .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 999865432211 11123458999999999875 568899999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=300.48 Aligned_cols=216 Identities=28% Similarity=0.404 Sum_probs=177.0
Q ss_pred HHhhcccccccccCceEEEEEEEC---------CcccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD---------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN 592 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~ 592 (749)
...+.+.+.||+|+||.||+|+.. +..||||++... .....+++.+|++++.++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 345667799999999999999863 356999999765 334567899999999999 999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCC----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTD----AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
+..++||||+++|+|.+++.......... .......+++..+++++.|+++||+|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999996532100000 001124589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999999999999987654332222334457889999999999999999999999999999999 9999987543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.66 Aligned_cols=205 Identities=30% Similarity=0.447 Sum_probs=178.2
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
...+.+.+.||+|+||.||+|... +..||+|++.... ...+++.+|++++++++|+||+++++++...+..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 344566789999999999999986 5789999997543 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 91 ~~~~~L~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 91 MTYGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp CTTEEHHHHHHHC----------CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred CCCCcHHHHHHhc----------ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence 9999999999642 345689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
++...... ........+++.|+|||.+.+..++.++||||||++++||++ |+.||...+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 158 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp GGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 98764332 222334457889999999999999999999999999999999 99999875543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.08 Aligned_cols=199 Identities=27% Similarity=0.449 Sum_probs=173.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.|.+.+.||+|+||.||+|... ++.||+|++... .....+.+.+|++++.+++|+||+++++++...+..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3566789999999999999874 578999998654 334457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc---EEEEe
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ---AKLAD 678 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~---~kL~D 678 (749)
+++++|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 87 ~~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 87 VTGGELFEDIVAR------------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp CCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 9999999988542 4589999999999999999999999 9999999999999986655 99999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||++...... .......|++.|+|||.+.+..++.++||||||++++||++|+.||...+.
T Consensus 152 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 152 FGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp CTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeeEEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 9999865432 222345689999999999999999999999999999999999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=316.00 Aligned_cols=199 Identities=28% Similarity=0.441 Sum_probs=174.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3566789999999999999974 68899999875422 234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 97 ~~~gg~L~~~l~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 97 YVSGGELFDYIC------------KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp CCSSEEHHHHTT------------SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCCCCcHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence 999999999983 345689999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+.
T Consensus 162 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 162 LSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp SCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred chhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 99876432 22334579999999999988765 6899999999999999999999987554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=304.86 Aligned_cols=200 Identities=21% Similarity=0.255 Sum_probs=164.7
Q ss_pred hhcccccccccCceEEEEEEECC-------cccEEEEecCCchhhH-----------HHHHHHHHHHHhcCCCceeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQGY-----------KQFQAEVELLMRAHHKNLTILVG 587 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~~~~~-----------~~f~~Ei~iL~~l~H~nIv~l~g 587 (749)
.+.+.+.||+|+||.||+|++.. +.||||++........ ..+..|+..+.+++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 56677999999999999998743 6799999876542211 12345566677788999999999
Q ss_pred EEecC----CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCC
Q 037623 588 YCDEN----TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKS 663 (749)
Q Consensus 588 ~~~~~----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp 663 (749)
++... ...+|||||+ +++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp 180 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-----------NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKA 180 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHH-----------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCH
Confidence 98764 4589999999 9999999954 235689999999999999999999999 999999999
Q ss_pred CcEEEc--CCCcEEEEecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 664 ANILLN--EKFQAKLADFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 664 ~NILl~--~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
+|||++ +++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 8899999999999876432211 111234599999999999999999999999999999999999999
Q ss_pred CCCC
Q 037623 737 IQKT 740 (749)
Q Consensus 737 f~~~ 740 (749)
|.+.
T Consensus 261 f~~~ 264 (364)
T 3op5_A 261 WEDN 264 (364)
T ss_dssp TGGG
T ss_pred cccc
Confidence 9863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=299.89 Aligned_cols=213 Identities=26% Similarity=0.410 Sum_probs=176.7
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
..+.+.+.||+|+||.||+|+.. ++.||||++.... .....++.+|++++.+++|+||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 34667799999999999999764 3679999997553 344567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++........ .......+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMA--NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHH--HCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEeCCCCcHHHHHHHhchhhc--cCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence 99999999999999965421100 001224578999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 99999986643322222223456889999999999999999999999999999999 8999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=289.67 Aligned_cols=203 Identities=25% Similarity=0.397 Sum_probs=174.7
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 35667789999999999999984 5889999986543 33457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~L~~~l~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 87 CSGGELFDRIE------------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp CTTEEGGGGSB------------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCcHHHHHh------------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999988873 334689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+................|++.|+|||.+.+..+ +.++||||||++++||++|+.||.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 987643322222334568999999999987765 7899999999999999999999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.57 Aligned_cols=199 Identities=25% Similarity=0.346 Sum_probs=167.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|++++.+++|+||+++++++...+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 556789999999999999985 58899999865432 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 85 ~~~~l~~~~~------------~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 85 DHTVLHELDR------------YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp SEEHHHHHHH------------TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCchHHHHHh------------hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 9999988874 234589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+...... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.+...
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 150 RLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 8764321 22234568999999999976 5689999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.63 Aligned_cols=215 Identities=27% Similarity=0.418 Sum_probs=177.9
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||.||+|...+ ..||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 345667899999999999999743 369999997653 34457799999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDA--EDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~--~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
++||||+++|+|.+++........... ......+++..++.++.|+++||+|||+. +|+||||||+|||+++++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCe
Confidence 999999999999999975432111100 01134689999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||.+...
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99999999987654433333334557889999999999999999999999999999999 9999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=315.96 Aligned_cols=196 Identities=27% Similarity=0.350 Sum_probs=163.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~ 595 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++... .....+++.+|+.++++++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3556789999999999999874 588999999754 334467789999999999999999999999654 467
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+|
T Consensus 143 ~lv~E~~~~-~l~~~~~--------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp EEEEECCSE-EHHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCC-CHHHHHh--------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEE
Confidence 999999976 4666652 2388999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||.+.+.
T Consensus 205 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 205 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp ECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999875432 223446799999999999999999999999999999999999999987653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=290.20 Aligned_cols=201 Identities=25% Similarity=0.400 Sum_probs=173.0
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCch------hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV------QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM 595 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~ 595 (749)
...+.+.+.||+|+||.||+++.. ++.||+|++..... ...+.+.+|+.++.+++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345777899999999999999985 58899999875422 1357899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC---
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF--- 672 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~--- 672 (749)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK------------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSS
T ss_pred EEEEeecCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCC
Confidence 9999999999999999532 3589999999999999999999999 999999999999999877
Q ss_pred -cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 673 -QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 673 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 149 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CceEEEecccceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 8999999999865432 122344689999999999999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=312.01 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=156.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-----CCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-----NTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-----~~~~~ 596 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++... .....+++.+|+++|.+++|+||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4667799999999999999874 588999998654 34456789999999999999999999999843 35789
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+ +|+|..++. ....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||
T Consensus 134 lv~e~~-~~~L~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR------------TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EEECCC-SEEHHHHHH------------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEecc-ccchhhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEee
Confidence 999998 578998884 345689999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCc-------------------------eeeeccccCCcccCcccc-ccCCCCCchhHHHHHHHHHHH
Q 037623 677 ADFGLSRIFPVEGGS-------------------------HVSTTVVGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLEL 730 (749)
Q Consensus 677 ~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~~-~~~~~s~k~DVwSfGvvL~El 730 (749)
+|||+++........ .......||+.|+|||++ ....++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876432211 122345689999999986 456799999999999999999
Q ss_pred Hc-----------CCCCCCCC
Q 037623 731 IT-----------GQPVIQKT 740 (749)
Q Consensus 731 lt-----------G~~pf~~~ 740 (749)
++ |+++|.+.
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGS 298 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--
T ss_pred HHhccccccccccccccCCCC
Confidence 99 66777553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.96 Aligned_cols=200 Identities=27% Similarity=0.375 Sum_probs=169.7
Q ss_pred hhcccccccccCceEEEEEEE-----CCcccEEEEecCCc----hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 526 TNNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS----VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
.+.+.+.||+|+||.||+++. +++.||||+++... ....+.+.+|++++.++ +|+||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 466779999999999999987 45889999987542 22345678899999999 699999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+|
T Consensus 135 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQR------------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp EEEECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEeecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEE
Confidence 9999999999999999542 3588999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 200 l~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 200 LTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp ESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred EeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 99999998653221 222234569999999999985 347899999999999999999999997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.41 Aligned_cols=191 Identities=27% Similarity=0.408 Sum_probs=158.0
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHh-cCCCceeEEEEEEec----CCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKNLTILVGYCDE----NTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~-l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 603 (749)
+.||+|+||+||+++.. ++.||||++... ..+.+|++++.+ .+|+||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999984 578999998643 456788888754 589999999999865 567899999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEEEEecC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAKLADFG 680 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~kL~DFG 680 (749)
+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 143 gg~L~~~l~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 143 GGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp SEEHHHHHHCC-------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcHHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999532 234689999999999999999999998 9999999999999997 7899999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99865322 222345689999999999999999999999999999999999999976543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.35 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=174.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+++.. ++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 3556789999999999999985 478999998654 23445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.. ...+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 96 ~~~~~~L~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 96 LCRRRSLLELHKR------------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp CCTTCBHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999998853 24589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++...... .......|++.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 161 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 161 LATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764322 22234568999999999999999999999999999999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=294.77 Aligned_cols=200 Identities=29% Similarity=0.486 Sum_probs=172.4
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
...+.+.+.||+|+||.||+++.. ++.||+|++........+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 346777899999999999999974 588999999876555556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcEEEEe
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLAD 678 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~kL~D 678 (749)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|
T Consensus 88 ~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 88 VSGGELFDRILER------------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp CCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred CCCccHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence 9999999998542 3588999999999999999999999 99999999999999 7788999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+++..... ......|++.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 153 FGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp CSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999754321 12234589999999999999999999999999999999999999976543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=298.93 Aligned_cols=202 Identities=30% Similarity=0.464 Sum_probs=166.2
Q ss_pred hcccccccccCceEEEEEEECC------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+.+.+.||+|+||+||+|+... ..||||++.... ......+.+|++++.+++|+||+++++++...+..++||
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 4456899999999999998743 249999997653 344567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 126 e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 126 EYMENGALDKFLRE-----------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp ECCTTEEHHHHHHH-----------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eCCCCCcHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence 99999999999954 234689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 9998764332111 1122346788999999999999999999999999999999 9999976543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.22 Aligned_cols=195 Identities=34% Similarity=0.581 Sum_probs=166.3
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhh-------HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQG-------YKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~-------~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
.+.+.+.||+|+||.||+|+.. ++.||+|++....... .+.+.+|++++.+++|+||+++++++.+.. +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 4566789999999999999984 5889999986543221 267899999999999999999999997655 6
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeeCCCCCcEEEcCCCc-
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP--IVHRDVKSANILLNEKFQ- 673 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g--IiHrDLkp~NILl~~~~~- 673 (749)
+||||+++|+|.+++.. ....+++..+++++.|+++||+|||+. + |+||||||+|||++.++.
T Consensus 98 lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLD-----------KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp EEEECCTTCBHHHHHHC-----------TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred EEEEecCCCCHHHHHhc-----------ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence 99999999999998853 345689999999999999999999998 7 999999999999988776
Q ss_pred ----EEEEecCCCccccCCCCceeeeccccCCcccCcccc--ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 674 ----AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYY--ISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 674 ----~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+||+|||+++.... ......|++.|+|||.+ ....++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999999985322 23345689999999998 45567899999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=305.20 Aligned_cols=197 Identities=24% Similarity=0.350 Sum_probs=164.8
Q ss_pred hcccccccccCceEEEEEEEC-CcccEEEEecCC--chhhHHHHHHHHHHHHhcC--CCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAH--HKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~--H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||.||++... ++.||||++... .....+.+.+|+.++.+++ |+||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 566789999999999999875 478999998654 3445678999999999996 5999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+.+++|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 137 ~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~ 200 (390)
T 2zmd_A 137 CGNIDLNSWLKK------------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGI 200 (390)
T ss_dssp CCSEEHHHHHHH------------CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred cCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCc
Confidence 568899999953 23678999999999999999999998 999999999999996 57999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----------NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 987654332223345579999999999865 46889999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=292.48 Aligned_cols=197 Identities=31% Similarity=0.461 Sum_probs=169.7
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCCch---hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
+.+.+.||+|+||.||+|+... ..||||++..... ...+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 5567899999999999998854 6799999865422 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~l~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 91 APLGTVYRELQKL------------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp CTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred CCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccc
Confidence 9999999998542 3588999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+...... ......|++.|+|||.+.+..++.++||||||++++||++|+.||...+.
T Consensus 156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 156 SVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp ESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 8654322 22345689999999999999999999999999999999999999986543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=300.74 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=171.6
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCch--------hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV--------QGYKQFQAEVELLMRAHHKNLTILVGYCDENTK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~ 594 (749)
..|.+.+.||+|+||.||+|+. +++.||||++..... ...+.+.+|++++.+++|+||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4566778999999999999986 458899999876532 123467889999999999999999999999999
Q ss_pred eEEEEeeCCCC-CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 595 MGLVYEFMANG-NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 595 ~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
.++||||+.+| +|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID------------RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH------------TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred EEEEEEeCCCCccHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCc
Confidence 99999999777 9999984 334689999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+||+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 169 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 169 IKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp EEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred EEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 9999999998764322 2234568999999999988876 88999999999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=298.37 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=164.5
Q ss_pred hhcccccccccCceEEEEEEEC--Ccc----cEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQ----VAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~----VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.+.+.+.||+|+||.||+|+.. ++. ||+|.+... .....+++.+|+.++.+++||||+++++++.... .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 3556789999999999999873 344 477776543 3345678999999999999999999999998754 7899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
+||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D 160 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp ECCCSSCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred EEecCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence 9999999999999642 34689999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp TTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 999987654333333334457889999999999999999999999999999999 99999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.66 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=174.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+++.. ++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3556789999999999999985 478999998654 23445778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.. ...+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 122 ~~~~~~L~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 122 LCRRRSLLELHKR------------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp CCTTCBHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred cCCCCCHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999998853 24589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 187 LATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 998764322 22234568999999999999999999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=288.95 Aligned_cols=201 Identities=30% Similarity=0.514 Sum_probs=173.5
Q ss_pred hhcccccccccCceEEEEEEEC-CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|+.. ++.||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 4556789999999999999984 47899999986543 346789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 88 ~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 88 GCLSDYLRTQ-----------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp CBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CcHHHHHhhC-----------cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccc
Confidence 9999999542 34688999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
.... .........++..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 154 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 154 VLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp BCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 5321 1111223456788999999999999999999999999999999 8999986543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.29 Aligned_cols=201 Identities=26% Similarity=0.384 Sum_probs=168.6
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+.+.+.||+|+||+||+|+..+ ..||+|.+... .....+.+.+|+.++.+++||||+++++++.+ +..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence 45567899999999999998643 34999998765 34456789999999999999999999999865 4568999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 92 e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 92 ELYPYGELGHYLERN-----------KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp ECCTTCBHHHHHHHH-----------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred ecCCCCCHHHHHHhc-----------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence 999999999999642 34588999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 158 GLSRYIEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred CCCccccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 9998764322 112233457889999999999999999999999999999998 9999976443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=293.79 Aligned_cols=201 Identities=31% Similarity=0.463 Sum_probs=170.2
Q ss_pred HHhhcccccccccCceEEEEEEE------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC--Ce
Q 037623 524 KITNNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN--TK 594 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~--~~ 594 (749)
...+.+.+.||+|+||.||+|++ .++.||||++.... ....+.+.+|++++.+++|+||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 33466678999999999999984 34789999987543 33457889999999999999999999999876 66
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN-----------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred EEEEEEeCCCCcHHHHHHhc-----------cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCE
Confidence 89999999999999999543 34589999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
||+|||+++........ .......+|..|+|||.+.+..++.++||||||++++||++|+.|+.
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999999876543221 22234568888999999999999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=295.67 Aligned_cols=214 Identities=28% Similarity=0.400 Sum_probs=175.0
Q ss_pred HhhcccccccccCceEEEEEEEC-------CcccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCC-e
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENT-K 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~-~ 594 (749)
..+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++.++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 34566789999999999999852 2679999997653 33456789999999999 7999999999987654 5
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.++||||+++|+|.+++......... ........+++..++.++.|+++||+|||+. +|+||||||+|||+++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 89999999999999999643210000 0000123489999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999999987654433333344567889999999999999999999999999999998 999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.23 Aligned_cols=204 Identities=25% Similarity=0.350 Sum_probs=156.9
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEe--------cCCe
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCD--------ENTK 594 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~--------~~~~ 594 (749)
.+.+.+.||+|+||.||+|+. +++.||||++........+.+.+|+.++.++. |+||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 456779999999999999998 55889999987776666788999999999996 999999999993 3456
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeeCCCCCcEEEcCCC
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP--IVHRDVKSANILLNEKF 672 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g--IiHrDLkp~NILl~~~~ 672 (749)
.++|+||++ |+|.+++.... ....+++..+++++.|++.||+|||+. + |+||||||+|||+++++
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME---------SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH---------TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred EEEEEEecC-CCHHHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence 889999995 79999986531 344689999999999999999999998 7 99999999999999999
Q ss_pred cEEEEecCCCccccCCCCce----------eeeccccCCcccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSH----------VSTTVVGTPGYLDPEYY---ISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.+||+|||+++......... ......+|+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998765332111 11134589999999998 566789999999999999999999999976
Q ss_pred CCc
Q 037623 740 TPE 742 (749)
Q Consensus 740 ~~~ 742 (749)
...
T Consensus 256 ~~~ 258 (337)
T 3ll6_A 256 GAK 258 (337)
T ss_dssp ---
T ss_pred hhH
Confidence 443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.57 Aligned_cols=200 Identities=31% Similarity=0.431 Sum_probs=174.3
Q ss_pred hhcccccccccCceEEEEEEE------CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe--cCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD--ENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~--~~~~~~L 597 (749)
.+.+.+.||+|+||.||++++ .++.||||++........+.+.+|++++.+++|+||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 456678999999999999985 34779999998877777788999999999999999999999986 4567889
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 104 v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~ 169 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRH-----------RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHH-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred EEeecCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEc
Confidence 99999999999999643 23589999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 678 DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|||+++......... ......++..|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus 170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 999998765433221 22234578889999999999999999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.50 Aligned_cols=210 Identities=27% Similarity=0.399 Sum_probs=164.6
Q ss_pred HhhcccccccccCceEEEEEEECC-----cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe---
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK--- 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~--- 594 (749)
..+.+.+.||+|+||.||+|+... ..||+|++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 345567899999999999998632 47999998754 33445779999999999999999999999977553
Q ss_pred --eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 595 --MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 595 --~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
.++||||+++|+|.+++..... ......+++..+++++.|+++||.|||+. +|+||||||+|||+++++
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRL------ETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTB------TTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred cccEEEEecccCCCHHHHHHHhhh------hcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 4899999999999999964321 12345799999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 999999999987643322222334457889999999999999999999999999999999 99999876544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=300.46 Aligned_cols=195 Identities=25% Similarity=0.400 Sum_probs=167.9
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
..|.+.+.||+|+||.||+++.. ++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45677899999999999999985 57899999976532 235788888888 799999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC----CcEEEE
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK----FQAKLA 677 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~----~~~kL~ 677 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+
T Consensus 98 ~~gg~L~~~i~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 98 MKGGELLDKILR------------QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp CCSCBHHHHHHT------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred CCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 999999999842 34689999999999999999999999 99999999999998543 359999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 163 DFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 999998764332 2223456899999999998888999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.07 Aligned_cols=200 Identities=27% Similarity=0.430 Sum_probs=168.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++.+++|+||+++++++...+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 3556789999999999999985 5789999986543 23356688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|..++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~l~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 106 VDHTILDDLEL------------FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp CSEEHHHHHHH------------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCcchHHHHHh------------hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence 99999888763 234589999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++.+.... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....+
T Consensus 171 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 171 ARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 98654321 222345689999999999875 789999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=321.60 Aligned_cols=202 Identities=31% Similarity=0.477 Sum_probs=173.0
Q ss_pred HhhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
..+.+.+.||+|+||.||+|++.+ ..||||+++.... ..++|.+|+++|++++|+||+++++++.+ +..++||||++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 345667899999999999999976 6799999986543 34689999999999999999999999976 67899999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.++|... ....+++..+++++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 345 ~gsL~~~l~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 345 KGSLLDFLKGE----------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp TEEHHHHHSHH----------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred CCcHHHHHhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 99999999542 224588999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
...... ........++..|+|||.+....++.++|||||||+||||++ |+.||.+...
T Consensus 412 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 412 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp TCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred ecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 653211 111123346788999999999999999999999999999999 9999987543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=290.10 Aligned_cols=201 Identities=30% Similarity=0.484 Sum_probs=171.6
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||+|+..+ ..||||++..... ..+.+.+|++++.+++|+||+++++++.. +..++||||+++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 45667899999999999999866 6899999876532 35789999999999999999999999864 568999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 92 ~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 92 GSLVDFLKTP----------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp CBHHHHTTSH----------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999998432 123589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
..... ........++..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 159 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 159 IEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp CSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 64321 112223456788999999998999999999999999999999 9999986543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.26 Aligned_cols=197 Identities=26% Similarity=0.455 Sum_probs=169.3
Q ss_pred ccccccCceEEEEEEE----CCcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 531 RVLGKGGFGTVYHGYL----DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~----~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.||+|+||.||+|+. .+..||||++... .....+++.+|++++.+++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 4899999999999986 3467999999865 344567899999999999999999999999 456789999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++.. ....+++..+++++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 95 ~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 95 PLHKFLVG-----------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EHHHHHTT-----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CHHHHHHh-----------CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999842 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcee-eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 686 PVEGGSHV-STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
........ .....+++.|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 54322111 123346889999999998899999999999999999998 9999987544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=304.81 Aligned_cols=202 Identities=33% Similarity=0.499 Sum_probs=161.1
Q ss_pred hcccccccccCceEEEEEEEC--C---cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--D---KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~---~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~LV~ 599 (749)
+.+.+.||+|+||+||+|+.. + ..||||.+... .....++|.+|+.++++++||||++++++|.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 445689999999999999863 2 35899998754 33456789999999999999999999999754 45789999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 171 e~~~~g~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp ECCTTCBHHHHHHC-----------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ECCCCCCHHHHHhh-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence 99999999999953 334578999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCc--eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++.+...... .......+++.|+|||.+.+..++.++|||||||++|||+| |.+||...+.
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 999866432211 11223457789999999999999999999999999999999 7788876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.66 Aligned_cols=203 Identities=33% Similarity=0.499 Sum_probs=168.3
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEe-cCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCD-ENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~-~~~~~~LV 598 (749)
.+.+.+.||+|+||+||+|+..+ ..+|+|.+... .....+++.+|+.++++++||||+++++++. .++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 35567899999999999998633 24899998764 3345678999999999999999999999975 45678999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++.. ....+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 106 ~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 106 LPYMKHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp EECCTTCBHHHHHHC-----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred EeCCCCCCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence 999999999999953 345678999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCC--ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 679 FGLSRIFPVEGG--SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+++....... ........+++.|+|||.+.+..++.++||||||++++||++ |.+||...+.
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 999986643221 112233457889999999999999999999999999999999 6677766543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=322.14 Aligned_cols=197 Identities=25% Similarity=0.453 Sum_probs=165.6
Q ss_pred cccccCceEEEEEEEC----CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 532 VLGKGGFGTVYHGYLD----DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
.||+|+||.||+|.+. +..||||+++... ....++|.+|++++.+++|+||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999873 2569999998653 3456789999999999999999999999976 56899999999999
Q ss_pred HHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcccc
Q 037623 607 LQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686 (749)
Q Consensus 607 L~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 686 (749)
|.+++.. ....+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 422 L~~~l~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 422 LHKFLVG-----------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp HHHHHTT-----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred HHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999942 345689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 687 VEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 687 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 332111 1122335689999999999999999999999999999998 99999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=308.87 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=161.9
Q ss_pred HHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc--------hhhHHHHHHHHHHHHhcCCCceeEEEEEEec
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--------VQGYKQFQAEVELLMRAHHKNLTILVGYCDE 591 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~ 591 (749)
.....|.+.+.||+|+||+||+|... ++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34456777899999999999999884 4789999987532 1122358899999999999999999999864
Q ss_pred CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC
Q 037623 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK 671 (749)
Q Consensus 592 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~ 671 (749)
+..++||||+++|+|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV------------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS------------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSS
T ss_pred -CceEEEEEcCCCCcHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecC
Confidence 56899999999999988773 345689999999999999999999999 99999999999999754
Q ss_pred C---cEEEEecCCCccccCCCCceeeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 672 F---QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 672 ~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+ .+||+|||+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 4 5999999999876422 22344579999999999853 567889999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-32 Score=289.44 Aligned_cols=197 Identities=30% Similarity=0.477 Sum_probs=173.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
+...+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++.+++|+||+++++++......++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 455689999999999999874 5889999987553 3446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 104 ~~~L~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 104 GGSALDLLE-------------PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEHHHHHT-------------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCcHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccce
Confidence 999999983 24689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
...... .......|++.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 168 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 168 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 764321 12234568999999999999999999999999999999999999997644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=287.04 Aligned_cols=194 Identities=29% Similarity=0.492 Sum_probs=166.4
Q ss_pred hcccccccccCceEEEEEEECC--cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE----NTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----~~~~~LV 598 (749)
+.+.+.||+|+||.||+|.... ..||+|++... .....+.+.+|+.++.+++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 3456789999999999999854 67999998754 34456789999999999999999999998864 4568999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceeeCCCCCcEEEc-CCCcEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP--IVHRDVKSANILLN-EKFQAK 675 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g--IiHrDLkp~NILl~-~~~~~k 675 (749)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+. + |+||||||+|||++ +++.+|
T Consensus 108 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEecCCCCHHHHHHHc------------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEE
Confidence 9999999999999532 4588999999999999999999998 6 99999999999998 788999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+|||++...... ......|++.|+|||.+. +.++.++||||||++++||++|+.||...
T Consensus 173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999754322 223456899999999876 45899999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-33 Score=309.83 Aligned_cols=202 Identities=19% Similarity=0.174 Sum_probs=161.5
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHH---HHHHhcCCCceeEEE-------EEEec
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEV---ELLMRAHHKNLTILV-------GYCDE 591 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei---~iL~~l~H~nIv~l~-------g~~~~ 591 (749)
+.+.+.||+|+||+||+|+. +++.||||++... .....+.+.+|+ +++++++||||++++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 44568999999999999986 3689999998743 334567889999 555666899999988 66655
Q ss_pred CC-----------------eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 037623 592 NT-----------------KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKP 654 (749)
Q Consensus 592 ~~-----------------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~ 654 (749)
.+ ..++||||+ +|+|.+++...... ......+++..+++++.|+++||+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~-----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 225 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH-----SSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT-----TTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc-----ccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 43 278999999 68999999754221 11224566788999999999999999999
Q ss_pred CceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC-----------CCCCchhHHHH
Q 037623 655 PIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-----------RLTEKSDVYSF 723 (749)
Q Consensus 655 gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~k~DVwSf 723 (749)
+|+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999998532 12334567 999999999887 89999999999
Q ss_pred HHHHHHHHcCCCCCCCCCcc
Q 037623 724 GVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 724 GvvL~ElltG~~pf~~~~~~ 743 (749)
||++|||++|+.||......
T Consensus 300 G~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHHHHSSCCC------
T ss_pred HHHHHHHHHCCCCCcccccc
Confidence 99999999999999875443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=299.10 Aligned_cols=213 Identities=28% Similarity=0.412 Sum_probs=173.6
Q ss_pred HHHHhhcccccccccCceEEEEEEEC-------CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT 593 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~ 593 (749)
+....+.+.+.||+|+||.||+|+.. +..||||++... ......++.+|+.++.+++|+||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34455677899999999999999842 357999999754 3445668899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--- 670 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--- 670 (749)
..++||||+++|+|.+++..... .......+++..+++++.|+++||.|||+. +|+||||||+|||++.
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRP-----RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSC-----CSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred CcEEEEecCCCCcHHHHHHhhcc-----cccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCC
Confidence 99999999999999999975421 112235689999999999999999999999 9999999999999994
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
+..+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 44699999999986543322222334567889999999999999999999999999999998 9999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=306.10 Aligned_cols=197 Identities=26% Similarity=0.389 Sum_probs=163.7
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~ 596 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... .....+++.+|++++++++|+||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4667799999999999999874 478999999754 334557899999999999999999999999765 5789
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||++ |+|.+++. ....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||
T Consensus 107 lv~e~~~-~~L~~~~~------------~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFK------------TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp EEEECCS-EEHHHHHH------------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEecCC-cCHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEE
Confidence 9999986 69999984 345689999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCc--------------------eeeeccccCCcccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCC
Q 037623 677 ADFGLSRIFPVEGGS--------------------HVSTTVVGTPGYLDPEYY-ISNRLTEKSDVYSFGVVLLELITGQP 735 (749)
Q Consensus 677 ~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~s~k~DVwSfGvvL~ElltG~~ 735 (749)
+|||+++........ .......||+.|+|||++ ....++.++|||||||+++||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876433211 122456789999999986 55669999999999999999998655
Q ss_pred CCC
Q 037623 736 VIQ 738 (749)
Q Consensus 736 pf~ 738 (749)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.3e-33 Score=289.85 Aligned_cols=198 Identities=30% Similarity=0.473 Sum_probs=165.6
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-CeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-TKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||.||++..+++.||||++.... ..+.+.+|++++.+++|+||+++++++.+. +..++||||+++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 45667899999999999999999999999987553 346789999999999999999999997654 478999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
++|.+++... ....+++..+++++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 100 ~~L~~~l~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 100 GSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEHHHHHHHH----------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCHHHHHHhc----------ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccc
Confidence 9999999643 223478999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
.... .....++..|+|||.+.+..++.++||||||++++||++ |+.||...+..
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 167 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred cccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 4322 123357889999999999999999999999999999998 99999875543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=301.96 Aligned_cols=199 Identities=26% Similarity=0.368 Sum_probs=172.7
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+++.. +..||+|++... .....+.+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 4556789999999999999985 588999998765 3444578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++... ..+++..+.+++.++++||+|||+.+ +|+||||||+|||++.++.+||+|||++
T Consensus 114 ~~~~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 114 DGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp TTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999542 35889999999999999999999832 7999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+..... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...+.
T Consensus 180 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 180 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred cccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 755321 22345689999999999999999999999999999999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=295.61 Aligned_cols=213 Identities=23% Similarity=0.354 Sum_probs=177.2
Q ss_pred ccccCHHHHHHHhhccc-ccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhc-CCCceeEEEE
Q 037623 514 NRKLSYANVLKITNNFE-RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRA-HHKNLTILVG 587 (749)
Q Consensus 514 ~~~~~~~~l~~~t~~f~-~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l-~H~nIv~l~g 587 (749)
+-.+...+.....|.+. +.||+|+||.||+|+.. ++.||+|++.... ....+++.+|+.++.++ +|+||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455555556666665 89999999999999885 5889999987643 23357889999999999 5699999999
Q ss_pred EEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEE
Q 037623 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 588 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
++...+..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl 163 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLP----------ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNIL 163 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSS----------CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHH----------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEE
Confidence 99999999999999999999888732 2345689999999999999999999999 9999999999999
Q ss_pred EcC---CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 668 LNE---KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 668 l~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++. ++.+||+|||+++..... .......|++.|+|||++.+..++.++||||||++++||++|+.||...+.
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EecCCCCCcEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 998 789999999999876432 122345699999999999999999999999999999999999999976543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=298.85 Aligned_cols=199 Identities=28% Similarity=0.423 Sum_probs=163.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhh-HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||+||+|+.. ++.||||++....... ...+.+|++++.+++|+||+++++++...+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 556789999999999999985 5789999987543322 2245679999999999999999999999999999999997
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 84 -KDLKQYLDD-----------CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp -EEHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred -cCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 589998854 234689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
..... ........+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||.+.+.
T Consensus 149 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 149 AKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65322 122234468999999999876 5689999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=288.54 Aligned_cols=197 Identities=30% Similarity=0.458 Sum_probs=172.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+|+.. +..||+|++.... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4566789999999999999985 4679999986542 1224678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 95 FAPRGELYKELQKH------------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp CCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred eCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence 99999999999542 3588999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++...... ......|++.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 160 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 160 WSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp TCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 98765322 1234568999999999999999999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-33 Score=298.59 Aligned_cols=199 Identities=24% Similarity=0.365 Sum_probs=162.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4666789999999999999874 58899999975533 2245678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc-----CCCcEEE
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-----EKFQAKL 676 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~-----~~~~~kL 676 (749)
++ |+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||
T Consensus 115 ~~-~~L~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 115 AE-NDLKKYMDK------------NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp CS-EEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred CC-CCHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEE
Confidence 97 599999853 23589999999999999999999999 999999999999994 5556999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++..... ........+|+.|+|||++.+. .++.++|||||||+++||++|+.||....+
T Consensus 179 ~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 179 GDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 999999876422 1222344689999999999875 489999999999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=301.91 Aligned_cols=195 Identities=29% Similarity=0.399 Sum_probs=162.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~ 595 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... .....+++.+|++++++++|+||+++++++... ...
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3556789999999999999974 588999998653 333456789999999999999999999999765 346
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+|
T Consensus 106 ~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-------------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEE
Confidence 9999999 8899999843 3588999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+.
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999875322 234568999999999987 6799999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=286.85 Aligned_cols=199 Identities=25% Similarity=0.417 Sum_probs=172.2
Q ss_pred HHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec------
Q 037623 520 ANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE------ 591 (749)
Q Consensus 520 ~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------ 591 (749)
.......+...+.||+|+||.||+|+.. ++.||+|++.... +.+.+|++++.+++|+||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3445566777899999999999999985 5889999987553 356789999999999999999998854
Q ss_pred ----------CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 592 ----------NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 592 ----------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
....++||||+++|+|.+++... ....+++..+++++.|+++||.|||+. +|+||||
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl 148 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR----------RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDL 148 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG----------GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 45578999999999999999653 235689999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
||+|||+++++.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||++++||++|..|+.
T Consensus 149 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp SGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999999999999999998764332 1234468999999999999999999999999999999999998874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=288.39 Aligned_cols=200 Identities=33% Similarity=0.464 Sum_probs=167.6
Q ss_pred cccccccccCceEEEEEEECC-----cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee-EEEEe
Q 037623 528 NFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM-GLVYE 600 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~-~LV~E 600 (749)
...+.||+|+||+||+|+..+ ..||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+.. ++|+|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345899999999999998632 269999987643 34567899999999999999999999999876655 89999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+.+|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 104 ~~~~~~L~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 104 YMCHGDLLQFIRS-----------PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CCTTCBHHHHHHC-----------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cccCCCHHHHHhc-----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence 9999999999953 345688999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCC--ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCC
Q 037623 681 LSRIFPVEGG--SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~-~pf~~~~ 741 (749)
+++....... ........++..|+|||.+.+..++.++||||||++++||++|. +||...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 9986533211 11223345788999999999999999999999999999999955 5555443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=291.57 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=163.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++|+|
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 4566789999999999999974 5789999987543 2334778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 115 LINGVDLAAMLRRQ------------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp CCCCEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred ecCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence 99999999999542 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++....... ........+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 180 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 180 IASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred cCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 998654321 112234468999999999999999999999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=311.03 Aligned_cols=202 Identities=31% Similarity=0.468 Sum_probs=173.2
Q ss_pred HHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
....|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3456788899999999999999984 5889999986432 23456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc---CCCcEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN---EKFQAK 675 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~---~~~~~k 675 (749)
|||+++|+|.+.+... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+|
T Consensus 100 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp ECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence 9999999999998542 3589999999999999999999999 999999999999995 456799
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+..
T Consensus 165 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 165 IIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999876432 22334569999999999875 5899999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.1e-33 Score=306.11 Aligned_cols=200 Identities=26% Similarity=0.380 Sum_probs=169.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC--eeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT--KMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~--~~~LV~E 600 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++|+||+++++++.... ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 3556789999999999999985 5889999997543 233567889999999999999999999997654 7799999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE----cCCCcEEE
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKL 676 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl----~~~~~~kL 676 (749)
|+++|+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 90 ~~~~g~L~~~l~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 90 FCPCGSLYTVLEEP---------SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp CCTTEEHHHHTTSG---------GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred cCCCCCHHHHHHhh---------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence 99999999998532 1233489999999999999999999999 99999999999999 77888999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCcccccc--------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS--------NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 158 TDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999875432 12234569999999999865 56788999999999999999999999753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-32 Score=288.38 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=163.6
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+|.. +++.||||++... .....+++.+|+.++.+++|+||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 466779999999999999997 4588999998753 34455778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++.... .....+++..+++++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 113 ~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 113 LADAGDLSRMIKHFK--------KQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp CCCSCBHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred cCCCCCHHHHHHHhc--------ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecc
Confidence 999999999996432 1345689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+++...... .......+++.|+|||.+.+..++.++||||||++++||++|+.||.+.
T Consensus 182 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 182 LGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 998654321 1223446899999999999999999999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=310.95 Aligned_cols=201 Identities=28% Similarity=0.442 Sum_probs=169.5
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
...|.+.+.||+|+||+||+|+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 445777899999999999999984 4789999987653 233567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC---CcEEE
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---FQAKL 676 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~---~~~kL 676 (749)
||+++|+|.+.+... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 116 e~~~~g~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 116 ECYKGGELFDEIIHR------------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred ecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEE
Confidence 999999999988542 3588999999999999999999999 99999999999999764 45999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++|++||.+....
T Consensus 181 ~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (494)
T 3lij_A 181 VDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243 (494)
T ss_dssp CCCTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999876432 2233456999999999886 56899999999999999999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=288.52 Aligned_cols=204 Identities=28% Similarity=0.386 Sum_probs=171.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEe--cCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCD--ENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~--~~~~~~LV~ 599 (749)
.+.+.+.||+|+||.||+++.. ++.||+|++... .....+.+.+|++++.+++|+||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3556789999999999999984 588999998754 3344577899999999999999999999874 467889999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceeeCCCCCcEEEcCCCcE
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPP-----IVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~g-----IiHrDLkp~NILl~~~~~~ 674 (749)
||+++++|.+++..... ....+++..+++++.|+++||+|||+. + |+||||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTK--------ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp ECCTTEEHHHHHHHHHH--------TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCE
T ss_pred eCCCCCCHHHHHHhhcc--------cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCE
Confidence 99999999999965421 345689999999999999999999998 6 9999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+|||+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus 156 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 156 KLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp EECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 999999998654321 112234689999999999999999999999999999999999999987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=313.17 Aligned_cols=202 Identities=31% Similarity=0.457 Sum_probs=175.5
Q ss_pred HHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
....|.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4456778899999999999999984 5889999986542 3345789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQA 674 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~ 674 (749)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+
T Consensus 104 v~e~~~~~~L~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS------------RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EECCCCSCBHHHHHHT------------CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEecCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcE
Confidence 9999999999999842 34689999999999999999999999 99999999999999 467899
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+..
T Consensus 169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999998764322 2234569999999999865 6899999999999999999999999876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=323.80 Aligned_cols=197 Identities=29% Similarity=0.460 Sum_probs=165.3
Q ss_pred ccccccCceEEEEEEEC----CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLD----DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~----~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.||+|+||.||+|.+. ++.||||+++.... ...+++.+|++++.+++|+||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999763 26799999976432 345789999999999999999999999964 568899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 454 g~L~~~l~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 454 GPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp EEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred CCHHHHHhh------------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 999999953 34689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 685 FPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
+...... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 6543221 12223346789999999999999999999999999999998 99999876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=296.69 Aligned_cols=199 Identities=28% Similarity=0.431 Sum_probs=172.0
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCch--------hhHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--------QGYKQFQAEVELLMRA-HHKNLTILVGYCDENT 593 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~ 593 (749)
..|.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++.++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 44666789999999999999984 58999999865431 1245678999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE------------KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEEEeCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 99999999999999999953 23589999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999998764322 2234579999999999863 358899999999999999999999997654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=291.51 Aligned_cols=199 Identities=30% Similarity=0.435 Sum_probs=163.2
Q ss_pred HHHHHHHhhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhc--CCCceeEEEEEEecC----
Q 037623 519 YANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA--HHKNLTILVGYCDEN---- 592 (749)
Q Consensus 519 ~~~l~~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l--~H~nIv~l~g~~~~~---- 592 (749)
........+.+.+.||+|+||.||+|+..++.||||++.... ...+..|.+++..+ +|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 344455677888999999999999999999999999986443 23455566666554 999999999999876
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceeeCCCCCcEE
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC-----KPPIVHRDVKSANIL 667 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~-----~~gIiHrDLkp~NIL 667 (749)
...++||||+++|+|.+++.. ..+++..+++++.|++.||+|||+.+ .++|+||||||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nil 174 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEE
T ss_pred CceEEEEeccCCCcHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEE
Confidence 788999999999999999943 25899999999999999999999762 458999999999999
Q ss_pred EcCCCcEEEEecCCCccccCCCCce--eeeccccCCcccCccccccCCCCCc------hhHHHHHHHHHHHHcC
Q 037623 668 LNEKFQAKLADFGLSRIFPVEGGSH--VSTTVVGTPGYLDPEYYISNRLTEK------SDVYSFGVVLLELITG 733 (749)
Q Consensus 668 l~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~k------~DVwSfGvvL~ElltG 733 (749)
++.++.+||+|||+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||+||
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999999999999998664332211 1124469999999999988776665 9999999999999999
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=292.29 Aligned_cols=196 Identities=29% Similarity=0.433 Sum_probs=169.2
Q ss_pred cccccccccCceEEEEEEE------CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEE
Q 037623 528 NFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGLV 598 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~LV 598 (749)
.+.+.||+|+||+||++.+ +++.||||++.... ....+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 5678999999999999865 34779999998653 3446779999999999999999999999987 4678999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 114 ~e~~~~~~L~~~l~~-------------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~D 177 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-------------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD 177 (318)
T ss_dssp ECCCTTCBHHHHGGG-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred EecccCCcHHHHHhh-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECC
Confidence 999999999999832 2489999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 679 FGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 679 FGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
||+++........ .......++..|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 9999876543221 122344578889999999999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-32 Score=283.06 Aligned_cols=199 Identities=18% Similarity=0.260 Sum_probs=170.2
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV 598 (749)
...+.+.+.||+|+||+||+|+.. ++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 345667799999999999999984 688999998764 234456788999999999 999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC--------
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-------- 670 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-------- 670 (749)
|||+++++|.+++..... ....+++..+..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR--------IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EECCTTCBHHHHHHHHHH--------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred EEecCCCcHHHHHHhhcc--------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 999999999999965421 235689999999999999999999999 9999999999999984
Q ss_pred -----------CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 671 -----------KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 671 -----------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
...+||+|||++...... ....|++.|+|||.+.+. .++.++|||||||+++||++|++|+.
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 447999999999875432 223589999999999876 56789999999999999999998775
Q ss_pred C
Q 037623 739 K 739 (749)
Q Consensus 739 ~ 739 (749)
.
T Consensus 233 ~ 233 (289)
T 1x8b_A 233 N 233 (289)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=287.39 Aligned_cols=196 Identities=29% Similarity=0.425 Sum_probs=167.2
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
.+||+|+||.||+|+.. +..||||.+........+.+.+|+.++.+++|+||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 48999999999999974 4789999998776666678999999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCcEEEEecCCCccccC
Q 037623 609 AHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQAKLADFGLSRIFPV 687 (749)
Q Consensus 609 ~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~ 687 (749)
+++... .....+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 108 ~~l~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 108 ALLRSK---------WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp HHHHHT---------TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred HHHHhh---------ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999643 1234567889999999999999999999 9999999999999987 88999999999986543
Q ss_pred CCCceeeeccccCCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 688 EGGSHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 688 ~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
. ........|++.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 176 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 176 I--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred C--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 2 11223456899999999997654 789999999999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=293.71 Aligned_cols=206 Identities=27% Similarity=0.405 Sum_probs=174.0
Q ss_pred ccCHHHHHHHhhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHh--cCCCceeEEEEEEecCC
Q 037623 516 KLSYANVLKITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMR--AHHKNLTILVGYCDENT 593 (749)
Q Consensus 516 ~~~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--l~H~nIv~l~g~~~~~~ 593 (749)
.+...+.....+.+.+.||+|+||.||+|+.+++.||||++... ..+.+.+|++++.. ++|+||+++++++....
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34445666677888999999999999999999999999998643 34567889999887 79999999999998765
Q ss_pred ----eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceeeCC
Q 037623 594 ----KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH--------DGCKPPIVHRDV 661 (749)
Q Consensus 594 ----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH--------~~~~~gIiHrDL 661 (749)
..++||||+++|+|.+++.. ..+++..+++++.|+++||+||| +. +|+||||
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dl 173 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDL 173 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCC
Confidence 78999999999999999943 24889999999999999999999 66 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccCCCCce--eeeccccCCcccCccccccCC------CCCchhHHHHHHHHHHHHcC
Q 037623 662 KSANILLNEKFQAKLADFGLSRIFPVEGGSH--VSTTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITG 733 (749)
Q Consensus 662 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~------~s~k~DVwSfGvvL~ElltG 733 (749)
||+|||+++++.+||+|||+++......... ......||+.|+|||.+.+.. ++.++|||||||++|||+||
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999998765433211 123446999999999997763 34789999999999999999
Q ss_pred ----------CCCCCCC
Q 037623 734 ----------QPVIQKT 740 (749)
Q Consensus 734 ----------~~pf~~~ 740 (749)
+.||...
T Consensus 254 ~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp BCBTTBCCCCCCTTTTT
T ss_pred cCcCCcccccccCcccc
Confidence 7788654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=295.24 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=169.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEec--------CC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDE--------NT 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--------~~ 593 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|++++.+++|+||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 4667789999999999999984 58899999865432 234578899999999999999999999976 44
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++||||+++ +|.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSN-----------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 162 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHC-----------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred eEEEEEeccCC-CHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCC
Confidence 68999999975 78777742 334689999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCC--ceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGG--SHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||+++||++|++||.+..+
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999987643221 122234568999999999876 4589999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=298.34 Aligned_cols=199 Identities=24% Similarity=0.282 Sum_probs=162.3
Q ss_pred HhhcccccccccCceEEEEEEEC-----CcccEEEEecCCchh-----------hHHHHHHHHHHHHhcCCCceeEEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD-----DKQVAVKMLSPSSVQ-----------GYKQFQAEVELLMRAHHKNLTILVGY 588 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~-----~~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~l~H~nIv~l~g~ 588 (749)
..+.+.+.||+|+||.||+|+.. +..+|||+....... ..+.+.+|+..+..++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45667789999999999999984 377999998765321 12346778889999999999999999
Q ss_pred Eec----CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCC
Q 037623 589 CDE----NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSA 664 (749)
Q Consensus 589 ~~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~ 664 (749)
+.. ....++||||+ +++|.+++.. ...+++..+++++.|+++||+|||+. +|+||||||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ------------NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG------------GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 987 78899999999 9999999842 23789999999999999999999999 9999999999
Q ss_pred cEEEcCCC--cEEEEecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 037623 665 NILLNEKF--QAKLADFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVI 737 (749)
Q Consensus 665 NILl~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf 737 (749)
|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999887 9999999999876432111 1113446999999999999999999999999999999999999999
Q ss_pred CC
Q 037623 738 QK 739 (749)
Q Consensus 738 ~~ 739 (749)
..
T Consensus 261 ~~ 262 (345)
T 2v62_A 261 EQ 262 (345)
T ss_dssp GG
T ss_pred cc
Confidence 64
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=303.80 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=171.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc------CCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA------HHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l------~H~nIv~l~g~~~~~~~~~L 597 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++.... ...+++.+|++++..+ +|+||+++++++......++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4667799999999999999875 4789999997543 3346778899888887 56799999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc--EE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ--AK 675 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~--~k 675 (749)
||||++ ++|.+++... ....+++..+.+++.|+++||+|||+. +|+||||||+|||++.++. +|
T Consensus 177 v~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKN----------KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp EECCCC-CBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEE
T ss_pred EEeccC-CCHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceE
Confidence 999996 6999998653 334589999999999999999999999 9999999999999999887 99
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.++.+
T Consensus 243 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 243 VIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999764321 234568999999999999999999999999999999999999998766543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=297.88 Aligned_cols=196 Identities=27% Similarity=0.364 Sum_probs=160.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC------ee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT------KM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~------~~ 595 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+.++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3566789999999999999874 578999998753 3344567899999999999999999999997654 78
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||++ |+|.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+|
T Consensus 106 ~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEECCS-EEHHHHHH--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEcCC-CCHHHHHh--------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence 99999997 47887773 2378999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||.+.+.
T Consensus 168 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 168 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999865322 122345689999999999999999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=298.40 Aligned_cols=200 Identities=29% Similarity=0.407 Sum_probs=166.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchh-----hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-----GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|++++.+++|+||+++++++...+..++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4566789999999999999974 588999998754221 124688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++ +|..++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 91 ~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 91 FDFMET-DLEVIIKD-----------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp EECCSE-EHHHHHTT-----------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEcCCC-CHHHHHHh-----------cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEe
Confidence 999986 88888742 334688889999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+++.+.... .......+|+.|+|||.+.+. .++.++|||||||++|||++|++||.+.++
T Consensus 156 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 156 FGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp CGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99998764322 223345689999999999764 488999999999999999999999987553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=289.69 Aligned_cols=200 Identities=28% Similarity=0.417 Sum_probs=163.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe-------------
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD------------- 590 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~------------- 590 (749)
.|...+.||+|+||.||+|+.. ++.||+|++........+++.+|++++++++|+||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3556789999999999999985 5889999998777777788999999999999999999999873
Q ss_pred -cCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 591 -ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 591 -~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
+....++||||++ |+|.+++. ...+++..+..++.|+++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE-------------QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFIN 154 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE
T ss_pred cccCceeEEeeccC-CCHHHHhh-------------cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 4467899999997 69999882 24588999999999999999999999 999999999999997
Q ss_pred -CCCcEEEEecCCCccccCCCC-ceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 670 -EKFQAKLADFGLSRIFPVEGG-SHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 670 -~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+++.+||+|||+++....... ........++..|+|||.+.. ..++.++||||||++++||++|+.||.....
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 567999999999987643211 111223457899999998865 6789999999999999999999999987653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=292.34 Aligned_cols=200 Identities=30% Similarity=0.478 Sum_probs=172.3
Q ss_pred hhcccccccccCceEEEEEEE------CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC--eeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL------DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT--KMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~--~~~L 597 (749)
.+.+.+.||+|+||.||+++. +++.||||++........+.+.+|++++.+++|+||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 456678999999999999985 34789999998777667788999999999999999999999987644 7899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++++|.+++... ...+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 122 v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKH-----------KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp EECCCTTCBHHHHHHHS-----------TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred EEECCCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEe
Confidence 99999999999999542 34589999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 678 DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|||+++......... ......++..|+|||.+.+..++.++||||||++++||+||+.|+..
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 999998765432211 12233567789999999999999999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=288.92 Aligned_cols=200 Identities=30% Similarity=0.451 Sum_probs=167.3
Q ss_pred hcccc-cccccCceEEEEEEEC----CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFER-VLGKGGFGTVYHGYLD----DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~-~LG~G~fG~Vykg~~~----~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+.+.+ .||+|+||.||+|... ++.||||++.... ....+++.+|++++.+++||||+++++++ ..+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 44455 8999999999999652 3679999987653 23357899999999999999999999999 566789999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++++|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 97 e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 97 EMAELGPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp ECCTTEEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred EeCCCCCHHHHHHh------------CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 99999999999953 23588999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|+++......... ......+++.|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9998765433221 1222346788999999999899999999999999999999 9999987543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-32 Score=287.24 Aligned_cols=200 Identities=27% Similarity=0.430 Sum_probs=170.3
Q ss_pred HHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
...+.+.+.||+|+||.||+|+.. ++.||||++.... ..+++.+|+.++.+++|+||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 345666789999999999999985 5889999987643 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. ....+++..+..++.+++.||.|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 106 ~~~~~L~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 106 CGAGSVSDIIRL-----------RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp CTTEEHHHHHHH-----------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CCCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 999999999853 234689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+...... ........|++.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 172 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 172 AGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred chhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 112234568999999999999999999999999999999999999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=309.77 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=170.6
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCch-------------hhHHHHHHHHHHHHhcCCCceeEEEEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-------------QGYKQFQAEVELLMRAHHKNLTILVGYC 589 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~ 589 (749)
..|.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34666789999999999999984 47899999875431 2346789999999999999999999999
Q ss_pred ecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 590 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
.+....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR------------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLE 180 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEe
Confidence 9999999999999999999998542 3589999999999999999999999 999999999999998
Q ss_pred CCC---cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 670 EKF---QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 670 ~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
.++ .+||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++|+.||.+.+..+
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 254 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 775 6999999999876432 2233456999999999986 568999999999999999999999998765443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=287.95 Aligned_cols=203 Identities=28% Similarity=0.356 Sum_probs=169.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc----hhhHHHHHHHHHHHHhcCCCceeEEEEEE--ecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS----VQGYKQFQAEVELLMRAHHKNLTILVGYC--DENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~--~~~~~~~L 597 (749)
.|.+.+.||+|+||.||++... ++.||+|++.... ....+.+.+|++++.+++|+||+++++++ .+....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4566789999999999999984 4789999987542 23457799999999999999999999998 44567899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||++++ |.+++... ....+++..+.+++.|+++||+|||++ +|+||||||+|||++.++.+||+
T Consensus 86 v~e~~~~~-l~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV----------PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EEECCSEE-HHHHHHHS----------TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EehhccCC-HHHHHHhC----------cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 99999877 77777542 345689999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR--LTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||++................|++.|+|||.+.+.. .+.++||||||++++||++|+.||...+.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence 999998765433333334556999999999997654 47899999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=286.01 Aligned_cols=201 Identities=22% Similarity=0.322 Sum_probs=167.2
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEE-ecCCeeEEEEee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC-DENTKMGLVYEF 601 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~-~~~~~~~LV~Ey 601 (749)
..+.+.+.||+|+||.||+|+. .++.||||+...... .+++.+|++++.+++|++++..++.+ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3466779999999999999996 458899998765432 24578999999999888877766665 667788999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcEEEEe
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLAD 678 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~kL~D 678 (749)
+ +++|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+ ++++.+||+|
T Consensus 87 ~-~~~L~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 87 L-GPSLEDLFNF-----------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp C-CCBHHHHHHH-----------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred c-CCCHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 9 9999999853 234589999999999999999999999 99999999999999 7888999999
Q ss_pred cCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 9999876543221 112345689999999999999999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=290.95 Aligned_cols=201 Identities=27% Similarity=0.451 Sum_probs=167.3
Q ss_pred HHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCch--------hhHHHHHHHHHHHHhcCCCceeEEEEEEec
Q 037623 522 VLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--------QGYKQFQAEVELLMRAHHKNLTILVGYCDE 591 (749)
Q Consensus 522 l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~ 591 (749)
.....|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|++++.+++|+||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34556788899999999999999884 47899999865421 123458899999999999999999999876
Q ss_pred CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC
Q 037623 592 NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK 671 (749)
Q Consensus 592 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~ 671 (749)
.. .++||||+++++|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~------------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVV------------GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHS------------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSS
T ss_pred Cc-eEEEEecCCCCcHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecC
Confidence 54 899999999999999883 345689999999999999999999999 99999999999999876
Q ss_pred Cc---EEEEecCCCccccCCCCceeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 672 FQ---AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 672 ~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+. +||+|||+++..... .......|++.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred CCCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 54 999999999875321 1223446899999999974 5678999999999999999999999997644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=290.62 Aligned_cols=203 Identities=27% Similarity=0.328 Sum_probs=169.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe----cCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD----ENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~----~~~~~~LV~ 599 (749)
.|.+.+.||+|+||.||+++. +++.||||++........+.+.+|++++.+++|+||+++++++. .....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 456678999999999999997 45889999987776677788999999999999999999999986 345788999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.... .....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 110 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 110 PFFKRGTLWNEIERLK--------DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ECCTTCBHHHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EeCCCCcHHHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEec
Confidence 9999999999996532 2346789999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCce-------eeeccccCCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 680 GLSRIFPVEGGSH-------VSTTVVGTPGYLDPEYYISNR---LTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 680 Gla~~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~---~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
|+++......... ......|++.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9987643211000 011234799999999987654 68999999999999999999999953
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=289.92 Aligned_cols=200 Identities=26% Similarity=0.414 Sum_probs=168.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|+.. ++.||+|++........+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4566789999999999999985 57899999987766667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++... ...+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 100 GGAVDAIMLEL-----------DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp TEEHHHHHHHH-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CCcHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 99999998542 34589999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCceeeeccccCCcccCcccc-----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYY-----ISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~-----~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
..... ........|++.|+|||.+ ....++.++||||||++++||++|+.||...+
T Consensus 166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 166 KNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 43211 1112234689999999998 46678999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=304.42 Aligned_cols=198 Identities=25% Similarity=0.344 Sum_probs=162.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------CeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~~L 597 (749)
.|...+.||+|+||.||+|+.. ++.||||++..... .+.+|++++++++|+||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3556789999999999999984 58899999865422 234799999999999999999998431 23669
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKL 676 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL 676 (749)
||||+++ +|...+.... .....+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 131 v~e~~~~-~l~~~~~~~~--------~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYS--------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp EEECCCE-EHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred ehhcccc-cHHHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEe
Confidence 9999975 6666664321 1345789999999999999999999998 99999999999999955 67899
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 199 ~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 199 CDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp CCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998764322 12345689999999999765 789999999999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=296.83 Aligned_cols=198 Identities=28% Similarity=0.473 Sum_probs=158.9
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHH--HHhcCCCceeEEEEEEec-----CCeeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVEL--LMRAHHKNLTILVGYCDE-----NTKMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~i--L~~l~H~nIv~l~g~~~~-----~~~~~LV 598 (749)
.+.+.+.||+|+||.||+|+.+++.||||++..... ..+..|.++ +..++|+||+++++.+.. ....++|
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred HhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 345678999999999999999999999999875433 344445544 445899999999986532 3366899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceeeCCCCCcEEEcCCC
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC------KPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~------~~gIiHrDLkp~NILl~~~~ 672 (749)
|||+++|+|.+++... ..++..+.+++.|+++||+|||+.+ .++|+||||||+|||+++++
T Consensus 91 ~e~~~~g~L~~~l~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH-------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp ECCCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred EecCCCCcHHHHHhhc-------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 9999999999999532 3488999999999999999999873 34899999999999999999
Q ss_pred cEEEEecCCCccccCCCC------ceeeeccccCCcccCcccccc-------CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGG------SHVSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999987643211 112224469999999999976 4567899999999999999999776643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=299.72 Aligned_cols=195 Identities=29% Similarity=0.413 Sum_probs=152.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecC------Cee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDEN------TKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~------~~~ 595 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|++++++++|+||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 3556789999999999999874 588999998753 334557789999999999999999999998654 567
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++|+|++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+|
T Consensus 110 ~lv~e~~-~~~L~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVK-------------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp EEEEECC-CEECC------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred EEEeccc-CCCHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEE
Confidence 9999999 789988873 24589999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+.
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999865321 234568999999999987 6789999999999999999999999987653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=300.15 Aligned_cols=204 Identities=27% Similarity=0.384 Sum_probs=153.9
Q ss_pred cccccccCceEEEEEEEC----CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEe--cCCeeEEEEeeCC
Q 037623 530 ERVLGKGGFGTVYHGYLD----DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCD--ENTKMGLVYEFMA 603 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~----~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~--~~~~~~LV~Ey~~ 603 (749)
.++||+|+||+||+|+.. ++.||||++..... .+.+.+|++++++++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999964 47899999975533 256889999999999999999999994 4778999999996
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE----cCCCcEEEEec
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL----NEKFQAKLADF 679 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl----~~~~~~kL~DF 679 (749)
|+|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+||
T Consensus 104 -~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 104 -HDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp -EEHHHHHHHHHHHC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred -CCHHHHHHHhcccc---ccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 58888885432210 011233589999999999999999999999 99999999999999 67789999999
Q ss_pred CCCccccCCCC-ceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGG-SHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|++||....+
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99987643211 1222345689999999999874 589999999999999999999999976543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=299.86 Aligned_cols=198 Identities=24% Similarity=0.368 Sum_probs=164.7
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec------------
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE------------ 591 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------------ 591 (749)
.|.+.+.||+|+||+||+|+. +++.||||++..... ...+|++++++++|+||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 456679999999999999987 458899999865432 23479999999999999999999843
Q ss_pred --------------------------CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHH
Q 037623 592 --------------------------NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645 (749)
Q Consensus 592 --------------------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL 645 (749)
....++||||++ |+|.+.+.... .....+++..+..++.|+++||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI--------RSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHH
Confidence 234789999998 58888886432 1346789999999999999999
Q ss_pred HHHHhCCCCCceeeCCCCCcEEEc-CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHH
Q 037623 646 EYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSF 723 (749)
Q Consensus 646 ~yLH~~~~~gIiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSf 723 (749)
+|||+. +|+||||||+|||++ +++.+||+|||+++.+.... ......+|+.|+|||.+.+. .++.++|||||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999998 999999999999998 68899999999998764322 22345689999999998775 48999999999
Q ss_pred HHHHHHHHcCCCCCCCCCc
Q 037623 724 GVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 724 GvvL~ElltG~~pf~~~~~ 742 (749)
||+++||++|+.||.+.+.
T Consensus 229 G~il~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETS 247 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHhCCCCCCCCCh
Confidence 9999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=284.07 Aligned_cols=199 Identities=23% Similarity=0.331 Sum_probs=168.1
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEE-ecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYC-DENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~-~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+|+. +++.||||++..... .+++.+|++++.+++|+++++.+.++ ......++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 355678999999999999996 458899999875543 25688999999999988877666655 5677889999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcEEEEec
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADF 679 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~kL~DF 679 (749)
+++|.+++.. ....+++..+++++.|+++||+|||++ +|+||||||+|||+ ++++.+||+||
T Consensus 88 -~~~L~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 88 -GPSLEDLFNF-----------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp -CCBHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred -CCCHHHHHHh-----------hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 9999999953 234689999999999999999999999 99999999999999 47889999999
Q ss_pred CCCccccCCCCce-----eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGSH-----VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+++......... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 9998765432211 1234569999999999999999999999999999999999999998743
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=284.36 Aligned_cols=198 Identities=27% Similarity=0.416 Sum_probs=164.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++.+++|+||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3556789999999999999985 5889999986542 2234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++++|.+++... ..+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 92 YVSGGELFDYICKH------------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp CCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence 99999999999542 3588999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++...... .......+++.|+|||.+.+... +.++||||||++++||++|+.||....
T Consensus 157 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 157 LSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99875432 12234468999999999987765 689999999999999999999997654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=296.30 Aligned_cols=202 Identities=26% Similarity=0.410 Sum_probs=169.7
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~L 597 (749)
.|.+.+.||+|+||.||+|+.. +..||||++.... ....+.+.+|++++.+++|+||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4566789999999999999874 4789999997543 33457789999999999999999999999654 46899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|+||++ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 108 v~e~~~-~~L~~~l~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp EEECCS-EEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred EEcccC-cCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEE
Confidence 999997 589998842 3489999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCc-eeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 678 DFGLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 678 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||+++||++|+.||.+....+
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 99999876432211 11234578999999998754 458999999999999999999999998765443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.01 Aligned_cols=198 Identities=30% Similarity=0.395 Sum_probs=170.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---------hhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---------VQGYKQFQAEVELLMRAH-HKNLTILVGYCDENT 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---------~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~ 593 (749)
.+.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++.+++ ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4556789999999999999984 4789999986543 122456889999999995 999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 162 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred eEEEEEeccCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCc
Confidence 999999999999999999532 3589999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI------SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+||+|||++....... ......+++.|+|||.+. ...++.++||||||++++||++|+.||...+
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999999998764322 223456899999999985 4568899999999999999999999997654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=290.55 Aligned_cols=209 Identities=30% Similarity=0.493 Sum_probs=157.3
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.+.+.+.||+|+||.||+|+. +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 455678999999999999986 45889999986543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++++|.+++...... .......+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 96 ~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAK----GEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp TTCBHHHHHHHHHHT----TTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred cCCchHHHHHHHhhc----cccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999643210 011345689999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC---ceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGG---SHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+....... ........|++.|+|||.+.. ..++.++||||||++++||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 76543211 111234468999999999876 568999999999999999999999998644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=287.53 Aligned_cols=199 Identities=28% Similarity=0.467 Sum_probs=164.0
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEec------CCeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDE------NTKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~------~~~~~L 597 (749)
+.+.+.||+|+||.||+|+. +++.||||++..... ..+.+.+|+.++.++ +|+||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 45678999999999999998 558899999875432 346789999999999 89999999999976 568899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 105 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT----------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp EEECCTTEEHHHHHHHS----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred EEEcCCCCcHHHHHHhc----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 99999999999999642 234688999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||++....... .......|++.|+|||.+. +..++.++|||||||++|||++|+.||...+
T Consensus 172 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 172 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999998654221 1223446899999999987 5678999999999999999999999997644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=286.38 Aligned_cols=191 Identities=23% Similarity=0.386 Sum_probs=166.0
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEec--CCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDE--NTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~--~~~~~LV~E 600 (749)
.|.+.+.||+|+||+||+|+. +++.||||++.... .+.+.+|++++.+++ |+||+++++++.. ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 456678999999999999987 45889999997543 367899999999997 9999999999987 677899999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEEEec
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADF 679 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL~DF 679 (749)
|+++++|.+++. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~l~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 114 HVNNTDFKQLYQ---------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp CCCCCCHHHHGG---------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ccCchhHHHHHH---------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 999999988872 278889999999999999999999 999999999999999766 8999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+++...... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||...
T Consensus 176 g~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 176 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998764332 2234468999999999977 67899999999999999999999999543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=298.09 Aligned_cols=194 Identities=10% Similarity=0.039 Sum_probs=149.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhc--CCCceeEEE-------EEEecC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRA--HHKNLTILV-------GYCDEN 592 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l--~H~nIv~l~-------g~~~~~ 592 (749)
+.+.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456789999999999999974 57899999987543 3345677886555555 699988855 344322
Q ss_pred -----------------CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHH------HHHHHHHHHHHHHHH
Q 037623 593 -----------------TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR------LQIATESAQGLEYLH 649 (749)
Q Consensus 593 -----------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~------l~ia~~ia~gL~yLH 649 (749)
...++||||++ |+|.+++.... ..+.+..+ +.++.|+++||+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----------FVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----------HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----------cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 34799999998 89999997532 12344455 788899999999999
Q ss_pred hCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCcccccc--CCCCCchhHHHHHHHH
Q 037623 650 DGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVL 727 (749)
Q Consensus 650 ~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL 727 (749)
++ +|+||||||+|||+++++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HC---CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 99 999999999999999999999999999986531 1224457799999999987 6799999999999999
Q ss_pred HHHHcCCCCCCCC
Q 037623 728 LELITGQPVIQKT 740 (749)
Q Consensus 728 ~ElltG~~pf~~~ 740 (749)
|||++|+.||...
T Consensus 284 ~elltg~~Pf~~~ 296 (371)
T 3q60_A 284 YRVWCLFLPFGLV 296 (371)
T ss_dssp HHHHHSSCSTTBC
T ss_pred HHHHhCCCCCCCc
Confidence 9999999999865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=291.55 Aligned_cols=212 Identities=30% Similarity=0.452 Sum_probs=169.7
Q ss_pred HhhcccccccccCceEEEEEEEC--Cc--ccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DK--QVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~--~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV 598 (749)
..+.+.+.||+|+||.||+|+.. +. .+|+|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34667799999999999999873 34 4599988754 334456789999999999 999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCC----CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcE
Q 037623 599 YEFMANGNLQAHLLAQLAILPT----DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQA 674 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~----~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~ 674 (749)
|||+++|+|.+++......... ........+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 9999999999999643100000 0001235789999999999999999999999 99999999999999999999
Q ss_pred EEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 675 KLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 9999999874321 111223357889999999999899999999999999999998 9999987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=286.13 Aligned_cols=202 Identities=29% Similarity=0.416 Sum_probs=162.6
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.+.+.+.||+|+||+||+|++.. ..||||++... .....+++.+|++++.+++|+||+++++++.... .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 45667899999999999998632 25899998754 2344678999999999999999999999998754 889
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
|+||+++++|.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+
T Consensus 98 v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKH-----------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp EEECCTTCBHHHHHHHH-----------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred eEecccCCCHHHHHHhc-----------cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEc
Confidence 99999999999999643 24588999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
|||+++......... ......++..|+|||.+.+..++.++||||||++++||++ |+.||...+.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 999998765433221 1223457888999999999889999999999999999999 9999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.58 Aligned_cols=199 Identities=21% Similarity=0.345 Sum_probs=171.4
Q ss_pred HhhcccccccccCceEEEEEEE---CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCc------eeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL---DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN------LTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~---~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n------Iv~l~g~~~~~~~~ 595 (749)
..|.+.+.||+|+||.||+|.. +++.||||++.... ...+.+.+|++++.+++|++ ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4567789999999999999987 34789999997543 34567889999999987654 99999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-----
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE----- 670 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~----- 670 (749)
++||||+ +++|.+++... ....+++..+.+++.|+++||+|||++ +|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN----------GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred EEEEcCC-CCCHHHHHHhc----------CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 9999999 89999999643 234688999999999999999999999 9999999999999987
Q ss_pred --------------CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 671 --------------KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 671 --------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 668999999999864321 2345689999999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 037623 737 IQKTPER 743 (749)
Q Consensus 737 f~~~~~~ 743 (749)
|...+..
T Consensus 234 f~~~~~~ 240 (339)
T 1z57_A 234 FPTHDSK 240 (339)
T ss_dssp CCCSCHH
T ss_pred CCCCChH
Confidence 9876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=294.91 Aligned_cols=206 Identities=22% Similarity=0.336 Sum_probs=173.7
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCchhh-----------------HHHHHHHHHHHHhcCCCceeEEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQG-----------------YKQFQAEVELLMRAHHKNLTILVGY 588 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~-----------------~~~f~~Ei~iL~~l~H~nIv~l~g~ 588 (749)
.|.+.+.||+|+||.||+|+.+++.||||++....... .+.+.+|+.++.+++|+||++++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45667899999999999999988999999987542211 1789999999999999999999999
Q ss_pred EecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEE
Q 037623 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANIL 667 (749)
Q Consensus 589 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NIL 667 (749)
+.+.+..++||||+++|+|.+++..... -.......+++..+..++.|+++||+|||+ . +|+||||||+|||
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFV----LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEES----SCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhh----hhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999887311000 001125679999999999999999999998 7 9999999999999
Q ss_pred EcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 668 LNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTE-KSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 668 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++.++.+||+|||+++..... ......++..|+|||.+.+. .++. ++||||||++++||++|+.||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999875332 23445689999999999877 5666 99999999999999999999987544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=297.24 Aligned_cols=206 Identities=25% Similarity=0.343 Sum_probs=172.2
Q ss_pred CHHHHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcC--------CCceeEEEE
Q 037623 518 SYANVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH--------HKNLTILVG 587 (749)
Q Consensus 518 ~~~~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~--------H~nIv~l~g 587 (749)
...++....|.+.+.||+|+||+||+|+.. ++.||||++... ....+.+.+|++++.+++ |+||+++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 334444456777899999999999999874 478999999754 334567899999999985 788999999
Q ss_pred EEe----cCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCC
Q 037623 588 YCD----ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKS 663 (749)
Q Consensus 588 ~~~----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp 663 (749)
++. .....++||||+ +++|.+.+... ....+++..++.++.|+++||+|||+++ +|+||||||
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp 175 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKS----------NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKP 175 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSG
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhc----------ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCH
Confidence 987 567889999999 66777777532 3356899999999999999999999853 899999999
Q ss_pred CcEEEcCCC-------------------------------------------------cEEEEecCCCccccCCCCceee
Q 037623 664 ANILLNEKF-------------------------------------------------QAKLADFGLSRIFPVEGGSHVS 694 (749)
Q Consensus 664 ~NILl~~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~~~~ 694 (749)
+|||++.++ .+||+|||+++..... .
T Consensus 176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~ 250 (397)
T 1wak_A 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----F 250 (397)
T ss_dssp GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----S
T ss_pred HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----C
Confidence 999999775 7999999999875422 2
Q ss_pred eccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 695 ~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 344689999999999999999999999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=298.55 Aligned_cols=198 Identities=25% Similarity=0.359 Sum_probs=162.0
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC------eeEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT------KMGLV 598 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~------~~~LV 598 (749)
.|.+.+.||+|+||+||+|+... ..||+|++..... ...+|++++++++|+||+++++++.... ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 46667899999999999999854 6699998865432 2247999999999999999999985433 37899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc-CCCcEEEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLA 677 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~-~~~~~kL~ 677 (749)
|||++++.+....... .....+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 117 ~e~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 117 LEYVPETVYRASRHYA---------KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp EECCSEEHHHHHHHHH---------HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeccCccHHHHHHHHH---------hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEe
Confidence 9999875444333221 1345789999999999999999999999 999999999999999 78999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||+++.+.... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 185 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 185 DFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp CCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999998764322 22345689999999999765 589999999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=296.27 Aligned_cols=196 Identities=19% Similarity=0.263 Sum_probs=167.3
Q ss_pred hhcccccccccCceEEEEEEEC----------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeE-----------
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD----------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTI----------- 584 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~----------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~----------- 584 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... +.+.+|++++.+++|+||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 4566789999999999999874 578999998754 46789999999999999887
Q ss_pred ----EEEEEec-CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceee
Q 037623 585 ----LVGYCDE-NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHR 659 (749)
Q Consensus 585 ----l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHr 659 (749)
+++++.. ....++||||+ +++|.+++... ....+++..+++++.|+++||+|||+. +|+||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~ 183 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS----------PKHVLSERSVLQVACRLLDALEFLHEN---EYVHG 183 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence 6777765 78899999999 99999999642 235689999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCC--cEEEEecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc
Q 037623 660 DVKSANILLNEKF--QAKLADFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732 (749)
Q Consensus 660 DLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt 732 (749)
||||+|||+++++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999998 9999999999876432211 11133469999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 037623 733 GQPVIQKT 740 (749)
Q Consensus 733 G~~pf~~~ 740 (749)
|+.||...
T Consensus 264 g~~pf~~~ 271 (352)
T 2jii_A 264 GFLPWTNC 271 (352)
T ss_dssp SCCTTGGG
T ss_pred CCCCcccC
Confidence 99999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=291.89 Aligned_cols=199 Identities=24% Similarity=0.397 Sum_probs=167.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecC-----CeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDEN-----TKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~-----~~~~L 597 (749)
.+.+.+.||+|+||.||+|+.. ++.||||++.... .....++.+|++++.+++|+||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3556789999999999999985 5889999997543 33456788999999999999999999998654 67899
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||++ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 92 v~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-------------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EECCCS-EEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred EEeccC-ccHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEE
Confidence 999997 689988842 3589999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCce--------eeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 678 DFGLSRIFPVEGGSH--------VSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 678 DFGla~~~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|||+++......... ......||+.|+|||++.. ..++.++|||||||+++||++|+.||.+.+
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998764321110 1123468999999998764 678999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=294.14 Aligned_cols=198 Identities=25% Similarity=0.331 Sum_probs=160.1
Q ss_pred hhcccccccccCceEEEEEEEC-CcccEEEEecCCch-----------hhHHHHHHHHHHHHhcCCCceeEEEEEEec--
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV-----------QGYKQFQAEVELLMRAHHKNLTILVGYCDE-- 591 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~-----------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-- 591 (749)
.|.+.+.||+|+||.||+|+.. +..||||++..... ...+.+.+|++++.+++||||+++++++..
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 3445689999999999999874 48899999864321 223778999999999999999999999843
Q ss_pred ---CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 592 ---NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 592 ---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
....++||||++ |+|.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHD-----------QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHC-----------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred CCCcceEEEEEccCC-CCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 346899999997 688888852 344689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++++.+||+|||+++..... .......+++.|+|||.+.+ ..++.++|||||||+++||++|+.||.+..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999854322 22234568999999999877 678999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=294.77 Aligned_cols=194 Identities=29% Similarity=0.392 Sum_probs=164.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCee------
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKM------ 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~------ 595 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+.++.+++|+||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3556789999999999999874 588999999764 333457789999999999999999999999877655
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 123 ~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG--------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp EEEEECCC-EEHHHHTT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEcccc-ccHHHHhh--------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEE
Confidence 99999997 68877661 2389999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+.
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999865322 234568999999999987 6789999999999999999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.97 Aligned_cols=200 Identities=28% Similarity=0.410 Sum_probs=167.5
Q ss_pred hhcccccccccCceEEEEEEEC---CcccEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeEEEEEEe-----cC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSV--QGYKQFQAEVELLMRA---HHKNLTILVGYCD-----EN 592 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l---~H~nIv~l~g~~~-----~~ 592 (749)
.|.+.+.||+|+||.||+|+.. ++.||+|++..... .....+.+|+.+++++ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 3566789999999999999873 47799999864322 1224566777777766 8999999999987 56
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
...++||||++ |+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV----------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS----------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred ceEEEEEecCC-CCHHHHHHhc----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCC
Confidence 77899999997 6999998642 234589999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.+..+
T Consensus 158 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 158 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999999999865322 122345689999999999999999999999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=282.26 Aligned_cols=200 Identities=23% Similarity=0.266 Sum_probs=155.6
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCch-hh-HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV-QG-YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~-~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.+.+.+.||+|+||+||+++. +++.||||++..... .. .+.+.++...++.++||||+++++++.+.+..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 456678999999999999998 558899999976522 22 23344555567888999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++ |+|.+++.... .....+++..+..++.|++.||+|||+++ +|+||||||+|||+++++.+||+|||+
T Consensus 88 ~~-~~l~~~l~~~~--------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 88 MD-TSLDKFYKQVI--------DKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp CS-EEHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred hc-cchHHHHHHHH--------hcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCC
Confidence 97 58988885432 24467999999999999999999999842 899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCcccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYY----ISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
++..... .......|++.|+|||.+ .+..++.++||||||++++||++|+.||..
T Consensus 157 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 157 SGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 9875432 122334689999999996 566789999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=299.01 Aligned_cols=200 Identities=22% Similarity=0.327 Sum_probs=169.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCC-CceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH-KNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++...... +++.+|++++..++| +++..+..++...+..+|||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 3566789999999999999974 588999987654332 457899999999977 55666666777888999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE---cCCCcEEEEec
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL---NEKFQAKLADF 679 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl---~~~~~~kL~DF 679 (749)
+++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||+ ++++.+||+||
T Consensus 86 -g~sL~~ll~~-----------~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 86 -GPSLEDLFNF-----------CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp -CCBHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred -CCCHHHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 9999999953 234689999999999999999999999 99999999999999 58889999999
Q ss_pred CCCccccCCCCce-----eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSH-----VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+++.+....... ......||..|+|||.+.+..++.++|||||||+||||++|+.||.+...
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 9998765432211 12245699999999999999999999999999999999999999987543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=292.53 Aligned_cols=200 Identities=27% Similarity=0.353 Sum_probs=169.0
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcC-CC-----ceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HK-----NLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~-----nIv~l~g~~~~~~~~~L 597 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++.... ...+++..|+.++..++ |+ +++++.+++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 5666789999999999999875 4789999997543 34567788999998884 55 49999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc--CCCcEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN--EKFQAK 675 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~--~~~~~k 675 (749)
||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ +++.+|
T Consensus 134 v~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT----------NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEECCC-CBHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred EEecCC-CCHHHHHhhc----------CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 999996 5999999653 234589999999999999999999952 23899999999999995 477899
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999875322 23456899999999999999999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=291.20 Aligned_cols=202 Identities=23% Similarity=0.324 Sum_probs=155.6
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe-------eE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK-------MG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~-------~~ 596 (749)
.+.+.+.||+|+||.||+|+.. ++.||||++.... .....+.+|++.+.+++|+||+++++++..... .+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 4566789999999999999985 5889999986543 223566788889999999999999999865332 78
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceeeCCCCCcEEEcC-CCc
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH--DGCKPPIVHRDVKSANILLNE-KFQ 673 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH--~~~~~gIiHrDLkp~NILl~~-~~~ 673 (749)
+||||+++ +|...+.... .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 103 lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYY--------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp EEEECCSC-BHHHHHHHHH--------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred EEeecccc-cHHHHHHHHh--------hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 99999986 5655553321 24557889999999999999999999 77 9999999999999996 899
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 9999999998764322 223456899999999987654 899999999999999999999999876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=282.28 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=162.9
Q ss_pred hhcccccccccCceEEEEEEEC-CcccEEEEecCC--chhhHHHHHHHHHHHHhcC--CCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAH--HKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~--H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|.+.+.||+|+||.||+++.. ++.||||++... .....+.+.+|++++.+++ |+||+++++++...+..++|||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 3556789999999999999875 477999998654 3445678999999999996 5999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
+.+++|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||+++ +.+||+|||
T Consensus 109 -~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 109 -CGNIDLNSWLKK------------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp -CCSEEHHHHHHH------------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred -cCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence 668899999953 24688999999999999999999999 9999999999999975 799999999
Q ss_pred CCccccCCCCceeeeccccCCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-----------NRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+++.+.............|++.|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 9987654322222334568999999999875 46888999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=279.34 Aligned_cols=203 Identities=32% Similarity=0.471 Sum_probs=173.0
Q ss_pred HHHHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeE
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMG 596 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~ 596 (749)
......|.+.+.||+|+||.||+|+.. ++.||+|++.... ....+.+.+|++++.+++|+||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344556788899999999999999984 5889999986542 234578899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC---Cc
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---FQ 673 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~---~~ 673 (749)
+|+||+++++|.+.+... ..+++..+.+++.|+++||+|||+. +|+||||||+||+++.+ +.
T Consensus 98 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EEECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred EEEEccCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCccc
Confidence 999999999999988542 3588999999999999999999999 99999999999999754 47
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+||+|||+++...... ......+++.|+|||.+.+ .++.++||||||++++||++|+.||...+.
T Consensus 163 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp EEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999999998654321 1223358889999998865 489999999999999999999999986543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=311.01 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=168.6
Q ss_pred HhhcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
..+.+.+.||+|+||.||+|+... ..||+|++... .....+.|.+|+.++.+++||||+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 345667899999999999998742 45899998754 3344578999999999999999999999985 4568999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 469 ~E~~~~g~L~~~l~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 469 MELCTLGELRSFLQV-----------RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EECCTTCBHHHHHHH-----------TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEcCCCCcHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence 999999999999954 234589999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
||+++...... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+...
T Consensus 535 FG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 535 FGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99998764321 122223456789999999999999999999999999999997 9999987554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=285.38 Aligned_cols=199 Identities=23% Similarity=0.361 Sum_probs=170.1
Q ss_pred HHhhcccccccccCceEEEEEEEC--C-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCc------eeEEEEEEecCCe
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLD--D-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN------LTILVGYCDENTK 594 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~--~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n------Iv~l~g~~~~~~~ 594 (749)
...|.+.+.||+|+||+||+|+.. + ..||+|++.... ...+.+.+|++++.+++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 345677899999999999999874 3 579999997543 34567889999999997766 8999999999999
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE------
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL------ 668 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl------ 668 (749)
.++||||+ +++|.+.+... ....+++..+++++.|+++||+|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~----------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN----------NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEE
T ss_pred EEEEEecc-CCChHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccc
Confidence 99999999 67787777542 334689999999999999999999998 99999999999999
Q ss_pred -------------cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 037623 669 -------------NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735 (749)
Q Consensus 669 -------------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~ 735 (749)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 56789999999999864322 234568999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 037623 736 VIQKTPE 742 (749)
Q Consensus 736 pf~~~~~ 742 (749)
||.....
T Consensus 238 pf~~~~~ 244 (355)
T 2eu9_A 238 LFQTHEN 244 (355)
T ss_dssp SCCCSSH
T ss_pred CCCCCCH
Confidence 9987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=288.14 Aligned_cols=193 Identities=30% Similarity=0.396 Sum_probs=162.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe------e
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK------M 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~------~ 595 (749)
.|.+.+.||+|+||.||+|+.. ++.||||++... .....+.+.+|+.++.+++|+||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3556789999999999999874 588999998754 23345678999999999999999999999987654 4
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||++ ++|.+++. ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+|
T Consensus 105 ~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG--------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp EEEEECCS-EEGGGTTT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred EEEecccc-CCHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 99999997 57766551 2489999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||.+.+
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999864321 234568999999999877 678999999999999999999999998755
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.44 Aligned_cols=193 Identities=26% Similarity=0.381 Sum_probs=158.7
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec-----------
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE----------- 591 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----------- 591 (749)
..+.+.+.||+|+||.||+|+. +++.||||++... ....+.+.+|++++.+++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 3466778999999999999997 4588999998643 3445788999999999999999999998854
Q ss_pred --CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 592 --NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 592 --~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
....++||||+++|+|.+++.. ....+++..+.+++.|+++||+|||++ +|+||||||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS-----------ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID 150 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH-----------SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc-----------cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc
Confidence 4567899999999999999964 234578889999999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCC------------ceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHc
Q 037623 670 EKFQAKLADFGLSRIFPVEGG------------SHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELIT 732 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~Ellt 732 (749)
+++.+||+|||+++....... ........|++.|+|||.+.+. .++.++|||||||++|||++
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999987642210 1112344689999999999764 68999999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=287.51 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=164.9
Q ss_pred hhcccccccccCceEEEEEEECCcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+.+.+.||+|+||.||+|+..+ .+|+|++.... ....+.+.+|+.++.+++|+||+++++++...+..++||||++
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 34567899999999999999865 59999987542 2334567899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+++|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+++
T Consensus 113 ~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 113 GRTLYSVVRD-----------AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SEEHHHHTTS-----------SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CCcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999842 234688999999999999999999999 999999999999998 5699999999987
Q ss_pred cccCCCC---ceeeeccccCCcccCcccccc---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGG---SHVSTTVVGTPGYLDPEYYIS---------NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~---~~~~~~~~gt~~y~APE~~~~---------~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
....... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6532211 112223458899999999864 4578999999999999999999999986543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=283.73 Aligned_cols=195 Identities=23% Similarity=0.359 Sum_probs=142.6
Q ss_pred hhcc-cccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEEE
Q 037623 526 TNNF-ERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE----NTKMGLV 598 (749)
Q Consensus 526 t~~f-~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----~~~~~LV 598 (749)
.|.+ .++||+|+||+||+|+.. ++.||||++..... ...+....+..++|+||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 3445 357999999999999985 58999999875421 12223334566799999999999865 4558899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAK 675 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~k 675 (749)
|||+++|+|.+++... ....+++..+++++.|+++||+|||+. +|+||||||+|||++. ++.+|
T Consensus 105 ~e~~~gg~L~~~l~~~----------~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 105 MECMEGGELFSRIQER----------GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EECCTTEEHHHHHHTC-----------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEE
T ss_pred EeccCCCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEE
Confidence 9999999999999542 234689999999999999999999999 9999999999999986 44599
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++..... ......+|+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 172 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 172 LTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp ECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred Eeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999999865322 2234468999999999998899999999999999999999999997644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=279.00 Aligned_cols=201 Identities=23% Similarity=0.303 Sum_probs=149.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHH-HHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVE-LLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~-iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|+||.||+|+.. ++.||||++.... ....+++..|+. +++.++|+||+++++++...+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 445688999999999999985 5889999997653 333455666666 667789999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++ +|.+++..... .....+++..+.+++.|+++||.|||+. .+|+||||||+|||+++++.+||+|||++
T Consensus 104 ~~-~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 104 ST-SFDKFYKYVYS-------VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SE-EHHHHHHHHHH-------TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CC-ChHHHHHHHHh-------hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 75 88888753221 1245689999999999999999999984 27999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCcccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYY----ISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+..... .......|++.|+|||.+ .+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 174 GQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred eecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 876432 112234689999999998 4667899999999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=283.16 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=162.6
Q ss_pred HHHHHhhcccccccccCceEEEEEEE--CCcccEEEEecCCchh------hHHHHHHHHHHHHhc----CCCceeEEEEE
Q 037623 521 NVLKITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ------GYKQFQAEVELLMRA----HHKNLTILVGY 588 (749)
Q Consensus 521 ~l~~~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~l----~H~nIv~l~g~ 588 (749)
+.....|.+.+.||+|+||.||+|+. +++.||||++...... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34455677889999999999999987 4578999999765321 233466799999998 89999999999
Q ss_pred EecCCeeEEEEee-CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEE
Q 037623 589 CDENTKMGLVYEF-MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 589 ~~~~~~~~LV~Ey-~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
+...+..++|+|+ +++++|.+++... ..+++..+++++.|+++||+|||+. +|+||||||+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 171 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK------------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENIL 171 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEE
Confidence 9999999999999 8899999999542 3589999999999999999999999 9999999999999
Q ss_pred Ec-CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 037623 668 LN-EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLT-EKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 668 l~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
++ +++.+||+|||+++..... ......|+..|+|||++.+..+. .++||||||++++||++|+.||..
T Consensus 172 ~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 172 IDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99 8899999999999876432 12345689999999999877664 589999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=283.99 Aligned_cols=196 Identities=25% Similarity=0.402 Sum_probs=167.8
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchh------hHHHHHHHHHHHHhcC--CCceeEEEEEEecCCe
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQ------GYKQFQAEVELLMRAH--HKNLTILVGYCDENTK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~l~--H~nIv~l~g~~~~~~~ 594 (749)
..|.+.+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++.+++ |+||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 3466779999999999999987 4588999998754321 2245678999999996 5999999999999999
Q ss_pred eEEEEeeCCC-CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc-CCC
Q 037623 595 MGLVYEFMAN-GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKF 672 (749)
Q Consensus 595 ~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~-~~~ 672 (749)
.++|+|++.+ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++ +++
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE------------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTT
T ss_pred EEEEEEcCCCCccHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCC
Confidence 9999999986 899999854 24588999999999999999999999 999999999999999 788
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
.+||+|||+++..... ......||+.|+|||++.+... +.++||||||+++|||++|+.||..
T Consensus 188 ~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 188 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999876432 1234568999999999987765 6889999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=284.72 Aligned_cols=198 Identities=25% Similarity=0.384 Sum_probs=165.5
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcC-----------CCceeEEEEEEec
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-----------HKNLTILVGYCDE 591 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-----------H~nIv~l~g~~~~ 591 (749)
..|.+.+.||+|+||+||+|+. +++.||||++.... ...+.+.+|++++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 3466789999999999999997 45889999997543 34567889999998886 8899999999875
Q ss_pred CC----eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEE
Q 037623 592 NT----KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANIL 667 (749)
Q Consensus 592 ~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NIL 667 (749)
.+ ..++||||+ +++|.+++... ....+++..+.+++.|++.||+|||+++ +|+||||||+|||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIl 164 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY----------EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 164 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh----------hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeE
Confidence 44 788999999 89999999643 2345899999999999999999999853 8999999999999
Q ss_pred Ec------CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 668 LN------EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 668 l~------~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
++ +.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 4458999999999865322 233468999999999999999999999999999999999999998644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=291.46 Aligned_cols=199 Identities=25% Similarity=0.362 Sum_probs=153.2
Q ss_pred cccccccCceEEEEE-EECCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 530 ERVLGKGGFGTVYHG-YLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg-~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.+.||+|+||+||.+ ..+++.||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++||||++ |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 578999999999654 5567999999986432 35678999999886 89999999999999999999999995 699
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-------------CcE
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-------------FQA 674 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-------------~~~ 674 (749)
.+++...... ........+..+++++.|++.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 96 ~~~l~~~~~~-----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 96 QDLVESKNVS-----DENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp HHHHHTC-----------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred HHHHhccCCC-----chhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9999643110 00111123445678999999999999999 99999999999999754 489
Q ss_pred EEEecCCCccccCCCCce--eeeccccCCcccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 037623 675 KLADFGLSRIFPVEGGSH--VSTTVVGTPGYLDPEYYIS-------NRLTEKSDVYSFGVVLLELIT-GQPVIQKT 740 (749)
Q Consensus 675 kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~-------~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~ 740 (749)
||+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 999999998765432111 1234569999999999975 678999999999999999999 99999754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=282.87 Aligned_cols=192 Identities=18% Similarity=0.194 Sum_probs=162.0
Q ss_pred HHhhcccccccccCceEEEEEEECCcccEEEEecCCc--------hhhHHHHHHHHHHHHhcC---------CCceeEEE
Q 037623 524 KITNNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSS--------VQGYKQFQAEVELLMRAH---------HKNLTILV 586 (749)
Q Consensus 524 ~~t~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~l~---------H~nIv~l~ 586 (749)
...|.+.+.||+|+||+||+|+.+++.||||++.... ....+.+.+|+.++++++ |+|++++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3456778999999999999999988999999997542 223477899999998885 89999888
Q ss_pred EEEe------------------------------cCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHH
Q 037623 587 GYCD------------------------------ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636 (749)
Q Consensus 587 g~~~------------------------------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ 636 (749)
+.+. ..+..++||||+++|++.+.+. ...+++..+..
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-------------~~~~~~~~~~~ 165 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-------------TKLSSLATAKS 165 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-------------TTCCCHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-------------hcCCCHHHHHH
Confidence 8753 2678999999999997766552 24579999999
Q ss_pred HHHHHHHHHHHHH-hCCCCCceeeCCCCCcEEEcCCC--------------------cEEEEecCCCccccCCCCceeee
Q 037623 637 IATESAQGLEYLH-DGCKPPIVHRDVKSANILLNEKF--------------------QAKLADFGLSRIFPVEGGSHVST 695 (749)
Q Consensus 637 ia~~ia~gL~yLH-~~~~~gIiHrDLkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~ 695 (749)
++.|++.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 88 999999999999999887 8999999999876421
Q ss_pred ccccCCcccCccccccCCCCCchhHHHHHHH-HHHHHcCCCCCCC
Q 037623 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVV-LLELITGQPVIQK 739 (749)
Q Consensus 696 ~~~gt~~y~APE~~~~~~~s~k~DVwSfGvv-L~ElltG~~pf~~ 739 (749)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||..
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 336999999999998766 899999998766 7888999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.68 Aligned_cols=197 Identities=30% Similarity=0.408 Sum_probs=155.7
Q ss_pred hcccccccccCceE-EEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGT-VYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~-Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+...+.||+|+||+ ||++..+++.||||++..... +.+.+|++++.++ +||||+++++++.+....++||||++
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 45568999999998 566667789999999875432 3357899999999 89999999999999999999999996
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-----CCcEEEEec
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-----KFQAKLADF 679 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-----~~~~kL~DF 679 (749)
|+|.+++... ...+.+..++.++.|+++||+|||+. +|+||||||+|||++. ...+||+||
T Consensus 102 g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 102 ATLQEYVEQK-----------DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EEHHHHHHSS-----------SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred CCHHHHHHhc-----------CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 6999998532 22233445678999999999999999 9999999999999953 336889999
Q ss_pred CCCccccCCCCc-eeeeccccCCcccCccccc---cCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 037623 680 GLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYI---SNRLTEKSDVYSFGVVLLELIT-GQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~~~---~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~ 741 (749)
|+++........ .......||+.|+|||++. ...++.++|||||||+++||++ |+.||....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 999876433211 2233456999999999997 4567889999999999999999 999997543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=307.04 Aligned_cols=191 Identities=24% Similarity=0.339 Sum_probs=163.6
Q ss_pred HhhcccccccccCceEEEEEEEC---CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCe-----e
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTK-----M 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~-----~ 595 (749)
..|.+.+.||+|+||.||+|++. ++.||||++... .....+.+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45677899999999999999873 578999998754 33445678999999999999999999999987554 6
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
+|||||+++++|.+++. ..+++..+++++.|+++||+|||++ +|+||||||+|||++++ .+|
T Consensus 160 ~lv~E~~~g~~L~~~~~--------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG--------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp EEEEECCCCEECC------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEE
T ss_pred EEEEEeCCCCcHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEE
Confidence 99999999999987662 1589999999999999999999999 99999999999999986 999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+|||+++..... ....||+.|+|||++.++. +.++|||||||+++||++|.+||.+.
T Consensus 222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred EEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 9999999875422 3456999999999987665 89999999999999999999998753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-30 Score=272.61 Aligned_cols=196 Identities=25% Similarity=0.312 Sum_probs=147.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hh-HHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QG-YKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~-~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
+.+.+.||+|+||.||+|+.. ++.||||++..... .. .+.+.++..++..++|+||+++++++...+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 455689999999999999984 58899999976532 22 233445556778889999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++.+..+... ....+++..+.+++.|+++||+|||+ . +|+||||||+|||++.++.+||+|||+
T Consensus 107 -~~~~~~l~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 107 -GTCAEKLKKR-----------MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp -SEEHHHHHHH-----------HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred -CCcHHHHHHH-----------hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 4555544432 23468999999999999999999998 5 899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
++..... .......+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 172 SGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred chhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 9765432 1223446899999999994 556889999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=300.17 Aligned_cols=200 Identities=28% Similarity=0.384 Sum_probs=171.0
Q ss_pred HhhcccccccccCceEEEEEEE--CCcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEec------CCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE------NTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------~~~~ 595 (749)
..|.+.+.||+|+||.||+|.. +++.||||++... .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3567789999999999999987 3588999998764 44456779999999999999999999999765 6778
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc--
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-- 673 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~-- 673 (749)
++||||+++|+|.+++... .....+++..+..++.+++.||+|||+. +|+||||||+|||++.++.
T Consensus 94 ~LVmEy~~ggsL~~~L~~~---------~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF---------ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS---------SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSC
T ss_pred EEEEEeCCCCCHHHHHHhc---------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCce
Confidence 9999999999999999542 2234588889999999999999999998 9999999999999997664
Q ss_pred -EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 674 -AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 674 -~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+||+|||+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp EEEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999999999876432 222345789999999999999999999999999999999999999965
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=263.57 Aligned_cols=175 Identities=14% Similarity=0.097 Sum_probs=151.0
Q ss_pred HHHhhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 523 LKITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 523 ~~~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
....|.+.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++.+++|+||+++++++...+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3345777899999999999999985 5889999997653 3345789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++++|.+++.. . ....++.+++.|+++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 109 v~e~~~g~~L~~~l~~-------------~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-------------S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEECCCEEEHHHHHTT-------------C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEecCCCCHHHHHhc-------------C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEE
Confidence 9999999999999831 1 24557889999999999999999 99999999999999999999998
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
++| |++ .++.++|||||||++|||+||+.||.+.+..
T Consensus 172 ~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 172 YPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp SCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 543 333 2588999999999999999999999876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=282.12 Aligned_cols=199 Identities=19% Similarity=0.158 Sum_probs=152.5
Q ss_pred ccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHHHHHHHHHhcCC-Cc----------eeEE-------
Q 037623 529 FERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHH-KN----------LTIL------- 585 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~l~H-~n----------Iv~l------- 585 (749)
..+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+.++..++| +| ++.+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4578999999999999975 68999999874322 235789999999999977 21 1111
Q ss_pred ----EEEEec-----CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 037623 586 ----VGYCDE-----NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPI 656 (749)
Q Consensus 586 ----~g~~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gI 656 (749)
..+... ....+++|+++ +++|.+++...... ......+++..++.++.|+++||+|||++ +|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~-----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH-----SSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHH-----TTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc-----cccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 111111 22356677755 78999988532110 12345688999999999999999999999 99
Q ss_pred eeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCcccc----------ccCCCCCchhHHHHHHH
Q 037623 657 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYY----------ISNRLTEKSDVYSFGVV 726 (749)
Q Consensus 657 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~k~DVwSfGvv 726 (749)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999886421 1334467 999999999 55668899999999999
Q ss_pred HHHHHcCCCCCCCCCc
Q 037623 727 LLELITGQPVIQKTPE 742 (749)
Q Consensus 727 L~ElltG~~pf~~~~~ 742 (749)
+|||++|+.||...+.
T Consensus 307 l~elltg~~Pf~~~~~ 322 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAA 322 (413)
T ss_dssp HHHHHHSSCCCCTTGG
T ss_pred HHHHHHCCCCCCCcch
Confidence 9999999999987544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=259.55 Aligned_cols=169 Identities=25% Similarity=0.415 Sum_probs=145.9
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHH-HhcCCCceeEEEEEEec----CCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELL-MRAHHKNLTILVGYCDE----NTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL-~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~ 603 (749)
+.||+|+||.||++.. +++.||+|++... ..+.+|++++ +..+|+||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 7899999999999988 4588999998643 4567888888 55699999999999876 677899999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEEEEecC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAKLADFG 680 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~kL~DFG 680 (749)
+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 99 ~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 99 GGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp SCBHHHHHHHC----------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999642 334689999999999999999999999 9999999999999998 7889999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+++... +..++.++|||||||++|||++|+.||....
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 987532 2346789999999999999999999997644
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-28 Score=276.96 Aligned_cols=185 Identities=16% Similarity=0.099 Sum_probs=129.5
Q ss_pred ccccccCceEEEEEE--ECCcccEEEEecCC----------chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEE
Q 037623 531 RVLGKGGFGTVYHGY--LDDKQVAVKMLSPS----------SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~--~~~~~VAVK~l~~~----------~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~L 597 (749)
...+.|+.|.+..++ .-++.++||++... .....++|.+|+++|+++ +|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456667777666543 35788999998653 123356799999999999 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||++|++|.++|.. .+.++.. +|+.||+.||+|+|++ |||||||||+|||+++++++||+
T Consensus 320 VMEyv~G~~L~d~i~~------------~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA------------GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp EEECCCSEEHHHHHHT------------TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHHh------------CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEe
Confidence 9999999999999953 2345543 5889999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
|||+|+..... ........||+.|||||++.+ ....++|+|++|++++++.+|..+
T Consensus 382 DFGlAr~~~~~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 382 DFGSIVTTPQD--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ecccCeeCCCC--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 99999876432 222345679999999999865 467789999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-25 Score=252.96 Aligned_cols=184 Identities=15% Similarity=0.183 Sum_probs=147.2
Q ss_pred cccccccCceEEEEEEECCcccEEEEecCCch--------hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 530 ERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSV--------QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 530 ~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
.+.||+|+||+||+|...+..+++|+...... ...+++.+|++++.+++|+||+++..++...+..+|||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 46899999999999988889999998654321 1135589999999999999999666666677788999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++++|.+++.. +++++.|+++||+|||++ +|+||||||+|||+++ ++||+|||+
T Consensus 421 ~~ggsL~~~l~~--------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 421 INGKLAKDVIED--------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp CCSEEHHHHSTT--------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTT
T ss_pred CCCCCHHHHHHH--------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999831 458999999999999999 9999999999999999 999999999
Q ss_pred CccccCCCCce-----eeeccccCCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 682 SRIFPVEGGSH-----VSTTVVGTPGYLDPEYYIS--NRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 682 a~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~--~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
++......... ......||+.|||||++.. ..|+.++|+|+..+-.++.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99764321111 1234579999999999976 567888999999999999998887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-21 Score=204.10 Aligned_cols=153 Identities=14% Similarity=0.125 Sum_probs=119.4
Q ss_pred ccccccccCceEEEEEEEC-CcccEEEEecCCch------------------hhHHHHHHHHHHHHhcCCCceeEEEEEE
Q 037623 529 FERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV------------------QGYKQFQAEVELLMRAHHKNLTILVGYC 589 (749)
Q Consensus 529 f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~------------------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~ 589 (749)
+.+.||+|+||.||+|... ++.||||+++.... .....+.+|++++.+++| +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 4589999999999999984 58899999864321 134578999999999994 5555544
Q ss_pred ecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 590 DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 590 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
.. +..++||||+++|+|.+ +. . .....++.|+++||+|||+. +|+||||||+|||++
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~------------~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VR------------V------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CC------------C------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred ec-cceEEEEEecCCCcHHH-cc------------h------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 33 56699999999999977 41 0 12346999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCCceeeeccccCCcccCcccccc----------CCCCCchhHHHH
Q 037623 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS----------NRLTEKSDVYSF 723 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~----------~~~s~k~DVwSf 723 (749)
++.+||+|||+++.. ..++|||++.. .++..++|+|.+
T Consensus 228 -~~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp -TTEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred -CCcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999999999998742 34788998753 345666677653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=173.66 Aligned_cols=134 Identities=21% Similarity=0.234 Sum_probs=103.0
Q ss_pred cccccccccCceEEEEEEE--CCcc--cEEEEecCCchh------------------------hHHHHHHHHHHHHhcCC
Q 037623 528 NFERVLGKGGFGTVYHGYL--DDKQ--VAVKMLSPSSVQ------------------------GYKQFQAEVELLMRAHH 579 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~--~~~~--VAVK~l~~~~~~------------------------~~~~f~~Ei~iL~~l~H 579 (749)
.+.+.||+|+||.||+|.. +++. ||||+++..... ....+.+|+.++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4568899999999999988 6778 999987543111 11367899999999988
Q ss_pred Cce--eEEEEEEecCCeeEEEEeeCCC-C----CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHH-hC
Q 037623 580 KNL--TILVGYCDENTKMGLVYEFMAN-G----NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLH-DG 651 (749)
Q Consensus 580 ~nI--v~l~g~~~~~~~~~LV~Ey~~~-g----sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH-~~ 651 (749)
+++ ...+.+ ...+|||||+.+ | +|.+.... .++..+..++.|+++||.||| +.
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------------~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------------LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------------cChHHHHHHHHHHHHHHHHHHHHC
Confidence 754 334432 356899999942 4 66554321 123456789999999999999 87
Q ss_pred CCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 652 CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 652 ~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|+||||||+|||+++ .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 9999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-14 Score=157.29 Aligned_cols=134 Identities=12% Similarity=0.094 Sum_probs=96.6
Q ss_pred hcccccccccCceEEEEEEEC-CcccEEEEecCCchh--------------hH--------HHHHHHHHHHHhcCCCcee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSVQ--------------GY--------KQFQAEVELLMRAHHKNLT 583 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~~--------------~~--------~~f~~Ei~iL~~l~H~nIv 583 (749)
|.+.+.||+|++|.||+|... ++.||||+++..... .. ....+|...|.++++.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 556789999999999999874 588999987542100 00 1124567777777655542
Q ss_pred --EEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCC
Q 037623 584 --ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDV 661 (749)
Q Consensus 584 --~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDL 661 (749)
..+++ ...+|||||+++++|..+. +.....+++.|++.+|.+||+. |||||||
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~------------------~~~~~~~l~~qll~~l~~lH~~---gIVHrDL 231 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVS------------------SVPDPASLYADLIALILRLAKH---GLIHGDF 231 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCC------------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhc------------------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence 22222 1347999999988874332 0112356889999999999998 9999999
Q ss_pred CCCcEEEcCCC----------cEEEEecCCCccc
Q 037623 662 KSANILLNEKF----------QAKLADFGLSRIF 685 (749)
Q Consensus 662 kp~NILl~~~~----------~~kL~DFGla~~~ 685 (749)
||.|||+++++ .+.|+||+.+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998876 3899999987543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.8e-11 Score=118.66 Aligned_cols=143 Identities=13% Similarity=0.143 Sum_probs=97.5
Q ss_pred eeeecCCCCCCCcccCCCceEEecCCccccCCCceecccc----ccccccccccccccccccCccceeeecccCCCCeeE
Q 037623 2 ISIDCGIPENANYTDSITGINYVSDASNIDTGVSHKISSE----FNKEITERQFSNLRSFPEGIRNCYTLKPDSDHEKFL 77 (749)
Q Consensus 2 ~sidCg~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~~----~~~~~~~~~~~tlR~Fp~~~~nCy~~~~~~~~~~yl 77 (749)
..||||++. .+|. .|++|.+|..|...|........ .........|+|.|+||. .-+|.+ |+.++|+|+
T Consensus 8 ~~INcGg~~---~~d~-~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~--~~tY~f-~v~~~G~Y~ 80 (174)
T 2jwp_A 8 WAVNAGGES---HVDV-HGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED--SFGYDI-PIKEEGEYV 80 (174)
T ss_dssp EEEEETSSS---EEET-TTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS--CEEEEE-ECCSCEEEE
T ss_pred EEEECCCCC---ccCC-CCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC--CeEEEE-EeCCCeEEE
Confidence 369999743 3565 79999999988644432211111 111233567999999985 569999 566789999
Q ss_pred EEEEEeeccCCCCCCCCceeEEecceeEE-EEEcC---CCCCcEEEEEEEe-------------ccCCceEEEEeecCCC
Q 037623 78 IRARFMYGNYNGQDKPPSFNLMLEADVWD-SVQFP---DSGSIVSKEIIHI-------------PKREYIHVCLVNTDSG 140 (749)
Q Consensus 78 vR~~f~ygnyd~~~~~p~fd~~~~~~~w~-~v~~~---~~~~~~~~e~~~~-------------~~~~~~~vCl~~t~~~ 140 (749)
||+.|.--.|.. .....||+++++.... -.++. .....++.|..+. ..++.+.|.|.....+
T Consensus 81 VrLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~ 159 (174)
T 2jwp_A 81 LVLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYD 159 (174)
T ss_dssp EEEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSC
T ss_pred EEEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCC
Confidence 999998777654 4557899999996542 33422 1233555666554 3566788999864467
Q ss_pred CceeeeeeeeeC
Q 037623 141 TPFISALELRPL 152 (749)
Q Consensus 141 ~Pfis~lEl~~l 152 (749)
.||||+||+.+-
T Consensus 160 ~a~inaIEI~~~ 171 (174)
T 2jwp_A 160 NPKVCALFIMKG 171 (174)
T ss_dssp SSSEEEEEEESS
T ss_pred CcEEEEEEEEeC
Confidence 899999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.1e-11 Score=123.78 Aligned_cols=141 Identities=11% Similarity=0.064 Sum_probs=109.9
Q ss_pred hcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.+...++.|+.+.||+....++.+++|+...........+.+|++++..+. |..+.++++++...+..++||||++|.
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 4456778888889999998878899999987532223346889999999884 566778999998888999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC--------------------------------- 652 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--------------------------------- 652 (749)
+|.+.+. +.....+++.+++++|+.||+..
T Consensus 96 ~l~~~~~-----------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 96 LCSEEYE-----------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EHHHHCC-----------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred ehhhccC-----------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9876531 01123467889999999999810
Q ss_pred -----------------------CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 -----------------------KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 -----------------------~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998876678999998764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.13 E-value=3.9e-11 Score=144.14 Aligned_cols=104 Identities=16% Similarity=0.275 Sum_probs=89.3
Q ss_pred ccchhHHHHHHHHHhcccCCCCCCCC----CCCCCCcc------------eeeecCCCCCCCCceeEEEccCCcceeecc
Q 037623 351 HIKISVDAIMNIKSKYELLRDWQGDP----CAPNDYLW------------QGLNCSYDANQAPRIKSLNLSSSGIAGEIL 414 (749)
Q Consensus 351 ~~~~~~~~l~~~k~~~~~~~~W~~dp----c~p~~~~w------------~Gv~C~~~~~~~~~l~~l~Ls~n~l~G~ip 414 (749)
....|..||++||++++.. +|+.+. +.|..|.| .||+|+. ..+|+.|+|++|+|+|.||
T Consensus 266 ~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~----~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN----NGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT----TSCEEEEECTTTCCEEEEC
T ss_pred cchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecC----CCCEEEEECccCCCCCcCc
Confidence 3346889999999998655 896433 23334689 9999975 2589999999999999999
Q ss_pred cCccCCCCCCeEEC-cCCccccC---------------------------------------------------------
Q 037623 415 PHIFSLTSIESLDL-SNNSLTGS--------------------------------------------------------- 436 (749)
Q Consensus 415 ~~~~~l~~L~~l~l-s~N~l~G~--------------------------------------------------------- 436 (749)
++|++|++|+.|+| ++|.|+|.
T Consensus 341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 99999999999999 88887776
Q ss_pred -------------------cchhhhhhhchhccccCCCCccc
Q 037623 437 -------------------VPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 437 -------------------iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
||+.++++++|+.|.+++|.+.+
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg 462 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY 462 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCG
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCC
Confidence 99999999999999999999988
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.13 E-value=3.2e-11 Score=128.33 Aligned_cols=106 Identities=26% Similarity=0.428 Sum_probs=89.0
Q ss_pred ccchhHHHHHHHHHhcc---cCCCCCC--CCCCCCCCcceeeecCCCCCCCCceeEEEccCCccee--ecccCccCCCCC
Q 037623 351 HIKISVDAIMNIKSKYE---LLRDWQG--DPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAG--EILPHIFSLTSI 423 (749)
Q Consensus 351 ~~~~~~~~l~~~k~~~~---~~~~W~~--dpc~p~~~~w~Gv~C~~~~~~~~~l~~l~Ls~n~l~G--~ip~~~~~l~~L 423 (749)
+.++|++||++||+.++ .+.+|+. |||. +.|.||.|+.. ....+|+.|+|++|+++| .+|+.++++++|
T Consensus 3 c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~---~~w~gv~C~~~-~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHHHHHHhcCCcccccCCCCCCCCCc---CCCcceEeCCC-CCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 45678899999999984 4578953 4552 24999999743 223689999999999999 999999999999
Q ss_pred CeEECcC-CccccCcchhhhhhhchhccccCCCCcccC
Q 037623 424 ESLDLSN-NSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 424 ~~l~ls~-N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
++|+|++ |+++|.+|..++++++|+.|.+++|.+.+.
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 116 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc
Confidence 9999995 999999999999999999999999888743
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-10 Score=112.52 Aligned_cols=147 Identities=12% Similarity=0.007 Sum_probs=91.1
Q ss_pred eEEeeecCCCCCccccCCCCCCCCccccCCCCC-ceeecc-ccccCCCCCCCCcHHHHhhceecCCCCcceEEEecCCCC
Q 037623 166 RYGRWDVGSTTNKTFRYPDDVYDRIWFPHNFYS-WAQIST-SSNMKSTGNFQPPSTVMQSAVIPANGGSSLMLSWKPANR 243 (749)
Q Consensus 166 ~~~R~~~G~~~~~~~ryp~D~~dR~W~p~~~~~-~~~~st-~~~~~~~~~~~~P~~v~~tA~~~~~~~~~l~~~w~~~~~ 243 (749)
.+.|.|||+.. +. |..+|.|.++.... ....+. ...........+|..|+|||-.. +.+++|..+-.
T Consensus 6 ~~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~-----~~~~tY~f~v~ 74 (174)
T 2jwp_A 6 VIWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYN-----EDSFGYDIPIK 74 (174)
T ss_dssp EEEEEEETSSS---EE---ETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCC-----CSCEEEEEECC
T ss_pred EEEEEECCCCC---cc---CCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccC-----CCCeEEEEEeC
Confidence 46799999753 22 67899999874321 011110 11111112234588999999652 23577876533
Q ss_pred -ccceEEEEeeeccccccccCcceEEEEEECCeeccCCCCccccee--eeE-----Ee---------cccccCCceeEEE
Q 037623 244 -MIKNYVYFYFSEFESERAKNQTRDLNIYINGKLWYGPLSPSYLDT--DTV-----FS---------TTPTMNRDRHDII 306 (749)
Q Consensus 244 -~~~~~~~~~Faei~~~~~~~~~Rvf~i~lng~~~~~~~~p~~~~~--~~l-----~~---------~~~~~~~~~~~is 306 (749)
.-.|.|.|||+|+.- .....|+|+|++||+.+...+.+..... ..+ .. ..+....+.++|+
T Consensus 75 ~~G~Y~VrLhF~ei~~--~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~ 152 (174)
T 2jwp_A 75 EEGEYVLVLKFAEVYF--AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVE 152 (174)
T ss_dssp SCEEEEEEEEEECCSC--CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEE
T ss_pred CCeEEEEEEEEecccc--CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEE
Confidence 457889999999974 4467899999999988766555322110 011 10 0011356789999
Q ss_pred EEeCCCCCCCcchhheeeeee
Q 037623 307 INTTENSALPPILNALEIYQV 327 (749)
Q Consensus 307 l~~t~~s~lpPiinA~Ei~~~ 327 (749)
+.|.. .-.|+|||+||++.
T Consensus 153 f~p~~--~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 153 FVKGY--YDNPKVCALFIMKG 171 (174)
T ss_dssp EECSS--SCSSSEEEEEEESS
T ss_pred EeccC--CCCcEEEEEEEEeC
Confidence 98753 45799999999964
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=9.7e-10 Score=112.71 Aligned_cols=129 Identities=15% Similarity=0.084 Sum_probs=93.3
Q ss_pred ccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCce--eEEEEEEecCCeeEEEEeeCCCCCHHH
Q 037623 533 LGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL--TILVGYCDENTKMGLVYEFMANGNLQA 609 (749)
Q Consensus 533 LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nI--v~l~g~~~~~~~~~LV~Ey~~~gsL~~ 609 (749)
.+.|..+.||+....+ ..+++|+.... ....+.+|+++++.+++.++ .+++++....+..++||||++|.+|.
T Consensus 28 ~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 28 TIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred ccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 3456669999997654 67999997654 22457889999999865554 45888888777889999999998873
Q ss_pred HHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 037623 610 HLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC------------------------------------- 652 (749)
Q Consensus 610 ~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~------------------------------------- 652 (749)
.. . .+ ...++.++++.|..||+..
T Consensus 104 -~~------------~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 104 -SS------------H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp -TS------------C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred -cC------------c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 20 0 01 1245566666666666531
Q ss_pred ------------------CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 ------------------KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 ------------------~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
.+.++|+|++|.|||++++..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.93 E-value=6.6e-10 Score=129.97 Aligned_cols=97 Identities=24% Similarity=0.335 Sum_probs=82.9
Q ss_pred hhHHHHHHHHHhcccC------------CCCCCC-CCCCCCCcc---eeeecCCCCCCCCceeEEEccCCcceeecccCc
Q 037623 354 ISVDAIMNIKSKYELL------------RDWQGD-PCAPNDYLW---QGLNCSYDANQAPRIKSLNLSSSGIAGEILPHI 417 (749)
Q Consensus 354 ~~~~~l~~~k~~~~~~------------~~W~~d-pc~p~~~~w---~Gv~C~~~~~~~~~l~~l~Ls~n~l~G~ip~~~ 417 (749)
.|..||++|+.+.+.. .+|+.+ +| |.| .||+|+.. .+|+.|+|++|+|+|.||+++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~----c~w~~~~GV~C~~~----~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL----DMWGAQPGVSLNSN----GRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG----GGTTCCTTEEECTT----CCEEEEECTTSCCEEEECGGG
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc----ccccCCCCeEEcCC----CCEEEEEecCcccCCcCChHH
Confidence 5889999999886422 257532 22 379 99999753 599999999999999999999
Q ss_pred cCCCCCCeEECcCC------------------------------------------------------------------
Q 037623 418 FSLTSIESLDLSNN------------------------------------------------------------------ 431 (749)
Q Consensus 418 ~~l~~L~~l~ls~N------------------------------------------------------------------ 431 (749)
++|++|++|+|++|
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 99999999999988
Q ss_pred ------------ccccCcchhhhhhhchhccccCCCCccc
Q 037623 432 ------------SLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 432 ------------~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+|+| ||+.++++++|+.|++++|.+.+
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~ 220 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA 220 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCG
T ss_pred chhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccc
Confidence 5567 99999999999999999999988
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=6.7e-10 Score=132.80 Aligned_cols=100 Identities=26% Similarity=0.400 Sum_probs=78.5
Q ss_pred cchhHHHHHHHHHhcc---cCCCCC-CCCCCCCCCcceeeecCCCCCCCCceeEEEccCCcceee---cc----------
Q 037623 352 IKISVDAIMNIKSKYE---LLRDWQ-GDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGE---IL---------- 414 (749)
Q Consensus 352 ~~~~~~~l~~~k~~~~---~~~~W~-~dpc~p~~~~w~Gv~C~~~~~~~~~l~~l~Ls~n~l~G~---ip---------- 414 (749)
..+|++||++||+.+. .+.+|+ ++.| |.|.||+|+ ..+|+.|||++++++|. ||
T Consensus 10 ~~~~~~all~~k~~~~~~~~l~~W~~~~~~----C~w~gv~C~-----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 10 LYREIHQLISFKDVLPDKNLLPDWSSNKNP----CTFDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp HHHHHHHHHHHHTTCSCTTSSTTCCTTSCG----GGSTTEEEE-----TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CHHHHHHHHHHHhhCCCcccccCCCCCCCC----cCCcceEEC-----CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 4468899999999874 567995 3334 379999996 24788888888888887 54
Q ss_pred -------------cCccCCCCCCeEECcCCccccCcch--hhhhhhchhccccCCCCcccC
Q 037623 415 -------------PHIFSLTSIESLDLSNNSLTGSVPE--FLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 415 -------------~~~~~l~~L~~l~ls~N~l~G~iP~--~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+.++++++|++|||++|+++|.+|. .++++++|+.|.+++|.+.+.
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~ 141 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECC
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCc
Confidence 3577788888888888888888888 888888888888888877654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.6e-09 Score=115.67 Aligned_cols=140 Identities=14% Similarity=0.178 Sum_probs=105.6
Q ss_pred ccccccCceEEEEEEECCcccEEEEec--CCc-hhhHHHHHHHHHHHHhcCC--CceeEEEEEEecC---CeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLS--PSS-VQGYKQFQAEVELLMRAHH--KNLTILVGYCDEN---TKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~--~~~-~~~~~~f~~Ei~iL~~l~H--~nIv~l~g~~~~~---~~~~LV~Ey~ 602 (749)
+.|+.|.++.||+....+..+++|+.. ... ......+.+|..++..+++ ..+.++++++.+. +..++||||+
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 568999999999999888889999876 332 1223567889999999864 4577888888765 4588999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC------------------------------ 652 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~------------------------------ 652 (749)
+|..+.+. ....++...+..++.++++.|+.||+..
T Consensus 124 ~G~~l~~~--------------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 124 SGRVLWDQ--------------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp CCBCCCCT--------------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred CCeecCCC--------------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 98766321 1223677888899999999999999731
Q ss_pred -------------------------CCCceeeCCCCCcEEEcCCCc--EEEEecCCCcc
Q 037623 653 -------------------------KPPIVHRDVKSANILLNEKFQ--AKLADFGLSRI 684 (749)
Q Consensus 653 -------------------------~~gIiHrDLkp~NILl~~~~~--~kL~DFGla~~ 684 (749)
.+.++|+|+++.|||+++++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=3.5e-09 Score=111.91 Aligned_cols=183 Identities=20% Similarity=0.189 Sum_probs=117.4
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCc--eeEEEEEEecCC---eeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKN--LTILVGYCDENT---KMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~n--Iv~l~g~~~~~~---~~~LV~Ey~~~ 604 (749)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +...++.....+ ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458899999999763 67888886532 33467889999998883 332 234444433332 34789999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG--------------------------------- 651 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~--------------------------------- 651 (749)
..|...... .++..++..++.++++.|+.||+.
T Consensus 101 ~~l~~~~~~--------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 101 VPLTPLLLN--------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp EECCHHHHH--------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred eECCccccc--------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 888654321 245555666666666666666641
Q ss_pred ----------------------CCCCceeeCCCCCcEEEcC--CCcEEEEecCCCccccCCCCceeeeccccCCcc---c
Q 037623 652 ----------------------CKPPIVHRDVKSANILLNE--KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY---L 704 (749)
Q Consensus 652 ----------------------~~~gIiHrDLkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y---~ 704 (749)
..+.++|+|+++.||++++ +..+.|+||+.+....+.. .. ...... .
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl----~~~~~~~~~~ 240 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DF----ISLMEDDEEY 240 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HH----HTTCCTTTSC
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HH----HHHHhhcccc
Confidence 1245899999999999998 5568999999887542210 00 000011 1
Q ss_pred Ccccccc-----CC---------CCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 705 DPEYYIS-----NR---------LTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 705 APE~~~~-----~~---------~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
.|+.... +. .....+.|+++.+++++.+|+.+|-
T Consensus 241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 2221110 01 1223689999999999999998874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.76 E-value=2.3e-09 Score=113.94 Aligned_cols=64 Identities=17% Similarity=0.390 Sum_probs=39.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhh-chhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQ-FLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~-~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.++|.+|..++++++|++|+|++|+++|.+|..++++. .|+.|.+++|.+.+
T Consensus 124 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~ 188 (313)
T 1ogq_A 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE
T ss_pred CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeec
Confidence 45566666666666666655566666666666666666666666666655 56666666655543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.60 E-value=3.2e-09 Score=113.60 Aligned_cols=107 Identities=15% Similarity=0.257 Sum_probs=82.3
Q ss_pred ccchhHHHHHHHHHhcc-----cCCCCC-CCCCCCCCCcceeeecCCC-----CCCCCceeEEEccCCcceeecccCccC
Q 037623 351 HIKISVDAIMNIKSKYE-----LLRDWQ-GDPCAPNDYLWQGLNCSYD-----ANQAPRIKSLNLSSSGIAGEILPHIFS 419 (749)
Q Consensus 351 ~~~~~~~~l~~~k~~~~-----~~~~W~-~dpc~p~~~~w~Gv~C~~~-----~~~~~~l~~l~Ls~n~l~G~ip~~~~~ 419 (749)
...+|.+||++||..+. .+..|. ...|.+..|.|.|+.|... ....++|+.|+|++|+|+ .||+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 34468899999999762 234562 1233344468999999521 113568999999999998 88888999
Q ss_pred CCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 420 LTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 420 l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
|++|++|+|++|+++ .||..++++++|+.|.+++|.+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~ 141 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA 141 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCC
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCcccc
Confidence 999999999999999 899999999999999998888763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.53 E-value=1.2e-08 Score=119.16 Aligned_cols=67 Identities=10% Similarity=0.201 Sum_probs=59.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCc-ccc-Ccchhhhhh------hchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNS-LTG-SVPEFLAEL------QFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~-l~G-~iP~~l~~~------~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|+++|.+|+.+++|++|+.|+|++|+ |+| .+|+.++++ ++|+.|.+++|++..-+
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip 321 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCC
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccC
Confidence 57889999999999999999889999999999999998 999 999999887 88999999988887433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-07 Score=101.44 Aligned_cols=80 Identities=18% Similarity=0.130 Sum_probs=70.4
Q ss_pred CcceeeecCCC--------CCCCCceeEEEccC-CcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhcccc
Q 037623 382 YLWQGLNCSYD--------ANQAPRIKSLNLSS-SGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVD 452 (749)
Q Consensus 382 ~~w~Gv~C~~~--------~~~~~~l~~l~Ls~-n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~ 452 (749)
|.|..|.|+.. ...+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|+|..|..+.++++|+.|++
T Consensus 8 C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred ccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 67999999865 23456799999996 9999877667999999999999999999988999999999999999
Q ss_pred CCCCcccCc
Q 037623 453 GNPNLCLSA 461 (749)
Q Consensus 453 ~n~~l~~~~ 461 (749)
++|+|.+-+
T Consensus 88 ~~N~l~~~~ 96 (347)
T 2ifg_A 88 SFNALESLS 96 (347)
T ss_dssp CSSCCSCCC
T ss_pred CCCccceeC
Confidence 999998764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.40 E-value=3.8e-08 Score=111.15 Aligned_cols=62 Identities=24% Similarity=0.202 Sum_probs=48.3
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+++|+.|+|++|.|+| +|+.++.+++|+.|+|++|+|++ ||..+..++.|+.|.+++|.+.
T Consensus 189 ~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred cCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 36778888888888886 45668888888888888888885 7887888888888877777663
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.38 E-value=3.6e-08 Score=118.41 Aligned_cols=68 Identities=13% Similarity=0.232 Sum_probs=61.0
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCc-ccc-Ccchhhhhhh-------chhccccCCCCcccCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNS-LTG-SVPEFLAELQ-------FLRVLVDGNPNLCLSAS 462 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~-l~G-~iP~~l~~~~-------~l~~l~~~n~~l~~~~~ 462 (749)
.+++|+.|+|++|++.|.||+.+++|++|+.|+|++|+ |+| .||+.++++. +|+.|.+++|.+..-+.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~ 565 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC
Confidence 57889999999999999999889999999999999998 999 9999999888 89999999998874343
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.38 E-value=3.7e-07 Score=92.12 Aligned_cols=79 Identities=20% Similarity=0.153 Sum_probs=66.9
Q ss_pred cceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC
Q 037623 383 LWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456 (749)
Q Consensus 383 ~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~ 456 (749)
+|++|.|+... ..+++|+.|+|++|++++..|..+.++++|+.|+|++|+|++-.|..+..+++|+.|.+++|+
T Consensus 20 s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 20 SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 79999998532 245789999999999999887779999999999999999975444567899999999999999
Q ss_pred cccCc
Q 037623 457 LCLSA 461 (749)
Q Consensus 457 l~~~~ 461 (749)
+.+-+
T Consensus 100 l~~l~ 104 (229)
T 3e6j_A 100 LTVLP 104 (229)
T ss_dssp CCCCC
T ss_pred CCccC
Confidence 87653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.4e-07 Score=112.57 Aligned_cols=66 Identities=24% Similarity=0.294 Sum_probs=51.4
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|||++|+|+|.||.++++|++|+.|+|++|+|+|.||+.+++++.|+.|++++|++.|.
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ 695 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEC
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCc
Confidence 456777788888888888877777788888888888888888887777777777777777777765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.36 E-value=4.8e-07 Score=86.85 Aligned_cols=80 Identities=23% Similarity=0.145 Sum_probs=68.1
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|+|+.+.|+... ...++|+.|+|++|+|++..|..++++++|+.|+|++|+|++-.|..+..+++|+.|.+++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 579999998542 23468899999999999887777999999999999999999766666789999999999999
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
++.+-+
T Consensus 89 ~l~~~~ 94 (170)
T 3g39_A 89 QLKSIP 94 (170)
T ss_dssp CCCCCC
T ss_pred ccCEeC
Confidence 998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=8.6e-06 Score=85.90 Aligned_cols=74 Identities=18% Similarity=0.099 Sum_probs=54.6
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCC---ceeEEEEEEe-cCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHK---NLTILVGYCD-ENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~---nIv~l~g~~~-~~~~~~LV~Ey~~~gs 606 (749)
+.++.|....||+. +..+++|+-. .......+.+|.++|..+.+. .+...+.++. ..+..++|||+++|..
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899987 6788888843 223446789999999999653 2445666664 4556789999999988
Q ss_pred HHH
Q 037623 607 LQA 609 (749)
Q Consensus 607 L~~ 609 (749)
|..
T Consensus 100 l~~ 102 (306)
T 3tdw_A 100 LGE 102 (306)
T ss_dssp CHH
T ss_pred Cch
Confidence 765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.2e-06 Score=86.06 Aligned_cols=79 Identities=16% Similarity=0.192 Sum_probs=64.6
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.|..+.|+... ...+.|+.|+|++|+|+ .||..+.++++|+.|+|++|++++-.|..+..+++|+.|++++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 678889997532 23457899999999998 78877889999999999999999877778888999999999988
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
.+.+-+
T Consensus 89 ~l~~i~ 94 (193)
T 2wfh_A 89 RLRCIP 94 (193)
T ss_dssp CCCBCC
T ss_pred ccCEeC
Confidence 887643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.9e-06 Score=82.86 Aligned_cols=80 Identities=18% Similarity=0.145 Sum_probs=64.5
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.|.++.|+... ...++|+.|+|++|++++..+..++++++|++|+|++|++++-.|..+..+++|+.|.+++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 689999997532 23468899999999998544334789999999999999999766666789999999999999
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
.+.+.+
T Consensus 87 ~l~~~~ 92 (177)
T 2o6r_A 87 KLQSLP 92 (177)
T ss_dssp CCCCCC
T ss_pred CccccC
Confidence 887653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.17 E-value=3e-06 Score=81.66 Aligned_cols=80 Identities=18% Similarity=0.076 Sum_probs=65.2
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|...-+.|+... ...++|+.|+|++|+|++..|..++++++|+.|+|++|+|++-.|..+..+++|+.|++++|
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 345668887432 23468999999999999887777999999999999999999844455689999999999999
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
++.+-+
T Consensus 92 ~l~~l~ 97 (174)
T 2r9u_A 92 HLKSIP 97 (174)
T ss_dssp CCCCCC
T ss_pred ccceeC
Confidence 998654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.14 E-value=1.8e-06 Score=84.56 Aligned_cols=66 Identities=20% Similarity=0.249 Sum_probs=59.0
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|+|++..|..++.+++|+.|+|++|+|+|.+|..+..+++|+.|.+++|.+.+
T Consensus 75 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 357889999999999998876679999999999999999999999999999999999999998864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.7e-06 Score=84.14 Aligned_cols=80 Identities=18% Similarity=0.112 Sum_probs=65.2
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.|.+|.|+... ...++|+.|+|++|++++..+..++++++|+.|+|++|++++-.|..+..+++|+.|.+++|
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 689999997532 24568999999999999544334889999999999999999655566789999999999999
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
.+.+-+
T Consensus 87 ~l~~~~ 92 (208)
T 2o6s_A 87 QLQSLP 92 (208)
T ss_dssp CCCCCC
T ss_pred cCCccC
Confidence 887543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.09 E-value=1.9e-06 Score=84.32 Aligned_cols=66 Identities=17% Similarity=0.220 Sum_probs=48.6
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|+|++.+|..++++++|+.|+|++|+|++..|..+..+++|+.|.+++|++.+.
T Consensus 52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 117 (192)
T 1w8a_A 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEE
T ss_pred cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCee
Confidence 356777777777777776666677777777777777777776666677777777777777777654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.8e-05 Score=81.37 Aligned_cols=135 Identities=18% Similarity=0.082 Sum_probs=90.6
Q ss_pred cccccCce-EEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCC-CceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 532 VLGKGGFG-TVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH-KNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 532 ~LG~G~fG-~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
.+..|..| .||+.... +..+.+|+-... ....+.+|..+|+.+.. --+.++++++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445555 68987653 367888886533 23567889999988742 2355678888888899999999999887
Q ss_pred HHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 037623 608 QAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG------------------------------------ 651 (749)
Q Consensus 608 ~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~------------------------------------ 651 (749)
.+...... ....+++.++++.|..||+.
T Consensus 108 ~~~~~~~~----------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 108 FQVLEEYP----------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp HHHHHHCG----------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred cccccCCH----------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 76543210 01123334444444444421
Q ss_pred -------------------CCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 652 -------------------CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 652 -------------------~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
..+.++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1123789999999999998877789999988753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.04 E-value=5e-06 Score=83.21 Aligned_cols=80 Identities=19% Similarity=0.182 Sum_probs=68.0
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.|..|.|+... ...++|+.|+|++|++++..|..+..+++|+.|+|++|++++-.|..+..+++|+.|.+++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 689999997532 13457999999999999755446999999999999999999988999999999999999999
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
.+..-+
T Consensus 91 ~l~~l~ 96 (220)
T 2v9t_B 91 KITELP 96 (220)
T ss_dssp CCCCCC
T ss_pred cCCccC
Confidence 987543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1e-05 Score=87.05 Aligned_cols=78 Identities=4% Similarity=-0.041 Sum_probs=54.0
Q ss_pred ccc-cccCceEEEEEEEC--------CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCC---CceeEEEEEEecC---
Q 037623 531 RVL-GKGGFGTVYHGYLD--------DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHH---KNLTILVGYCDEN--- 592 (749)
Q Consensus 531 ~~L-G~G~fG~Vykg~~~--------~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H---~nIv~l~g~~~~~--- 592 (749)
+.| +.|....+|+.... ++.+++|+..... ......+.+|+.++..+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998765 5678888765432 1112456788888888743 2456677777654
Q ss_pred CeeEEEEeeCCCCCHH
Q 037623 593 TKMGLVYEFMANGNLQ 608 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~ 608 (749)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=6.8e-06 Score=91.26 Aligned_cols=85 Identities=15% Similarity=0.133 Sum_probs=63.4
Q ss_pred CCCCCCCCccee--eecCCCC-----CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcc-hhhhhhhc
Q 037623 375 DPCAPNDYLWQG--LNCSYDA-----NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVP-EFLAELQF 446 (749)
Q Consensus 375 dpc~p~~~~w~G--v~C~~~~-----~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP-~~l~~~~~ 446 (749)
|||. ..|.|.+ |.|+... ..+++|+.|+|++|++++..|..++++++|++|+|++|.+.+.|| ..+..+++
T Consensus 2 ~p~~-~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~ 80 (455)
T 3v47_A 2 DPGT-SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80 (455)
T ss_dssp ------CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT
T ss_pred CCcc-ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc
Confidence 5663 4567777 8897532 134678999999999988777778999999999999999888885 46888888
Q ss_pred hhccccCCCCcccC
Q 037623 447 LRVLVDGNPNLCLS 460 (749)
Q Consensus 447 l~~l~~~n~~l~~~ 460 (749)
|+.|.+++|.+.+.
T Consensus 81 L~~L~Ls~n~l~~~ 94 (455)
T 3v47_A 81 LIILKLDYNQFLQL 94 (455)
T ss_dssp CCEEECTTCTTCEE
T ss_pred CCEEeCCCCccCcc
Confidence 88888888887654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=97.96 E-value=7.2e-06 Score=78.55 Aligned_cols=65 Identities=17% Similarity=0.166 Sum_probs=56.8
Q ss_pred CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|+|++ ||+. +..|++|+.|+|++|+|++-.|..+..+++|+.|.+++|.+..
T Consensus 51 ~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 51 DRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp TTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 357899999999999995 5565 7899999999999999998666679999999999999998853
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=97.95 E-value=2.9e-06 Score=79.02 Aligned_cols=65 Identities=25% Similarity=0.245 Sum_probs=39.3
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCcccc-CcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG-SVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G-~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++ +.|..++.+++|+.|.+++|.+++
T Consensus 62 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~ 127 (149)
T 2je0_A 62 KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127 (149)
T ss_dssp CCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG
T ss_pred cCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc
Confidence 35566666666666666554445556666666666666665 244556666666666666665554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=5.6e-05 Score=80.30 Aligned_cols=150 Identities=16% Similarity=0.181 Sum_probs=83.1
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcC-----CCceeEEE-E--EEecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-----HKNLTILV-G--YCDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-----H~nIv~l~-g--~~~~~~~~~LV~Ey~ 602 (749)
+.|+.|..+.||+...++..+++|+..... .+...|.+++..+. .|.++... | +....+..+++|||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 346667789999998877779999987531 23344555555442 24333310 0 112356778999999
Q ss_pred CCCCHH--------------HHHHHhhccC--CCCccCCCCCCCHHHHH-------------------------------
Q 037623 603 ANGNLQ--------------AHLLAQLAIL--PTDAEDKTGILSWKGRL------------------------------- 635 (749)
Q Consensus 603 ~~gsL~--------------~~L~~~~~~~--~~~~~~~~~~l~~~~~l------------------------------- 635 (749)
+|..+. ..+|...... +.........-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 1223221111 00000001112332210
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 636 QIATESAQGLEYLHD----------GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 636 ~ia~~ia~gL~yLH~----------~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
.+...+.+++++|++ ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224446667763 1245899999999999998888999999998864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.94 E-value=7.4e-06 Score=81.97 Aligned_cols=63 Identities=24% Similarity=0.198 Sum_probs=42.5
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++|+.|.+++|.+.
T Consensus 104 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 104 LESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 556677777777777665555666777777777777777666666666666776666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.92 E-value=8.3e-06 Score=79.88 Aligned_cols=64 Identities=22% Similarity=0.228 Sum_probs=34.5
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.|++..|..+.+|++|+.|+|++|+|++-.|..+..+++|+.|.+++|.+..
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~ 116 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV 116 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCe
Confidence 3455555555555554333335555555555555555555444555555555555555555543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=97.91 E-value=8.9e-06 Score=86.64 Aligned_cols=66 Identities=17% Similarity=0.082 Sum_probs=55.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|++.|.+|..++++++|+.|+|++|++.|.+|..++++++|+.|.+++|.+.+.
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 467888888888888888888888888888888888888888888888888888888888777665
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.89 E-value=8.5e-06 Score=81.54 Aligned_cols=67 Identities=18% Similarity=0.166 Sum_probs=59.9
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|.|++..|..+..+++|++|+|++|++++..|..+..+++|+.|.+++|++.+.
T Consensus 78 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 144 (220)
T 2v70_A 78 EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTV 144 (220)
T ss_dssp TTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCB
T ss_pred CCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEE
Confidence 4578899999999999976655699999999999999999998899999999999999999998775
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=97.89 E-value=1.1e-05 Score=75.00 Aligned_cols=64 Identities=16% Similarity=0.227 Sum_probs=57.7
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|++++. +.++++++|+.|+|++|++++.+|..+..+++|+.|.+++|.+.+
T Consensus 39 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~ 102 (149)
T 2je0_A 39 DEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102 (149)
T ss_dssp TTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCS
T ss_pred hhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCC
Confidence 3578899999999999976 679999999999999999999999999999999999999998876
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=97.89 E-value=1.1e-05 Score=77.67 Aligned_cols=65 Identities=20% Similarity=0.191 Sum_probs=56.4
Q ss_pred CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|+|++ ||+. +.+|++|+.|+|++|+|++-.|..+..+++|+.|++++|.+..
T Consensus 54 ~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 54 DHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred cCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 357899999999999997 6666 6899999999999999997555569999999999999998753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.1e-05 Score=92.68 Aligned_cols=62 Identities=29% Similarity=0.319 Sum_probs=34.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|+|+ .||+.+++|++|+.|+|++|+|+| || .++++++|+.|.+++|.+.+.
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~ 523 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQS 523 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSS
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCC
Confidence 445555555555555 555555555555555555555554 45 455555555555555555443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=97.80 E-value=1.9e-05 Score=79.41 Aligned_cols=66 Identities=18% Similarity=0.167 Sum_probs=52.1
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .||..+..+++|+.|.+++|.+..-+
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIP 151 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccC
Confidence 4678888888888888544333778888888888888888 78888888888888888888887543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=97.78 E-value=2.1e-05 Score=75.55 Aligned_cols=64 Identities=22% Similarity=0.144 Sum_probs=35.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|+|++..+..++++++|+.|+|++|++++..|..+..+++|+.|.+++|++.+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 114 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS 114 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE
Confidence 4455666666666653222224556666666666666665444445555566666666555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=1.5e-05 Score=90.84 Aligned_cols=60 Identities=20% Similarity=0.119 Sum_probs=28.8
Q ss_pred ceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 398 RIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 398 ~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
+|+.|+|++|++++..|..++++++|++|+|++|++++..|+.++++++|+.|.+++|.+
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 455555555555544444444445555554444444444444444444444444444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.77 E-value=1.7e-05 Score=77.62 Aligned_cols=62 Identities=16% Similarity=0.258 Sum_probs=49.2
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~ 456 (749)
.+++|+.|+|++|.+++..|+.++.|++|+.|+|++|++++.+|..++.+++|+.|.+++|.
T Consensus 86 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp TCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred cCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 35678888888888887777778888888888888888888778888888888888777776
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.77 E-value=1.2e-05 Score=82.86 Aligned_cols=64 Identities=25% Similarity=0.347 Sum_probs=54.9
Q ss_pred CCCceeEEEccCCccee--ecccCccCCCCCCeEECcCCccccCcchhhhhhh--chhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAG--EILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQ--FLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G--~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~--~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+||+|+|++ .||..+..+++|+.|+|++|+|++. +.+..+. .|+.|.+.+|.+|+.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccc
Confidence 36789999999999999 7766688999999999999999985 4455555 889999999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=97.76 E-value=1.7e-05 Score=84.92 Aligned_cols=64 Identities=20% Similarity=0.167 Sum_probs=53.6
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
..+++|+.|+|++|+|+|..|..+++|++|+.|+|++|+|++-.|..+..++ |+.|.+.+|.+.
T Consensus 53 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 3578999999999999998766799999999999999999964444455554 999999988874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=2.4e-05 Score=90.33 Aligned_cols=74 Identities=20% Similarity=0.147 Sum_probs=48.5
Q ss_pred eeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 386 GLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 386 Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
-+.|+... +.++.++.|||++|+|++-.|.++++|++|++|||++|++++-.|..+.++++|+.|.+++|++.+
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 46786421 123467778888887775443357777777777777777776445567777777777777666543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=1.5e-05 Score=91.42 Aligned_cols=66 Identities=21% Similarity=0.225 Sum_probs=56.5
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCc-chhhhhhhchhccccCCCCcccCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSV-PEFLAELQFLRVLVDGNPNLCLSAS 462 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~i-P~~l~~~~~l~~l~~~n~~l~~~~~ 462 (749)
.+++|+.|+|++|+|+| || .+++|++|+.|+|++|+|++.+ |..++.+++|+.|.+++|.+++.+.
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 46788999999999987 76 8888999999999999999877 8889999999999999988887654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=97.72 E-value=4.1e-05 Score=77.94 Aligned_cols=66 Identities=24% Similarity=0.219 Sum_probs=58.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+.++.|+|++|++++..|..++++++|++|+|++|++++..|..+..+++|+.|.+++|.+..-+
T Consensus 34 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 99 (251)
T 3m19_A 34 PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccC
Confidence 467899999999999877667999999999999999999988888999999999999999887543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=97.71 E-value=3.3e-05 Score=77.15 Aligned_cols=65 Identities=22% Similarity=0.161 Sum_probs=41.4
Q ss_pred CCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|+|+ .||+. +..+++|+.|+|++|++++..|..+..+++|+.|.+++|.+.+-
T Consensus 78 ~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 143 (220)
T 2v9t_B 78 GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI 143 (220)
T ss_dssp TCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEE
Confidence 4556666666666666 44444 45666666666666666666666666666666666666666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=97.71 E-value=1.5e-05 Score=75.74 Aligned_cols=65 Identities=29% Similarity=0.292 Sum_probs=38.3
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccC-cchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGS-VPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~-iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|.+++.+|..+.++++|+.|+|++|++++- .+..+..+++|+.|.+++|.+++
T Consensus 69 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~ 134 (168)
T 2ell_A 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN 134 (168)
T ss_dssp CCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT
T ss_pred cCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc
Confidence 355666666666666665544455566666666666666652 22556666666666666665554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=97.70 E-value=2e-05 Score=74.84 Aligned_cols=64 Identities=20% Similarity=0.235 Sum_probs=58.1
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.+++. +.++.+++|+.|+|++|++++.+|..+.++++|+.|.+++|.+.+-
T Consensus 47 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 110 (168)
T 2ell_A 47 EFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110 (168)
T ss_dssp GGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSS
T ss_pred hCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcc
Confidence 467899999999999875 7799999999999999999999999999999999999999998774
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=97.69 E-value=1.8e-05 Score=93.60 Aligned_cols=64 Identities=17% Similarity=0.170 Sum_probs=47.4
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.|+ .||.+|++|++|++|+|++|+|+ .||..++++++|+.|.+++|.+.+.
T Consensus 268 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~ 331 (727)
T 4b8c_D 268 NLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQ 331 (727)
T ss_dssp GGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSH
T ss_pred CCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCC
Confidence 4567777777777777 77777777777777777777775 6777777777777777777777653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=5.1e-05 Score=80.51 Aligned_cols=79 Identities=22% Similarity=0.171 Sum_probs=68.2
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.|..+.|+... ...+.++.|+|++|++++..+..++++++|++|+|++|++++..|..++++++|+.|.+++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 579999997432 13468999999999999766557999999999999999999988999999999999999999
Q ss_pred CcccC
Q 037623 456 NLCLS 460 (749)
Q Consensus 456 ~l~~~ 460 (749)
.+..-
T Consensus 111 ~l~~l 115 (330)
T 1xku_A 111 QLKEL 115 (330)
T ss_dssp CCSBC
T ss_pred cCCcc
Confidence 88744
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=97.67 E-value=3.4e-05 Score=80.91 Aligned_cols=77 Identities=18% Similarity=0.168 Sum_probs=65.4
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccc--cCcchhhhhhhchhcccc
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLT--GSVPEFLAELQFLRVLVD 452 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~--G~iP~~l~~~~~l~~l~~ 452 (749)
|.|.+|.|+... ...++|+.|+|++|+++ .||+. ++++++|+.|+|++|+++ |.+|..+..+++|+.|.+
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 689999998532 23468999999999998 68776 789999999999999998 556888888999999999
Q ss_pred CCCCccc
Q 037623 453 GNPNLCL 459 (749)
Q Consensus 453 ~n~~l~~ 459 (749)
++|.+..
T Consensus 86 s~n~i~~ 92 (306)
T 2z66_A 86 SFNGVIT 92 (306)
T ss_dssp CSCSEEE
T ss_pred CCCcccc
Confidence 9988754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=3.6e-05 Score=88.81 Aligned_cols=68 Identities=21% Similarity=0.140 Sum_probs=60.4
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
..+++|+.|+|++|+|++.+|..+++|++|+.|+|++|+|++-.|..+..+++|+.|++++|++.+..
T Consensus 491 ~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~ 558 (635)
T 4g8a_A 491 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 558 (635)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCC
T ss_pred hhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCC
Confidence 45778999999999999888777999999999999999999988888999999999999999998763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=97.64 E-value=1.8e-05 Score=93.61 Aligned_cols=65 Identities=25% Similarity=0.267 Sum_probs=60.2
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|.|+ .||++|++|++|+.|+|++|+|+ .||..+++|++|+.|.+++|.+..-+
T Consensus 245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp 309 (727)
T 4b8c_D 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLP 309 (727)
T ss_dssp GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCC
T ss_pred CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccC
Confidence 4678999999999999 99988999999999999999999 89999999999999999999986543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00011 Score=80.18 Aligned_cols=73 Identities=19% Similarity=0.247 Sum_probs=48.8
Q ss_pred ccccccCceEEEEEEE--CCcccEEEEecCCch-------hhHHHHHHHHHHHHhcCC--Ccee-EEEEEEecCCeeEEE
Q 037623 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV-------QGYKQFQAEVELLMRAHH--KNLT-ILVGYCDENTKMGLV 598 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~-------~~~~~f~~Ei~iL~~l~H--~nIv-~l~g~~~~~~~~~LV 598 (749)
+.||.|.++.||++.. .++.++||....... ...+++..|.+++..+.+ +..+ .++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 5789999999999965 347899998654321 123456789999888743 3444 44443 23456899
Q ss_pred EeeCCCC
Q 037623 599 YEFMANG 605 (749)
Q Consensus 599 ~Ey~~~g 605 (749)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.63 E-value=4.3e-05 Score=88.25 Aligned_cols=66 Identities=20% Similarity=0.162 Sum_probs=55.3
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
+++|+.|+|++|.+++..|..++++++|++|+|++|.+++..|..++.++.|+.|.+++|.+..-+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 139 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 139 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCC
Confidence 467889999999998877667889999999999999999877778888888999988888877543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=97.62 E-value=6.6e-05 Score=83.49 Aligned_cols=79 Identities=19% Similarity=0.141 Sum_probs=65.8
Q ss_pred cceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC
Q 037623 383 LWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456 (749)
Q Consensus 383 ~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~ 456 (749)
.|..|.|+... ...++++.|+|++|++++..|..++++++|+.|+|++|++++-.|..+..+++|+.|.+++|.
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 36789997532 234678999999999998777779999999999999999998888889999999999999988
Q ss_pred cccCc
Q 037623 457 LCLSA 461 (749)
Q Consensus 457 l~~~~ 461 (749)
+..-+
T Consensus 135 l~~~~ 139 (452)
T 3zyi_A 135 LTVIP 139 (452)
T ss_dssp CSBCC
T ss_pred CCccC
Confidence 87543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=97.61 E-value=6.8e-05 Score=79.65 Aligned_cols=80 Identities=19% Similarity=0.170 Sum_probs=68.9
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.|..+.|+... ...++|+.|+|++|++++..|..++++++|++|+|++|++++..|..++++++|+.|.+++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 579999997532 23468999999999999776667999999999999999999988999999999999999999
Q ss_pred CcccCc
Q 037623 456 NLCLSA 461 (749)
Q Consensus 456 ~l~~~~ 461 (749)
.+..-+
T Consensus 113 ~l~~l~ 118 (332)
T 2ft3_A 113 HLVEIP 118 (332)
T ss_dssp CCCSCC
T ss_pred cCCccC
Confidence 887443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=97.61 E-value=5.2e-05 Score=77.20 Aligned_cols=64 Identities=19% Similarity=0.192 Sum_probs=43.6
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+++|+.|+|++|+|++..|..++.+++|+.|+|++|+|++..|..+..+++|+.|.+++|.+.
T Consensus 129 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 129 RLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred cCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 3566777777777777443334777777777777777777666666777777777777777664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=97.61 E-value=3.6e-05 Score=79.28 Aligned_cols=89 Identities=24% Similarity=0.255 Sum_probs=64.0
Q ss_pred CCCCCCCCCCCcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhh
Q 037623 372 WQGDPCAPNDYLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQ 445 (749)
Q Consensus 372 W~~dpc~p~~~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~ 445 (749)
|.|..|... ..|..|.|+... ..++.++.|+|++|++++..+..++++++|++|+|++|+++.-.+..+.+++
T Consensus 7 ~~~~~C~c~-~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~ 85 (270)
T 2o6q_A 7 KDGGVCSCN-NNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK 85 (270)
T ss_dssp GGTCSBEEE-TTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCT
T ss_pred CCCCCCEeC-CCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCC
Confidence 555555211 135667776321 1345689999999999865444699999999999999999954344468899
Q ss_pred chhccccCCCCcccCc
Q 037623 446 FLRVLVDGNPNLCLSA 461 (749)
Q Consensus 446 ~l~~l~~~n~~l~~~~ 461 (749)
+|+.|.+++|.+..-+
T Consensus 86 ~L~~L~l~~n~l~~~~ 101 (270)
T 2o6q_A 86 NLETLWVTDNKLQALP 101 (270)
T ss_dssp TCCEEECCSSCCCCCC
T ss_pred CCCEEECCCCcCCcCC
Confidence 9999999998887543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.60 E-value=7.4e-05 Score=80.55 Aligned_cols=79 Identities=24% Similarity=0.151 Sum_probs=61.0
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCcc-CCCCCCeEECcCCccccCcchhhhhhhchhccccCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIF-SLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~-~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
|.+.-+.|+... ...+.++.|+|++|+|++-.+..+. ++++|+.|+|++|+|++-.|..+..+++|+.|++++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 578889997532 1234578899999999876544566 889999999999999876677788888888888888
Q ss_pred CCcccC
Q 037623 455 PNLCLS 460 (749)
Q Consensus 455 ~~l~~~ 460 (749)
|.+..-
T Consensus 98 N~l~~~ 103 (361)
T 2xot_A 98 NHLHTL 103 (361)
T ss_dssp SCCCEE
T ss_pred CcCCcC
Confidence 887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=97.60 E-value=5.4e-05 Score=74.58 Aligned_cols=64 Identities=22% Similarity=0.145 Sum_probs=37.8
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|+|++..+..++++++|++|+|++|++++-.|..+..+++|+.|.+++|.+.+
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 138 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce
Confidence 4566666666666663322225666666666666666665444445666666666666666554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.58 E-value=4.3e-05 Score=86.07 Aligned_cols=74 Identities=18% Similarity=0.005 Sum_probs=58.3
Q ss_pred cceeeecCCCCCCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhh-hhhchhccccCCCCcccC
Q 037623 383 LWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLA-ELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 383 ~w~Gv~C~~~~~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~-~~~~l~~l~~~n~~l~~~ 460 (749)
.+.++.|.. +++|+.|+|++|.|+|..|..++++++|+.|+|++|+|+|.+|..+. .++.|+.|.+++|.+.+.
T Consensus 110 ~l~~~~~~~----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 110 NISRVSCSR----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp CCCCEEECC----CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred cCCCCCccc----cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 355666642 56788888888888887777788888888888888888888888776 688888888888887654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=97.57 E-value=6.2e-05 Score=77.66 Aligned_cols=65 Identities=17% Similarity=0.112 Sum_probs=48.0
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|.+++|.+.+
T Consensus 155 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 155 KLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 45678888888888875444346778888888888888887666667778888888777776654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.57 E-value=4.9e-05 Score=81.48 Aligned_cols=78 Identities=19% Similarity=0.175 Sum_probs=60.4
Q ss_pred CcceeeecCCCC--------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccC
Q 037623 382 YLWQGLNCSYDA--------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDG 453 (749)
Q Consensus 382 ~~w~Gv~C~~~~--------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~ 453 (749)
|.|.|+ |+... ...++|+.|+|++|++++..+..++++++|+.|+|++|++++..|..+.++++|+.|.++
T Consensus 30 C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 30 CDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp ECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 468886 54221 123578999999999986444368899999999999999998778888899999999998
Q ss_pred CCCcccC
Q 037623 454 NPNLCLS 460 (749)
Q Consensus 454 n~~l~~~ 460 (749)
+|.+..-
T Consensus 109 ~n~l~~~ 115 (353)
T 2z80_A 109 YNYLSNL 115 (353)
T ss_dssp SSCCSSC
T ss_pred CCcCCcC
Confidence 8887654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=97.56 E-value=5e-05 Score=72.81 Aligned_cols=64 Identities=27% Similarity=0.187 Sum_probs=49.0
Q ss_pred CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcch--hhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPE--FLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~--~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|.|++ +|+. ++.+++|+.|+|++|++ +.+|+ .+..+++|+.|.+++|.++.
T Consensus 61 ~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i-~~~~~~~~l~~l~~L~~L~l~~N~i~~ 127 (176)
T 1a9n_A 61 PLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSL-VELGDLDPLASLKSLTYLCILRNPVTN 127 (176)
T ss_dssp CCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCC-CCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcC-CcchhhHhhhcCCCCCEEEecCCCCCC
Confidence 346778888888888874 5566 47888888888888888 45776 77788888888888887764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.55 E-value=9.5e-05 Score=82.63 Aligned_cols=78 Identities=21% Similarity=0.201 Sum_probs=63.1
Q ss_pred cceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC
Q 037623 383 LWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456 (749)
Q Consensus 383 ~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~ 456 (749)
.|..|.|+... ..+++++.|+|++|++++..|..+.++++|++|+|++|++++..|..+.++++|+.|.+++|.
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 47789997432 234578899999999988776678899999999999999998888888888889988888887
Q ss_pred cccC
Q 037623 457 LCLS 460 (749)
Q Consensus 457 l~~~ 460 (749)
+..-
T Consensus 92 l~~~ 95 (477)
T 2id5_A 92 LKLI 95 (477)
T ss_dssp CCSC
T ss_pred CCcc
Confidence 7654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.55 E-value=3.3e-05 Score=81.42 Aligned_cols=64 Identities=23% Similarity=0.262 Sum_probs=41.8
Q ss_pred CCceeEEEccCCcceeecccCc--cCCCCCCeEECcCCccccCcchhhhhh-----hchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHI--FSLTSIESLDLSNNSLTGSVPEFLAEL-----QFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~--~~l~~L~~l~ls~N~l~G~iP~~l~~~-----~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|+++|.+|..+ +.+++|++|+|++|++++. |..++.+ ++|+.|.+++|++.+.
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~ 164 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNF 164 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccc
Confidence 4466667777777776666654 6666777777777777665 6666666 6666666666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.55 E-value=4.5e-05 Score=74.60 Aligned_cols=66 Identities=24% Similarity=0.207 Sum_probs=57.9
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|.+++.+|+.++++++|+.|+|++|++.+.+| .+..+++|+.|.+++|.+..-
T Consensus 109 ~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp TTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC
T ss_pred cCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh
Confidence 347889999999999999888889999999999999999777788 689999999999999888654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=97.51 E-value=8.3e-05 Score=76.68 Aligned_cols=68 Identities=22% Similarity=0.164 Sum_probs=55.7
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
..+++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..++.+++|+.|.+++|.+.+.+
T Consensus 130 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (272)
T 3rfs_A 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP 197 (272)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred ccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence 34678999999999998655444788999999999999999877777888899999999988887654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=9.5e-05 Score=76.22 Aligned_cols=75 Identities=20% Similarity=0.136 Sum_probs=59.6
Q ss_pred eeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 386 GLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 386 Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+.|.... ...++|+.|+|++|++++..+..++++++|++|+|++|++++-.|..+.++++|+.|.+++|.+.+
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred eEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 57786432 123468999999999987665578999999999999999997667788899999999999888765
Q ss_pred C
Q 037623 460 S 460 (749)
Q Consensus 460 ~ 460 (749)
.
T Consensus 91 ~ 91 (276)
T 2z62_A 91 L 91 (276)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=97.47 E-value=8.3e-05 Score=71.26 Aligned_cols=62 Identities=18% Similarity=0.134 Sum_probs=53.5
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.++|+.|+|++|.|++- +.++.+++|+.|+|++|++++-.|..+..+++|+.|++++|.+..
T Consensus 41 ~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 102 (176)
T 1a9n_A 41 LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102 (176)
T ss_dssp TTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC
T ss_pred CCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc
Confidence 34899999999999974 679999999999999999996433445999999999999999854
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=97.44 E-value=8.6e-05 Score=74.84 Aligned_cols=74 Identities=16% Similarity=0.132 Sum_probs=57.7
Q ss_pred eecCCCC---CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCc-cccCcchhhhhhhchhccccCC-CCcccC
Q 037623 387 LNCSYDA---NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNS-LTGSVPEFLAELQFLRVLVDGN-PNLCLS 460 (749)
Q Consensus 387 v~C~~~~---~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~-l~G~iP~~l~~~~~l~~l~~~n-~~l~~~ 460 (749)
|.|..-. ...+.|+.|+|++|++++..+..++++++|+.|+|++|+ +++--|..+..+++|+.|.+++ |.+..-
T Consensus 18 v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i 96 (239)
T 2xwt_C 18 VTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96 (239)
T ss_dssp EEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE
T ss_pred eEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc
Confidence 5596411 134579999999999996554469999999999999997 7754445788999999999987 888654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.44 E-value=9.6e-05 Score=79.66 Aligned_cols=66 Identities=20% Similarity=0.151 Sum_probs=44.3
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|+|++..+..+.+|++|+.|+|++|++++-.|..+..+++|+.|.+++|.+..-
T Consensus 86 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l 151 (361)
T 2xot_A 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF 151 (361)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred CCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee
Confidence 356677777777777654433466777777777777777766666677777777777777766543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00011 Score=75.98 Aligned_cols=64 Identities=22% Similarity=0.135 Sum_probs=44.4
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+++|+.|+|++|.+++.+|..++++++|+.|+|++|++++..|..+..+++|+.|.+++|.+.
T Consensus 175 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 3566777777777777766666777777777777777777655556777777777777666653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00013 Score=76.28 Aligned_cols=67 Identities=21% Similarity=0.144 Sum_probs=50.4
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|++++..|..++++++|+.|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 172 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 238 (306)
T 2z66_A 172 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238 (306)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence 3466788888888888776666677788888888888888776666677777888888887777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00011 Score=76.65 Aligned_cols=64 Identities=25% Similarity=0.181 Sum_probs=42.7
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|+|+ .||..+..+++|+.|+|++|++++-.|..+..+++|+.|.+++|++..
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence 3566777777777776 566666667777777777777775555666666777777776666654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00011 Score=84.63 Aligned_cols=64 Identities=17% Similarity=0.104 Sum_probs=37.2
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+++|+.|+|++|++++.+|..++++++|+.|+|++|++++.+|..+.++++|+.|++++|++.
T Consensus 471 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred cCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 3455556666666665555445555666666666666666555555555556666655555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00013 Score=75.63 Aligned_cols=67 Identities=21% Similarity=0.138 Sum_probs=57.2
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+.++++|+.|.+++|.+.+.
T Consensus 150 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 216 (285)
T 1ozn_A 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (285)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcC
Confidence 3467899999999999865434588999999999999999998899999999999999999988764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00014 Score=75.81 Aligned_cols=62 Identities=24% Similarity=0.321 Sum_probs=28.6
Q ss_pred CCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 396 APRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+++|+.|+|++|+|++ +|+. +..+++|+.|+|++|+|++-.+..+..+++|+.|.+++|++.
T Consensus 123 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 123 LGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp CTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCEEECCCCCCCc-cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence 3445555555555543 2222 444555555555555555322222344455555555555444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00014 Score=77.16 Aligned_cols=66 Identities=24% Similarity=0.291 Sum_probs=54.9
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|.+++..|..++.+++|+.|+|++|+++ .+|..+..+++|+.|.+++|.+..-+
T Consensus 214 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~ 279 (330)
T 1xku_A 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 279 (330)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccC
Confidence 4678888999999988776656888889999999999888 78888888888888888888887643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00015 Score=80.25 Aligned_cols=64 Identities=23% Similarity=0.151 Sum_probs=36.9
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.+++..|..++++++|+.|+|++|++++..|..+..+++|+.|.+++|++.+
T Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 322 LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 4555666666666655444445556666666666666655555555555566666555555544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.36 E-value=8.7e-05 Score=78.05 Aligned_cols=61 Identities=30% Similarity=0.315 Sum_probs=42.6
Q ss_pred CCceeEEEccCCcceeecccCccCC---CCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSL---TSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l---~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|||++|.|++.+|+.++.+ ++|+.|+|++|+|+ .||..+. ++|+.|.+++|++.+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR 286 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC
Confidence 3567777777777777766666665 57777777777777 6776654 567777777777765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=97.36 E-value=1.9e-05 Score=90.48 Aligned_cols=83 Identities=27% Similarity=0.392 Sum_probs=43.7
Q ss_pred CCCC--CCCCCCCCCCcceee-ecCCCC----------------CCCCceeEEEccCCcceeecccCccCCCCCCeEECc
Q 037623 369 LRDW--QGDPCAPNDYLWQGL-NCSYDA----------------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLS 429 (749)
Q Consensus 369 ~~~W--~~dpc~p~~~~w~Gv-~C~~~~----------------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls 429 (749)
+.+| +++||......|.|+ .|.... ..+++|+.|+|++|+|+ .|| ..+++|+.|+|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~lp~~l~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls 108 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDNLPPQITVLEITQNALI-SLP---ELPASLEYLDAC 108 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSCCCSCCCTTCSEEECCSSCCS-CCC---CCCTTCCEEECC
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCccCHhHcCCCCEEECcCCCCc-ccc---cccCCCCEEEcc
Confidence 4456 456774322258888 674210 01234555555555555 454 335566666666
Q ss_pred CCccccCcchhhhhhhchhccccCCCCccc
Q 037623 430 NNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 430 ~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+|+|++ ||. +.+ +|+.|.+++|.+.+
T Consensus 109 ~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~ 134 (571)
T 3cvr_A 109 DNRLST-LPE-LPA--SLKHLDVDNNQLTM 134 (571)
T ss_dssp SSCCSC-CCC-CCT--TCCEEECCSSCCSC
T ss_pred CCCCCC-cch-hhc--CCCEEECCCCcCCC
Confidence 666665 555 443 55555566555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00015 Score=82.40 Aligned_cols=65 Identities=28% Similarity=0.257 Sum_probs=43.7
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|++++..|..++++++|++|+|++|++++..|..++++++|+.|.+++|.+.+
T Consensus 48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 112 (549)
T 2z81_A 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112 (549)
T ss_dssp SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence 35567777777777776555556777777777777777776666666777777777776666653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00011 Score=82.98 Aligned_cols=65 Identities=18% Similarity=0.253 Sum_probs=59.9
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCcccc--CcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG--SVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G--~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..++.+++|+.|.+++|.+.+
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 388 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence 46789999999999999998889999999999999999998 788899999999999999999886
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0001 Score=77.73 Aligned_cols=38 Identities=21% Similarity=0.300 Sum_probs=14.9
Q ss_pred ceeEEEccCCcceeecccCccCCCCCCeEECcCCcccc
Q 037623 398 RIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG 435 (749)
Q Consensus 398 ~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G 435 (749)
+|+.|+|++|++++..|..++++++|+.|+|++|+++|
T Consensus 150 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187 (312)
T ss_dssp TCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred CCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence 33444444444433332334444444444444444433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00019 Score=81.95 Aligned_cols=66 Identities=20% Similarity=0.200 Sum_probs=46.9
Q ss_pred CCCceeEEEccCCcce-eecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIA-GEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~-G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.++ |.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|.+++|.+.+.
T Consensus 443 ~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 509 (570)
T 2z63_A 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509 (570)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred cCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCC
Confidence 4567777777777776 56766677777777777777777776677777777777777777766654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00019 Score=74.00 Aligned_cols=64 Identities=25% Similarity=0.235 Sum_probs=39.7
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.+++..+..++++++|++|+|++|++++..|..+.++++|+.|.+++|.+.+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 114 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc
Confidence 4566666666666664443346666666666666666666555666666666666666665544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00015 Score=80.58 Aligned_cols=68 Identities=16% Similarity=0.082 Sum_probs=56.9
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
..+++|+.|+|++|.|++..|..+.++++|+.|+|++|++++..|..+..+++|+.|.+++|++..-+
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 282 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccC
Confidence 35678889999999998877777888899999999999998888888888888888888888887543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00029 Score=77.92 Aligned_cols=78 Identities=19% Similarity=0.128 Sum_probs=62.4
Q ss_pred cceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC
Q 037623 383 LWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456 (749)
Q Consensus 383 ~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~ 456 (749)
.|..|.|.... ...+.++.|+|++|++++..+..++++++|+.|+|++|++++-.|..+.++++|+.|.+++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 36789997532 234578899999999987776678899999999999999988777888888889999888888
Q ss_pred cccC
Q 037623 457 LCLS 460 (749)
Q Consensus 457 l~~~ 460 (749)
+..-
T Consensus 124 l~~~ 127 (440)
T 3zyj_A 124 LTTI 127 (440)
T ss_dssp CSSC
T ss_pred CCee
Confidence 7654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00057 Score=75.21 Aligned_cols=78 Identities=10% Similarity=0.114 Sum_probs=46.6
Q ss_pred CCCceeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeecc-ccCCcccCccccccC---CCCCchhHHHHHHHHH
Q 037623 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV-VGTPGYLDPEYYISN---RLTEKSDVYSFGVVLL 728 (749)
Q Consensus 653 ~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~---~~s~k~DVwSfGvvL~ 728 (749)
.+.++|+|+++.|||+++++ ++|+||+.+..-.+. ....... .-...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999999876 999999988753211 0000000 011345666654311 1122345557777777
Q ss_pred HHHcC
Q 037623 729 ELITG 733 (749)
Q Consensus 729 ElltG 733 (749)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00013 Score=77.51 Aligned_cols=66 Identities=24% Similarity=0.271 Sum_probs=57.8
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|.+++..|..++.+++|+.|+|++|+++ .||..+..+++|+.|.+++|.+..-
T Consensus 214 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence 34678999999999999866556999999999999999999 8999999999999999999988764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00017 Score=78.35 Aligned_cols=65 Identities=20% Similarity=0.162 Sum_probs=50.5
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|.+++..|..++.+++|++|+|++|++++..|..++++++|+.|.+++|.+..-
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l 132 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcC
Confidence 46778888888888765555688888888888888888877777788888888888888777643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00025 Score=75.87 Aligned_cols=68 Identities=26% Similarity=0.217 Sum_probs=56.8
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
..+++|+.|+|++|++++..|..++++++|++|+|++|++++-.|..+.++++|+.|.+++|.+..-+
T Consensus 73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 140 (353)
T 2z80_A 73 QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLG 140 (353)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSC
T ss_pred ccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccC
Confidence 35788999999999999877667999999999999999999644445889999999999998887543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00022 Score=82.24 Aligned_cols=66 Identities=18% Similarity=0.092 Sum_probs=52.9
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|.+++..|..+++|++|++|+|++|++++-.|..++++.+|+.|.+++|.+.+
T Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 142 (606)
T 3vq2_A 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142 (606)
T ss_dssp TTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCC
T ss_pred hchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccc
Confidence 356788888888888887777778888888888888888887666778888888888888887764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00019 Score=79.44 Aligned_cols=67 Identities=16% Similarity=0.127 Sum_probs=52.7
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|.|++..|..+.++++|+.|+|++|++++..|..+.++++|+.|++++|++...
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 270 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCC
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCcc
Confidence 3466788888888888877666688888888888888888877777788888888888888877654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00021 Score=82.42 Aligned_cols=66 Identities=12% Similarity=0.073 Sum_probs=51.8
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|.+++..|..++++++|++|+|++|++++-.|..++++++|+.|.+++|.+.+
T Consensus 78 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp TTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred cCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccc
Confidence 356778888888888887776678888888888888888887556777888888888888887765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0002 Score=81.67 Aligned_cols=66 Identities=21% Similarity=0.216 Sum_probs=42.5
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccc-cCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLT-GSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~-G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++ |.+|..+..+++|+.|.+++|.+.+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 485 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccC
Confidence 3556666666666666666555666666666666666665 56666666666666666666666543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00032 Score=82.08 Aligned_cols=79 Identities=22% Similarity=0.255 Sum_probs=58.8
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
|.++-+.|+... ...++|+.|+|++|++++..|..++++++|++|+|++|++++..|..++++++|+.|.+++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 456678887421 12357888888888888755455888888888888888888888888888888888887777
Q ss_pred CcccC
Q 037623 456 NLCLS 460 (749)
Q Consensus 456 ~l~~~ 460 (749)
.+..-
T Consensus 84 ~l~~l 88 (680)
T 1ziw_A 84 ELSQL 88 (680)
T ss_dssp CCCCC
T ss_pred ccCcc
Confidence 66543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00027 Score=81.46 Aligned_cols=63 Identities=27% Similarity=0.254 Sum_probs=36.9
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|++++.+|..++++++|+.|+|++|++++.+|..+.+++.| .|.+++|.+.+
T Consensus 475 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~ 537 (606)
T 3t6q_A 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI 537 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCC
T ss_pred CCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccc
Confidence 4555666666666665555555666666666666666666556566655555 55555555544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00032 Score=72.06 Aligned_cols=61 Identities=23% Similarity=0.161 Sum_probs=24.9
Q ss_pred CceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
++|+.|+|++|.+++..|..++++++|++|+|++|++++-.+..+..+++|+.|.+++|.+
T Consensus 109 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 109 VNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 3444444444444432222244444444444444444432222334444444444444433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=97.17 E-value=3.8e-05 Score=75.24 Aligned_cols=62 Identities=19% Similarity=0.194 Sum_probs=51.3
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|++++ || .++.+++|+.|+|++|+++ .+|..+..+++|+.|.+++|.+.+
T Consensus 46 ~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~ 107 (198)
T 1ds9_A 46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC
T ss_pred cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc
Confidence 35678899999998887 76 8888889999999999888 688888888888888888777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00049 Score=72.55 Aligned_cols=152 Identities=11% Similarity=0.134 Sum_probs=82.2
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCce--eEEEEE------EecCCeeEEEEeeC
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL--TILVGY------CDENTKMGLVYEFM 602 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nI--v~l~g~------~~~~~~~~LV~Ey~ 602 (749)
+.|+.|....+|+...++..+++|+..... ..+++..|+.++..+...++ .+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 356678889999998877789999887531 12345667777776642222 222211 11235568999999
Q ss_pred CCCCHH-----------H---HHHHhhccCCCCccCCCCCCCHHHHHH------------HHHHHHHHHHHHHhC----C
Q 037623 603 ANGNLQ-----------A---HLLAQLAILPTDAEDKTGILSWKGRLQ------------IATESAQGLEYLHDG----C 652 (749)
Q Consensus 603 ~~gsL~-----------~---~L~~~~~~~~~~~~~~~~~l~~~~~l~------------ia~~ia~gL~yLH~~----~ 652 (749)
+|..+. . .+|..................|..... +...+.+.++.+++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 986531 1 122211100000000001112332111 011244455566532 2
Q ss_pred CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 ~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
..+++|+|+++.|||++++..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34789999999999999876668999998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00023 Score=85.69 Aligned_cols=66 Identities=20% Similarity=0.256 Sum_probs=49.2
Q ss_pred CCCCceeEEEccCCcceeecccC--ccCCCCCCeEECcCCccccCcc-hhhhhhhchhccccCCCCccc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH--IFSLTSIESLDLSNNSLTGSVP-EFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~--~~~l~~L~~l~ls~N~l~G~iP-~~l~~~~~l~~l~~~n~~l~~ 459 (749)
..+++|+.|+|++|+|++.+|+. +++|++|+.|+|++|++++..| +.++++++|+.|.+++|.+.+
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 34677788888888888777665 7778888888888888877654 567778888888777777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0045 Score=65.15 Aligned_cols=146 Identities=18% Similarity=0.136 Sum_probs=93.1
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcC---CCceeEEEEEEecCCeeEEEEeeCCCCCH
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH---HKNLTILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~---H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
+.|+.|....+|+...+++.+++|+.... ....+..|.+.|+.+. ...+.+.++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 46889999999999887788999987643 2466889999888873 24577788888877889999999998764
Q ss_pred H--------H---HHHHhhc--cCC--CC------ccCCCCCCCHHHHH---HHHH----------------HHHHH-HH
Q 037623 608 Q--------A---HLLAQLA--ILP--TD------AEDKTGILSWKGRL---QIAT----------------ESAQG-LE 646 (749)
Q Consensus 608 ~--------~---~L~~~~~--~~~--~~------~~~~~~~l~~~~~l---~ia~----------------~ia~g-L~ 646 (749)
. . .||.... ... .+ .......-+|.... ++.. .+.+. ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 1 1222110 000 00 00001123565322 1111 11111 12
Q ss_pred HHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 647 YLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 647 yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
.|.. ...+.++|+|+.+.|+++++++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3322 2357899999999999999887 8999984
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00025 Score=81.05 Aligned_cols=65 Identities=17% Similarity=0.189 Sum_probs=58.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCcccc--CcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG--SVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G--~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..+.++++|+.|.+++|.+.+
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 417 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence 46789999999999999898889999999999999999998 677888999999999999999876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00016 Score=77.45 Aligned_cols=77 Identities=13% Similarity=0.156 Sum_probs=59.4
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchh-hhhhhchhc-ccc
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEF-LAELQFLRV-LVD 452 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~-l~~~~~l~~-l~~ 452 (749)
|+|..|.|+... ..+++++.|+|++|+|+ .||+. +.+|++|+.|+|++|++.+.||.. +.+++++.. +.+
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 689999997532 23457999999999998 68775 899999999999999999989864 566766554 455
Q ss_pred CCCCccc
Q 037623 453 GNPNLCL 459 (749)
Q Consensus 453 ~n~~l~~ 459 (749)
++|++..
T Consensus 88 ~~N~l~~ 94 (350)
T 4ay9_X 88 KANNLLY 94 (350)
T ss_dssp EETTCCE
T ss_pred cCCcccc
Confidence 5566543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00019 Score=81.10 Aligned_cols=62 Identities=19% Similarity=0.090 Sum_probs=45.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|++++..|..+++|++|++|+|++|+++ .||.. .+++|+.|.+++|.+.+
T Consensus 43 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~ 104 (520)
T 2z7x_B 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDA 104 (520)
T ss_dssp TCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSS
T ss_pred ccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCcccc
Confidence 4567777777777777766666777777777777777777 57766 67777777777777765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00051 Score=71.37 Aligned_cols=73 Identities=19% Similarity=0.119 Sum_probs=52.2
Q ss_pred ccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCC---ceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHK---NLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~---nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
+.+|.|..+.||+..+.+ +.+.||+...........|..|.+.|+.+... -+.+.+++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 568999999999999865 78999987655444445688999999888422 233444442 3478999998765
Q ss_pred H
Q 037623 607 L 607 (749)
Q Consensus 607 L 607 (749)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00025 Score=74.44 Aligned_cols=63 Identities=22% Similarity=0.212 Sum_probs=27.4
Q ss_pred CCceeEEEccCCcceee--cccC--ccCCCCCCeEECcCCccccCcch---h-hhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGE--ILPH--IFSLTSIESLDLSNNSLTGSVPE---F-LAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~--ip~~--~~~l~~L~~l~ls~N~l~G~iP~---~-l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|++.|. +|+. ++++++|++|+|++|+++ .+|. . ++.+++|+.|++++|.+.+
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~ 238 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRA 238 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCc
Confidence 34455555555554432 2222 244455555555555554 1221 1 2344445555555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00013 Score=77.10 Aligned_cols=59 Identities=29% Similarity=0.340 Sum_probs=27.0
Q ss_pred ceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 398 RIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 398 ~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+|+.|+|++|++++..|..++++++|+.|+|++|++++..| +..+++|+.|.+++|.+.
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~ 93 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc
Confidence 44444444444444333334444444444444444444333 444444444444444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00029 Score=84.79 Aligned_cols=67 Identities=21% Similarity=0.103 Sum_probs=59.9
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchh--hhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEF--LAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~--l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|++++..|..+++|++|++|+|++|++++.+|.. ++++++|+.|.+++|.+.+.
T Consensus 70 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 138 (844)
T 3j0a_A 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138 (844)
T ss_dssp SSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCC
T ss_pred cCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccc
Confidence 46789999999999999888888999999999999999999988876 88999999999999988764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00045 Score=79.69 Aligned_cols=66 Identities=17% Similarity=0.207 Sum_probs=53.0
Q ss_pred CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|+|++|.|+ .+|+. ++++++|+.|+|++|++++..|..++.+++|+.|.+++|.+.+.
T Consensus 120 ~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 120 QNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp TTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred cCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 34678888888888888 56565 58888888888888888888888888888888888888877654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00033 Score=80.08 Aligned_cols=64 Identities=28% Similarity=0.250 Sum_probs=46.8
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|++++..|..++++++|++|+|++|++++-.|+.+..+++|+.|.+++|.+..
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 114 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN 114 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc
Confidence 3567777777777776555567777777777777777777667777777777777777777653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00046 Score=76.99 Aligned_cols=63 Identities=19% Similarity=0.179 Sum_probs=41.6
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
.+++|+.|+|++|++++..|..+.++++|+.|+|++|+|++-.|..+..+++|+.|.+++|.+
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 332 (477)
T 2id5_A 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332 (477)
T ss_dssp TCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCE
T ss_pred ccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCc
Confidence 456667777777777766655666677777777777777665455556666666666666665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=96.95 E-value=3.9e-05 Score=85.59 Aligned_cols=63 Identities=14% Similarity=-0.021 Sum_probs=30.6
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhch-------------hccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFL-------------RVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l-------------~~l~~~n~~l~~ 459 (749)
..+|+.|+|++|+| |.||+++++|++|++|+|++|+++|.+|+.++++..| +.|.++++++.+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~ 85 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS 85 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc
Confidence 45788888888888 8888888888888888888888888888888877765 566666666655
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00034 Score=74.44 Aligned_cols=63 Identities=27% Similarity=0.305 Sum_probs=37.7
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|.+++ + +.+..+++|+.|+|++|++++..|..++.+++|+.|.+++|.+.+.
T Consensus 264 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 4556666666666654 2 3455666666666666666666666666666666666666655543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00062 Score=79.60 Aligned_cols=66 Identities=23% Similarity=0.230 Sum_probs=42.0
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhh--hhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLA--ELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~--~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.+++..|..++++++|+.|+|++|++++..|..+. .+++|+.|.+++|.+.+.
T Consensus 119 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 186 (680)
T 1ziw_A 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186 (680)
T ss_dssp TCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCB
T ss_pred ccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccccc
Confidence 456667777777777666655566677777777777777666555543 335666666666666543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0022 Score=66.96 Aligned_cols=70 Identities=9% Similarity=0.071 Sum_probs=43.9
Q ss_pred ccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEeeC-CCCCH
Q 037623 531 RVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVYEFM-ANGNL 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~-~~gsL 607 (749)
+.|+.|....+|+. ..+++|+....... .....+|..++..+...++. ++++++ .+.-++++||+ ++..+
T Consensus 24 ~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 66888999999998 67888887653221 12235677777777433333 455443 33457899999 65444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00089 Score=72.57 Aligned_cols=64 Identities=17% Similarity=0.215 Sum_probs=38.2
Q ss_pred CCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|.++ .+|+. ++++++|++|+|++|++++..|..+..+++|+.|.+++|.+.+
T Consensus 115 ~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 115 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 3555666666666665 45454 4566666666666666665555556666666666666665544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00069 Score=78.18 Aligned_cols=63 Identities=24% Similarity=0.279 Sum_probs=41.7
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|.|++.+| +..|++|+.|+|++|+|++ +| .+..+++|+.|.+++|.+++.+
T Consensus 151 ~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 151 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp SCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECCC
T ss_pred ccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCCc
Confidence 45667777777777776543 6677777777777777765 33 4666777777777776666543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00064 Score=71.63 Aligned_cols=65 Identities=17% Similarity=-0.040 Sum_probs=53.4
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhh-hhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLA-ELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~-~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..+. .++.|+.|.+++|.+...
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 184 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc
Confidence 56789999999999876666788899999999999999987777664 688888898888887654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00082 Score=69.99 Aligned_cols=60 Identities=28% Similarity=0.405 Sum_probs=37.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|++++. +.++.+++|+.|+|++|++++..| +..+++|+.|.+++|.+..
T Consensus 133 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 133 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 45666666666666643 446666666666666666665433 6666666666666666554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=96.81 E-value=7.6e-05 Score=73.03 Aligned_cols=61 Identities=21% Similarity=0.305 Sum_probs=55.0
Q ss_pred CceeEEEccCCcceeeccc------CccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 397 PRIKSLNLSSSGIAGEILP------HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~------~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++.++|+.+.|+|.+|+ .++++++|+.|+|++|++++ +| .+..+++|+.|.+++|.+..
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~ 84 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK 84 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc
Confidence 4678889999999999987 79999999999999999998 88 89999999999999887763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00029 Score=74.59 Aligned_cols=60 Identities=20% Similarity=0.165 Sum_probs=39.7
Q ss_pred CCceeEEEccCCcceee-cccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 396 APRIKSLNLSSSGIAGE-ILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~-ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
+++|+.|+|++|.+++. +|..+..+++|++|+|++|++++.+|..++++++|+.|.+++|
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~ 152 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCC
Confidence 45666677776666655 5555666667777777776666666666666666666666665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00098 Score=77.12 Aligned_cols=60 Identities=22% Similarity=0.205 Sum_probs=45.8
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|+|+ .||+ .+++|+.|+|++|+|+ .||+.+.++++|+.|.+++|.+.+.
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~ 299 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHH
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCc
Confidence 467788888888887 5655 5677888888888888 7788888888888888887777653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0063 Score=64.34 Aligned_cols=150 Identities=13% Similarity=0.030 Sum_probs=74.3
Q ss_pred ccccccCceE-EEEEEEC-CcccEEEEecCCchhhHHHHHHHHHHHHhcCCC--ceeEEEEEEecCCeeEEEEeeCCCCC
Q 037623 531 RVLGKGGFGT-VYHGYLD-DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHK--NLTILVGYCDENTKMGLVYEFMANGN 606 (749)
Q Consensus 531 ~~LG~G~fG~-Vykg~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~--nIv~l~g~~~~~~~~~LV~Ey~~~gs 606 (749)
+.|+.|+... +|+.... ++.+++|....... .++..|+.++..+... .+.+++.+..+.. +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455555444 6677664 56677776543321 2334566666666322 2445666544333 78999998777
Q ss_pred HHHHHHHhhcc--------------CCCCccCCCCCCCHHHH---------------H-----HHHHHHHHHHHHHH---
Q 037623 607 LQAHLLAQLAI--------------LPTDAEDKTGILSWKGR---------------L-----QIATESAQGLEYLH--- 649 (749)
Q Consensus 607 L~~~L~~~~~~--------------~~~~~~~~~~~l~~~~~---------------l-----~ia~~ia~gL~yLH--- 649 (749)
+.+.+...... +..........++.... + .....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 76655321100 00000000011111100 0 00011222223331
Q ss_pred hCCCCCceeeCCCCCcEEEcCC----CcEEEEecCCCccc
Q 037623 650 DGCKPPIVHRDVKSANILLNEK----FQAKLADFGLSRIF 685 (749)
Q Consensus 650 ~~~~~gIiHrDLkp~NILl~~~----~~~kL~DFGla~~~ 685 (749)
....+.++|||+.+.|||++++ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1223478999999999999875 68999999988754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0011 Score=68.98 Aligned_cols=62 Identities=19% Similarity=0.249 Sum_probs=47.3
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|++++.. + ++++++|+.|+|++|++++ +| .+..+++|+.|.+++|.+..-
T Consensus 66 ~l~~L~~L~L~~n~l~~~~-~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~ 127 (291)
T 1h6t_A 66 YLPNVTKLFLNGNKLTDIK-P-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI 127 (291)
T ss_dssp GCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC
T ss_pred cCCCCCEEEccCCccCCCc-c-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC
Confidence 3577888888888888643 4 8888888888888888876 44 377888888888888777653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.001 Score=70.74 Aligned_cols=62 Identities=27% Similarity=0.270 Sum_probs=48.7
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+++|+.|+|++|.+++..|..++++++|+.|+|++|++++..| +..+++|+.|.+++|.+.
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 46788888888888888776668888888888888888887666 778888888888887663
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0013 Score=67.42 Aligned_cols=60 Identities=22% Similarity=0.277 Sum_probs=46.9
Q ss_pred CceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
++|+.|+|++|++++ + +.++++++|+.|+|++|++++ +| .+..+++|+.|.+++|.+.+.
T Consensus 106 ~~L~~L~L~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 106 ACLSRLFLDNNELRD-T-DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp SSCCEEECCSSCCSB-S-GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred CcccEEEccCCccCC-C-hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch
Confidence 578888888888886 4 458888888888888888886 44 577888888888888877665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00062 Score=73.78 Aligned_cols=62 Identities=19% Similarity=0.276 Sum_probs=35.1
Q ss_pred CCceeEEEccC---CcceeecccCc-------cCCCCCCeEECcCCcccc----CcchhhhhhhchhccccCCCCc
Q 037623 396 APRIKSLNLSS---SGIAGEILPHI-------FSLTSIESLDLSNNSLTG----SVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 396 ~~~l~~l~Ls~---n~l~G~ip~~~-------~~l~~L~~l~ls~N~l~G----~iP~~l~~~~~l~~l~~~n~~l 457 (749)
+++|+.|+|++ |+++|.+|+.+ .++++|++|+|++|++++ .+|..+.++++|+.|.+++|.+
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l 134 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCC
Confidence 44556666655 34455555444 455666666666666655 3555556666666666655555
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0011 Score=68.02 Aligned_cols=59 Identities=22% Similarity=0.268 Sum_probs=28.7
Q ss_pred CceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
++|+.|+|++|+++ .+| .++.+++|+.|+|++|++++- |. +..+++|+.|.+++|.+.+
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~ 99 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN 99 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC
Confidence 44555555555554 332 445555555555555555542 22 4455555555555554443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00049 Score=72.80 Aligned_cols=65 Identities=15% Similarity=0.209 Sum_probs=53.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCC-cccc-CcchhhhhhhchhccccCCC-Cccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNN-SLTG-SVPEFLAELQFLRVLVDGNP-NLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N-~l~G-~iP~~l~~~~~l~~l~~~n~-~l~~ 459 (749)
.+++|+.|+|++|.+++.+|..++++++|++|+|++| .+++ .+|..+.++++|+.|.+++| .+.+
T Consensus 116 ~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred hCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 3568899999999988888777888999999999998 7887 47888888888998888887 6653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00098 Score=76.89 Aligned_cols=63 Identities=27% Similarity=0.378 Sum_probs=56.9
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|.|++. +.++.|++|+.|+|++|+|++..| +..+++|+.|.+++|.+.+.+
T Consensus 129 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~ 191 (605)
T 1m9s_A 129 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR 191 (605)
T ss_dssp GCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG
T ss_pred CCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCCh
Confidence 478899999999999974 679999999999999999998777 899999999999999987753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0005 Score=69.09 Aligned_cols=63 Identities=24% Similarity=0.372 Sum_probs=38.2
Q ss_pred CCceeEEEccCCc-ceeeccc-CccCCCCCCeEECcC-CccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSG-IAGEILP-HIFSLTSIESLDLSN-NSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~-l~G~ip~-~~~~l~~L~~l~ls~-N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|. ++ .||+ .+.++++|++|+|++ |++++-.|..+..+++|+.|.+++|.+.+
T Consensus 54 l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~ 119 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119 (239)
T ss_dssp CTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS
T ss_pred CCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc
Confidence 4566666666665 44 3434 366666666666666 66665444556666666666666665544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0014 Score=73.07 Aligned_cols=56 Identities=14% Similarity=0.123 Sum_probs=32.5
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN 456 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~ 456 (749)
.+++|+.|+|++|.|++ +| ++++++|+.|+|++|+++| +| +++++.|+.|.+++|.
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNK 159 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCS
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCC
Confidence 35556666666666665 32 5566666666666666665 33 5555666666655553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0039 Score=67.46 Aligned_cols=149 Identities=17% Similarity=0.206 Sum_probs=81.7
Q ss_pred ccccccCceEEEEEEEC---------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCce-eEEEEEEecCCeeEEEEe
Q 037623 531 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL-TILVGYCDENTKMGLVYE 600 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nI-v~l~g~~~~~~~~~LV~E 600 (749)
+.|..|-...+|+.... ++.+.+|+.... ........+|.++++.+...++ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45667888889998874 257888885332 2234556789999988743333 456666543 29999
Q ss_pred eCCCCCHHH----------HHHHhhccCCCCccCCCCCCC--HHHHHHHHHHHH-------------------HHHHH--
Q 037623 601 FMANGNLQA----------HLLAQLAILPTDAEDKTGILS--WKGRLQIATESA-------------------QGLEY-- 647 (749)
Q Consensus 601 y~~~gsL~~----------~L~~~~~~~~~~~~~~~~~l~--~~~~l~ia~~ia-------------------~gL~y-- 647 (749)
|++|..|.. .+......+........+... |.++.++..++. +.+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999755431 111111111111001111222 344444433321 12333
Q ss_pred --HHhC-CCCCceeeCCCCCcEEEcCC----CcEEEEecCCCcc
Q 037623 648 --LHDG-CKPPIVHRDVKSANILLNEK----FQAKLADFGLSRI 684 (749)
Q Consensus 648 --LH~~-~~~gIiHrDLkp~NILl~~~----~~~kL~DFGla~~ 684 (749)
|... ....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3322 23468999999999999876 6899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0051 Score=67.76 Aligned_cols=70 Identities=14% Similarity=0.201 Sum_probs=47.6
Q ss_pred ccccccCceEEEEEEEC---------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCce-eEEEEEEecCCeeEEEEe
Q 037623 531 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNL-TILVGYCDENTKMGLVYE 600 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nI-v~l~g~~~~~~~~~LV~E 600 (749)
+.|+.|....+|+.... ++.+++|+...... ...+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 56778888999999875 36788888743211 1455678888888854444 456666542 38999
Q ss_pred eCCCCC
Q 037623 601 FMANGN 606 (749)
Q Consensus 601 y~~~gs 606 (749)
|++|..
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00055 Score=74.19 Aligned_cols=61 Identities=23% Similarity=0.300 Sum_probs=29.7
Q ss_pred ceeEEEccCCcce--e---ecccCccCCCCCCeEECcCCccc----cCcchhhhhhhchhccccCCCCcc
Q 037623 398 RIKSLNLSSSGIA--G---EILPHIFSLTSIESLDLSNNSLT----GSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 398 ~l~~l~Ls~n~l~--G---~ip~~~~~l~~L~~l~ls~N~l~----G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+|+.|+|++|+++ | .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|.+++|.+.
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCc
Confidence 4555555555554 2 22224445555555555555554 445555555555555555555443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0011 Score=73.73 Aligned_cols=60 Identities=27% Similarity=0.327 Sum_probs=33.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCcccc--Ccchhhhhh-------------hchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG--SVPEFLAEL-------------QFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G--~iP~~l~~~-------------~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.++ .||. .+++|+.|+|++|+++| .+|..+.++ ++|+.|++++|.+.+
T Consensus 336 ~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 336 PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 456777777777777 4655 46778888888888887 777777776 667777777777765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0013 Score=75.34 Aligned_cols=57 Identities=14% Similarity=0.180 Sum_probs=27.6
Q ss_pred ceeEEEccCCcceeecccCccCCCCC-------CeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 398 RIKSLNLSSSGIAGEILPHIFSLTSI-------ESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 398 ~l~~l~Ls~n~l~G~ip~~~~~l~~L-------~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+|+.|+|++|+|+ .||+ +.. +| +.|+|++|+|+ .||..+.++++|+.|.+++|.+++
T Consensus 181 ~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 181 SLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp TCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred CCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 4555555555555 4444 332 44 55555555555 355555555555555555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0021 Score=67.39 Aligned_cols=61 Identities=16% Similarity=0.280 Sum_probs=35.6
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|.+++ +|+ +.++++|+.|+|++|++++- |. +..+++|+.|.+++|.+.+.
T Consensus 150 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 150 LTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCCBC
T ss_pred CCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccCcc
Confidence 4556666666666664 323 56666666666666666643 22 55666666666666665543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.015 Score=61.17 Aligned_cols=147 Identities=12% Similarity=0.079 Sum_probs=79.7
Q ss_pred cccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeEEEEE-----EecCCeeEEEEeeCC
Q 037623 532 VLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN--LTILVGY-----CDENTKMGLVYEFMA 603 (749)
Q Consensus 532 ~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~-----~~~~~~~~LV~Ey~~ 603 (749)
.++ |....||+....+ +.+++|...... .....+..|..++..+.... +.+++.. ....+..++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 7778999887654 579999986432 12345667888887774222 2333332 112345678999998
Q ss_pred CCCHH-----------HH---HHHhhccCCCCccCCCCCCCHHHH----H---------------HHHHHHHHHHHHHHh
Q 037623 604 NGNLQ-----------AH---LLAQLAILPTDAEDKTGILSWKGR----L---------------QIATESAQGLEYLHD 650 (749)
Q Consensus 604 ~gsL~-----------~~---L~~~~~~~~~~~~~~~~~l~~~~~----l---------------~ia~~ia~gL~yLH~ 650 (749)
|..+. .. +|........ .....+++... . .+...+.+.++.+.+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLF---IHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCC---SSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCC---ccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 75432 11 2221110000 01111222111 0 011111222333332
Q ss_pred C----CCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 651 G----CKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 651 ~----~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
. ....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1 234679999999999999 4 8999999987643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.002 Score=67.49 Aligned_cols=62 Identities=21% Similarity=0.298 Sum_probs=45.0
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.+++.. + ++++++|+.|+|++|++++ +|. +..+++|+.|.+++|.+.+-
T Consensus 127 ~l~~L~~L~l~~n~l~~~~-~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 127 GLSNLQVLYLDLNQITNIS-P-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp TCTTCCEEECCSSCCCCCG-G-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCEEECCCCccCcCc-c-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC
Confidence 4667888888888887533 3 7778888888888888876 444 77777788888877777654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0023 Score=71.24 Aligned_cols=59 Identities=20% Similarity=0.152 Sum_probs=31.3
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|++++. +++++++|+.|+|++|+++| || ++.+++|+.|.+++|.+.+.
T Consensus 190 l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 190 NKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred CCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence 34555555555555542 25555555555555555555 44 45555555555555555443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0019 Score=71.85 Aligned_cols=62 Identities=18% Similarity=0.240 Sum_probs=41.7
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
+++|+.|+|++|.+++. +.++++++|+.|+|++|+++|.+| +..+++|+.|.+++|.+.+.+
T Consensus 330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence 55667777777776653 456677777777777777777666 666777777777776666543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0013 Score=70.52 Aligned_cols=62 Identities=19% Similarity=0.172 Sum_probs=26.7
Q ss_pred CceeEEEccCCcceeecccCccCC-----CCCCeEECcCCccccCcchhhhhh-----hchhccccCCCCcc
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFSL-----TSIESLDLSNNSLTGSVPEFLAEL-----QFLRVLVDGNPNLC 458 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~l-----~~L~~l~ls~N~l~G~iP~~l~~~-----~~l~~l~~~n~~l~ 458 (749)
++|+.|+|++|.+++..+..++.+ ++|+.|+|++|++++..+..++.. ..|+.|.+++|.+.
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 344455555554444333322221 445555555555444444333321 24444444444443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0029 Score=70.38 Aligned_cols=60 Identities=22% Similarity=0.264 Sum_probs=30.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.+++.. + ++.+++|+.|+|++|++++..| +..+++|+.|.+++|.+.+
T Consensus 286 l~~L~~L~L~~n~l~~~~-~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 286 LTALTNLELNENQLEDIS-P-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CTTCSEEECCSSCCSCCG-G-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCccCeEEcCCCcccCch-h-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 345555555555555422 2 4555555555555555555443 4455555555555554443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.017 Score=64.10 Aligned_cols=72 Identities=14% Similarity=0.174 Sum_probs=47.3
Q ss_pred ccccccCceEEEEEEECC--cccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEeeCCCCCH
Q 037623 531 RVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVYEFMANGNL 607 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~~gsL 607 (749)
+.|+.|-...+|+....+ ..+++|+....... .-...+|..++..+...++. ++++.+. + .+||||++|..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 567888889999999876 77889887543211 11125788899888655554 5666663 2 359999987444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0057 Score=55.47 Aligned_cols=54 Identities=22% Similarity=0.297 Sum_probs=32.3
Q ss_pred EEEccCCcce-eecccCccCCCCCCeEECcCCccccCcc-hhhhhhhchhccccCCCCc
Q 037623 401 SLNLSSSGIA-GEILPHIFSLTSIESLDLSNNSLTGSVP-EFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 401 ~l~Ls~n~l~-G~ip~~~~~l~~L~~l~ls~N~l~G~iP-~~l~~~~~l~~l~~~n~~l 457 (749)
.++.++++|+ -.||..|. ++|+.|+|++|+|+. || ..+..+++|+.|.+++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCe
Confidence 5666666665 45554332 356777777777774 44 3456666677776665544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0024 Score=68.57 Aligned_cols=63 Identities=24% Similarity=0.255 Sum_probs=43.2
Q ss_pred ceeEEEccCCcceeecccCccCC-----CCCCeEECcCCccccCcchhhhhh-----hchhccccCCCCcccC
Q 037623 398 RIKSLNLSSSGIAGEILPHIFSL-----TSIESLDLSNNSLTGSVPEFLAEL-----QFLRVLVDGNPNLCLS 460 (749)
Q Consensus 398 ~l~~l~Ls~n~l~G~ip~~~~~l-----~~L~~l~ls~N~l~G~iP~~l~~~-----~~l~~l~~~n~~l~~~ 460 (749)
+|+.|+|++|.+++..+..++.+ ++|+.|+|++|++++..|..++.. ++|+.|.+++|.+...
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 124 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK 124 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGS
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcH
Confidence 67777777777776655555554 777777777777777766655554 6677777777776544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0072 Score=64.95 Aligned_cols=71 Identities=13% Similarity=0.156 Sum_probs=42.9
Q ss_pred ccccccCceEEEEEEECC----------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEE
Q 037623 531 RVLGKGGFGTVYHGYLDD----------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVY 599 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~ 599 (749)
+.|+.|....+|+....+ +.+++|+....... ......|.+++..+...+++ ++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457788888999988754 57888876543221 12236788888877433433 555543 1 36899
Q ss_pred eeCCCCC
Q 037623 600 EFMANGN 606 (749)
Q Consensus 600 Ey~~~gs 606 (749)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.003 Score=67.45 Aligned_cols=68 Identities=16% Similarity=0.137 Sum_probs=57.9
Q ss_pred CCCCceeEEEccCCcceeecccC-ccCCCCCCe-EECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIES-LDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~-l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
..+++|+.|+|++|.+.+.||+. +.+|++|.. +++++|++++-.|..+..+++|+.|.+++|.+...+
T Consensus 51 ~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~ 120 (350)
T 4ay9_X 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 120 (350)
T ss_dssp TTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCC
T ss_pred cCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCC
Confidence 35789999999999999999886 788998876 677789999877888899999999999999887654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.0044 Score=71.67 Aligned_cols=52 Identities=17% Similarity=0.254 Sum_probs=47.4
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhch
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFL 447 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l 447 (749)
.+++|+.|+|++|+|+ .||+.++++++|+.|+|++|.|+|.+|..+.++...
T Consensus 259 ~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~~ 310 (622)
T 3g06_A 259 LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310 (622)
T ss_dssp CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHHS
T ss_pred ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcccc
Confidence 3578999999999999 898889999999999999999999999998887743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.036 Score=58.80 Aligned_cols=32 Identities=16% Similarity=0.305 Sum_probs=28.1
Q ss_pred CCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 654 PPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 654 ~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46899999999999998888999999877643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=95.50 E-value=0.0022 Score=65.84 Aligned_cols=59 Identities=19% Similarity=0.193 Sum_probs=47.6
Q ss_pred EEccCC---cceeecccCccCCCCCCeEECcCCcccc--CcchhhhhhhchhccccCCCCcccC
Q 037623 402 LNLSSS---GIAGEILPHIFSLTSIESLDLSNNSLTG--SVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 402 l~Ls~n---~l~G~ip~~~~~l~~L~~l~ls~N~l~G--~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
++++.| .+.+.++..-.++++|+.|+||+|+|++ .||+.+..+++|+.|.+++|.+.+.
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 667777 3444332223578999999999999999 8899999999999999999999764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=95.46 E-value=0.0027 Score=70.20 Aligned_cols=62 Identities=18% Similarity=0.128 Sum_probs=38.5
Q ss_pred CceeEEEccCCcceeecccCccC-----CCCCCeEECcCCcccc----CcchhhhhhhchhccccCCCCcc
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFS-----LTSIESLDLSNNSLTG----SVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~-----l~~L~~l~ls~N~l~G----~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
++|+.|+|++|.+++..+..++. +++|+.|+|++|++++ .+|..+..+++|+.|.+++|.+.
T Consensus 341 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 45666666666666554343332 4566666666666665 66666666666666666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.60 E-value=0.0099 Score=64.13 Aligned_cols=64 Identities=16% Similarity=0.180 Sum_probs=46.4
Q ss_pred CCceeEEEccCCcceee----cccCccCCCCCCeEECcCCcccc----CcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGE----ILPHIFSLTSIESLDLSNNSLTG----SVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G----~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.++|+.|||++|.|+.. |+..+..+++|+.|+|++|+++. .++..+...+.|+.|++++|.+..
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 45688888888888742 33446677788888888888875 355556666788888888887754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=94.53 E-value=0.0092 Score=65.78 Aligned_cols=62 Identities=26% Similarity=0.251 Sum_probs=31.2
Q ss_pred CceeEEEccCCcceeecccCccC-----CCCCCeEECcCCccccC----cchhhhhhhchhccccCCCCcc
Q 037623 397 PRIKSLNLSSSGIAGEILPHIFS-----LTSIESLDLSNNSLTGS----VPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~~~~-----l~~L~~l~ls~N~l~G~----iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
++|+.|+|++|.+++.-+..++. .++|+.|+|++|++++. +|..+..++.|+.|++++|.+.
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence 44555555555554432222222 24555555555555544 4445555555555555555543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=94.50 E-value=0.0078 Score=68.73 Aligned_cols=65 Identities=14% Similarity=0.248 Sum_probs=50.2
Q ss_pred CCceeEEEccCCcceee-cccCccCCCCCCeEECcCCccccC-cchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGE-ILPHIFSLTSIESLDLSNNSLTGS-VPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~-ip~~~~~l~~L~~l~ls~N~l~G~-iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++|+.|+|++|++++. ++..+..+++|+.|+|++|.|++. +|..+..+++|+.|.+++|++...
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 56788999999988873 433467888999999999998765 555667788888888888876543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.46 E-value=0.0097 Score=64.21 Aligned_cols=62 Identities=19% Similarity=0.177 Sum_probs=43.8
Q ss_pred CceeEEEccCCccee----ecccCccCCCCCCeEECcCCcccc----CcchhhhhhhchhccccCCCCcc
Q 037623 397 PRIKSLNLSSSGIAG----EILPHIFSLTSIESLDLSNNSLTG----SVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G----~ip~~~~~l~~L~~l~ls~N~l~G----~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
++|+.|+|++|.|+. .++..+..+++|++|+|++|+++. .++..+...+.|+.|.+++|.+.
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 468888888888764 243345677888888888888875 34566666777888888877664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=93.92 E-value=0.011 Score=63.42 Aligned_cols=64 Identities=17% Similarity=0.314 Sum_probs=51.6
Q ss_pred CCCceeEEEccCCcceeecccCcc---CCCCCCeEECcCCccccC----cchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIF---SLTSIESLDLSNNSLTGS----VPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~---~l~~L~~l~ls~N~l~G~----iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+|+|+.|+|++|.+++..+..++ .+++|+.|+|+.|++++. |+..+..+++|+.|.+++|.+.
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 468999999999999876544443 588999999999999874 6666778889999998877653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.86 E-value=0.086 Score=57.70 Aligned_cols=72 Identities=10% Similarity=0.177 Sum_probs=46.5
Q ss_pred ccccccCceEEEEEEEC---------CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEe
Q 037623 531 RVLGKGGFGTVYHGYLD---------DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVYE 600 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~---------~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~E 600 (749)
+.+..|-...+|+.... ++.+++|+....... .-...+|..+++.+...+++ ++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 45667888899999876 577888886543221 12235788888877433333 4555432 378999
Q ss_pred eCCCCCH
Q 037623 601 FMANGNL 607 (749)
Q Consensus 601 y~~~gsL 607 (749)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=93.76 E-value=0.063 Score=48.46 Aligned_cols=48 Identities=15% Similarity=0.260 Sum_probs=38.9
Q ss_pred eeecCCCCC--------CCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccc
Q 037623 386 GLNCSYDAN--------QAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLT 434 (749)
Q Consensus 386 Gv~C~~~~~--------~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~ 434 (749)
-|.|+...- .+++|+.|+|++|+|+ .||+. +..|++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 477875421 2347999999999999 68776 788999999999999886
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.024 Score=64.70 Aligned_cols=58 Identities=14% Similarity=0.192 Sum_probs=44.3
Q ss_pred CCceeEEEccCCcce----eecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCC
Q 037623 396 APRIKSLNLSSSGIA----GEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~----G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
+++|+.|+|++|.++ +.++..+.++++|+.|+|++|.++| +|..+.++++|+.|.++.
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 567888888888886 4554446678888888888888886 788888888888887653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=92.25 E-value=0.038 Score=53.07 Aligned_cols=62 Identities=18% Similarity=0.178 Sum_probs=37.5
Q ss_pred CceeEEEccCCcceee----cccCccCCCCCCeEECcCCccccC----cchhhhhhhchhcccc--CCCCcc
Q 037623 397 PRIKSLNLSSSGIAGE----ILPHIFSLTSIESLDLSNNSLTGS----VPEFLAELQFLRVLVD--GNPNLC 458 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G~----iP~~l~~~~~l~~l~~--~n~~l~ 458 (749)
+.|+.|+|++|.+... |...+...++|++|+|++|+++.. |...+...+.|+.|.+ +.|.+.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 4577777777776532 222244456777777777777653 4555566666777777 445553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=91.97 E-value=0.053 Score=52.06 Aligned_cols=62 Identities=23% Similarity=0.227 Sum_probs=49.0
Q ss_pred CceeEEEccCCcceee----cccCccCCCCCCeEEC--cCCccccC----cchhhhhhhchhccccCCCCcc
Q 037623 397 PRIKSLNLSSSGIAGE----ILPHIFSLTSIESLDL--SNNSLTGS----VPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~----ip~~~~~l~~L~~l~l--s~N~l~G~----iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
+.|+.|+|++|.++.. |...+...++|++|+| ++|.++.. |-..+...+.|+.|.+++|.+.
T Consensus 93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4699999999999864 4455778899999999 88999865 4455566678889988887663
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=91.32 E-value=0.035 Score=63.24 Aligned_cols=61 Identities=15% Similarity=0.116 Sum_probs=37.0
Q ss_pred CCceeEEEccCCcceeecccCccC-CCCCCeEECcCCccccCcchhh-hhhhchhccccCCCCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTGSVPEFL-AELQFLRVLVDGNPNL 457 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~-l~~L~~l~ls~N~l~G~iP~~l-~~~~~l~~l~~~n~~l 457 (749)
+++|+.|+|++ ++++..++.++. +++|+.|+|++|.+++..+..+ ..+++|+.|.+++|.+
T Consensus 431 ~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 431 CKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp CTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred CCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 34566667655 555555455554 6666777777666665544444 4566666666666665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=89.01 E-value=0.068 Score=60.77 Aligned_cols=62 Identities=15% Similarity=0.193 Sum_probs=34.1
Q ss_pred CCceeEEEccCCcceeecccCc-cCCCCCCeEECcCCccccCcch-hhhhhhchhccccCCCCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHI-FSLTSIESLDLSNNSLTGSVPE-FLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~-~~l~~L~~l~ls~N~l~G~iP~-~l~~~~~l~~l~~~n~~l 457 (749)
+++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|.++++.+
T Consensus 455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 4456666666666655544443 4466666666666666544333 233455666665555433
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=87.48 E-value=2.2 Score=41.88 Aligned_cols=101 Identities=15% Similarity=0.126 Sum_probs=65.9
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
.-+|.+.|.. ....+++.++..++.|.+++|.-+-....+ ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~-----------~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~ 97 (229)
T 2yle_A 32 ALSLEEILRL-----------YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD 97 (229)
T ss_dssp EEEHHHHHHH-----------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---
T ss_pred cccHHHHHHH-----------cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc
Confidence 3479999864 456899999999999999998776221111 1333456899999999888764 1110
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcC
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 733 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG 733 (749)
.....+.+||... ...+.+.=|||+|+++|..+-=
T Consensus 98 --------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 --------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred --------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1122356787763 3456888999999999998853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.45 E-value=1.4 Score=47.60 Aligned_cols=29 Identities=41% Similarity=0.568 Sum_probs=24.9
Q ss_pred ceeeCCCCCcEEE------cCCCcEEEEecCCCcc
Q 037623 656 IVHRDVKSANILL------NEKFQAKLADFGLSRI 684 (749)
Q Consensus 656 IiHrDLkp~NILl------~~~~~~kL~DFGla~~ 684 (749)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4456799999998864
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=86.25 E-value=0.47 Score=49.57 Aligned_cols=55 Identities=18% Similarity=0.242 Sum_probs=35.4
Q ss_pred CceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcch-hhhhhhchh-ccccCC
Q 037623 397 PRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPE-FLAELQFLR-VLVDGN 454 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~-~l~~~~~l~-~l~~~n 454 (749)
++|+.|+|++|+++ .||+. +.++++|+.|+|++| ++ .||+ .+..+.+|+ .+.+.+
T Consensus 226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp TTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT
T ss_pred CCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc
Confidence 45777777777766 56665 667777777777776 44 3553 356666666 665554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=83.95 E-value=0.33 Score=50.75 Aligned_cols=60 Identities=15% Similarity=0.208 Sum_probs=37.4
Q ss_pred CCceeEEEccCCcce----------e---------ecccC-ccC--------CCCCCeEECcCCccccCcch-hhhhhhc
Q 037623 396 APRIKSLNLSSSGIA----------G---------EILPH-IFS--------LTSIESLDLSNNSLTGSVPE-FLAELQF 446 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~----------G---------~ip~~-~~~--------l~~L~~l~ls~N~l~G~iP~-~l~~~~~ 446 (749)
+++|+.|||++|+++ + .||+. +.+ +++|+.|+|.+ +++ .|++ .+..|++
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~ 125 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDN 125 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTT
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcc
Confidence 345667777776665 0 34444 555 77777777777 665 3554 4667777
Q ss_pred hhccccCCCCc
Q 037623 447 LRVLVDGNPNL 457 (749)
Q Consensus 447 l~~l~~~n~~l 457 (749)
|+.+.+.+|.+
T Consensus 126 L~~l~l~~n~i 136 (329)
T 3sb4_A 126 LKICQIRKKTA 136 (329)
T ss_dssp CCEEEBCCSSC
T ss_pred cceEEcCCCCc
Confidence 77777776654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.33 E-value=3.2 Score=40.51 Aligned_cols=117 Identities=8% Similarity=0.058 Sum_probs=79.4
Q ss_pred cCCCceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 037623 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPI 656 (749)
Q Consensus 577 l~H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gI 656 (749)
..||++++. ..-.+++...+.|+.-+++- .+ ..-+.++...+++++..|+....+++..
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~--~f-------------~~ik~~~~~eKlr~l~ni~~l~~~~~~r----- 100 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHT--PF-------------DNIKSFTKNEKLRYLLNIKNLEEVNRTR----- 100 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSE--EG-------------GGGGGSCHHHHHHHHHHGGGGGGGGGSS-----
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccC--CH-------------HHHHhcCHHHHHHHHHHHHHHHHHhcCc-----
Confidence 478888877 45556666666666543221 11 1334578899999999999988766644
Q ss_pred eeeCCCCCcEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 037623 657 VHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV 736 (749)
Q Consensus 657 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p 736 (749)
+|--|.|+||+++.++.+++.=.|+-..+++. ..+...=.-.+=+++..+++++..
T Consensus 101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~------------------------~~~ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 101 YTFVLAPDELFFTRDGLPIAKTRGLQNVVDPL------------------------PVSEAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp EECCCSGGGEEECTTSCEEESCCEETTTBSCC------------------------CCCHHHHHHHHHHHHHHHHCTTCC
T ss_pred eEEEEecceEEEcCCCCEEEEEccCccCCCCC------------------------CCCHHHHHHHHHHHHHHHHcCCCC
Confidence 78899999999999999999988765433221 112222233466778888888777
Q ss_pred CC
Q 037623 737 IQ 738 (749)
Q Consensus 737 f~ 738 (749)
|.
T Consensus 157 Fe 158 (215)
T 4ann_A 157 FD 158 (215)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 749 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 9e-62
Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILV 586
+ +G G FGTVY G VAVKML+ + + Q + F+ EV +L + H N+ + +
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
GY +V ++ +L HL + IA ++AQG++
Sbjct: 71 GYSTAPQLA-IVTQWCEGSSLYHHL-----------HIIETKFEMIKLIDIARQTAQGMD 118
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YLH I+HRD+KS NI L+E K+ DFGL+ + GSH + G+ ++ P
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 707 EYY---ISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
E N + +SDVY+FG+VL EL+TGQ R I
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-57
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 526 TNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGY-KQFQAEVELLMRAHHK 580
++FE LG G G V+ +A K++ Q E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ G + ++ + E M G+L L K G + + +++
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGKVSIA 112
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
+GL YL + K I+HRDVK +NIL+N + + KL DFG+S ++ + VGT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 166
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-53
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTI 584
F+ +G+G F TVY G +VA L + ++F+ E E+L H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 585 LVGYCDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
+ K LV E M +G L+ +L + ++ K +
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL------------KRFKVMKIKVLRSWCRQ 120
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+GL++LH PPI+HRD+K NI + K+ D GL+ + + + V+G
Sbjct: 121 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIG 175
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP ++ PE + E DVY+FG+ +LE+ T +
Sbjct: 176 TPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-53
Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 20/232 (8%)
Query: 528 NFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKN 581
++E +G G +G D K + K L S+ + +EV LL H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 582 LTILVGYC--DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ NT + +V E+ G+L + + T + L + L++ T
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYLDEEFVLRVMT 116
Query: 640 ESAQGLEYLHD--GCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ L+ H ++HRD+K AN+ L+ K KL DFGL+RI + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAF 174
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQW 749
VGTP Y+ PE EKSD++S G +L EL P ++ L G+
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 1e-52
Identities = 71/243 (29%), Positives = 103/243 (42%), Gaps = 27/243 (11%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGY-KQFQAEVELLMR 576
NN E R +G+G FG V+ VAVKML + FQ E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHL------------LAQLAILPTDAED 624
+ N+ L+G C M L++E+MA G+L L + L+ +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
LS +L IA + A G+ YL + VHRD+ + N L+ E K+ADFGLSR
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ--PVIQKTPE 742
++ PE NR T +SDV+++GVVL E+ + P E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 743 RTL 745
+
Sbjct: 250 EVI 252
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-52
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 529 FERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
LG G FG V+ GY + +VAVK L S F AE L+ + H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+ ++ E+M NG+L L L+ L +A + A+G+ +
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFLK----------TPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
+ + +HRD+++ANIL+++ K+ADFGL+R+ + + PE
Sbjct: 125 IEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE 180
Query: 708 YYISNRLTEKSDVYSFGVVLLELITG 733
T KSDV+SFG++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTH 206
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+ +GKG FG V+ G ++VAVK+ S + +AE+ + H+N+ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 589 CDEN----TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
+++ T++ LV ++ +G+L +L ++ +G +++A +A G
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL-------------NRYTVTVEGMIKLALSTASG 112
Query: 645 LEYLHDGC-----KPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG--SHVSTTV 697
L +LH KP I HRD+KS NIL+ + +AD GL+
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 698 VGTPGYLDPEYYISN------RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742
VGT Y+ PE + +++D+Y+ G+V E+ + +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 8e-52
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 18/221 (8%)
Query: 528 NFERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
F + +G G FG V+ GY + +VA+K + + + F E E++M+ H L L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C E + LV+EFM +G L + + G+ + + L + + +G+
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDY-----------LRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YL + ++HRD+ + N L+ E K++DFG++R + ST + P
Sbjct: 116 YL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 171
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746
E + +R + KSDV+SFGV++ E+ + G+ + ++
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-51
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGY 588
+ +GKG FG V G +VAVK + + + F AE ++ + H NL L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 68
Query: 589 C-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
+E + +V E+MA G+L +L ++ +L L+ + + + +EY
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEY 118
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
L VHRD+ + N+L++E AK++DFGL++ S T + PE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPE 170
Query: 708 YYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLIGQW 749
+ + KSDV+SFG++L E+ + G+ + P + ++ +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 24/239 (10%)
Query: 529 FERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSSVQGY-KQFQAEVELLMR-AHH 579
F +VLG G FG V + QVAVKML + + +E++++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTD-----------AEDKTGI 628
+N+ L+G C + + L++E+ G+L +L ++ D E+ +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 629 LSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVE 688
L+++ L A + A+G+E+L VHRD+ + N+L+ K+ DFGL+R +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 689 GGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746
V ++ PE T KSDV+S+G++L E+ + G P
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 23/214 (10%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
LG G FG VY A K++ S + + + E+++L H N+ L+
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ ++ EF A G + A + + L+ + ++ L
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVM-----------LELERPLTESQIQVVCKQTLDALN 124
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YLHD I+HRD+K+ NIL KLADFG+S + +GTP ++ P
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAP 179
Query: 707 EYYISNRL-----TEKSDVYSFGVVLLELITGQP 735
E + K+DV+S G+ L+E+ +P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-51
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 528 NFERVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
F + LG G FG V +G VA+KM+ S +F E +++M H+ L L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
G C + + ++ E+MANG L +L + + L++ + + +E
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYL-----------REMRHRFQTQQLLEMCKDVCEAME 114
Query: 647 YLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDP 706
YL +HRD+ + N L+N++ K++DFGLSR + S + P
Sbjct: 115 YLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170
Query: 707 EYYISNRLTEKSDVYSFGVVLLELIT 732
E + ++ + KSD+++FGV++ E+ +
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYS 196
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-51
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 21/222 (9%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKN 581
+++ + LG+G +G V ++ VAVK++ +V + + E+ + +H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ G+ E L E+ + G L + + + + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 112
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
G+ YLH I HRD+K N+LL+E+ K++DFGL+ +F + + GT
Sbjct: 113 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 702 GYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPE 742
Y+ PE E DV+S G+VL ++ G+ + +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-51
Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLT 583
R LGKG FG VY +A+K+L + + Q + EVE+ H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L GY + T++ L+ E+ G + L K + TE A
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYREL------------QKLSKFDEQRTATYITELAN 117
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
L Y H ++HRD+K N+LL + K+ADFG S P S TT+ GT Y
Sbjct: 118 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDY 170
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
L PE EK D++S GV+ E + G+P
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 19/237 (8%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQGYKQ-FQAEVELLMR-AHH 579
F + LG G FG V VAVKML PS+ ++ +E+++L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHL------LAQLAILPTDAEDKTGILSWKG 633
N+ L+G C ++ E+ G+L L P ED L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
L + + A+G+ +L +HRD+ + NILL K+ DFGL+R + V
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLIGQW 749
++ PE + T +SDV+S+G+ L EL + G P + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 7e-49
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 29/224 (12%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQG---YKQFQAEVELLMRAHHKNLTIL 585
R +G G FG VY + + VA+K +S S Q ++ EV L + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
G LV E+ + + L + + QGL
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHK------------KPLQEVEIAAVTHGALQGL 128
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
YLH ++HRDVK+ NILL+E KL DFG + I + + VGTP ++
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMA 179
Query: 706 PEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
PE ++ + K DV+S G+ +EL +P + + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-48
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 529 FERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVG 587
E LG+G FG V+ G + +VA+K L P + + F E +++ + H+ L L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 588 YCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEY 647
E + +V E+M+ G+L L + L + +A + A G+ Y
Sbjct: 80 VVSEE-PIYIVTEYMSKGSLLDFLKGE----------TGKYLRLPQLVDMAAQIASGMAY 128
Query: 648 LHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPE 707
+ VHRD+++ANIL+ E K+ADFGL+R+ + + PE
Sbjct: 129 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 184
Query: 708 YYISNRLTEKSDVYSFGVVLLELITGQP 735
+ R T KSDV+SFG++L EL T
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGR 212
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 530 ERVLGKGGFGTVYHGYLDDKQ----VAVKMLSPSSVQGY--KQFQAEVELLMRAHHKNLT 583
++ LG G FGTV GY K+ VAVK+L + + AE ++ + + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
++G C+ + M LV E G L +L + + K +++ + +
Sbjct: 72 RMIGICEAESWM-LVMEMAELGPLNKYL------------QQNRHVKDKNIIELVHQVSM 118
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT-VVGTPG 702
G++YL + VHRD+ + N+LL + AK++DFGLS+ + + + T
Sbjct: 119 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQP 735
+ PE + + KSDV+SFGV++ E + GQ
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 524 KITNNFERVLGKGGFGTVYHGYLDDK-----QVAVKMLSPSSVQG-YKQFQAEVELLMRA 577
+ +F V+G+G FG VYHG L D AVK L+ + G QF E ++
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 578 HHKNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H N+ L+G C +V +M +G+L+ ++T + K +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-----------IRNETHNPTVKDLIG 134
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGS--HVS 694
+ A+G+ VHRD+ + N +L+EKF K+ADFGL+R + H
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ 734
T ++ E + + T KSDV+SFGV+L EL+T
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-48
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 22/229 (9%)
Query: 511 ELKNRKLSYANVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ 566
E+ + S +V + +G+G GTVY ++VA++ ++ +
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 567 FQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKT 626
E+ ++ + N+ + ++ +V E++A G+L +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-------------TE 110
Query: 627 GILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFP 686
+ + E Q LE+LH ++HRD+KS NILL KL DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 687 VEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
E +T+VGTP ++ PE K D++S G++ +E+I G+P
Sbjct: 168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 4e-48
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 528 NFERVLGKGGFGTVYHGYLDD--KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
+ LG G +G VY G VAVK L +++ ++F E ++ H NL L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78
Query: 586 VGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGL 645
+G C ++ EFM GNL +L E +S L +AT+ + +
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYL----------RECNRQEVSAVVLLYMATQISSAM 128
Query: 646 EYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLD 705
EYL K +HRD+ + N L+ E K+ADFGLSR+ +
Sbjct: 129 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 184
Query: 706 PEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE N+ + KSDV++FGV+L E+ T
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 5e-48
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 34/235 (14%)
Query: 518 SYANVLKITNNF-----------ERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPS-S 560
++ + + F E+V+G G FG V G+L + VA+K L +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 561 VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPT 620
+ + F +E ++ + H N+ L G ++T + ++ EFM NG+L +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---------- 117
Query: 621 DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680
G + + + A G++YL D VHRD+ + NIL+N K++DFG
Sbjct: 118 -LRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFG 173
Query: 681 LSRIFPVEGGSHVSTTVVG---TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT 732
LSR + T+ +G + PE + T SDV+S+G+V+ E+++
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-48
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV---QGYKQFQAEVELLMRAHHKNLT 583
F ++LG+G F TV ++ A+K+L + E +++ R H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L ++ K+ + NG L ++ K G +A+
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYI------------RKIGSFDET---CTRFYTAE 116
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
+ L I+HRD+K NILLNE ++ DFG +++ E + + VGT Y
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ PE + SD+++ G ++ +L+ G P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-47
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 530 ERVLGKGGFGTVYHGYLDDKQ----VAVKMLSPSSVQG-YKQFQAEVELLMRAHHKNLTI 584
+ LG G FG+V G ++ VA+K+L + + ++ E +++ + + +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 585 LVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQG 644
L+G C + + LV E G L L+ K + ++ + + G
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLV-----------GKREEIPVSNVAELLHQVSMG 121
Query: 645 LEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGG-SHVSTTVVGTPGY 703
++YL + VHRD+ + N+LL + AK++DFGLS+ + + +
Sbjct: 122 MKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 704 LDPEYYISNRLTEKSDVYSFGVVLLELIT-GQP 735
PE + + +SDV+S+GV + E ++ GQ
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 528 NFERVLGKGGFGTVYHGYLDD----KQVAVKMLSP-SSVQGYKQFQAEVELLMR-AHHKN 581
F+ V+G+G FG V + A+K + +S ++ F E+E+L + HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDA----EDKTGILSWKGRLQI 637
+ L+G C+ + L E+ +GNL L + A LS + L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
A + A+G++YL + +HRD+ + NIL+ E + AK+ADFGLSR V T
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMG 186
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG 733
++ E + T SDV+S+GV+L E+++
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 8e-46
Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 23/228 (10%)
Query: 528 NFERVLGKGGFGTVYHGYLDD------KQVAVKMLSPSSVQGYK-QFQAEVELLMRAHHK 580
++V+G G FG VY G L VA+K L + + F E ++ + H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ L G + M ++ E+M NG L L +K G S + +
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLR-----------EKDGEFSVLQLVGMLRG 118
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEG-GSHVSTTVVG 699
A G++YL VHRD+ + NIL+N K++DFGLSR+ + ++ ++
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746
+ PE + T SDV+SFG+V+ E++T G+ + ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (415), Expect = 2e-45
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 23/217 (10%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHK 580
+ ++++ LG G FG V+ A K + + + E++ + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
L L +++ +M ++YEFM+ G L + D+ +S ++ +
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-----------ADEHNKMSEDEAVEYMRQ 132
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKF--QAKLADFGLSRIFPVEGGSHVSTTVV 698
+GL ++H+ VH D+K NI+ K + KL DFGL+
Sbjct: 133 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTT 186
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
GT + PE + +D++S GV+ L++G
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-45
Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 24/234 (10%)
Query: 522 VLKITN-NFERVLGKGGFGTVYHGYLDDK------QVAVKMLSPS-SVQGYKQFQAEVEL 573
+LK T +VLG G FGTVY G + VA+K L + S + K+ E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 574 LMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
+ + ++ L+G C +T L+ + M G L + + + +
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY-----------VREHKDNIGSQY 112
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
L + A+G+ YL +VHRD+ + N+L+ K+ DFGL+++ E +
Sbjct: 113 LLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLI 746
+ ++ E + T +SDV+S+GV + EL+T G P +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 13/215 (6%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHK 580
R LG+G FG VY G + +VA+K ++ + S++ +F E ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
++ L+G + ++ E M G+L+++L + + S +Q+A E
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM--ANNPVLAPPSLSKMIQMAGE 141
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
A G+ YL VHRD+ + N ++ E F K+ DFG++R +
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 701 PGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
++ PE T SDV+SFGVVL E+ T
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (401), Expect = 3e-44
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 27/237 (11%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQG---YKQFQAEVELLMR 576
+++ +E +LG GG V+ + VAVK+L + Y +F+ E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 577 AHHKNLTILVGYCDENTKMG----LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK 632
+H + + + T G +V E++ L+ + G ++ K
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV------------HTEGPMTPK 111
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
+++ ++ Q L + + I+HRDVK ANI+++ K+ DFG++R G S
Sbjct: 112 RAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 168
Query: 693 VST-TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
T V+GT YL PE + + +SDVYS G VL E++TG+P ++ Q
Sbjct: 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 60/228 (26%), Positives = 84/228 (36%), Gaps = 26/228 (11%)
Query: 529 FERVLGKGGFGTVYHGYLDDK-----QVAVKMLSPSSV---QGYKQFQAEVELLMRAHHK 580
LG G FG V G D VAVK L P + + F EV + H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
NL L G M +V E G+L G + A +
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLLDR-----------LRKHQGHFLLGTLSRYAVQ 119
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT-VVG 699
A+G+ YL +HRD+ + N+LL + K+ DFGL R P +V
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG--QPVIQKTPERTL 745
+ PE + + SD + FGV L E+ T +P I + L
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 23/228 (10%)
Query: 529 FERVLGKGGFGTVYHGYLDDKQ-----VAVKMLSPSSVQGYKQ-FQAEVELLMRAHHKNL 582
R +G+G FG V+ G + VA+K + ++ F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
L+G EN ++ E G L++ + + L + A + +
Sbjct: 71 VKLIGVITENPVW-IIMELCTLGELRSF-----------LQVRKYSLDLASLILYAYQLS 118
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
L YL VHRD+ + N+L++ KL DFGLSR + + ++
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLIGQW 749
++ PE R T SDV+ FGV + E++ G Q +IG+
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 529 FERVLGKGGFGTVYHGYL-------DDKQVAVKMLSPSSVQG-YKQFQAEVELLMR-AHH 579
+ LG+G FG V + VAVKML + ++ +E+++L+ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 580 KNLTILVGYC-DENTKMGLVYEFMANGNLQAHLLAQ----LAILPTDAEDKTGILSWKGR 634
N+ L+G C + ++ EF GNL +L ++ + + L+ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVS 694
+ + + A+G+E+L +HRD+ + NILL+EK K+ DFGL+R +
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 695 TTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
++ PE T +SDV+SFGV+L E+ +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 19/237 (8%)
Query: 529 FERVLGKGGFGTVYHGYL---------DDKQVAVKMLSPSSVQ-GYKQFQAEVELLMR-A 577
+ LG+G FG V +VAVKML + + +E+E++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQ----LAILPTDAEDKTGILSWKG 633
HKN+ L+G C ++ + ++ E+ + GNL+ +L A+ L + + LS K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+ A + A+G+EYL +HRD+ + N+L+ E K+ADFGL+R
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTLIGQW 749
+T ++ PE T +SDV+SFGV+L E+ T G P L
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 8e-43
Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 20/229 (8%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-KQFQAEVELLMRAHH 579
I + ++ VLG G F V K VA+K ++ +++G + E+ +L + H
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
N+ L + + L+ + ++ G L ++ + G + + ++
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIV------------EKGFYTERDASRLIF 114
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+ ++YLHD + L+E + ++DFGLS++ E V +T G
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACG 171
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
TPGY+ PE ++ D +S GV+ L+ G P + L Q
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 156 bits (396), Expect = 8e-43
Identities = 43/218 (19%), Positives = 88/218 (40%), Gaps = 23/218 (10%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH 579
+ + ++ LG G FG V+ + K ++ + E+ ++ + HH
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
L L ++ +M L+ EF++ G L + A + +S +
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-----------EDYKMSEAEVINYMR 134
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILL--NEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
++ +GL+++H+ IVH D+K NI+ + K+ DFGL+ +
Sbjct: 135 QACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVT 188
Query: 698 VGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T + PE + +D+++ GV+ L++G
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 38/211 (18%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
LG+G FG V+ K K + + E+ +L A H+N+ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLH 67
Query: 587 GYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLE 646
+ ++ +++EF++ ++ + L+ + + + + L+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI-----------NTSAFELNEREIVSYVHQVCEALQ 116
Query: 647 YLHDGCKPPIVHRDVKSANILLNEK--FQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYL 704
+LH I H D++ NI+ + K+ +FG +R + P Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYY 170
Query: 705 DPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
PE + + ++ +D++S G ++ L++G
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (373), Expect = 2e-40
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY---------KQFQAEVELLMRA 577
+ +LG+G V K+ AVK++ + + + EV++L +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 578 H-HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
H N+ L + NT LV++ M G L +L + LS K +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------------TEKVTLSEKETRK 114
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
I + + LH K IVHRD+K NILL++ KL DFG S
Sbjct: 115 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLRE 168
Query: 697 VVGTPGYLDPEYYISNRL------TEKSDVYSFGVVLLELITGQP 735
V GTP YL PE + ++ D++S GV++ L+ G P
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 8e-40
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQ---FQAEVELLMRAHH 579
+F+ R LG G FG V+ + + A+K+L V KQ E +L H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ + G + ++ ++ +++ G L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELF---------------SLLRKSQRFPNPVAKF 108
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVG 699
+A+ L I++RD+K NILL++ K+ DFG ++ P V+ T+ G
Sbjct: 109 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCG 163
Query: 700 TPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
TP Y+ PE + + D +SFG+++ E++ G
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 529 FERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVELLMRA-HHKNL 582
++LGKG FG V+ ++ A+K L V + E +L A H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 583 TILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESA 642
T + + V E++ G+L H+ A E
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHI------------QSCHKFDLSRATFYAAEII 113
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPG 702
GL++L IV+RD+K NILL++ K+ADFG+ + + T GTP
Sbjct: 114 LGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPD 168
Query: 703 YLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y+ PE + + D +SFGV+L E++ GQ
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-39
Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 521 NVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY-KQFQAEVELLM 575
V + + +G+G +G V Y ++ +VA+K +SP Q Y ++ E+++L+
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 576 RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
R H+N+ + T + ++ + A L L KT LS
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---------KTQHLSNDHIC 112
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH-VS 694
+ +GL+Y+H ++HRD+K +N+LLN K+ DFGL+R+ +
Sbjct: 113 YFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
Query: 695 TTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
T V T Y PE ++++ T+ D++S G +L E+++ +P
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 6e-39
Identities = 45/239 (18%), Positives = 85/239 (35%), Gaps = 28/239 (11%)
Query: 523 LKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH 578
L++ N + R +G G FG +Y G ++VA+K+ + Q E ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+ +C ++ + +L+ + S K L +A
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDL-----------FNFCSRKFSLKTVLLLA 109
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLNEK---FQAKLADFGLSRIFPVEGGS---- 691
+ +EY+H +HRDVK N L+ + DFGL++ +
Sbjct: 110 DQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 692 -HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQW 749
+ + GT Y ++ + + D+ S G VL+ G Q T ++
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 8e-39
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 30/230 (13%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---QGYKQFQAEVE---LLMR 576
N+F R++G+GGFG VY K A+K L + QG E L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 577 AHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQ 636
+ + K+ + + M G+L HL + G+ S
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------------SQHGVFSEADMRF 111
Query: 637 IATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTT 696
A E GLE++H+ +V+RD+K ANILL+E +++D GL+ F
Sbjct: 112 YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHA 164
Query: 697 VVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPERTL 745
VGT GY+ PE +D +S G +L +L+ G ++ +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 531 RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQG-----YKQFQAEVELLMRAHHKNLT 583
LG+G F TVY ++ VA+K + + E++LL H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 584 ILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQ 643
L+ + + LV++FM +D + +L+ + Q
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII------------KDNSLVLTPSHIKAYMLMTLQ 111
Query: 644 GLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGY 703
GLEYLH I+HRD+K N+LL+E KLADFGL++ F ++ T V T Y
Sbjct: 112 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWY 166
Query: 704 LDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
PE R+ D+++ G +L EL+ P
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 2e-38
Identities = 40/237 (16%), Positives = 82/237 (34%), Gaps = 32/237 (13%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHH 579
+ +++ R +G+G FG ++ G L+++QVA+K S Q + E A
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGC 60
Query: 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ + + E LV + + + S K A
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL------------DLCGRKFSVKTVAMAAK 108
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ-----AKLADFGLSRIFPVEGGS--- 691
+ ++ +H+ +V+RD+K N L+ + DFG+ + +
Sbjct: 109 QMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 692 --HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
+ GT Y+ ++ + + D+ + G V + + G Q T
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 22/235 (9%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY---LDDKQVAVKMLSPSSVQGYKQFQAEVEL----- 573
+ +E +G+G +G V+ + VA+K + + + E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 574 LMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
L H N+ L C + + ++ L L + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV------PEPGVPTET 117
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV 693
+ + +GL++LH +VHRD+K NIL+ Q KLADFGL+RI+ +
Sbjct: 118 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MA 171
Query: 694 STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERTLIGQ 748
T+VV T Y PE + + D++S G + E+ +P+ + + + +G+
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 30/219 (13%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGY------KQFQAEVELL--MRAH 578
+LG GGFG+VY G D+ VA+K + + + + EV LL + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 579 HKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIA 638
+ L+ + + L+ E + + G L +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFF 116
Query: 639 TESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ + + + ++HRD+K NIL++ + + KL DFG + V T
Sbjct: 117 WQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF 169
Query: 698 VGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
GT Y PE+ +R + V+S G++L +++ G
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 524 KIT-NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV---QGYKQFQAEVELLM 575
K+T N+F+ ++LGKG FG V + A+K+L + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 576 RAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
H LT L + ++ V E+ G L HL + + + +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL------------SRERVFTEERAR 108
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVST 695
A+ + L +V+RD+K N++L++ K+ DFGL + +G +
Sbjct: 109 FYG---AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--K 163
Query: 696 TVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
T GTP YL PE N D + GVV+ E++ G+
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 23/215 (10%)
Query: 528 NFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKN 581
NF+ +G+G +G VY L + VA+K + + E+ LL +H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L+ K+ LV+EF+ + + +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-----------SALTGIPLPLIKSYLFQL 111
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
QGL + ++HRD+K N+L+N + KLADFGL+R F V ++ T V T
Sbjct: 112 LQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTL 166
Query: 702 GYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQP 735
Y PE + + + D++S G + E++T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-35
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 34/225 (15%)
Query: 524 KITNNFE---RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRA- 577
I ++++ +VLG G G V + ++ A+KML + + EVEL RA
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS 62
Query: 578 HHKNLTILVGYCD----ENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKG 633
++ +V + + +V E + G L + + + + +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR----------GDQAFTERE 112
Query: 634 RLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ---AKLADFGLSRIFPVEGG 690
+I + ++YLH I HRDVK N+L K KL DFG ++
Sbjct: 113 ASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---S 166
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ TT TP Y+ PE + + D++S GV++ L+ G P
Sbjct: 167 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 32/237 (13%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQG--YKQFQAEVELLMRAHHK 580
+ +E +G+G FG V+ ++VA+K + + + E+++L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 581 NLTILVGYCDENT--------KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK 632
N+ L+ C + LV++F + + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------------NVLVKFTLS 117
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
++ L L+ + I+HRD+K+AN+L+ KLADFGL+R F + S
Sbjct: 118 EIKRVM---QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 693 VS--TTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPERTLI 746
+ T V T Y PE + R D++ G ++ E+ T P++Q E+ +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 2e-35
Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 512 LKNRKLSYANVLKITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQ- 566
LK + N ++ + F+ + LG G FG V A+K+L V KQ
Sbjct: 27 LKKWETPSQNTAQL-DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI 85
Query: 567 --FQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAED 624
E +L + L L +N+ + +V E++A G + +HL
Sbjct: 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL------------R 133
Query: 625 KTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684
+ G S A + EYLH +++RD+K N+L++++ ++ DFG ++
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T+ GTP L PE +S + D ++ GV++ E+ G P
Sbjct: 191 VK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 4e-35
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 33/236 (13%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQG------YKQFQAEVELL 574
+ + ++ LG G F V Q A K + + + + EV +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 575 MRAHHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGR 634
H N+ L + T + L+ E +A G L D + L+ +
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELF------------DFLAEKESLTEEEA 115
Query: 635 LQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE----KFQAKLADFGLSRIFPVEGG 690
+ Q L ++ I H D+K NI+L + K + K+ DFGL+
Sbjct: 116 TEFL---KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---F 169
Query: 691 SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERTL 745
+ + GTP ++ PE L ++D++S GV+ L++G P + T + TL
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 132 bits (333), Expect = 5e-35
Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 23/215 (10%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKN 581
+ +G+G +G VY + A+K + E+ +L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 582 LTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATES 641
+ L ++ LV+E + + + + G L +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE------------GGLESV---TAKSFL 106
Query: 642 AQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
Q L + ++HRD+K N+L+N + + K+ADFGL+R F + + T + T
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTL 164
Query: 702 GYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQP 735
Y P+ + + + + D++S G + E++ G P
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-35
Identities = 47/217 (21%), Positives = 80/217 (36%), Gaps = 27/217 (12%)
Query: 528 NFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTIL 585
+V+G G FG VY L + VA+K + + E++++ + H N+ L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRL 78
Query: 586 VGYC------DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ + + LV +++ + L
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR---------HYSRAKQTLPVIYVKLYMY 129
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADFGLSRIFPVEGGSHVSTTVV 698
+ + L Y+H I HRD+K N+LL+ KL DFG ++ G + +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC 184
Query: 699 GTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ + T DV+S G VL EL+ GQP
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 24/216 (11%)
Query: 527 NNFE--RVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHK 580
+E +G+G +GTV+ + VA+K + E+ LL HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 581 NLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATE 640
N+ L + K+ LV+EF + + G L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF------------DSCNGDLDPEIVKSFL-- 107
Query: 641 SAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGT 700
Q L+ L ++HRD+K N+L+N + KLA+FGL+R F + + + V T
Sbjct: 108 -FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVT 164
Query: 701 PGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQP 735
Y P+ + + D++S G + EL
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-31
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 23/219 (10%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV--QGYKQFQAEVELLMRA 577
++ + + +G G +G V +VA+K L K+ E+ LL
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H+N+ L+ + + +F L +L K L +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--------KHEKLGEDRIQFL 126
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ +GL Y+H HRD+K N+ +NE + K+ DFGL+R T
Sbjct: 127 VYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGY 178
Query: 698 VGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQP 735
V T Y PE ++ R T+ D++S G ++ E+ITG+
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 53/239 (22%), Positives = 92/239 (38%), Gaps = 30/239 (12%)
Query: 511 ELKNRKLSYANVLKIT-NNFE--RVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSSV- 561
EL+ L+ + K+ NFE +VLG G +G V+ K A+K+L +++
Sbjct: 8 ELRTANLT-GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 562 ---QGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAI 617
+ + + E ++L L L TK+ L+ +++ G L HL +
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126
Query: 618 LPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677
+ + + + L K I++RD+K NILL+ L
Sbjct: 127 TEHEVQIYV---------------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171
Query: 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQP 735
DFGLS+ F + + + D +S GV++ EL+TG
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 8e-30
Identities = 43/218 (19%), Positives = 90/218 (41%), Gaps = 33/218 (15%)
Query: 527 NNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMR-AHHKN 581
++++ R LG+G + V+ ++++V VK+L P K+ + E+++L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 582 LTILVGYCDENTK--MGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIAT 639
+ L + LV+E + N + + L+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------------QTLTDYDIRFYMY 136
Query: 640 ESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKLADFGLSRIFPVEGGSHVSTTVV 698
E + L+Y H I+HRDVK N++++ + + +L D+GL+ + V
Sbjct: 137 EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRV 190
Query: 699 GTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQP 735
+ + PE + ++ D++S G +L +I +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-28
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 525 ITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSV--QGYKQFQAEVELLMRAH 578
+ ++ + +G G G V Y + D+ VA+K LS K+ E+ L+ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 579 HKNLTILVGYC------DENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWK 632
HKN+ L+ +E + LV E M Q + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---------------DHE 119
Query: 633 GRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSH 692
+ + G+++LH I+HRD+K +NI++ K+ DFGL+R G S
Sbjct: 120 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSF 173
Query: 693 VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
+ T V T Y PE + E D++S G ++ E++ +
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 4e-27
Identities = 43/214 (20%), Positives = 87/214 (40%), Gaps = 10/214 (4%)
Query: 529 FERVLGKGGFGTVYHGY--LDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILV 586
R LG G F TV+ +++ VA+K++ V + + E++LL R + + T
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKED 75
Query: 587 GYCDEN-TKMGLVYEFMANGNLQAHLLAQLA---ILPTDAEDKTGILSWKGRLQIATESA 642
+ K+ + + ++ ++ +L + + + QI+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 643 QGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTP 701
GL+Y+H + I+H D+K N+L+ L ++ + T + T
Sbjct: 136 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 702 GYLDPEYYISNRLTEKSDVYSFGVVLLELITGQP 735
Y PE + +D++S ++ ELITG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-27
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 524 KITNNFE--RVLGKGGFGTVYHGY--LDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRA 577
++ ++ +G G +G+V + +VAVK LS S+ K+ E+ LL
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 578 HHKNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQI 637
H+N+ L+ + + +L L + K L+ +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--------VKCQKLTDDHVQFL 126
Query: 638 ATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIFPVEGGSHVSTTV 697
+ +GL+Y+H HRD+K +N+ +NE + K+ DFGL+R T
Sbjct: 127 IYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGY 178
Query: 698 VGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQP 735
V T Y PE ++ + D++S G ++ EL+TG+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 24/168 (14%), Positives = 46/168 (27%), Gaps = 38/168 (22%)
Query: 531 RVLGKGGFGTVYHGYL-DDKQVAVKMLSPSSV----------QGYKQFQAEVELLMRAHH 579
+++G+G V++ Y + VK G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 580 KNLTILVGYCDENT----KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRL 635
+ L L G ++ E + L +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------------------RVENPD 106
Query: 636 QIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683
++ + + + IVH D+ N+L++E + DF S
Sbjct: 107 EVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 2/88 (2%)
Query: 372 WQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNN 431
+ + + + L+L ++ I G + + L + SL++S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 432 SLTGSVPEFLAELQFLRVL-VDGNPNLC 458
+L G +P+ LQ V N LC
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLC 305
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 6e-05
Identities = 11/54 (20%), Positives = 27/54 (50%), Gaps = 4/54 (7%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVL 450
+++ L +++ ++ + + +LT+I L +N ++ P LA L + L
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 4/64 (6%)
Query: 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454
++ +L GI + + + L ++ ++ SNN LT P L L L ++ N
Sbjct: 42 DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 455 PNLC 458
+
Sbjct: 98 NQIA 101
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 20/84 (23%), Positives = 30/84 (35%), Gaps = 7/84 (8%)
Query: 372 WQGDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNN 431
P + P ++ LN+S++ + LP +E L S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE--LPA--LPPRLERLIASFN 314
Query: 432 SLTGSVPEFLAELQFLRVLVDGNP 455
L VPE L+ L V+ NP
Sbjct: 315 HLA-EVPELPQNLKQLH--VEYNP 335
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.002
Identities = 11/53 (20%), Positives = 24/53 (45%), Gaps = 5/53 (9%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRV 449
PR++ L S + + +P +++ L + N L P+ ++ LR+
Sbjct: 304 PRLERLIASFNHL--AEVPE--LPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 7e-04
Identities = 8/52 (15%), Positives = 18/52 (34%), Gaps = 4/52 (7%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS----LTSIESLDLSNNSLTGSVPEFLAEL 444
+ + + L G+ I S ++ L+L +N L + +
Sbjct: 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 10/57 (17%), Positives = 20/57 (35%), Gaps = 5/57 (8%)
Query: 399 IKSLNLSSSGIAGEILPHIFS-LTSIESLDLSNNSLTG----SVPEFLAELQFLRVL 450
I+SL++ ++ + L + + L + LT + L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 10/66 (15%), Positives = 25/66 (37%), Gaps = 11/66 (16%)
Query: 397 PRIKSLNLSSSGIAGEILPHIFS-----LTSIESLDLSNNSLTGSVPEFLAELQFLRVLV 451
++ L+LS++ + + + +E L L + + + + L L+
Sbjct: 397 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD---- 452
Query: 452 DGNPNL 457
P+L
Sbjct: 453 --KPSL 456
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 12/41 (29%), Positives = 20/41 (48%), Gaps = 2/41 (4%)
Query: 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEF 440
+ L+L+ + +L H+ L + LDLS+N L P
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL 39
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.9 bits (89), Expect = 0.001
Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 6/80 (7%)
Query: 384 WQGLNCSY------DANQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSV 437
+ + CS + P L+L ++ I +L ++ +L L NN ++
Sbjct: 12 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 438 PEFLAELQFLRVLVDGNPNL 457
P A L L L L
Sbjct: 72 PGAFAPLVKLERLYLSKNQL 91
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 16/84 (19%), Positives = 31/84 (36%), Gaps = 10/84 (11%)
Query: 383 LWQGLNCSYDANQAPRI--------KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLT 434
LWQ L+ + + S + + L FS ++ +DLSN+ +
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFM-DQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 435 G-SVPEFLAELQFLRVLVDGNPNL 457
++ L++ L+ L L
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRL 83
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 749 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.5 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.08 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 97.92 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 97.87 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 97.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 97.72 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 97.54 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 97.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 97.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 97.31 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 97.3 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 97.23 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 97.19 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 97.08 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.03 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 97.02 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 96.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 96.64 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 96.61 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 96.6 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 96.54 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 96.51 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 96.35 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 96.21 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 96.04 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 95.57 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 95.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.23 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 94.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 94.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.14 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 93.79 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 93.48 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 92.99 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 91.93 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 89.83 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 88.3 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 87.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 84.09 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 81.49 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=363.30 Aligned_cols=200 Identities=35% Similarity=0.578 Sum_probs=167.6
Q ss_pred hcccccccccCceEEEEEEECCcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
+.+.+.||+|+||+||+|+..+ .||||+++.. +....++|++|++++.+++|||||+++|++.+ +..++||||+++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 4556899999999999998755 5999998754 34556889999999999999999999999865 568999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ....+++..+++++.|+|+||+|||++ +||||||||+|||+++++.+||+|||+|+.
T Consensus 88 g~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 88 SSLYHHLHI-----------IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEHHHHHHT-----------SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred CCHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 999999953 234689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
..............||+.|||||++.+ ..++.++|||||||+||||+||+.||.+.+.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 654433334455679999999999864 3579999999999999999999999987543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=362.13 Aligned_cols=201 Identities=25% Similarity=0.400 Sum_probs=173.9
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|.+.+.||+|+||+||+|+.. ++.||||++..... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 566789999999999999974 58899999875532 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 87 gg~L~~~l~------------~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 87 GGELFDRIE------------PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp TEEGGGGSB------------TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCcHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhhe
Confidence 999998883 345689999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+.............||+.|||||++.+..+ +.++|||||||++|||+||+.||....+
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 7754433333455679999999999988876 5789999999999999999999976543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=360.52 Aligned_cols=198 Identities=26% Similarity=0.405 Sum_probs=177.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
|.+.+.||+|+||+||+|+.. ++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 566789999999999999864 688999999766555567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+.
T Consensus 102 g~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 102 GSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp CBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999988742 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+.... .......||+.|+|||++.++.++.++|||||||++|||+||+.||.+.+.
T Consensus 166 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 166 ITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp CCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 64332 223455799999999999999999999999999999999999999987553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=356.09 Aligned_cols=199 Identities=32% Similarity=0.459 Sum_probs=176.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||+||+|+.. ++.||+|++.... ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 667799999999999999984 4789999986532 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 88 ~~~g~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 88 APLGTVYRELQKL------------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred cCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccce
Confidence 9999999999542 4589999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 153 a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 153 SVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp CSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred eeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 9865422 2234579999999999999999999999999999999999999998765443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-42 Score=362.20 Aligned_cols=213 Identities=28% Similarity=0.457 Sum_probs=169.5
Q ss_pred cCHHHHHHHhhcc-----------cccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCC
Q 037623 517 LSYANVLKITNNF-----------ERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHH 579 (749)
Q Consensus 517 ~~~~~l~~~t~~f-----------~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H 579 (749)
++++++.+++.+| .++||+|+||+||+|++.. ..||||++... .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4455555555444 4689999999999998742 24889988654 44456789999999999999
Q ss_pred CceeEEEEEEecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceee
Q 037623 580 KNLTILVGYCDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHR 659 (749)
Q Consensus 580 ~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHr 659 (749)
||||+++|+|.+.+..++|||||++|+|.+++.. ....++|.++++++.|+|+||+|||++ +|+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-----------~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHr 152 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-----------NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHR 152 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-----------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-----------ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccC
Confidence 9999999999999999999999999999998853 345689999999999999999999998 99999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCCccccCCCCcee---eeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCC
Q 037623 660 DVKSANILLNEKFQAKLADFGLSRIFPVEGGSHV---STTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQP 735 (749)
Q Consensus 660 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~ 735 (749)
||||+|||+++++.+||+|||+++.+........ .....+|+.|||||.+.++.++.++|||||||+||||+| |+.
T Consensus 153 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp CCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence 9999999999999999999999987654322211 122357899999999999999999999999999999998 899
Q ss_pred CCCCCCcc
Q 037623 736 VIQKTPER 743 (749)
Q Consensus 736 pf~~~~~~ 743 (749)
||.+....
T Consensus 233 Pf~~~~~~ 240 (299)
T d1jpaa_ 233 PYWDMTNQ 240 (299)
T ss_dssp TTTTCCHH
T ss_pred CCCCCCHH
Confidence 99876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=361.93 Aligned_cols=203 Identities=26% Similarity=0.433 Sum_probs=175.4
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|.+.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 677899999999999999984 5889999987532 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 90 ~~gg~L~~~~~~------------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 90 AKNGELLKYIRK------------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCCCHHHhhhc------------cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccc
Confidence 999999998853 34689999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+.+.............||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 998754433334445679999999999999999999999999999999999999998765443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=357.98 Aligned_cols=202 Identities=27% Similarity=0.430 Sum_probs=177.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
|++.+.||+|+||+||+|+.. ++.||||++........+++.+|+++|++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 566789999999999999984 478999999877667778899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++++||+|||+|+.
T Consensus 94 g~L~~~~~~-----------~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 94 GAVDAVMLE-----------LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEHHHHHHH-----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhc
Confidence 999998854 234689999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCCceeeeccccCCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYI-----SNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
.... ........||+.|||||++. ...++.++|||||||++|||+||+.||.+.+..+
T Consensus 160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 4321 11223457999999999984 4568899999999999999999999998765543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=352.66 Aligned_cols=200 Identities=30% Similarity=0.525 Sum_probs=164.9
Q ss_pred hcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.+.+.||+|+||+||+|++.+ +.||||++.... ...++|.+|++++++++|||||+++|+|.+.+..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 4567899999999999999864 679999997643 34578999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.+++.. ....++|..+++++.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 ~L~~~l~~-----------~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 86 CLSDYLRT-----------QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp BHHHHHHT-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred cHHHHhhc-----------cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheec
Confidence 99999853 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPE 742 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~ 742 (749)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |++||...+.
T Consensus 152 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 152 LDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred cCCC-ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH
Confidence 4332 222234568999999999999999999999999999999999 5666665443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=356.17 Aligned_cols=208 Identities=27% Similarity=0.387 Sum_probs=166.0
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEec--CCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDE--NTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--~~~~~LV~E 600 (749)
|++.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 567799999999999999874 5789999987653 3445678999999999999999999999864 456889999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGC--KPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|+++|+|.+++.... .....+++..++.++.|+++||+|||++. ..+|+||||||+|||+++++.+||+|
T Consensus 86 y~~~g~L~~~i~~~~--------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 86 YCEGGDLASVITKGT--------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp CCTTEEHHHHHHHHH--------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred cCCCCcHHHHHHhcc--------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 999999999996542 13457999999999999999999999862 12499999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
||+|+.+... ........||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+
T Consensus 158 FG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~ 221 (269)
T d2java1 158 FGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH
Confidence 9999876432 222345679999999999999999999999999999999999999998765443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-41 Score=355.02 Aligned_cols=199 Identities=31% Similarity=0.438 Sum_probs=174.5
Q ss_pred HhhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
..+.+.+.||+|+||+||+|++. ++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 34566789999999999999984 5789999987543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
++|+|.+++... ....+++..+++++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+|
T Consensus 96 ~~g~l~~~l~~~----------~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 96 TYGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp TTCBHHHHHHHS----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred cCcchHHHhhhc----------cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence 999999999652 346789999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQ 738 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~ 738 (749)
+..... .........|++.|+|||++.++.++.++|||||||++|||++|..|+.
T Consensus 163 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 163 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp TTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 976433 2233334568899999999999999999999999999999999766554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=365.22 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=173.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||+||+|+.. ++.||+|+++.. .....+++.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3556789999999999999974 588999998754 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
++|+|.+++... ..+++..+..++.|+++||+|||+ + +|+||||||+|||+++++++||+|||+
T Consensus 87 ~gg~L~~~l~~~------------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 87 DGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp TTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCC
Confidence 999999999642 358999999999999999999996 5 899999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+.+.. .......||+.|||||++.+..++.++||||+||+++||++|+.||.+.+.
T Consensus 152 a~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 152 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp CHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 987632 222356799999999999999999999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=354.23 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=171.1
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||+||+|++.+ +.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 45667899999999999999965 789999997653 345789999999999999999999998864 567899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++... ....++|..+++++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+.
T Consensus 92 g~L~~~~~~~----------~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 92 GSLVDFLKTP----------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp CBHHHHTTSH----------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CcHHHHHhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEE
Confidence 9999987432 234589999999999999999999998 999999999999999999999999999997
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCC
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTP 741 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~-~pf~~~~ 741 (749)
+... .........||+.|||||++.++.++.++|||||||++|||+||. +|+....
T Consensus 159 ~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 159 IEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp CSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 6533 222334456899999999999999999999999999999999965 5555443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=348.02 Aligned_cols=196 Identities=30% Similarity=0.512 Sum_probs=167.3
Q ss_pred cccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec----CCeeEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE----NTKMGLVY 599 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~----~~~~~LV~ 599 (749)
.|.++||+|+||+||+|+.. ++.||+|++... .....+.|.+|+++|++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999985 478999998654 33445779999999999999999999999864 45678999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc-CCCcEEEEe
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN-EKFQAKLAD 678 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~-~~~~~kL~D 678 (749)
||+++|+|.+++... ..+++..++.++.||++||+|||++ +++|+||||||+|||++ +++.+||+|
T Consensus 92 E~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred eCCCCCcHHHHHhcc------------ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEee
Confidence 999999999999542 4689999999999999999999997 22399999999999997 578999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
||+|+..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..
T Consensus 159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 9999864322 2335679999999998865 59999999999999999999999997643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=352.47 Aligned_cols=197 Identities=29% Similarity=0.455 Sum_probs=167.6
Q ss_pred ccccccCceEEEEEEECC----cccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 531 RVLGKGGFGTVYHGYLDD----KQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
++||+|+||+||+|.+.+ +.||||+++.. +....++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 56999998754 23345789999999999999999999999965 467899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|.+++.. ...+++..+++++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 g~L~~~l~~------------~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 92 GPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp EEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcHHHHHhh------------ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhh
Confidence 999999853 34689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 685 FPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 685 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
+....... ......||++|||||.+.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 65443222 2234568999999999999999999999999999999998 89999876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=349.90 Aligned_cols=199 Identities=26% Similarity=0.444 Sum_probs=170.9
Q ss_pred cc-cccccCceEEEEEEECC----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 530 ER-VLGKGGFGTVYHGYLDD----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 530 ~~-~LG~G~fG~Vykg~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.+ +||+|+||+||+|.+.. ..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..++||||++
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~ 91 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 91 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence 45 49999999999997632 46999999765 34456789999999999999999999999865 56889999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
+|+|.+++.. ....+++..+++++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 92 ~g~L~~~l~~-----------~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 92 GGPLHKFLVG-----------KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp TEEHHHHHTT-----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCcHHHHhhc-----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhh
Confidence 9999998842 345689999999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 684 IFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 684 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
.+....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 775443222 2233458899999999999999999999999999999998 99999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=356.95 Aligned_cols=216 Identities=28% Similarity=0.454 Sum_probs=176.8
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.++||+|+||+||+|+..+ ..||||++... .....+.+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345677999999999999998743 25899998654 334456789999999998 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCC-----------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCC
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTD-----------AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSA 664 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~-----------~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~ 664 (749)
++||||+++|+|.++|.......... .......+++..++.++.|+++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999997643221110 011234689999999999999999999999 9999999999
Q ss_pred cEEEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 665 NILLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 665 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+.+..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987765544444445668999999999999999999999999999999998 89999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=342.27 Aligned_cols=202 Identities=28% Similarity=0.456 Sum_probs=177.7
Q ss_pred hcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~g 605 (749)
+.+.++||+|+||+||+|+..+ +.||||+++.... ..++|++|+.++++++||||++++|+|.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 3567899999999999999965 6899999986543 3478999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|..++.. ....+++..+++++.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 85 ~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 85 CLLNYLRE-----------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp EHHHHHHS-----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred cHHHhhhc-----------cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheec
Confidence 99999853 345688999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
.... ........+|+.|+|||.+.++.++.++|||||||++|||+| |+.||.+....+
T Consensus 151 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 151 LDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp SSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred cCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 5432 222334568999999999999999999999999999999998 899998765543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-40 Score=358.06 Aligned_cols=202 Identities=22% Similarity=0.360 Sum_probs=179.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677899999999999999974 58899999987776677889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC--CCcEEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE--KFQAKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~--~~~~kL~DFGl 681 (749)
+|+|.+++.. ....+++..+..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+
T Consensus 107 gg~L~~~l~~-----------~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 107 GGELFEKVAD-----------EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp SCBHHHHHTC-----------TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CCCHHHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999842 345699999999999999999999999 9999999999999964 57899999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
++.+... .......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 173 a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 173 TAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp CEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred heecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 9876433 22345679999999999999999999999999999999999999998765443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=354.33 Aligned_cols=201 Identities=27% Similarity=0.392 Sum_probs=177.9
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|++.+.||+|+||+||+|+. +++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 66779999999999999997 45899999997542 23457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+
T Consensus 87 ~~gg~L~~~~~~------------~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 87 ANGGELFFHLSR------------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CTTCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCchhhhhhc------------ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999854 34688999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
|+..... ........||+.|||||++.+..++.++||||+||++|||++|++||.+.+..+
T Consensus 152 a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 152 CKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp CBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 9875432 222345679999999999999999999999999999999999999998876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=351.78 Aligned_cols=199 Identities=27% Similarity=0.474 Sum_probs=159.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch-hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV-QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4677899999999999999984 57899999876533 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc---CCCcEEEEec
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN---EKFQAKLADF 679 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~---~~~~~kL~DF 679 (749)
++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+. +++.+||+||
T Consensus 90 ~gg~L~~~l~------------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 90 SGGELFDRIV------------EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CSCBHHHHHH------------TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCCcHHHhhh------------cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence 9999999994 345699999999999999999999999 999999999999995 5789999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|+..... .......||+.|||||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 155 G~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 155 GLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 999865322 223345799999999999999999999999999999999999999987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-40 Score=352.97 Aligned_cols=197 Identities=25% Similarity=0.399 Sum_probs=175.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEee
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEF 601 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey 601 (749)
|++.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 567799999999999999974 5889999987532 23457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCC
Q 037623 602 MANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGL 681 (749)
Q Consensus 602 ~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGl 681 (749)
+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~gg~l~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 86 IEGGELFSLLRK------------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CCSCBHHHHHHH------------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred cCCccccccccc------------cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCcc
Confidence 999999998853 34578889999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+..... .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 207 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH
Confidence 9876422 23467999999999999999999999999999999999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-40 Score=350.37 Aligned_cols=196 Identities=30% Similarity=0.419 Sum_probs=171.2
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|...+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4666789999999999999874 5789999987543 2345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|..++. ....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 96 ~~~~g~l~~~~~------------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 96 YCLGSASDLLEV------------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp CCSEEHHHHHHH------------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ecCCCchHHHHH------------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 999999976663 234689999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS---NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|+.... .....||+.|||||++.+ +.++.++|||||||++|||++|+.||.+...
T Consensus 161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 9986532 234569999999999864 4689999999999999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.1e-40 Score=353.96 Aligned_cols=201 Identities=21% Similarity=0.347 Sum_probs=178.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
.|++.+.||+|+||+||+|+.. ++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3677899999999999999974 58899999987766667788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc--CCCcEEEEecCC
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN--EKFQAKLADFGL 681 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~--~~~~~kL~DFGl 681 (749)
+|+|.+++.. ....+++..++.++.||++||+|||++ +|+||||||+|||++ +++.+||+|||+
T Consensus 110 gg~L~~~~~~-----------~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 110 GGELFDRIAA-----------EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp CCBHHHHTTC-----------TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CChHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence 9999887732 344699999999999999999999999 999999999999998 578999999999
Q ss_pred CccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 682 SRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 682 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
|+.+... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..
T Consensus 176 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 176 ATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp CEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9987543 2234457999999999999999999999999999999999999999876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=344.69 Aligned_cols=201 Identities=30% Similarity=0.446 Sum_probs=164.7
Q ss_pred hcccccccccCceEEEEEEECC------cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD------KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
+...++||+|+||+||+|++.+ ..||||++... .....++|.+|++++++++|||||+++|+|.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 4557899999999999998743 36999998754 3344567999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|++.+.+.. ....++|..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 89 e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 89 EYMENGALDKFLRE-----------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp ECCTTEEHHHHHHH-----------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EecccCcchhhhhc-----------ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEccc
Confidence 99999999988754 345699999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCc-eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC-CCCCC
Q 037623 680 GLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV-IQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p-f~~~~ 741 (749)
|+++.+...... .......||+.|||||++.++.++.++|||||||++|||++|..| +...+
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~ 218 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC
Confidence 999876443221 222334689999999999999999999999999999999996554 54433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=343.73 Aligned_cols=201 Identities=25% Similarity=0.373 Sum_probs=176.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch------hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV------QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..+|
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4677899999999999999974 58899999865322 235789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC----c
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF----Q 673 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~----~ 673 (749)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 91 v~E~~~gg~L~~~i~~~------------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred EEEcCCCccccchhccc------------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence 99999999999999542 4689999999999999999999999 999999999999998776 5
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+||+|||+|+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 156 vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp EEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 999999999876432 22334578999999999999999999999999999999999999998765443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=344.90 Aligned_cols=201 Identities=31% Similarity=0.473 Sum_probs=166.7
Q ss_pred hhcccccccccCceEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
.+.+.+.||+|+||+||+|++.+ +.||||+++... ...++|.+|+.++++++|+|||+++|+|.+ ++.++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 46778999999999999999966 679999987543 345789999999999999999999999854 568899999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
|+|..++... ....++|..+++++.|||+||+|||+. +|+||||||+|||+++++++||+|||+++.
T Consensus 96 g~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 96 GSLLDFLKGE----------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp CBHHHHHSHH----------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred Cchhhhhhhc----------ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 9999998653 234689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCc
Q 037623 685 FPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPV-IQKTPE 742 (749)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~p-f~~~~~ 742 (749)
+.... ........||+.|+|||++.++.++.++|||||||++|||+||..| +.....
T Consensus 163 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~ 220 (285)
T d1fmka3 163 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH
Confidence 64332 2223345689999999999999999999999999999999996555 554443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=345.61 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=170.1
Q ss_pred hcccccccccCceEEEEEEECC--c----ccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD--K----QVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~--~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
|++.++||+|+||+||+|+... + +||+|++... +.+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 5667899999999999998742 2 5899988654 344567899999999999999999999999865 567889
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+.+|+|.+.+.. ....+++..+++++.|||+||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 90 e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DF 155 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE-----------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 155 (317)
T ss_dssp ECCTTCBHHHHHHH-----------TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCC
T ss_pred EeccCCcccccccc-----------cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecc
Confidence 99999999998854 345789999999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
|+|+.+.............||+.|+|||++.++.++.++|||||||++|||+| |++||.+.+..+
T Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp SHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 99998765443333344568999999999999999999999999999999998 899998765543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=337.12 Aligned_cols=198 Identities=30% Similarity=0.473 Sum_probs=166.1
Q ss_pred hcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEEeeCCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMGLVYEFMANG 605 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~~~g 605 (749)
+.+.+.||+|+||.||+|+++++.||||+++... ..++|.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 4567899999999999999999999999997543 34789999999999999999999999965 45689999999999
Q ss_pred CHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCccc
Q 037623 606 NLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSRIF 685 (749)
Q Consensus 606 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~~ 685 (749)
+|.++|... ....++|..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~L~~~l~~~----------~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 87 SLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EHHHHHHHH----------HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CHHHHHHhc----------CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceec
Confidence 999999653 233589999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 686 PVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
... .....++..|+|||++.++.++.++|||||||++|||+| |++||...+..+
T Consensus 154 ~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 154 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred CCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 322 233457889999999999999999999999999999998 788888765443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-39 Score=350.01 Aligned_cols=198 Identities=25% Similarity=0.365 Sum_probs=175.7
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
.|++.+.||+|+||+||+|+.. ++.||||++.... ....+.+.+|+++|++++||||+++++++......++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 3566789999999999999974 5889999986432 2335678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+.+|+|..++... +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 122 ~~~~g~l~~~l~~~------------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp CCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccchhhhHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 99999999999542 4589999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+|+.+... .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..
T Consensus 187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 244 (350)
T d1rdqe_ 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH
Confidence 99876422 23457999999999999999999999999999999999999999876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-39 Score=342.85 Aligned_cols=216 Identities=30% Similarity=0.436 Sum_probs=176.9
Q ss_pred hcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
+++.+.||+|+||+||+|+..+ +.||||+++... .+..++|.+|++++++++||||++++++|...+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 4567899999999999998743 579999987653 34457899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCC------------CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcE
Q 037623 599 YEFMANGNLQAHLLAQLAILPT------------DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANI 666 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~------------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NI 666 (749)
|||+++|+|.+++......... ........+++..+++++.|+|.||+|||+. +||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 9999999999999753221100 0112334689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCcccc
Q 037623 667 LLNEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPERTL 745 (749)
Q Consensus 667 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~-~pf~~~~~~~~ 745 (749)
|++.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++|. +||...++.++
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 99999999999999998765443333344567889999999999999999999999999999999985 67877665443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=343.86 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=174.5
Q ss_pred hcccccccccCceEEEEEEE--CCcccEEEEecCCc---hhhHHHHHHHHHHHH-hcCCCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSS---VQGYKQFQAEVELLM-RAHHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~-~l~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
|.+.+.||+|+||+||+|+. +++.||||+++... ....+.+..|..++. .++|||||++++++.+++..+||||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 56789999999999999998 45889999997532 233456677777765 6899999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecC
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFG 680 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFG 680 (749)
|+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|||
T Consensus 84 y~~~g~L~~~i~~~------------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp CCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ecCCCcHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccc
Confidence 99999999999543 3578999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 681 LSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 681 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+++..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+
T Consensus 149 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~ 210 (320)
T d1xjda_ 149 MCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210 (320)
T ss_dssp TCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 99865432 223344579999999999999999999999999999999999999998766543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=337.45 Aligned_cols=204 Identities=25% Similarity=0.364 Sum_probs=164.0
Q ss_pred hhcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVY 599 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~ 599 (749)
.+++.+.||+|+||+||+|+... ..||||.++.. .....+.|.+|++++++++||||++++|++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 46677999999999999998743 35888888654 3344577999999999999999999999996 46789999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 87 E~~~~g~l~~~~~~-----------~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 87 ELCTLGELRSFLQV-----------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp ECCTTEEHHHHHHH-----------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EeccCCcHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence 99999999998754 344689999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERTL 745 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~~ 745 (749)
|+|+.+.... ........||+.|+|||.+.++.++.++|||||||++|||+| |++||...+..++
T Consensus 153 G~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~ 218 (273)
T d1mp8a_ 153 GLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred hhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence 9998764322 223344568999999999999999999999999999999998 8999987665543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-39 Score=335.47 Aligned_cols=203 Identities=28% Similarity=0.451 Sum_probs=167.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCc---hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC----eeE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS---VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT----KMG 596 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~----~~~ 596 (749)
.|.+.+.||+|+||+||+|+.. ++.||||+++... ....+.|.+|++++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 3667899999999999999974 6889999997543 334567999999999999999999999987543 478
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+++|+|.+++.. .+.+++.+++.++.|+++||+|||++ +|+||||||+|||++.++..+|
T Consensus 88 lvmE~~~g~~L~~~~~~------------~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT------------EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEEECCCEEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEE
T ss_pred EEEECCCCCEehhhhcc------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcccccee
Confidence 99999999999998853 34689999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCC-ceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 677 ADFGLSRIFPVEGG-SHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 677 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+|||.++....... ........||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence 99999876543322 12234557999999999999999999999999999999999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-38 Score=344.26 Aligned_cols=197 Identities=28% Similarity=0.449 Sum_probs=167.8
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch---hhHHHHH---HHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV---QGYKQFQ---AEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~---~~~~~f~---~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
|.+.++||+|+||.||+|+.. ++.||||++..... .....+. +|+.+++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 566799999999999999984 58899999864321 1223334 446677777899999999999999999999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +||||||||+|||+++++.+||+|
T Consensus 86 mE~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH------------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp ECCCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECC
T ss_pred EEecCCCcHHHHHHhc------------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEee
Confidence 9999999999999542 4578999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 679 FGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 679 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
||+|+.+... ......||+.|+|||++.. ..++.++|||||||+||||+||+.||.....
T Consensus 151 FGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 151 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp CTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred eceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 9999876432 2234579999999999975 4689999999999999999999999986543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=336.78 Aligned_cols=215 Identities=27% Similarity=0.379 Sum_probs=166.9
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecC-Ce
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDEN-TK 594 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~-~~ 594 (749)
..+.+.+.||+|+||.||+|+..+ +.||||+++.. .....+++.+|..++.++ +|+||+.+.+++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 346678999999999999998632 46999998754 334456788888888887 789999999998664 56
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCCCC----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILPTD----AEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~----~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.++||||+++|+|.+++.......... .......+++..++.++.||++||+|||++ +||||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 899999999999999997653321110 011234689999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCc
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKTPE 742 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG-~~pf~~~~~ 742 (749)
++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||+|| ++||.....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999876544333334456799999999999999999999999999999999997 567876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=334.24 Aligned_cols=200 Identities=33% Similarity=0.472 Sum_probs=171.2
Q ss_pred hcccccccccCceEEEEEEECC-----cccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-CCeeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-NTKMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-~~~~~LV~ 599 (749)
.+|.++||+|+||+||+|++.+ ..||||+++.. +....++|.+|++++++++||||++++|+|.+ +...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3567899999999999999743 25899998753 55566889999999999999999999999865 56889999
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+++|+|.+++.. ....+++..+++++.|+|+||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 109 E~~~~g~l~~~~~~-----------~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DF 174 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 174 (311)
T ss_dssp ECCTTCBHHHHHHC-----------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred EEeecCchhhhhcc-----------ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecc
Confidence 99999999999853 345678899999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCc--eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 680 GLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 680 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
|+++.+...... .......||+.|+|||.+..+.++.++||||||+++|||+||+.||...
T Consensus 175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 999976543221 1223346899999999999999999999999999999999988777643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-38 Score=328.64 Aligned_cols=200 Identities=30% Similarity=0.388 Sum_probs=173.4
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCch---------hhHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSV---------QGYKQFQAEVELLMRAH-HKNLTILVGYCDENT 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~---------~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~ 593 (749)
.|.+.+.||+|+||+||+|+. +++.||||++..... ...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 356679999999999999997 458899999865421 12346889999999997 999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..+|||||+++|+|.+++... ..+++.+++.++.||++||+|||++ +|+||||||+|||+++++.
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred ceEEEEEcCCCchHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 999999999999999999542 3589999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS------NRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||+++||++|+.||.+.+..
T Consensus 149 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 9999999998764322 2344579999999999853 34788999999999999999999999876644
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=332.39 Aligned_cols=203 Identities=29% Similarity=0.414 Sum_probs=164.4
Q ss_pred hcccccccccCceEEEEEEECC-----cccEEEEecCC---chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD-----KQVAVKMLSPS---SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLV 598 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~-----~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV 598 (749)
+.+.+.||+|+||+||+|++.. ..||||++... ..+..++|.+|+++|++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 5667899999999999998632 36899998654 33445789999999999999999999999965 467899
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEe
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLAD 678 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~D 678 (749)
|||+++|+|.+++... ...+++..+++++.|+|+||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 89 ~e~~~~~~l~~~~~~~-----------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKH-----------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp EECCTTCBHHHHHHHH-----------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred eeeecCcchhhhhhcc-----------cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeecc
Confidence 9999999999988643 34689999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCce-eeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 037623 679 FGLSRIFPVEGGSH-VSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPERT 744 (749)
Q Consensus 679 FGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~~ 744 (749)
||+++.+....... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~ 222 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence 99999875443222 2233457889999999999999999999999999999998 899998765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=336.76 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=163.3
Q ss_pred hcccccccccCceEEEEEEECCcccEEEEecCCchhhHHHHH--HHHHHHHhcCCCceeEEEEEEecCC----eeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQ--AEVELLMRAHHKNLTILVGYCDENT----KMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~--~Ei~iL~~l~H~nIv~l~g~~~~~~----~~~LV~E 600 (749)
+-+.+.||+|+||+||+|+++++.||||+++.... +++. .|+..+.+++||||++++|+|.+.+ .+++|||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 44568899999999999999999999999864432 3344 4455556789999999999997643 6789999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeeCCCCCcEEEcCCCcEE
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDG-----CKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~-----~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
||++|+|.++|.. ..++|..+++++.|+|.||+|||+. ..++|+||||||+|||+++++.+|
T Consensus 82 y~~~g~L~~~l~~-------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 82 YHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp CCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred cccCCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 9999999999953 2489999999999999999999974 235999999999999999999999
Q ss_pred EEecCCCccccCCCCce--eeeccccCCcccCccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 676 LADFGLSRIFPVEGGSH--VSTTVVGTPGYLDPEYYISNR------LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~------~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|||+++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+....
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 99999999875443221 223457999999999987653 5778999999999999999998886543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=335.87 Aligned_cols=199 Identities=19% Similarity=0.325 Sum_probs=174.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMAN 604 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 604 (749)
|.+.+.||+|+||+||+|+.. ++.||||+++.... ....+.+|+++|.+++|||||++++++.+.+..+|||||+++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 667799999999999999974 57899999976543 345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC--CcEEEEecCCC
Q 037623 605 GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK--FQAKLADFGLS 682 (749)
Q Consensus 605 gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~--~~~kL~DFGla 682 (749)
|+|.+++.. ....+++.++..++.||++||+|||+. +|+||||||+|||++.+ ..+||+|||++
T Consensus 86 g~L~~~i~~-----------~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 86 LDIFERINT-----------SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CBHHHHHTS-----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchh
Confidence 999999842 234689999999999999999999999 99999999999999854 48999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPER 743 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~ 743 (749)
+..... .......+++.|+|||.+.+..++.++||||+||++|||++|+.||...+..
T Consensus 152 ~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 152 RQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp EECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred hccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 876432 2234456899999999999999999999999999999999999999876544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=334.87 Aligned_cols=195 Identities=30% Similarity=0.406 Sum_probs=164.4
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCCchh-----hHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQ-----GYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
++||+|+||+||+|+.. ++.||||+++..... ..+.+.+|++++++++|||||++++++..++..++||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 68999999999999874 588999998654322 13568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++++.... .....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 84 ~~~~~~~~------------~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 84 TDLEVIIK------------DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEHHHHHT------------TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred chHHhhhh------------hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence 88766554 2345688889999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
...... .......||+.|+|||++... .++.++|||||||++|||+||++||.+.++
T Consensus 149 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 149 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 764332 222345799999999998755 579999999999999999999999987554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=337.88 Aligned_cols=213 Identities=27% Similarity=0.409 Sum_probs=178.8
Q ss_pred hhcccccccccCceEEEEEEEC-------CcccEEEEecCC-chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD-------DKQVAVKMLSPS-SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~-------~~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~L 597 (749)
.+.+.+.||+|+||+||+|.+. ++.||||+++.. .......|.+|++++++++||||++++|+|...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 3456789999999999999874 267999999754 34455679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
||||+++|+|.+++........ .......+++..+++++.|+|+||.|||++ +|+||||||+|||+++++++||+
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMA--NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHH--HCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEeecCCCCHHHHHHhcccccc--cccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 9999999999999975432110 112334579999999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCcc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITG-QPVIQKTPER 743 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG-~~pf~~~~~~ 743 (749)
|||+|+.+.............+|+.|+|||.+.++.++.++|||||||++|||+|| ++||.+.+..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999877544333333444689999999999999999999999999999999998 5788765543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-38 Score=337.28 Aligned_cols=195 Identities=27% Similarity=0.399 Sum_probs=166.4
Q ss_pred hccc-ccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhc-CCCceeEEEEEEec----CCeeEEE
Q 037623 527 NNFE-RVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRA-HHKNLTILVGYCDE----NTKMGLV 598 (749)
Q Consensus 527 ~~f~-~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~----~~~~~LV 598 (749)
|.+. ++||+|+||+||+|+.. ++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....++|
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 4443 57999999999999973 588999998643 4567899987665 89999999999864 4678999
Q ss_pred EeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEE
Q 037623 599 YEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAK 675 (749)
Q Consensus 599 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~k 675 (749)
||||++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++ ++.+|
T Consensus 88 mEy~~gg~L~~~i~~~----------~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 88 MECLDGGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EECCCSEEHHHHHHSC----------SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEE
T ss_pred EECCCCCcHHHHHHhc----------CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccc
Confidence 9999999999999531 235699999999999999999999999 9999999999999985 45799
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|||+|+...... ......||+.|||||++.+..++.++|||||||+||||+||+.||.+.+.
T Consensus 155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 155 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp ECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred ccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 99999998764332 23345799999999999999999999999999999999999999976543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-38 Score=330.99 Aligned_cols=215 Identities=30% Similarity=0.421 Sum_probs=174.9
Q ss_pred hhcccccccccCceEEEEEEECC---------cccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLDD---------KQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTK 594 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~ 594 (749)
.+.+.+.||+|+||.||+|+..+ ..||||+++... .....++.+|...+.++ +|||||+++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 45667999999999999998632 369999997653 34457889999999888 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHHHhhccCC----CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC
Q 037623 595 MGLVYEFMANGNLQAHLLAQLAILP----TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE 670 (749)
Q Consensus 595 ~~LV~Ey~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~ 670 (749)
.++||||+++|+|.+++........ .........+++..+++++.|+++||+|||+. +||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 9999999999999999965422110 01122346799999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 671 KFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 671 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |++||...+..
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999998765544444455678999999999999999999999999999999998 78999876544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=331.54 Aligned_cols=216 Identities=28% Similarity=0.401 Sum_probs=180.0
Q ss_pred HhhcccccccccCceEEEEEEECC-------cccEEEEecCCc-hhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCee
Q 037623 525 ITNNFERVLGKGGFGTVYHGYLDD-------KQVAVKMLSPSS-VQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKM 595 (749)
Q Consensus 525 ~t~~f~~~LG~G~fG~Vykg~~~~-------~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~ 595 (749)
..+.+.+.||+|+||.||+|++.+ +.||||+++... .....+|.+|+.++.++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 456678999999999999998622 579999997653 34556799999999999 799999999999999999
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCC------CccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEc
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPT------DAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~------~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~ 669 (749)
++||||+++|+|.++++........ ........+++..+++++.||++||+|||++ +|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 9999999999999999765321110 1112345689999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 037623 670 EKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELIT-GQPVIQKTPER 743 (749)
Q Consensus 670 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~Ellt-G~~pf~~~~~~ 743 (749)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |++||...+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999998765444444455679999999999999999999999999999999999 66667665443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=330.83 Aligned_cols=211 Identities=30% Similarity=0.441 Sum_probs=170.3
Q ss_pred hcccccccccCceEEEEEEECC----cccEEEEecCC-chhhHHHHHHHHHHHHhc-CCCceeEEEEEEecCCeeEEEEe
Q 037623 527 NNFERVLGKGGFGTVYHGYLDD----KQVAVKMLSPS-SVQGYKQFQAEVELLMRA-HHKNLTILVGYCDENTKMGLVYE 600 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~iL~~l-~H~nIv~l~g~~~~~~~~~LV~E 600 (749)
+.+.++||+|+||+||+|++.+ ..||||++... .....++|.+|+++|.++ +|||||+++|+|.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 4567899999999999998743 25788887654 344567899999999998 79999999999999999999999
Q ss_pred eCCCCCHHHHHHHhhccCC----CCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 601 FMANGNLQAHLLAQLAILP----TDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
|+++|+|.++|+....... .........+++..+++++.|||+||.|||+. +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 9999999999964311000 00112456799999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCcc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQ-PVIQKTPER 743 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~-~pf~~~~~~ 743 (749)
+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|. +||...+..
T Consensus 169 ~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~ 233 (309)
T d1fvra_ 169 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233 (309)
T ss_dssp CCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence 999999864322 1122346899999999999999999999999999999999975 578765543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=324.84 Aligned_cols=199 Identities=27% Similarity=0.386 Sum_probs=167.6
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|...+.||+|+||+||+|+.. ++.||||+++.... ...+++.+|++++++++|||||++++++.+....++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 455689999999999999974 58899999865432 23578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
.+ ++..++.. .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 84 ~~-~~~~~~~~----------~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 84 HQ-DLKKFMDA----------SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp SE-EHHHHHHH----------TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred CC-chhhhhhh----------hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcc
Confidence 75 45555533 2455699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
+..... ........||+.|+|||.+.... .+.++|||||||++|||++|+.||.+.+
T Consensus 150 ~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 150 RAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp HHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 876432 22233457999999999987665 5789999999999999999999997654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=322.89 Aligned_cols=196 Identities=24% Similarity=0.385 Sum_probs=166.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCch------hhHHHHHHHHHHHHhcC--CCceeEEEEEEecCCee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSV------QGYKQFQAEVELLMRAH--HKNLTILVGYCDENTKM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~l~--H~nIv~l~g~~~~~~~~ 595 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... ...+++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4667899999999999999974 58899999865321 12244678999999996 89999999999999999
Q ss_pred EEEEeeCCC-CCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-CCc
Q 037623 596 GLVYEFMAN-GNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-KFQ 673 (749)
Q Consensus 596 ~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-~~~ 673 (749)
++||||+.+ +++.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++. ++.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~------------~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE------------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred EEEEEeccCcchHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence 999999976 677777743 34689999999999999999999999 9999999999999985 579
Q ss_pred EEEEecCCCccccCCCCceeeeccccCCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 037623 674 AKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRL-TEKSDVYSFGVVLLELITGQPVIQKT 740 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~k~DVwSfGvvL~ElltG~~pf~~~ 740 (749)
+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||...
T Consensus 150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 999999999865322 2345679999999999987765 57789999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.5e-37 Score=320.06 Aligned_cols=199 Identities=24% Similarity=0.368 Sum_probs=168.0
Q ss_pred hcccccccccCceEEEEEEEC-CcccEEEEecCCch--hhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeCC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV--QGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFMA 603 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 603 (749)
|...+.||+|+||+||+|+.. ++.||||++..... ...+++.+|+.+|++++||||+++++++...+..++++||+.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 455689999999999999985 48899999976532 235789999999999999999999999999999999999998
Q ss_pred CCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCCc
Q 037623 604 NGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLSR 683 (749)
Q Consensus 604 ~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla~ 683 (749)
++.+..+. ...+.+++..+..++.|+++||+|||+. +||||||||+|||++.++.+||+|||.+.
T Consensus 84 ~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 84 QDLKKLLD------------VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp EEHHHHHH------------TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred hhhHHHHH------------hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccce
Confidence 87666655 2456799999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 684 IFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
...... .......+++.|+|||.+.+. .++.++|||||||+++||++|+.||.+.++
T Consensus 149 ~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 149 AFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 764332 222344689999999998754 568999999999999999999999986543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=322.67 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=165.2
Q ss_pred hhcccccccccCceEEEEEEEC---CcccEEEEecCCch--hhHHHHHHHHHHHHhc---CCCceeEEEEEEec-----C
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD---DKQVAVKMLSPSSV--QGYKQFQAEVELLMRA---HHKNLTILVGYCDE-----N 592 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~---~~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~l---~H~nIv~l~g~~~~-----~ 592 (749)
.|++.+.||+|+||+||+|+.. ++.||||+++.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4566789999999999999873 35699999864322 2234566777777665 89999999999853 3
Q ss_pred CeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC
Q 037623 593 TKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF 672 (749)
Q Consensus 593 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~ 672 (749)
...++++||++++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK-----------VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH-----------SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred ceEEEEEEeccCCchhhhhh-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 56889999998887654442 2456789999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 673 QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 673 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
.+||+|||+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.++
T Consensus 154 ~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 154 QIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Ceeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 999999999986432 2233456799999999999999999999999999999999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-35 Score=311.46 Aligned_cols=200 Identities=20% Similarity=0.272 Sum_probs=170.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCC-CceeEEEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHH-KNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... .+++.+|++++..++| +|++.+.+++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4667899999999999999974 58899999865432 2457789999999965 89999999999999999999998
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC-----CCcEEEE
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE-----KFQAKLA 677 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~-----~~~~kL~ 677 (749)
+++|.+++.. ....+++..+++++.|++.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 84 -~~~l~~~~~~-----------~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 84 -GPSLEDLLDL-----------CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp -CCBHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred -CCCHHHHHHh-----------hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence 7899998853 334689999999999999999999999 9999999999999974 5689999
Q ss_pred ecCCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.+...
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 99999876533221 122345799999999999999999999999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=319.75 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=162.9
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeEEEEEEec------CCeeEE
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTILVGYCDE------NTKMGL 597 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------~~~~~L 597 (749)
+|...++||+|+||+||+|+.. ++.||||++..... .+.+|+++|++++|+||+++++++.. ....+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4556689999999999999984 58899999875432 23479999999999999999999853 235789
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCC-cEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKF-QAKL 676 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~-~~kL 676 (749)
||||++++.+....... .....+++..+..++.|+++||+|||++ +|+||||||+|||++.++ .+||
T Consensus 97 v~Ey~~~~~~~~l~~~~---------~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS---------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp EEECCSEEHHHHHHHHH---------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEE
T ss_pred EEeccCCccHHHHHhhh---------hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeE
Confidence 99999876444443221 2455799999999999999999999998 999999999999999765 8999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++..... .......|+..|+|||.+.+ ..++.++||||+||++|||++|++||...+.
T Consensus 165 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 165 CDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CCCTTCEECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ecccchhhccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 999999876432 22334579999999999875 4689999999999999999999999986554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-35 Score=313.98 Aligned_cols=202 Identities=26% Similarity=0.367 Sum_probs=164.8
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec--------CC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE--------NT 593 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~--------~~ 593 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++... .....+++.+|+++|++++|+|++++++++.. ..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 4566789999999999999974 588999998644 22345678999999999999999999999855 34
Q ss_pred eeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCc
Q 037623 594 KMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQ 673 (749)
Q Consensus 594 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~ 673 (749)
..++||||++++.+.... .....++...+..++.|+++||+|||++ +|+||||||+|||+++++.
T Consensus 91 ~~~iv~e~~~~~~~~~~~------------~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLS------------NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGV 155 (318)
T ss_dssp CEEEEEECCCEEHHHHHT------------CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred eEEEEEeccCCCccchhh------------hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCc
Confidence 678999999887665443 2445688899999999999999999999 9999999999999999999
Q ss_pred EEEEecCCCccccCCCCc--eeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 674 AKLADFGLSRIFPVEGGS--HVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 674 ~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+||+|||+++........ .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||.+.++
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 999999999876533211 122234699999999999765 689999999999999999999999986543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-35 Score=316.23 Aligned_cols=199 Identities=26% Similarity=0.411 Sum_probs=163.5
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc-hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC----eeEEEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS-VQGYKQFQAEVELLMRAHHKNLTILVGYCDENT----KMGLVY 599 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~----~~~LV~ 599 (749)
|.+.+.||+|+||+||+|+.. ++.||||++.... ....+++.+|+++|.+++|||++++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 556689999999999999874 6889999997543 344568899999999999999999999996543 334555
Q ss_pred eeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEec
Q 037623 600 EFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADF 679 (749)
Q Consensus 600 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DF 679 (749)
||+.+|+|.+++.. ..+++..+..++.|+++||+|||++ +||||||||+|||+++++.+||+||
T Consensus 90 ~~~~~g~L~~~l~~-------------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 90 THLMGADLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EECCCEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EeecCCchhhhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEccc
Confidence 66779999999842 2589999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCc-eeeeccccCCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGS-HVSTTVVGTPGYLDPEYYIS-NRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+++........ .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||...+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 999876433211 12234568999999999854 567899999999999999999999998654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=316.35 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=171.1
Q ss_pred hcccccccccCceEEEEEEE-----CCcccEEEEecCCc----hhhHHHHHHHHHHHHhcCC-CceeEEEEEEecCCeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYL-----DDKQVAVKMLSPSS----VQGYKQFQAEVELLMRAHH-KNLTILVGYCDENTKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~-----~~~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~l~H-~nIv~l~g~~~~~~~~~ 596 (749)
|.+.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|++++.+++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 77789999999999999986 24789999986532 2234678899999999966 79999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
++|||+.+|+|.+++... ..++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 106 ~v~e~~~~~~L~~~i~~~------------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR------------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred eeeecccccHHHHHHHhc------------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEE
Confidence 999999999999999543 3567888999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN--RLTEKSDVYSFGVVLLELITGQPVIQKTPERT 744 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~k~DVwSfGvvL~ElltG~~pf~~~~~~~ 744 (749)
+|||+++.+.... ........|++.|+|||.+... .++.++|||||||+||||++|+.||.+.+..+
T Consensus 171 ~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 171 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred eeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999998764322 2223345799999999999764 47889999999999999999999998765443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-35 Score=307.65 Aligned_cols=200 Identities=22% Similarity=0.278 Sum_probs=164.5
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcCCCceeE-EEEEEecCCeeEEEEeeC
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLTI-LVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv~-l~g~~~~~~~~~LV~Ey~ 602 (749)
.|.+.+.||+|+||+||+|+.. ++.||||++..... .+++..|++++++++|+|++. +.++..+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 3667899999999999999974 58899999876533 246789999999998776555 455557788899999998
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcC---CCcEEEEec
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNE---KFQAKLADF 679 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~---~~~~kL~DF 679 (749)
+++|...+.. ....+++..++.++.|+++||+|||++ +|+||||||+|||++. +..+||+||
T Consensus 86 -~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 86 -GPSLEDLFNF-----------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp -CCBHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred -CCchhhhhhh-----------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeecc
Confidence 5667666643 345689999999999999999999999 9999999999999864 457999999
Q ss_pred CCCccccCCCCc-----eeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 680 GLSRIFPVEGGS-----HVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 680 Gla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|+|+.+...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 999977543221 122345799999999999999999999999999999999999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=317.41 Aligned_cols=195 Identities=29% Similarity=0.393 Sum_probs=161.4
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEecCC------ee
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDENT------KM 595 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~------~~ 595 (749)
.|.+.+.||+|+||+||+|+.. ++.||||+++.. +....+.+.+|+++|++++|||||++++++...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 3556689999999999999974 588999999754 3344567899999999999999999999997654 57
Q ss_pred EEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEE
Q 037623 596 GLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAK 675 (749)
Q Consensus 596 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~k 675 (749)
++||||+ +.+|..... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 99 ~lv~e~~-~~~l~~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK-------------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp EEEEECC-SEEHHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecc-cccHHHHHH-------------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccc
Confidence 9999999 567777663 23589999999999999999999999 999999999999999999999
Q ss_pred EEecCCCccccCCCCceeeeccccCCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 676 LADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISN-RLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 676 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
++|||+|+..... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.||.+.+.
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 9999999875322 2445799999999998764 578999999999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-34 Score=301.38 Aligned_cols=196 Identities=25% Similarity=0.320 Sum_probs=169.1
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCCc--hhhHHHHHHHHHHHHhcCCCceeEEEEEEecCCeeEEEEeeC
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSS--VQGYKQFQAEVELLMRAHHKNLTILVGYCDENTKMGLVYEFM 602 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 602 (749)
|+..+.||+|+||+||+|+.. ++.||||+++... ....+++.+|+.++++++|+||+++++++......++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 456689999999999999984 4789999986542 334678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEEecCCC
Q 037623 603 ANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLADFGLS 682 (749)
Q Consensus 603 ~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~DFGla 682 (749)
.+++|..++. ..+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.+
T Consensus 84 ~~~~l~~~~~------------~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 84 DQDLKKYFDS------------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SEEHHHHHHH------------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred cccccccccc------------cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchh
Confidence 9998887773 345678999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 037623 683 RIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQK 739 (749)
Q Consensus 683 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~ 739 (749)
+...... .......++..|+|||.+.... ++.++|||||||+++||++|+.||..
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp EECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred hcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 8765432 2223345778899999987665 68999999999999999999998643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.4e-34 Score=304.90 Aligned_cols=192 Identities=22% Similarity=0.369 Sum_probs=164.1
Q ss_pred hhcccccccccCceEEEEEEEC--CcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEec--CCeeEEEEe
Q 037623 526 TNNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDE--NTKMGLVYE 600 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~--~~~~~LV~E 600 (749)
.|.+.++||+|+||+||+|+.. ++.||||+++... .+++.+|+++|.+++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4667789999999999999974 5889999987543 367889999999995 9999999999874 456899999
Q ss_pred eCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCC-CcEEEEec
Q 037623 601 FMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEK-FQAKLADF 679 (749)
Q Consensus 601 y~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~-~~~kL~DF 679 (749)
|+++++|.... +.+++..+..++.||++||+|||++ +|+||||||+|||++.+ ..+||+||
T Consensus 113 ~~~~~~L~~~~---------------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 113 HVNNTDFKQLY---------------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp CCCSCBGGGTT---------------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCG
T ss_pred ecCCCcHHHHh---------------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccc
Confidence 99999985432 3589999999999999999999999 99999999999999865 46999999
Q ss_pred CCCccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 680 GLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 680 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
|+|+...... ......+|+.|+|||.+.+.. ++.++||||+||+++||++|+.||....
T Consensus 175 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 175 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp GGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 9998764332 234456899999999987654 7999999999999999999999997644
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-34 Score=307.17 Aligned_cols=195 Identities=27% Similarity=0.371 Sum_probs=162.7
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec-----CCeeEE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE-----NTKMGL 597 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~-----~~~~~L 597 (749)
|...+.||+|+||+||+|+.. ++.||||++... +....+++.+|+++|++++|+|+|++++++.. ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 556689999999999999873 588999999754 33445678999999999999999999999853 334567
Q ss_pred EEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEEE
Q 037623 598 VYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKLA 677 (749)
Q Consensus 598 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL~ 677 (749)
++||+.+|+|.+++. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++
T Consensus 100 i~~~~~gg~L~~~~~-------------~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK-------------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp EEEECCSEEHHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeecCCchhhhcc-------------cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccc
Confidence 778889999999883 23589999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCceeeeccccCCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 678 DFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNR-LTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 678 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
|||++..... ......|++.|+|||...+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 164 dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 164 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp CC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 9999976432 223456889999999877654 68999999999999999999999987543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-34 Score=307.09 Aligned_cols=195 Identities=26% Similarity=0.340 Sum_probs=157.3
Q ss_pred hcccccccccCceEEEEEEEC--CcccEEEEecCC--chhhHHHHHHHHHHHHhcCCCceeEEEEEEec------CCeeE
Q 037623 527 NNFERVLGKGGFGTVYHGYLD--DKQVAVKMLSPS--SVQGYKQFQAEVELLMRAHHKNLTILVGYCDE------NTKMG 596 (749)
Q Consensus 527 ~~f~~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~l~H~nIv~l~g~~~~------~~~~~ 596 (749)
|.+.++||+|+||+||+|+.. ++.||||++... +....+++.+|+.++++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 555689999999999999974 688999999754 33445678999999999999999999999953 46889
Q ss_pred EEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEEcCCCcEEE
Q 037623 597 LVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILLNEKFQAKL 676 (749)
Q Consensus 597 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl~~~~~~kL 676 (749)
+||||+.++ +...+. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+|+
T Consensus 99 iv~Ey~~~~-l~~~~~--------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEECCSEE-HHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEeccchH-HHHhhh--------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceee
Confidence 999999765 444441 3478999999999999999999999 9999999999999999999999
Q ss_pred EecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 037623 677 ADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTPE 742 (749)
Q Consensus 677 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~~ 742 (749)
+|||+++..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||.+.++
T Consensus 161 ~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 161 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred echhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 999998865322 223445689999999999999999999999999999999999999987653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=2.6e-29 Score=271.75 Aligned_cols=198 Identities=25% Similarity=0.339 Sum_probs=158.0
Q ss_pred hhcccccccccCceEEEEEEE--CCcccEEEEecCCchhhHHHHHHHHHHHHhcC-----------CCceeEEEEEEec-
Q 037623 526 TNNFERVLGKGGFGTVYHGYL--DDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-----------HKNLTILVGYCDE- 591 (749)
Q Consensus 526 t~~f~~~LG~G~fG~Vykg~~--~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-----------H~nIv~l~g~~~~- 591 (749)
.|.+.++||+|+||+||+|+. +++.||||+++.... ..+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 367789999999999999987 458899999976533 3467788999888875 5789999988754
Q ss_pred -CCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeeCCCCCcEEEc
Q 037623 592 -NTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHD-GCKPPIVHRDVKSANILLN 669 (749)
Q Consensus 592 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~gIiHrDLkp~NILl~ 669 (749)
.....++++++..+......... .....+++..+..++.|+++||+|||+ . +|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK---------YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLME 160 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH---------TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEE
T ss_pred cccceeeeeeeccccccccccccc---------ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeee
Confidence 35666777776655444333222 245678899999999999999999998 5 899999999999998
Q ss_pred CCC------cEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 037623 670 EKF------QAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVLLELITGQPVIQKTP 741 (749)
Q Consensus 670 ~~~------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL~ElltG~~pf~~~~ 741 (749)
.++ .++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...+
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 654 4999999999864322 234569999999999999999999999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=4.5e-21 Score=187.50 Aligned_cols=168 Identities=15% Similarity=0.181 Sum_probs=117.7
Q ss_pred cccccccccCceEEEEEEEC-CcccEEEEecCCch------------------hhHHHHHHHHHHHHhcCCCceeEEEEE
Q 037623 528 NFERVLGKGGFGTVYHGYLD-DKQVAVKMLSPSSV------------------QGYKQFQAEVELLMRAHHKNLTILVGY 588 (749)
Q Consensus 528 ~f~~~LG~G~fG~Vykg~~~-~~~VAVK~l~~~~~------------------~~~~~f~~Ei~iL~~l~H~nIv~l~g~ 588 (749)
.+.+.||+|+||+||+|+.. ++.||||+++.... .....+.+|...+.+++|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999874 58899998753211 112345678889999999999988766
Q ss_pred EecCCeeEEEEeeCCCCCHHHHHHHhhccCCCCccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeeCCCCCcEEE
Q 037623 589 CDENTKMGLVYEFMANGNLQAHLLAQLAILPTDAEDKTGILSWKGRLQIATESAQGLEYLHDGCKPPIVHRDVKSANILL 668 (749)
Q Consensus 589 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~gIiHrDLkp~NILl 668 (749)
.. .+++|||++++.+. .++.....+++.|++++|+|||++ +|+||||||+|||+
T Consensus 83 ~~----~~lvme~~~~~~~~-------------------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 83 EG----NAVLMELIDAKELY-------------------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp ET----TEEEEECCCCEEGG-------------------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred cC----CEEEEEeecccccc-------------------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence 32 37999999875432 123334567999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCCccccCCCCceeeeccccCCcccCccccccCCCCCchhHHHHHHHH
Q 037623 669 NEKFQAKLADFGLSRIFPVEGGSHVSTTVVGTPGYLDPEYYISNRLTEKSDVYSFGVVL 727 (749)
Q Consensus 669 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k~DVwSfGvvL 727 (749)
+++ .++|+|||+|.....+...... ......+ .|. ..+.++.++|+||..--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~~~l---~rd~~~~-~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWREIL---ERDVRNI-ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHHHHH---HHHHHHH-HHH-HHHHHCCCCCHHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcHHHH---HHHHHHH-HHH-HcCCCCCcccHHHHHHHH
Confidence 976 5899999999765322111000 0000000 011 135678899999975433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.50 E-value=4.7e-15 Score=155.35 Aligned_cols=106 Identities=26% Similarity=0.430 Sum_probs=92.4
Q ss_pred ccchhHHHHHHHHHhcc---cCCCCC--CCCCCCCCCcceeeecCCCCCCCCceeEEEccCCccee--ecccCccCCCCC
Q 037623 351 HIKISVDAIMNIKSKYE---LLRDWQ--GDPCAPNDYLWQGLNCSYDANQAPRIKSLNLSSSGIAG--EILPHIFSLTSI 423 (749)
Q Consensus 351 ~~~~~~~~l~~~k~~~~---~~~~W~--~dpc~p~~~~w~Gv~C~~~~~~~~~l~~l~Ls~n~l~G--~ip~~~~~l~~L 423 (749)
+.++|++||++||+.+. .+.+|. +|+|. ++|.||+|+.. +...||+.|||++|+++| +||++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~~-~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC---CcCCCeEEeCC-CCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 56789999999999873 567894 46663 46999999753 345689999999999998 688999999999
Q ss_pred CeEECcC-CccccCcchhhhhhhchhccccCCCCcccC
Q 037623 424 ESLDLSN-NSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 424 ~~l~ls~-N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
++|+|++ |+|+|+||+.++++++|+.|++++|++.+.
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~ 116 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred cccccccccccccccccccccccccchhhhcccccccc
Confidence 9999997 999999999999999999999999998775
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.08 E-value=2.5e-11 Score=126.43 Aligned_cols=68 Identities=29% Similarity=0.464 Sum_probs=58.6
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCC-cccC--ccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPN-LCLS--ASC 463 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~-l~~~--~~c 463 (749)
.++.|+.|+|++|+|+|.||+.|++|++|++|+|++|+|+|.||+ ++++++|+.+.+.+|+ +||. |+|
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCCCC
Confidence 357889999999999999999999999999999999999999995 5888899888766665 8986 466
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.22 E-value=7e-07 Score=85.13 Aligned_cols=79 Identities=16% Similarity=0.164 Sum_probs=67.3
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
|.|.-|.|+... +.++.++.|+|++|.|++.+++. ++++++|+.|+|++|++++.+|..+..+..|+.|++++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 469999998532 23457899999999999888666 78999999999999999999899999999999999999
Q ss_pred CCcccC
Q 037623 455 PNLCLS 460 (749)
Q Consensus 455 ~~l~~~ 460 (749)
|++..-
T Consensus 88 N~l~~l 93 (192)
T d1w8aa_ 88 NKIKEI 93 (192)
T ss_dssp CCCCEE
T ss_pred cccccc
Confidence 988754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=2.6e-06 Score=84.92 Aligned_cols=75 Identities=8% Similarity=0.030 Sum_probs=55.9
Q ss_pred cCceEEEEEEECCcccEEEEecCCchhhHHHHHHHHHHHHhcC-CCceeEEEEEEecCCeeEEEEeeCCCCCHHHH
Q 037623 536 GGFGTVYHGYLDDKQVAVKMLSPSSVQGYKQFQAEVELLMRAH-HKNLTILVGYCDENTKMGLVYEFMANGNLQAH 610 (749)
Q Consensus 536 G~fG~Vykg~~~~~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 610 (749)
+..+.||+...+++.+.+|+...........+.+|...+..+. +--+.+++.+...++..++||+++++..+.+.
T Consensus 25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 25 MSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 3447899988788889999887655444456788888887774 32245677788888889999999999877544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.92 E-value=3.4e-06 Score=74.33 Aligned_cols=64 Identities=30% Similarity=0.328 Sum_probs=53.1
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..+++|+.|||++|.|+ .||+.++.+++|+.|+|++|++++ +| .++++++|+.|.+++|.+..-
T Consensus 17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~ 80 (124)
T d1dcea3 17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQS 80 (124)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSS
T ss_pred ccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCC
Confidence 34678899999999997 688788899999999999999985 66 478888999999998888643
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=9.1e-06 Score=74.51 Aligned_cols=84 Identities=19% Similarity=0.252 Sum_probs=66.5
Q ss_pred CCCCCCCCcceeeecCCCC--------CCCCceeEEEccCCc-ceeecccC-ccCCCCCCeEECcCCccccCcchhhhhh
Q 037623 375 DPCAPNDYLWQGLNCSYDA--------NQAPRIKSLNLSSSG-IAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAEL 444 (749)
Q Consensus 375 dpc~p~~~~w~Gv~C~~~~--------~~~~~l~~l~Ls~n~-l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~ 444 (749)
+.|.+. .++++.|+... ..+++|+.|+|++|+ |+ .|++. +.+|++|+.|+|++|+|+.--|..+..+
T Consensus 3 ~~C~c~--~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l 79 (156)
T d2ifga3 3 DACCPH--GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79 (156)
T ss_dssp SSSCCS--SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSC
T ss_pred CCCCcC--CCCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCccccccccc
Confidence 345443 57889997432 245788999998775 66 56655 9999999999999999997557779999
Q ss_pred hchhccccCCCCcccCc
Q 037623 445 QFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 445 ~~l~~l~~~n~~l~~~~ 461 (749)
++|+.|++++|++..-+
T Consensus 80 ~~L~~L~Ls~N~l~~l~ 96 (156)
T d2ifga3 80 PRLSRLNLSFNALESLS 96 (156)
T ss_dssp SCCCEEECCSSCCSCCC
T ss_pred ccccceeccCCCCcccC
Confidence 99999999999997543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.76 E-value=9.7e-06 Score=71.25 Aligned_cols=59 Identities=31% Similarity=0.408 Sum_probs=53.0
Q ss_pred eEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 400 KSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 400 ~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
+.|||++|+++ .+ +.++++++|++|+|++|+++ .||+.++.+++|+.|.+++|.+..-+
T Consensus 1 R~L~Ls~n~l~-~l-~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~ 59 (124)
T d1dcea3 1 RVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD 59 (124)
T ss_dssp SEEECTTSCCS-SC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG
T ss_pred CEEEcCCCCCC-CC-cccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC
Confidence 47999999998 66 46999999999999999998 69999999999999999999987643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=97.72 E-value=9.7e-06 Score=76.88 Aligned_cols=62 Identities=21% Similarity=0.283 Sum_probs=33.7
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
+++|+.|+|++|+|++-.|..+.+|++|+.|+|++|+|++--|..+..+++|+.|.+++|.+
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 45556666666666533222355566666666666666554444455555555555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.54 E-value=4.3e-05 Score=77.57 Aligned_cols=79 Identities=24% Similarity=0.239 Sum_probs=67.0
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeeccc-CccCCCCCCeEECcCCccccCcchhhhhhhchhccccCC
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILP-HIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~-~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
|.|.+|.|+... ..++.|+.|+|++|+++ .||+ ++.++++|+.|++++|.++.-.|..+.++..|+.|.+++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 689999998531 12467999999999998 5766 499999999999999999987788899999999999999
Q ss_pred CCcccCc
Q 037623 455 PNLCLSA 461 (749)
Q Consensus 455 ~~l~~~~ 461 (749)
|++..-+
T Consensus 89 n~l~~l~ 95 (305)
T d1xkua_ 89 NQLKELP 95 (305)
T ss_dssp SCCSBCC
T ss_pred CccCcCc
Confidence 9886543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=3.4e-05 Score=76.90 Aligned_cols=62 Identities=18% Similarity=0.256 Sum_probs=55.1
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
.+++++.|+|++|+|++..|..+..+++|++|+|++|+|+ .||+.+..+++|+.|.+++|.+
T Consensus 146 ~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 4678999999999999765555899999999999999999 8999999999999999888766
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.47 E-value=4.2e-05 Score=69.86 Aligned_cols=62 Identities=21% Similarity=0.135 Sum_probs=52.7
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
.+++|+.|+|++|+|+.--|..+..+++|+.|+|++|+|+ .||..+.....|+.|.+++|.+
T Consensus 54 ~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 54 GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp SCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred cccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCcc
Confidence 4789999999999999544444899999999999999999 7887766666788999988877
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.42 E-value=0.0003 Score=68.92 Aligned_cols=149 Identities=15% Similarity=0.067 Sum_probs=83.3
Q ss_pred ccccCc-eEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCc--eeEEEEEEecCCeeEEEEeeCCCCCHH
Q 037623 533 LGKGGF-GTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKN--LTILVGYCDENTKMGLVYEFMANGNLQ 608 (749)
Q Consensus 533 LG~G~f-G~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~ 608 (749)
+..|.. +.||+...++ ..+.+|....... ..+..|++.++.+.... +.++++++.+.+..++|||+++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 6789988866 4567787654432 34667888887764333 455777778888889999999876542
Q ss_pred H----------HHHHhhccCCCCc-cCCCCCCCHHHHHHH--------------------HHHHHHHHHHHHhC----CC
Q 037623 609 A----------HLLAQLAILPTDA-EDKTGILSWKGRLQI--------------------ATESAQGLEYLHDG----CK 653 (749)
Q Consensus 609 ~----------~L~~~~~~~~~~~-~~~~~~l~~~~~l~i--------------------a~~ia~gL~yLH~~----~~ 653 (749)
+ .+......+.... ......-.+...+.- .......+..+.+. ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 2 1111101111000 000000011111100 00112223333332 12
Q ss_pred CCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 654 PPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 654 ~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3479999999999999887778999998764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=8.2e-05 Score=68.31 Aligned_cols=62 Identities=18% Similarity=0.177 Sum_probs=46.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.||||+|.++ .| +.+..+++|+.|+|++|+++.--|..+..+++|+.|++++|.+..
T Consensus 40 l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~ 101 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101 (162)
T ss_dssp TTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC
T ss_pred cccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccccccceeccccccc
Confidence 567888888888887 56 457788888888888888875333345668888888888887753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.30 E-value=8.6e-05 Score=73.89 Aligned_cols=73 Identities=21% Similarity=0.208 Sum_probs=57.9
Q ss_pred eecCCCC------CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 387 LNCSYDA------NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 387 v~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
|.|+... ..++.++.|+|++|+|++--+..+.++++|++|+|++|+|+ .||. ++.++.|+.|++++|++...
T Consensus 15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~~ 92 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQSL 92 (266)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSSC
T ss_pred EEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccccc
Confidence 6786421 23357999999999999644345999999999999999998 5775 47889999999999988764
Q ss_pred c
Q 037623 461 A 461 (749)
Q Consensus 461 ~ 461 (749)
+
T Consensus 93 ~ 93 (266)
T d1p9ag_ 93 P 93 (266)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.23 E-value=0.00012 Score=73.47 Aligned_cols=64 Identities=22% Similarity=0.135 Sum_probs=54.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLC 458 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~ 458 (749)
.+++|+.|+|++|++++..|..+.++++|++|++++|++++..|..+..+++|+.|.+++|.+.
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 4678899999999999877777889999999999999999888888888889999988888774
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.19 E-value=9.4e-05 Score=67.91 Aligned_cols=62 Identities=24% Similarity=0.314 Sum_probs=53.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+.+++.|||++|+++ .||.-...+++|+.||||+|+++ +|+ .+..+++|+.|.+++|.+..-
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l 78 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRI 78 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCC
Confidence 457999999999998 56544678999999999999998 675 478899999999999998754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.08 E-value=0.00019 Score=72.52 Aligned_cols=64 Identities=25% Similarity=0.307 Sum_probs=47.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.++.++.|++++|.+++-.|..+.++++|++|+|++|+|+ .||+.+.++++|+.|.+++|++..
T Consensus 193 ~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 3456777888888887665555777888888888888887 577777778888888877777653
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.07 E-value=0.00014 Score=75.65 Aligned_cols=61 Identities=25% Similarity=0.263 Sum_probs=38.1
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++++.|+|++|++++- + .+..+++|+.|+|++|++++ +| .++++++|+.|++++|++.+-
T Consensus 306 ~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 306 LKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred hcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 45566667777766653 2 25666667777777776664 44 466666666666666666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.03 E-value=0.00052 Score=72.23 Aligned_cols=74 Identities=19% Similarity=0.226 Sum_probs=46.9
Q ss_pred ccccccCceEEEEEEEC--CcccEEEEecCC-------chhhHHHHHHHHHHHHhcC-C-C-ceeEEEEEEecCCeeEEE
Q 037623 531 RVLGKGGFGTVYHGYLD--DKQVAVKMLSPS-------SVQGYKQFQAEVELLMRAH-H-K-NLTILVGYCDENTKMGLV 598 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~--~~~VAVK~l~~~-------~~~~~~~f~~Ei~iL~~l~-H-~-nIv~l~g~~~~~~~~~LV 598 (749)
+.||.|....||+.... ++.++||.-.+. ......+...|.+.|..+. + | .+.+++++ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 57899999999999764 367888865431 1112234556888887662 2 3 34445544 34456899
Q ss_pred EeeCCCCC
Q 037623 599 YEFMANGN 606 (749)
Q Consensus 599 ~Ey~~~gs 606 (749)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.02 E-value=0.00025 Score=71.00 Aligned_cols=66 Identities=21% Similarity=0.139 Sum_probs=57.8
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
..++|+.|+|++|+|++-.|..+.++++|+.|+|++|++++-.|..+..+++|+.|++++|.+.+.
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~ 216 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccc
Confidence 456899999999999876555588999999999999999998899999999999999999998765
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=96.81 E-value=0.00028 Score=68.05 Aligned_cols=61 Identities=15% Similarity=0.236 Sum_probs=37.7
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.++|+.|++++|.+++. +.++++++|+.|+|++|++++ ||+ ++++++|+.|.+++|++..-
T Consensus 150 ~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC
T ss_pred ccccccccccccccccc--hhhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC
Confidence 34566677776666532 236666777777777776664 443 56666666666666666543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=96.64 E-value=0.0012 Score=63.37 Aligned_cols=57 Identities=23% Similarity=0.334 Sum_probs=48.1
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
..+++|+.|+|++|++++ | +.+++|++|++|+|++|++++ ||+ +.++++|+.|.++|
T Consensus 170 ~~l~~L~~L~Ls~n~l~~-l-~~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISD-I-SPLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEECCSSCCCC-C-GGGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred cccccceecccCCCccCC-C-hhhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 357899999999999985 6 448999999999999999995 664 78888888887653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=96.61 E-value=0.0008 Score=64.06 Aligned_cols=61 Identities=20% Similarity=0.252 Sum_probs=49.9
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|.+++ ++ .+++|++|+.|+|++|++++ || .+..+++|+.|.+.++.+..
T Consensus 66 ~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~ 126 (210)
T d1h6ta2 66 YLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD 126 (210)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC
T ss_pred hCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccccccccc
Confidence 46789999999999986 53 47889999999999999985 66 47888889999888776543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=96.60 E-value=0.0005 Score=65.54 Aligned_cols=55 Identities=29% Similarity=0.385 Sum_probs=42.9
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDG 453 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~ 453 (749)
.+++|+.|++++|++++ ++ .+++|++|+.|+|++|+++ .|| .+..+++|+.|.++
T Consensus 154 ~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEcc
Confidence 36778888899888885 43 3888888999999988887 476 47888888877654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=96.54 E-value=0.00081 Score=69.55 Aligned_cols=58 Identities=19% Similarity=0.327 Sum_probs=51.2
Q ss_pred CCCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCC
Q 037623 394 NQAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNP 455 (749)
Q Consensus 394 ~~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~ 455 (749)
..+++|+.|+|++|+|++ + +.+++|++|++|+|++|++++-+| +.++++|+.|.++||
T Consensus 326 ~~l~~L~~L~L~~n~l~~-l-~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 326 SSLTKLQRLFFANNKVSD-V-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGCTTCCEEECCSSCCCC-C-GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ccCCCCCEEECCCCCCCC-C-hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 357899999999999985 5 479999999999999999998655 889999999999887
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=96.51 E-value=0.00019 Score=68.17 Aligned_cols=62 Identities=19% Similarity=0.220 Sum_probs=52.1
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+++|+.|+|++|+++ .| +.+..|++|+.|+|++|+++ .||.....++.|+.|.+++|++..
T Consensus 46 ~L~~L~~L~Ls~n~I~-~i-~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~ 107 (198)
T d1m9la_ 46 TLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107 (198)
T ss_dssp HTTTCCEEECSEEEES-CC-CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC
T ss_pred cccccceeECcccCCC-Cc-ccccCCccccChhhcccccc-cccccccccccccccccccccccc
Confidence 4678999999999998 67 46889999999999999997 688777777889999888887753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=96.35 E-value=0.0012 Score=62.24 Aligned_cols=58 Identities=24% Similarity=0.355 Sum_probs=29.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l 457 (749)
+++|+.|+|++|++++ +++ +++|++|+.|++++|.+.. +|. +.+++.|+.|.++++..
T Consensus 61 l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~-~~~-l~~l~~L~~L~l~~~~~ 118 (199)
T d2omxa2 61 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGLTLFNNQI 118 (199)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCC
T ss_pred CCCcCcCccccccccC-ccc-ccCCccccccccccccccc-ccc-ccccccccccccccccc
Confidence 4455555555555554 222 5555555555555555542 332 44555555555554444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.21 E-value=0.00052 Score=62.69 Aligned_cols=64 Identities=23% Similarity=0.166 Sum_probs=48.0
Q ss_pred CCceeEEEccCCcceee--cccCccCCCCCCeEECcCCccccCcch-hhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGE--ILPHIFSLTSIESLDLSNNSLTGSVPE-FLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~--ip~~~~~l~~L~~l~ls~N~l~G~iP~-~l~~~~~l~~l~~~n~~l~~~ 460 (749)
++.|+.|+||+|+++.- ++..+..+++|+.|+|++|+++- +++ .......|+.|.+.+|.++..
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcC
Confidence 57899999999999852 32336789999999999999994 554 222334578888888888753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=96.04 E-value=0.0027 Score=59.54 Aligned_cols=61 Identities=23% Similarity=0.289 Sum_probs=48.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
+++++.|+|++|+++ .| +.+..|++|++|+|++|++++- |+ ++++++|+.|.+++|.+..-
T Consensus 39 l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~~ 99 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADI 99 (199)
T ss_dssp HTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC
T ss_pred hcCCCEEECCCCCCC-Cc-cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccccc
Confidence 567889999999887 45 4588889999999999999874 43 78888888888888776543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.57 E-value=0.0024 Score=61.58 Aligned_cols=75 Identities=13% Similarity=0.158 Sum_probs=56.1
Q ss_pred CcceeeecCCCC------CCCCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcch-hhhhhhchhcccc-
Q 037623 382 YLWQGLNCSYDA------NQAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPE-FLAELQFLRVLVD- 452 (749)
Q Consensus 382 ~~w~Gv~C~~~~------~~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~-~l~~~~~l~~l~~- 452 (749)
|....|.|+... ..++.++.|+|++|+++ .||+. +.++++|++|+|++|.+...||. .+..+..+..+..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 567789997432 12347999999999998 57665 89999999999999999988865 4566777776643
Q ss_pred CCCCc
Q 037623 453 GNPNL 457 (749)
Q Consensus 453 ~n~~l 457 (749)
..|++
T Consensus 87 ~~n~l 91 (242)
T d1xwdc1 87 KANNL 91 (242)
T ss_dssp CCTTC
T ss_pred ccccc
Confidence 33444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=95.40 E-value=0.0049 Score=62.32 Aligned_cols=59 Identities=29% Similarity=0.274 Sum_probs=48.1
Q ss_pred CCCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCcccCc
Q 037623 395 QAPRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCLSA 461 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~~ 461 (749)
.+++|+.|+|++|+|+ .||.. +++|+.|+|++|+|+ .||+.+ .+|+.|.+++|.+..-+
T Consensus 282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~---~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSSCC
T ss_pred cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccccc---CCCCEEECcCCcCCCCC
Confidence 3678999999999998 78754 678999999999998 799754 46778888888886543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.23 E-value=0.022 Score=57.53 Aligned_cols=140 Identities=12% Similarity=0.121 Sum_probs=75.7
Q ss_pred eEEEEEEECC-cccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee--EEEE-----EEecCCeeEEEEeeCCCCCHH--
Q 037623 539 GTVYHGYLDD-KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT--ILVG-----YCDENTKMGLVYEFMANGNLQ-- 608 (749)
Q Consensus 539 G~Vykg~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv--~l~g-----~~~~~~~~~LV~Ey~~~gsL~-- 608 (749)
-.||+...++ ..+++|+..... ...+++..|.+.+..+...++. ..+. ....+...+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799998855 679999876542 2346778888888777432221 1111 123356678899998763321
Q ss_pred ------------HHHHHhhccCCCCccCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCC
Q 037623 609 ------------AHLLAQLAILPTDAEDKTGILSWK-------------------GRLQIATESAQGLEYLHD----GCK 653 (749)
Q Consensus 609 ------------~~L~~~~~~~~~~~~~~~~~l~~~-------------------~~l~ia~~ia~gL~yLH~----~~~ 653 (749)
..+|..... ........+++. .+..+...+.+.++.+.. ...
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~---~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRK---QLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTS---SCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CHHHHHHHHHHHHHHHhhccc---CCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 111111100 000011111111 111122222233333322 233
Q ss_pred CCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 654 PPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 654 ~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 478999999999999754 45899998774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=94.91 E-value=0.00095 Score=63.03 Aligned_cols=61 Identities=23% Similarity=0.206 Sum_probs=41.0
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccccCcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+++|+.|+|++|.++ .||+....+++|+.|+|++|+++. |+ .+..+++|+.|++++|.+..
T Consensus 69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred CccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhcc
Confidence 556777777777776 564434455677777777777773 43 46677777777777776643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=94.80 E-value=0.011 Score=59.48 Aligned_cols=35 Identities=31% Similarity=0.427 Sum_probs=18.2
Q ss_pred CCceeEEEccCCcceeecccCccCCCCCCeEECcCCccc
Q 037623 396 APRIKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLT 434 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~ 434 (749)
+++|+.|+|++|+|+ .||..+ .+|+.|++++|+++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc
Confidence 345666666666666 555433 23444444444443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.67 E-value=0.036 Score=57.51 Aligned_cols=71 Identities=15% Similarity=0.222 Sum_probs=47.0
Q ss_pred ccccccCceEEEEEEECC---------cccEEEEecCCchhhHHHHHHHHHHHHhcCCCcee-EEEEEEecCCeeEEEEe
Q 037623 531 RVLGKGGFGTVYHGYLDD---------KQVAVKMLSPSSVQGYKQFQAEVELLMRAHHKNLT-ILVGYCDENTKMGLVYE 600 (749)
Q Consensus 531 ~~LG~G~fG~Vykg~~~~---------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~l~H~nIv-~l~g~~~~~~~~~LV~E 600 (749)
+.|+.|-.-.+|+....+ ..|.+++..... ......+|..+++.+.-.++. ++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 567888889999988643 346666655332 223456788888888544554 66776643 68999
Q ss_pred eCCCCCH
Q 037623 601 FMANGNL 607 (749)
Q Consensus 601 y~~~gsL 607 (749)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.14 E-value=0.099 Score=51.93 Aligned_cols=32 Identities=19% Similarity=0.251 Sum_probs=28.1
Q ss_pred CCCceeeCCCCCcEEEcCCCcEEEEecCCCcc
Q 037623 653 KPPIVHRDVKSANILLNEKFQAKLADFGLSRI 684 (749)
Q Consensus 653 ~~gIiHrDLkp~NILl~~~~~~kL~DFGla~~ 684 (749)
..++||+|+.+.||+++++...-|.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34799999999999999987778999998863
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.79 E-value=0.022 Score=56.33 Aligned_cols=59 Identities=24% Similarity=0.309 Sum_probs=44.7
Q ss_pred CCceeEEEccCC-cceeecccCccCCCCCCeEECcC-CccccCcchhhhhhhchhccccCC
Q 037623 396 APRIKSLNLSSS-GIAGEILPHIFSLTSIESLDLSN-NSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 396 ~~~l~~l~Ls~n-~l~G~ip~~~~~l~~L~~l~ls~-N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
+++|+.|+|+++ .+++..+..++++++|++|+|++ ++++..-...++++++|+.|.+.+
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 467888888875 57777767788888888888888 577777777777788888776654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.48 E-value=0.0092 Score=59.19 Aligned_cols=59 Identities=22% Similarity=0.207 Sum_probs=51.4
Q ss_pred CCceeEEEccCCcceeecccC-ccCCCCCCeEECcCCccccCcchhhhhhhchhccccCC
Q 037623 396 APRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLSNNSLTGSVPEFLAELQFLRVLVDGN 454 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~~~~l~~l~~~n 454 (749)
..+|+.|||+++.+++..... +..+++|++|+|+++++++..+..++++++|+.|.+++
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 458999999999988765444 77899999999999999999999999999999998876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.99 E-value=0.018 Score=55.05 Aligned_cols=66 Identities=17% Similarity=0.207 Sum_probs=55.3
Q ss_pred CCCceeEEEccCCcceeecccC-ccCCCCCCeEECc-CCccccCcchhhhhhhchhccccCCCCcccC
Q 037623 395 QAPRIKSLNLSSSGIAGEILPH-IFSLTSIESLDLS-NNSLTGSVPEFLAELQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 395 ~~~~l~~l~Ls~n~l~G~ip~~-~~~l~~L~~l~ls-~N~l~G~iP~~l~~~~~l~~l~~~n~~l~~~ 460 (749)
.+++|+.|+|++|.+...||+. +..+++|+.|++. .|++....|..+..+++|+.+.+.++.+...
T Consensus 51 ~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 51 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp TCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSC
T ss_pred ccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccc
Confidence 4678999999999999888775 7889999999876 4788877777888999999998888877543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.93 E-value=0.021 Score=59.48 Aligned_cols=64 Identities=17% Similarity=0.095 Sum_probs=49.6
Q ss_pred CCceeEEEccCCcceee----cccCcc-CCCCCCeEECcCCcccc----CcchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGE----ILPHIF-SLTSIESLDLSNNSLTG----SVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~----ip~~~~-~l~~L~~l~ls~N~l~G----~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.++|+.|+|++|.++.. ++..+. ..+.|+.|+|++|+++. .|++.+..++.|+.|.+++|.+..
T Consensus 339 ~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 339 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 35789999999998753 433443 46779999999999985 367777888899999999888753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.83 E-value=0.022 Score=59.33 Aligned_cols=65 Identities=18% Similarity=0.154 Sum_probs=44.5
Q ss_pred CCceeEEEccCCcce----eecccCccCCCCCCeEECcCCccccC----cchhhhh-hhchhccccCCCCcccC
Q 037623 396 APRIKSLNLSSSGIA----GEILPHIFSLTSIESLDLSNNSLTGS----VPEFLAE-LQFLRVLVDGNPNLCLS 460 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~----G~ip~~~~~l~~L~~l~ls~N~l~G~----iP~~l~~-~~~l~~l~~~n~~l~~~ 460 (749)
++++++|+|++|+++ ..|+..+..+++|+.|||++|+++.. +...+.. ..+|+.|.+++|+++..
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~ 99 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGG
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccc
Confidence 567788999999887 24434467888999999999988631 2222221 23688888888887643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=88.30 E-value=0.091 Score=52.88 Aligned_cols=64 Identities=22% Similarity=0.236 Sum_probs=48.6
Q ss_pred CCceeEEEccCCcceee-----cccCccCCCCCCeEECcCCccccC----cchhhhhhhchhccccCCCCccc
Q 037623 396 APRIKSLNLSSSGIAGE-----ILPHIFSLTSIESLDLSNNSLTGS----VPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~-----ip~~~~~l~~L~~l~ls~N~l~G~----iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
.+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..++.|+.|.+++|.+..
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 35789999999988642 334477889999999999998643 45566778888888888887653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.54 E-value=0.1 Score=46.63 Aligned_cols=60 Identities=25% Similarity=0.193 Sum_probs=43.5
Q ss_pred eeEEEccCCcceeecccCccCCCCCCeEECcCCcccc--CcchhhhhhhchhccccCCCCccc
Q 037623 399 IKSLNLSSSGIAGEILPHIFSLTSIESLDLSNNSLTG--SVPEFLAELQFLRVLVDGNPNLCL 459 (749)
Q Consensus 399 l~~l~Ls~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G--~iP~~l~~~~~l~~l~~~n~~l~~ 459 (749)
+..|++.++ +...++....++++|++|+||+|+++. .++..+..+++|+.|++++|.+..
T Consensus 44 ~~~l~~~~~-~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~ 105 (162)
T d1koha1 44 DVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 105 (162)
T ss_dssp CCCTTSHHH-HHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred hhhcchhhh-HhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc
Confidence 334444443 333442224578999999999999986 356778889999999999998865
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=84.09 E-value=0.16 Score=51.05 Aligned_cols=63 Identities=14% Similarity=0.103 Sum_probs=43.7
Q ss_pred CCceeEEEccCCcceee----cccCccCCCCCCeEECcCCccccCcchhhh----h--hhchhccccCCCCcc
Q 037623 396 APRIKSLNLSSSGIAGE----ILPHIFSLTSIESLDLSNNSLTGSVPEFLA----E--LQFLRVLVDGNPNLC 458 (749)
Q Consensus 396 ~~~l~~l~Ls~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G~iP~~l~----~--~~~l~~l~~~n~~l~ 458 (749)
.++|+.|+|++|.++.. |...+..+++|++|+|++|++++.=...++ . ...|+.|.+++|++.
T Consensus 214 ~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 214 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred hhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 56788999999988643 434467888999999999998865333332 2 235677777777654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=81.49 E-value=0.33 Score=43.24 Aligned_cols=61 Identities=18% Similarity=0.151 Sum_probs=27.3
Q ss_pred CceeEEEccCCcceeecccC----ccCCCCCCeEECcCCccccCc----chhhhhhhchhccccCCCCc
Q 037623 397 PRIKSLNLSSSGIAGEILPH----IFSLTSIESLDLSNNSLTGSV----PEFLAELQFLRVLVDGNPNL 457 (749)
Q Consensus 397 ~~l~~l~Ls~n~l~G~ip~~----~~~l~~L~~l~ls~N~l~G~i----P~~l~~~~~l~~l~~~n~~l 457 (749)
+.|+.|+|++|.+.-.-... +...+.|+.|+|++|.++..= =..+...+.|+.|.+.||..
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 34555666665554221111 223455566666666555321 11223334455555555443
|